Psyllid ID: psy2579
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 267 | 2.2.26 [Sep-21-2011] | |||||||
| Q8BHI9 | 436 | Serine/threonine-protein | yes | N/A | 0.764 | 0.467 | 0.404 | 3e-46 | |
| Q8IY84 | 436 | Serine/threonine-protein | yes | N/A | 0.670 | 0.410 | 0.426 | 3e-45 | |
| Q9TW45 | 1192 | Serine/threonine-protein | no | N/A | 0.554 | 0.124 | 0.348 | 4e-27 | |
| A8WYE4 | 1088 | Serine/threonine-protein | N/A | N/A | 0.554 | 0.136 | 0.348 | 4e-27 | |
| Q6NSM8 | 1187 | Serine/threonine-protein | no | N/A | 0.558 | 0.125 | 0.346 | 4e-26 | |
| Q6P4S6 | 1311 | Serine/threonine-protein | no | N/A | 0.569 | 0.115 | 0.321 | 1e-24 | |
| O08678 | 793 | Serine/threonine-protein | no | N/A | 0.565 | 0.190 | 0.323 | 1e-24 | |
| Q8VHJ5 | 795 | Serine/threonine-protein | no | N/A | 0.565 | 0.189 | 0.323 | 1e-24 | |
| Q8CIP4 | 752 | MAP/microtubule affinity- | no | N/A | 0.565 | 0.200 | 0.328 | 1e-24 | |
| Q96L34 | 752 | MAP/microtubule affinity- | no | N/A | 0.565 | 0.200 | 0.328 | 2e-24 |
| >sp|Q8BHI9|NIM1_MOUSE Serine/threonine-protein kinase NIM1 OS=Mus musculus GN=Nim1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 185 bits (470), Expect = 3e-46, Method: Compositional matrix adjust.
Identities = 104/257 (40%), Positives = 141/257 (54%), Gaps = 53/257 (20%)
Query: 7 ANRYYNRHIIERVAIKILDKAKLTPKARKMLIYEKTQNQLQNDKKWQHETSLGKRVALYK 66
+R+ R +E K + R++ +EK + D+K E +LGKR+ Y+
Sbjct: 16 CDRWERRDSVESSCQTEGGKDSEEDQQRQLTPFEKLTQDMCQDEKVVREITLGKRIGFYR 75
Query: 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV 126
++ E+G GNFS VK+ IH + +AIKILDK KL K +++LSREI SME +
Sbjct: 76 IRGEIGSGNFSQVKLGIHSLTK-------EKVAIKILDKTKLDQKTQRLLSREISSMEKL 128
Query: 127 HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLET 186
HHPNI+RLYEV+ET K+ LV+EYA GGEL+ KI+TEG+LSE ++K+ F QI
Sbjct: 129 HHPNIVRLYEVVETLSKLHLVMEYAGGGELFGKISTEGKLSEPESKLIFSQI-------- 180
Query: 187 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENV 246
LSAVKH+H+ IIHRD+KAENV
Sbjct: 181 --------------------------------------LSAVKHMHENQIIHRDLKAENV 202
Query: 247 FLSVRGIVKLGDLGFST 263
F + R VK+GD GFST
Sbjct: 203 FYTSRTCVKVGDFGFST 219
|
Mus musculus (taxid: 10090) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8IY84|NIM1_HUMAN Serine/threonine-protein kinase NIM1 OS=Homo sapiens GN=NIM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (461), Expect = 3e-45, Method: Compositional matrix adjust.
Identities = 99/232 (42%), Positives = 133/232 (57%), Gaps = 53/232 (22%)
Query: 32 KARKMLIYEKTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPIL 91
+ R++ +EK + D+K E +LGKR+ Y+++ E+G GNFS VK+ IH +
Sbjct: 41 QPRQLTPFEKLTQDMSQDEKVVREITLGKRIGFYRIRGEIGSGNFSQVKLGIHSLTK--- 97
Query: 92 CTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYA 151
+AIKILDK KL K +++LSREI SME +HHPNIIRLYEV+ET K+ LV+EYA
Sbjct: 98 ----EKVAIKILDKTKLDQKTQRLLSREISSMEKLHHPNIIRLYEVVETLSKLHLVMEYA 153
Query: 152 SGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGR 211
GGEL+ KI+TEG+LSE ++K+ F Q
Sbjct: 154 GGGELFGKISTEGKLSEPESKLIFSQ---------------------------------- 179
Query: 212 LSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFST 263
I+SAVKH+H+ IIHRD+KAENVF + VK+GD GFST
Sbjct: 180 ------------IVSAVKHMHENQIIHRDLKAENVFYTSNTCVKVGDFGFST 219
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9TW45|PAR1_CAEEL Serine/threonine-protein kinase par-1 OS=Caenorhabditis elegans GN=par-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 121 bits (304), Expect = 4e-27, Method: Composition-based stats.
Identities = 70/201 (34%), Positives = 104/201 (51%), Gaps = 53/201 (26%)
Query: 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIV 121
V YKL +G+GNF+ VK+A H I +AIKI+DK L P + + L RE+
Sbjct: 167 VGKYKLLKTIGKGNFAKVKLAKHVITG-------HEVAIKIIDKTALNPSSLQKLFREVK 219
Query: 122 SMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLY 181
M+ + HPNI++LY+V+ET ++LV+EYASGGE+++ + GR+ E +A+ F Q
Sbjct: 220 IMKQLDHPNIVKLYQVMETEQTLYLVLEYASGGEVFDYLVAHGRMKEKEARAKFRQ---- 275
Query: 182 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
I+SAV++LH ++IIHRD+
Sbjct: 276 ------------------------------------------IVSAVQYLHSKNIIHRDL 293
Query: 242 KAENVFLSVRGIVKLGDLGFS 262
KAEN+ L +K+ D GFS
Sbjct: 294 KAENLLLDQDMNIKIADFGFS 314
|
Required for cytoplasmic partitioning and asymmetric cell division in early embryogenesis. Phosphorylates and restricts the asymmetry effector mex-5 (and possibly also mex-6) to the anterior cytoplasm of the zygote. Critical role in postembryonic vulval morphogenesis. Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A8WYE4|PAR1_CAEBR Serine/threonine-protein kinase par-1 OS=Caenorhabditis briggsae GN=par-1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 121 bits (304), Expect = 4e-27, Method: Composition-based stats.
Identities = 70/201 (34%), Positives = 104/201 (51%), Gaps = 53/201 (26%)
Query: 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIV 121
V YKL +G+GNF+ VK+A H I +AIKI+DK L P + + L RE+
Sbjct: 125 VGKYKLLKTIGKGNFAKVKLAKHVITG-------HEVAIKIIDKTALNPSSLQKLFREVK 177
Query: 122 SMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLY 181
M+ + HPNI++LY+V+ET ++LV+EYASGGE+++ + GR+ E +A+ F Q
Sbjct: 178 IMKQLDHPNIVKLYQVMETEQTLYLVLEYASGGEVFDYLVAHGRMKEKEARAKFRQ---- 233
Query: 182 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
I+SAV++LH ++IIHRD+
Sbjct: 234 ------------------------------------------IVSAVQYLHSKNIIHRDL 251
Query: 242 KAENVFLSVRGIVKLGDLGFS 262
KAEN+ L +K+ D GFS
Sbjct: 252 KAENLLLDQDMNIKIADFGFS 272
|
Required for cytoplasmic partitioning and asymmetric cell division in early embryogenesis. Phosphorylates and restricts the asymmetry effector mex-5 (and possibly also mex-6) to the anterior cytoplasm of the zygote. Critical role in postembryonic vulval morphogenesis. Caenorhabditis briggsae (taxid: 6238) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6NSM8|SIK3_DANRE Serine/threonine-protein kinase SIK3 homolog OS=Danio rerio GN=zgc:66101 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 118 bits (296), Expect = 4e-26, Method: Composition-based stats.
Identities = 70/202 (34%), Positives = 104/202 (51%), Gaps = 53/202 (26%)
Query: 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
RV Y+++ +G+GNF+ VK+A H I + +AIKI+DK +L + K + RE+
Sbjct: 55 RVGYYEMERTIGKGNFAVVKLATHMITK-------AKVAIKIVDKTQLDDENLKKIFREV 107
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
M+ + HP+IIRLY+V+ET I+LV EYASGGE+++ + GR++E DA+ F QI+
Sbjct: 108 QIMKMLRHPHIIRLYQVMETERMIYLVTEYASGGEIFDHLVAHGRMAEKDARRKFKQIV- 166
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
A +YF H R I+HRD
Sbjct: 167 ------------------------------------AAVYF---------CHCRSIVHRD 181
Query: 241 IKAENVFLSVRGIVKLGDLGFS 262
+KAEN+ L +K+ D GFS
Sbjct: 182 LKAENLLLDHNLNIKIADFGFS 203
|
Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P4S6|SIK3_MOUSE Serine/threonine-protein kinase SIK3 OS=Mus musculus GN=Sik3 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 114 bits (284), Expect = 1e-24, Method: Composition-based stats.
Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 53/205 (25%)
Query: 58 LGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLS 117
+ R+ Y++ +G+GNF+ VK A H + + +AIKI+DK++L + K +
Sbjct: 1 MAARIGYYEIDRTIGKGNFAVVKRATHLVTK-------AKVAIKIIDKSQLDEENLKKIF 53
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
RE+ M+ + HP+IIRLY+V+ET I+LV EYASGGE+++ + GR++E +A+ F Q
Sbjct: 54 REVQIMKMLCHPHIIRLYQVMETERMIYLVTEYASGGEIFDHLVAHGRMAEKEARRKFKQ 113
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
I++AV H R+I+
Sbjct: 114 ----------------------------------------------IVTAVYFCHCRNIV 127
Query: 238 HRDIKAENVFLSVRGIVKLGDLGFS 262
HRD+KAEN+ L +K+ D GFS
Sbjct: 128 HRDLKAENLLLDANLNIKIADFGFS 152
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O08678|MARK1_RAT Serine/threonine-protein kinase MARK1 OS=Rattus norvegicus GN=Mark1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 113 bits (283), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 66/204 (32%), Positives = 107/204 (52%), Gaps = 53/204 (25%)
Query: 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIV 121
+ Y+LQ +G+GNF+ VK+A H +L +A+KI+DK +L P + + L RE+
Sbjct: 57 IGNYRLQKTIGKGNFAKVKLARH-----VLTGR--EVAVKIIDKTQLNPTSLQKLFREVR 109
Query: 122 SMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLY 181
M+ ++HPNI++L+EV+ET ++LV+EYASGGE+++ + GR+ E +A+ F Q
Sbjct: 110 IMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ---- 165
Query: 182 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
I+SAV++ H + I+HRD+
Sbjct: 166 ------------------------------------------IVSAVQYCHQKCIVHRDL 183
Query: 242 KAENVFLSVRGIVKLGDLGFSTKL 265
KAEN+ L +K+ D GFS +
Sbjct: 184 KAENLLLDADMNIKIADFGFSNEF 207
|
Serine/threonine-protein kinase involved in cell polarity and microtubule dynamics regulation. Phosphorylates DCX, MAP2, MAP4 and MAPT/TAU. Involved in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q8VHJ5|MARK1_MOUSE Serine/threonine-protein kinase MARK1 OS=Mus musculus GN=Mark1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 113 bits (283), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 66/204 (32%), Positives = 107/204 (52%), Gaps = 53/204 (25%)
Query: 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIV 121
+ Y+LQ +G+GNF+ VK+A H +L +A+KI+DK +L P + + L RE+
Sbjct: 57 IGNYRLQKTIGKGNFAKVKLARH-----VLTGR--EVAVKIIDKTQLNPTSLQKLFREVR 109
Query: 122 SMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLY 181
M+ ++HPNI++L+EV+ET ++LV+EYASGGE+++ + GR+ E +A+ F Q
Sbjct: 110 IMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ---- 165
Query: 182 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
I+SAV++ H + I+HRD+
Sbjct: 166 ------------------------------------------IVSAVQYCHQKCIVHRDL 183
Query: 242 KAENVFLSVRGIVKLGDLGFSTKL 265
KAEN+ L +K+ D GFS +
Sbjct: 184 KAENLLLDADMNIKIADFGFSNEF 207
|
Serine/threonine-protein kinase involved in cell polarity and microtubule dynamics regulation. Phosphorylates DCX, MAP2, MAP4 and MAPT/TAU. Involved in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q8CIP4|MARK4_MOUSE MAP/microtubule affinity-regulating kinase 4 OS=Mus musculus GN=Mark4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 113 bits (282), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 53/204 (25%)
Query: 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIV 121
V Y+L +G+GNF+ VK+A H IL +AIKI+DK +L P + + L RE+
Sbjct: 56 VGNYRLLRTIGKGNFAKVKLARH-----ILTGR--EVAIKIIDKTQLNPSSLQKLFREVR 108
Query: 122 SMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLY 181
M+ ++HPNI++L+EV+ET ++LV+EYAS GE+++ + + GR+ E +A+ F Q
Sbjct: 109 IMKGLNHPNIVKLFEVIETEKTLYLVMEYASAGEVFDYLVSHGRMKEKEARAKFRQ---- 164
Query: 182 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
I+SAV + H ++I+HRD+
Sbjct: 165 ------------------------------------------IVSAVHYCHQKNIVHRDL 182
Query: 242 KAENVFLSVRGIVKLGDLGFSTKL 265
KAEN+ L +K+ D GFS +
Sbjct: 183 KAENLLLDAEANIKIADFGFSNEF 206
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96L34|MARK4_HUMAN MAP/microtubule affinity-regulating kinase 4 OS=Homo sapiens GN=MARK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 113 bits (282), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 53/204 (25%)
Query: 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIV 121
V Y+L +G+GNF+ VK+A H IL +AIKI+DK +L P + + L RE+
Sbjct: 56 VGNYRLLRTIGKGNFAKVKLARH-----ILTGR--EVAIKIIDKTQLNPSSLQKLFREVR 108
Query: 122 SMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLY 181
M+ ++HPNI++L+EV+ET ++LV+EYAS GE+++ + + GR+ E +A+ F Q
Sbjct: 109 IMKGLNHPNIVKLFEVIETEKTLYLVMEYASAGEVFDYLVSHGRMKEKEARAKFRQ---- 164
Query: 182 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
I+SAV + H ++I+HRD+
Sbjct: 165 ------------------------------------------IVSAVHYCHQKNIVHRDL 182
Query: 242 KAENVFLSVRGIVKLGDLGFSTKL 265
KAEN+ L +K+ D GFS +
Sbjct: 183 KAENLLLDAEANIKIADFGFSNEF 206
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 267 | ||||||
| 260832267 | 442 | hypothetical protein BRAFLDRAFT_70429 [B | 0.670 | 0.404 | 0.439 | 2e-45 | |
| 328703020 | 430 | PREDICTED: serine/threonine-protein kina | 0.655 | 0.406 | 0.469 | 7e-45 | |
| 242011103 | 445 | cAMP-dependent protein kinase catalytic | 0.659 | 0.395 | 0.449 | 7e-45 | |
| 328703022 | 412 | PREDICTED: serine/threonine-protein kina | 0.674 | 0.436 | 0.463 | 8e-45 | |
| 301606967 | 436 | PREDICTED: serine/threonine-protein kina | 0.670 | 0.410 | 0.443 | 1e-44 | |
| 26336503 | 350 | unnamed protein product [Mus musculus] | 0.764 | 0.582 | 0.404 | 2e-44 | |
| 115623693 | 437 | PREDICTED: serine/threonine-protein kina | 0.674 | 0.411 | 0.431 | 2e-44 | |
| 148686387 | 437 | RIKEN cDNA E130304F04, isoform CRA_a [Mu | 0.764 | 0.466 | 0.404 | 2e-44 | |
| 30425320 | 436 | serine/threonine-protein kinase NIM1 [Mu | 0.764 | 0.467 | 0.404 | 2e-44 | |
| 431908570 | 436 | Serine/threonine-protein kinase NIM1 [Pt | 0.756 | 0.463 | 0.407 | 3e-44 |
| >gi|260832267|ref|XP_002611079.1| hypothetical protein BRAFLDRAFT_70429 [Branchiostoma floridae] gi|229296449|gb|EEN67089.1| hypothetical protein BRAFLDRAFT_70429 [Branchiostoma floridae] | Back alignment and taxonomy information |
|---|
Score = 188 bits (478), Expect = 2e-45, Method: Compositional matrix adjust.
Identities = 102/232 (43%), Positives = 135/232 (58%), Gaps = 53/232 (22%)
Query: 32 KARKMLIYEKTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPIL 91
K RK+ YE+ L ND+K Q E +LGKR+ Y+L+ E+G GNFS VKM IH +
Sbjct: 46 KERKLSPYERVTYDLSNDEKIQKEVTLGKRIGFYRLRAEIGSGNFSQVKMGIHALTK--- 102
Query: 92 CTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYA 151
+A+KILDK KL K +++LSREI SME + HPN+IRLYEV+ET K+ LV+EYA
Sbjct: 103 ----EKVAVKILDKTKLDQKTQRLLSREISSMEKLRHPNVIRLYEVVETLTKLHLVMEYA 158
Query: 152 SGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGR 211
GGEL+ KI+T+G+L EDDA+ F Q
Sbjct: 159 PGGELFTKISTDGKLVEDDARALFAQ---------------------------------- 184
Query: 212 LSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFST 263
++SAVKH+H++ IIHRD+KAENVF + +VK+GD GFST
Sbjct: 185 ------------VVSAVKHMHEQCIIHRDLKAENVFYATPAMVKIGDFGFST 224
|
Source: Branchiostoma floridae Species: Branchiostoma floridae Genus: Branchiostoma Family: Branchiostomidae Order: Class: Phylum: Chordata Superkingdom: Eukaryota |
| >gi|328703020|ref|XP_001950225.2| PREDICTED: serine/threonine-protein kinase NIM1-like isoform 1 [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 186 bits (473), Expect = 7e-45, Method: Compositional matrix adjust.
Identities = 107/228 (46%), Positives = 138/228 (60%), Gaps = 53/228 (23%)
Query: 35 KMLIYEKTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTY 94
K+ Y K + L ND+KWQ +T++GKR+ LYKL ELG+GNFS VK HE+
Sbjct: 33 KLTAYRKAIDNLDNDRKWQTDTAVGKRIGLYKLSGELGKGNFSQVKTGYHELTK------ 86
Query: 95 ISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGG 154
+AIKILDK KLT KA+KMLSREI MES+HH N+IRL+EV+ET+ K +L++E+A+ G
Sbjct: 87 -ERVAIKILDKTKLTAKAKKMLSREISVMESIHHQNVIRLFEVIETYTKYYLIMEHAAAG 145
Query: 155 ELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214
EL+ ++ +EGR+ E +AK F QI+L
Sbjct: 146 ELFKRLISEGRMHESEAKNIFSQIVL---------------------------------- 171
Query: 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
AVKHLHDR+I+HRDIKAENVFLS RG+ KLGD GFS
Sbjct: 172 ------------AVKHLHDRNIVHRDIKAENVFLSSRGVAKLGDFGFS 207
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242011103|ref|XP_002426295.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] gi|212510363|gb|EEB13557.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 186 bits (473), Expect = 7e-45, Method: Compositional matrix adjust.
Identities = 103/229 (44%), Positives = 133/229 (58%), Gaps = 53/229 (23%)
Query: 39 YEKTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYL 98
YEK + L +D KW E +LG+RV LYK + +LG GNFS VK+A+H++ +
Sbjct: 27 YEKLMHSLHHDPKWLQEVNLGRRVGLYKFRGKLGSGNFSQVKLAVHQLTK-------ERV 79
Query: 99 AIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYN 158
AIKI+DK L K +ML++EI +MES+HHPN+IRLYEV+ET+ K++LV+EYASGGELYN
Sbjct: 80 AIKIVDKGMLDDKMMRMLNQEISTMESIHHPNLIRLYEVVETYSKLYLVMEYASGGELYN 139
Query: 159 KITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218
K+TT G+L E A+ F Q
Sbjct: 140 KVTTLGKLEEMVARNLFAQ----------------------------------------- 158
Query: 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
I SAV H+H+R I+HRDIKAENVF S VKLGD GFST L +
Sbjct: 159 -----ICSAVNHMHERHIVHRDIKAENVFFSNPNRVKLGDFGFSTHLTE 202
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328703022|ref|XP_003242070.1| PREDICTED: serine/threonine-protein kinase NIM1-like isoform 2 [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 186 bits (472), Expect = 8e-45, Method: Compositional matrix adjust.
Identities = 109/235 (46%), Positives = 141/235 (60%), Gaps = 55/235 (23%)
Query: 28 KLTPKARKMLIYEKTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIY 87
K +P K+ Y K + L ND+KWQ +T++GKR+ LYKL ELG+GNFS VK HE+
Sbjct: 10 KASPT--KLTAYRKAIDNLDNDRKWQTDTAVGKRIGLYKLSGELGKGNFSQVKTGYHELT 67
Query: 88 VPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLV 147
+AIKILDK KLT KA+KMLSREI MES+HH N+IRL+EV+ET+ K +L+
Sbjct: 68 K-------ERVAIKILDKTKLTAKAKKMLSREISVMESIHHQNVIRLFEVIETYTKYYLI 120
Query: 148 VEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKIT 207
+E+A+ GEL+ ++ +EGR+ E +AK F QI+L
Sbjct: 121 MEHAAAGELFKRLISEGRMHESEAKNIFSQIVL--------------------------- 153
Query: 208 TEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
AVKHLHDR+I+HRDIKAENVFLS RG+ KLGD GFS
Sbjct: 154 -------------------AVKHLHDRNIVHRDIKAENVFLSSRGVAKLGDFGFS 189
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|301606967|ref|XP_002933080.1| PREDICTED: serine/threonine-protein kinase NIM1-like [Xenopus (Silurana) tropicalis] | Back alignment and taxonomy information |
|---|
Score = 186 bits (471), Expect = 1e-44, Method: Compositional matrix adjust.
Identities = 103/232 (44%), Positives = 134/232 (57%), Gaps = 53/232 (22%)
Query: 32 KARKMLIYEKTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPIL 91
K RK+ +EK + D+K E +LGKR+ LY+++ E+G GNFS VK+ IH +
Sbjct: 41 KQRKLTPFEKLTQDMSRDEKTVKELTLGKRIGLYRMRGEIGSGNFSQVKLGIHVLTK--- 97
Query: 92 CTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYA 151
+AIKILDK KL K +++LSREI SME +HHPN+IRLYEV+ET K+ LV+EYA
Sbjct: 98 ----EKVAIKILDKTKLDQKTQRLLSREISSMEKLHHPNVIRLYEVVETLSKLHLVMEYA 153
Query: 152 SGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGR 211
+GGEL+ KI TEG+LSE ++K+ F QI
Sbjct: 154 AGGELFAKINTEGKLSESESKVIFSQI--------------------------------- 180
Query: 212 LSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFST 263
LSAVKH+HD IIHRD+KAENVF + VK+GD GFST
Sbjct: 181 -------------LSAVKHMHDNQIIHRDLKAENVFYTSNTCVKVGDFGFST 219
|
Source: Xenopus (Silurana) tropicalis Species: Xenopus (Silurana) tropicalis Genus: Xenopus Family: Pipidae Order: Anura Class: Amphibia Phylum: Chordata Superkingdom: Eukaryota |
| >gi|26336503|dbj|BAC31934.1| unnamed protein product [Mus musculus] | Back alignment and taxonomy information |
|---|
Score = 185 bits (470), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 104/257 (40%), Positives = 141/257 (54%), Gaps = 53/257 (20%)
Query: 7 ANRYYNRHIIERVAIKILDKAKLTPKARKMLIYEKTQNQLQNDKKWQHETSLGKRVALYK 66
+R+ R +E K + R++ +EK + D+K E +LGKR+ Y+
Sbjct: 16 CDRWERRDSVESSCQTEGGKDSEEDQQRQLTPFEKLTQDMCQDEKVVREITLGKRIGFYR 75
Query: 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV 126
++ E+G GNFS VK+ IH + +AIKILDK KL K +++LSREI SME +
Sbjct: 76 IRGEIGSGNFSQVKLGIHSLTK-------EKVAIKILDKTKLDQKTQRLLSREISSMEKL 128
Query: 127 HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLET 186
HHPNI+RLYEV+ET K+ LV+EYA GGEL+ KI+TEG+LSE ++K+ F QI
Sbjct: 129 HHPNIVRLYEVVETLSKLHLVMEYAGGGELFGKISTEGKLSEPESKLIFSQI-------- 180
Query: 187 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENV 246
LSAVKH+H+ IIHRD+KAENV
Sbjct: 181 --------------------------------------LSAVKHMHENQIIHRDLKAENV 202
Query: 247 FLSVRGIVKLGDLGFST 263
F + R VK+GD GFST
Sbjct: 203 FYTSRTCVKVGDFGFST 219
|
Source: Mus musculus Species: Mus musculus Genus: Mus Family: Muridae Order: Rodentia Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
| >gi|115623693|ref|XP_783422.2| PREDICTED: serine/threonine-protein kinase NIM1-like [Strongylocentrotus purpuratus] gi|390347303|ref|XP_003726741.1| PREDICTED: serine/threonine-protein kinase NIM1-like [Strongylocentrotus purpuratus] | Back alignment and taxonomy information |
|---|
Score = 185 bits (470), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 101/234 (43%), Positives = 133/234 (56%), Gaps = 54/234 (23%)
Query: 30 TPKARKMLIYEKTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVP 89
TP R++ YEK ++ ND + E +LGKR+A YK++NELG GNFS VKM +H +
Sbjct: 40 TP-VRRLTAYEKYMEEMNNDPRALKEVTLGKRIAFYKIRNELGSGNFSQVKMGLHALTK- 97
Query: 90 ILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVE 149
+AIKILDK KL K +++LSREI ME +HHPNIIRLYEV+ET K+ LV+E
Sbjct: 98 ------EKVAIKILDKTKLDQKTQRLLSREISCMERLHHPNIIRLYEVVETLAKLHLVME 151
Query: 150 YASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTE 209
YA GGEL+ KI+ EG+++E + K F Q
Sbjct: 152 YAPGGELFTKISNEGKIAEAECKPIFAQ-------------------------------- 179
Query: 210 GRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFST 263
+ SAV H+H ++IIHRD+KAENVF + G VK+GD GFST
Sbjct: 180 --------------VTSAVYHMHSKNIIHRDLKAENVFYAANGYVKVGDFGFST 219
|
Source: Strongylocentrotus purpuratus Species: Strongylocentrotus purpuratus Genus: Strongylocentrotus Family: Strongylocentrotidae Order: Echinoida Class: Echinoidea Phylum: Echinodermata Superkingdom: Eukaryota |
| >gi|148686387|gb|EDL18334.1| RIKEN cDNA E130304F04, isoform CRA_a [Mus musculus] | Back alignment and taxonomy information |
|---|
Score = 185 bits (470), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 104/257 (40%), Positives = 141/257 (54%), Gaps = 53/257 (20%)
Query: 7 ANRYYNRHIIERVAIKILDKAKLTPKARKMLIYEKTQNQLQNDKKWQHETSLGKRVALYK 66
+R+ R +E K + R++ +EK + D+K E +LGKR+ Y+
Sbjct: 17 CDRWERRDSVESSCQTEGGKDSEEDQQRQLTPFEKLTQDMCQDEKVVREITLGKRIGFYR 76
Query: 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV 126
++ E+G GNFS VK+ IH + +AIKILDK KL K +++LSREI SME +
Sbjct: 77 IRGEIGSGNFSQVKLGIHSLTK-------EKVAIKILDKTKLDQKTQRLLSREISSMEKL 129
Query: 127 HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLET 186
HHPNI+RLYEV+ET K+ LV+EYA GGEL+ KI+TEG+LSE ++K+ F QI
Sbjct: 130 HHPNIVRLYEVVETLSKLHLVMEYAGGGELFGKISTEGKLSEPESKLIFSQI-------- 181
Query: 187 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENV 246
LSAVKH+H+ IIHRD+KAENV
Sbjct: 182 --------------------------------------LSAVKHMHENQIIHRDLKAENV 203
Query: 247 FLSVRGIVKLGDLGFST 263
F + R VK+GD GFST
Sbjct: 204 FYTSRTCVKVGDFGFST 220
|
Source: Mus musculus Species: Mus musculus Genus: Mus Family: Muridae Order: Rodentia Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
| >gi|30425320|ref|NP_780747.1| serine/threonine-protein kinase NIM1 [Mus musculus] gi|81913150|sp|Q8BHI9.1|NIM1_MOUSE RecName: Full=Serine/threonine-protein kinase NIM1 gi|26339506|dbj|BAC33424.1| unnamed protein product [Mus musculus] gi|26343681|dbj|BAC35497.1| unnamed protein product [Mus musculus] gi|77415368|gb|AAI06123.1| RIKEN cDNA E130304F04 gene [Mus musculus] gi|109730827|gb|AAI17956.1| RIKEN cDNA E130304F04 gene [Mus musculus] gi|109734776|gb|AAI17957.1| RIKEN cDNA E130304F04 gene [Mus musculus] gi|114205451|gb|AAH51189.2| RIKEN cDNA E130304F04 gene [Mus musculus] | Back alignment and taxonomy information |
|---|
Score = 185 bits (470), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 104/257 (40%), Positives = 141/257 (54%), Gaps = 53/257 (20%)
Query: 7 ANRYYNRHIIERVAIKILDKAKLTPKARKMLIYEKTQNQLQNDKKWQHETSLGKRVALYK 66
+R+ R +E K + R++ +EK + D+K E +LGKR+ Y+
Sbjct: 16 CDRWERRDSVESSCQTEGGKDSEEDQQRQLTPFEKLTQDMCQDEKVVREITLGKRIGFYR 75
Query: 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV 126
++ E+G GNFS VK+ IH + +AIKILDK KL K +++LSREI SME +
Sbjct: 76 IRGEIGSGNFSQVKLGIHSLTK-------EKVAIKILDKTKLDQKTQRLLSREISSMEKL 128
Query: 127 HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLET 186
HHPNI+RLYEV+ET K+ LV+EYA GGEL+ KI+TEG+LSE ++K+ F QI
Sbjct: 129 HHPNIVRLYEVVETLSKLHLVMEYAGGGELFGKISTEGKLSEPESKLIFSQI-------- 180
Query: 187 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENV 246
LSAVKH+H+ IIHRD+KAENV
Sbjct: 181 --------------------------------------LSAVKHMHENQIIHRDLKAENV 202
Query: 247 FLSVRGIVKLGDLGFST 263
F + R VK+GD GFST
Sbjct: 203 FYTSRTCVKVGDFGFST 219
|
Source: Mus musculus Species: Mus musculus Genus: Mus Family: Muridae Order: Rodentia Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
| >gi|431908570|gb|ELK12163.1| Serine/threonine-protein kinase NIM1 [Pteropus alecto] | Back alignment and taxonomy information |
|---|
Score = 184 bits (467), Expect = 3e-44, Method: Compositional matrix adjust.
Identities = 104/255 (40%), Positives = 141/255 (55%), Gaps = 53/255 (20%)
Query: 9 RYYNRHIIERVAIKILDKAKLTPKARKMLIYEKTQNQLQNDKKWQHETSLGKRVALYKLQ 68
R+ R +E K + +AR++ +EK + D+K E +LGKR+ Y+++
Sbjct: 18 RWGWRDSVESGCQTECSKEEEEGQARQLTPFEKLTQDMSQDEKVVREITLGKRIGFYRIR 77
Query: 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHH 128
E+G GNFS VK+ IH + +AIKILDK KL K +++LSREI SME +HH
Sbjct: 78 GEIGSGNFSQVKLGIHSLTK-------EKVAIKILDKTKLDQKTQRLLSREISSMEKLHH 130
Query: 129 PNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFG 188
PNIIRLYEV+ET K+ LV+EYA GGEL+ KI+TEG+LSE ++K+ F Q
Sbjct: 131 PNIIRLYEVVETLSKLHLVMEYAGGGELFGKISTEGKLSEPESKLIFSQ----------- 179
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
I+SAVKH+H+ IIHRD+KAENVF
Sbjct: 180 -----------------------------------IVSAVKHMHENQIIHRDLKAENVFY 204
Query: 249 SVRGIVKLGDLGFST 263
+ VK+GD GFST
Sbjct: 205 TSNTCVKVGDFGFST 219
|
Source: Pteropus alecto Species: Pteropus alecto Genus: Pteropus Family: Pteropodidae Order: Chiroptera Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 267 | ||||||
| UNIPROTKB|Q8IY84 | 436 | NIM1 "Serine/threonine-protein | 0.520 | 0.318 | 0.506 | 3.6e-34 | |
| MGI|MGI:2442399 | 436 | Nim1 "serine/threonine-protein | 0.520 | 0.318 | 0.506 | 4.6e-34 | |
| UNIPROTKB|E2RHT3 | 436 | NIM1 "Uncharacterized protein" | 0.520 | 0.318 | 0.506 | 4.6e-34 | |
| UNIPROTKB|F1SMG7 | 436 | LOC100524404 "Uncharacterized | 0.614 | 0.376 | 0.450 | 4.6e-34 | |
| UNIPROTKB|D4A9H8 | 436 | RGD1308116 "Protein RGD1308116 | 0.520 | 0.318 | 0.5 | 9.5e-34 | |
| UNIPROTKB|E1C6B4 | 436 | NIM1 "Uncharacterized protein" | 0.528 | 0.323 | 0.5 | 2.5e-33 | |
| UNIPROTKB|E1BN72 | 436 | NIM1 "Uncharacterized protein" | 0.520 | 0.318 | 0.493 | 4.1e-33 | |
| WB|WBGene00009867 | 503 | F49C5.4 [Caenorhabditis elegan | 0.501 | 0.266 | 0.482 | 6.5e-31 | |
| UNIPROTKB|J3KNR0 | 776 | MARK3 "MAP/microtubule affinit | 0.397 | 0.136 | 0.415 | 5.4e-27 | |
| ZFIN|ZDB-GENE-091204-283 | 433 | si:ch211-22d5.2 "si:ch211-22d5 | 0.524 | 0.323 | 0.387 | 4e-26 |
| UNIPROTKB|Q8IY84 NIM1 "Serine/threonine-protein kinase NIM1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 371 (135.7 bits), Expect = 3.6e-34, P = 3.6e-34
Identities = 74/146 (50%), Positives = 102/146 (69%)
Query: 34 RKMLIYEKTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCT 93
R++ +EK + D+K E +LGKR+ Y+++ E+G GNFS VK+ IH +
Sbjct: 43 RQLTPFEKLTQDMSQDEKVVREITLGKRIGFYRIRGEIGSGNFSQVKLGIHSLTK----- 97
Query: 94 YISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASG 153
+AIKILDK KL K +++LSREI SME +HHPNIIRLYEV+ET K+ LV+EYA G
Sbjct: 98 --EKVAIKILDKTKLDQKTQRLLSREISSMEKLHHPNIIRLYEVVETLSKLHLVMEYAGG 155
Query: 154 GELYNKITTEGRLSEDDAKIYFLQIL 179
GEL+ KI+TEG+LSE ++K+ F QI+
Sbjct: 156 GELFGKISTEGKLSEPESKLIFSQIV 181
|
|
| MGI|MGI:2442399 Nim1 "serine/threonine-protein kinase NIM1" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 370 (135.3 bits), Expect = 4.6e-34, P = 4.6e-34
Identities = 74/146 (50%), Positives = 102/146 (69%)
Query: 34 RKMLIYEKTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCT 93
R++ +EK + D+K E +LGKR+ Y+++ E+G GNFS VK+ IH +
Sbjct: 43 RQLTPFEKLTQDMCQDEKVVREITLGKRIGFYRIRGEIGSGNFSQVKLGIHSLTK----- 97
Query: 94 YISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASG 153
+AIKILDK KL K +++LSREI SME +HHPNI+RLYEV+ET K+ LV+EYA G
Sbjct: 98 --EKVAIKILDKTKLDQKTQRLLSREISSMEKLHHPNIVRLYEVVETLSKLHLVMEYAGG 155
Query: 154 GELYNKITTEGRLSEDDAKIYFLQIL 179
GEL+ KI+TEG+LSE ++K+ F QIL
Sbjct: 156 GELFGKISTEGKLSEPESKLIFSQIL 181
|
|
| UNIPROTKB|E2RHT3 NIM1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 370 (135.3 bits), Expect = 4.6e-34, P = 4.6e-34
Identities = 74/146 (50%), Positives = 102/146 (69%)
Query: 34 RKMLIYEKTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCT 93
R++ +EK + D+K E +LGKR+ Y+++ E+G GNFS VK+ IH +
Sbjct: 43 RQLTPFEKLTQDMAQDEKVVREITLGKRIGFYRIRGEIGSGNFSQVKLGIHSLTK----- 97
Query: 94 YISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASG 153
+AIKILDK KL K +++LSREI SME +HHPNIIRLYEV+ET K+ LV+EYA G
Sbjct: 98 --EKVAIKILDKTKLDQKTQRLLSREISSMEKLHHPNIIRLYEVVETLSKLHLVMEYAGG 155
Query: 154 GELYNKITTEGRLSEDDAKIYFLQIL 179
GEL+ KI+TEG+LSE ++K+ F QI+
Sbjct: 156 GELFGKISTEGKLSEPESKLIFSQIV 181
|
|
| UNIPROTKB|F1SMG7 LOC100524404 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 370 (135.3 bits), Expect = 4.6e-34, P = 4.6e-34
Identities = 77/171 (45%), Positives = 109/171 (63%)
Query: 9 RYYNRHIIERVAIKILDKAKLTPKARKMLIYEKTQNQLQNDKKWQHETSLGKRVALYKLQ 68
R+ R +E +K + R++ +EK + D+K E +LGKR+ Y+++
Sbjct: 18 RWDRRESVESGCQTECNKEDEEGQPRQLTPFEKLMQDMSQDEKVVREITLGKRIGFYRIR 77
Query: 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHH 128
E+G GNFS VK+ IH + +AIKILDK KL K +++LSREI SME +HH
Sbjct: 78 GEIGSGNFSQVKLGIHSLTK-------EKVAIKILDKTKLDQKTQRLLSREISSMEKLHH 130
Query: 129 PNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 179
PNIIRLYEV+ET K+ LV+EYA GGEL+ KI+TEG+ SE ++K+ F QI+
Sbjct: 131 PNIIRLYEVVETLSKLHLVMEYAGGGELFGKISTEGKFSESESKLIFSQIV 181
|
|
| UNIPROTKB|D4A9H8 RGD1308116 "Protein RGD1308116" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 367 (134.2 bits), Expect = 9.5e-34, P = 9.5e-34
Identities = 73/146 (50%), Positives = 102/146 (69%)
Query: 34 RKMLIYEKTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCT 93
R++ +EK + D+K E +LGKR+ Y+++ E+G GNFS VK+ IH +
Sbjct: 43 RQLTPFEKLTQDMCQDEKVVREITLGKRIGFYRIRGEIGSGNFSQVKLGIHSLTK----- 97
Query: 94 YISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASG 153
+AIKILDK KL K +++LSREI SME +HHPNI+RLYEV+ET K+ LV+EYA G
Sbjct: 98 --EKVAIKILDKTKLDQKTQRLLSREISSMEKLHHPNIVRLYEVVETLSKLHLVMEYAGG 155
Query: 154 GELYNKITTEGRLSEDDAKIYFLQIL 179
GEL+ KI+TEG+LSE ++K+ F QI+
Sbjct: 156 GELFGKISTEGKLSEPESKLIFSQIV 181
|
|
| UNIPROTKB|E1C6B4 NIM1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 363 (132.8 bits), Expect = 2.5e-33, P = 2.5e-33
Identities = 74/148 (50%), Positives = 101/148 (68%)
Query: 32 KARKMLIYEKTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPIL 91
+ +++ EK + +++K E +LGKR+ Y+++ E+G GNFS VK+ IH +
Sbjct: 41 RQQRLTPLEKLMQDMSHNEKVVKELTLGKRIGFYRVRGEIGSGNFSQVKLGIHSLTK--- 97
Query: 92 CTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYA 151
+AIKILDK KL K +++LSREI SME +HHPNIIRLYEV+ET K+ LV+EYA
Sbjct: 98 ----EKVAIKILDKTKLDQKTQRLLSREISSMEKLHHPNIIRLYEVVETLSKLHLVMEYA 153
Query: 152 SGGELYNKITTEGRLSEDDAKIYFLQIL 179
GGEL+ KITTEG+L E D KI F QI+
Sbjct: 154 GGGELFTKITTEGKLIETDCKIIFSQIV 181
|
|
| UNIPROTKB|E1BN72 NIM1 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 361 (132.1 bits), Expect = 4.1e-33, P = 4.1e-33
Identities = 72/146 (49%), Positives = 100/146 (68%)
Query: 34 RKMLIYEKTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCT 93
R++ +EK + D+K E +LGKR+ Y+++ E+G GNFS VK+ IH +
Sbjct: 43 RQLTPFEKLTQDMSQDEKVVREITLGKRIGFYRIRGEIGSGNFSQVKLGIHSLTK----- 97
Query: 94 YISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASG 153
+AIKILDK KL K +++LSREI SME +HHPNIIRLYEV+ET K+ LV+EYA G
Sbjct: 98 --EKVAIKILDKTKLDQKTQRLLSREISSMEKLHHPNIIRLYEVVETLSKLHLVMEYAGG 155
Query: 154 GELYNKITTEGRLSEDDAKIYFLQIL 179
GEL+ KI+ EG+ SE ++K+ F QI+
Sbjct: 156 GELFGKISMEGKFSEPESKLIFSQIV 181
|
|
| WB|WBGene00009867 F49C5.4 [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
Score = 341 (125.1 bits), Expect = 6.5e-31, P = 6.5e-31
Identities = 68/141 (48%), Positives = 97/141 (68%)
Query: 39 YEKTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYL 98
YE+ QL ND E +LG+R+ Y+L ELG GNFS VK+ +H++ +
Sbjct: 111 YERAILQLNNDPVVHKEVALGRRIGFYRLGKELGAGNFSKVKLGVHQLTK-------EKV 163
Query: 99 AIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYN 158
A+KI+DKAK+ KA+K+LSREI +ME ++HPNI++L+EV+ET ++ LV+EYASGGELY
Sbjct: 164 AVKIMDKAKMDAKAQKLLSREIQAMEEMNHPNIVKLFEVVETLTRVHLVIEYASGGELYT 223
Query: 159 KITTEGRLSEDDAKIYFLQIL 179
+ G+L+E DAK F QI+
Sbjct: 224 YVHERGKLTEGDAKPLFAQIV 244
|
|
| UNIPROTKB|J3KNR0 MARK3 "MAP/microtubule affinity-regulating kinase 3" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 226 (84.6 bits), Expect = 5.4e-27, Sum P(2) = 5.4e-27
Identities = 47/113 (41%), Positives = 76/113 (67%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y+L +G+GNF+ VK+A H IL +AIKI+DK +L P + + L RE+ M+
Sbjct: 56 YRLLKTIGKGNFAKVKLARH-----ILTG--REVAIKIIDKTQLNPTSLQKLFREVRIMK 108
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
++HPNI++L+EV+ET ++L++EYASGGE+++ + GR+ E +A+ F Q
Sbjct: 109 ILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ 161
|
|
| ZFIN|ZDB-GENE-091204-283 si:ch211-22d5.2 "si:ch211-22d5.2" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 295 (108.9 bits), Expect = 4.0e-26, P = 4.0e-26
Identities = 57/147 (38%), Positives = 103/147 (70%)
Query: 33 ARKMLIYEKTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILC 92
++++ EK ++ D+ E ++GKRV YK++ ++G GNFS VK+A H +
Sbjct: 37 SKRLTPLEKLTLEMCKDENTVKELTVGKRVGFYKVRGQIGCGNFSKVKLATHALTK---- 92
Query: 93 TYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYAS 152
+A+KI+DK +L + ++ML+REI +MES++HPN+++L+EVLET +++L++E+A
Sbjct: 93 ---DKVAVKIMDKMRLDVQTQRMLTREISNMESLYHPNLLQLFEVLETPSRLYLILEFAG 149
Query: 153 GGELYNKITTEGRLSEDDAKIYFLQIL 179
GG+L+ +I++ G+L++ ++KI F QIL
Sbjct: 150 GGDLHTRISSGGKLTDLESKIVFAQIL 176
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 267 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-38 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-35 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-31 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-23 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-21 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-20 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-20 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-20 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-18 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-18 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-18 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-17 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-16 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-16 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-14 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-14 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-14 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-12 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-11 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-10 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-09 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-08 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-07 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-06 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-05 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-05 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-05 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-04 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-04 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-04 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-04 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-04 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.001 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.001 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.002 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 0.003 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 0.003 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 1e-42
Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 62/206 (30%)
Query: 65 YKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
Y++ +LG G+F V +A ++ AIK++ K K+ K R+ + REI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLV-----------AIKVIKKKKIK-KDRERILREI 48
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
++ + HPNI+RLY+V E K++LV+EY GG+L++ + GRLSED+A+ Y QIL
Sbjct: 49 KILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQIL- 107
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
SA+++LH + I+HRD
Sbjct: 108 ---------------------------------------------SALEYLHSKGIVHRD 122
Query: 241 IKAENVFLSVRGIVKLGDLGFSTKLQ 266
+K EN+ L G VKL D G + +L
Sbjct: 123 LKPENILLDEDGHVKLADFGLARQLD 148
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 9e-38
Identities = 63/201 (31%), Positives = 90/201 (44%), Gaps = 53/201 (26%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y+L +LG G+F TV A H+ T A+KIL K K + REI +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKG------TGKIV-AVKILKKRSEKSKKDQTARREIRILR 53
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ HPNI+RL + E ++LV+EY GG+L++ ++ G LSED+AK LQIL
Sbjct: 54 RLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQIL----- 108
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+++LH IIHRD+K E
Sbjct: 109 -----------------------------------------RGLEYLHSNGIIHRDLKPE 127
Query: 245 NVFLSVRGIVKLGDLGFSTKL 265
N+ L G+VK+ D G + KL
Sbjct: 128 NILLDENGVVKIADFGLAKKL 148
|
Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 2e-35
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 57/207 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
Y++ ++G+G+F V + ++YV +K +D + ++ K R+ E+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYV-----------LKEIDLSNMSEKEREDALNEV 50
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
++ ++HPNII+ YE E GK+ +V+EYA GG+L KI
Sbjct: 51 KILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIK------------------- 91
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
+ G+ E+ +F+Q+ A+K+LH R I+HRD
Sbjct: 92 --------------KQKKEGKP---------FPEEQILDWFVQLCLALKYLHSRKILHRD 128
Query: 241 IKAENVFLSVRGIVKLGDLGFSTKLQQ 267
IK +N+FL+ G+VKLGD G S L
Sbjct: 129 IKPQNIFLTSNGLVKLGDFGISKVLSS 155
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-31
Identities = 61/198 (30%), Positives = 86/198 (43%), Gaps = 54/198 (27%)
Query: 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPN 130
LG G F TV +A + +AIKI+ K + + + L REI ++ ++HPN
Sbjct: 1 LGEGGFGTVYLARDKKTGK-------KVAIKIIKK-EDSSSLLEELLREIEILKKLNHPN 52
Query: 131 IIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKI 190
I++LY V E ++LV+EY GG L + +
Sbjct: 53 IVKLYGVFEDENHLYLVMEYCEGGSLKDLLKEN--------------------------- 85
Query: 191 FLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL-S 249
EG+LSED+ LQIL +++LH IIHRD+K EN+ L S
Sbjct: 86 ------------------EGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDS 127
Query: 250 VRGIVKLGDLGFSTKLQQ 267
G VKL D G S L
Sbjct: 128 DNGKVKLADFGLSKLLTS 145
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-26
Identities = 53/197 (26%), Positives = 81/197 (41%), Gaps = 51/197 (25%)
Query: 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPN 130
LGRG+F +V Y+ + +A+K ++ + + + + L REI + S+ HPN
Sbjct: 8 LGRGSFGSV-------YLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 131 IIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKI 190
I+R + E N I
Sbjct: 61 IVR-----------YYGSERDEEKNTLN-------------------------------I 78
Query: 191 FLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSV 250
FL EY SGG L + + G+L E + Y QIL + +LH I+HRDIK N+ +
Sbjct: 79 FL--EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDS 136
Query: 251 RGIVKLGDLGFSTKLQQ 267
G+VKL D G + +L
Sbjct: 137 DGVVKLADFGCAKRLGD 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 62/200 (31%), Positives = 90/200 (45%), Gaps = 59/200 (29%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKM----LSREI 120
+K +G G+FSTV +A E T Y AIKILDK +L K +K+ + +E+
Sbjct: 3 FKFGKIIGEGSFSTVVLAK-EK-----ETNKEY-AIKILDKRQLI-KEKKVKYVKIEKEV 54
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
++ + HP II+LY TF +D+ +YF
Sbjct: 55 LTRLN-GHPGIIKLYY---TF--------------------------QDEENLYF----- 79
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
V+EYA GEL I G L E + Y +IL A+++LH + IIHRD
Sbjct: 80 ------------VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRD 127
Query: 241 IKAENVFLSVRGIVKLGDLG 260
+K EN+ L +K+ D G
Sbjct: 128 LKPENILLDKDMHIKITDFG 147
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 3e-23
Identities = 55/202 (27%), Positives = 85/202 (42%), Gaps = 53/202 (26%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y+L + +GRG F V ++ ++AIK + K+ +A K + +EI ++
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNL-------ETGDFVAIKQISLEKIKEEALKSIMQEIDLLK 54
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
++ HPNI++ +ET LY
Sbjct: 55 NLKHPNIVKYIGSIET------------SDSLY--------------------------- 75
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
I L EYA G L I G E +Y Q+L + +LH++ +IHRDIKA
Sbjct: 76 -----IIL--EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAA 128
Query: 245 NVFLSVRGIVKLGDLGFSTKLQ 266
N+ + G+VKL D G +TKL
Sbjct: 129 NILTTKDGVVKLADFGVATKLN 150
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 3e-23
Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 62/200 (31%)
Query: 71 LGRGNFSTVKMAIHE----IYVPILCTYISYLAIKILDKAK-LTPKARKMLSREIVSMES 125
LG+G+F V + + +Y A+K+L K K + K + E +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLY-----------AMKVLKKKKIIKRKEVEHTLTERNILSR 49
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
++HP I++L+ YA TE +L
Sbjct: 50 INHPFIVKLH--------------YA--------FQTEEKL------------------- 68
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
+LV+EYA GGEL++ ++ EGR SE+ A+ Y +I+ A+++LH II+RD+K EN
Sbjct: 69 -----YLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPEN 123
Query: 246 VFLSVRGIVKLGDLGFSTKL 265
+ L G +KL D G + +L
Sbjct: 124 ILLDADGHIKLTDFGLAKEL 143
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 3e-21
Identities = 43/197 (21%), Positives = 72/197 (36%), Gaps = 49/197 (24%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
L +LG G F V +A+K L K + + + RE M
Sbjct: 2 TLGKKLGEGAFGEVYKGK---LKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRK 57
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+ HPN+++L V +++V+EY GG+L + +L+
Sbjct: 58 LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLS----------------YLR-------- 93
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
+LS D + LQI +++L ++ IHRD+ A N
Sbjct: 94 ---------------------KNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARN 132
Query: 246 VFLSVRGIVKLGDLGFS 262
+ +VK+ D G S
Sbjct: 133 CLVGENLVVKISDFGLS 149
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 8e-21
Identities = 52/197 (26%), Positives = 81/197 (41%), Gaps = 54/197 (27%)
Query: 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHP 129
LG G F V++ + ++ A+K + K + ++ + E +E +HP
Sbjct: 1 LGVGGFGRVELVKVKS------KNRTF-ALKCVKKRHIVETGQQEHIFSEKEILEECNHP 53
Query: 130 NIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGK 189
I++LY TF +D IY L
Sbjct: 54 FIVKLYR---TF--------------------------KDKKYIYMLM------------ 72
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS 249
EY GGEL+ + G E A+ Y ++ A ++LH+R II+RD+K EN+ L
Sbjct: 73 -----EYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD 127
Query: 250 VRGIVKLGDLGFSTKLQ 266
G VKL D GF+ KL+
Sbjct: 128 SNGYVKLVDFGFAKKLK 144
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 1e-20
Identities = 51/166 (30%), Positives = 83/166 (50%), Gaps = 44/166 (26%)
Query: 100 IKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNK 159
IK ++ +K++PK R+ +E+ + ++ HPNI++ E E G +++V++Y GG+LY K
Sbjct: 30 IKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKK 89
Query: 160 ITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219
I + G +F ED
Sbjct: 90 INAQR-----------------------GVLF---------------------PEDQILD 105
Query: 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
+F+QI A+KH+HDR I+HRDIK++N+FL+ G +KLGD G + L
Sbjct: 106 WFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 1e-20
Identities = 44/196 (22%), Positives = 72/196 (36%), Gaps = 46/196 (23%)
Query: 69 NELGRGNFSTVK--MAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV 126
+LG G F V + A+K L K + + RK +E M+ +
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEV------AVKTL-KEDASEEERKDFLKEARVMKKL 53
Query: 127 HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLET 186
HPN++RL V ++LV+EY GG+L D +L+
Sbjct: 54 GHPNVVRLLGVCTEEEPLYLVLEYMEGGDL------------LD----YLRKS------- 90
Query: 187 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENV 246
+ LS D + +QI +++L + +HRD+ A N
Sbjct: 91 --------------RPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNC 136
Query: 247 FLSVRGIVKLGDLGFS 262
+ +VK+ D G S
Sbjct: 137 LVGEDLVVKISDFGLS 152
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 2e-20
Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 54/197 (27%)
Query: 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHP 129
LG G+F V + H+ Y A+KIL KAK+ K + + E ++S+ HP
Sbjct: 9 LGTGSFGRVMLVRHK-------GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHP 61
Query: 130 NIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGK 189
++ LY +F +DD+ +Y
Sbjct: 62 FLVNLYG---SF--------------------------QDDSNLY--------------- 77
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS 249
LV+EY GGEL++ + GR E A+ Y Q++ A+++LH DI++RD+K EN+ L
Sbjct: 78 --LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD 135
Query: 250 VRGIVKLGDLGFSTKLQ 266
G +K+ D GF+ +++
Sbjct: 136 SDGYIKITDFGFAKRVK 152
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 3e-20
Identities = 50/170 (29%), Positives = 75/170 (44%), Gaps = 44/170 (25%)
Query: 96 SYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGE 155
S + K ++ +L+ K R+ EIV + + HPNII Y + + +EYA+GG
Sbjct: 26 SLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGT 85
Query: 156 LYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215
LY+KI + G++F E+
Sbjct: 86 LYDKI-----------------------VRQKGQLF---------------------EEE 101
Query: 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
Y QI+SAV ++H I+HRDIK N+FL+ G++KLGD G S L
Sbjct: 102 MVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 3e-20
Identities = 45/199 (22%), Positives = 71/199 (35%), Gaps = 52/199 (26%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
L +LG G F V +A+K L K + + + RE M
Sbjct: 2 TLGKKLGEGAFGEVYKGT---LKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRK 57
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGEL--YNKITTEGRLSEDDAKIYFLQILLYEV 183
+ HPNI++L V + +V+EY GG+L Y + LS D
Sbjct: 58 LDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSD------------- 104
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
++ +A LQI +++L ++ IHRD+ A
Sbjct: 105 ---------LLSFA------------------------LQIARGMEYLESKNFIHRDLAA 131
Query: 244 ENVFLSVRGIVKLGDLGFS 262
N + +VK+ D G S
Sbjct: 132 RNCLVGENLVVKISDFGLS 150
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 88.3 bits (217), Expect = 4e-20
Identities = 62/204 (30%), Positives = 89/204 (43%), Gaps = 56/204 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAK-LTPKARKMLSREIVSM 123
Y++ +LG G+F V +A V A+K+L K K + REI +
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKLV----------ALKVLAKKLESKSKEVERFLREIQIL 51
Query: 124 ESV-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYE 182
S+ H PNI++LY+ + G ++LV+EY GG L
Sbjct: 52 ASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLE------------------------- 86
Query: 183 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIK 242
+L KI +G LSE +A QILSA+++LH + IIHRDIK
Sbjct: 87 ------------------DLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIK 128
Query: 243 AENVFLS-VRGIVKLGDLGFSTKL 265
EN+ L +VKL D G + L
Sbjct: 129 PENILLDRDGRVVKLIDFGLAKLL 152
|
Length = 384 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 8e-20
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 52/202 (25%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y++ ++G G+F + +A + + + IK +D K+ K ++ +E++ +
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAK-------SDSEHCVIKEIDLTKMPVKEKEASKKEVILLA 54
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ HPNI+ + + G++F+V+EY GG+L +I +
Sbjct: 55 KMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQ--------------------- 93
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
G +F SED +F+QI +KH+HDR I+HRDIK++
Sbjct: 94 --RGVLF---------------------SEDQILSWFVQISLGLKHIHDRKILHRDIKSQ 130
Query: 245 NVFLSVRGIV-KLGDLGFSTKL 265
N+FLS G+V KLGD G + +L
Sbjct: 131 NIFLSKNGMVAKLGDFGIARQL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (206), Expect = 8e-19
Identities = 45/198 (22%), Positives = 76/198 (38%), Gaps = 51/198 (25%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
+L +LG G F V + T + A+K L K + + R+ E M+
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKV---AVKTL-KEGASEEEREEFLEEASIMKK 57
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+ HPNI+RL V +++V EY GG+L + FL+
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLD----------------FLR-------- 93
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF-LQILSAVKHLHDRDIIHRDIKAE 244
+L+ D + LQI +++L ++ +HRD+ A
Sbjct: 94 ---------------------KHGEKLTLKD-LLQMALQIAKGMEYLESKNFVHRDLAAR 131
Query: 245 NVFLSVRGIVKLGDLGFS 262
N ++ +VK+ D G S
Sbjct: 132 NCLVTENLVVKISDFGLS 149
|
Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 8e-19
Identities = 45/141 (31%), Positives = 67/141 (47%), Gaps = 15/141 (10%)
Query: 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAK--------IYFLQILLYE-------VLE 185
FG+++L + +G EL K S + K I L+ L +E L
Sbjct: 15 FGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR 74
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
+ + +EY GG + +++ G L+E + Y QIL V++LH I+HRDIK N
Sbjct: 75 DDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGAN 134
Query: 246 VFLSVRGIVKLGDLGFSTKLQ 266
+ G VKLGD G S +LQ
Sbjct: 135 ILRDSAGNVKLGDFGASKRLQ 155
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 8e-19
Identities = 47/214 (21%), Positives = 79/214 (36%), Gaps = 64/214 (29%)
Query: 65 YKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
Y++ +G+G+F TV+ +I L K +D +T K ++ L E+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKI-----------LVWKEIDYGNMTEKEKQQLVSEV 50
Query: 121 VSMESVHHPNIIRLY--EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 178
+ + HPNI+R Y + + +++V+EY GG+L I
Sbjct: 51 NILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQ----------------- 93
Query: 179 LLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRD--- 235
+ E+ Q+L A+ H+R
Sbjct: 94 -------------------------KCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG 128
Query: 236 --IIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
++HRD+K N+FL VKLGD G + L
Sbjct: 129 NTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (205), Expect = 2e-18
Identities = 36/145 (24%), Positives = 60/145 (41%), Gaps = 46/145 (31%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI ++ + HPNI++L +V+ T K++LV EY D
Sbjct: 47 REISLLKELKHPNIVKLLDVIHTERKLYLVFEY---------------CDMD-------- 83
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
L + L+ G LS + K Q+L + + H I+
Sbjct: 84 --LKKYLDKR---------------------PGPLSPNLIKSIMYQLLRGLAYCHSHRIL 120
Query: 238 HRDIKAENVFLSVRGIVKLGDLGFS 262
HRD+K +N+ ++ G++KL D G +
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLA 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 2e-18
Identities = 52/203 (25%), Positives = 77/203 (37%), Gaps = 63/203 (31%)
Query: 70 ELGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
LG+G+ V H +IY A+K + + RK L RE+ ++ S
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIY-----------ALKKI-HVDGDEEFRKQLLRELKTLRS 55
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
P +++ Y G+I +V+EY GG L D +L+
Sbjct: 56 CESPYVVKCYGAFYKEGEISIVLEYMDGGSL------------AD------------LLK 91
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLH-DRDIIHRDIKAE 244
GKI E QIL + +LH R IIHRDIK
Sbjct: 92 KVGKI----------------------PEPVLAYIARQILKGLDYLHTKRHIIHRDIKPS 129
Query: 245 NVFLSVRGIVKLGDLGFSTKLQQ 267
N+ ++ +G VK+ D G S L+
Sbjct: 130 NLLINSKGEVKIADFGISKVLEN 152
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-18
Identities = 39/86 (45%), Positives = 56/86 (65%), Gaps = 1/86 (1%)
Query: 175 FLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR 234
F+ L+Y +T GK++L++EY SGGEL+ + EG ED A Y +I A++HLH +
Sbjct: 61 FIVDLIY-AFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 235 DIIHRDIKAENVFLSVRGIVKLGDLG 260
II+RD+K EN+ L +G VKL D G
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFG 145
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 4e-18
Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 57/207 (27%)
Query: 65 YKLQNELGRGNFSTV----KMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
+K+ +LG+G++ +V +++ ++ Y A+K +D ++ K R+ EI
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFY-----------ALKEVDLGSMSQKEREDAVNEI 50
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
+ SV+HPNII E K+ +V+EYA G+L I+
Sbjct: 51 RILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAIS------------------- 91
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
+ + E + F+Q+L ++ LH++ I+HRD
Sbjct: 92 -----------------------KRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRD 128
Query: 241 IKAENVFLSVRGIVKLGDLGFSTKLQQ 267
+K+ N+ L +VK+GDLG S L++
Sbjct: 129 LKSANILLVANDLVKIGDLGISKVLKK 155
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 7e-18
Identities = 49/205 (23%), Positives = 84/205 (40%), Gaps = 56/205 (27%)
Query: 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSM 123
L+++ ++G+G F V A H +AIK++ + ++ + EI +
Sbjct: 1 LFEILEKIGKGGFGEVYKARH---KRTGKE----VAIKVIKLESK--EKKEKIINEIQIL 51
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ HPNI++ Y G L
Sbjct: 52 KKCKHPNIVKYY-----------------GSYLKK------------------------- 69
Query: 184 LETFGKIFLVVEYASGGELYNKI-TTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIK 242
++++V+E+ SGG L + + +T L+E ++L +++LH IIHRDIK
Sbjct: 70 ----DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIK 125
Query: 243 AENVFLSVRGIVKLGDLGFSTKLQQ 267
A N+ L+ G VKL D G S +L
Sbjct: 126 AANILLTSDGEVKLIDFGLSAQLSD 150
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-18
Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 52/205 (25%)
Query: 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
+++ +++ LG G+F V++A H+ Y AIK L K REI
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHK-------GTGEYYAIKCLKK------------REI 56
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
+ M+ V H + + +L F+V S +D+ ++YFL
Sbjct: 57 LKMKQVQH--VAQEKSILMELSHPFIVNMMCS--------------FQDENRVYFL---- 96
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
+E+ GGEL+ + GR D AK Y +++ A ++LH +DII+RD
Sbjct: 97 -------------LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRD 143
Query: 241 IKAENVFLSVRGIVKLGDLGFSTKL 265
+K EN+ L +G VK+ D GF+ K+
Sbjct: 144 LKPENLLLDNKGHVKVTDFGFAKKV 168
|
Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 49/137 (35%), Positives = 77/137 (56%), Gaps = 17/137 (12%)
Query: 140 TFGKIFLVVEYASGGELYNKI---------------TTEGRLSEDDAKIYFLQILLYEVL 184
TFGK+ LV E A+G KI TE R+ ++ + FL L Y
Sbjct: 7 TFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALKY-AF 64
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+T ++ V+EYA+GGEL+ ++ E +E+ A+ Y +I+SA+++LH RD+++RDIK E
Sbjct: 65 QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLE 124
Query: 245 NVFLSVRGIVKLGDLGF 261
N+ L G +K+ D G
Sbjct: 125 NLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 1e-17
Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 50/168 (29%)
Query: 99 AIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYN 158
AIK K +L + ++++ EI+ M+ HPNI+ Y+ ++++V+EY GG L
Sbjct: 48 AIK---KMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL-- 102
Query: 159 KITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218
T+ ++ E +++
Sbjct: 103 ---TD-----------------------------IITQ------NFVRMNEPQIA----- 119
Query: 219 IYFL-QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
Y ++L +++LH +++IHRDIK++N+ LS G VKL D GF+ +L
Sbjct: 120 -YVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-17
Identities = 50/150 (33%), Positives = 78/150 (52%), Gaps = 19/150 (12%)
Query: 113 RKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 172
RK +R I +M+ + I+ EV T G+ ++V R D++
Sbjct: 13 RKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILV----------------RTLLDESP 56
Query: 173 IYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLH 232
F+ L + +T ++LV +Y SGGEL+ + EGR SED AK Y +++ A++HLH
Sbjct: 57 --FIVGLKFS-FQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLH 113
Query: 233 DRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
DI++RD+K EN+ L G + L D G S
Sbjct: 114 KYDIVYRDLKPENILLDATGHIALCDFGLS 143
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-17
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 60/211 (28%)
Query: 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLA----IKILDKAKLTPKARKMLS 117
+ +K++ ++G+G FS V AI C + ++I + + KAR+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAI--------CLLDGRVVALKKVQIFEM--MDAKARQDCL 50
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
+EI ++ + HPN+I+ ++ +V+E A G+L I
Sbjct: 51 KEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIK---------------- 94
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
+ L + E YF+Q+ SA++H+H + I+
Sbjct: 95 -----------------HFKKQKRL---------IPERTIWKYFVQLCSALEHMHSKRIM 128
Query: 238 HRDIKAENVFLSVRGIVKLGDLG----FSTK 264
HRDIK NVF++ G+VKLGDLG FS+K
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSK 159
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 3e-17
Identities = 43/136 (31%), Positives = 70/136 (51%), Gaps = 15/136 (11%)
Query: 141 FGKIFLVVEYASGGELY-----------NKITTEGRLSEDDAKIYFLQ---ILLYEVLET 186
+G++FL + S G++Y K + L+E D + LY +
Sbjct: 6 YGRVFLA-KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG 64
Query: 187 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENV 246
++LV+EY GG+L + + G L ED A+IY +I+ A+++LH IIHRD+K +N+
Sbjct: 65 KKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNI 124
Query: 247 FLSVRGIVKLGDLGFS 262
+ G +KL D G S
Sbjct: 125 LIDSNGHLKLTDFGLS 140
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 5e-17
Identities = 39/145 (26%), Positives = 62/145 (42%), Gaps = 48/145 (33%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGK--IFLVVEYASGGELYNKITTEGRLSEDDAKIYF 175
REI ++ + HPNI+RL E++ + GK I++V EY +
Sbjct: 47 REIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD---------------------HD 85
Query: 176 LQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRD 235
L LL + E + +E K Y Q+L +++LH
Sbjct: 86 LTGLLD-------------------------SPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 236 IIHRDIKAENVFLSVRGIVKLGDLG 260
I+HRDIK N+ ++ G++KL D G
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFG 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 5e-17
Identities = 46/169 (27%), Positives = 70/169 (41%), Gaps = 46/169 (27%)
Query: 99 AIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYN 158
AIK +++ +K RE+ + + H NI+ L E G+++LV EY
Sbjct: 30 AIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVE------ 83
Query: 159 KITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218
+ LL E+LE G L D +
Sbjct: 84 ------------------RTLL-ELLE---------ASPGG------------LPPDAVR 103
Query: 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
Y Q+L A+ + H +IIHRDIK EN+ +S G++KL D GF+ L+
Sbjct: 104 SYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 9e-17
Identities = 50/202 (24%), Positives = 77/202 (38%), Gaps = 64/202 (31%)
Query: 65 YKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
YK+ +LG G F +V +A + E+ +AIK + K K M RE+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGEL-----------VAIKKM-KKKFYSWEECMNLREV 48
Query: 121 VSMESV-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITT-EGRLSEDDAKIYFLQI 178
S+ + HPNI++L EV +++ V EY G LY + +G+
Sbjct: 49 KSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKP------------ 95
Query: 179 LLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIH 238
SE + QIL + H+H H
Sbjct: 96 ---------------------------------FSESVIRSIIYQILQGLAHIHKHGFFH 122
Query: 239 RDIKAENVFLSVRGIVKLGDLG 260
RD+K EN+ +S +VK+ D G
Sbjct: 123 RDLKPENLLVSGPEVVKIADFG 144
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-16
Identities = 51/198 (25%), Positives = 78/198 (39%), Gaps = 56/198 (28%)
Query: 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIK---ILDKAKLTPKARKMLSREIVSMESVH 127
LG G+F +V Y + + A+K + D + +A K L +EI + +
Sbjct: 8 LGSGSFGSV-------YEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 128 HPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETF 187
HPNI++ G E E L
Sbjct: 61 HPNIVQYL-----------------GTE-----REEDNLY-------------------- 78
Query: 188 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVF 247
IFL E GG L + G E ++Y QIL +++LHDR+ +HRDIK N+
Sbjct: 79 --IFL--ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANIL 134
Query: 248 LSVRGIVKLGDLGFSTKL 265
+ G+VKL D G + ++
Sbjct: 135 VDTNGVVKLADFGMAKQV 152
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-16
Identities = 35/81 (43%), Positives = 55/81 (67%), Gaps = 2/81 (2%)
Query: 182 EVLETFGKIFLVVEYASGGELYNKITTE-GRL-SEDDAKIYFLQILSAVKHLHDRDIIHR 239
E E G +++V+EY GG+L KI + G+L ED +F+Q+ V+H+H++ ++HR
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHR 124
Query: 240 DIKAENVFLSVRGIVKLGDLG 260
DIK++N+FL+ G VKLGD G
Sbjct: 125 DIKSKNIFLTQNGKVKLGDFG 145
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-16
Identities = 50/137 (36%), Positives = 77/137 (56%), Gaps = 19/137 (13%)
Query: 140 TFGKIFLVVEYASGGELYN-KI---------------TTEGRLSEDDAKIYFLQILLYEV 183
TFGK+ LV E A+G + Y KI TE R+ ++ + FL L Y
Sbjct: 7 TFGKVILVREKATG-KYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTALKYS- 63
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+T ++ V+EYA+GGEL+ ++ E SED A+ Y +I+SA+ +LH D+++RD+K
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKL 123
Query: 244 ENVFLSVRGIVKLGDLG 260
EN+ L G +K+ D G
Sbjct: 124 ENLMLDKDGHIKITDFG 140
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-16
Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 65/204 (31%)
Query: 69 NELGRGNFSTVKMAI----HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
N++G G F V A+ E+ +A+K + PK K ++ E+ +E
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGEL-----------MAVKEIRIQDNDPKTIKEIADEMKVLE 54
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ HPN+++ Y V K+++ +EY SGG L E+L
Sbjct: 55 LLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLE------------------------ELL 90
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDA--KIYFLQILSAVKHLHDRDIIHRDIK 242
E GR+ D+ ++Y LQ+L + +LH I+HRDIK
Sbjct: 91 E-----------------------HGRI-LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIK 126
Query: 243 AENVFLSVRGIVKLGDLGFSTKLQ 266
N+FL G++KLGD G + KL+
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVKLK 150
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-16
Identities = 48/141 (34%), Positives = 71/141 (50%), Gaps = 20/141 (14%)
Query: 141 FGKIFLV--VEYASGGELY-----NKIT------------TEGRLSEDDAKIYFLQILLY 181
+GK+FLV V G+LY K T TE ++ E + FL L Y
Sbjct: 13 YGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHY 72
Query: 182 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
+T K+ L+++Y +GGEL+ + +E + ++Y +I+ A+ HLH II+RDI
Sbjct: 73 -AFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDI 131
Query: 242 KAENVFLSVRGIVKLGDLGFS 262
K EN+ L G V L D G S
Sbjct: 132 KLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 4e-16
Identities = 34/77 (44%), Positives = 52/77 (67%), Gaps = 4/77 (5%)
Query: 190 IFLVVEYASGGELYNKITTEGRLS----EDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
I LV++YA+ G+L +I + + + E +A + F+Q+L AV H+H + +IHRDIK+ N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173
Query: 246 VFLSVRGIVKLGDLGFS 262
+ L G+VKLGD GFS
Sbjct: 174 ILLCSNGLVKLGDFGFS 190
|
Length = 496 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-16
Identities = 43/138 (31%), Positives = 69/138 (50%), Gaps = 16/138 (11%)
Query: 140 TFGKIFLVVEYASGGELYN-KITTEGRLSEDD--------AKIYFLQ------ILLYEVL 184
+FGK+ L E ELY K+ + + +DD ++ L L+
Sbjct: 7 SFGKVLLA-ELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF 65
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+T ++F V+EY +GG+L I GR E A+ Y +I+ ++ LH+R II+RD+K +
Sbjct: 66 QTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLD 125
Query: 245 NVFLSVRGIVKLGDLGFS 262
NV L G +K+ D G
Sbjct: 126 NVLLDSEGHIKIADFGMC 143
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 5e-16
Identities = 44/202 (21%), Positives = 70/202 (34%), Gaps = 61/202 (30%)
Query: 65 YKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
YK+ +G G V A E +A+K + +L REI
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGET-----------VALKKVALRRLEGGIPNQALREI 50
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
++++ HP +++L +V LV+EY L
Sbjct: 51 KALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSD-------------------------L 85
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
EVL E L E K Y +L V ++H I+HRD
Sbjct: 86 SEVLRD---------------------EERPLPEAQVKSYMRMLLKGVAYMHANGIMHRD 124
Query: 241 IKAENVFLSVRGIVKLGDLGFS 262
+K N+ +S G++K+ D G +
Sbjct: 125 LKPANLLISADGVLKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 8e-16
Identities = 36/83 (43%), Positives = 51/83 (61%)
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
LY ++ ++LV+EY +GG+ + I T G L ED AK Y +++ V+ LH R IIHR
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121
Query: 240 DIKAENVFLSVRGIVKLGDLGFS 262
DIK EN+ + G +KL D G S
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLS 144
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-15
Identities = 51/199 (25%), Positives = 87/199 (43%), Gaps = 56/199 (28%)
Query: 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHH 128
++G G+ V +A + + +A+K +D K + R++L E+V M H
Sbjct: 25 VKIGEGSTGIVCIA-TDK------STGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQH 75
Query: 129 PNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFG 188
PNI+ +Y +LV G EL+
Sbjct: 76 PNIVEMY-------SSYLV-----GDELW------------------------------- 92
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
+V+E+ GG L + I T R++E+ L +L A+ LH + +IHRDIK++++ L
Sbjct: 93 ---VVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL 148
Query: 249 SVRGIVKLGDLGFSTKLQQ 267
+ G VKL D GF ++ +
Sbjct: 149 TSDGRVKLSDFGFCAQVSK 167
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-15
Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 50/166 (30%)
Query: 99 AIKILDKA--KLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGEL 156
A+K+L KA K+ + R + R+I++ V+HP I++L+ +T GK++L++++ GG+L
Sbjct: 28 AMKVLKKATLKVRDRVRTKMERDILA--EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL 85
Query: 157 YNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216
+ +++ E +E+D K Y ++ L
Sbjct: 86 FTRLSKEVMFTEEDVKFYLAELAL------------------------------------ 109
Query: 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
A+ HLH II+RD+K EN+ L G +KL D G S
Sbjct: 110 ----------ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 145
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-15
Identities = 48/138 (34%), Positives = 78/138 (56%), Gaps = 18/138 (13%)
Query: 140 TFGKIFLVVEYASGGELYNKIT---------------TEGRLSEDDAKIYFLQILLYEVL 184
TFGK+ LV E A+G KI TE R+ ++ ++ FL L Y
Sbjct: 7 TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALKYS-F 64
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLH-DRDIIHRDIKA 243
+T ++ V+EYA+GGEL+ ++ E SED A+ Y +I+SA+ +LH ++++++RD+K
Sbjct: 65 QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 124
Query: 244 ENVFLSVRGIVKLGDLGF 261
EN+ L G +K+ D G
Sbjct: 125 ENLMLDKDGHIKITDFGL 142
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-15
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 56/209 (26%)
Query: 62 VALYKLQNELGRGNFSTVKMAIHEI-YVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
+A ++++ ++GRG FS V A + VP+ + ++I D + KAR +EI
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPV-----ALKKVQIFDL--MDAKARADCIKEI 53
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
++ ++HPN+I+ Y ++ +V+E A G+L
Sbjct: 54 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLS----------------------- 90
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRL-SEDDAKIYFLQILSAVKHLHDRDIIHR 239
+++ F K + RL E YF+Q+ SA++H+H R ++HR
Sbjct: 91 -RMIKHFKK-------------------QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHR 130
Query: 240 DIKAENVFLSVRGIVKLGDLG----FSTK 264
DIK NVF++ G+VKLGDLG FS+K
Sbjct: 131 DIKPANVFITATGVVKLGDLGLGRFFSSK 159
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 9e-15
Identities = 52/209 (24%), Positives = 83/209 (39%), Gaps = 68/209 (32%)
Query: 64 LYKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPK-ARKMLSR 118
Y+L +G G + V A E+ +AIK++ KL P +++ +
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGEL-----------VAIKVI---KLEPGDDFEIIQQ 49
Query: 119 EIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 178
EI ++ HPNI+ + K+++V+EY GG L
Sbjct: 50 EISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL---------------------- 87
Query: 179 LLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL--QILSAVKHLHDRDI 236
++Y T G LSE +I ++ + L + +LH+
Sbjct: 88 ---------------------QDIYQV--TRGPLSEL--QIAYVCRETLKGLAYLHETGK 122
Query: 237 IHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
IHRDIK N+ L+ G VKL D G S +L
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQL 151
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 53/203 (26%), Positives = 83/203 (40%), Gaps = 66/203 (32%)
Query: 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKIL----DKAKLTPKARKMLSREIVSME 124
N +G G TV IH P Y A+K++ + R+ + REI +
Sbjct: 80 NRIGSGAGGTVYKVIHR---PTGRLY----ALKVIYGNHEDT-----VRRQICREIEILR 127
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
V+HPN+++ +++ + G+I +++E+ GG L EG
Sbjct: 128 DVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL------EGT------------------- 162
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
I E L+ D A+ QILS + +LH R I+HRDIK
Sbjct: 163 --------------------HIADEQFLA-DVAR----QILSGIAYLHRRHIVHRDIKPS 197
Query: 245 NVFLSVRGIVKLGDLGFSTKLQQ 267
N+ ++ VK+ D G S L Q
Sbjct: 198 NLLINSAKNVKIADFGVSRILAQ 220
|
Length = 353 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-14
Identities = 50/198 (25%), Positives = 78/198 (39%), Gaps = 50/198 (25%)
Query: 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHP 129
+LG G+F V+ + I +A+K L KL+ +E M S+ H
Sbjct: 2 KLGDGSFGVVRRGE---WSTSGGKVIP-VAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHE 56
Query: 130 NIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGK 189
N+IRLY V+ T + +V E A G L +++ DA +FL L +
Sbjct: 57 NLIRLYGVVLT-HPLMMVTELAPLGSLLDRL-------RKDALGHFLISTLCD------- 101
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS 249
Y +QI + +++L + IHRD+ A N+ L+
Sbjct: 102 ------------------------------YAVQIANGMRYLESKRFIHRDLAARNILLA 131
Query: 250 VRGIVKLGDLGFSTKLQQ 267
VK+GD G L Q
Sbjct: 132 SDDKVKIGDFGLMRALPQ 149
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-14
Identities = 47/201 (23%), Positives = 77/201 (38%), Gaps = 61/201 (30%)
Query: 65 YKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
Y+ ++G G + V A EI AIK + + K REI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIV-----------AIKKIKLRFESEGIPKTALREI 49
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
++ ++HPNII+L +V G ++LV E+ + D L
Sbjct: 50 KLLKELNHPNIIKLLDVFRHKGDLYLVFEF---------------MDTD----------L 84
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
Y++++ + L E K Y Q+L + H I+HRD
Sbjct: 85 YKLIKDRQRG---------------------LPESLIKSYLYQLLQGLAFCHSHGILHRD 123
Query: 241 IKAENVFLSVRGIVKLGDLGF 261
+K EN+ ++ G++KL D G
Sbjct: 124 LKPENLLINTEGVLKLADFGL 144
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 42/136 (30%), Positives = 69/136 (50%), Gaps = 15/136 (11%)
Query: 141 FGKIFL----------VVEYASGGELYNKITTEGRLSEDDA----KIYFLQILLYEVLET 186
FGK++L V+ ++ NK +E DA K F+ + LY L++
Sbjct: 17 FGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFI-VHLYYSLQS 75
Query: 187 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENV 246
++LV+EY GG++ + + G E+ A Y ++ A+ +LH IIHRD+K +N+
Sbjct: 76 ANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNM 135
Query: 247 FLSVRGIVKLGDLGFS 262
+S G +KL D G S
Sbjct: 136 LISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-14
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 56/209 (26%)
Query: 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREI 120
+A ++++ ++GRG FS E+Y +A+K + ++ KAR+ +EI
Sbjct: 1 LANFQIEKKIGRGQFS-------EVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEI 53
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
++ ++HPN+I+ + ++ +V+E A G+L I YF +
Sbjct: 54 DLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIK------------YFKK--- 98
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRL-SEDDAKIYFLQILSAVKHLHDRDIIHR 239
+ RL E YF+Q+ SAV+H+H R ++HR
Sbjct: 99 ----------------------------QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHR 130
Query: 240 DIKAENVFLSVRGIVKLGDLG----FSTK 264
DIK NVF++ G+VKLGDLG FS+K
Sbjct: 131 DIKPANVFITATGVVKLGDLGLGRFFSSK 159
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 4e-14
Identities = 27/77 (35%), Positives = 49/77 (63%)
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
++LVV+ GG+L ++ + + SE+ K + +I+ A+++LH + IIHRDIK +N+ L
Sbjct: 74 NMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL 133
Query: 249 SVRGIVKLGDLGFSTKL 265
+G V + D +TK+
Sbjct: 134 DEQGHVHITDFNIATKV 150
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-14
Identities = 44/143 (30%), Positives = 74/143 (51%), Gaps = 17/143 (11%)
Query: 141 FGKIFLVVEYASGGELYNKIT--------TEGRLSEDDAKIYFLQILLYE-VLETFG--- 188
FG+++L + +G EL K T ++ + +I L+ L ++ +++ +G
Sbjct: 15 FGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLR 74
Query: 189 -----KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
K+ + VEY GG + +++ G L+E+ + Y QIL V +LH I+HRDIK
Sbjct: 75 DPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKG 134
Query: 244 ENVFLSVRGIVKLGDLGFSTKLQ 266
N+ G VKLGD G S ++Q
Sbjct: 135 ANILRDSAGNVKLGDFGASKRIQ 157
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-14
Identities = 54/153 (35%), Positives = 79/153 (51%), Gaps = 22/153 (14%)
Query: 134 LYEVLET--FGKIFLV--VEYASGGELY-----NKIT------------TEGRLSEDDAK 172
L +VL T +GK+FLV V G+LY K T TE ++ E +
Sbjct: 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 63
Query: 173 IYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLH 232
FL L Y +T K+ L+++Y +GGEL+ ++ R E + +IY +I+ A++HLH
Sbjct: 64 SPFLVTLHY-AFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH 122
Query: 233 DRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
II+RDIK EN+ L G V L D G S +
Sbjct: 123 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-14
Identities = 48/137 (35%), Positives = 72/137 (52%), Gaps = 17/137 (12%)
Query: 140 TFGKIFLVVEYASGGELYNKIT---------------TEGRLSEDDAKIYFLQILLYEVL 184
TFGK+ LV E ASG KI TE R+ ++ + FL L Y
Sbjct: 7 TFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTSLKYS-F 64
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+T ++ V+EY +GGEL+ ++ E SED + Y +I+SA+ +LH I++RD+K E
Sbjct: 65 QTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLE 124
Query: 245 NVFLSVRGIVKLGDLGF 261
N+ L G +K+ D G
Sbjct: 125 NLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-14
Identities = 51/151 (33%), Positives = 76/151 (50%), Gaps = 24/151 (15%)
Query: 134 LYEVLET--FGKIFLVVEYASG---GELY-----------------NKITTEGRLSEDDA 171
L +VL T +GK+FLV + +G G+LY TE + E
Sbjct: 4 LLKVLGTGAYGKVFLVRK-VTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR 62
Query: 172 KIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHL 231
+ FL L Y +T K+ L+++Y SGGE++ + SED+ + Y +I+ A++HL
Sbjct: 63 QSPFLVTLHY-AFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 232 HDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
H I++RDIK EN+ L G V L D G S
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-14
Identities = 37/90 (41%), Positives = 53/90 (58%), Gaps = 2/90 (2%)
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEG--RLSEDDAKIYFLQILSAVKHLHDRD 235
I YE GK+ +V+EYA G+L+ + + L ED +F+QIL + HLH +
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 236 IIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
I+HRDIK+ N+FL VK+GDLG + L
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL 151
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 7e-14
Identities = 33/81 (40%), Positives = 47/81 (58%)
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
LY +T ++F V+E+ +GG+L I R E A+ Y +I SA+ LHD+ II+R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 240 DIKAENVFLSVRGIVKLGDLG 260
D+K +NV L G KL D G
Sbjct: 121 DLKLDNVLLDHEGHCKLADFG 141
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-14
Identities = 44/143 (30%), Positives = 75/143 (52%), Gaps = 17/143 (11%)
Query: 141 FGKIFLVVEYASGGELYNKIT--------TEGRLSEDDAKIYFLQILLYE-VLETFG--- 188
FG+++L + +G EL K T ++ + +I L+ LL+E +++ +G
Sbjct: 15 FGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLR 74
Query: 189 -----KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+ + +E+ GG + +++ + G L+E+ + Y QIL V +LH I+HRDIK
Sbjct: 75 DPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKG 134
Query: 244 ENVFLSVRGIVKLGDLGFSTKLQ 266
N+ G VKLGD G S +LQ
Sbjct: 135 ANILRDSVGNVKLGDFGASKRLQ 157
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 32/88 (36%), Positives = 54/88 (61%), Gaps = 4/88 (4%)
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGR----LSEDDAKIYFLQILSAVKHLHDRDI 236
++ ++ K+ L++EY SGG+L +I + E + + F QI+ A+ +H R +
Sbjct: 131 FDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKM 190
Query: 237 IHRDIKAENVFLSVRGIVKLGDLGFSTK 264
+HRD+K+ N+FL GI+KLGD GFS +
Sbjct: 191 MHRDLKSANIFLMPTGIIKLGDFGFSKQ 218
|
Length = 478 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 40/131 (30%), Positives = 71/131 (54%), Gaps = 1/131 (0%)
Query: 131 IIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKI 190
++RL + + + E + E + + TE + E + FL + L+ +T ++
Sbjct: 13 LVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL-VGLHSCFQTESRL 71
Query: 191 FLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSV 250
F V+EY +GG+L + + +L E+ A+ Y +I A+ +LH+R II+RD+K +NV L
Sbjct: 72 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 131
Query: 251 RGIVKLGDLGF 261
G +KL D G
Sbjct: 132 EGHIKLTDYGM 142
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-13
Identities = 50/200 (25%), Positives = 72/200 (36%), Gaps = 58/200 (29%)
Query: 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHH 128
ELG GN V +H I+ L I +K + RE+ + +
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--------EAIQKQILRELDILHKCNS 58
Query: 129 PNIIRLYEVLETFGKIFLVVEYASGGELYNKITTE--GRLSEDDAKIYFLQILLYEVLET 186
P I+ Y G I + +EY GG L +KI E GR+ E
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPER----------------I 101
Query: 187 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLH-DRDIIHRDIKAEN 245
GKI + +L + +LH IIHRD+K N
Sbjct: 102 LGKIAV------------------------------AVLKGLTYLHEKHKIIHRDVKPSN 131
Query: 246 VFLSVRGIVKLGDLGFSTKL 265
+ ++ RG +KL D G S +L
Sbjct: 132 ILVNSRGQIKLCDFGVSGQL 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-13
Identities = 44/143 (30%), Positives = 72/143 (50%), Gaps = 17/143 (11%)
Query: 141 FGKIFLVVEYASGGELYNKIT--------TEGRLSEDDAKIYFLQILLYE-VLETFG--- 188
FG+++L + +G EL K T +S + +I L+ L +E +++ +G
Sbjct: 15 FGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLR 74
Query: 189 -----KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+ + +EY GG + +++ G L+E + Y QIL + +LH I+HRDIK
Sbjct: 75 DRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKG 134
Query: 244 ENVFLSVRGIVKLGDLGFSTKLQ 266
N+ G VKLGD G S +LQ
Sbjct: 135 ANILRDSAGNVKLGDFGASKRLQ 157
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 1e-13
Identities = 45/145 (31%), Positives = 63/145 (43%), Gaps = 48/145 (33%)
Query: 118 REIVSMESVHHPNIIRLYEVL--ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 175
REI + + HPNI+ + EV+ KI++V+EY E D K
Sbjct: 53 REINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV----------------EHDLK--- 93
Query: 176 LQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRD 235
++ET + FL E K LQ+LS V HLHD
Sbjct: 94 ------SLMETMKQPFLQSE---------------------VKCLMLQLLSGVAHLHDNW 126
Query: 236 IIHRDIKAENVFLSVRGIVKLGDLG 260
I+HRD+K N+ L+ RGI+K+ D G
Sbjct: 127 ILHRDLKTSNLLLNNRGILKICDFG 151
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-13
Identities = 27/74 (36%), Positives = 48/74 (64%)
Query: 188 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVF 247
K++LV+ + +GGEL++ + EGR A+ Y ++L A+++LH ++I+RD+K EN+
Sbjct: 66 EKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENIL 125
Query: 248 LSVRGIVKLGDLGF 261
L +G + L D G
Sbjct: 126 LDYQGHIALCDFGL 139
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 26/78 (33%), Positives = 45/78 (57%)
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS 249
++LV+EY GG+L N + + E+ A+ Y +++ A+ +H IHRDIK +N+ +
Sbjct: 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID 135
Query: 250 VRGIVKLGDLGFSTKLQQ 267
G +KL D G K+ +
Sbjct: 136 ADGHIKLADFGLCKKMNK 153
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 29/76 (38%), Positives = 50/76 (65%)
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS 249
+++++EY GGEL++ + GR S Y +I+ A+++LH ++I++RD+K EN+ L
Sbjct: 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD 135
Query: 250 VRGIVKLGDLGFSTKL 265
G +KL D GF+ KL
Sbjct: 136 KEGHIKLTDFGFAKKL 151
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 42/147 (28%), Positives = 62/147 (42%), Gaps = 48/147 (32%)
Query: 118 REIVSMESVHHPNIIRLYEVL--ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 175
REI + ++ HPNI+ L EV+ + IFLV+EY E D
Sbjct: 55 REITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC----------------EQD----- 93
Query: 176 LQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRD 235
L LL + F SE K LQ+L +++LH+
Sbjct: 94 LASLLDNMPTPF-------------------------SESQVKCLMLQLLRGLQYLHENF 128
Query: 236 IIHRDIKAENVFLSVRGIVKLGDLGFS 262
IIHRD+K N+ L+ +G +K+ D G +
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLA 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 36/101 (35%), Positives = 59/101 (58%), Gaps = 1/101 (0%)
Query: 160 ITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219
+ TE + E + FL + L+ +T ++F V+E+ SGG+L + + +L E+ A+
Sbjct: 42 VQTEKHVFETASNHPFL-VGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARF 100
Query: 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLG 260
Y +I A+ LH+R II+RD+K +NV L G +KL D G
Sbjct: 101 YSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYG 141
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 37/101 (36%), Positives = 60/101 (59%), Gaps = 1/101 (0%)
Query: 160 ITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219
+ TE + E + FL + L+ +T ++FLV+EY +GG+L + + +L E+ A+
Sbjct: 42 VQTEKHVFEQASSNPFL-VGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF 100
Query: 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLG 260
Y +I A+ LH+R II+RD+K +NV L G +KL D G
Sbjct: 101 YAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYG 141
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 5e-13
Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 21/138 (15%)
Query: 141 FGKIFLVVEYASGGELY----------------NKITTEGRLSE--DDAKIYFLQILLYE 182
FGK+ L EY GELY + E R+ E + + FL + L+
Sbjct: 12 FGKVLLA-EYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL-VNLFA 69
Query: 183 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIK 242
+T + V+EYA+GG+L I T+ SE A Y ++ +++LH+ I++RD+K
Sbjct: 70 CFQTEDHVCFVMEYAAGGDLMMHIHTD-VFSEPRAVFYAACVVLGLQYLHENKIVYRDLK 128
Query: 243 AENVFLSVRGIVKLGDLG 260
+N+ L G VK+ D G
Sbjct: 129 LDNLLLDTEGFVKIADFG 146
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-13
Identities = 46/193 (23%), Positives = 85/193 (44%), Gaps = 55/193 (28%)
Query: 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARK--MLSREIVSMESVHH 128
+G+G+F V +A + + S+ A+K+L K + K + +++ V ++++ H
Sbjct: 3 IGKGSFGKVLLAKRK-------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKH 55
Query: 129 PNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFG 188
P ++ L+ +T K++ V++Y +GGEL+ + LQ
Sbjct: 56 PFLVGLHYSFQTAEKLYFVLDYVNGGELF----------------FHLQ----------- 88
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
E E A+ Y ++ SA+ +LH +II+RD+K EN+ L
Sbjct: 89 -------------------RERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL 129
Query: 249 SVRGIVKLGDLGF 261
+G V L D G
Sbjct: 130 DSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-13
Identities = 33/89 (37%), Positives = 51/89 (57%), Gaps = 2/89 (2%)
Query: 176 LQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRD 235
+Q L +E E + IFL EY GG + + + T GR E + + Q+L + +LH +
Sbjct: 71 VQYLGFETTEEYLSIFL--EYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128
Query: 236 IIHRDIKAENVFLSVRGIVKLGDLGFSTK 264
I+HRD+KA+N+ + GI K+ D G S K
Sbjct: 129 ILHRDLKADNLLVDADGICKISDFGISKK 157
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-12
Identities = 30/81 (37%), Positives = 48/81 (59%)
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
L+ +T +F V+EY +GG+L I + GR E A+ Y +I+ ++ LH + II+R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 240 DIKAENVFLSVRGIVKLGDLG 260
D+K +NV L G +K+ D G
Sbjct: 121 DLKLDNVLLDKDGHIKIADFG 141
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 1e-12
Identities = 56/203 (27%), Positives = 83/203 (40%), Gaps = 66/203 (32%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYI---SYLAIKILDKAKLTPKARKMLSREIV 121
YK+ ++G G FS V + Y AIK + K + REI
Sbjct: 1 YKILGKIGEGTFSEV----------LKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQ 49
Query: 122 SMESV-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
++ + HPNI+RL EVL +++ T GRL+ L+
Sbjct: 50 ALRRLSPHPNILRLIEVL------------------FDRKT--GRLA-----------LV 78
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGR---LSEDDAKIYFLQILSAVKHLHDRDII 237
+E+++ LY I +GR L E K Y Q+L ++ H+H I
Sbjct: 79 FELMD--------------MNLYELI--KGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIF 122
Query: 238 HRDIKAENVFLSVRGIVKLGDLG 260
HRDIK EN+ + I+KL D G
Sbjct: 123 HRDIKPENILIK-DDILKLADFG 144
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-12
Identities = 49/169 (28%), Positives = 69/169 (40%), Gaps = 49/169 (28%)
Query: 100 IKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNK 159
IK + ++T R E ++ + HPNII YE FL
Sbjct: 30 IKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN-------FL------------- 69
Query: 160 ITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGR--LSEDDA 217
ED A + +V+EYA GG L I L ED
Sbjct: 70 --------EDKA------------------LMIVMEYAPGGTLAEYIQKRCNSLLDEDTI 103
Query: 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG-IVKLGDLGFSTKL 265
+F+QIL A+ H+H + I+HRD+K +N+ L +VK+GD G S L
Sbjct: 104 LHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-12
Identities = 54/204 (26%), Positives = 80/204 (39%), Gaps = 57/204 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y+L +G G + V AI +P +AIK +D K L +E+ +M
Sbjct: 3 YELIEVIGVGATAVVYAAI---CLP----NNEKVAIKRIDLEKCQTSV-DELRKEVQAMS 54
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+HPN+++ Y F+V G EL+
Sbjct: 55 QCNHPNVVKYYTS-------FVV-----GDELW--------------------------- 75
Query: 185 ETFGKIFLVVEYASGGELYNKITT---EGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
LV+ Y SGG L + + + G L E ++L +++LH IHRDI
Sbjct: 76 -------LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDI 128
Query: 242 KAENVFLSVRGIVKLGDLGFSTKL 265
KA N+ L G VK+ D G S L
Sbjct: 129 KAGNILLGEDGSVKIADFGVSASL 152
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-12
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 2/88 (2%)
Query: 180 LYEVLETFGKIFLVVEYASGGELYN--KITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
LY +T + LV++Y GGEL+ + LSE+ A+ Y ++L A+++LH I+
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIV 125
Query: 238 HRDIKAENVFLSVRGIVKLGDLGFSTKL 265
+RD+K EN+ L G + L D S +
Sbjct: 126 YRDLKPENILLHESGHIMLSDFDLSKQS 153
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-12
Identities = 49/203 (24%), Positives = 78/203 (38%), Gaps = 60/203 (29%)
Query: 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIK--ILDKAKLTPKARK-----MLSREIVSM 123
+G G+F +V + ++ ++ A+K L + K RK L+REI +
Sbjct: 8 IGSGSFGSVYLGMNASSGELM-------AVKQVELPSVSASSKDRKRSMLDALAREIALL 60
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ + H NI+ Q L +
Sbjct: 61 KELQHENIV--------------------------------------------QYLGSSL 76
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
IFL EY GG + + G E + + QIL + +LH+R IIHRDIK
Sbjct: 77 DADHLNIFL--EYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKG 134
Query: 244 ENVFLSVRGIVKLGDLGFSTKLQ 266
N+ + +G +K+ D G S KL+
Sbjct: 135 ANILVDNKGGIKISDFGISKKLE 157
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 29/75 (38%), Positives = 41/75 (54%)
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
++L +EY GG+ + G LSED A+ Y ++ AV LH+ IHRD+K EN +
Sbjct: 75 YLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI 134
Query: 249 SVRGIVKLGDLGFST 263
G +KL D G S
Sbjct: 135 DASGHIKLTDFGLSK 149
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 32/81 (39%), Positives = 58/81 (71%), Gaps = 2/81 (2%)
Query: 188 GKIFLVVEYASGGELYNKITTE-GRL-SEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
G +++V+ + GG+LY+K+ + G+L E+ +F+QI A+++LH++ I+HRD+K +N
Sbjct: 73 GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQN 132
Query: 246 VFLSVRGIVKLGDLGFSTKLQ 266
VFL+ I+K+GDLG + L+
Sbjct: 133 VFLTRTNIIKVGDLGIARVLE 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 37/143 (25%), Positives = 57/143 (39%), Gaps = 46/143 (32%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI ++ + HPNII L +V I LV E+ D
Sbjct: 51 REIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMET----------------D------- 87
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
L +V++ +K L+ D K Y L L +++LH I+
Sbjct: 88 --LEKVIK------------------DKSI---VLTPADIKSYMLMTLRGLEYLHSNWIL 124
Query: 238 HRDIKAENVFLSVRGIVKLGDLG 260
HRD+K N+ ++ G++KL D G
Sbjct: 125 HRDLKPNNLLIASDGVLKLADFG 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-12
Identities = 27/81 (33%), Positives = 43/81 (53%), Gaps = 1/81 (1%)
Query: 188 GKIFLVVEYASGGELYNKI-TTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENV 246
+++V+EY G + + + T L+E++ Q L +++LH IHRDIKA N+
Sbjct: 71 TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNI 130
Query: 247 FLSVRGIVKLGDLGFSTKLQQ 267
L+ G KL D G S +L
Sbjct: 131 LLNEEGQAKLADFGVSGQLTD 151
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-12
Identities = 45/168 (26%), Positives = 69/168 (41%), Gaps = 46/168 (27%)
Query: 98 LAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELY 157
+AIK +++ +K+ REI ++ + H N++ L EV +++LV E+ L
Sbjct: 29 VAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVL- 87
Query: 158 NKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217
DD LE + L E
Sbjct: 88 -----------DD-------------LEKY---------------------PNGLDESRV 102
Query: 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
+ Y QIL ++ H +IIHRDIK EN+ +S G+VKL D GF+ L
Sbjct: 103 RKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-12
Identities = 34/86 (39%), Positives = 51/86 (59%), Gaps = 1/86 (1%)
Query: 175 FLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR 234
FL L Y +T K++ V++Y +GGEL+ + E E A+ Y +I SA+ +LH
Sbjct: 57 FLVGLHYS-FQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL 115
Query: 235 DIIHRDIKAENVFLSVRGIVKLGDLG 260
+II+RD+K EN+ L +G V L D G
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFG 141
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 41/172 (23%), Positives = 62/172 (36%), Gaps = 49/172 (28%)
Query: 98 LAIKIL-DKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGEL 156
+AIK+L A R RE ++HPNI+ L + E
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA---------------- 49
Query: 157 YNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216
G +F V EY G L + +G L +
Sbjct: 50 -----------PP------------------GLLFAVFEYVPGRTLREVLAADGALPAGE 80
Query: 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGI---VKLGDLGFSTKL 265
LQ+L A+ H++ I+HRD+K +N+ +S G+ K+ D G T L
Sbjct: 81 TGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL 132
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-12
Identities = 43/136 (31%), Positives = 66/136 (48%), Gaps = 16/136 (11%)
Query: 140 TFGKIFLVVEYASGGELYN-KITTEGRLSEDD--------AKIYFLQ------ILLYEVL 184
+FGK+ L E ELY KI + + +DD ++ LQ L+
Sbjct: 12 SFGKVMLA-ERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF 70
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+T +++ V+EY +GG+L I G+ E A Y +I + LH R II+RD+K +
Sbjct: 71 QTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLD 130
Query: 245 NVFLSVRGIVKLGDLG 260
NV L G +K+ D G
Sbjct: 131 NVMLDSEGHIKIADFG 146
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-12
Identities = 44/170 (25%), Positives = 77/170 (45%), Gaps = 49/170 (28%)
Query: 98 LAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELY 157
+A+K +D K + R++L E+V M HH N++ +Y Y G EL+
Sbjct: 50 VAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYN------------SYLVGDELW 95
Query: 158 NKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217
+V+E+ GG L + I T R++E+
Sbjct: 96 ----------------------------------VVMEFLEGGALTD-IVTHTRMNEEQI 120
Query: 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
L +L A+ +LH++ +IHRDIK++++ L+ G +KL D GF ++ +
Sbjct: 121 ATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-12
Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 35/154 (22%)
Query: 110 PKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 169
P++ K REI + + H NI+++YEVL G L+ED
Sbjct: 43 PQSVKHALREIKIIRRLDHDNIVKVYEVL------------GPSGS---------DLTED 81
Query: 170 DAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVK 229
L +++V EY +L N + +G LSE+ A+++ Q+L +K
Sbjct: 82 -----------VGSLTELNSVYIVQEYMET-DLAN-VLEQGPLSEEHARLFMYQLLRGLK 128
Query: 230 HLHDRDIIHRDIKAENVFLSVRGIV-KLGDLGFS 262
++H +++HRD+K NVF++ +V K+GD G +
Sbjct: 129 YIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-11
Identities = 32/87 (36%), Positives = 49/87 (56%), Gaps = 1/87 (1%)
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKI-TTEGRLSEDDAKIYFLQILSAVKHLHDRDIIH 238
LYE K+++++E+ GG L + + E L+E + Q+L A+ LH +IH
Sbjct: 67 LYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIH 126
Query: 239 RDIKAENVFLSVRGIVKLGDLGFSTKL 265
RD+KA N+ L++ G VKL D G S K
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKN 153
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-11
Identities = 27/82 (32%), Positives = 47/82 (57%), Gaps = 4/82 (4%)
Query: 189 KIFLVVEYASGG---ELYNKITTEGRLSEDDAKIYFLQ-ILSAVKHLHDRDIIHRDIKAE 244
+++LV+E GG +L + +G+ +++ Y L+ L + +LH+ +IHRDIK +
Sbjct: 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQ 142
Query: 245 NVFLSVRGIVKLGDLGFSTKLQ 266
N+ L+ VKL D G S +L
Sbjct: 143 NILLTKNAEVKLVDFGVSAQLD 164
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 1e-11
Identities = 29/77 (37%), Positives = 45/77 (58%), Gaps = 1/77 (1%)
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
K+++++EY GG + + G+L E ++L +++LH+ IHRDIKA N+ L
Sbjct: 73 KLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL 131
Query: 249 SVRGIVKLGDLGFSTKL 265
S G VKL D G S +L
Sbjct: 132 SEEGDVKLADFGVSGQL 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 2e-11
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 53/200 (26%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPK-ARKMLSREIVSM 123
Y+L +G G + V A+ + T +AIK + A+++L REI +
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKR------TGR-KVAIKKISNVFDDLIDAKRIL-REIKLL 53
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ H NII L L IL
Sbjct: 54 RHLRHENIIGL-----------------------------------------LDILRPPS 72
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL-QILSAVKHLHDRDIIHRDIK 242
E F +++V E +L+ I + L++D + YFL QIL +K+LH ++IHRD+K
Sbjct: 73 PEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQ-YFLYQILRGLKYLHSANVIHRDLK 130
Query: 243 AENVFLSVRGIVKLGDLGFS 262
N+ ++ +K+ D G +
Sbjct: 131 PSNILVNSNCDLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 47/163 (28%), Positives = 67/163 (41%), Gaps = 52/163 (31%)
Query: 109 TPKARKMLSREIVSMESVHHPNIIRLYE--VLETFGKIFLVVEYASGGEL---YNKITTE 163
P +K + RE+ +S P I++ Y + E+ I + +EY GG L Y K+
Sbjct: 39 NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98
Query: 164 G-RLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222
G R+ E +VL GKI A
Sbjct: 99 GGRIGE-------------KVL---GKI------AES----------------------- 113
Query: 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
+L + +LH R IIHRDIK N+ L+ +G VKL D G S +L
Sbjct: 114 -VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 18/137 (13%)
Query: 140 TFGKIFLVVEYASGGELYN-KITTEGRLSEDD---------------AKIYFLQILLYEV 183
+FGK+ L E ELY KI + + +DD K FL L+
Sbjct: 12 SFGKVMLA-ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL-TQLHSC 69
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+T +++ V+EY +GG+L I G+ E A Y +I + LH + II+RD+K
Sbjct: 70 FQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKL 129
Query: 244 ENVFLSVRGIVKLGDLG 260
+NV L G +K+ D G
Sbjct: 130 DNVMLDAEGHIKIADFG 146
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-11
Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 1/99 (1%)
Query: 162 TEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221
TE R+ AK FL L+ +T ++F V+EY +GG+L +I + E ++ Y
Sbjct: 44 TEKRILALAAKHPFLT-ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYA 102
Query: 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLG 260
++ A+ LH +I+RD+K +N+ L G KL D G
Sbjct: 103 AEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFG 141
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-11
Identities = 42/170 (24%), Positives = 78/170 (45%), Gaps = 49/170 (28%)
Query: 98 LAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELY 157
+A+K++D K + R++L E+V M H N++ +Y+ Y G EL+
Sbjct: 49 VAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYK------------SYLVGEELW 94
Query: 158 NKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217
+++E+ GG L + I ++ RL+E+
Sbjct: 95 ----------------------------------VLMEFLQGGALTD-IVSQTRLNEEQI 119
Query: 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
+L A+ +LH + +IHRDIK++++ L++ G VKL D GF ++ +
Sbjct: 120 ATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-11
Identities = 52/200 (26%), Positives = 83/200 (41%), Gaps = 56/200 (28%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKI--LDKAKLTPKARKMLSREIVS 122
+K +LG G ++TV Y T +A+K LD + TP REI
Sbjct: 2 FKQLEKLGEGTYATV-------YKGRNRTTGEIVALKEIHLDAEEGTPSTA---IREISL 51
Query: 123 MESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYE 182
M+ + H NI+RL++V+ T K+ LV EY + D K Y
Sbjct: 52 MKELKHENIVRLHDVIHTENKLMLVFEYM----------------DKDLKKY-------- 87
Query: 183 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIK 242
++T G G L + K + Q+L + H+ ++HRD+K
Sbjct: 88 -MDTHGV-------------------RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLK 127
Query: 243 AENVFLSVRGIVKLGDLGFS 262
+N+ ++ RG +KL D G +
Sbjct: 128 PQNLLINKRGELKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-11
Identities = 47/193 (24%), Positives = 85/193 (44%), Gaps = 55/193 (28%)
Query: 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKA--RKMLSREIVSMESVHH 128
+G+G+F V +A H+ + A+K+L K + K + ++S V +++V H
Sbjct: 3 IGKGSFGKVLLARHK-------AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 55
Query: 129 PNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFG 188
P ++ L+ +T K++ V++Y +GGEL+ + E
Sbjct: 56 PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE------------------------- 90
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
+ FL E A+ Y +I SA+ +LH +I++RD+K EN+ L
Sbjct: 91 RCFL---------------------EPRARFYAAEIASALGYLHSLNIVYRDLKPENILL 129
Query: 249 SVRGIVKLGDLGF 261
+G + L D G
Sbjct: 130 DSQGHIVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-11
Identities = 28/77 (36%), Positives = 46/77 (59%), Gaps = 1/77 (1%)
Query: 190 IFLVVEYASGGELYNKITT-EGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
++LV++Y GG+L ++ E RL ED A+ Y +++ A+ +H +HRDIK +NV L
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL 135
Query: 249 SVRGIVKLGDLGFSTKL 265
G ++L D G +L
Sbjct: 136 DKNGHIRLADFGSCLRL 152
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-11
Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 49/170 (28%)
Query: 98 LAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELY 157
+A+K +D K + R++L E+V M H N++ +Y Y G EL+
Sbjct: 48 VAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYN------------SYLVGDELW 93
Query: 158 NKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217
+V+E+ GG L + I T R++E+
Sbjct: 94 ----------------------------------VVMEFLEGGALTD-IVTHTRMNEEQI 118
Query: 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
L +L A+ LH + +IHRDIK++++ L+ G VKL D GF ++ +
Sbjct: 119 AAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-11
Identities = 29/79 (36%), Positives = 48/79 (60%), Gaps = 1/79 (1%)
Query: 190 IFLVVEYASGGELYNKITT-EGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
++LV++Y GG+L ++ E RL ED A+ Y +++ A+ +H +HRDIK +NV L
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL 135
Query: 249 SVRGIVKLGDLGFSTKLQQ 267
+ G ++L D G K+ Q
Sbjct: 136 DMNGHIRLADFGSCLKMNQ 154
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 44/137 (32%), Positives = 66/137 (48%), Gaps = 18/137 (13%)
Query: 140 TFGKIFLVVEYASGGELYN-KITTEGRLSEDD---------------AKIYFLQILLYEV 183
+FGK+ L E ELY KI + + +DD K FL L+
Sbjct: 12 SFGKVMLA-ERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLT-QLHSC 69
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+T +++ V+EY +GG+L +I GR E A Y +I + LH + II+RD+K
Sbjct: 70 FQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKL 129
Query: 244 ENVFLSVRGIVKLGDLG 260
+NV L G +K+ D G
Sbjct: 130 DNVMLDSEGHIKIADFG 146
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 29/82 (35%), Positives = 49/82 (59%)
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
L+ +T K++ V+++ +GGEL+ + E E A+ Y +I SA+ +LH +I++R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 240 DIKAENVFLSVRGIVKLGDLGF 261
D+K EN+ L +G V L D G
Sbjct: 121 DLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-10
Identities = 28/83 (33%), Positives = 50/83 (60%)
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
++ ET + +V+EY GG+ + G L D A++YF + + A+++LH+ I+HR
Sbjct: 66 MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHR 125
Query: 240 DIKAENVFLSVRGIVKLGDLGFS 262
D+K +N+ ++ G +KL D G S
Sbjct: 126 DLKPDNLLITSMGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 28/77 (36%), Positives = 47/77 (61%), Gaps = 1/77 (1%)
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
++++V+EY +GG L + + TE + E + L A++ LH +IHRDIK++N+ L
Sbjct: 90 ELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 148
Query: 249 SVRGIVKLGDLGFSTKL 265
+ G VKL D GF ++
Sbjct: 149 GMDGSVKLTDFGFCAQI 165
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 28/77 (36%), Positives = 46/77 (59%), Gaps = 1/77 (1%)
Query: 190 IFLVVEYASGGELYNKITT-EGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
++LV+EY GG+L + + E + ED A+ Y +++ A+ +H +HRDIK ENV +
Sbjct: 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI 135
Query: 249 SVRGIVKLGDLGFSTKL 265
G +KL D G + +L
Sbjct: 136 DRTGHIKLADFGSAARL 152
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-10
Identities = 35/145 (24%), Positives = 59/145 (40%), Gaps = 46/145 (31%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI ++ + H NI+RLY+VL + K+ LV EY + D K YF
Sbjct: 48 REICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC----------------DQDLKKYF-- 89
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
+ G + + K + Q+L + H +++
Sbjct: 90 ----------------------------DSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVL 121
Query: 238 HRDIKAENVFLSVRGIVKLGDLGFS 262
HRD+K +N+ ++ G +KL D G +
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-10
Identities = 26/78 (33%), Positives = 46/78 (58%)
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS 249
++L++E+ GG++ + + LSE+ + Y + + A+ +H IHRDIK +N+ L
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD 135
Query: 250 VRGIVKLGDLGFSTKLQQ 267
+G VKL D G T L++
Sbjct: 136 AKGHVKLSDFGLCTGLKK 153
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-10
Identities = 28/89 (31%), Positives = 51/89 (57%), Gaps = 1/89 (1%)
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITT-EGRLSEDDAKIYFLQILSAVKHLHDRDIIH 238
L+ + ++LV++Y GG+L ++ E RL ED A+ Y +++ A+ +H +H
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH 125
Query: 239 RDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
RDIK +N+ + + G ++L D G KL +
Sbjct: 126 RDIKPDNILMDMNGHIRLADFGSCLKLME 154
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-10
Identities = 42/199 (21%), Positives = 73/199 (36%), Gaps = 51/199 (25%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
K +LG G+F V++ ++ P+ +A+K L + R REI + +
Sbjct: 7 KFIKQLGEGHFGKVELCRYD---PLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRT 62
Query: 126 VHHPNIIRLYEVLETFGK--IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ H NI++ V E G + L++EY G L L +I ++LL+
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSL------RDYLQRHRDQINLKRLLLFS- 115
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
QI + +L + IHRD+ A
Sbjct: 116 --------------------------------------SQICKGMDYLGSQRYIHRDLAA 137
Query: 244 ENVFLSVRGIVKLGDLGFS 262
N+ + +VK+ D G +
Sbjct: 138 RNILVESEDLVKISDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 27/86 (31%), Positives = 46/86 (53%)
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
+ LY + ++ V++Y GG++ + + G ED A+ Y ++ AV+ +H I
Sbjct: 64 VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFI 123
Query: 238 HRDIKAENVFLSVRGIVKLGDLGFST 263
HRDIK +N+ + G +KL D G T
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCT 149
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-10
Identities = 45/144 (31%), Positives = 68/144 (47%), Gaps = 19/144 (13%)
Query: 141 FGKIFLVVEYASGGELYNKITTEGRLSEDD------------AKIY--FLQILLYEVLET 186
FG++ A+G K + RL + AK++ F+ L Y +T
Sbjct: 6 FGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY-AFQT 64
Query: 187 FGKIFLVVEYASGGEL----YNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIK 242
+ LV+ +GG+L YN E A Y QI+S ++HLH R II+RD+K
Sbjct: 65 KTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLK 124
Query: 243 AENVFLSVRGIVKLGDLGFSTKLQ 266
ENV L G V++ DLG + +L+
Sbjct: 125 PENVLLDNDGNVRISDLGLAVELK 148
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-10
Identities = 25/78 (32%), Positives = 47/78 (60%)
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS 249
++L++E+ GG++ + + L+E++ + Y + + A+ +H IHRDIK +N+ L
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD 135
Query: 250 VRGIVKLGDLGFSTKLQQ 267
+G VKL D G T L++
Sbjct: 136 SKGHVKLSDFGLCTGLKK 153
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-10
Identities = 30/76 (39%), Positives = 42/76 (55%), Gaps = 2/76 (2%)
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS 249
IF+ E+ GG + + + G L E Y QIL V +LH+ ++HRDIK NV L
Sbjct: 79 IFM--EFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM 136
Query: 250 VRGIVKLGDLGFSTKL 265
GI+KL D G + +L
Sbjct: 137 PNGIIKLIDFGCARRL 152
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-10
Identities = 32/83 (38%), Positives = 46/83 (55%), Gaps = 2/83 (2%)
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGR--LSEDDAKIYFLQILSAVKHLHDRDIIHRDIK 242
ET + LV+ +GG+L I G E A Y QI+ ++HLH R I++RD+K
Sbjct: 63 ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLK 122
Query: 243 AENVFLSVRGIVKLGDLGFSTKL 265
ENV L G V++ DLG + +L
Sbjct: 123 PENVLLDDHGNVRISDLGLAVEL 145
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 5e-10
Identities = 30/77 (38%), Positives = 47/77 (61%), Gaps = 1/77 (1%)
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
++F+V+EY +GG L + + TE + E + L A++ LH +IHRDIK++NV L
Sbjct: 90 ELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL 148
Query: 249 SVRGIVKLGDLGFSTKL 265
+ G VKL D GF ++
Sbjct: 149 GMDGSVKLTDFGFCAQI 165
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-10
Identities = 41/137 (29%), Positives = 72/137 (52%), Gaps = 15/137 (10%)
Query: 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI---------LLYEVLETF---G 188
FGK++ +G K+ SE++ + Y ++I + ++L F G
Sbjct: 25 FGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82
Query: 189 KIFLVVEYASGGELYNKITTEGR-LSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVF 247
K+++++E+ GG + + R L+E ++ Q+L A+++LH IIHRD+KA NV
Sbjct: 83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVL 142
Query: 248 LSVRGIVKLGDLGFSTK 264
L++ G +KL D G S K
Sbjct: 143 LTLDGDIKLADFGVSAK 159
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-10
Identities = 29/81 (35%), Positives = 46/81 (56%)
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
LY +T +F V+E+ +GG+L I +GR A Y +I+ ++ LH + II+R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 240 DIKAENVFLSVRGIVKLGDLG 260
D+K +NV L G +K+ D G
Sbjct: 121 DLKLDNVMLDRDGHIKIADFG 141
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 24/77 (31%), Positives = 45/77 (58%)
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS 249
++L++EY GG++ + + +E++ + Y + + A+ +H IHRDIK +N+ L
Sbjct: 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD 135
Query: 250 VRGIVKLGDLGFSTKLQ 266
+G +KL D G T L+
Sbjct: 136 AKGHIKLSDFGLCTGLK 152
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 37/146 (25%), Positives = 60/146 (41%), Gaps = 44/146 (30%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI ++ + HPN++ L + + VE
Sbjct: 56 REIKILKKLKHPNVVPLID---------MAVERPD------------------------- 81
Query: 178 ILLYEVLETFGKIFLVVEYAS---GGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR 234
+ G +++V Y G L N +L+E K Y LQ+L + +LH+
Sbjct: 82 ----KSKRKRGSVYMVTPYMDHDLSGLLENPSV---KLTESQIKCYMLQLLEGINYLHEN 134
Query: 235 DIIHRDIKAENVFLSVRGIVKLGDLG 260
I+HRDIKA N+ + +GI+K+ D G
Sbjct: 135 HILHRDIKAANILIDNQGILKIADFG 160
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 22/74 (29%), Positives = 47/74 (63%)
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
K+ +++ +GG+L+ ++ G SE + + Y +I+ ++H+H+R +++RD+K N+ L
Sbjct: 71 KLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL 130
Query: 249 SVRGIVKLGDLGFS 262
G V++ DLG +
Sbjct: 131 DEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 27/84 (32%), Positives = 45/84 (53%)
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
LY + ++L++E+ GG+L + SED + Y + + A++ +H IHR
Sbjct: 66 LYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHR 125
Query: 240 DIKAENVFLSVRGIVKLGDLGFST 263
DIK +N+ + G +KL D G ST
Sbjct: 126 DIKPDNILIDRGGHIKLSDFGLST 149
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-09
Identities = 30/78 (38%), Positives = 47/78 (60%), Gaps = 5/78 (6%)
Query: 192 LVVEYASGGELYNKIT----TEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVF 247
++ EY G +L K+ T LSE+ +F+Q+L V ++H R I+HRD+KA+N+F
Sbjct: 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIF 138
Query: 248 LSVRGIVKLGDLGFSTKL 265
L ++K+GD G S L
Sbjct: 139 LK-NNLLKIGDFGVSRLL 155
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-09
Identities = 34/83 (40%), Positives = 50/83 (60%), Gaps = 6/83 (7%)
Query: 187 FGKIFLVVEYASGGELYNKITTE-GRLSEDDAKIYFL--QILSAVKHLHDRDIIHRDIKA 243
F KIF+ E GG L + ++ G L +++ I F QIL +K+LHD I+HRDIK
Sbjct: 79 FFKIFM--EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKG 136
Query: 244 ENVFLSV-RGIVKLGDLGFSTKL 265
+NV ++ G+VK+ D G S +L
Sbjct: 137 DNVLVNTYSGVVKISDFGTSKRL 159
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 48/220 (21%), Positives = 83/220 (37%), Gaps = 64/220 (29%)
Query: 55 ETSLGKRVALYK-LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKAR 113
S+ +R Y LG G + V+ A Y + ++ +KI++ + K R
Sbjct: 3 SFSISER---YIQKGAHLGEGTYGKVEKA----YDTLTGKIVAIKKVKIIEISNDVTKDR 55
Query: 114 KMLS---------REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEG 164
+++ RE+ M + H NI+ L +V I LV++ +
Sbjct: 56 QLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS----------- 104
Query: 165 RLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 224
D K+ + KI RL+E K LQI
Sbjct: 105 ----DLKKV----------------------------VDRKI----RLTESQVKCILLQI 128
Query: 225 LSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264
L+ + LH +HRD+ N+F++ +GI K+ D G + +
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARR 168
|
Length = 335 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 32/111 (28%), Positives = 61/111 (54%), Gaps = 13/111 (11%)
Query: 167 SEDDAKIYFLQI---------LLYEVLETF---GKIFLVVEYASGGELYN-KITTEGRLS 213
SE++ + Y ++I + ++L+ F +++++E+ +GG + + E L+
Sbjct: 42 SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT 101
Query: 214 EDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264
E ++ Q L A+ +LH+ IIHRD+KA N+ ++ G +KL D G S K
Sbjct: 102 EPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAK 152
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-09
Identities = 26/61 (42%), Positives = 37/61 (60%), Gaps = 1/61 (1%)
Query: 201 ELYNKITTE-GRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDL 259
+LY +T L D A I QIL +++LH + IIHRD+K EN+F++ V +GDL
Sbjct: 142 DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDL 201
Query: 260 G 260
G
Sbjct: 202 G 202
|
Length = 357 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 3e-09
Identities = 28/77 (36%), Positives = 47/77 (61%), Gaps = 1/77 (1%)
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
++++V+EY +GG L + + TE + E + L A++ LH +IHRDIK++N+ L
Sbjct: 91 ELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149
Query: 249 SVRGIVKLGDLGFSTKL 265
+ G VKL D GF ++
Sbjct: 150 GMDGSVKLTDFGFCAQI 166
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-09
Identities = 23/79 (29%), Positives = 48/79 (60%)
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
T K+ +++ +GG+L+ ++ G SE + + Y +I+ ++H+H+R +++RD+K
Sbjct: 66 FHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKP 125
Query: 244 ENVFLSVRGIVKLGDLGFS 262
N+ L G V++ DLG +
Sbjct: 126 ANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 37/153 (24%), Positives = 60/153 (39%), Gaps = 52/153 (33%)
Query: 118 REIVSMESVHHPNIIRLYEVL--ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 175
REI + + H N++ L EV ++L+ +YA E D
Sbjct: 51 REIALLRELKHENVVSLVEVFLEHADKSVYLLFDYA----------------EHD----L 90
Query: 176 LQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL--QILSAVKHLHD 233
QI+ + R+S + + L QIL+ V +LH
Sbjct: 91 WQIIKFH------------------------RQAKRVSIPPSMVKSLLWQILNGVHYLHS 126
Query: 234 RDIIHRDIKAENVFL----SVRGIVKLGDLGFS 262
++HRD+K N+ + RG+VK+GDLG +
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 36/136 (26%), Positives = 66/136 (48%), Gaps = 16/136 (11%)
Query: 140 TFGKIFLVVEYASGGELY--NKITTEGRLSEDDAKIYFLQ--IL-----------LYEVL 184
+FGK+FL E + + + + L +DD + ++ +L LY
Sbjct: 7 SFGKVFLA-ELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF 65
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+T +F V+EY +GG+L I + + A Y +I+ ++ LH + I++RD+K +
Sbjct: 66 QTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLD 125
Query: 245 NVFLSVRGIVKLGDLG 260
N+ L G +K+ D G
Sbjct: 126 NILLDTDGHIKIADFG 141
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 4e-09
Identities = 28/77 (36%), Positives = 46/77 (59%), Gaps = 1/77 (1%)
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
++++V+EY +GG L + + TE + E + L A+ LH +IHRDIK++N+ L
Sbjct: 90 ELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL 148
Query: 249 SVRGIVKLGDLGFSTKL 265
+ G VKL D GF ++
Sbjct: 149 GMDGSVKLTDFGFCAQI 165
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-09
Identities = 29/88 (32%), Positives = 44/88 (50%)
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
L E GK++LV EY L + + + Y Q++ A+ H DI+HR
Sbjct: 65 LKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHR 124
Query: 240 DIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
DIK EN+ +S ++KL D GF+ L +
Sbjct: 125 DIKPENLLISHNDVLKLCDFGFARNLSE 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 5e-09
Identities = 46/200 (23%), Positives = 69/200 (34%), Gaps = 64/200 (32%)
Query: 69 NELGRGNFSTVKMAIH------EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVS 122
ELG GNF +V ++ E+ V A+K L + + ++ L RE
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEV----------AVKTLKQEHIAAGKKEFL-REASV 49
Query: 123 MESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYE 182
M + HP I+RL V + GE
Sbjct: 50 MAQLDHPCIVRLIGVCK--------------GE--------------------------- 68
Query: 183 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIK 242
+ LV+E A G L + + D K Q+ + +L + +HRD+
Sbjct: 69 ------PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLA 122
Query: 243 AENVFLSVRGIVKLGDLGFS 262
A NV L R K+ D G S
Sbjct: 123 ARNVLLVNRHQAKISDFGMS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 5e-09
Identities = 21/45 (46%), Positives = 33/45 (73%)
Query: 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
Q+L AV+++HD+ +IHRDIK EN+FL+ G + LGD G + ++
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK 319
|
Length = 501 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-09
Identities = 32/82 (39%), Positives = 45/82 (54%), Gaps = 4/82 (4%)
Query: 188 GKIFLVVEYASGG---ELYNKITTEG-RLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
G+++LV+E +GG EL + G RL E L ++HLH+ IIHRD+K
Sbjct: 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKG 156
Query: 244 ENVFLSVRGIVKLGDLGFSTKL 265
N+ L+ G VKL D G S +L
Sbjct: 157 NNILLTTEGGVKLVDFGVSAQL 178
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-09
Identities = 24/77 (31%), Positives = 43/77 (55%)
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS 249
++ V++Y GG++ + + G ED A+ Y ++ A++ +H IHRDIK +N+ +
Sbjct: 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID 135
Query: 250 VRGIVKLGDLGFSTKLQ 266
G +KL D G T +
Sbjct: 136 RDGHIKLTDFGLCTGFR 152
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 6e-09
Identities = 27/79 (34%), Positives = 48/79 (60%), Gaps = 1/79 (1%)
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
++++++EYA GG + + G ++E + ++L A+K++H +IHRDIKA N+ +
Sbjct: 76 RLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV 134
Query: 249 SVRGIVKLGDLGFSTKLQQ 267
+ G VKL D G + L Q
Sbjct: 135 TNTGNVKLCDFGVAALLNQ 153
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 6e-09
Identities = 45/195 (23%), Positives = 72/195 (36%), Gaps = 55/195 (28%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
KL+ +LG G F V M + A+K L ++P+A +E M+
Sbjct: 9 KLERKLGAGQFGEVWMGTWNGTTKV--------AVKTLKPGTMSPEA---FLQEAQIMKK 57
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+ H +++LY V I++V EY S G L + L + K L L
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD------FLKSGEGKKLRLPQL------ 105
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
V+ A+ QI + +L R+ IHRD+ A N
Sbjct: 106 --------VDMAA------------------------QIAEGMAYLESRNYIHRDLAARN 133
Query: 246 VFLSVRGIVKLGDLG 260
+ + + K+ D G
Sbjct: 134 ILVGENLVCKIADFG 148
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 7e-09
Identities = 35/143 (24%), Positives = 60/143 (41%), Gaps = 44/143 (30%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI ++ + HPNI+ L +VL +++L+ E FL
Sbjct: 48 REISLLKELQHPNIVCLQDVLMQESRLYLIFE-------------------------FLS 82
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
+ L + L++ K G+ + K Y QIL + H R ++
Sbjct: 83 MDLKKYLDSLPK----------GQYMDAELV---------KSYLYQILQGILFCHSRRVL 123
Query: 238 HRDIKAENVFLSVRGIVKLGDLG 260
HRD+K +N+ + +G++KL D G
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFG 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 7e-09
Identities = 56/222 (25%), Positives = 87/222 (39%), Gaps = 48/222 (21%)
Query: 46 LQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILC-TYISYLAIKILD 104
L D +W+ R+ L K LG G F V A V + S +A+K+L
Sbjct: 1 LPLDPEWELPRD---RLTLGKP---LGEGAFGQVVKAE---AVGLDNPNETSTVAVKML- 50
Query: 105 KAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTE 163
K T K L E+ M+ + H NII L V G +++VVEYA+ G L +
Sbjct: 51 KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRD----- 105
Query: 164 GRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNK---ITTEGRLSEDDAKIY 220
FL+ GE + E L++ D +
Sbjct: 106 -----------FLR-----------------ARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
Q+ ++ L + IHRD+ A NV ++ ++K+ D G +
Sbjct: 138 AYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA 179
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 7e-09
Identities = 23/75 (30%), Positives = 41/75 (54%), Gaps = 1/75 (1%)
Query: 192 LVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVR 251
L VE+ +GG + + ++ G E Y Q+L + +LH+ IIHRD+K N+ +
Sbjct: 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDST 139
Query: 252 G-IVKLGDLGFSTKL 265
G +++ D G + +L
Sbjct: 140 GQRLRIADFGAAARL 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 8e-09
Identities = 26/85 (30%), Positives = 47/85 (55%)
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
+LL++++ T + LV EY G L ++ K++ Q+L + ++H R I+
Sbjct: 66 VLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYIL 125
Query: 238 HRDIKAENVFLSVRGIVKLGDLGFS 262
HRD+K +N+ +S G +KL D G +
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 9e-09
Identities = 40/145 (27%), Positives = 65/145 (44%), Gaps = 49/145 (33%)
Query: 118 REIVSMESV-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 176
REI+ ++ + HPNI++L V++ +E+D IY
Sbjct: 55 REIMFLQELGDHPNIVKLLNVIK---------------------------AENDKDIY-- 85
Query: 177 QILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY-FLQILSAVKHLHDRD 235
L++E +ET +L+ I + ED K Y Q+L A+K++H +
Sbjct: 86 --LVFEYMET--------------DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN 127
Query: 236 IIHRDIKAENVFLSVRGIVKLGDLG 260
+IHRD+K N+ L+ VKL D G
Sbjct: 128 VIHRDLKPSNILLNSDCRVKLADFG 152
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 9e-09
Identities = 32/145 (22%), Positives = 58/145 (40%), Gaps = 45/145 (31%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI ++ ++HPNI++L +V+ T K++LV E+ L +D K
Sbjct: 48 REISLLKELNHPNIVKLLDVIHTENKLYLVFEF---------------LHQDLKK----- 87
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
+ + + K Y Q+L + H ++
Sbjct: 88 -------------------------FMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVL 122
Query: 238 HRDIKAENVFLSVRGIVKLGDLGFS 262
HRD+K +N+ ++ G +KL D G +
Sbjct: 123 HRDLKPQNLLINTEGAIKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 9e-09
Identities = 26/77 (33%), Positives = 41/77 (53%)
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
K+++ +E+ GG L + G LSE + L + +LH + +HRDIK N+ L
Sbjct: 80 KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL 139
Query: 249 SVRGIVKLGDLGFSTKL 265
+ G VKL D G S ++
Sbjct: 140 TDNGHVKLADFGVSAQI 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 44/164 (26%), Positives = 66/164 (40%), Gaps = 46/164 (28%)
Query: 99 AIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYN 158
AIK +++ P +K+ REI ++ + HPN++ L EV K+ LV E
Sbjct: 30 AIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE--------- 80
Query: 159 KITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218
Y +L E LE + G + E K
Sbjct: 81 ---------------YCDHTVLNE-LE---------KNPRG------------VPEHLIK 103
Query: 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
Q L AV H + IHRD+K EN+ ++ +G +KL D GF+
Sbjct: 104 KIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFA 147
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 33/143 (23%), Positives = 58/143 (40%), Gaps = 45/143 (31%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI ++ ++HPNI+RL +V+ + K++LV E FL
Sbjct: 47 REISLLKELNHPNIVRLLDVVHSENKLYLVFE-------------------------FLD 81
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
+ L + +++ L K Y Q+L + + H ++
Sbjct: 82 LDLKKYMDSSPLT--------------------GLDPPLIKSYLYQLLQGIAYCHSHRVL 121
Query: 238 HRDIKAENVFLSVRGIVKLGDLG 260
HRD+K +N+ + G +KL D G
Sbjct: 122 HRDLKPQNLLIDREGALKLADFG 144
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 26/78 (33%), Positives = 46/78 (58%), Gaps = 1/78 (1%)
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS 249
+++V+EY GG+L N + + + E AK Y +++ A+ +H +IHRD+K +N+ L
Sbjct: 118 LYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD 176
Query: 250 VRGIVKLGDLGFSTKLQQ 267
G +KL D G K+ +
Sbjct: 177 KHGHLKLADFGTCMKMDE 194
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 29/81 (35%), Positives = 47/81 (58%), Gaps = 2/81 (2%)
Query: 189 KIFLVVEYASGGELYNKI-TTEGRLSEDDAKIYFL-QILSAVKHLHDRDIIHRDIKAENV 246
+++LV+E+ G + + + T+G ++D Y +IL + HLH +IHRDIK +NV
Sbjct: 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNV 152
Query: 247 FLSVRGIVKLGDLGFSTKLQQ 267
L+ VKL D G S +L +
Sbjct: 153 LLTENAEVKLVDFGVSAQLDR 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 25/76 (32%), Positives = 44/76 (57%), Gaps = 1/76 (1%)
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS 249
+++V+EY GG+L N + + + E A+ Y +++ A+ +H IHRD+K +N+ L
Sbjct: 118 LYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 176
Query: 250 VRGIVKLGDLGFSTKL 265
G +KL D G K+
Sbjct: 177 KSGHLKLADFGTCMKM 192
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 24/161 (14%)
Query: 129 PNIIRLYEVLET-----FGKIFLVVEYASGGELYNKITTE---------------GRLSE 168
P+ +E++ET +GK+F V+ +G + KI LS+
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSD 73
Query: 169 DDAKIYFLQILLYEVLETFGKIFLVVEYASGG---ELYNKITTEG-RLSEDDAKIYFLQI 224
+ F + + ++ +++LV+E +GG +L G R+ E +
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 225 LSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
L ++HLH IHRD+K N+ L+ G VKL D G S +L
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 3e-08
Identities = 30/77 (38%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
K+++++EY GG + + G L E +IL + +LH IHRDIKA NV L
Sbjct: 76 KLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL 134
Query: 249 SVRGIVKLGDLGFSTKL 265
S G VKL D G + +L
Sbjct: 135 SEHGEVKLADFGVAGQL 151
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 24/84 (28%), Positives = 44/84 (52%)
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
LY + ++ V++Y GG++ + + E A+ Y ++ A++ +H IHR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125
Query: 240 DIKAENVFLSVRGIVKLGDLGFST 263
DIK +N+ + + G +KL D G T
Sbjct: 126 DIKPDNILIDLDGHIKLTDFGLCT 149
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-08
Identities = 27/77 (35%), Positives = 41/77 (53%)
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
K+++ +EY GG L + G LSE + L + +LH + +HRDIK N+ L
Sbjct: 80 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL 139
Query: 249 SVRGIVKLGDLGFSTKL 265
+ G VKL D G + K+
Sbjct: 140 TDNGDVKLADFGVAAKI 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 3e-08
Identities = 42/164 (25%), Positives = 61/164 (37%), Gaps = 46/164 (28%)
Query: 99 AIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYN 158
AIK L KA + K R E M HPNIIRL V+ + ++ EY G L
Sbjct: 36 AIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLD- 93
Query: 159 KITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218
L E+D K Q++ G L
Sbjct: 94 -----KFLRENDGKFTVGQLV--------------------GMLRG-------------- 114
Query: 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
I S +K+L + + +HRD+ A N+ ++ + K+ D G S
Sbjct: 115 -----IASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-08
Identities = 48/196 (24%), Positives = 73/196 (37%), Gaps = 35/196 (17%)
Query: 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV 126
L+ ELG G F V + E Y +A+K L K + ARK RE + +
Sbjct: 9 LKRELGEGAFGKVFLG--ECYHLEPENDKELVAVKTL-KETASNDARKDFEREAELLTNF 65
Query: 127 HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLET 186
H NI++ Y V +V EY G+L + + G DA
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGP----DAAF------------- 108
Query: 187 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENV 246
L + + G L+ +QI S + +L + +HRD+ N
Sbjct: 109 ---------------LKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNC 153
Query: 247 FLSVRGIVKLGDLGFS 262
+ +VK+GD G S
Sbjct: 154 LVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 4e-08
Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 3/95 (3%)
Query: 175 FLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI--YFLQILSAVKHLH 232
F+ L Y E+ + LV+ +GG+L I G + ++ Y QI + HLH
Sbjct: 54 FIVNLAY-AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH 112
Query: 233 DRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
DI++RD+K ENV L +G +L DLG + +L+
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 29/87 (33%), Positives = 49/87 (56%), Gaps = 1/87 (1%)
Query: 176 LQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRD 235
L IL ++ F +I++V E +L+ I + LS D K++ QIL +K+LH
Sbjct: 65 LDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG 123
Query: 236 IIHRDIKAENVFLSVRGIVKLGDLGFS 262
I+HRDIK N+ ++ ++K+ D G +
Sbjct: 124 ILHRDIKPGNLLVNSNCVLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-08
Identities = 29/81 (35%), Positives = 47/81 (58%), Gaps = 2/81 (2%)
Query: 189 KIFLVVEYASGGELYNKI-TTEGRLSEDDAKIYFL-QILSAVKHLHDRDIIHRDIKAENV 246
+++LV+E+ G + + I T+G +++ Y +IL + HLH +IHRDIK +NV
Sbjct: 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNV 142
Query: 247 FLSVRGIVKLGDLGFSTKLQQ 267
L+ VKL D G S +L +
Sbjct: 143 LLTENAEVKLVDFGVSAQLDR 163
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-08
Identities = 30/77 (38%), Positives = 43/77 (55%), Gaps = 1/77 (1%)
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
K+++++EY GG + + G L E +IL + +LH IHRDIKA NV L
Sbjct: 76 KLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL 134
Query: 249 SVRGIVKLGDLGFSTKL 265
S +G VKL D G + +L
Sbjct: 135 SEQGDVKLADFGVAGQL 151
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-08
Identities = 41/168 (24%), Positives = 74/168 (44%), Gaps = 23/168 (13%)
Query: 95 ISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGG 154
+ +A+K+L + + + R +LS E ++ V+HP++I+LY G + L+VEYA G
Sbjct: 30 YTTVAVKMLKENASSSELRDLLS-EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG 88
Query: 155 ELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214
L + + R S Y + + Y E L+
Sbjct: 89 SLRSFL----RESRKVGPSY------------------LGSDGNRNSSYLDNPDERALTM 126
Query: 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
D + QI +++L + ++HRD+ A NV ++ +K+ D G S
Sbjct: 127 GDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-08
Identities = 25/65 (38%), Positives = 36/65 (55%)
Query: 201 ELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLG 260
+L+ + G L + A ++L A+ +LH R IIHRD+K EN+FL LGD G
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG 230
Query: 261 FSTKL 265
+ KL
Sbjct: 231 AACKL 235
|
Length = 392 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 8e-08
Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
K+++++EY GG + + G E +IL + +LH IHRDIKA NV L
Sbjct: 76 KLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL 134
Query: 249 SVRGIVKLGDLGFSTKL 265
S +G VKL D G + +L
Sbjct: 135 SEQGDVKLADFGVAGQL 151
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 8e-08
Identities = 36/148 (24%), Positives = 60/148 (40%), Gaps = 42/148 (28%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI + ++H NI+ L E++ + DA
Sbjct: 55 REIKILRQLNHRNIVNLKEIV---------------------------TDKQDA------ 81
Query: 178 ILLYEVLETFGKIFLVVEYASG---GELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR 234
+ + G +LV EY G L + + SED K + Q+L + + H +
Sbjct: 82 ---LDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKSFMKQLLEGLNYCHKK 135
Query: 235 DIIHRDIKAENVFLSVRGIVKLGDLGFS 262
+ +HRDIK N+ L+ +G +KL D G +
Sbjct: 136 NFLHRDIKCSNILLNNKGQIKLADFGLA 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 9e-08
Identities = 49/197 (24%), Positives = 80/197 (40%), Gaps = 53/197 (26%)
Query: 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHH 128
+ELG GN V H+ I+ + +L IK P R + RE+ + +
Sbjct: 11 SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--------PAIRNQIIRELQVLHECNS 62
Query: 129 PNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFG 188
P I+ Y + G+I + +E+ GG L + GR+ E QIL G
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--------QIL--------G 106
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
K+ + V ++ L+ ++ H I+HRD+K N+ +
Sbjct: 107 KVSIAV---------------------------IKGLTYLREKHK--IMHRDVKPSNILV 137
Query: 249 SVRGIVKLGDLGFSTKL 265
+ RG +KL D G S +L
Sbjct: 138 NSRGEIKLCDFGVSGQL 154
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 24/73 (32%), Positives = 41/73 (56%)
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS 249
++LV+E+ GGE + + R D Y QI+ ++L +I++RD+K EN+ L
Sbjct: 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD 165
Query: 250 VRGIVKLGDLGFS 262
G +K+ D GF+
Sbjct: 166 KDGFIKMTDFGFA 178
|
Length = 340 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 27/75 (36%), Positives = 37/75 (49%), Gaps = 10/75 (13%)
Query: 191 FLVVEYASGG-----ELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
+LV+EY G E++ K L E + L + +LH + IHRDIKA N
Sbjct: 91 WLVMEYCLGSASDILEVHKK-----PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGN 145
Query: 246 VFLSVRGIVKLGDLG 260
+ L+ G VKL D G
Sbjct: 146 ILLTEPGTVKLADFG 160
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 1e-07
Identities = 28/73 (38%), Positives = 42/73 (57%), Gaps = 2/73 (2%)
Query: 174 YFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHD 233
F I LY + T L+++Y G+L++ + EG+LSE + K Q++ A+ LH
Sbjct: 70 NF--IKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 234 RDIIHRDIKAENV 246
+IIH DIK ENV
Sbjct: 128 HNIIHNDIKLENV 140
|
Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 33/145 (22%), Positives = 56/145 (38%), Gaps = 38/145 (26%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI ++ + H N++ L E+ K T R Y
Sbjct: 60 REIKILQLLKHENVVNLIEIC------------------RTKATPYNR---YKGSFYL-- 96
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
+F E+ G L NK + + + K +L+ + ++H I+
Sbjct: 97 ------------VFEFCEHDLAGLLSNKNV---KFTLSEIKKVMKMLLNGLYYIHRNKIL 141
Query: 238 HRDIKAENVFLSVRGIVKLGDLGFS 262
HRD+KA N+ ++ GI+KL D G +
Sbjct: 142 HRDMKAANILITKDGILKLADFGLA 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 35/114 (30%), Positives = 54/114 (47%), Gaps = 10/114 (8%)
Query: 159 KITTEGRLSEDD----AKIYF-LQ----ILLYEVLETFGKIFLVVEYASGGELYNKI-TT 208
K+ EG +SEDD AK+ L + LY V IF+V EY + G L N +
Sbjct: 34 KMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRER 93
Query: 209 EGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
+G+L + + A+++L IHRD+ A N + +VK+ D G +
Sbjct: 94 KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLA 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 37/149 (24%), Positives = 54/149 (36%), Gaps = 45/149 (30%)
Query: 118 REIVSM---ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 174
REI + ES HPNI+RL +V + EL
Sbjct: 47 REIALLKQLESFEHPNIVRLLDVCHG---------PRTDREL------------------ 79
Query: 175 FLQILLYEVLETFGKIFLVVEYASGG-ELYNKITTEGRLSEDDAKIYFLQILSAVKHLHD 233
K+ LV E+ Y + L + K Q+L V LH
Sbjct: 80 --------------KLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS 125
Query: 234 RDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
I+HRD+K +N+ ++ G VK+ D G +
Sbjct: 126 HRIVHRDLKPQNILVTSDGQVKIADFGLA 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 27/85 (31%), Positives = 46/85 (54%), Gaps = 2/85 (2%)
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGR--LSEDDAKIYFLQILSAVKHLHDRDIIHRDIK 242
ET + LV+ +GG+L I G E+ A Y +IL ++ LH + ++RD+K
Sbjct: 70 ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLK 129
Query: 243 AENVFLSVRGIVKLGDLGFSTKLQQ 267
EN+ L G +++ DLG + K+ +
Sbjct: 130 PENILLDDYGHIRISDLGLAVKIPE 154
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 26/74 (35%), Positives = 40/74 (54%), Gaps = 1/74 (1%)
Query: 190 IFLVVEYASGGELYNKITTEG-RLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
+++V+E A GEL + + L +Y Q+ +A+ +L + +HRDI A NV +
Sbjct: 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV 140
Query: 249 SVRGIVKLGDLGFS 262
S VKLGD G S
Sbjct: 141 SSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-07
Identities = 24/83 (28%), Positives = 46/83 (55%), Gaps = 2/83 (2%)
Query: 174 YFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHD 233
+ + Y V E +FLV+++A GG+L++ I+ + E+ K + +++ A+ LH
Sbjct: 46 NMVCLHKYIVSED--SVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHR 103
Query: 234 RDIIHRDIKAENVFLSVRGIVKL 256
I+ RD+ N+ L RG ++L
Sbjct: 104 EGIVCRDLNPNNILLDDRGHIQL 126
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 47/196 (23%), Positives = 76/196 (38%), Gaps = 53/196 (27%)
Query: 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHP 129
ELG GN V H+ I+ + +L IK P R + RE+ + + P
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--------PAIRNQIIRELQVLHECNSP 63
Query: 130 NIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGK 189
I+ Y + G+I + +E+ GG L + R+ E E GK
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE----------------EILGK 107
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS 249
+ + V L+ L+ ++ H I+HRD+K N+ ++
Sbjct: 108 VSIAV---------------------------LRGLAYLREKHQ--IMHRDVKPSNILVN 138
Query: 250 VRGIVKLGDLGFSTKL 265
RG +KL D G S +L
Sbjct: 139 SRGEIKLCDFGVSGQL 154
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 31/89 (34%), Positives = 50/89 (56%), Gaps = 4/89 (4%)
Query: 173 IYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL-QILSAVKHL 231
I L I+ E+F +++V E +LY I T+ LS D + YFL QIL +K++
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQ-YFLYQILRGLKYI 122
Query: 232 HDRDIIHRDIKAENVFLSVRGIVKLGDLG 260
H +++HRD+K N+ L+ +K+ D G
Sbjct: 123 HSANVLHRDLKPSNLLLNTNCDLKICDFG 151
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 25/78 (32%), Positives = 45/78 (57%), Gaps = 1/78 (1%)
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS 249
+++V+EY GG+L N + + + E A+ Y +++ A+ +H IHRD+K +N+ L
Sbjct: 118 LYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 176
Query: 250 VRGIVKLGDLGFSTKLQQ 267
G +KL D G K+ +
Sbjct: 177 KSGHLKLADFGTCMKMNK 194
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-07
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 22/125 (17%)
Query: 161 TTEGRLSEDDAKIYFLQILL----------------YEVLETFGKIFLVVEYASGG---E 201
E RL D++K F QI++ Y G +++ +EY G +
Sbjct: 31 MKEIRLELDESK--FNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDK 88
Query: 202 LYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR-DIIHRDIKAENVFLSVRGIVKLGDLG 260
LY + ED + ++ +K L + +IIHRD+K NV ++ G VKL D G
Sbjct: 89 LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFG 148
Query: 261 FSTKL 265
S L
Sbjct: 149 VSGNL 153
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-07
Identities = 47/197 (23%), Positives = 74/197 (37%), Gaps = 33/197 (16%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
+ ELG G F V E+ P + +AIK L + PK ++ +E M
Sbjct: 8 RFLEELGEGAFGKVYKG--ELTGPNERLSATSVAIKTLKE-NAEPKVQQEFRQEAELMSD 64
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+ HPNI+ L V ++ EY + G+L+ + S+
Sbjct: 65 LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSD----------------- 107
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
V SG E T + L D +QI + +++L +HRD+ A N
Sbjct: 108 --------VGAESGDE-----TVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARN 154
Query: 246 VFLSVRGIVKLGDLGFS 262
+ VK+ D G S
Sbjct: 155 CLVGEGLTVKISDFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 21/37 (56%), Positives = 29/37 (78%)
Query: 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLG 260
+L A+++LH+ IIHRDIKAEN+F++ G V LGD G
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG 227
|
Length = 391 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-07
Identities = 24/85 (28%), Positives = 46/85 (54%)
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
+LL++++ T + V EY I G L + +++ Q+L + ++H + I+
Sbjct: 66 VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125
Query: 238 HRDIKAENVFLSVRGIVKLGDLGFS 262
HRD+K +N+ +S G +KL D G +
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-07
Identities = 20/80 (25%), Positives = 44/80 (55%), Gaps = 2/80 (2%)
Query: 190 IFLVVEYASGGELYNKITTEGR--LSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVF 247
+++V EY + G L + + + GR ++ + L + +++L +++ +HRD+ A NV
Sbjct: 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVL 134
Query: 248 LSVRGIVKLGDLGFSTKLQQ 267
+S + K+ D G + + Q
Sbjct: 135 VSEDLVAKVSDFGLAKEASQ 154
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-07
Identities = 27/86 (31%), Positives = 49/86 (56%), Gaps = 2/86 (2%)
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRL-SEDDAKIYFLQILSAVKHLHDRDI 236
+ L++++ T + LV EY +L + G L S + KI+ Q+L + + H R I
Sbjct: 66 VTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKI 124
Query: 237 IHRDIKAENVFLSVRGIVKLGDLGFS 262
+HRD+K +N+ ++ +G +KL D G +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-07
Identities = 26/85 (30%), Positives = 45/85 (52%), Gaps = 2/85 (2%)
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGR--LSEDDAKIYFLQILSAVKHLHDRDIIHRDIK 242
ET + LV+ +GG+L I G E+ A Y +I ++ LH I++RD+K
Sbjct: 70 ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLK 129
Query: 243 AENVFLSVRGIVKLGDLGFSTKLQQ 267
EN+ L G +++ DLG + ++ +
Sbjct: 130 PENILLDDYGHIRISDLGLAVEIPE 154
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 6e-07
Identities = 19/38 (50%), Positives = 26/38 (68%)
Query: 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLG 260
Q+LSA+ ++H IIHRDIK ENV ++ + LGD G
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG 305
|
Length = 461 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 7e-07
Identities = 44/165 (26%), Positives = 64/165 (38%), Gaps = 49/165 (29%)
Query: 99 AIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYN 158
AIK L + K RE+V M+ V+H NII L N
Sbjct: 45 AIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL----------------------N 82
Query: 159 KITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEY--ASGGELYNKITTEGRLSEDD 216
T + + LE F ++LV+E A+ ++ R+S
Sbjct: 83 VFTPQ------------------KSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS--- 121
Query: 217 AKIYFL-QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLG 260
Y L Q+L +KHLH IIHRD+K N+ + +K+ D G
Sbjct: 122 ---YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 163
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-07
Identities = 26/86 (30%), Positives = 48/86 (55%), Gaps = 2/86 (2%)
Query: 179 LLYEVLETFGKIFLVVEYASGGELYNKITTEGR-LSEDDAKIYF-LQILSAVKHLHDRDI 236
LL ++E G +++V EY + G L + + + GR + D + F L + A+++L +
Sbjct: 64 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNF 123
Query: 237 IHRDIKAENVFLSVRGIVKLGDLGFS 262
+HRD+ A NV +S + K+ D G +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLT 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 49/197 (24%), Positives = 77/197 (39%), Gaps = 55/197 (27%)
Query: 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHP 129
ELG GN V +H I+ + +L IK P R + RE+ + + P
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK--------PAIRNQIIRELKVLHECNSP 59
Query: 130 NIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGK 189
I+ Y + G+I + +E+ GG L + GR+ E+ IL GK
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEN--------IL--------GK 103
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHD-RDIIHRDIKAENVFL 248
I + V L + +L + I+HRD+K N+ +
Sbjct: 104 ISIAV------------------------------LRGLTYLREKHKIMHRDVKPSNILV 133
Query: 249 SVRGIVKLGDLGFSTKL 265
+ RG +KL D G S +L
Sbjct: 134 NSRGEIKLCDFGVSGQL 150
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-06
Identities = 53/196 (27%), Positives = 78/196 (39%), Gaps = 52/196 (26%)
Query: 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHP 129
ELG GNF TVK ++++ +A+KIL P + L RE M+ + +P
Sbjct: 2 ELGSGNFGTVKKGMYKMK-----KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNP 56
Query: 130 NIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGK 189
I+R+ + E LV+E A G L NK FLQ
Sbjct: 57 YIVRMIGICEA-ESWMLVMELAELGPL-NK---------------FLQ------------ 87
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS 249
NK TE ++E Q+ +K+L + + +HRD+ A NV L
Sbjct: 88 -------------KNKHVTEKNITE-----LVHQVSMGMKYLEETNFVHRDLAARNVLLV 129
Query: 250 VRGIVKLGDLGFSTKL 265
+ K+ D G S L
Sbjct: 130 TQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 27/86 (31%), Positives = 49/86 (56%), Gaps = 2/86 (2%)
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGR-LSEDDAKIYFLQILSAVKHLHDRDI 236
+ L++++ T + LV EY +L + G +S + KI+ QIL + + H R +
Sbjct: 67 VTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKV 125
Query: 237 IHRDIKAENVFLSVRGIVKLGDLGFS 262
+HRD+K +N+ ++ RG +KL D G +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 13/106 (12%)
Query: 166 LSEDDAKIYFLQILLYE-VLETFGK--IFLVVEYASGGELYNKITTEGR-----LSEDDA 217
LSE IY +++L E V E GK ++LV EY +L + + GR L
Sbjct: 57 LSES---IYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTI 112
Query: 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFL-SVRGIVKLGDLGFS 262
K + Q+L V H H ++HRD+K +N+ + +G++K+ DLG
Sbjct: 113 KSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 23/65 (35%), Positives = 36/65 (55%), Gaps = 2/65 (3%)
Query: 182 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
LE F ++LV G +L N + + +LS+D + QIL +K++H IIHRD+
Sbjct: 87 SSLEDFQDVYLVTHLM-GADLNNIVKCQ-KLSDDHIQFLVYQILRGLKYIHSAGIIHRDL 144
Query: 242 KAENV 246
K N+
Sbjct: 145 KPSNI 149
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 34/162 (20%), Positives = 65/162 (40%), Gaps = 43/162 (26%)
Query: 99 AIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYN 158
AIK + A P K RE+ + H NII + ++L G F
Sbjct: 34 AIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF------------- 80
Query: 159 KITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218
+Y V++ +L++ I ++ L+E+ +
Sbjct: 81 -------------------KDVYVVMDLME-----------SDLHHIIHSDQPLTEEHIR 110
Query: 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLG 260
+ Q+L +K++H ++IHRD+K N+ ++ +++GD G
Sbjct: 111 YFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFG 152
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-06
Identities = 38/131 (29%), Positives = 60/131 (45%), Gaps = 13/131 (9%)
Query: 145 FLVVEYASGGELYN---KITTEGRLSEDD----AKIYF-----LQILLYEVLETFGKIFL 192
F VV+Y Y+ K+ EG +SED+ AK+ + LY V I++
Sbjct: 17 FGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76
Query: 193 VVEYASGGELYNKITTEGRLSEDDAKIYFLQ-ILSAVKHLHDRDIIHRDIKAENVFLSVR 251
V EY S G L N + G+ + + + + + +L + IHRD+ A N + +
Sbjct: 77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQ 136
Query: 252 GIVKLGDLGFS 262
G VK+ D G S
Sbjct: 137 GCVKVSDFGLS 147
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 19/51 (37%), Positives = 33/51 (64%)
Query: 210 GRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLG 260
G LS + +++ Q+L + + H R ++HRD+K +N+ +S RG +KL D G
Sbjct: 98 GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFG 148
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-06
Identities = 45/211 (21%), Positives = 72/211 (34%), Gaps = 45/211 (21%)
Query: 64 LYKLQNELGRGNFSTV---------KMAIHEIYVPILCTYISYLAIKILDKAKLTPKARK 114
+ +LG G F V K + + + +A+K+L + AR
Sbjct: 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDANKNARN 64
Query: 115 MLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 174
+EI M + PNIIRL V T + ++ EY G+L N+ + E
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQEA----- 118
Query: 175 FLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR 234
E + +T S QI S +K+L
Sbjct: 119 -------------------------AEKADVVTI----SYSTLIFMATQIASGMKYLSSL 149
Query: 235 DIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
+ +HRD+ N + +K+ D G S L
Sbjct: 150 NFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-06
Identities = 38/197 (19%), Positives = 74/197 (37%), Gaps = 56/197 (28%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
+ L+ +LG G F V + + V + AIKIL K+ K + +E+ +++
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRV--------AIKIL-KSDDLLKQQ-DFQKEVQALK 57
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ H ++I L+ V ++++ E G L
Sbjct: 58 RLRHKHLISLFAVCSVGEPVYIITELMEKGSL---------------------------- 89
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF-LQILSAVKHLHDRDIIHRDIKA 243
FL + EG++ + I Q+ + +L +++ IHRD+ A
Sbjct: 90 ----LAFLR-------------SPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAA 132
Query: 244 ENVFLSVRGIVKLGDLG 260
N+ + + K+ D G
Sbjct: 133 RNILVGEDLVCKVADFG 149
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-06
Identities = 40/196 (20%), Positives = 77/196 (39%), Gaps = 54/196 (27%)
Query: 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV 126
++++LG G + E+Y + Y +A+K L + + + +E M+ +
Sbjct: 10 MKHKLGGGQYG-------EVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEI 59
Query: 127 HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLET 186
HPN+++L V +++ E+ + G L + + R + +LLY
Sbjct: 60 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV------VLLY----- 108
Query: 187 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENV 246
A+ QI SA+++L ++ IHRD+ A N
Sbjct: 109 ---------MAT------------------------QISSAMEYLEKKNFIHRDLAARNC 135
Query: 247 FLSVRGIVKLGDLGFS 262
+ +VK+ D G S
Sbjct: 136 LVGENHLVKVADFGLS 151
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 22/76 (28%), Positives = 43/76 (56%), Gaps = 1/76 (1%)
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
E F +++V E +L+ I + LS+D + + Q+L +K++H +++HRD+K
Sbjct: 79 EAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPS 137
Query: 245 NVFLSVRGIVKLGDLG 260
N+ L+ +K+ D G
Sbjct: 138 NLLLNANCDLKICDFG 153
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 53/200 (26%), Positives = 81/200 (40%), Gaps = 57/200 (28%)
Query: 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI-VSMESVHH 128
ELGRG + V H I+ A+K + +A + + +K L ++ +SM SV
Sbjct: 8 ELGRGAYGVVDKMRHVPTGTIM-------AVKRI-RATVNSQEQKRLLMDLDISMRSVDC 59
Query: 129 PNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFG 188
P + Y G L+ E D I EV++T
Sbjct: 60 PYTVTFY------------------GALFR---------EGDVWICM------EVMDT-- 84
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDD--AKIYFLQILSAVKHLHDR-DIIHRDIKAEN 245
S + Y K+ +G +D KI I+ A+++LH + +IHRD+K N
Sbjct: 85 ---------SLDKFYKKVYDKGLTIPEDILGKIAV-SIVKALEYLHSKLSVIHRDVKPSN 134
Query: 246 VFLSVRGIVKLGDLGFSTKL 265
V ++ G VKL D G S L
Sbjct: 135 VLINRNGQVKLCDFGISGYL 154
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-06
Identities = 43/170 (25%), Positives = 64/170 (37%), Gaps = 46/170 (27%)
Query: 97 YLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGEL 156
+AIK L KA T K R+ E M HPNII L V+ + +V EY G L
Sbjct: 34 PVAIKTL-KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL 92
Query: 157 YNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216
+ L + D + +Q++ G L
Sbjct: 93 ------DAFLRKHDGQFTVIQLV------------------------------GMLR--- 113
Query: 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266
I S +K+L D +HRD+ A N+ ++ + K+ D G S L+
Sbjct: 114 ------GIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 6e-06
Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 2/79 (2%)
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
LE F ++LV + G +L N I +L++D + QIL +K++H DIIHRD+K
Sbjct: 91 LEEFNDVYLVT-HLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKP 148
Query: 244 ENVFLSVRGIVKLGDLGFS 262
N+ ++ +K+ D G +
Sbjct: 149 SNLAVNEDCELKILDFGLA 167
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 6e-06
Identities = 21/75 (28%), Positives = 42/75 (56%), Gaps = 2/75 (2%)
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKI--YFLQILSAVKHLHDRDIIHRDIKAENVF 247
+++V+E S G L N + T GR ++ + L + +++L + ++HRD+ A N+
Sbjct: 73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNIL 132
Query: 248 LSVRGIVKLGDLGFS 262
+S G+ K+ D G +
Sbjct: 133 VSEDGVAKVSDFGLA 147
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 32/110 (29%), Positives = 48/110 (43%), Gaps = 7/110 (6%)
Query: 163 EGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGE--LYNKITTEGRLSEDDAKIY 220
+S Y+L + YE T + E+ E L K+ + E + KI
Sbjct: 199 LEPVSSKKEDEYWL-VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKII 257
Query: 221 ---FLQILSAVKHLHDRDIIHRDIKAENVFLS-VRGIVKLGDLGFSTKLQ 266
QIL A+ LH I+HRD+K +N+ S G K+ DLG + L+
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLR 307
|
Length = 566 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 7e-06
Identities = 25/85 (29%), Positives = 44/85 (51%), Gaps = 2/85 (2%)
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGR--LSEDDAKIYFLQILSAVKHLHDRDIIHRDIK 242
ET + LV+ +GG+L I G E A Y ++ ++ L I++RD+K
Sbjct: 70 ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLK 129
Query: 243 AENVFLSVRGIVKLGDLGFSTKLQQ 267
EN+ L RG +++ DLG + ++ +
Sbjct: 130 PENILLDDRGHIRISDLGLAVQIPE 154
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 7e-06
Identities = 47/199 (23%), Positives = 81/199 (40%), Gaps = 52/199 (26%)
Query: 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPN 130
LG+GNF +V++ Y P+ +A+K L + T + + REI ++S+ H N
Sbjct: 12 LGKGNFGSVELCR---YDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDN 66
Query: 131 IIRLYEVLETFGK--IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFG 188
I++ V + G+ + LV+EY G L L + ++ ++LL
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSL------RDYLQKHRERLDHRKLLL-------- 112
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
YAS QI +++L + +HRD+ N+ +
Sbjct: 113 -------YAS------------------------QICKGMEYLGSKRYVHRDLATRNILV 141
Query: 249 SVRGIVKLGDLGFSTKLQQ 267
VK+GD G + L Q
Sbjct: 142 ESENRVKIGDFGLTKVLPQ 160
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 7e-06
Identities = 54/223 (24%), Positives = 88/223 (39%), Gaps = 32/223 (14%)
Query: 66 KLQNELGRGNFSTVKMA-IHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
KL LGRG F V A I C + A+K+L + + R ++S + +
Sbjct: 10 KLGKPLGRGAFGQVIEADAFGIDKTATCRTV---AVKMLKEGATHSEHRALMSELKILIH 66
Query: 125 SVHHPNIIRLY-EVLETFGKIFLVVEYASGGELYNKI-----------TTEGRLSEDDAK 172
HH N++ L + G + ++VE+ G L N + T + R + +
Sbjct: 67 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSG 126
Query: 173 IYFLQILLYEVLETFGKIFLVVEYASGG----ELYNKITTEGRLSED---------DAKI 219
+ L L++ I AS G + + + E ED D
Sbjct: 127 YGDISEDLKRRLDS---ITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLIC 183
Query: 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
Y Q+ ++ L R IHRD+ A N+ LS +VK+ D G +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA 226
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 8e-06
Identities = 49/196 (25%), Positives = 78/196 (39%), Gaps = 52/196 (26%)
Query: 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHP 129
ELG GNF VK ++++ + +AIK+L K + R + RE M + +P
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQI-----DVAIKVL-KNENEKSVRDEMMREAEIMHQLDNP 55
Query: 130 NIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGK 189
I+R+ V E + LV+E ASGG L NK + +
Sbjct: 56 YIVRMIGVCEA-EALMLVMEMASGGPL-NKFLSGKK------------------------ 89
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS 249
++IT + Q+ +K+L ++ +HRD+ A NV L
Sbjct: 90 --------------DEITVS------NVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV 129
Query: 250 VRGIVKLGDLGFSTKL 265
+ K+ D G S L
Sbjct: 130 NQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 34/115 (29%), Positives = 53/115 (46%), Gaps = 14/115 (12%)
Query: 155 ELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGEL--YNKITTE--G 210
EL +I +E + Y I Y +I + E+ GG L Y KI G
Sbjct: 41 ELQKQIMSELEILYKCDSPYI--IGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG 98
Query: 211 RLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
R++ + ++ + +L I+HRD+K N+ ++ RG VKL D G ST+L
Sbjct: 99 RIA--------VAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 2/85 (2%)
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGR--LSEDDAKIYFLQILSAVKHLHDRDIIHRDIK 242
ET + LV+ +GG+L I G E A Y +I ++ LH I++RD+K
Sbjct: 70 ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLK 129
Query: 243 AENVFLSVRGIVKLGDLGFSTKLQQ 267
EN+ L G +++ DLG + + +
Sbjct: 130 PENILLDDHGHIRISDLGLAVHVPE 154
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 39/171 (22%), Positives = 67/171 (39%), Gaps = 41/171 (23%)
Query: 98 LAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELY 157
+A+K+L +A +T AR +EI M + +PNIIRL V + + ++ EY G+L
Sbjct: 47 VAVKML-RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 158 NKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRL---SE 214
++ S E+ + T + S
Sbjct: 106 -------------------------------------QFLSQREIESTFTHANNIPSVSI 128
Query: 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
+ +QI S +K+L + +HRD+ N + +K+ D G S L
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 36/145 (24%), Positives = 54/145 (37%), Gaps = 50/145 (34%)
Query: 123 MESVHHPNIIRLYEVLETF-----GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
+E+ HPNI+RL +V T K+ LV E+ + D + Y
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHV----------------DQDLRTYL-- 97
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
+K+ G L + K Q L + LH I+
Sbjct: 98 --------------------------DKVPPPG-LPAETIKDLMRQFLRGLDFLHANCIV 130
Query: 238 HRDIKAENVFLSVRGIVKLGDLGFS 262
HRD+K EN+ ++ G VKL D G +
Sbjct: 131 HRDLKPENILVTSGGQVKLADFGLA 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 38/172 (22%), Positives = 67/172 (38%), Gaps = 46/172 (26%)
Query: 96 SYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGE 155
++AIK L K+ T K R+ E M HPNII L V+ + ++ E+ G
Sbjct: 33 IFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGA 91
Query: 156 LYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215
L + L ++D + +Q++ G L
Sbjct: 92 L------DSFLRQNDGQFTVIQLV------------------------------GMLR-- 113
Query: 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
I + +K+L + + +HRD+ A N+ ++ + K+ D G S L+
Sbjct: 114 -------GIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 33/114 (28%), Positives = 54/114 (47%), Gaps = 10/114 (8%)
Query: 159 KITTEGRLSEDD----AKIYF-----LQILLYEVLETFGKIFLVVEYASGGELYNKI-TT 208
K EG +SE+D AK+ + LY V +++V E+ G L N +
Sbjct: 34 KAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQR 93
Query: 209 EGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
+G+LS+D + +++L IHRD+ A N +S G+VK+ D G +
Sbjct: 94 QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 43/194 (22%), Positives = 76/194 (39%), Gaps = 55/194 (28%)
Query: 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHP 129
+GRGNF E++ L + +A+K + L P + +E ++ HP
Sbjct: 2 RIGRGNFG-------EVFSGRLRADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHP 53
Query: 130 NIIRLYEVLETFGKIFLVVEYASGGELYNKITTEG-RLSEDDAKIYFLQILLYEVLETFG 188
NI+RL V I++V+E GG+ + TEG RL
Sbjct: 54 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRL---------------------- 91
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
K+ ++ E+ A + +++L + IHRD+ A N +
Sbjct: 92 ----------------KVKELIQMVENAA--------AGMEYLESKHCIHRDLAARNCLV 127
Query: 249 SVRGIVKLGDLGFS 262
+ + ++K+ D G S
Sbjct: 128 TEKNVLKISDFGMS 141
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 36/173 (20%)
Query: 98 LAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETFGKIFLVVEYASGGEL 156
+A+K+L K T K L E+ M+ + H NII L V G ++++VEYA+ G L
Sbjct: 47 VAVKML-KDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL 105
Query: 157 YNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKIT--TEGRLSE 214
+ FL G + IT E +LS
Sbjct: 106 --------------------------------REFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
D Q+ +++L R IHRD+ A NV ++ ++K+ D G + +
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHD 186
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 38/157 (24%), Positives = 67/157 (42%), Gaps = 45/157 (28%)
Query: 113 RKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 172
++S + E + HPNI+R Y K FL E+D
Sbjct: 53 GDIVSEVTIIKEQLRHPNIVRYY-------KTFL---------------------ENDR- 83
Query: 173 IYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEG-RLSEDDAKIYFLQILSAVKHL 231
LY V++ ++E A GE +N + + R +E+ F+Q++ A+++L
Sbjct: 84 -------LYIVMD-------LIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYL 129
Query: 232 H-DRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
H ++ I+HRD+ N+ L V + D G + + Q
Sbjct: 130 HKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 24/86 (27%), Positives = 48/86 (55%), Gaps = 2/86 (2%)
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRL-SEDDAKIYFLQILSAVKHLHDRDI 236
+ L++++ T + LV EY +L + G + + K++ Q+L + + H R +
Sbjct: 67 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKV 125
Query: 237 IHRDIKAENVFLSVRGIVKLGDLGFS 262
+HRD+K +N+ ++ RG +KL D G +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 35/136 (25%), Positives = 56/136 (41%), Gaps = 30/136 (22%)
Query: 127 HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLET 186
HHPNII L E G +++ +EYA G L + + L D A
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPA--------------- 105
Query: 187 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENV 246
F K E+ + L ++ + + D A + +++L ++ IHRD+ A NV
Sbjct: 106 FAK-----EHGTASTLTSQQLL--QFASDVA--------TGMQYLSEKQFIHRDLAARNV 150
Query: 247 FLSVRGIVKLGDLGFS 262
+ K+ D G S
Sbjct: 151 LVGENLASKIADFGLS 166
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-05
Identities = 18/38 (47%), Positives = 27/38 (71%)
Query: 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLG 260
Q+L+ ++ LH I+HRDIK EN+ ++V G VK+ D G
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 19/36 (52%), Positives = 26/36 (72%)
Query: 225 LSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLG 260
L + +LH ++IHRD+KA N+ LS G+VKLGD G
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG 160
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-05
Identities = 44/197 (22%), Positives = 72/197 (36%), Gaps = 55/197 (27%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
+L +LG G F V + P+ A+K L + PK E M+
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTPV--------AVKTLKPGTMDPKD---FLAEAQIMKK 57
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+ HP +I+LY V I++V E G L + +LQ L
Sbjct: 58 LRHPKLIQLYAVCTLEEPIYIVTELMKYGSL----------------LEYLQGGAGRAL- 100
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
K+ +++ A+ Q+ S + +L ++ IHRD+ A N
Sbjct: 101 ---KLPQLIDMAA------------------------QVASGMAYLEAQNYIHRDLAARN 133
Query: 246 VFLSVRGIVKLGDLGFS 262
V + I K+ D G +
Sbjct: 134 VLVGENNICKVADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 4e-05
Identities = 44/197 (22%), Positives = 74/197 (37%), Gaps = 49/197 (24%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
K LG G+F V + Y P +A+K L K + + +EI +++
Sbjct: 7 KKIRVLGEGHFGKVSLYC---YDPANDGTGEMVAVKTL-KRECGQQNTSGWKKEINILKT 62
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
++H NI++ +G SE K
Sbjct: 63 LYHENIVKY----------------------------KGCCSEQGGKG------------ 82
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
+ L++EY G L + +L+ ++ QI + +LH + IHRD+ A N
Sbjct: 83 ----LQLIMEYVPLGSL-RDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARN 137
Query: 246 VFLSVRGIVKLGDLGFS 262
V L +VK+GD G +
Sbjct: 138 VLLDNDRLVKIGDFGLA 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-05
Identities = 43/198 (21%), Positives = 72/198 (36%), Gaps = 31/198 (15%)
Query: 70 ELGRGNFSTVKMAIHEIYVPILCTYISYL--AIKILDKAKLTPKARKMLSREIVSMESVH 127
++G+G F V A P L Y + A+K+L K + + + RE M
Sbjct: 12 DIGQGAFGRVFQA----RAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFD 66
Query: 128 HPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETF 187
HPNI++L V + L+ EY + G+L FL+ +
Sbjct: 67 HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE----------------FLRHRSPRAQCSL 110
Query: 188 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVF 247
L LS + Q+ + + +L +R +HRD+ N
Sbjct: 111 SHSTSSARKCGLNPL--------PLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162
Query: 248 LSVRGIVKLGDLGFSTKL 265
+ +VK+ D G S +
Sbjct: 163 VGENMVVKIADFGLSRNI 180
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-05
Identities = 33/136 (24%), Positives = 51/136 (37%), Gaps = 30/136 (22%)
Query: 127 HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLET 186
HHPNII L E G ++L +EYA G L + + L D A
Sbjct: 54 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA--------------- 98
Query: 187 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENV 246
F ++ L ++ + D A + +L + IHRD+ A N+
Sbjct: 99 FAI-----ANSTASTLSSQQLL--HFAADVA--------RGMDYLSQKQFIHRDLAARNI 143
Query: 247 FLSVRGIVKLGDLGFS 262
+ + K+ D G S
Sbjct: 144 LVGENYVAKIADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 5e-05
Identities = 41/193 (21%), Positives = 72/193 (37%), Gaps = 56/193 (29%)
Query: 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPN 130
+G+GNF ++Y +L +A+K ++ L P ++ +E ++ HPN
Sbjct: 3 IGKGNFG-------DVYKGVLKGNTE-VAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPN 53
Query: 131 IIRLYEVLETFGKIFLVVEYASGGELYNKI-TTEGRLSEDDAKIYFLQILLYEVLETFGK 189
I++L V I++V+E GG L + + RL T K
Sbjct: 54 IVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRL-------------------TVKK 94
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS 249
+ + A+ G Y L ++ IHRD+ A N +
Sbjct: 95 LLQMSLDAAAGMEY---------------------------LESKNCIHRDLAARNCLVG 127
Query: 250 VRGIVKLGDLGFS 262
++K+ D G S
Sbjct: 128 ENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 5e-05
Identities = 44/196 (22%), Positives = 65/196 (33%), Gaps = 53/196 (27%)
Query: 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHP 129
+LG GN +V H ++ + ++ K RK + RE+ M P
Sbjct: 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--------SSVRKQILRELQIMHECRSP 63
Query: 130 NIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGK 189
I+ Y I + +E+ G L G + E GK
Sbjct: 64 YIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPV----------------EILGK 107
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS 249
I + V G Y L V I+HRDIK N+ ++
Sbjct: 108 IAVAV---VEGLTY---------------------LYNVHR-----IMHRDIKPSNILVN 138
Query: 250 VRGIVKLGDLGFSTKL 265
RG +KL D G S +L
Sbjct: 139 SRGQIKLCDFGVSGEL 154
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-05
Identities = 23/86 (26%), Positives = 45/86 (52%), Gaps = 4/86 (4%)
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD--AKIYFLQILSAVKHLHDRDII 237
L +V+ + +++LV EY +L + + +++ K Y QIL + + H ++
Sbjct: 66 LQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVL 124
Query: 238 HRDIKAENVFLSVR-GIVKLGDLGFS 262
HRD+K +N+ + R +KL D G +
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLA 150
|
Length = 294 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 6e-05
Identities = 25/77 (32%), Positives = 40/77 (51%), Gaps = 2/77 (2%)
Query: 188 GKIFLVVEYASGGELYNKI--TTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
G I ++ EY G+L N + E L+ +D + Q+ + L ++ IHRD+ A N
Sbjct: 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 171
Query: 246 VFLSVRGIVKLGDLGFS 262
V L+ IVK+ D G +
Sbjct: 172 VLLTHGKIVKICDFGLA 188
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 6e-05
Identities = 42/165 (25%), Positives = 60/165 (36%), Gaps = 43/165 (26%)
Query: 98 LAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELY 157
+AIK L + K RE+V M+ V+H NII L V
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP----------------- 87
Query: 158 NKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217
+ LE F ++LV+E L I E L +
Sbjct: 88 -----------------------QKSLEEFQDVYLVMELMDA-NLCQVIQME--LDHERM 121
Query: 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
Q+L +KHLH IIHRD+K N+ + +K+ D G +
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 7e-05
Identities = 25/84 (29%), Positives = 40/84 (47%), Gaps = 13/84 (15%)
Query: 190 IFLVVEYASGGEL-------YNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIK 242
I L++E+ G L NKI + +L Y +QI + +L R +HRD+
Sbjct: 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLK------YAVQICKGMDYLGSRQYVHRDLA 136
Query: 243 AENVFLSVRGIVKLGDLGFSTKLQ 266
A NV + VK+GD G + ++
Sbjct: 137 ARNVLVESEHQVKIGDFGLTKAIE 160
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 7e-05
Identities = 50/198 (25%), Positives = 80/198 (40%), Gaps = 38/198 (19%)
Query: 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV 126
L+ ELG G F V +A E Y +A+K L L ARK RE + ++
Sbjct: 9 LKRELGEGAFGKVFLA--ECYNLSPTKDKMLVAVKALKDPTLA--ARKDFQREAELLTNL 64
Query: 127 HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLET 186
H +I++ Y V + +V EY G+L + G DA I ++ + +
Sbjct: 65 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHG----PDAMI----LVDGQPRQA 116
Query: 187 FGKIFL--VVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
G++ L ++ AS QI S + +L + +HRD+
Sbjct: 117 KGELGLSQMLHIAS------------------------QIASGMVYLASQHFVHRDLATR 152
Query: 245 NVFLSVRGIVKLGDLGFS 262
N + +VK+GD G S
Sbjct: 153 NCLVGANLLVKIGDFGMS 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 9e-05
Identities = 54/219 (24%), Positives = 84/219 (38%), Gaps = 30/219 (13%)
Query: 66 KLQNELGRGNFSTVKMA-IHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
KL LGRG F V A I C + A+K+L K T K L E+ +
Sbjct: 10 KLGKPLGRGAFGKVIQASAFGIEKSASCRTV---AVKML-KEGATASEYKALMTELKILI 65
Query: 125 SV-HHPNIIRLYEVLETF-GKIFLVVEYASGGELYNKITT--EGRLSEDDAKIYFLQILL 180
+ HH N++ L G + ++VEY G L N + + E + ++
Sbjct: 66 HIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQ 125
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLS-----EDDAKI------------YFLQ 223
E K L +S + + LS E+ ++ Y Q
Sbjct: 126 KEGK----KQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQ 181
Query: 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
+ ++ L R IHRD+ A N+ LS +VK+ D G +
Sbjct: 182 VARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA 220
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 43/200 (21%), Positives = 74/200 (37%), Gaps = 47/200 (23%)
Query: 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV 126
L LG G F V ++ + +A+K L ++ + + E + M
Sbjct: 10 LLRALGHGAFGEVYEGLY-RGRDGDAVELQ-VAVKTLPESC-SEQDESDFLMEALIMSKF 66
Query: 127 HHPNIIRLYEV-LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+H NI+RL V E + F+++E +GG+L + E R + ++ L
Sbjct: 67 NHQNIVRLIGVSFERLPR-FILLELMAGGDLKS-FLRENRPRPERPSSLTMKDL------ 118
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
+F + A G K+L + IHRDI A N
Sbjct: 119 ----LFCARDVAKG----------------------------CKYLEENHFIHRDIAARN 146
Query: 246 VFLSVRG---IVKLGDLGFS 262
L+ +G + K+ D G +
Sbjct: 147 CLLTCKGPGRVAKIADFGMA 166
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 56/229 (24%), Positives = 91/229 (39%), Gaps = 42/229 (18%)
Query: 42 TQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIK 101
++ +L D +W+ R+ L K LG G F V MA ++ +A+K
Sbjct: 3 SEYELPEDPRWEVPRD---RLVLGK---PLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVK 56
Query: 102 ILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKI 160
+L K+ T K L E+ M+ + H NII L G ++++VEYAS G L
Sbjct: 57 ML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL---- 111
Query: 161 TTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGEL-YN-KITTEGRLSEDDAK 218
+ +L G E YN E +LS D
Sbjct: 112 ----------------------------REYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
Q+ +++L + IHRD+ A NV ++ ++K+ D G + +
Sbjct: 144 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 192
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 33/136 (24%), Positives = 50/136 (36%), Gaps = 30/136 (22%)
Query: 127 HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLET 186
HHPNII L E G ++L +EYA G L + + L D A
Sbjct: 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA--------------- 110
Query: 187 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENV 246
F + +T LS + + + +L + IHRD+ A N+
Sbjct: 111 ----FAIAN-----------STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI 155
Query: 247 FLSVRGIVKLGDLGFS 262
+ + K+ D G S
Sbjct: 156 LVGENYVAKIADFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 46/200 (23%), Positives = 78/200 (39%), Gaps = 54/200 (27%)
Query: 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI-VSMESVHH 128
E+GRG F TV +H+ + +A+K + ++ + K +K L ++ V M S
Sbjct: 11 EIGRGAFGTVNKMLHK-------PSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 129 PNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLET-F 187
P I++ Y G +F E D I E+++
Sbjct: 63 PYIVKFY------GALF---------------------REGDCWI------CMELMDISL 89
Query: 188 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHL-HDRDIIHRDIKAENV 246
K + V Y + + E+ + + A+ +L + IIHRD+K N+
Sbjct: 90 DKFYKYV--------YEV--LKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNI 139
Query: 247 FLSVRGIVKLGDLGFSTKLQ 266
L G +KL D G S +L
Sbjct: 140 LLDRNGNIKLCDFGISGQLV 159
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 24/79 (30%), Positives = 44/79 (55%), Gaps = 2/79 (2%)
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+E F +++LV G +L N I +LS++ + Q+L +K++H IIHRD+K
Sbjct: 89 IENFNEVYLVTNLM-GADL-NNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKP 146
Query: 244 ENVFLSVRGIVKLGDLGFS 262
NV ++ +++ D G +
Sbjct: 147 SNVAVNEDCELRILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 40/165 (24%), Positives = 60/165 (36%), Gaps = 43/165 (26%)
Query: 98 LAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELY 157
+A+K L + K RE+V ++ V+H NII L V
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTP----------------- 91
Query: 158 NKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217
+ LE F ++LV+E L I E L +
Sbjct: 92 -----------------------QKSLEEFQDVYLVMELMDA-NLCQVIHME--LDHERM 125
Query: 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
Q+L +KHLH IIHRD+K N+ + +K+ D G +
Sbjct: 126 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 41/171 (23%), Positives = 62/171 (36%), Gaps = 46/171 (26%)
Query: 96 SYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGE 155
+AIK L K T K R+ E M H NIIRL V+ F ++ EY G
Sbjct: 34 VAVAIKTL-KPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGA 92
Query: 156 LYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215
L + L + D + Q++ G L
Sbjct: 93 L------DKYLRDHDGEFSSYQLV------------------------------GMLR-- 114
Query: 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266
I + +K+L D + +HRD+ A N+ ++ K+ D G S L+
Sbjct: 115 -------GIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 44/197 (22%), Positives = 78/197 (39%), Gaps = 56/197 (28%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
KL +LG G F V M + + + AIK L + ++P+A E M+
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGHTKV--------AIKSLKQGSMSPEA---FLAEANLMKQ 57
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+ HP ++RLY V+ T I+++ EY G L + + T + K+
Sbjct: 58 LQHPRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKT-----PEGIKL------------ 99
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
I +++ A+ QI + + ++ IHRD++A N
Sbjct: 100 ---TINKLIDMAA------------------------QIAEGMAFIERKNYIHRDLRAAN 132
Query: 246 VFLSVRGIVKLGDLGFS 262
+ +S K+ D G +
Sbjct: 133 ILVSETLCCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 23/76 (30%), Positives = 36/76 (47%), Gaps = 5/76 (6%)
Query: 192 LVVEYASGGELYNKITTEGRLSEDDAKIYFLQ-----ILSAVKHLHDRDIIHRDIKAENV 246
LV+E+ G+L N + + + A+ LQ + S + LH D IH D+ N
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131
Query: 247 FLSVRGIVKLGDLGFS 262
L+ VK+GD G +
Sbjct: 132 QLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 48/196 (24%), Positives = 74/196 (37%), Gaps = 53/196 (27%)
Query: 66 KLQNELGRG--NFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSM 123
+LQ E+GRG N ++V +A H P + + ++I D T + K L E+V
Sbjct: 1 ELQVEIGRGFCNLTSVYLARH---TPTG----TLVTVRITDLENCTEEHLKALQNEVVLS 53
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
HPNI+ + V + +G L+ V
Sbjct: 54 HFFRHPNIMTSWTV------------FTTGSWLW-------------------------V 76
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+ F + Y S L EG +SE L + +LH IHR+IKA
Sbjct: 77 ISPF------MAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQNGYIHRNIKA 129
Query: 244 ENVFLSVRGIVKLGDL 259
++ +S G+V L L
Sbjct: 130 SHILISGDGLVSLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 33/167 (19%), Positives = 59/167 (35%), Gaps = 36/167 (21%)
Query: 99 AIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYN 158
A+K+L + + AR+ +E+ + + PNI RL V + +++EY G+L N
Sbjct: 50 AVKVL-RPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-N 107
Query: 159 KITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218
+ + + S L T
Sbjct: 108 QFLQKHVAETSGLACNSKSL-------------------SFSTLLYMAT----------- 137
Query: 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
QI S +++L + +HRD+ N + +K+ D G S L
Sbjct: 138 ----QIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 40/165 (24%), Positives = 68/165 (41%), Gaps = 47/165 (28%)
Query: 98 LAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELY 157
+AIK + K TP K RE+ ++ + H NII L + IF+
Sbjct: 38 VAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSD-------IFI----------- 79
Query: 158 NKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217
ED IYF+ LL G +L +++ T L +
Sbjct: 80 -------SPLED---IYFVTELL------------------GTDL-HRLLTSRPLEKQFI 110
Query: 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
+ + QIL +K++H ++HRD+K N+ ++ +K+ D G +
Sbjct: 111 QYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLA 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 24/81 (29%), Positives = 42/81 (51%), Gaps = 2/81 (2%)
Query: 182 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
L+ F +LV+ + G K+ +LSED + Q+L +K++H IIHRD+
Sbjct: 87 LSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDL 144
Query: 242 KAENVFLSVRGIVKLGDLGFS 262
K N+ ++ +K+ D G +
Sbjct: 145 KPGNLAVNEDCELKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 19/44 (43%), Positives = 24/44 (54%), Gaps = 4/44 (9%)
Query: 226 SAVKHLH----DRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
+ VK LH +IHRD+K N+ L G VKL D G S +L
Sbjct: 122 AIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 3e-04
Identities = 41/166 (24%), Positives = 60/166 (36%), Gaps = 43/166 (25%)
Query: 97 YLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGEL 156
+AIK L + K RE+V M+ V+H NII L V
Sbjct: 51 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP---------------- 94
Query: 157 YNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216
+ LE F +++V+E L I E L +
Sbjct: 95 ------------------------QKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHER 127
Query: 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
Q+L +KHLH IIHRD+K N+ + +K+ D G +
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 4e-04
Identities = 19/40 (47%), Positives = 27/40 (67%)
Query: 225 LSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264
L + +LH ++IHRDIKA N+ L+ G VKL D G ++K
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK 170
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 4e-04
Identities = 47/196 (23%), Positives = 76/196 (38%), Gaps = 37/196 (18%)
Query: 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV 126
L+ ELG G F V +A E Y LC + + + + ARK RE + ++
Sbjct: 9 LKRELGEGAFGKVFLA--ECYN--LCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 127 HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLET 186
H +I++ Y V + +V EY G+L + G DA +L+ E
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHG----PDA------VLMAE---- 110
Query: 187 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENV 246
G ++T L QI + + +L + +HRD+ N
Sbjct: 111 -------------GNRPAELTQSQMLHIAQ------QIAAGMVYLASQHFVHRDLATRNC 151
Query: 247 FLSVRGIVKLGDLGFS 262
+ +VK+GD G S
Sbjct: 152 LVGENLLVKIGDFGMS 167
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 5e-04
Identities = 30/114 (26%), Positives = 52/114 (45%), Gaps = 10/114 (8%)
Query: 159 KITTEGRLSEDD----AKIYF-----LQILLYEVLETFGKIFLVVEYASGGELYNKITTE 209
K EG +SE+D A++ + LY V I LV E+ G L + + +
Sbjct: 34 KTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQ 93
Query: 210 -GRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
G+ S++ L + + +L ++IHRD+ A N + +VK+ D G +
Sbjct: 94 RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 38/162 (23%), Positives = 64/162 (39%), Gaps = 30/162 (18%)
Query: 132 IRLYEVLE--TFGKIF----LVVEYASGGELYNKITTEG-------RLSEDDAKIY---- 174
+ L ++L+ TFG+IF + + E++ K + L ++ +Y
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67
Query: 175 --FLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF---------LQ 223
L IL +E F++ Y + G L + RL E + +Q
Sbjct: 68 QNILPILHV-CIEDGEPPFVLYPYMNWGNL-KLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
I + +LH R +IH+DI A N + VK+ D S L
Sbjct: 126 IACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDL 167
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 5e-04
Identities = 18/39 (46%), Positives = 26/39 (66%)
Query: 225 LSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFST 263
L + +LH ++IHRDIKA N+ L+ G VKL D G ++
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSAS 173
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 6e-04
Identities = 15/45 (33%), Positives = 26/45 (57%)
Query: 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
K Q+L + LH ++HRD+K +N+ ++ G +KL D G +
Sbjct: 113 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 6e-04
Identities = 51/202 (25%), Positives = 78/202 (38%), Gaps = 47/202 (23%)
Query: 67 LQNELGRGNFSTVKMAIHEIYVPILCTYIS------YLAIKILDKAKLTPKARKMLSREI 120
L+ ELG G F V +A C + +A+K L +A + AR+ RE
Sbjct: 9 LKWELGEGAFGKVFLA--------ECHNLLPEQDKMLVAVKALKEA--SESARQDFQREA 58
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
+ + H +I+R Y V + +V EY G+L + + G DAKI
Sbjct: 59 ELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHG----PDAKIL------ 108
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
+GGE G+L+ QI S + +L +HRD
Sbjct: 109 -----------------AGGED----VAPGQLTLGQMLAIASQIASGMVYLASLHFVHRD 147
Query: 241 IKAENVFLSVRGIVKLGDLGFS 262
+ N + +VK+GD G S
Sbjct: 148 LATRNCLVGQGLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 7e-04
Identities = 36/182 (19%), Positives = 76/182 (41%), Gaps = 17/182 (9%)
Query: 98 LAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLY-EVLETFGKIFLVVEYASGGEL 156
+A+K+L + + + ++S + + +H N++ L + G + ++VE+ G L
Sbjct: 40 VAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNL 99
Query: 157 YNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNK--ITTEGR--- 211
N + + + Q + + ++ +E L+++ +T G
Sbjct: 100 SNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159
Query: 212 -----------LSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLG 260
L+ +D Y Q+ ++ L R IHRD+ A N+ LS +VK+ D G
Sbjct: 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 219
Query: 261 FS 262
+
Sbjct: 220 LA 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 7e-04
Identities = 22/87 (25%), Positives = 46/87 (52%), Gaps = 2/87 (2%)
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTE--GRLSEDDAKIYFLQILSAVKHLHDRD 235
+ LY V+ I+++ EY + G L + + ++ G++ + QI + ++ ++
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 236 IIHRDIKAENVFLSVRGIVKLGDLGFS 262
IHRD++A NV +S + K+ D G +
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 15/57 (26%), Positives = 33/57 (57%)
Query: 206 ITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
I + L++ + + QIL +K++H +++HRD+K N+ ++ +K+ D G +
Sbjct: 96 IRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLA 152
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 8e-04
Identities = 36/149 (24%), Positives = 62/149 (41%), Gaps = 40/149 (26%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI + + HPN+I L +V LS D K++
Sbjct: 47 REIALLRELKHPNVIALQKVF---------------------------LSHSDRKVW--- 76
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
LL++ E ++ ++++ + K +L K QIL + +LH ++
Sbjct: 77 -LLFDYAEH--DLWHIIKFHRASKANKKPM---QLPRSMVKSLLYQILDGIHYLHANWVL 130
Query: 238 HRDIKAENVFL----SVRGIVKLGDLGFS 262
HRD+K N+ + RG VK+ D+GF+
Sbjct: 131 HRDLKPANILVMGEGPERGRVKIADMGFA 159
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 8e-04
Identities = 54/212 (25%), Positives = 85/212 (40%), Gaps = 57/212 (26%)
Query: 55 ETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARK 114
ET L KRV + LG G F TV I +VP T +AIKIL++ PKA
Sbjct: 6 ETEL-KRVKV------LGSGAFGTVYKGI---WVPEGETVKIPVAIKILNETT-GPKANV 54
Query: 115 MLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 174
E + M S+ HP+++RL L V + +L ++ G L +
Sbjct: 55 EFMDEALIMASMDHPHLVRL-----------LGVCLSPTIQLVTQLMPHGCLLD------ 97
Query: 175 FLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR 234
++E + G L+ + +QI + +L +R
Sbjct: 98 ----YVHEHKDNIGSQLLLN-------------------------WCVQIAKGMMYLEER 128
Query: 235 DIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266
++HRD+ A NV + VK+ D G + L+
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 9e-04
Identities = 52/233 (22%), Positives = 89/233 (38%), Gaps = 79/233 (33%)
Query: 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILC-TYISYLAIKILDKAKLTPKARKMLSRE 119
R+ Y++ ++G G F V + H+ C ISY +K +K++L E
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI--------E 62
Query: 120 IVSMESVHHPNIIRLYEVL--ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
+ M + H NI+R + + K+++++E+ G+L I K Y
Sbjct: 63 VNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQ----------KCY--- 109
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL-QILSAVKHLHD--- 233
+ FGKI E+ A + Q+L A+ + H+
Sbjct: 110 -------KMFGKI-----------------------EEHAIVDITRQLLHALAYCHNLKD 139
Query: 234 ----RDIIHRDIKAENVFLSV-----------------RGIVKLGDLGFSTKL 265
++HRD+K +N+FLS R I K+GD G S +
Sbjct: 140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
|
Length = 1021 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 37/169 (21%), Positives = 61/169 (36%), Gaps = 30/169 (17%)
Query: 98 LAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELY 157
+A+KIL + AR +E+ + + PNIIRL V + ++ EY G+L
Sbjct: 49 VAVKIL-RPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 158 NKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217
Q L L+ + G +
Sbjct: 108 -------------------QFLSSHHLD---------DKEENGNDAVPPAHCLPAISYSS 139
Query: 218 KIYF-LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
++ LQI S +K+L + +HRD+ N + +K+ D G S L
Sbjct: 140 LLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.001
Identities = 36/149 (24%), Positives = 62/149 (41%), Gaps = 40/149 (26%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI + + HPN+I L +V LS D K++
Sbjct: 47 REIALLRELKHPNVISLQKVF---------------------------LSHADRKVW--- 76
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
LL++ E ++ ++++ + K +L K QIL + +LH ++
Sbjct: 77 -LLFDYAEH--DLWHIIKFHRASKANKKPV---QLPRGMVKSLLYQILDGIHYLHANWVL 130
Query: 238 HRDIKAENVFL----SVRGIVKLGDLGFS 262
HRD+K N+ + RG VK+ D+GF+
Sbjct: 131 HRDLKPANILVMGEGPERGRVKIADMGFA 159
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 22/85 (25%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
I+L F I++V E +L+ I L+ + + + Q+L A+K++H ++
Sbjct: 67 IMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVF 125
Query: 238 HRDIKAENVFLSVRGIVKLGDLGFS 262
HRD+K +N+ + +K+ D G +
Sbjct: 126 HRDLKPKNILANADCKLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 45/206 (21%), Positives = 81/206 (39%), Gaps = 45/206 (21%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
+ ELG F K+ +Y+P + + +AIK L K P+ +E M
Sbjct: 8 RFMEELGECAFG--KIYKGHLYLPGM-DHAQLVAIKTL-KDINNPQQWGEFQQEASLMAE 63
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTE------GRLSEDDAKIYFLQIL 179
+HHPNI+ L V+ + ++ EY + G+L+ + G S++D
Sbjct: 64 LHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG-------- 115
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
T + L D +QI + +++L +H+
Sbjct: 116 ---------------------------TVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHK 148
Query: 240 DIKAENVFLSVRGIVKLGDLGFSTKL 265
D+ A N+ + + VK+ DLG S ++
Sbjct: 149 DLAARNILIGEQLHVKISDLGLSREI 174
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 43/196 (21%), Positives = 76/196 (38%), Gaps = 38/196 (19%)
Query: 98 LAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETFGKIFLVVEYASGGEL 156
+A+K+L KA R+ L E+ + + H NI+ L G + ++ EY G+L
Sbjct: 71 VAVKML-KASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDL 129
Query: 157 ---------------------------YNKITTEGRLSEDDAKIYFLQILLYEVLETFGK 189
Y IT E + D+ + +T+ +
Sbjct: 130 LNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGF------SSQGSDTYVE 183
Query: 190 IFLVVEYAS-GGELYNKITTEGR--LSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENV 246
+ V +S + ++ TE L DD + Q+ + L ++ IHRD+ A NV
Sbjct: 184 MRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNV 243
Query: 247 FLSVRGIVKLGDLGFS 262
L+ + K+ D G +
Sbjct: 244 LLTDGRVAKICDFGLA 259
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 37/197 (18%), Positives = 79/197 (40%), Gaps = 56/197 (28%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
KL+ +LG G F V MA + + + A+K + ++ +A E M++
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHTKV--------AVKTMKPGSMSVEA---FLAEANVMKT 57
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+ H +++L+ V+ T I+++ E+ + G L + + S++ +K +++ +
Sbjct: 58 LQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLK-----SDEGSKQPLPKLIDFSA-- 109
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
QI + + R+ IHRD++A N
Sbjct: 110 -------------------------------------QIAEGMAFIEQRNYIHRDLRAAN 132
Query: 246 VFLSVRGIVKLGDLGFS 262
+ +S + K+ D G +
Sbjct: 133 ILVSASLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 38/166 (22%), Positives = 67/166 (40%), Gaps = 32/166 (19%)
Query: 98 LAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETFGKIFLVVEYASGGEL 156
+A+K+L K T K L E+ M+ + H NII L G ++++VEYAS G L
Sbjct: 50 VAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 108
Query: 157 YNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216
+ +EY+ ++ E +D
Sbjct: 109 REYLRARRPPG--------------------------MEYSYD---IARVPDEQMTFKDL 139
Query: 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
+ Q+ +++L + IHRD+ A NV ++ ++K+ D G +
Sbjct: 140 VSCTY-QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 184
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 37.5 bits (87), Expect = 0.004
Identities = 23/76 (30%), Positives = 38/76 (50%), Gaps = 6/76 (7%)
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ-----ILSAVKHLHDRDIIHRDIKAE 244
LV EY G+L + ++ E + +++ LQ I + V H+H + +H D+
Sbjct: 70 YLLVFEYCELGDLKSYLSQEQWHRRN-SQLLLLQRMACEIAAGVTHMHKHNFLHSDLALR 128
Query: 245 NVFLSVRGIVKLGDLG 260
N FL+ VK+GD G
Sbjct: 129 NCFLTSDLTVKVGDYG 144
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 267 | |||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0597|consensus | 808 | 99.98 | ||
| KOG0663|consensus | 419 | 99.98 | ||
| KOG0611|consensus | 668 | 99.98 | ||
| KOG0582|consensus | 516 | 99.97 | ||
| KOG0594|consensus | 323 | 99.97 | ||
| KOG0660|consensus | 359 | 99.97 | ||
| KOG0194|consensus | 474 | 99.97 | ||
| KOG1187|consensus | 361 | 99.97 | ||
| KOG0198|consensus | 313 | 99.97 | ||
| KOG0193|consensus | 678 | 99.97 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.97 | |
| KOG0578|consensus | 550 | 99.97 | ||
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0588|consensus | 786 | 99.97 | ||
| KOG0580|consensus | 281 | 99.97 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| KOG0589|consensus | 426 | 99.97 | ||
| KOG0610|consensus | 459 | 99.97 | ||
| KOG0694|consensus | 694 | 99.97 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.96 | |
| KOG0658|consensus | 364 | 99.96 | ||
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0586|consensus | 596 | 99.96 | ||
| KOG1026|consensus | 774 | 99.96 | ||
| KOG0662|consensus | 292 | 99.96 | ||
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.96 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.96 | |
| KOG4236|consensus | 888 | 99.96 | ||
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.96 | |
| KOG0032|consensus | 382 | 99.96 | ||
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.96 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.96 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.96 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.96 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.96 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG4250|consensus | 732 | 99.96 | ||
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.96 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.96 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.96 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.96 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| KOG0033|consensus | 355 | 99.96 | ||
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.96 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.95 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.95 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.95 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.95 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.95 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.95 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.95 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.95 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0599|consensus | 411 | 99.95 | ||
| KOG0196|consensus | 996 | 99.95 | ||
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG1094|consensus | 807 | 99.95 | ||
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.95 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.95 | |
| KOG0608|consensus | 1034 | 99.95 | ||
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG1035|consensus | 1351 | 99.95 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.95 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.95 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG1989|consensus | 738 | 99.95 | ||
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.95 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.95 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.95 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.95 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.95 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.95 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.95 | |
| KOG0667|consensus | 586 | 99.95 | ||
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG4717|consensus | 864 | 99.95 | ||
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.95 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.95 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.95 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.95 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.95 | |
| KOG1095|consensus | 1025 | 99.95 | ||
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.95 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.95 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.95 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.95 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.95 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.95 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.95 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.95 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.95 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.95 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.95 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.95 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.95 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.95 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.95 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.95 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.94 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.94 | |
| KOG0574|consensus | 502 | 99.94 | ||
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG4257|consensus | 974 | 99.94 | ||
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.94 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.94 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.94 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.94 | |
| KOG0201|consensus | 467 | 99.94 | ||
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.94 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.94 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.94 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.94 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.94 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.94 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.94 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.94 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.94 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.94 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.94 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.94 | |
| KOG0666|consensus | 438 | 99.94 | ||
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.94 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.94 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.94 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.94 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.94 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.94 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.94 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.94 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.94 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.94 | |
| KOG1152|consensus | 772 | 99.94 | ||
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.94 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.94 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.94 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.94 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.94 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.94 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG2345|consensus | 302 | 99.94 | ||
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.94 | |
| KOG2052|consensus | 513 | 99.94 | ||
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.94 | |
| KOG0690|consensus | 516 | 99.94 | ||
| KOG0607|consensus | 463 | 99.94 | ||
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.94 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.94 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0986|consensus | 591 | 99.93 | ||
| KOG0579|consensus | 1187 | 99.93 | ||
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.93 | |
| KOG0577|consensus | 948 | 99.93 | ||
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.93 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.93 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.93 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.93 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.93 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.93 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.93 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0612|consensus | 1317 | 99.93 | ||
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.93 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.93 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.93 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.93 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.93 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.93 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.93 | |
| KOG0584|consensus | 632 | 99.93 | ||
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.93 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.93 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.93 | |
| KOG0199|consensus | 1039 | 99.93 | ||
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.93 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.93 | |
| KOG0664|consensus | 449 | 99.93 | ||
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.93 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.93 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG4279|consensus | 1226 | 99.93 | ||
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| KOG4278|consensus | 1157 | 99.93 | ||
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.93 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.93 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.93 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.93 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.93 | |
| KOG3653|consensus | 534 | 99.93 | ||
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.93 | |
| KOG0669|consensus | 376 | 99.93 | ||
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.93 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.93 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.92 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG4721|consensus | 904 | 99.92 | ||
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.92 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.92 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.92 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.92 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.92 | |
| KOG0696|consensus | 683 | 99.92 | ||
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.92 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.92 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.92 | |
| KOG4645|consensus | 1509 | 99.92 | ||
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.92 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.92 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.92 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.92 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.92 | |
| KOG1151|consensus | 775 | 99.92 | ||
| KOG0604|consensus | 400 | 99.92 | ||
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.91 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.91 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.91 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0587|consensus | 953 | 99.91 | ||
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.91 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.91 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.91 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.91 | |
| KOG0668|consensus | 338 | 99.91 | ||
| KOG1025|consensus | 1177 | 99.9 | ||
| KOG0200|consensus | 609 | 99.9 | ||
| KOG0984|consensus | 282 | 99.9 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.9 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.9 | |
| KOG0983|consensus | 391 | 99.89 | ||
| KOG1163|consensus | 341 | 99.89 | ||
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.89 | |
| KOG0576|consensus | 829 | 99.89 | ||
| KOG0596|consensus | 677 | 99.88 | ||
| KOG1006|consensus | 361 | 99.88 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.88 | |
| KOG0614|consensus | 732 | 99.88 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.87 | |
| KOG1027|consensus | 903 | 99.87 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.87 | |
| KOG1345|consensus | 378 | 99.87 | ||
| KOG0603|consensus | 612 | 99.87 | ||
| KOG0695|consensus | 593 | 99.87 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0671|consensus | 415 | 99.86 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.86 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.85 | |
| KOG1164|consensus | 322 | 99.84 | ||
| KOG1165|consensus | 449 | 99.84 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.84 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.84 | |
| KOG0665|consensus | 369 | 99.83 | ||
| KOG1167|consensus | 418 | 99.83 | ||
| KOG0670|consensus | 752 | 99.82 | ||
| KOG1290|consensus | 590 | 99.82 | ||
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.81 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.78 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.77 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.74 | |
| KOG1024|consensus | 563 | 99.73 | ||
| KOG1166|consensus | 974 | 99.71 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.64 | |
| KOG4158|consensus | 598 | 99.63 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.6 | |
| KOG0590|consensus | 601 | 99.59 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.55 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.53 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.52 | |
| KOG0603|consensus | 612 | 99.49 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.43 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.4 | |
| KOG1240|consensus | 1431 | 99.38 | ||
| KOG3087|consensus | 229 | 99.38 | ||
| KOG0195|consensus | 448 | 99.37 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.3 | |
| KOG0590|consensus | 601 | 99.23 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.2 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.19 | |
| KOG1023|consensus | 484 | 99.07 | ||
| KOG0601|consensus | 524 | 99.07 | ||
| KOG0606|consensus | 1205 | 99.05 | ||
| KOG0601|consensus | 524 | 99.04 | ||
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.04 | |
| KOG1243|consensus | 690 | 99.04 | ||
| KOG1033|consensus | 516 | 99.0 | ||
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.98 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.88 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.78 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.77 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.73 | |
| KOG3741|consensus | 655 | 98.68 | ||
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.68 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.67 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.49 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.49 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.41 | |
| KOG1266|consensus | 458 | 98.37 | ||
| KOG1235|consensus | 538 | 98.3 | ||
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.29 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.19 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.15 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.11 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.9 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.87 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.87 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.86 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.81 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.79 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.72 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.67 | |
| KOG0606|consensus | 1205 | 97.64 | ||
| KOG2268|consensus | 465 | 97.6 | ||
| KOG2270|consensus | 520 | 97.27 | ||
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.23 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.18 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.17 | |
| PLN02236 | 344 | choline kinase | 97.08 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.95 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.86 | |
| KOG0576|consensus | 829 | 96.78 | ||
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.78 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.77 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 96.6 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.55 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.14 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.06 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.01 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.74 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 95.7 | |
| KOG2137|consensus | 700 | 95.6 | ||
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.57 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.56 | |
| KOG1236|consensus | 565 | 95.55 | ||
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 95.46 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.11 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.82 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 94.69 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.99 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.58 |
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=275.77 Aligned_cols=156 Identities=38% Similarity=0.633 Sum_probs=142.5
Q ss_pred cCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeee
Q psy2579 58 LGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 58 ~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~ 137 (267)
....+++|.+.++||.|+||+||+|+++ .++..||||.+.+..++.+.++.+..|+.+|+.++|||||.++++
T Consensus 5 ~~~~~~~y~~~~~iG~GsfavVykg~h~-------~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~ 77 (429)
T KOG0595|consen 5 SMRVVGDYELSREIGSGSFAVVYKGRHK-------KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDC 77 (429)
T ss_pred cccccccceehhhccCcceEEEEEeEec-------cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEE
Confidence 3456788999999999999999999998 455999999999988888889999999999999999999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
+.+++.+|+|||||.||||.+++++. +.+++..+
T Consensus 78 ~~~~~~i~lVMEyC~gGDLs~yi~~~----------------------------------------------~~l~e~t~ 111 (429)
T KOG0595|consen 78 IEDDDFIYLVMEYCNGGDLSDYIRRR----------------------------------------------GRLPEATA 111 (429)
T ss_pred EecCCeEEEEEEeCCCCCHHHHHHHc----------------------------------------------CCCCHHHH
Confidence 99999999999999998887777643 47899999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecC------CceEEeccccccccC
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVR------GIVKLGDLGFSTKLQ 266 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~------~~~kl~DFGla~~l~ 266 (267)
+.++.|++.||++||+++||||||||+|||++.. -.+||+|||+|+.++
T Consensus 112 r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 112 RHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred HHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 9999999999999999999999999999999765 468999999999876
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=251.58 Aligned_cols=151 Identities=38% Similarity=0.616 Sum_probs=130.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-----HHHHHHHHHHHHHhhcCCCceeeeeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-----KARKMLSREIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~Ei~~l~~l~hpnIv~~~~~ 137 (267)
..|.+.+.||+|+||.|-+|..+ .+++.||||++++..... .....+.+|+++|++|+|||||+++++
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~-------~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~ 244 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEK-------KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF 244 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEc-------ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee
Confidence 44888999999999999999997 667999999998766432 123446799999999999999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
|+.++..|+||||++||+|.+++ ...+.+.+...
T Consensus 245 f~~~ds~YmVlE~v~GGeLfd~v----------------------------------------------v~nk~l~ed~~ 278 (475)
T KOG0615|consen 245 FEVPDSSYMVLEYVEGGELFDKV----------------------------------------------VANKYLREDLG 278 (475)
T ss_pred eecCCceEEEEEEecCccHHHHH----------------------------------------------Hhccccccchh
Confidence 99999999999999886665554 45556788888
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecC---CceEEeccccccccC
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVR---GIVKLGDLGFSTKLQ 266 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~---~~~kl~DFGla~~l~ 266 (267)
..+++|++.|+.|||++||+||||||+|||+..+ ..+||+|||+|+...
T Consensus 279 K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g 330 (475)
T KOG0615|consen 279 KLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG 330 (475)
T ss_pred HHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc
Confidence 9999999999999999999999999999999766 689999999999764
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=257.88 Aligned_cols=151 Identities=34% Similarity=0.548 Sum_probs=137.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
..|+..+.||+|||+.||++++. .+++.||+|++.+... .+..++.+.+||++.+.|+|||||+++++|++.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~-------~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs 90 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDL-------DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS 90 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEc-------CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC
Confidence 34999999999999999999996 5669999999987654 346678899999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+.+|||.|+|..++|..+++ ..++++|.+++.++
T Consensus 91 ~nVYivLELC~~~sL~el~K----------------------------------------------rrk~ltEpEary~l 124 (592)
T KOG0575|consen 91 NNVYIVLELCHRGSLMELLK----------------------------------------------RRKPLTEPEARYFL 124 (592)
T ss_pred CceEEEEEecCCccHHHHHH----------------------------------------------hcCCCCcHHHHHHH
Confidence 99999999999988876665 34579999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.||+.||.|||+++|+|||||..|++++++-++||+|||||+.+.
T Consensus 125 ~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 125 RQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred HHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeec
Confidence 999999999999999999999999999999999999999999875
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=254.57 Aligned_cols=153 Identities=27% Similarity=0.463 Sum_probs=134.7
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
..+...|+.+++||+|+||.||+|++. .+++.||+|.+......+.....+.|||.+|++|+||||+++.+..
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~-------~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eiv 185 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDL-------ETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIV 185 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeec-------ccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEE
Confidence 344566999999999999999999997 5669999999988776667778889999999999999999999998
Q ss_pred eec--CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcc-cCCCChh
Q psy2579 139 ETF--GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITT-EGRLSED 215 (267)
Q Consensus 139 ~~~--~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~ 215 (267)
.+. +.+|+|+|||+. +|.-++.. .-.|++.
T Consensus 186 t~~~~~siYlVFeYMdh-----------------------------------------------DL~GLl~~p~vkft~~ 218 (560)
T KOG0600|consen 186 TSKLSGSIYLVFEYMDH-----------------------------------------------DLSGLLSSPGVKFTEP 218 (560)
T ss_pred EecCCceEEEEEecccc-----------------------------------------------hhhhhhcCCCcccChH
Confidence 877 789999999976 33333333 2379999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++..++.|++.||+|+|++||+|||||.+||||+.+|.+||+|||||+..
T Consensus 219 qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 219 QIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred HHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 99999999999999999999999999999999999999999999999854
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=243.13 Aligned_cols=151 Identities=32% Similarity=0.566 Sum_probs=136.2
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchH-HHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPK-ARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
...+|++++.||+|+||.|+.++.+ ++++.+|+|++++...... ..+....|..+|..++||.||+++..|.
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~-------dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKK-------DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ 95 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEc-------ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence 3567999999999999999999997 5569999999998876543 5678899999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
+.+.+|+|+||+.||.|...+. .++.+++..++-
T Consensus 96 t~~kLylVld~~~GGeLf~hL~----------------------------------------------~eg~F~E~~arf 129 (357)
T KOG0598|consen 96 TEEKLYLVLDYLNGGELFYHLQ----------------------------------------------REGRFSEDRARF 129 (357)
T ss_pred cCCeEEEEEeccCCccHHHHHH----------------------------------------------hcCCcchhHHHH
Confidence 9999999999998877766665 445788999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
++.+|+.||.|||++|||||||||+|||++.+|+++|+|||||+.
T Consensus 130 YlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 130 YLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKE 174 (357)
T ss_pred HHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchh
Confidence 999999999999999999999999999999999999999999984
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=238.81 Aligned_cols=151 Identities=30% Similarity=0.477 Sum_probs=133.6
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+.|+.+.++|+|+||.||+|+++ ++|+-||||.+..+.-++...+-.+|||++|++++|||+|.++.+|....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk-------~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr 74 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNK-------DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR 74 (396)
T ss_pred cHHhhhhccccCcceEEEEeccC-------CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc
Confidence 35888999999999999999998 66799999999877766777788999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
.+++|+|||+..-|...- .....++...+..++.
T Consensus 75 klhLVFE~~dhTvL~eLe----------------------------------------------~~p~G~~~~~vk~~l~ 108 (396)
T KOG0593|consen 75 KLHLVFEYCDHTVLHELE----------------------------------------------RYPNGVPSELVKKYLY 108 (396)
T ss_pred eeEEEeeecchHHHHHHH----------------------------------------------hccCCCCHHHHHHHHH
Confidence 999999999864332221 1233588999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
|++.|+.|+|++++|||||||+|||++.+|.+||||||+|+.+.
T Consensus 109 Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 109 QLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLS 152 (396)
T ss_pred HHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhc
Confidence 99999999999999999999999999999999999999999764
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=239.11 Aligned_cols=152 Identities=30% Similarity=0.449 Sum_probs=135.5
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++.+.++.||+|+.|+||+++|+ .+++.+|+|++... ..+..++++.+|+++++..+||+||.+|++|..
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk-------~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHK-------PTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEc-------CCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 3456788889999999999999998 55699999999443 356778899999999999999999999999999
Q ss_pred cCe-EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 141 FGK-IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 141 ~~~-~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
++. .+|+||||++|||...+.. .+++++.....
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~----------------------------------------------~g~i~E~~L~~ 182 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKR----------------------------------------------VGRIPEPVLGK 182 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhh----------------------------------------------cCCCCHHHHHH
Confidence 995 9999999999888776643 35799999999
Q ss_pred HHHHHHHHHHHHHh-CCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 220 YFLQILSAVKHLHD-RDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 220 ~~~ql~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
++.+|++||.|||. ++||||||||+|||++..|.+||||||.|+.+.
T Consensus 183 ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 183 IARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred HHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 99999999999995 999999999999999999999999999998763
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=246.18 Aligned_cols=154 Identities=28% Similarity=0.521 Sum_probs=136.8
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~ 137 (267)
...+++|+++..||+|+||.||+|+-+ .+|..+|+|+++++.+-. ....-+..|-.+|....+|+||+++.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk-------~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs 209 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKK-------DTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS 209 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEc-------cCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE
Confidence 335678999999999999999999988 566999999999887643 446778899999999999999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
|.+...+|+||||++|||+..+|. ..+.+++..+
T Consensus 210 FQD~~~LYLiMEylPGGD~mTLL~----------------------------------------------~~~~L~e~~a 243 (550)
T KOG0605|consen 210 FQDKEYLYLIMEYLPGGDMMTLLM----------------------------------------------RKDTLTEDWA 243 (550)
T ss_pred ecCCCeeEEEEEecCCccHHHHHH----------------------------------------------hcCcCchHHH
Confidence 999999999999988877766554 4457889999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.++.+++.|++.||+.|+|||||||+|+|||..|++||+|||||+-+
T Consensus 244 rfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 244 RFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred HHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999999999999999999999999999999999999754
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=240.32 Aligned_cols=159 Identities=30% Similarity=0.500 Sum_probs=140.0
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeee-e
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYE-V 137 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~-~ 137 (267)
...+.+|+++++||.|+||+||++.+. .++..||.|.++-...+...++....|+.+|++|+|||||++++ .
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~-------~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~ 87 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCL-------LDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHS 87 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeec-------cCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHh
Confidence 345677999999999999999999987 55689999999877778888999999999999999999999999 5
Q ss_pred eeecCe-EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 138 LETFGK-IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 138 ~~~~~~-~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
|...+. ++|+||+|.+|+|.+.++..+. ....+++..
T Consensus 88 f~~~~evlnivmE~c~~GDLsqmIk~~K~------------------------------------------qkr~ipE~~ 125 (375)
T KOG0591|consen 88 FIEDNEVLNIVMELCDAGDLSQMIKHFKK------------------------------------------QKRLIPEKT 125 (375)
T ss_pred hhccchhhHHHHHhhcccCHHHHHHHHHh------------------------------------------ccccCchHH
Confidence 666666 9999999999999887764321 345699999
Q ss_pred HHHHHHHHHHHHHHHHh--CC--CcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 217 AKIYFLQILSAVKHLHD--RD--IIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~--~~--ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
++.++.|+|.||..+|+ .+ |+||||||.||+++.+|.+||+||||++.+.
T Consensus 126 Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 126 VWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999999999 44 8999999999999999999999999999764
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=227.21 Aligned_cols=149 Identities=29% Similarity=0.421 Sum_probs=131.8
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|...++||+|+||.||+|++. .+++.||||.++.............|||+.|+.++||||+.++++|...+.
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~-------~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~ 75 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDT-------ETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN 75 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEec-------CCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence 5888999999999999999997 566999999998876655445678899999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhccc-CCCChhHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTE-GRLSEDDAKIYFL 222 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~ 222 (267)
+.+|+||++. +|...+... -.++..++..++.
T Consensus 76 l~lVfEfm~t-----------------------------------------------dLe~vIkd~~i~l~pa~iK~y~~ 108 (318)
T KOG0659|consen 76 LSLVFEFMPT-----------------------------------------------DLEVVIKDKNIILSPADIKSYML 108 (318)
T ss_pred eEEEEEeccc-----------------------------------------------cHHHHhcccccccCHHHHHHHHH
Confidence 9999999974 344444432 3689999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
++++||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+.
T Consensus 109 m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 109 MTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFG 152 (318)
T ss_pred HHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccC
Confidence 99999999999999999999999999999999999999999763
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=227.69 Aligned_cols=155 Identities=32% Similarity=0.590 Sum_probs=138.1
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~ 137 (267)
+..+.+|+.++.||.|+||.|.+++++ .++..+|+|++++.... ..+.+-..+|..+|+.+.||.++++++.
T Consensus 40 ~~~l~dfe~~~tlGtGSFGrV~LVr~k-------~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t 112 (355)
T KOG0616|consen 40 PYSLQDFERLKTLGTGSFGRVHLVREK-------HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT 112 (355)
T ss_pred CcchhhhhheeeeccCccceEEEEEEc-------cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe
Confidence 356788999999999999999999997 55699999999887653 3556778999999999999999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
|.+.+.+|+||||.+||.|..++ ...+++++..+
T Consensus 113 ~~d~~~lymvmeyv~GGElFS~L----------------------------------------------rk~~rF~e~~a 146 (355)
T KOG0616|consen 113 FKDNSNLYMVMEYVPGGELFSYL----------------------------------------------RKSGRFSEPHA 146 (355)
T ss_pred eccCCeEEEEEeccCCccHHHHH----------------------------------------------HhcCCCCchhH
Confidence 99999988888888876665555 45568999999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+.++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+|+.+.
T Consensus 147 rFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 147 RFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred HHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 9999999999999999999999999999999999999999999999864
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=247.33 Aligned_cols=150 Identities=30% Similarity=0.532 Sum_probs=131.1
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-CCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-HPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~ 140 (267)
..+|+++++||.|+||.||+|... .++..||||.++....+.+.. .=+||+..|++++ ||||+++.+.+.+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~-------~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d 80 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSK-------ETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRD 80 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeec-------CCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhc
Confidence 356999999999999999999987 556889999998877665432 2369999999997 9999999999998
Q ss_pred cC-eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcc-cCCCChhHHH
Q psy2579 141 FG-KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITT-EGRLSEDDAK 218 (267)
Q Consensus 141 ~~-~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~ 218 (267)
.+ .+|+|||||+. +|.+++.. ...+++..++
T Consensus 81 ~~~~L~fVfE~Md~-----------------------------------------------NLYqLmK~R~r~fse~~ir 113 (538)
T KOG0661|consen 81 NDRILYFVFEFMDC-----------------------------------------------NLYQLMKDRNRLFSESDIR 113 (538)
T ss_pred cCceEeeeHHhhhh-----------------------------------------------hHHHHHhhcCCcCCHHHHH
Confidence 88 89999999975 44444443 3469999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.|+.||+.||+|+|.+|+.|||+||+|||+.....+||+||||||.+.
T Consensus 114 nim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 114 NIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 999999999999999999999999999999999999999999999874
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=241.49 Aligned_cols=149 Identities=28% Similarity=0.489 Sum_probs=133.0
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccce-EEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISY-LAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~-vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
...+.+.||.|+||+||+|.|+ +.. ||||++.....+....+.|.+|+.+|+.++|||||+++|++..+.
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~---------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR---------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC---------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3556667999999999999996 244 999999987776666889999999999999999999999999887
Q ss_pred -eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 143 -KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 143 -~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
..++||||+.+|+|.+++... ....+++..+..++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~--------------------------------------------~~~~l~~~~~l~~a 148 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKK--------------------------------------------RKRKLPLKVRLRIA 148 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhc--------------------------------------------ccCCCCHHHHHHHH
Confidence 799999999999998887652 13479999999999
Q ss_pred HHHHHHHHHHHhCC-CcccCCCCCcEEeecCC-ceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRD-IIHRDIKAENVFLSVRG-IVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~-ivHrDlkp~NIll~~~~-~~kl~DFGla~~l 265 (267)
.||+.||.|||+++ ||||||||+|||++.++ ++||+|||+|+..
T Consensus 149 ldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 149 LDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred HHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 99999999999999 99999999999999998 9999999999764
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=245.70 Aligned_cols=154 Identities=34% Similarity=0.559 Sum_probs=137.1
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchH-HHHHHHHHHHHHhhc-CCCceeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPK-ARKMLSREIVSMESV-HHPNIIRLYEV 137 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~Ei~~l~~l-~hpnIv~~~~~ 137 (267)
+...+|.+.+.||.|+|++|++|++. .+++.+|||++.+.....+ ..+-+.+|-.+|..| .||+|++|+..
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~-------~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T 142 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREK-------ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT 142 (604)
T ss_pred CChhhcchhheeccccceeEEEeeec-------CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE
Confidence 34577999999999999999999997 5569999999988765443 356678999999999 99999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
|.+...+|+|+||+++|+|.++++ ..+.+++..+
T Consensus 143 FQD~~sLYFvLe~A~nGdll~~i~----------------------------------------------K~Gsfde~ca 176 (604)
T KOG0592|consen 143 FQDEESLYFVLEYAPNGDLLDLIK----------------------------------------------KYGSFDETCA 176 (604)
T ss_pred eecccceEEEEEecCCCcHHHHHH----------------------------------------------HhCcchHHHH
Confidence 999999999999999877766655 4457999999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+.++.||+.||+|||++|||||||||+|||++.+++++|+|||.|+.+.
T Consensus 177 R~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 177 RFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred HHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 9999999999999999999999999999999999999999999999875
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=238.27 Aligned_cols=153 Identities=39% Similarity=0.628 Sum_probs=129.4
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchH------------HHHHHHHHHHHHhhc
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPK------------ARKMLSREIVSMESV 126 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~~Ei~~l~~l 126 (267)
.+.++.|++++.||+|.||.|-+|++. .+++.||||++.+...... ..+.+.+||.+|+++
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~-------~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl 165 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDE-------VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL 165 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeec-------CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc
Confidence 345788999999999999999999997 5569999999987543211 125789999999999
Q ss_pred CCCceeeeeeeeeec--CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhh
Q psy2579 127 HHPNIIRLYEVLETF--GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYN 204 (267)
Q Consensus 127 ~hpnIv~~~~~~~~~--~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~ 204 (267)
+|||||+++.+..++ +.+|+|+|||..|.+..
T Consensus 166 ~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w---------------------------------------------- 199 (576)
T KOG0585|consen 166 HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKW---------------------------------------------- 199 (576)
T ss_pred CCcCeeEEEEeecCcccCceEEEEEeccCCcccc----------------------------------------------
Confidence 999999999998766 56888888887766532
Q ss_pred hhcccCC-CChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 205 KITTEGR-LSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 205 ~~~~~~~-~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.....+ +++.+++.+++.++.||+|||.+|||||||||+|+|++.+|++||+|||.|..+
T Consensus 200 -~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~ 260 (576)
T KOG0585|consen 200 -CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEF 260 (576)
T ss_pred -CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeec
Confidence 112234 899999999999999999999999999999999999999999999999998765
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=242.53 Aligned_cols=147 Identities=27% Similarity=0.468 Sum_probs=132.0
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeE
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKI 144 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 144 (267)
+++++.||+|.||+||.|.++. ...||+|.++...+++ +.|.+|+++|.+|+|+|||+++++|..++.+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~--------~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNG--------STKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcC--------CCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 6778899999999999999953 3589999998776554 4577999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHH
Q psy2579 145 FLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 224 (267)
Q Consensus 145 ~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql 224 (267)
||||||+..|+|.++|+.. ....++..+.+.++.||
T Consensus 277 yIVtE~m~~GsLl~yLr~~--------------------------------------------~~~~l~~~~Ll~~a~qI 312 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTR--------------------------------------------EGGLLNLPQLLDFAAQI 312 (468)
T ss_pred EEEEEecccCcHHHHhhhc--------------------------------------------CCCccchHHHHHHHHHH
Confidence 9999999999999988762 23368889999999999
Q ss_pred HHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 225 LSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 225 ~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
|.||+||.++++|||||.++||||+++..+||+|||||+.+.
T Consensus 313 aeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 313 AEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred HHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence 999999999999999999999999999999999999999543
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=239.17 Aligned_cols=154 Identities=44% Similarity=0.732 Sum_probs=133.8
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc---hHHHHHHHHHHHHHhhcC-CCceeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT---PKARKMLSREIVSMESVH-HPNIIRL 134 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~Ei~~l~~l~-hpnIv~~ 134 (267)
....+.|.+.+.||+|+||.|+.|.+. .++..||+|+++..... ....+.+.+|+.+++.++ ||||+++
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~-------~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l 85 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHR-------LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRL 85 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeec-------cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEE
Confidence 345678999999999999999999997 44599999988775322 123456779999999998 9999999
Q ss_pred eeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCCh
Q psy2579 135 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214 (267)
Q Consensus 135 ~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~ 214 (267)
++++......|+|||||.||+|.+++. ..+++.+
T Consensus 86 ~ev~~t~~~~~ivmEy~~gGdL~~~i~----------------------------------------------~~g~l~E 119 (370)
T KOG0583|consen 86 LEVFATPTKIYIVMEYCSGGDLFDYIV----------------------------------------------NKGRLKE 119 (370)
T ss_pred EEEEecCCeEEEEEEecCCccHHHHHH----------------------------------------------HcCCCCh
Confidence 999999999999999988877766554 4557999
Q ss_pred hHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecC-CceEEecccccccc
Q psy2579 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVR-GIVKLGDLGFSTKL 265 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DFGla~~l 265 (267)
.++..++.|++.|++|+|++||+||||||+|||++.+ +++||+|||+|...
T Consensus 120 ~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 120 DEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred HHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 9999999999999999999999999999999999999 99999999999865
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-33 Score=243.48 Aligned_cols=149 Identities=32% Similarity=0.586 Sum_probs=137.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|.+.+.||+|+||.||+|+.+ .+.+.||+|.+.+..-+.+....+.+|+++++.++|||||.++++|++..
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK-------~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~ 74 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRK-------YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA 74 (808)
T ss_pred cchhHHHHhcCCccceeeecccc-------cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc
Confidence 46899999999999999999987 55699999999998877778888999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
++|+|+|||.| +|..++...+.++++.++.++.
T Consensus 75 ~~~vVte~a~g-----------------------------------------------~L~~il~~d~~lpEe~v~~~a~ 107 (808)
T KOG0597|consen 75 HLWVVTEYAVG-----------------------------------------------DLFTILEQDGKLPEEQVRAIAY 107 (808)
T ss_pred eEEEEehhhhh-----------------------------------------------hHHHHHHhccCCCHHHHHHHHH
Confidence 99999999976 4555556667899999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||+.+|+|||+||.|||++..|.+|+||||+|+.+
T Consensus 108 ~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 108 DLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAM 150 (808)
T ss_pred HHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhc
Confidence 9999999999999999999999999999999999999999865
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-33 Score=229.81 Aligned_cols=152 Identities=31% Similarity=0.461 Sum_probs=128.1
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
.++.|+.+++|++|+||.||+|++.. +.+-||+|.++.........-.-.|||.+|.+++|||||.+-.+...
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~-------t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKK-------TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG 146 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCC-------cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence 35679999999999999999999984 44899999998766333333456799999999999999999988765
Q ss_pred c--CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcc-cCCCChhHH
Q psy2579 141 F--GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITT-EGRLSEDDA 217 (267)
Q Consensus 141 ~--~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~ 217 (267)
. +.+|+|||||+. +|..++.. ..++.+.++
T Consensus 147 ~~~d~iy~VMe~~Eh-----------------------------------------------DLksl~d~m~q~F~~~ev 179 (419)
T KOG0663|consen 147 SNMDKIYIVMEYVEH-----------------------------------------------DLKSLMETMKQPFLPGEV 179 (419)
T ss_pred cccceeeeeHHHHHh-----------------------------------------------hHHHHHHhccCCCchHHH
Confidence 4 568888888875 33333333 248999999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
..++.|++.|++|||.+.|+||||||+|+|+++.|.+||+||||||...
T Consensus 180 K~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 180 KTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999999999999999999999999999999999999999999999754
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=233.52 Aligned_cols=151 Identities=40% Similarity=0.668 Sum_probs=134.7
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
-+|++.+.||+|+||.|-+|... ..++.||||.+.+.... .+..-.+.+||++|+.|+||||+.+|.+|+..
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~-------~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk 125 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEH-------KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK 125 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhc-------cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC
Confidence 45999999999999999999886 44699999999887754 34456688999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+...|||||..+|.|++++. ..+.+++.++++++
T Consensus 126 dKIvivMEYaS~GeLYDYiS----------------------------------------------er~~LsErEaRhfF 159 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYIS----------------------------------------------ERGSLSEREARHFF 159 (668)
T ss_pred ceEEEEEEecCCccHHHHHH----------------------------------------------HhccccHHHHHHHH
Confidence 99999999988877776664 44579999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+||..|+.|+|.++++|||||.+|||+|.++++||+||||+-.++
T Consensus 160 RQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 160 RQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred HHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999999999999999999999999999999987553
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=228.14 Aligned_cols=156 Identities=29% Similarity=0.435 Sum_probs=139.3
Q ss_pred cCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeee
Q psy2579 58 LGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 58 ~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~ 137 (267)
.......|++...||.|..+.||+|+.. .++..||||+++..+++.. .+.+.+|+..|+.++||||++++.+
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~-------p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~s 92 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCI-------PTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCS 92 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeec-------ccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEE
Confidence 3344567999999999999999999987 4459999999998887765 7889999999999999999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
|.....+|+||+||.+||+.+.++..- ...+++..+
T Consensus 93 Fvv~~~LWvVmpfMa~GS~ldIik~~~--------------------------------------------~~Gl~E~~I 128 (516)
T KOG0582|consen 93 FVVDSELWVVMPFMAGGSLLDIIKTYY--------------------------------------------PDGLEEASI 128 (516)
T ss_pred EEecceeEEeehhhcCCcHHHHHHHHc--------------------------------------------cccccHHHH
Confidence 999999999999999999988876431 114899999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..+++++++||.|||.+|.||||||+.||||+.+|.+||+|||.+.-+
T Consensus 129 a~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 129 ATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred HHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 999999999999999999999999999999999999999999987543
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=223.97 Aligned_cols=150 Identities=27% Similarity=0.454 Sum_probs=125.8
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCc-eeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPN-IIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~~~~~~~~ 140 (267)
...|+.+++||+|+||+||+|+.+ .+++.||+|.+......+.......||+.+++.++|+| |+++++++.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~-------~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~ 82 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSK-------RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHT 82 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEe-------cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeee
Confidence 345888899999999999999998 44599999999876543223456789999999999999 9999999988
Q ss_pred cC------eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhccc----C
Q psy2579 141 FG------KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTE----G 210 (267)
Q Consensus 141 ~~------~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~----~ 210 (267)
.+ .+++|+||+.. +|.+++... .
T Consensus 83 ~~~~~~~~~l~lvfe~~d~-----------------------------------------------DL~~ymd~~~~~~~ 115 (323)
T KOG0594|consen 83 SNNHRGIGKLYLVFEFLDR-----------------------------------------------DLKKYMDSLPKKPQ 115 (323)
T ss_pred cccccccceEEEEEEeecc-----------------------------------------------cHHHHHHhcccccc
Confidence 77 77788888753 333433332 2
Q ss_pred CCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 211 RLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 211 ~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++...+..+++|++.||+|||++||+||||||.|||++.+|.+||+|||+|+.+
T Consensus 116 g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 116 GLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHh
Confidence 4777899999999999999999999999999999999999999999999999864
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=224.57 Aligned_cols=149 Identities=29% Similarity=0.471 Sum_probs=131.5
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee---
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET--- 140 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~--- 140 (267)
.|..++.||+|+||.|+.|.+. .++..||||.+.....+....++..||+.+|+.++|+||+.+.+.+..
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~-------~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDK-------RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eecccccccCcceeeEEEEEEc-------CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 3666899999999999999997 556999999998666566777899999999999999999999999865
Q ss_pred --cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 141 --FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 141 --~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
.+.+|+|+|+|+ .+|.+.+.++..++...+.
T Consensus 96 ~~f~DvYiV~elMe-----------------------------------------------tDL~~iik~~~~L~d~H~q 128 (359)
T KOG0660|consen 96 DKFNDVYLVFELME-----------------------------------------------TDLHQIIKSQQDLTDDHAQ 128 (359)
T ss_pred cccceeEEehhHHh-----------------------------------------------hHHHHHHHcCccccHHHHH
Confidence 356888888774 3666777777779999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.+++|++.||.|+||.+++||||||+|++++.+..+||||||+|+...
T Consensus 129 ~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 129 YFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred HHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence 999999999999999999999999999999999999999999999763
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=233.59 Aligned_cols=153 Identities=27% Similarity=0.438 Sum_probs=133.5
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccc-cchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAK-LTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+-.+.++||+|+||+||+|.....+.. ....||||..+... ........+.+|+++|+.++|||||+++|+.....
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~---~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGF---KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCc---eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 355568999999999999998754311 11239999998633 56778899999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
++++|||+|.||+|.+++...+. .++..+...++.
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~---------------------------------------------~v~~~ek~~~~~ 269 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKK---------------------------------------------SLPTLEKLRFCY 269 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCC---------------------------------------------CCCHHHHHHHHH
Confidence 99999999999999888876521 588899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
+.+.||+|||+++++||||..+|+|++.++.+||+|||||+.
T Consensus 270 ~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 270 DAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred HHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 999999999999999999999999999999999999999975
|
|
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=230.43 Aligned_cols=155 Identities=26% Similarity=0.340 Sum_probs=132.6
Q ss_pred cCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeee
Q psy2579 58 LGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 58 ~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~ 137 (267)
+....++|.-.+.||+|+||.||+|... .+..||||.+....... ..+|.+|+.++..++|||+|+++|+
T Consensus 70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~--------~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 70 LRKATNNFSESNLIGEGGFGTVYKGVLS--------DGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred HHHHHhCCchhcceecCCCeEEEEEEEC--------CCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 3334566888889999999999999874 34789999887654322 3459999999999999999999999
Q ss_pred eeecC-eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 138 LETFG-KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 138 ~~~~~-~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
|.+.+ ..++|+||+.+|+|.++++.... . +++|..
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~-------------------------------------------~-~L~W~~ 175 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKG-------------------------------------------E-PLDWET 175 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCC-------------------------------------------C-CCCHHH
Confidence 99999 59999999999999888875421 1 689999
Q ss_pred HHHHHHHHHHHHHHHHhCC---CcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 217 AKIYFLQILSAVKHLHDRD---IIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
...|+.+++.||+|||... ||||||||+|||+|.+..+||+|||+|+..+
T Consensus 176 R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 176 RLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP 228 (361)
T ss_pred HHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence 9999999999999999853 9999999999999999999999999997654
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=222.14 Aligned_cols=150 Identities=34% Similarity=0.554 Sum_probs=125.1
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|...+.||+|+||.||++.+. .++...|||.+..... +. .+.+.+|+.+|+.++|||||++++......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~-------~~g~~~AvK~v~~~~~-~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNK-------KTGELMAVKSVELEDS-PT-SESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred chhhhhccccCccceEEEEEEec-------CCCcceeeeeeecccc-hh-HHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 34888889999999999999986 3468899999977632 22 677899999999999999999999744443
Q ss_pred --eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 143 --KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 143 --~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
..++.|||+.+|+|.+++.+.+ +++++..++.+
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g---------------------------------------------~~l~E~~v~~y 122 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYG---------------------------------------------GKLPEPLVRRY 122 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcC---------------------------------------------CCCCHHHHHHH
Confidence 5777777777766665554431 16999999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeec-CCceEEeccccccccC
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSV-RGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~l~ 266 (267)
.+|++.||+|||++||+||||||+|||++. ++.+||+|||+|+.+.
T Consensus 123 tr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 123 TRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred HHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 999999999999999999999999999999 7999999999998754
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=236.45 Aligned_cols=147 Identities=26% Similarity=0.426 Sum_probs=135.6
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.+...+...||+|.||+||+|+|. -.||||+++....+++..+.|.+|+..+++.+|.||+-++|+|..+
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh----------GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH----------GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred HHHhhccceeccccccceeecccc----------cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 455778899999999999999996 5799999999998889999999999999999999999999999988
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+. .||+.||+|.+|+.+++-. +..|....++.|+
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~---------------------------------------------etkfdm~~~idIA 494 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQ---------------------------------------------ETKFDMNTTIDIA 494 (678)
T ss_pred ce-eeeehhccCchhhhhccch---------------------------------------------hhhhhHHHHHHHH
Confidence 88 9999999999999988743 2268889999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
+|++.||.|||.++|||||||..||++.+++.+||+||||+..
T Consensus 495 qQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 495 QQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred HHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceee
Confidence 9999999999999999999999999999999999999999864
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=229.73 Aligned_cols=149 Identities=25% Similarity=0.481 Sum_probs=131.2
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+|++.+.||+|+||.||+|.+. .+++.||+|++...... ......+.+|+.++..++||||+++++.+.+.+
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~ 74 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKK-------DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL 74 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 5999999999999999999986 45689999999765432 234567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+|||||.+|+|.+++. ..+.+++..+..++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~----------------------------------------------~~~~l~~~~~~~~~~ 108 (363)
T cd05628 75 NLYLIMEFLPGGDMMTLLM----------------------------------------------KKDTLTEEETQFYIA 108 (363)
T ss_pred eEEEEEcCCCCCcHHHHHH----------------------------------------------hcCCCCHHHHHHHHH
Confidence 9999999999877766654 334688999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 109 qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~ 151 (363)
T cd05628 109 ETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151 (363)
T ss_pred HHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence 9999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=230.01 Aligned_cols=148 Identities=25% Similarity=0.464 Sum_probs=130.3
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+|++++.||+|+||.||+|.+. .+++.||||++..... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~ 74 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKK-------DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ 74 (377)
T ss_pred CceEeEEEeecCCEEEEEEEEC-------CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 5999999999999999999886 4568999999865432 2334567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+|||||.+|+|.+++.. .+.+++..+..++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~----------------------------------------------~~~~~~~~~~~~~~ 108 (377)
T cd05629 75 YLYLIMEFLPGGDLMTMLIK----------------------------------------------YDTFSEDVTRFYMA 108 (377)
T ss_pred eeEEEEeCCCCCcHHHHHHh----------------------------------------------cCCCCHHHHHHHHH
Confidence 99999999998888766543 34688889999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
|++.||+|||++||+||||||+|||++.++.++|+|||+|+.
T Consensus 109 ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 109 ECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred HHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence 999999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=225.62 Aligned_cols=156 Identities=31% Similarity=0.579 Sum_probs=135.0
Q ss_pred cCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeee
Q psy2579 58 LGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYE 136 (267)
Q Consensus 58 ~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~ 136 (267)
....+++|++.+.||+|+||.||+|.+. .+++.||+|++..... .......+.+|+.+++.++||||+++++
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 85 (329)
T PTZ00263 13 SSWKLSDFEMGETLGTGSFGRVRIAKHK-------GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85 (329)
T ss_pred CCCCchheEEEEEEEecCCeEEEEEEEC-------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 3345677999999999999999999986 4568999999976542 2234567889999999999999999999
Q ss_pred eeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 137 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 137 ~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
++...+..|++|||+.+|+|.+.+.. .+.+++..
T Consensus 86 ~~~~~~~~~lv~e~~~~~~L~~~l~~----------------------------------------------~~~~~~~~ 119 (329)
T PTZ00263 86 SFQDENRVYFLLEFVVGGELFTHLRK----------------------------------------------AGRFPNDV 119 (329)
T ss_pred EEEcCCEEEEEEcCCCCChHHHHHHH----------------------------------------------cCCCCHHH
Confidence 99999999999999998887666543 34678888
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++.+.
T Consensus 120 ~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 120 AKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred HHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 99999999999999999999999999999999999999999999998653
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=231.80 Aligned_cols=154 Identities=34% Similarity=0.556 Sum_probs=136.6
Q ss_pred ccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeee
Q psy2579 57 SLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYE 136 (267)
Q Consensus 57 ~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~ 136 (267)
..++....|+-..+||+|+.|.||.|... .+++.||||.+....... ++.+.+|+.+|+..+|+|||++++
T Consensus 267 ~~~dP~~~y~~~~kigqgaSG~vy~A~~~-------~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~ 337 (550)
T KOG0578|consen 267 SQGDPRSKYTDFKKIGQGATGGVYVARKI-------STKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLD 337 (550)
T ss_pred cCCChhhhhcchhhhccccccceeeeeec-------cCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHH
Confidence 44667778999999999999999999986 455889999998776433 467899999999999999999999
Q ss_pred eeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 137 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 137 ~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
.|...+.+|+||||++||+|-+.+.. -.+++.+
T Consensus 338 Sylv~deLWVVMEym~ggsLTDvVt~-----------------------------------------------~~~~E~q 370 (550)
T KOG0578|consen 338 SYLVGDELWVVMEYMEGGSLTDVVTK-----------------------------------------------TRMTEGQ 370 (550)
T ss_pred HhcccceeEEEEeecCCCchhhhhhc-----------------------------------------------ccccHHH
Confidence 99988999999999998887655432 2599999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+.
T Consensus 371 IA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 371 IAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred HHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 99999999999999999999999999999999999999999999998874
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=228.95 Aligned_cols=149 Identities=23% Similarity=0.440 Sum_probs=131.2
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.|++++.||+|+||.||+|++. .++..||||++...... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~-------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKV-------DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC
Confidence 5999999999999999999986 45689999999765432 344567899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+|||||.+|+|.+++.+ ...+++..+..++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~----------------------------------------------~~~~~e~~~~~~~~ 108 (381)
T cd05626 75 NLYFVMDYIPGGDMMSLLIR----------------------------------------------MEVFPEVLARFYIA 108 (381)
T ss_pred EEEEEEecCCCCcHHHHHHh----------------------------------------------cCCCCHHHHHHHHH
Confidence 99999999998887666543 33688889999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 109 qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 109 ELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred HHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 9999999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=228.15 Aligned_cols=149 Identities=25% Similarity=0.510 Sum_probs=131.5
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+|++.+.||+|+||.||+|++. .+++.||||++...... ......+.+|+.++..++||||+++++++.+.+
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~ 74 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKK-------DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN 74 (364)
T ss_pred CceEEEEEEecCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence 5999999999999999999986 45689999999765432 234466889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+|||||.+|+|.+++.. .+.+++..+..++.
T Consensus 75 ~~~lv~E~~~~g~L~~~l~~----------------------------------------------~~~l~~~~~~~~~~ 108 (364)
T cd05599 75 YLYLIMEYLPGGDMMTLLMK----------------------------------------------KDTFTEEETRFYIA 108 (364)
T ss_pred eEEEEECCCCCcHHHHHHHH----------------------------------------------cCCCCHHHHHHHHH
Confidence 99999999999887766543 34688999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++|++||||||+|||++.++.++|+|||+++.+
T Consensus 109 qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 109 ETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred HHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence 9999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=228.62 Aligned_cols=149 Identities=26% Similarity=0.471 Sum_probs=130.7
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.|++++.||+|+||.||+|++. .+++.||+|++...... ......+.+|+.+++.++||||+++++.+.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~-------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~ 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKV-------DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEEC-------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC
Confidence 5999999999999999999986 45689999999765432 334567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+|||||.+|+|.+.+.+ .+.+++..+..++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~----------------------------------------------~~~~~e~~~~~~~~ 108 (382)
T cd05625 75 NLYFVMDYIPGGDMMSLLIR----------------------------------------------MGIFPEDLARFYIA 108 (382)
T ss_pred EEEEEEeCCCCCcHHHHHHh----------------------------------------------cCCCCHHHHHHHHH
Confidence 99999999999888665543 23578889999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 109 qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 109 ELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred HHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 9999999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=227.79 Aligned_cols=151 Identities=27% Similarity=0.494 Sum_probs=131.9
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
..++|++.+.||+|+||.||+|.+. .+++.||+|++...... ......+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHK-------SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ 113 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4467999999999999999999986 45689999999754322 233456889999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+..|+|||||.+|+|.+++.. ..+++..+..
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~-----------------------------------------------~~~~~~~~~~ 146 (370)
T cd05621 114 DDKYLYMVMEYMPGGDLVNLMSN-----------------------------------------------YDVPEKWAKF 146 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHh-----------------------------------------------cCCCHHHHHH
Confidence 99999999999999888776642 2578889999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 147 ~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 147 YTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred HHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999999999999999999999999999999999999765
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=228.39 Aligned_cols=149 Identities=24% Similarity=0.462 Sum_probs=130.1
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
++|++++.||+|+||.||+|.+. .+++.||+|++...... ......+.+|+.+++.++||||+++++.+...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~ 73 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKV-------DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK 73 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC-------CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 35999999999999999999986 45689999999754332 23346688999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+|||||.+|+|.+++.. .+.+++..+..++
T Consensus 74 ~~~~lv~E~~~~g~L~~~i~~----------------------------------------------~~~~~~~~~~~~~ 107 (376)
T cd05598 74 DNLYFVMDYIPGGDMMSLLIR----------------------------------------------LGIFEEDLARFYI 107 (376)
T ss_pred CEEEEEEeCCCCCcHHHHHHh----------------------------------------------cCCCCHHHHHHHH
Confidence 999999999998888766543 3357888999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
.|++.||+|||++||+||||||+|||++.++.++|+|||+|+.
T Consensus 108 ~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~ 150 (376)
T cd05598 108 AELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (376)
T ss_pred HHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence 9999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=234.46 Aligned_cols=151 Identities=38% Similarity=0.658 Sum_probs=135.3
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccc-ccchHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKA-KLTPKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
-+|.|++.+.||.|+-|.|.+|++. .+|+.+|||++.+. ..+......+.+||.+|+.+.||||+++|+.|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~-------~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe 82 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHA-------ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE 82 (786)
T ss_pred cccceeccccccCCCCceehhhhcc-------cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec
Confidence 4566999999999999999999996 77899999999876 444555677899999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
....+|+|.||+.+ |.|++++...+++++.++.+
T Consensus 83 ~~~~lylvlEyv~g----------------------------------------------GELFdylv~kG~l~e~eaa~ 116 (786)
T KOG0588|consen 83 NKQHLYLVLEYVPG----------------------------------------------GELFDYLVRKGPLPEREAAH 116 (786)
T ss_pred cCceEEEEEEecCC----------------------------------------------chhHHHHHhhCCCCCHHHHH
Confidence 98888888887776 55566667778999999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
++.||+.|+.|+|..+|+|||+||+|+|++..+.+||+|||+|..
T Consensus 117 ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsL 161 (786)
T KOG0588|consen 117 FFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASL 161 (786)
T ss_pred HHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeec
Confidence 999999999999999999999999999999999999999999974
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=211.93 Aligned_cols=153 Identities=33% Similarity=0.585 Sum_probs=135.3
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
.+++|++.+.||+|-||.||.|+.+ .++.-||+|++.++.... ....++.||+++-+.|+||||+++|++|.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarek-------ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh 92 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREK-------KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH 92 (281)
T ss_pred chhhccccccccCCccccEeEeeec-------cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence 4567999999999999999999987 555889999998765432 23467899999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
+....|+++||...|+++..+... ...++++..+..
T Consensus 93 d~~riyLilEya~~gel~k~L~~~--------------------------------------------~~~~f~e~~~a~ 128 (281)
T KOG0580|consen 93 DSKRIYLILEYAPRGELYKDLQEG--------------------------------------------RMKRFDEQRAAT 128 (281)
T ss_pred ccceeEEEEEecCCchHHHHHHhc--------------------------------------------ccccccccchhH
Confidence 999999999999998888777632 234689999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
++.|++.||.|+|..+++||||||+|+|++..|.+||+|||-+..
T Consensus 129 Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 129 YIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred HHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 999999999999999999999999999999999999999997754
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=223.30 Aligned_cols=155 Identities=26% Similarity=0.459 Sum_probs=133.2
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~ 137 (267)
....++|++.+.||+|+||.||+|.+.. ..+..||+|++..... .......+.+|+.+++.++||||++++++
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~ 99 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKN------EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGS 99 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEEC------CCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEE
Confidence 3456679999999999999999998752 2236899999875443 23345678899999999999999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
+...+..|++|||+.+|+|.+++.. ...+++..+
T Consensus 100 ~~~~~~~~lv~Ey~~~g~L~~~i~~----------------------------------------------~~~~~~~~~ 133 (340)
T PTZ00426 100 FKDESYLYLVLEFVIGGEFFTFLRR----------------------------------------------NKRFPNDVG 133 (340)
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHH----------------------------------------------cCCCCHHHH
Confidence 9999999999999998887666543 346888999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..++.|++.||.|||++|++||||||+|||++.++.+||+|||+|+.+
T Consensus 134 ~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred HHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999999999999999999999999999999999999764
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=220.69 Aligned_cols=149 Identities=30% Similarity=0.550 Sum_probs=130.3
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+|++.+.||+|+||.||+|.+. .+++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 74 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDR-------ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR 74 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEc-------CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC
Confidence 5999999999999999999986 45689999999754432 234567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++|||+.+|+|.+++. ..+.+++..+..++.
T Consensus 75 ~~~lv~e~~~~~~L~~~~~----------------------------------------------~~~~~~~~~~~~~~~ 108 (291)
T cd05612 75 FLYMLMEYVPGGELFSYLR----------------------------------------------NSGRFSNSTGLFYAS 108 (291)
T ss_pred eEEEEEeCCCCCCHHHHHH----------------------------------------------HcCCCCHHHHHHHHH
Confidence 9999999998877766554 334688899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++|++||||||+||+++.++.+||+|||+++.+
T Consensus 109 qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~ 151 (291)
T cd05612 109 EIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL 151 (291)
T ss_pred HHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence 9999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=227.96 Aligned_cols=154 Identities=31% Similarity=0.541 Sum_probs=141.7
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|..++++|+|+||.++.++++. ..+.+++|.+.....+...++...+|+.++++++|||||.+.+.|+.+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~-------~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~ 75 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKS-------DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED 75 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhcc-------CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC
Confidence 4569999999999999999999984 447999999999998888888999999999999999999999999999
Q ss_pred Ce-EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 142 GK-IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 142 ~~-~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
+. ++|+|+||+||++.+.+...+ ...++++.+..|
T Consensus 76 ~~~l~Ivm~Y~eGg~l~~~i~~~k--------------------------------------------~~~f~E~~i~~~ 111 (426)
T KOG0589|consen 76 GQLLCIVMEYCEGGDLAQLIKEQK--------------------------------------------GVLFPEERILKW 111 (426)
T ss_pred CceEEEEEeecCCCCHHHHHHHHh--------------------------------------------hccccHHHHHHH
Confidence 98 999999999999998887642 236899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+.|++.|+.|||+++|+|||||+.||+++.++.++|+|||+|+.+.
T Consensus 112 ~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 112 FVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred HHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999999999999999999999999999999999999875
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=219.46 Aligned_cols=153 Identities=30% Similarity=0.443 Sum_probs=137.5
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
+..|++++.||.|.-|+||+|..+ .+...+|+|++++..+.. ....+.+.|-+||+.++||.++.+|+.|++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~-------~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet 148 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELR-------GTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET 148 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEec-------CCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence 456999999999999999999987 344899999999887653 456788999999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
....|++||||.||+|....++. ..+.+++..++.+
T Consensus 149 ~~~~cl~meyCpGGdL~~LrqkQ--------------------------------------------p~~~fse~~aRFY 184 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQKQ--------------------------------------------PGKRFSESAARFY 184 (459)
T ss_pred cceeEEEEecCCCccHHHHHhhC--------------------------------------------CCCccchhhHHHH
Confidence 99999999999999997766543 2347999999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.+++.||+|||..|||.|||||+||||.++|++-|+||.||...
T Consensus 185 aAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 185 AAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred HHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 999999999999999999999999999999999999999998754
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=230.43 Aligned_cols=150 Identities=31% Similarity=0.557 Sum_probs=135.0
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhc-CCCceeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESV-HHPNIIRLYEVL 138 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~ 138 (267)
.+.+|.+++.||+|.||.|++|... .+++.+|||++++... ....++....|..++... +||.+++++.+|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k-------~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f 438 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELK-------GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF 438 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEc-------CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc
Confidence 4577999999999999999999997 4558999999998774 345678889999999888 699999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
.+..++|+||||+.||++...++ .+.+++..++
T Consensus 439 QT~~~l~fvmey~~Ggdm~~~~~-----------------------------------------------~~~F~e~rar 471 (694)
T KOG0694|consen 439 QTKEHLFFVMEYVAGGDLMHHIH-----------------------------------------------TDVFSEPRAR 471 (694)
T ss_pred ccCCeEEEEEEecCCCcEEEEEe-----------------------------------------------cccccHHHHH
Confidence 99999999999999988654443 3479999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
-++..|+.||+|||++|||+||||.+|||+|.+|++||+|||+|+.
T Consensus 472 fyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 472 FYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred HHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999999999999999999999999999999999999986
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=221.65 Aligned_cols=150 Identities=26% Similarity=0.467 Sum_probs=131.5
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||.||+|.+. .+++.||+|++...... ......+.+|+.++..++||||+++++++...
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~ 73 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKK-------DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD 73 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEEC-------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC
Confidence 35999999999999999999986 45689999999765432 23456688999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|++|||+++|+|.+++.. .+.+++..+..++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~----------------------------------------------~~~l~~~~~~~~~ 107 (333)
T cd05600 74 EYLYLAMEYVPGGDFRTLLNN----------------------------------------------LGVLSEDHARFYM 107 (333)
T ss_pred CEEEEEEeCCCCCCHHHHHHH----------------------------------------------cCCCCHHHHHHHH
Confidence 999999999999888766643 3468889999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||.|||++|++||||||+||+++.++.+||+|||+|+..
T Consensus 108 ~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~ 151 (333)
T cd05600 108 AEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI 151 (333)
T ss_pred HHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence 99999999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=216.20 Aligned_cols=150 Identities=26% Similarity=0.432 Sum_probs=127.7
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
+++|++.+.||.|+||.||+|.+. .++..||+|+++.... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSK-------LTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEEC-------CCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 456999999999999999999986 4568999999875432 22334677999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..+++||++.+ +|.+.+... ...+++..+..++
T Consensus 76 ~~~~lv~e~~~~-~l~~~l~~~---------------------------------------------~~~~~~~~~~~~~ 109 (288)
T cd07871 76 RCLTLVFEYLDS-DLKQYLDNC---------------------------------------------GNLMSMHNVKIFM 109 (288)
T ss_pred CeEEEEEeCCCc-CHHHHHHhc---------------------------------------------CCCCCHHHHHHHH
Confidence 999999999875 665554321 2247888999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 110 ~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~ 153 (288)
T cd07871 110 FQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAK 153 (288)
T ss_pred HHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeec
Confidence 99999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=223.70 Aligned_cols=151 Identities=26% Similarity=0.490 Sum_probs=131.6
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
..++|++.+.||+|+||.||+|.+. .+++.||+|++..... .......+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~-------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHK-------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEEC-------CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3467999999999999999999987 4568999999875432 2233456789999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+..|+|||||.+|+|.+++.. ..+++..+..
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~-----------------------------------------------~~~~~~~~~~ 146 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSN-----------------------------------------------YDVPEKWARF 146 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHh-----------------------------------------------cCCCHHHHHH
Confidence 99999999999999888766642 2578888999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 147 ~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred HHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 9999999999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=214.47 Aligned_cols=150 Identities=26% Similarity=0.398 Sum_probs=129.9
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
|++.+.||+|+||.||+|.+. .+++.||+|.+...... ......+.+|+.+++.++||||+++++++...+.
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~ 74 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVR-------ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA 74 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEe-------cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCe
Confidence 888999999999999999987 45689999998765432 2334567899999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.+++|||+.+|+|...+... ....+++..+..++.|
T Consensus 75 ~~lv~e~~~~g~L~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~q 110 (285)
T cd05631 75 LCLVLTIMNGGDLKFHIYNM--------------------------------------------GNPGFDEQRAIFYAAE 110 (285)
T ss_pred EEEEEEecCCCcHHHHHHhh--------------------------------------------CCCCCCHHHHHHHHHH
Confidence 99999999998887655422 1225888999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||+|||++|++||||||+|||++.++.++|+|||+|+.+
T Consensus 111 i~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05631 111 LCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI 152 (285)
T ss_pred HHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence 999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=220.32 Aligned_cols=150 Identities=27% Similarity=0.460 Sum_probs=130.9
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+|++.+.||+|+||.||+|.+. .+++.||+|++..... .......+.+|+.++..++||||+++++++...+
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMK-------NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN 74 (331)
T ss_pred CceEEEEEEecCCeEEEEEEEC-------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 5999999999999999999986 4458999999975432 2234466889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+||||+.+|+|.+++... ...+++..+..++.
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~---------------------------------------------~~~~~~~~~~~~~~ 109 (331)
T cd05597 75 NLYLVMDYYVGGDLLTLLSKF---------------------------------------------EDRLPEDMARFYLA 109 (331)
T ss_pred eEEEEEecCCCCcHHHHHHHh---------------------------------------------cCCCCHHHHHHHHH
Confidence 999999999998887766432 23588899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++|++||||||+|||++.++.+||+|||+|..+
T Consensus 110 qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 152 (331)
T cd05597 110 EMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152 (331)
T ss_pred HHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence 9999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=219.52 Aligned_cols=151 Identities=27% Similarity=0.456 Sum_probs=130.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||.||+|++. .+++.||+|++..... .......+.+|+.++..++||||+++++++...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~ 73 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMK-------HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE 73 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 35999999999999999999986 4558899999975432 223345678899999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+||||+.+|+|.+++... ...+++..+..++
T Consensus 74 ~~~~lv~Ey~~gg~L~~~l~~~---------------------------------------------~~~l~~~~~~~~~ 108 (331)
T cd05624 74 NYLYLVMDYYVGGDLLTLLSKF---------------------------------------------EDRLPEDMARFYI 108 (331)
T ss_pred CEEEEEEeCCCCCcHHHHHHHh---------------------------------------------cCCCCHHHHHHHH
Confidence 9999999999998887776532 2357888999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 109 ~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~ 152 (331)
T cd05624 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152 (331)
T ss_pred HHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=223.69 Aligned_cols=152 Identities=26% Similarity=0.451 Sum_probs=132.1
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
...++|++.+.||+|+||.||+|.+. .++..||+|++...... ......+.+|+.+++.++||||+++++++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~ 112 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHK-------SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF 112 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 34567999999999999999999986 45689999999754332 23345578999999999999999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
...+..|+|||||.+|+|.+++.. ..+++..+.
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~-----------------------------------------------~~l~~~~~~ 145 (370)
T cd05596 113 QDDKYLYMVMEYMPGGDLVNLMSN-----------------------------------------------YDIPEKWAR 145 (370)
T ss_pred ecCCEEEEEEcCCCCCcHHHHHHh-----------------------------------------------cCCCHHHHH
Confidence 999999999999999888776642 257888899
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 146 ~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred HHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=219.64 Aligned_cols=150 Identities=27% Similarity=0.505 Sum_probs=132.5
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+|++.+.||+|+||.||+|.+. .++..||+|+++.... .......+.+|+.+++.++||||+++++++...+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~ 74 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREK-------ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD 74 (330)
T ss_pred CceEEEEEEeccCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence 5999999999999999999986 4568999999986543 2345567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+||||+.+|+|.+++... ...+++..+..++.
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~l~~~~~~~~~~ 109 (330)
T cd05601 75 NLYLVMEYQPGGDLLSLLNRY---------------------------------------------EDQFDEDMAQFYLA 109 (330)
T ss_pred eEEEEECCCCCCCHHHHHHHh---------------------------------------------cCCCCHHHHHHHHH
Confidence 999999999998887766532 13688999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 110 qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred HHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 9999999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=220.14 Aligned_cols=200 Identities=23% Similarity=0.318 Sum_probs=135.1
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||.||+|.+..... ..++..||+|++.... .......+.+|+.++..+ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDK--KSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCC--cccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 469999999999999999998642211 1334689999997543 334456789999999999 899999999988765
Q ss_pred -CeEEEEEeecCCCchhhhhhccCCCChh----hHH---HHHHHHHHHH---hhhccCeEEEEEEEc--cCC---chhh-
Q psy2579 142 -GKIFLVVEYASGGELYNKITTEGRLSED----DAK---IYFLQILLYE---VLETFGKIFLVVEYA--SGG---ELYN- 204 (267)
Q Consensus 142 -~~~~iv~e~~~~gsl~~~l~~~~~~~~~----~~~---~~~~~~~~~~---~~~~~~~~~~v~e~~--~~~---~l~~- 204 (267)
+..+++|||+.+|+|.+++......... ... .......... .........+...+. .+. ....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999999764321100 000 0000000000 000000000000000 000 0000
Q ss_pred hhcccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 205 KITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.-....++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~ 224 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 224 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeeccccccc
Confidence 0011346889999999999999999999999999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=214.95 Aligned_cols=175 Identities=23% Similarity=0.327 Sum_probs=135.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccc---------cccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPI---------LCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIR 133 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~ 133 (267)
++|++.++||+|+||.||+|.+...... ...++..||+|++.... .......+.+|+.++..++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 5699999999999999999987432110 01234579999987643 3445677999999999999999999
Q ss_pred eeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCC
Q psy2579 134 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLS 213 (267)
Q Consensus 134 ~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~ 213 (267)
+++++...+..+++|||+.+|+|.+++.......... ..............++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~ 136 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEE---------------------------NGNDAVPPAHCLPAIS 136 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhcccccccc---------------------------cccccccccccccccc
Confidence 9999999999999999999999998886532110000 0000000011223578
Q ss_pred hhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 214 EDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 214 ~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||+++.+
T Consensus 137 ~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~ 188 (304)
T cd05096 137 YSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188 (304)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceec
Confidence 8999999999999999999999999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=221.27 Aligned_cols=149 Identities=26% Similarity=0.493 Sum_probs=130.8
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+|++.+.||+|+||.||+|.+. .++..||+|++..... .......+.+|+.++..++||||+++++.+...+
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 74 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKK-------DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR 74 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 5899999999999999999986 4568999999975432 2334567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+|||||.+|+|.+++.. .+.+++..+..++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~----------------------------------------------~~~l~~~~~~~~~~ 108 (360)
T cd05627 75 NLYLIMEFLPGGDMMTLLMK----------------------------------------------KDTLSEEATQFYIA 108 (360)
T ss_pred EEEEEEeCCCCccHHHHHHh----------------------------------------------cCCCCHHHHHHHHH
Confidence 99999999998777766543 34688999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++||+||||||+|||++.++.++|+|||+|+.+
T Consensus 109 qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 109 ETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred HHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 9999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=221.97 Aligned_cols=151 Identities=26% Similarity=0.512 Sum_probs=132.5
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||.||+|.+. .+++.||||++....... .....+.+|+.++..++||||+++++++...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 73 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDK-------DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE 73 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEEC-------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC
Confidence 35999999999999999999986 456899999997654332 3456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+||||+.+++|.+++.. ...+++..+..++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~----------------------------------------------~~~l~~~~~~~i~ 107 (350)
T cd05573 74 EHLYLVMEYMPGGDLMNLLIR----------------------------------------------KDVFPEETARFYI 107 (350)
T ss_pred CeEEEEEcCCCCCCHHHHHHH----------------------------------------------cCCCCHHHHHHHH
Confidence 999999999998777666543 3468899999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.|++.||+|||++|++||||||+||+++.++.++|+|||+++.+.
T Consensus 108 ~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 108 AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred HHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 999999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=217.12 Aligned_cols=148 Identities=30% Similarity=0.449 Sum_probs=117.4
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
.|.-.+.+|.|+||.||.|... ++++.||||..-... +.-.+|+.+|+.++|||||++..+|.....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~-------e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLR-------ETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEeeEEEeecccceEEEEEEc-------CCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence 4888999999999999999986 456999999875432 223479999999999999999998865432
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhc----ccCCCChhHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKIT----TEGRLSEDDAKI 219 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~----~~~~~~~~~~~~ 219 (267)
.- + -.+.+||||+| .+|.+.+. ....++...+.-
T Consensus 92 ~d---~--------------------------------------~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKL 129 (364)
T KOG0658|consen 92 SD---E--------------------------------------VYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKL 129 (364)
T ss_pred Cc---h--------------------------------------hHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHH
Confidence 10 0 01123444443 35555554 356899999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecC-CceEEeccccccccC
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVR-GIVKLGDLGFSTKLQ 266 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DFGla~~l~ 266 (267)
++.|+++||.|||+.||+||||||.|+|+|.+ |.+||||||.|+.+.
T Consensus 130 Yt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 130 YTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99999999999999999999999999999876 899999999999864
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=221.21 Aligned_cols=201 Identities=20% Similarity=0.277 Sum_probs=146.5
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 140 (267)
.++|++.+.||+|+||.||+|.+.... ...++..||||+++.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~--~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLF--KSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccc--cCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 346999999999999999999763211 013457899999975442 33456788999999999 89999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCCh------hhHHHHHHHHH-----HHHhhhc-----------------cCeEEE
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSE------DDAKIYFLQIL-----LYEVLET-----------------FGKIFL 192 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~------~~~~~~~~~~~-----~~~~~~~-----------------~~~~~~ 192 (267)
.+..++|||||.+|+|.+++........ ........... ....+.. ......
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999999986542110 00000000000 0000000 001123
Q ss_pred EEEEccCCchhhhhcc-cCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 193 VVEYASGGELYNKITT-EGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 193 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..++.+...+...+.. ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+|+.+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 264 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 264 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceec
Confidence 3444444555554443 346899999999999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=223.75 Aligned_cols=157 Identities=44% Similarity=0.742 Sum_probs=140.1
Q ss_pred ccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeee
Q psy2579 57 SLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYE 136 (267)
Q Consensus 57 ~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~ 136 (267)
..+..++.|.+..+||+|.|+.|.+|++. .++..||||++++...+...+..+.+|+++|..++|||||+++.
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~-------~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~ 122 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHI-------LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFS 122 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEec-------CCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 34456788999999999999999999997 44599999999999988887777999999999999999999999
Q ss_pred eeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 137 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 137 ~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
+.+++..+|+||||+.+|.+.+++ ...+++.+..
T Consensus 123 v~~t~~~lylV~eya~~ge~~~yl----------------------------------------------~~~gr~~e~~ 156 (596)
T KOG0586|consen 123 VIETEATLYLVMEYASGGELFDYL----------------------------------------------VKHGRMKEKE 156 (596)
T ss_pred eeeecceeEEEEEeccCchhHHHH----------------------------------------------Hhcccchhhh
Confidence 999999888888888876665555 4556788889
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+..++.|+..|++|+|+++|+|||||++|||++.+-++||+|||++..+.
T Consensus 157 ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 157 ARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred hhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec
Confidence 99999999999999999999999999999999999999999999998764
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=234.53 Aligned_cols=169 Identities=27% Similarity=0.378 Sum_probs=142.9
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
..+.+..+.||+|+||+||+|+-....+ ......||||.++... +.+.+.+|+||+.++..++|||||+++|.|..+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p--~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLP--GQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCC--CccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 4557888999999999999998654332 2455889999997654 456788999999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+|+|||..|||.+||.....-.... +++.+ ...+++..+.+.++
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~--------------------------~~g~~------~~~~L~~~q~L~iA 609 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKL--------------------------ASGQD------TPPPLSTSQFLHIA 609 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccc--------------------------cCCCC------CCCCCCHHHHHHHH
Confidence 99999999999999999998764422110 01111 14569999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.||+.||+||-++.+|||||..+|+||+++-.+||+||||+|.+
T Consensus 610 ~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdi 653 (774)
T KOG1026|consen 610 TQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDI 653 (774)
T ss_pred HHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhh
Confidence 99999999999999999999999999999999999999999874
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=197.92 Aligned_cols=149 Identities=26% Similarity=0.455 Sum_probs=129.9
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
.|.-+++||+|++|+||+|+.+ ++++-||+|.+...+.++.-.....+||-+++.++|.|||++++...+...
T Consensus 3 ~ydkmekigegtygtvfkarn~-------~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkk 75 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNR-------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_pred chHHHHhhcCCcceeeEecccC-------CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCce
Confidence 4777889999999999999987 556899999998776554445778899999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcc-cCCCChhHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITT-EGRLSEDDAKIYFL 222 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~ 222 (267)
+-+|+|+|.. +|..+..+ .+.++.+.++.++.
T Consensus 76 ltlvfe~cdq-----------------------------------------------dlkkyfdslng~~d~~~~rsfml 108 (292)
T KOG0662|consen 76 LTLVFEFCDQ-----------------------------------------------DLKKYFDSLNGDLDPEIVRSFML 108 (292)
T ss_pred eEEeHHHhhH-----------------------------------------------HHHHHHHhcCCcCCHHHHHHHHH
Confidence 9999999963 23333332 45689999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
|+++||.|+|+++++|||+||.|++|+.+|.+|++|||+|+.+.
T Consensus 109 qllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafg 152 (292)
T KOG0662|consen 109 QLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFG 152 (292)
T ss_pred HHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcC
Confidence 99999999999999999999999999999999999999998763
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=218.02 Aligned_cols=148 Identities=24% Similarity=0.443 Sum_probs=123.5
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC-
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG- 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~- 142 (267)
+|++.+.||+|+||.||+|.+. .++..||||.+............+.+|+.+++.++||||+++++++...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 73 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDT-------HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 73 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEEC-------CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCC
Confidence 4899999999999999999986 45689999998754333344567889999999999999999999875432
Q ss_pred ----eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 143 ----KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 143 ----~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
..|++||||. ++|.+ .+.....+++..+.
T Consensus 74 ~~~~~~~lv~e~~~-~~L~~----------------------------------------------~l~~~~~~~~~~~~ 106 (338)
T cd07859 74 REFKDIYVVFELME-SDLHQ----------------------------------------------VIKANDDLTPEHHQ 106 (338)
T ss_pred CCCceEEEEEecCC-CCHHH----------------------------------------------HHHhcccCCHHHHH
Confidence 3677777774 34443 33344568999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||.|||++|++||||||+|||++.++.+||+|||+|+..
T Consensus 107 ~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 107 FFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred HHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 99999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=217.79 Aligned_cols=143 Identities=32% Similarity=0.526 Sum_probs=124.8
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLV 147 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv 147 (267)
+.||+|+||.||+|.+. .+++.||+|++..... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 73 (323)
T cd05571 1 KLLGKGTFGKVILVREK-------ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFV 73 (323)
T ss_pred CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEE
Confidence 35999999999999986 4568999999976543 233456678999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHH
Q psy2579 148 VEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSA 227 (267)
Q Consensus 148 ~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~ 227 (267)
|||+.+|+|.+.+. ..+.+++..+..++.|++.|
T Consensus 74 ~e~~~~~~L~~~l~----------------------------------------------~~~~~~~~~~~~~~~qi~~~ 107 (323)
T cd05571 74 MEYANGGELFFHLS----------------------------------------------RERVFSEDRARFYGAEIVSA 107 (323)
T ss_pred EeCCCCCcHHHHHH----------------------------------------------HcCCCCHHHHHHHHHHHHHH
Confidence 99999887766554 33468899999999999999
Q ss_pred HHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 228 VKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 228 L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
|+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 108 L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 144 (323)
T cd05571 108 LGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKE 144 (323)
T ss_pred HHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcc
Confidence 9999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=213.66 Aligned_cols=150 Identities=27% Similarity=0.475 Sum_probs=130.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|++. .+++.||+|++............+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHK-------ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEEC-------CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC
Confidence 35999999999999999999986 45588999999776544555677889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+||||+.++++..... ....+++..+..++.
T Consensus 74 ~~~lv~e~~~~~~l~~~~~----------------------------------------------~~~~~~~~~~~~~~~ 107 (287)
T cd07848 74 KLYLVFEYVEKNMLELLEE----------------------------------------------MPNGVPPEKVRSYIY 107 (287)
T ss_pred EEEEEEecCCCCHHHHHHh----------------------------------------------cCCCCCHHHHHHHHH
Confidence 9999999998866543221 223688899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||+.|++||||||+||+++.++.+||+|||+|+.+
T Consensus 108 qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 150 (287)
T cd07848 108 QLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL 150 (287)
T ss_pred HHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence 9999999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=214.98 Aligned_cols=148 Identities=26% Similarity=0.471 Sum_probs=126.3
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+. .+++.||+|++...... .....+.+|+.+++.++||||+++++++....
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSK-------VNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEEC-------CCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCC
Confidence 56999999999999999999986 44688999998754322 22345778999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+||||+. +++.+++.. ....+++..+..++.
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~---------------------------------------------~~~~~~~~~~~~~~~ 110 (303)
T cd07869 77 TLTLVFEYVH-TDLCQYMDK---------------------------------------------HPGGLHPENVKLFLF 110 (303)
T ss_pred eEEEEEECCC-cCHHHHHHh---------------------------------------------CCCCCCHHHHHHHHH
Confidence 9999999996 455544432 123588889999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
|++.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 111 qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 152 (303)
T cd07869 111 QLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA 152 (303)
T ss_pred HHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCccee
Confidence 999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=219.44 Aligned_cols=149 Identities=30% Similarity=0.452 Sum_probs=128.9
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
......|+..+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 141 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHR-------PTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMF 141 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEEC-------CCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEe
Confidence 344667999999999999999999886 456899999986543 334557789999999999999999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
...+..|++|||+.+|+|... ...++..+.
T Consensus 142 ~~~~~~~lv~e~~~~~~L~~~--------------------------------------------------~~~~~~~~~ 171 (353)
T PLN00034 142 DHNGEIQVLLEFMDGGSLEGT--------------------------------------------------HIADEQFLA 171 (353)
T ss_pred ccCCeEEEEEecCCCCccccc--------------------------------------------------ccCCHHHHH
Confidence 999999999999999877421 134567788
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||+|||++|++||||||+|||++.++.+||+|||+++.+
T Consensus 172 ~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 172 DVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218 (353)
T ss_pred HHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence 89999999999999999999999999999999999999999999764
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=216.16 Aligned_cols=146 Identities=31% Similarity=0.504 Sum_probs=124.9
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHH---hhcCCCceeeeeeeeee
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSM---ESVHHPNIIRLYEVLET 140 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l---~~l~hpnIv~~~~~~~~ 140 (267)
|++.+.||+|+||.||+|.+. .+++.||||+++..... ....+.+.+|+.++ +.++||||+++++++..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~ 73 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYK-------KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT 73 (324)
T ss_pred CeEEEEEeecCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc
Confidence 788999999999999999986 45689999999765422 23345677777665 45689999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+||||+.+|+|...+.. ..+++..+..+
T Consensus 74 ~~~~~lv~E~~~~~~L~~~~~~-----------------------------------------------~~l~~~~~~~~ 106 (324)
T cd05589 74 EDHVCFVMEYAAGGDLMMHIHT-----------------------------------------------DVFSEPRAVFY 106 (324)
T ss_pred CCEEEEEEcCCCCCcHHHHhhc-----------------------------------------------CCCCHHHHHHH
Confidence 9999999999999888655432 36899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
+.|++.||+|||++|++||||||+||+++.++.+||+|||+|+.
T Consensus 107 ~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 107 AACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE 150 (324)
T ss_pred HHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence 99999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=214.98 Aligned_cols=147 Identities=33% Similarity=0.548 Sum_probs=127.0
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVV 148 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 148 (267)
+.||+|+||.||++.+.... .++..||+|++............+.+|+.+++.++||||+++++++...+..|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGP----DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccC----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEE
Confidence 56999999999999874322 45789999999865544444566789999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHH
Q psy2579 149 EYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAV 228 (267)
Q Consensus 149 e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L 228 (267)
||+.+|+|.+++.. ...+++..+..++.|++.||
T Consensus 78 e~~~~~~L~~~l~~----------------------------------------------~~~l~~~~~~~~~~qi~~~l 111 (318)
T cd05582 78 DFLRGGDLFTRLSK----------------------------------------------EVMFTEEDVKFYLAELALAL 111 (318)
T ss_pred cCCCCCcHHHHHHH----------------------------------------------cCCCCHHHHHHHHHHHHHHH
Confidence 99998887665532 33688999999999999999
Q ss_pred HHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 229 KHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 229 ~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+|||++|++||||||+||+++.++.++|+|||+++..
T Consensus 112 ~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 148 (318)
T cd05582 112 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 148 (318)
T ss_pred HHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCccc
Confidence 9999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=207.85 Aligned_cols=152 Identities=22% Similarity=0.303 Sum_probs=131.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|++.+.||+|+||.||+|.+.... ..+..||+|.++... +......+.+|+..++.++||||+++++++...+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~----~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPS----KRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCC----CceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 45999999999999999999875332 345789999997653 3344567899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..++||||+++|+|.+++... ...+++..++.++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~l~~~~~~~~~~ 114 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKH---------------------------------------------EGQLVAGQLMGMLP 114 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhC---------------------------------------------CCCCCHHHHHHHHH
Confidence 999999999998887766532 23588999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
|++.||+|||++|++||||||+||+++.++.++++|||.+..
T Consensus 115 ~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 115 GLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred HHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=218.28 Aligned_cols=151 Identities=34% Similarity=0.545 Sum_probs=133.1
Q ss_pred eEEe--cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 65 YKLQ--NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 65 y~~~--~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
|++. +.||+|.||+||-|.++ .+|+.||||++++-.......+.+++|+.||+.++||+||.+.-+|++++
T Consensus 564 YQif~devLGSGQFG~VYgg~hR-------ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e 636 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHR-------KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE 636 (888)
T ss_pred HHhhhHhhccCCcceeeecceec-------ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc
Confidence 6664 68999999999999998 56799999999998888777799999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
++++|||.+.|.=|.-.+.+ ..+++++.....++.
T Consensus 637 rvFVVMEKl~GDMLEMILSs---------------------------------------------EkgRL~er~TkFlvt 671 (888)
T KOG4236|consen 637 RVFVVMEKLHGDMLEMILSS---------------------------------------------EKGRLPERITKFLVT 671 (888)
T ss_pred eEEEEehhhcchHHHHHHHh---------------------------------------------hcccchHHHHHHHHH
Confidence 99999999876444433332 245899999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCC---ceEEeccccccccCC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRG---IVKLGDLGFSTKLQQ 267 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~---~~kl~DFGla~~l~~ 267 (267)
||+.||.|||-++|+|.||||+|+|+.... .+||||||+|+.+.|
T Consensus 672 QIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE 719 (888)
T KOG4236|consen 672 QILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE 719 (888)
T ss_pred HHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence 999999999999999999999999996543 799999999998864
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=215.08 Aligned_cols=152 Identities=32% Similarity=0.499 Sum_probs=129.5
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc--hHHHHHHHHHHHHHhhc-CCCceeeeeeeeee
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT--PKARKMLSREIVSMESV-HHPNIIRLYEVLET 140 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 140 (267)
+|++.+.||+|+||.||+|++.... .++..||+|++...... ....+.+.+|+.++..+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGH----DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccC----CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 4899999999999999999874322 45689999999754322 23345678999999999 69999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..+++|||+.+|+|.+.+. ....+++..+..+
T Consensus 77 ~~~~~lv~e~~~~g~L~~~l~----------------------------------------------~~~~~~~~~~~~~ 110 (332)
T cd05614 77 EAKLHLILDYVSGGEMFTHLY----------------------------------------------QRDNFSEDEVRFY 110 (332)
T ss_pred CCEEEEEEeCCCCCcHHHHHH----------------------------------------------HcCCCCHHHHHHH
Confidence 999999999999888766554 2346889999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||+|||++|++||||||+|||++.++.+||+|||+++.+
T Consensus 111 ~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 111 SGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred HHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=216.81 Aligned_cols=153 Identities=36% Similarity=0.597 Sum_probs=133.6
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcC-CCceeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVH-HPNIIRLYEV 137 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~-hpnIv~~~~~ 137 (267)
.....|++.+.||+|.||.||+|... .++..+|+|++.+..... .....+.+|+.+|+.+. |||||.++++
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~-------~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~ 104 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREK-------STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA 104 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEec-------CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 34456999999999999999999997 557999999998876543 34578999999999997 9999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
|++....++|||+|.||.|.+.+.. . .+++.++
T Consensus 105 ~e~~~~~~lvmEL~~GGeLfd~i~~----------------------------------------------~-~~sE~da 137 (382)
T KOG0032|consen 105 FEDPDSVYLVMELCEGGELFDRIVK----------------------------------------------K-HYSERDA 137 (382)
T ss_pred EEcCCeEEEEEEecCCchHHHHHHH----------------------------------------------c-cCCHHHH
Confidence 9999999999999999887765532 2 3999999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecC----CceEEeccccccccC
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVR----GIVKLGDLGFSTKLQ 266 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~----~~~kl~DFGla~~l~ 266 (267)
..++.|++.++.|||+.|++||||||+|+|+... +.+|++|||+|..+.
T Consensus 138 ~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 138 AGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred HHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999999999999999999999543 479999999998764
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=214.71 Aligned_cols=150 Identities=27% Similarity=0.469 Sum_probs=130.0
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+|++.+.||+|+||.||++.+. .++..||+|++...... ......+.+|+.++..++||||+++++++...+
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLK-------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN 74 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEEC-------CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 5999999999999999999986 44588999999653322 233455788999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+||||+.+|+|.+++... ...+++..+..++.
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~---------------------------------------------~~~l~~~~~~~~~~ 109 (332)
T cd05623 75 NLYLVMDYYVGGDLLTLLSKF---------------------------------------------EDRLPEDMARFYLA 109 (332)
T ss_pred EEEEEEeccCCCcHHHHHHHh---------------------------------------------cCCCCHHHHHHHHH
Confidence 999999999998887776532 23588889999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++|++||||||+|||++.++.++|+|||+|..+
T Consensus 110 qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~ 152 (332)
T cd05623 110 EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 152 (332)
T ss_pred HHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheec
Confidence 9999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=219.34 Aligned_cols=144 Identities=26% Similarity=0.333 Sum_probs=124.4
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
+...++|++++.||+|+||.||+|.+. .+++.||+|... ...+.+|+.+++.++||||+++++++
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~-------~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~ 152 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDN-------KTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTF 152 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEEC-------CCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEE
Confidence 344567999999999999999999987 456899999753 23467899999999999999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
...+..++++|++. ++|..++ .....+++.++.
T Consensus 153 ~~~~~~~lv~e~~~-~~L~~~l----------------------------------------------~~~~~l~~~~~~ 185 (391)
T PHA03212 153 TYNKFTCLILPRYK-TDLYCYL----------------------------------------------AAKRNIAICDIL 185 (391)
T ss_pred EECCeeEEEEecCC-CCHHHHH----------------------------------------------HhcCCCCHHHHH
Confidence 99999999999885 4554433 333468889999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 186 ~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~ 231 (391)
T PHA03212 186 AIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACF 231 (391)
T ss_pred HHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence 9999999999999999999999999999999999999999999864
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=213.05 Aligned_cols=141 Identities=28% Similarity=0.511 Sum_probs=123.4
Q ss_pred cCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEEe
Q psy2579 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVE 149 (267)
Q Consensus 71 iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~e 149 (267)
||+|+||.||+|.+. .+++.||+|++..... .......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 lg~G~~g~Vy~~~~~-------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 73 (312)
T cd05585 1 IGKGSFGKVMQVRKR-------DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLA 73 (312)
T ss_pred CCcCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEc
Confidence 799999999999986 4558899999975432 33445678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHH
Q psy2579 150 YASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVK 229 (267)
Q Consensus 150 ~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~ 229 (267)
|+.+|+|.+.+.. .+.+++..+..++.|++.||.
T Consensus 74 ~~~~g~L~~~l~~----------------------------------------------~~~~~~~~~~~~~~qi~~~l~ 107 (312)
T cd05585 74 FINGGELFHHLQR----------------------------------------------EGRFDLSRARFYTAELLCALE 107 (312)
T ss_pred CCCCCcHHHHHHh----------------------------------------------cCCCCHHHHHHHHHHHHHHHH
Confidence 9998877665543 346888999999999999999
Q ss_pred HHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 230 HLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 230 ~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
|||++|++||||||+||+++.++.++|+|||+|+.
T Consensus 108 ~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~ 142 (312)
T cd05585 108 NLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL 142 (312)
T ss_pred HHHhCCeEeCCCCHHHeEECCCCcEEEEECccccc
Confidence 99999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=215.06 Aligned_cols=143 Identities=32% Similarity=0.546 Sum_probs=124.3
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLV 147 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv 147 (267)
+.||+|+||.||+|.+. .++..||+|++..... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv 73 (323)
T cd05595 1 KLLGKGTFGKVILVREK-------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 73 (323)
T ss_pred CeeeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEE
Confidence 35999999999999986 4568999999976432 223446678899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHH
Q psy2579 148 VEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSA 227 (267)
Q Consensus 148 ~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~ 227 (267)
|||+++|+|...+.. ...+++..+..++.|++.|
T Consensus 74 ~E~~~~~~L~~~l~~----------------------------------------------~~~~~~~~~~~~~~qi~~a 107 (323)
T cd05595 74 MEYANGGELFFHLSR----------------------------------------------ERVFTEERARFYGAEIVSA 107 (323)
T ss_pred EeCCCCCcHHHHHHH----------------------------------------------cCCCCHHHHHHHHHHHHHH
Confidence 999999887655532 3468899999999999999
Q ss_pred HHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 228 VKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 228 L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
|+|||++|++||||||+|||++.++.+||+|||+|+.
T Consensus 108 L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 144 (323)
T cd05595 108 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 144 (323)
T ss_pred HHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhcc
Confidence 9999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=214.63 Aligned_cols=143 Identities=31% Similarity=0.507 Sum_probs=124.9
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLV 147 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv 147 (267)
+.||+|+||.||+|.+. .++..||+|++..... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 73 (328)
T cd05593 1 KLLGKGTFGKVILVREK-------ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFV 73 (328)
T ss_pred CeeeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEE
Confidence 35999999999999986 4568999999976543 233456788999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHH
Q psy2579 148 VEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSA 227 (267)
Q Consensus 148 ~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~ 227 (267)
|||+.+|+|...+. ....+++..+..++.|++.|
T Consensus 74 ~Ey~~~g~L~~~l~----------------------------------------------~~~~l~~~~~~~~~~qi~~a 107 (328)
T cd05593 74 MEYVNGGELFFHLS----------------------------------------------RERVFSEDRTRFYGAEIVSA 107 (328)
T ss_pred EeCCCCCCHHHHHH----------------------------------------------hcCCCCHHHHHHHHHHHHHH
Confidence 99999888765553 23468899999999999999
Q ss_pred HHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 228 VKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 228 L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
|+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 108 L~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~ 144 (328)
T cd05593 108 LDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKE 144 (328)
T ss_pred HHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCcc
Confidence 9999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=209.10 Aligned_cols=151 Identities=26% Similarity=0.399 Sum_probs=130.5
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.|++.+.||+|+||.||+|.+. .++..||+|++....... .....+.+|+.+++.++||||+++++.+...+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVR-------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEc-------CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC
Confidence 3889999999999999999986 446899999997654332 23455778999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++|||+++|+|...+... ....+++..+..++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~ 109 (285)
T cd05605 74 ALCLVLTLMNGGDLKFHIYNM--------------------------------------------GNPGFDEERAVFYAA 109 (285)
T ss_pred eEEEEEeccCCCcHHHHHHhc--------------------------------------------CcCCCCHHHHHHHHH
Confidence 999999999998887666432 123588999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||+.|++||||||+||+++.++.++|+|||+++.+
T Consensus 110 qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05605 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEI 152 (285)
T ss_pred HHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence 9999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=221.82 Aligned_cols=154 Identities=27% Similarity=0.480 Sum_probs=131.7
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
...|.+.+.||+|+||.||+|.+..+ .+..||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~------~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~ 137 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSD------PKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSD 137 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCC------CCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC
Confidence 34599999999999999999987632 2478899977543 233445678899999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+||||+.+|+|.+.+... +....++++..+..++
T Consensus 138 ~~~~lv~E~~~gg~L~~~l~~~------------------------------------------~~~~~~l~~~~~~~i~ 175 (478)
T PTZ00267 138 DKLLLIMEYGSGGDLNKQIKQR------------------------------------------LKEHLPFQEYEVGLLF 175 (478)
T ss_pred CEEEEEEECCCCCCHHHHHHHH------------------------------------------HhccCCCCHHHHHHHH
Confidence 9999999999999998766432 1223468899999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||.|+|++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 176 ~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 176 YQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred HHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 99999999999999999999999999999999999999999865
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=213.08 Aligned_cols=148 Identities=28% Similarity=0.473 Sum_probs=126.8
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCC-Cceeeeeeeeeec
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHH-PNIIRLYEVLETF 141 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h-pnIv~~~~~~~~~ 141 (267)
+|++++.||+|+||.||+|.+. .+++.||+|++..... .......+..|+.++..+.| ++|+.+++++...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~ 73 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERK-------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 73 (324)
T ss_pred CceEEEEEeeccCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC
Confidence 4899999999999999999986 4458899999976543 23345678889999999965 5688999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+||||+.+|+|...+. ....+++..+..++
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~----------------------------------------------~~~~~~~~~~~~~~ 107 (324)
T cd05587 74 DRLYFVMEYVNGGDLMYHIQ----------------------------------------------QVGKFKEPHAVFYA 107 (324)
T ss_pred CEEEEEEcCCCCCcHHHHHH----------------------------------------------HcCCCCHHHHHHHH
Confidence 99999999999888766553 23468889999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
.|++.||+|||++||+||||||+|||++.++.++|+|||+|+.
T Consensus 108 ~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05587 108 AEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE 150 (324)
T ss_pred HHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence 9999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=225.16 Aligned_cols=154 Identities=31% Similarity=0.541 Sum_probs=123.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
..|..-+.||+|+||.||+|+++ .+|+.||||.++... ....++++.+|+++|++++|||||++++.-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnk-------etG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~ 84 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNK-------ETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKF 84 (732)
T ss_pred cceeehhhhcCCccceeeeeccc-------ccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccc
Confidence 44778889999999999999997 677999999998765 4566788999999999999999999999865543
Q ss_pred ------eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 143 ------KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 143 ------~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
...++||||.+|||...+.+- .....+++.+
T Consensus 85 ~~~~~~~~vlvmEyC~gGsL~~~L~~P-------------------------------------------EN~~GLpE~e 121 (732)
T KOG4250|consen 85 LGLVTRLPVLVMEYCSGGSLRKVLNSP-------------------------------------------ENAYGLPESE 121 (732)
T ss_pred cCcccccceEEEeecCCCcHHHHhcCc-------------------------------------------ccccCCCHHH
Confidence 244555555555554444321 0123599999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeec--CC--ceEEeccccccccCC
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSV--RG--IVKLGDLGFSTKLQQ 267 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~--~~--~~kl~DFGla~~l~~ 267 (267)
.+.++..++.||.|||.+||+||||||.||++-. +| .-||+|||.|+.+.+
T Consensus 122 ~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d 176 (732)
T KOG4250|consen 122 FLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDD 176 (732)
T ss_pred HHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCC
Confidence 9999999999999999999999999999999843 34 579999999998864
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=217.56 Aligned_cols=201 Identities=20% Similarity=0.251 Sum_probs=143.0
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 140 (267)
.++|++.+.||+|+||.||+|.+...+. ..+...||+|++.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGK--EDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCc--ccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 3469999999999999999998754331 1334689999997654 234456788999999999 89999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHH----------HHHHH-H---H---HHHhhhccCeEEEEEEEccCCchh
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAK----------IYFLQ-I---L---LYEVLETFGKIFLVVEYASGGELY 203 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~----------~~~~~-~---~---~~~~~~~~~~~~~v~e~~~~~~l~ 203 (267)
.+..|++||||.+|+|.+++............ .+... . . ...........++.|+........
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 99999999999999999998653211000000 00000 0 0 000001112233444433222211
Q ss_pred hh-------hcccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 204 NK-------ITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 204 ~~-------~~~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.. .....++++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||+|+.+
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~ 262 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI 262 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeec
Confidence 11 112346889999999999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=212.17 Aligned_cols=143 Identities=31% Similarity=0.529 Sum_probs=123.9
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLV 147 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv 147 (267)
+.||+|+||.||+|.+. .++..||+|++...... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 1 ~~lG~G~~g~V~~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv 73 (325)
T cd05594 1 KLLGKGTFGKVILVKEK-------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 73 (325)
T ss_pred CeeeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEE
Confidence 35999999999999986 45689999999765432 23446678899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHH
Q psy2579 148 VEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSA 227 (267)
Q Consensus 148 ~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~ 227 (267)
|||+.+|+|...+. ....+++..+..++.|++.|
T Consensus 74 ~E~~~~~~L~~~l~----------------------------------------------~~~~l~~~~~~~~~~qi~~a 107 (325)
T cd05594 74 MEYANGGELFFHLS----------------------------------------------RERVFSEDRARFYGAEIVSA 107 (325)
T ss_pred EeCCCCCcHHHHHH----------------------------------------------hcCCCCHHHHHHHHHHHHHH
Confidence 99999988765553 23468899999999999999
Q ss_pred HHHHHh-CCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 228 VKHLHD-RDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 228 L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
|+|||+ .|++||||||+|||++.++.+||+|||+|+.
T Consensus 108 L~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~ 145 (325)
T cd05594 108 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 145 (325)
T ss_pred HHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCee
Confidence 999997 7999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=222.22 Aligned_cols=156 Identities=31% Similarity=0.503 Sum_probs=131.5
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++.+.||+|+||.||+|.+. .+++.||||++.....+......+.+|+.++..++|+||+++++.+..
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~ 102 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRV-------SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAK 102 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEc-------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence 3457999999999999999999986 456899999998776666677788999999999999999999887754
Q ss_pred cC--------eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCC
Q psy2579 141 FG--------KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRL 212 (267)
Q Consensus 141 ~~--------~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~ 212 (267)
.+ ..++||||+.+|+|.+.+.... .....+
T Consensus 103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~------------------------------------------~~~~~l 140 (496)
T PTZ00283 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRA------------------------------------------KTNRTF 140 (496)
T ss_pred ccccCcccceEEEEEEeCCCCCcHHHHHHHhh------------------------------------------ccCCCC
Confidence 32 3567888888777776664321 123468
Q ss_pred ChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 213 SEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 213 ~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++..+..++.|++.||.|+|++||+||||||+|||++.++.+||+|||+++.+
T Consensus 141 ~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~ 193 (496)
T PTZ00283 141 REHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY 193 (496)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeec
Confidence 89999999999999999999999999999999999999999999999998754
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=217.08 Aligned_cols=148 Identities=25% Similarity=0.370 Sum_probs=125.2
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC-
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG- 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~- 142 (267)
+|++.+.||+|+||.||+|.+. .+++.||||.+............+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 73 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDP-------RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI 73 (372)
T ss_pred CCcccceeeeCCCEEEEEEEEC-------CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc
Confidence 3788999999999999999986 45689999998765434445567889999999999999999999988766
Q ss_pred ----eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 143 ----KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 143 ----~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
..|++|||+.+ + +.+.+.....+++..+.
T Consensus 74 ~~~~~~~lv~e~~~~-~----------------------------------------------l~~~~~~~~~l~~~~~~ 106 (372)
T cd07853 74 DPFEEIYVVTELMQS-D----------------------------------------------LHKIIVSPQPLSSDHVK 106 (372)
T ss_pred cccceEEEEeecccc-C----------------------------------------------HHHHHhcCCCCCHHHHH
Confidence 67777777653 3 33444445578999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||.|||++|++||||||+|||++.++.+||+|||+|+..
T Consensus 107 ~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 107 VFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred HHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 99999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=212.82 Aligned_cols=146 Identities=36% Similarity=0.568 Sum_probs=124.0
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccc--hHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT--PKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFL 146 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~i 146 (267)
+.||+|+||.||+|.+.... .+++.||+|++...... ......+.+|+.+++.++||||+++++++...+..|+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l 77 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGA----DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYL 77 (323)
T ss_pred ceeeecCCeEEEEEEEcccC----CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEE
Confidence 57999999999999874322 45689999999764321 2334567899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS 226 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~ 226 (267)
+|||+.+|+|.+.+.. .+.+++..+..++.|++.
T Consensus 78 v~e~~~~~~L~~~~~~----------------------------------------------~~~~~~~~~~~~~~qi~~ 111 (323)
T cd05584 78 ILEYLSGGELFMHLER----------------------------------------------EGIFMEDTACFYLSEISL 111 (323)
T ss_pred EEeCCCCchHHHHHHH----------------------------------------------cCCCCHHHHHHHHHHHHH
Confidence 9999998877665543 345778888899999999
Q ss_pred HHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 227 AVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 227 ~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
||+|||++|++||||||+|||++.++.+||+|||+++.
T Consensus 112 ~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 112 ALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred HHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 99999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=206.47 Aligned_cols=146 Identities=33% Similarity=0.447 Sum_probs=125.3
Q ss_pred cCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEEe
Q psy2579 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVE 149 (267)
Q Consensus 71 iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~e 149 (267)
||+|+||+||+|.+. .+++.||+|.+....... .....+..|+.+++.++||||+++.+++...+..|++||
T Consensus 1 lg~G~~g~Vy~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 73 (280)
T cd05608 1 LGKGGFGEVSACQMR-------ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMT 73 (280)
T ss_pred CCCCCceeEEEEEEc-------cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEe
Confidence 799999999999986 456899999997654332 234567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHH
Q psy2579 150 YASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVK 229 (267)
Q Consensus 150 ~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~ 229 (267)
|+.+|+|...+.... .....+++..+..++.|++.||+
T Consensus 74 ~~~~g~L~~~~~~~~------------------------------------------~~~~~l~~~~~~~~~~qi~~~l~ 111 (280)
T cd05608 74 IMNGGDLRYHIYNVD------------------------------------------EENPGFPEPRACFYTAQIISGLE 111 (280)
T ss_pred CCCCCCHHHHHHhcc------------------------------------------ccCCCCCHHHHHHHHHHHHHHHH
Confidence 999999876653211 12346899999999999999999
Q ss_pred HHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 230 HLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 230 ~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|||++|++||||||+||+++.++.++|+|||+++.+
T Consensus 112 ~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 147 (280)
T cd05608 112 HLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL 147 (280)
T ss_pred HHHHCCcccCCCCHHHEEECCCCCEEEeeCccceec
Confidence 999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=209.53 Aligned_cols=153 Identities=27% Similarity=0.366 Sum_probs=127.7
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|++.+.||+|+||.||+|.+...+. .....||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGE---KVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCC---ccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 459999999999999999999864331 123469999987532 344567788999999999999999999998764
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++++++.+|+|.+++... ...+++..+..++.
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~---------------------------------------------~~~~~~~~~~~~~~ 116 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREH---------------------------------------------KDNIGSQYLLNWCV 116 (316)
T ss_pred CceeeeecCCCCCHHHHHHhc---------------------------------------------cccCCHHHHHHHHH
Confidence 567888888888887766532 22578888999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 117 qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred HHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 9999999999999999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-28 Score=209.56 Aligned_cols=149 Identities=27% Similarity=0.438 Sum_probs=131.3
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++++.||+|+||.||+|.+. .++..||+|++.... .+.....+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHK-------PSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEEC-------CCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 56999999999999999999986 456889999997643 3445677999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++|||+.+|+|.+++.. ...+++..+..++.
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~----------------------------------------------~~~~~~~~~~~~~~ 110 (331)
T cd06649 77 EISICMEHMDGGSLDQVLKE----------------------------------------------AKRIPEEILGKVSI 110 (331)
T ss_pred EEEEEeecCCCCcHHHHHHH----------------------------------------------cCCCCHHHHHHHHH
Confidence 99999999999888766543 23588899999999
Q ss_pred HHHHHHHHHHhC-CCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDR-DIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++ +++||||||+|||++.++.++|+|||+++.+
T Consensus 111 ~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 154 (331)
T cd06649 111 AVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (331)
T ss_pred HHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence 999999999986 6999999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=211.70 Aligned_cols=143 Identities=29% Similarity=0.537 Sum_probs=124.3
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhc-CCCceeeeeeeeeecCeEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESV-HHPNIIRLYEVLETFGKIFL 146 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~i 146 (267)
+.||+|+||.||+|.+. .+++.||+|+++..... ......+.+|+.++..+ +||||+++++++...+..|+
T Consensus 1 ~~lG~G~~g~V~~~~~~-------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~l 73 (329)
T cd05588 1 RVIGRGSYAKVLLVELK-------KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFF 73 (329)
T ss_pred CeEeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEE
Confidence 35999999999999986 45689999999865433 23456688999999988 79999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS 226 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~ 226 (267)
|||||.+|+|..++. ..+++++..+..++.|++.
T Consensus 74 v~e~~~~g~L~~~~~----------------------------------------------~~~~l~~~~~~~~~~qi~~ 107 (329)
T cd05588 74 VIEFVSGGDLMFHMQ----------------------------------------------RQRKLPEEHARFYSAEISL 107 (329)
T ss_pred EEeCCCCCCHHHHHH----------------------------------------------HcCCCCHHHHHHHHHHHHH
Confidence 999999887765543 3346899999999999999
Q ss_pred HHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 227 AVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 227 ~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
||+|||++|++||||||+||+++.++.+||+|||+|+.
T Consensus 108 ~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 108 ALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred HHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccc
Confidence 99999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=210.29 Aligned_cols=148 Identities=29% Similarity=0.476 Sum_probs=126.9
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESV-HHPNIIRLYEVLETF 141 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~ 141 (267)
+|++.+.||+|+||.||+|.+. .++..||+|++...... .........|..++..+ +||+|+.+++++...
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~ 73 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERK-------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM 73 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC
Confidence 4889999999999999999986 45589999999765432 23345567788888877 689999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+||||+.+|+|.+.+.. .+.+++..+..++
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~----------------------------------------------~~~~~~~~~~~~~ 107 (323)
T cd05616 74 DRLYFVMEYVNGGDLMYQIQQ----------------------------------------------VGRFKEPHAVFYA 107 (323)
T ss_pred CEEEEEEcCCCCCCHHHHHHH----------------------------------------------cCCCCHHHHHHHH
Confidence 999999999998887665532 3468889999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
.|++.||+|||++|++||||||+|||++.++.+||+|||+|+.
T Consensus 108 ~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~ 150 (323)
T cd05616 108 AEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred HHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence 9999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=208.30 Aligned_cols=150 Identities=27% Similarity=0.429 Sum_probs=126.5
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .++..||+|.++..... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSK-------LTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEec-------CCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 356999999999999999999886 44588999998754322 2234577899999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..+++|||+.+ ++.+.+.. ....+++..+..++
T Consensus 77 ~~~~lv~e~~~~-~l~~~~~~---------------------------------------------~~~~~~~~~~~~~~ 110 (309)
T cd07872 77 KSLTLVFEYLDK-DLKQYMDD---------------------------------------------CGNIMSMHNVKIFL 110 (309)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---------------------------------------------cCCCCCHHHHHHHH
Confidence 999999999875 55443322 12347888999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++|++||||||+||+++.++.+||+|||+++..
T Consensus 111 ~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 111 YQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAK 154 (309)
T ss_pred HHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceec
Confidence 99999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=207.67 Aligned_cols=151 Identities=35% Similarity=0.575 Sum_probs=133.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
..|++.+.||+|.|+.|+++.+. .+++.+|+|+++...++....+.+.+|+.+.+.|+||||+++.+...+.+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~-------~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~ 83 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHK-------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES 83 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhc-------cchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccc
Confidence 45999999999999999999987 56699999999988888778888999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+|+|++.|++|..-+- ...-+++..+..+++
T Consensus 84 ~~ylvFe~m~G~dl~~eIV----------------------------------------------~R~~ySEa~aSH~~r 117 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIV----------------------------------------------AREFYSEADASHCIQ 117 (355)
T ss_pred eeEEEEecccchHHHHHHH----------------------------------------------HHHHHHHHHHHHHHH
Confidence 9999999999988854321 223578899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecC---CceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVR---GIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~---~~~kl~DFGla~~l~ 266 (267)
||+.+|.|+|.+||||||+||+|+++... .-+||+|||+|..++
T Consensus 118 QiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 118 QILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred HHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 99999999999999999999999999543 369999999998764
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-28 Score=228.06 Aligned_cols=161 Identities=20% Similarity=0.331 Sum_probs=135.0
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
++|++.++||+|+||.||+|.+. .+++.||+|++..... .+...+++.+|+.+++.++||||+++++++...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~-------~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~ 74 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDP-------VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG 74 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEEC-------CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC
Confidence 67999999999999999999986 4568999999975432 234567799999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|++|||+++|+|.+.+.+..... .+.. .....++...+..++
T Consensus 75 ~~lyLVMEY~eGGSL~~lL~s~~~~~---------------------------------~l~e--~~~~~lsv~~iL~I~ 119 (932)
T PRK13184 75 DPVYYTMPYIEGYTLKSLLKSVWQKE---------------------------------SLSK--ELAEKTSVGAFLSIF 119 (932)
T ss_pred CEEEEEEEcCCCCCHHHHHHHhhhcc---------------------------------ccch--hhhcccCHHHHHHHH
Confidence 99999999999999998886431100 0000 012246778889999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++||+||||||+||+++.++.++|+|||+|+.+
T Consensus 120 ~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i 163 (932)
T PRK13184 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFK 163 (932)
T ss_pred HHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceec
Confidence 99999999999999999999999999999999999999999865
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=211.60 Aligned_cols=149 Identities=28% Similarity=0.413 Sum_probs=123.9
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++.+.||+|+||.||+|.+. .++..||+|++............+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDT-------VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTP 91 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEc-------CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence 3567999999999999999999986 456899999997655455556778899999999999999999998865
Q ss_pred cC------eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCCh
Q psy2579 141 FG------KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214 (267)
Q Consensus 141 ~~------~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~ 214 (267)
.+ ..|++|||+.++ +. +.+. ..+++
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~-l~----------------------------------------------~~~~--~~~~~ 122 (359)
T cd07876 92 QKSLEEFQDVYLVMELMDAN-LC----------------------------------------------QVIH--MELDH 122 (359)
T ss_pred CCCccccceeEEEEeCCCcC-HH----------------------------------------------HHHh--ccCCH
Confidence 43 367777777542 22 2221 24788
Q ss_pred hHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+|+..
T Consensus 123 ~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 123 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 889999999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=201.53 Aligned_cols=153 Identities=25% Similarity=0.389 Sum_probs=132.6
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+...+ .+...||+|.+.... .......+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~----~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPG----KKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCC----CCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC
Confidence 45999999999999999999986432 234689999987543 3445567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++||++.+++|.+++... .+.+++..+..++.
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~---------------------------------------------~~~~~~~~~~~~~~ 113 (266)
T cd05033 79 PVMIITEYMENGSLDKFLREN---------------------------------------------DGKFTVGQLVGMLR 113 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhc---------------------------------------------cCCCCHHHHHHHHH
Confidence 999999999998887766432 22688999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++|++|+||||+||+++.++.++|+|||+++.+
T Consensus 114 ~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 114 GIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred HHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=214.18 Aligned_cols=202 Identities=21% Similarity=0.271 Sum_probs=140.9
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-CCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-HPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~ 139 (267)
..++|++.+.||+|+||.||+|.+..... ......||||++.... .....+.+.+|+.+++.+. ||||+++++++.
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~--~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSR--SQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCC--CCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 34579999999999999999998753221 1223579999997543 3344577999999999995 999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhH--------------------HHHHHHH-HH------------------
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDA--------------------KIYFLQI-LL------------------ 180 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~--------------------~~~~~~~-~~------------------ 180 (267)
..+..|+|||||.+|+|.+++........... ..+.... ..
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 99999999999999999999876422110000 0000000 00
Q ss_pred ------HHhhhccCeEEEEEEE---ccCCchhhhhcc--cCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEee
Q psy2579 181 ------YEVLETFGKIFLVVEY---ASGGELYNKITT--EGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS 249 (267)
Q Consensus 181 ------~~~~~~~~~~~~v~e~---~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~ 249 (267)
..........+-.... ..++++.+.+.. ...+++..+..++.|++.||+|||+.|++||||||+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 0000000000000000 012233333433 23589999999999999999999999999999999999999
Q ss_pred cCCceEEecccccccc
Q psy2579 250 VRGIVKLGDLGFSTKL 265 (267)
Q Consensus 250 ~~~~~kl~DFGla~~l 265 (267)
.++.+||+|||+++.+
T Consensus 272 ~~~~~kL~DfGla~~~ 287 (400)
T cd05105 272 QGKIVKICDFGLARDI 287 (400)
T ss_pred CCCEEEEEeCCcceec
Confidence 9999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=209.84 Aligned_cols=143 Identities=28% Similarity=0.468 Sum_probs=122.9
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhc-CCCceeeeeeeeeecCeEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESV-HHPNIIRLYEVLETFGKIFL 146 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~i 146 (267)
+.||+|+||.||+|.+. .+++.||+|++..... .......+..|..++..+ +||||+++++++...+..|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~l 73 (321)
T cd05591 1 KVLGKGSFGKVMLAELK-------GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFF 73 (321)
T ss_pred CccccCCCeEEEEEEEC-------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEE
Confidence 36999999999999986 4568999999976532 233456677899999876 89999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS 226 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~ 226 (267)
||||+++|+|...+. ....+++..+..++.|++.
T Consensus 74 v~E~~~~~~L~~~l~----------------------------------------------~~~~~~~~~~~~~~~qi~~ 107 (321)
T cd05591 74 VMEYVNGGDLMFQIQ----------------------------------------------RSRKFDEPRSRFYAAEVTL 107 (321)
T ss_pred EEeCCCCCcHHHHHH----------------------------------------------HcCCCCHHHHHHHHHHHHH
Confidence 999999888766553 2346888999999999999
Q ss_pred HHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 227 AVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 227 ~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
||.|||++|++||||||+||+++.++.++|+|||+|+.
T Consensus 108 aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~ 145 (321)
T cd05591 108 ALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKE 145 (321)
T ss_pred HHHHHHHCCeeccCCCHHHeEECCCCCEEEeeccccee
Confidence 99999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=210.13 Aligned_cols=147 Identities=29% Similarity=0.480 Sum_probs=126.1
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhc-CCCceeeeeeeeeecC
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESV-HHPNIIRLYEVLETFG 142 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~ 142 (267)
|++.+.||+|+||.||+|.+. .+++.||+|++...... ......+..|+.++..+ +||+|+++++++...+
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~ 74 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERK-------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD 74 (323)
T ss_pred ceEEEEEEecCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC
Confidence 788899999999999999986 45689999999764322 23445677899999888 4678889999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+||||+.+|+|.+.+. ..+.+++..+..++.
T Consensus 75 ~~~lv~Ey~~~g~L~~~i~----------------------------------------------~~~~l~~~~~~~i~~ 108 (323)
T cd05615 75 RLYFVMEYVNGGDLMYHIQ----------------------------------------------QVGKFKEPQAVFYAA 108 (323)
T ss_pred EEEEEEcCCCCCcHHHHHH----------------------------------------------HcCCCCHHHHHHHHH
Confidence 9999999999888766553 334688999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
|++.||+|||++|++||||||+|||++.++.++|+|||+|+.
T Consensus 109 qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~ 150 (323)
T cd05615 109 EISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred HHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccc
Confidence 999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=209.15 Aligned_cols=149 Identities=27% Similarity=0.442 Sum_probs=130.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.++||+|+||.||+|.+. .++..+|+|++.... .......+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~-------~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHK-------PSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (333)
T ss_pred hhhheeccccCCCCEEEEEEEEC-------CCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC
Confidence 56999999999999999999986 455889999987643 3445577899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++|||+.+|+|.+++.. .+.+++..+..++.
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~----------------------------------------------~~~~~~~~~~~~~~ 110 (333)
T cd06650 77 EISICMEHMDGGSLDQVLKK----------------------------------------------AGRIPEQILGKVSI 110 (333)
T ss_pred EEEEEEecCCCCcHHHHHHH----------------------------------------------cCCCCHHHHHHHHH
Confidence 99999999999888766643 23578888999999
Q ss_pred HHHHHHHHHHhC-CCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDR-DIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||+. +++||||||+|||++.++.+||+|||+++.+
T Consensus 111 ~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 111 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred HHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 999999999975 7999999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=209.27 Aligned_cols=144 Identities=31% Similarity=0.527 Sum_probs=121.2
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhc-CCCceeeeeeeeeecCeEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESV-HHPNIIRLYEVLETFGKIFL 146 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~i 146 (267)
+.||+|+||.||+|.+. .+++.||+|+++..... .........|..++..+ +||||+++++++...+..|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~l 73 (316)
T cd05592 1 KVLGKGSFGKVMLAELK-------GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEE
Confidence 36999999999999986 45688999999765322 23344556677777654 89999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS 226 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~ 226 (267)
||||+.+|+|...+.. .+.+++..+..++.|++.
T Consensus 74 v~e~~~gg~L~~~~~~----------------------------------------------~~~~~~~~~~~~~~qi~~ 107 (316)
T cd05592 74 VMEYLNGGDLMFHIQS----------------------------------------------SGRFDEARARFYAAEIIC 107 (316)
T ss_pred EEcCCCCCcHHHHHHH----------------------------------------------cCCCCHHHHHHHHHHHHH
Confidence 9999998887665542 346888999999999999
Q ss_pred HHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 227 AVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 227 ~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
||.|||++||+||||||+||+++.++.+||+|||+|+..
T Consensus 108 al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 108 GLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred HHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=209.68 Aligned_cols=143 Identities=29% Similarity=0.528 Sum_probs=123.7
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhc-CCCceeeeeeeeeecCeEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESV-HHPNIIRLYEVLETFGKIFL 146 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~i 146 (267)
+.||+|+||.||+|.+. .+++.||+|++...... ......+.+|+.++..+ +||||+++++++...+..|+
T Consensus 1 ~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 73 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK-------KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 73 (329)
T ss_pred CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEE
Confidence 35999999999999986 45689999999865432 34456678899998877 89999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS 226 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~ 226 (267)
||||+.+|+|...+. ....+++..+..++.|++.
T Consensus 74 v~E~~~~~~L~~~~~----------------------------------------------~~~~l~~~~~~~i~~qi~~ 107 (329)
T cd05618 74 VIEYVNGGDLMFHMQ----------------------------------------------RQRKLPEEHARFYSAEISL 107 (329)
T ss_pred EEeCCCCCCHHHHHH----------------------------------------------HcCCCCHHHHHHHHHHHHH
Confidence 999999888765543 2346889999999999999
Q ss_pred HHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 227 AVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 227 ~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
||+|||++|++||||||+||+++.++.+||+|||+|+.
T Consensus 108 ~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~ 145 (329)
T cd05618 108 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 145 (329)
T ss_pred HHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence 99999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-28 Score=202.03 Aligned_cols=147 Identities=37% Similarity=0.598 Sum_probs=130.8
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeE
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKI 144 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 144 (267)
|++.+.||+|+||.||+|.+. .+++.||+|++..............+|+.+++.++||||+++++++......
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 73 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNK-------KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYL 73 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEET-------TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEE
T ss_pred CEEeEEEEeCCCEEEEEEEEC-------CCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccc
Confidence 889999999999999999986 5568999999988765555445556799999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHH
Q psy2579 145 FLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 224 (267)
Q Consensus 145 ~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql 224 (267)
+++||++.+++|.+++. ....+++..+..++.|+
T Consensus 74 ~~v~~~~~~~~L~~~l~----------------------------------------------~~~~~~~~~~~~~~~qi 107 (260)
T PF00069_consen 74 YIVMEYCPGGSLQDYLQ----------------------------------------------KNKPLSEEEILKIAYQI 107 (260)
T ss_dssp EEEEEEETTEBHHHHHH----------------------------------------------HHSSBBHHHHHHHHHHH
T ss_pred ccccccccccccccccc----------------------------------------------ccccccccccccccccc
Confidence 99999999877776664 23468999999999999
Q ss_pred HHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 225 LSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 225 ~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
+.||++||++|++|+||||+||+++.++.++|+|||.+..
T Consensus 108 ~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 108 LEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVK 147 (260)
T ss_dssp HHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred cccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=204.99 Aligned_cols=151 Identities=25% Similarity=0.407 Sum_probs=120.7
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc---CCCceeeeeeeeee
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV---HHPNIIRLYEVLET 140 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~~~~~~~~ 140 (267)
+|++.+.||+|+||.||+|.+.. .++..||+|.+............+.+|+.+++.+ +||||+++++++..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~ 75 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLK------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 75 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcC------CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEec
Confidence 59999999999999999998752 3357899999876543333334566788777765 69999999998752
Q ss_pred -----cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 141 -----FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 141 -----~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
....+++||++. ++|.+++... ....+++.
T Consensus 76 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~--------------------------------------------~~~~~~~~ 110 (290)
T cd07862 76 SRTDRETKLTLVFEHVD-QDLTTYLDKV--------------------------------------------PEPGVPTE 110 (290)
T ss_pred ccCCCCCcEEEEEccCC-CCHHHHHHhC--------------------------------------------CCCCCCHH
Confidence 345788888876 4555544321 12358889
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+|+..
T Consensus 111 ~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 111 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred HHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 99999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-28 Score=209.01 Aligned_cols=143 Identities=31% Similarity=0.524 Sum_probs=120.3
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHH-HHhhcCCCceeeeeeeeeecCeEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIV-SMESVHHPNIIRLYEVLETFGKIFL 146 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~-~l~~l~hpnIv~~~~~~~~~~~~~i 146 (267)
+.||+|+||.||+|.+. .+++.||+|++..... .......+.+|.. +++.++||||+++++++...+..|+
T Consensus 1 ~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~l 73 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK-------LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYF 73 (325)
T ss_pred CceeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEE
Confidence 36999999999999986 4568999999976432 2233345555654 5677899999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS 226 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~ 226 (267)
+|||+.+|+|...+. ....+++..+..++.|++.
T Consensus 74 v~e~~~~~~L~~~l~----------------------------------------------~~~~~~~~~~~~~~~qi~~ 107 (325)
T cd05604 74 VLDFVNGGELFFHLQ----------------------------------------------RERSFPEPRARFYAAEIAS 107 (325)
T ss_pred EEcCCCCCCHHHHHH----------------------------------------------HcCCCCHHHHHHHHHHHHH
Confidence 999999877765543 3346889999999999999
Q ss_pred HHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 227 AVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 227 ~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
||+|||++|++||||||+|||++.++.+||+|||+|+.
T Consensus 108 al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~ 145 (325)
T cd05604 108 ALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKE 145 (325)
T ss_pred HHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCccc
Confidence 99999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=200.17 Aligned_cols=154 Identities=33% Similarity=0.535 Sum_probs=132.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||.||+|.+. .++..||||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCL-------LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED 74 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEe-------CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC
Confidence 57999999999999999999986 4458999998865432 344556788999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..++++||+.+|+|.+++.... .....+++..+..++
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~------------------------------------------~~~~~~~~~~~~~~~ 112 (267)
T cd08228 75 NELNIVLELADAGDLSQMIKYFK------------------------------------------KQKRLIPERTVWKYF 112 (267)
T ss_pred CeEEEEEEecCCCcHHHHHHHhh------------------------------------------hccCCCCHHHHHHHH
Confidence 99999999999999877664321 112357889999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++|++|+||||+||+++.++.++|+|||++..+
T Consensus 113 ~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 113 VQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred HHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 99999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=209.18 Aligned_cols=143 Identities=31% Similarity=0.542 Sum_probs=120.0
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHH-HHhhcCCCceeeeeeeeeecCeEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIV-SMESVHHPNIIRLYEVLETFGKIFL 146 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~-~l~~l~hpnIv~~~~~~~~~~~~~i 146 (267)
+.||+|+||.||+|.+. .++..||+|++...... ......+.+|.. +++.++||||+++++++...+..|+
T Consensus 1 ~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~l 73 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK-------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYF 73 (321)
T ss_pred CeeeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEE
Confidence 36999999999999986 45689999999764332 223344555554 6788899999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS 226 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~ 226 (267)
||||+++|+|...+. ....+++..+..++.|++.
T Consensus 74 v~e~~~~~~L~~~l~----------------------------------------------~~~~~~~~~~~~~~~qi~~ 107 (321)
T cd05603 74 VLDYVNGGELFFHLQ----------------------------------------------RERCFLEPRARFYAAEVAS 107 (321)
T ss_pred EEcCCCCCCHHHHHH----------------------------------------------HcCCCCHHHHHHHHHHHHH
Confidence 999999988765543 2346888899999999999
Q ss_pred HHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 227 AVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 227 ~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
||.|||++|++||||||+||+++.++.+||+|||+|+.
T Consensus 108 ~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 145 (321)
T cd05603 108 AIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (321)
T ss_pred HHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence 99999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-29 Score=201.19 Aligned_cols=153 Identities=35% Similarity=0.544 Sum_probs=131.7
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc------hHHHHHHHHHHHHHhhc-CCCceeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT------PKARKMLSREIVSMESV-HHPNIIRL 134 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~Ei~~l~~l-~hpnIv~~ 134 (267)
.+.|...+.||.|..+.|.++.++ .++..+|+|++...... .+.++...+|+.+|+++ .||+|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k-------~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l 88 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHK-------ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDL 88 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhc-------ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEe
Confidence 355888889999999999999987 56688999998754421 23356678999999998 89999999
Q ss_pred eeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCCh
Q psy2579 135 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214 (267)
Q Consensus 135 ~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~ 214 (267)
.++++++..+++|+|.|..|.|.+++ .+.-.+++
T Consensus 89 ~D~yes~sF~FlVFdl~prGELFDyL----------------------------------------------ts~VtlSE 122 (411)
T KOG0599|consen 89 QDVYESDAFVFLVFDLMPRGELFDYL----------------------------------------------TSKVTLSE 122 (411)
T ss_pred eeeccCcchhhhhhhhcccchHHHHh----------------------------------------------hhheeecH
Confidence 99999999888888888875555544 45557999
Q ss_pred hHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccCC
Q psy2579 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~~ 267 (267)
..++.+++|+..|++|||.++||||||||+|||++++.+++|+|||+|++++.
T Consensus 123 K~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 123 KETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred HHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999999999999999999999999999999999999999999998863
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=222.27 Aligned_cols=159 Identities=26% Similarity=0.364 Sum_probs=143.2
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
.-..+..+|.+.||.|.||+|++|+.+..+ .....||||.++... +++++..|+.|+.||.+++||||+++.|+.
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pg----kre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVV 699 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPG----KREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVV 699 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCC----CcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence 334456889999999999999999987655 455789999997654 677888999999999999999999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
.....+.||+|||++|+|..||+.++ +.++..++.
T Consensus 700 Tks~PvMIiTEyMENGsLDsFLR~~D---------------------------------------------GqftviQLV 734 (996)
T KOG0196|consen 700 TKSKPVMIITEYMENGSLDSFLRQND---------------------------------------------GQFTVIQLV 734 (996)
T ss_pred ecCceeEEEhhhhhCCcHHHHHhhcC---------------------------------------------CceEeehHH
Confidence 99999999999999999999998753 358888999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccCC
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~~ 267 (267)
.+++.|+.||.||.+.|+|||||..+|||++.+-.+|++||||+|.+++
T Consensus 735 gMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 735 GMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred HHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999999999999999999999999999999999999998753
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=208.74 Aligned_cols=143 Identities=33% Similarity=0.567 Sum_probs=119.8
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHH-HHhhcCCCceeeeeeeeeecCeEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIV-SMESVHHPNIIRLYEVLETFGKIFL 146 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~-~l~~l~hpnIv~~~~~~~~~~~~~i 146 (267)
+.||+|+||.||+|.+. .+++.||+|++...... ......+.+|.. +++.++||||+++++.+...+..|+
T Consensus 1 ~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~l 73 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK-------ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYF 73 (323)
T ss_pred CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEE
Confidence 36999999999999986 45689999999764322 222344555554 5677899999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS 226 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~ 226 (267)
||||+.+|+|...+. ....+++..+..++.|++.
T Consensus 74 v~e~~~~g~L~~~l~----------------------------------------------~~~~~~~~~~~~~~~qi~~ 107 (323)
T cd05575 74 VLDYVNGGELFFHLQ----------------------------------------------RERSFPEPRARFYAAEIAS 107 (323)
T ss_pred EEcCCCCCCHHHHHH----------------------------------------------hcCCCCHHHHHHHHHHHHH
Confidence 999999888766554 2346888999999999999
Q ss_pred HHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 227 AVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 227 ~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
||+|||++|++||||||+|||++.++.+||+|||+++.
T Consensus 108 ~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~ 145 (323)
T cd05575 108 ALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (323)
T ss_pred HHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence 99999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=200.82 Aligned_cols=153 Identities=27% Similarity=0.371 Sum_probs=131.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+...+ .....+|+|.++... .......+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPG----KREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCC----CCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 46999999999999999999875332 223579999987643 3345578899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++|||+++++|.+++... .+.+++.++..++.
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~---------------------------------------------~~~~~~~~~~~i~~ 113 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKH---------------------------------------------DGQFTVIQLVGMLR 113 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhc---------------------------------------------CCCCCHHHHHHHHH
Confidence 999999999998887766432 12578899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++|++||||||+||+++.++.++|+|||+++.+
T Consensus 114 ~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 114 GIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred HHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=208.55 Aligned_cols=143 Identities=32% Similarity=0.568 Sum_probs=118.7
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHH-HHHhhcCCCceeeeeeeeeecCeEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREI-VSMESVHHPNIIRLYEVLETFGKIFL 146 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei-~~l~~l~hpnIv~~~~~~~~~~~~~i 146 (267)
+.||+|+||.||+|++. .++..||+|++...... ......+..|. .+++.++||||+++++++...+..|+
T Consensus 1 ~~lg~G~fg~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~l 73 (325)
T cd05602 1 KVIGKGSFGKVLLARHK-------AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 73 (325)
T ss_pred CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEE
Confidence 36999999999999986 45588999999764322 12223344444 45677899999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS 226 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~ 226 (267)
+|||+.+|+|.+.+.. ...+++..+..++.|++.
T Consensus 74 v~e~~~~~~L~~~~~~----------------------------------------------~~~~~~~~~~~~~~qi~~ 107 (325)
T cd05602 74 VLDYINGGELFYHLQR----------------------------------------------ERCFLEPRARFYAAEIAS 107 (325)
T ss_pred EEeCCCCCcHHHHHHh----------------------------------------------cCCCCHHHHHHHHHHHHH
Confidence 9999999887665543 335788889999999999
Q ss_pred HHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 227 AVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 227 ~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 108 ~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~ 145 (325)
T cd05602 108 ALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE 145 (325)
T ss_pred HHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence 99999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=215.28 Aligned_cols=149 Identities=24% Similarity=0.378 Sum_probs=130.7
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
...+.++||+|.||+|.+|.-. ....||+|.++.... ...+..|.+||++|.+|+||||++++++|..++.
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeve--------g~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVE--------GPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred heehhhhhcCcccceeEEEEec--------CceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 4778899999999999999763 348899999988764 3457889999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
+++++||+++|+|.+++..... ..+......+++.|
T Consensus 610 icmI~EYmEnGDLnqFl~ahea--------------------------------------------pt~~t~~~vsi~tq 645 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHEL--------------------------------------------PTAETAPGVSICTQ 645 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccC--------------------------------------------cccccchhHHHHHH
Confidence 9999999999999998875421 11344556679999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|+.||+||.+.++||||+.++|+|++.++++||+|||+|+.+
T Consensus 646 iasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 646 IASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHHHHHHhhchhhccccccceeecCcccEEecCccccccc
Confidence 999999999999999999999999999999999999999854
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=211.43 Aligned_cols=148 Identities=24% Similarity=0.415 Sum_probs=122.2
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec-
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF- 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~- 141 (267)
++|++.+.||+|+||.||+|.+. .++..||+|.+............+.+|+.+++.++||||+++++++...
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDT-------RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhheecccCCCeEEEEEEEC-------CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 45999999999999999999886 4558999999976544444456688999999999999999999987543
Q ss_pred -----CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 142 -----GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 142 -----~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
...|++++++ +++|. +.+. ...+++..
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~----------------------------------------------~~~~-~~~l~~~~ 119 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLN----------------------------------------------NIVK-CQKLSDEH 119 (343)
T ss_pred cccccCcEEEEeecC-CCCHH----------------------------------------------HHHh-cCCCCHHH
Confidence 2356666655 33443 3332 23689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+|+.+
T Consensus 120 ~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 120 VQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred HHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 9999999999999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=208.61 Aligned_cols=143 Identities=32% Similarity=0.525 Sum_probs=122.8
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhc-CCCceeeeeeeeeecCeEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESV-HHPNIIRLYEVLETFGKIFL 146 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~i 146 (267)
+.||+|+||.||+|.+. .+++.||+|++..... .......+.+|..++..+ +||||+++++++...+..|+
T Consensus 1 ~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~i 73 (320)
T cd05590 1 RVLGKGSFGKVMLARLK-------ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFF 73 (320)
T ss_pred CeeeeCCCeEEEEEEEc-------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEE
Confidence 36999999999999986 4568999999976432 223456677888888876 79999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS 226 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~ 226 (267)
||||+.+|+|...+.. ...+++..+..++.|++.
T Consensus 74 v~Ey~~~g~L~~~i~~----------------------------------------------~~~l~~~~~~~~~~ql~~ 107 (320)
T cd05590 74 VMEFVNGGDLMFHIQK----------------------------------------------SRRFDEARARFYAAEITS 107 (320)
T ss_pred EEcCCCCchHHHHHHH----------------------------------------------cCCCCHHHHHHHHHHHHH
Confidence 9999998888665542 346888999999999999
Q ss_pred HHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 227 AVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 227 ~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
||+|||++|++||||||+|||++.++.++|+|||+++.
T Consensus 108 ~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~ 145 (320)
T cd05590 108 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 145 (320)
T ss_pred HHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence 99999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=216.46 Aligned_cols=151 Identities=25% Similarity=0.468 Sum_probs=130.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.-|..++.||-|+||+|.+++-- .+...+|+|.+.+.+.- ...+.-+..|-.||...+.+.||+||..|.+.
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~Kv-------DT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk 701 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKV-------DTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK 701 (1034)
T ss_pred cceEEEeeecccccceeEEEeec-------chhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC
Confidence 45999999999999999999865 44578999999877643 23445577899999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+.+|+||+|+.||++..+| ...+-|.+..++.++
T Consensus 702 dnLYFVMdYIPGGDmMSLL----------------------------------------------IrmgIFeE~LARFYI 735 (1034)
T KOG0608|consen 702 DNLYFVMDYIPGGDMMSLL----------------------------------------------IRMGIFEEDLARFYI 735 (1034)
T ss_pred CceEEEEeccCCccHHHHH----------------------------------------------HHhccCHHHHHHHHH
Confidence 9999999988887775544 344578899999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.++..|++++|..|+|||||||+|||||.+|++||+|||||+-|+
T Consensus 736 AEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 736 AELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred HHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccce
Confidence 999999999999999999999999999999999999999998653
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=210.29 Aligned_cols=149 Identities=29% Similarity=0.418 Sum_probs=123.5
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++.+.||+|+||.||+|.+. .++..||||.+............+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 87 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDA-------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEec-------CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeec
Confidence 3567999999999999999999886 445889999997665455556778899999999999999999998764
Q ss_pred cC------eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCCh
Q psy2579 141 FG------KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214 (267)
Q Consensus 141 ~~------~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~ 214 (267)
.. ..|++|||+.+ ++. +.+. ..+++
T Consensus 88 ~~~~~~~~~~~lv~e~~~~-~l~----------------------------------------------~~~~--~~l~~ 118 (355)
T cd07874 88 QKSLEEFQDVYLVMELMDA-NLC----------------------------------------------QVIQ--MELDH 118 (355)
T ss_pred cccccccceeEEEhhhhcc-cHH----------------------------------------------HHHh--hcCCH
Confidence 32 35677777654 222 2221 24788
Q ss_pred hHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+|+..
T Consensus 119 ~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 889999999999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-29 Score=232.99 Aligned_cols=196 Identities=24% Similarity=0.330 Sum_probs=140.0
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
..+|+.++.||+||||.||+++.+. +|..+|||.+.... +......+.+|+..+++|+|||||+++.+|...
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKl-------DGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs 549 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKL-------DGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVES 549 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecc-------cchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhcc
Confidence 5679999999999999999999984 45999999998776 666677899999999999999999999999765
Q ss_pred CeEEEEEeecCC--Cchhhh-----------------------h--hccCCCChh------------------hHHHH--
Q psy2579 142 GKIFLVVEYASG--GELYNK-----------------------I--TTEGRLSED------------------DAKIY-- 174 (267)
Q Consensus 142 ~~~~iv~e~~~~--gsl~~~-----------------------l--~~~~~~~~~------------------~~~~~-- 174 (267)
.....++|-... .++.+- + ..++..+.. ....+
T Consensus 550 ~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~ 629 (1351)
T KOG1035|consen 550 TAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRN 629 (1351)
T ss_pred CCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccc
Confidence 433333322110 000000 0 000000000 00000
Q ss_pred ------------------HHHHHHHHhhh--------ccCeEEEEEEEccCCchhhhhcccCCC-ChhHHHHHHHHHHHH
Q psy2579 175 ------------------FLQILLYEVLE--------TFGKIFLVVEYASGGELYNKITTEGRL-SEDDAKIYFLQILSA 227 (267)
Q Consensus 175 ------------------~~~~~~~~~~~--------~~~~~~~v~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~ql~~~ 227 (267)
..+........ ....+||-||||+..++.+++...... ....++++++||+.|
T Consensus 630 ~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 630 LSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEG 709 (1351)
T ss_pred cccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHH
Confidence 00000000011 114679999999988888888776555 578899999999999
Q ss_pred HHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 228 VKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 228 L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|.|+|++|+|||||||.||+++.++.+||+|||+|+.+
T Consensus 710 LaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~ 747 (1351)
T KOG1035|consen 710 LAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDL 747 (1351)
T ss_pred HHHHHhCceeeccCCcceeEEcCCCCeeecccccchhh
Confidence 99999999999999999999999999999999999863
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=224.73 Aligned_cols=151 Identities=27% Similarity=0.480 Sum_probs=132.4
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
+++|++.++||+|+||.||+|.+. .+++.||||++..... .......+.+|+.++..++||||+++++++..
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 75 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKK-------NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS 75 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEEC-------CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE
Confidence 467999999999999999999986 4568999999976543 33445778899999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+||||+.+++|..++.. .+.+++..++.+
T Consensus 76 ~~~~~lVmEy~~g~~L~~li~~----------------------------------------------~~~l~~~~~~~i 109 (669)
T cd05610 76 ANNVYLVMEYLIGGDVKSLLHI----------------------------------------------YGYFDEEMAVKY 109 (669)
T ss_pred CCEEEEEEeCCCCCCHHHHHHh----------------------------------------------cCCCCHHHHHHH
Confidence 9999999999998888766543 235788889999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.||+.||+|||++||+||||||+|||++.++.++|+|||+++..
T Consensus 110 ~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 110 ISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred HHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 999999999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=196.72 Aligned_cols=151 Identities=33% Similarity=0.549 Sum_probs=134.3
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++.+.||+|++|.||+|.+. .++..|++|.+............+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRK-------ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGK 73 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEc-------CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCE
Confidence 4889999999999999999886 456899999998766566667889999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.|++|||+.+++|.+++... ....+++..+..++.|
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~--------------------------------------------~~~~~~~~~~~~i~~~ 109 (256)
T cd08529 74 LNIVMEYAENGDLHKLLKMQ--------------------------------------------RGRPLPEDQVWRFFIQ 109 (256)
T ss_pred EEEEEEeCCCCcHHHHHHHh--------------------------------------------cCCCCCHHHHHHHHHH
Confidence 99999999998888776542 1236888999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||.|||+.|++|+||||+||+++.++.++|+|||+++.+
T Consensus 110 l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~ 151 (256)
T cd08529 110 ILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL 151 (256)
T ss_pred HHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceec
Confidence 999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=201.59 Aligned_cols=150 Identities=27% Similarity=0.417 Sum_probs=129.5
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
|+..+.||+|+||+||+|.+. .+++.||+|.+....... .....+.+|+.+++.++|+||+.+.+++...+.
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~ 74 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVR-------ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDA 74 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEC-------CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCE
Confidence 778889999999999999986 456899999997654332 234557889999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.|++|||+.+++|...+... ...++++..+..++.|
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~q 110 (285)
T cd05632 75 LCLVLTIMNGGDLKFHIYNM--------------------------------------------GNPGFEEERALFYAAE 110 (285)
T ss_pred EEEEEEeccCccHHHHHHHh--------------------------------------------cCCCCCHHHHHHHHHH
Confidence 99999999998887665432 1226899999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||.|||+.||+||||||+||+++.++.++|+|||++..+
T Consensus 111 l~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05632 111 ILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKI 152 (285)
T ss_pred HHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceec
Confidence 999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=197.30 Aligned_cols=144 Identities=26% Similarity=0.422 Sum_probs=124.6
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVV 148 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 148 (267)
+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++...+..|++|
T Consensus 1 ~~lg~g~~g~vy~~~~~-------~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 72 (252)
T cd05084 1 ERIGRGNFGEVFSGRLR-------ADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 72 (252)
T ss_pred CccCcccCccEEEEEEe-------cCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEE
Confidence 36999999999999986 445889999876432 3455677899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHH
Q psy2579 149 EYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAV 228 (267)
Q Consensus 149 e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L 228 (267)
||+.+++|.+++... ...+++..+..++.|++.||
T Consensus 73 e~~~~~~L~~~~~~~---------------------------------------------~~~~~~~~~~~~~~qi~~~L 107 (252)
T cd05084 73 ELVQGGDFLTFLRTE---------------------------------------------GPRLKVKELIQMVENAAAGM 107 (252)
T ss_pred eeccCCcHHHHHHhC---------------------------------------------CCCCCHHHHHHHHHHHHHHH
Confidence 999988887666432 22578899999999999999
Q ss_pred HHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 229 KHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 229 ~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|||++|++|+||||+||+++.++.++|+|||+++.+
T Consensus 108 ~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 144 (252)
T cd05084 108 EYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREE 144 (252)
T ss_pred HHHHhCCccccccchheEEEcCCCcEEECccccCccc
Confidence 9999999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=207.04 Aligned_cols=143 Identities=29% Similarity=0.529 Sum_probs=124.4
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhc-CCCceeeeeeeeeecCeEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESV-HHPNIIRLYEVLETFGKIFL 146 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~i 146 (267)
+.||+|+||.||+|.+. .+++.||+|++...... ......+.+|+.++..+ +||||+.+++++...+..|+
T Consensus 1 ~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 73 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK-------KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFL 73 (327)
T ss_pred CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEE
Confidence 36999999999999986 45689999999865432 34456788999999888 79999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS 226 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~ 226 (267)
||||+.+|+|...+. ..+.+++..+..++.|++.
T Consensus 74 v~e~~~~~~L~~~~~----------------------------------------------~~~~l~~~~~~~~~~qi~~ 107 (327)
T cd05617 74 VIEYVNGGDLMFHMQ----------------------------------------------RQRKLPEEHARFYAAEICI 107 (327)
T ss_pred EEeCCCCCcHHHHHH----------------------------------------------HcCCCCHHHHHHHHHHHHH
Confidence 999999888765553 2346899999999999999
Q ss_pred HHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 227 AVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 227 ~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
||+|||++|++||||||+|||++.++.+||+|||+|+.
T Consensus 108 al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~ 145 (327)
T cd05617 108 ALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE 145 (327)
T ss_pred HHHHHHHCCeeccCCCHHHEEEeCCCCEEEecccccee
Confidence 99999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=196.62 Aligned_cols=151 Identities=35% Similarity=0.561 Sum_probs=134.5
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|+..+.||.|+||.||.+.+. .++..+++|.+.....+......+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 73 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRT-------EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNT 73 (256)
T ss_pred CceEeeEecccCCceEEEEEEc-------CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCe
Confidence 4899999999999999999886 455889999998776666667788999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.+++|||+.+++|.+++.... ...+++..+..++.|
T Consensus 74 ~~~~~e~~~~~~L~~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~ 109 (256)
T cd08221 74 LLIEMEYANGGTLYDKIVRQK--------------------------------------------GQLFEEEMVLWYLFQ 109 (256)
T ss_pred EEEEEEecCCCcHHHHHHhcc--------------------------------------------ccCCCHHHHHHHHHH
Confidence 999999999988887765421 235888999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||.|||+.|++|+||+|+||+++.++.+||+|||+++..
T Consensus 110 l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~ 151 (256)
T cd08221 110 IVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL 151 (256)
T ss_pred HHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence 999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=220.21 Aligned_cols=148 Identities=32% Similarity=0.427 Sum_probs=121.5
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-CCceeeeeeeeeec-
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-HPNIIRLYEVLETF- 141 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~- 141 (267)
++++.+.|.+|||+.||+|.+. ..+..||+|.+-.. +......+.+||.+|+.|+ |||||.+++.....
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~-------~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDV-------KGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEec-------CCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 4888999999999999999986 33488999998665 5667788999999999995 99999999943211
Q ss_pred ------CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 142 ------GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 142 ------~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
-..++.||||.||+|-+++... -...|++.
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~R--------------------------------------------lq~~lte~ 144 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTR--------------------------------------------LQTRLTED 144 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHH--------------------------------------------HhccCChH
Confidence 1355666666665555554321 13359999
Q ss_pred HHHHHHHHHHHHHHHHHhCC--CcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRD--IIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
+++.|+.|+|+|+++||.+. |||||||-+||||+.+|..||||||.|+.
T Consensus 145 eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 145 EVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred HHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 99999999999999999997 99999999999999999999999998864
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=206.99 Aligned_cols=143 Identities=29% Similarity=0.494 Sum_probs=121.8
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhc-CCCceeeeeeeeeecCeEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESV-HHPNIIRLYEVLETFGKIFL 146 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~i 146 (267)
+.||+|+||.||+|.+. .++..||+|+++..... .........|..++..+ +||||+++++++...+..|+
T Consensus 1 ~~lg~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 73 (316)
T cd05620 1 KVLGKGSFGKVLLAELK-------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEE
Confidence 36999999999999986 45689999999765321 23345567788888765 89999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS 226 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~ 226 (267)
||||+.+|+|...+.. ...+++..+..++.|++.
T Consensus 74 v~E~~~~g~L~~~i~~----------------------------------------------~~~~~~~~~~~~~~qi~~ 107 (316)
T cd05620 74 VMEFLNGGDLMFHIQD----------------------------------------------KGRFDLYRATFYAAEIVC 107 (316)
T ss_pred EECCCCCCcHHHHHHH----------------------------------------------cCCCCHHHHHHHHHHHHH
Confidence 9999998887665542 346888999999999999
Q ss_pred HHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 227 AVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 227 ~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
||+|||++|++||||||+||+++.++.++|+|||+++.
T Consensus 108 ~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05620 108 GLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKE 145 (316)
T ss_pred HHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence 99999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=210.21 Aligned_cols=200 Identities=20% Similarity=0.230 Sum_probs=140.2
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-CCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-HPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~ 139 (267)
...+|.+.+.||+|+||.||+|++..... ...+..||+|+++... .......+.+|+.++..+. ||||+++++++.
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~--~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSH--SQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCC--CCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 33468899999999999999999753210 1345789999997643 2334457889999999997 999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHH-----------------------------------------------
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAK----------------------------------------------- 172 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~----------------------------------------------- 172 (267)
..+..++|||||.+|+|.++++...........
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 999999999999999999999765321000000
Q ss_pred -------HHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q psy2579 173 -------IYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245 (267)
Q Consensus 173 -------~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~N 245 (267)
.......+ ...........+.................+++..+..++.|++.||+|||+.|++||||||+|
T Consensus 192 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 192 MQDMKGTVKYADIES--SNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred hhcchhhhhhhhhhc--cCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 00000000 000000000001111111111222334568899999999999999999999999999999999
Q ss_pred EEeecCCceEEecccccccc
Q psy2579 246 VFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 246 Ill~~~~~~kl~DFGla~~l 265 (267)
||++.++.++|+|||+++.+
T Consensus 270 iLl~~~~~~kL~DfGla~~~ 289 (401)
T cd05107 270 VLICEGKLVKICDFGLARDI 289 (401)
T ss_pred EEEeCCCEEEEEecCcceec
Confidence 99999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=197.42 Aligned_cols=147 Identities=26% Similarity=0.466 Sum_probs=127.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+.|++.+.||+|+||.||+|.+. .+..+|+|.+...... ...+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~--------~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR--------AQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec--------cCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 45999999999999999999774 2357999988654433 246888999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++|||+.+|+|.+++... .+.+++..+..++.
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~---------------------------------------------~~~~~~~~~~~~~~ 107 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQR---------------------------------------------QGKLSKDMLLSMCQ 107 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhC---------------------------------------------ccCCCHHHHHHHHH
Confidence 999999999998887766432 12578899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++|++||||||+||+++.++.++|+|||+++.+
T Consensus 108 ~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~ 150 (256)
T cd05114 108 DVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV 150 (256)
T ss_pred HHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCcccc
Confidence 9999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=198.59 Aligned_cols=154 Identities=25% Similarity=0.384 Sum_probs=132.2
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.+.|++.+.||+|+||.||+|.+...+ .....||||++.... .......+..|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~----~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 77 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPG----KREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCC----CCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence 356999999999999999999986433 223579999987543 445567899999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..+++|||+.+++|.+++... .+.+++..+..++
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~i~ 112 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQN---------------------------------------------DGQFTVIQLVGML 112 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhC---------------------------------------------CCCCCHHHHHHHH
Confidence 9999999999998887766432 2357889999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.+
T Consensus 113 ~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 113 RGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred HHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 99999999999999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=199.07 Aligned_cols=157 Identities=22% Similarity=0.284 Sum_probs=130.2
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe-
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK- 143 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~- 143 (267)
|++.+.||+|+||.||+|.+.... .....||+|.+............+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 76 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDD----GSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSL 76 (273)
T ss_pred CccccccCcCCCceEEEEEEecCC----CCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcc
Confidence 578889999999999999876432 234789999998765555566789999999999999999999998766554
Q ss_pred -----EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 144 -----IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 144 -----~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
.++++||+.+|+|...+...... .....+++..+.
T Consensus 77 ~~~~~~~~v~e~~~~~~l~~~l~~~~~~----------------------------------------~~~~~~~~~~~~ 116 (273)
T cd05035 77 QKIPKPMVILPFMKHGDLHSFLLYSRLG----------------------------------------GLPEKLPLQTLL 116 (273)
T ss_pred ccCcccEEEEeccCCCCHHHHHHHhhcc----------------------------------------CCcccCCHHHHH
Confidence 78999999998887776432110 012358889999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||+|||++|++||||||+||++++++.+||+|||+|+.+
T Consensus 117 ~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 163 (273)
T cd05035 117 KFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI 163 (273)
T ss_pred HHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeec
Confidence 99999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=200.40 Aligned_cols=144 Identities=34% Similarity=0.455 Sum_probs=123.1
Q ss_pred cCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEEe
Q psy2579 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVE 149 (267)
Q Consensus 71 iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~e 149 (267)
||+|+||.||++.+. .+++.||+|.+....... .....+..|+.+++.++||||+++++++......|++||
T Consensus 1 lg~G~~g~Vy~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e 73 (277)
T cd05607 1 LGKGGFGEVCAVQVK-------NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMS 73 (277)
T ss_pred CCCCCceEEEEEEEc-------cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEe
Confidence 799999999999986 456899999997644332 223455679999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHH
Q psy2579 150 YASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVK 229 (267)
Q Consensus 150 ~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~ 229 (267)
|+.+++|...+... ....+++..+..++.|++.||+
T Consensus 74 ~~~g~~L~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~qi~~al~ 109 (277)
T cd05607 74 LMNGGDLKYHIYNV--------------------------------------------GERGLEMERVIHYSAQITCGIL 109 (277)
T ss_pred cCCCCCHHHHHHhc--------------------------------------------cccCCCHHHHHHHHHHHHHHHH
Confidence 99998887666432 1125788889999999999999
Q ss_pred HHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 230 HLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 230 ~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|||+.|++||||||+||+++.++.++|+|||++..+
T Consensus 110 ~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~ 145 (277)
T cd05607 110 HLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL 145 (277)
T ss_pred HHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeec
Confidence 999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=198.99 Aligned_cols=164 Identities=21% Similarity=0.279 Sum_probs=133.1
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+..... ...+..||+|.+.... .......+.+|+.+++.++||||+++++++...+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~--~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVK--DEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCC--CCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 459999999999999999998753211 1335779999986543 2334566889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++|||+.+|+|.+++....... ........+++..+..++.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~~~~~~ 126 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEM------------------------------------ENNPVQAPPSLKKMIQMAG 126 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccc------------------------------------cccccccCCCHHHHHHHHH
Confidence 9999999999999988876532110 0000122467888999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||+.|++|+||||+||+++.++.++|+|||+|+.+
T Consensus 127 ~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 169 (277)
T cd05062 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 169 (277)
T ss_pred HHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCcccc
Confidence 9999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=201.64 Aligned_cols=155 Identities=29% Similarity=0.479 Sum_probs=134.4
Q ss_pred ccccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeee
Q psy2579 55 ETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRL 134 (267)
Q Consensus 55 ~~~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~ 134 (267)
....++...+|++.+.||+|+||.||+|.+. .++..||+|.+...... ..+.+.+|+.+++.++||||+++
T Consensus 11 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~ 81 (297)
T cd06656 11 IVSVGDPKKKYTRFEKIGQGASGTVYTAIDI-------ATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNY 81 (297)
T ss_pred hcccCChhhhceeeeeeccCCCeEEEEEEEC-------CCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeE
Confidence 3455666778999999999999999999875 45689999999754432 34568899999999999999999
Q ss_pred eeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCCh
Q psy2579 135 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214 (267)
Q Consensus 135 ~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~ 214 (267)
++++...+..|++|||+.+++|.+++.. ..+++
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----------------------------------------------~~~~~ 114 (297)
T cd06656 82 LDSYLVGDELWVVMEYLAGGSLTDVVTE-----------------------------------------------TCMDE 114 (297)
T ss_pred EEEEecCCEEEEeecccCCCCHHHHHHh-----------------------------------------------CCCCH
Confidence 9999999999999999999888766532 25788
Q ss_pred hHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..+
T Consensus 115 ~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 115 GQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (297)
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence 889999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=197.27 Aligned_cols=154 Identities=32% Similarity=0.526 Sum_probs=133.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||.||+|.+. .+++.||+|.++..... ......+.+|+.+++.++|+||+++++++...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~ 74 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICL-------LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN 74 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEc-------CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence 56999999999999999999986 45688999998764433 34467899999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..+++|||+.+|+|..++.... .....+++..+..++
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------~~~~~~~~~~~~~~~ 112 (267)
T cd08224 75 NELNIVLELADAGDLSRMIKHFK------------------------------------------KQKRLIPERTIWKYF 112 (267)
T ss_pred CeEEEEEecCCCCCHHHHHHHhc------------------------------------------ccCCCcCHHHHHHHH
Confidence 99999999999999987765321 112357889999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+
T Consensus 113 ~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 113 VQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred HHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 99999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=202.16 Aligned_cols=168 Identities=25% Similarity=0.364 Sum_probs=134.3
Q ss_pred cceEEecccCccCceeEEEeEEeeccc-------ccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVP-------ILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLY 135 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~-------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~ 135 (267)
.+|++.+.||+|+||.||+|.+..... ........||+|.+.... .......+.+|+.+++.++||||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 469999999999999999998753221 001122468999987542 445567799999999999999999999
Q ss_pred eeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 136 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 136 ~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
+++...+..+++|||+.+++|.+++...... +..........+++.
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----------------------------------~~~~~~~~~~~~~~~ 129 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIE----------------------------------STFTHANNIPSVSIA 129 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhcccc----------------------------------ccccccccCCcccHH
Confidence 9999999999999999999999888543110 000111112347888
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||+++.+
T Consensus 130 ~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 179 (295)
T cd05097 130 NLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179 (295)
T ss_pred HHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEeccccccccc
Confidence 99999999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=202.63 Aligned_cols=150 Identities=25% Similarity=0.435 Sum_probs=127.6
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
+++|++.+.||.|+||.||+|.+. .++..||+|.+...... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~-------~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSK-------LTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEc-------CCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 466999999999999999999986 44588999998754322 2234577899999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..+++|||+.+ +|.+.+... ...+++..+..++
T Consensus 77 ~~~~lv~e~~~~-~l~~~l~~~---------------------------------------------~~~~~~~~~~~~~ 110 (301)
T cd07873 77 KSLTLVFEYLDK-DLKQYLDDC---------------------------------------------GNSINMHNVKLFL 110 (301)
T ss_pred CeEEEEEecccc-CHHHHHHhc---------------------------------------------CCCCCHHHHHHHH
Confidence 999999999974 665544321 2357889999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||+.|++|+||||+||+++.++.++|+|||+++..
T Consensus 111 ~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 154 (301)
T cd07873 111 FQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAK 154 (301)
T ss_pred HHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence 99999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=200.42 Aligned_cols=151 Identities=25% Similarity=0.448 Sum_probs=129.3
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++.+.||+|++|.||+|.+. .++..||+|.+............+.+|+.+++.++||||+++++++..++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNK-------KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESR 73 (285)
T ss_pred CceEeeEecccCceEEEEEEEC-------CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCe
Confidence 4899999999999999999986 446899999987654444444678899999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.|+||||+. ++|.+++... .....+++..+..++.|
T Consensus 74 ~~~v~e~~~-~~l~~~~~~~-------------------------------------------~~~~~~~~~~~~~~~~q 109 (285)
T cd07861 74 LYLIFEFLS-MDLKKYLDSL-------------------------------------------PKGQYMDAELVKSYLYQ 109 (285)
T ss_pred EEEEEecCC-CCHHHHHhcC-------------------------------------------CCCCcCCHHHHHHHHHH
Confidence 999999997 4665554322 11236899999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||+|||++|++|+||||+||+++.++.++|+|||++..+
T Consensus 110 i~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 151 (285)
T cd07861 110 ILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF 151 (285)
T ss_pred HHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence 999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=205.61 Aligned_cols=143 Identities=28% Similarity=0.490 Sum_probs=121.3
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhc-CCCceeeeeeeeeecCeEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESV-HHPNIIRLYEVLETFGKIFL 146 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~i 146 (267)
+.||+|+||.||+|.+. .+++.||+|+++..... .........|..++... +||||+++++++.+.+..|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~l 73 (316)
T cd05619 1 KMLGKGSFGKVFLAELK-------GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFF 73 (316)
T ss_pred CeeeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEE
Confidence 36999999999999986 44588999999765321 22345566788888764 99999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS 226 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~ 226 (267)
||||+.+|+|...+.. ...+++..+..++.|++.
T Consensus 74 v~ey~~~g~L~~~l~~----------------------------------------------~~~~~~~~~~~~~~qi~~ 107 (316)
T cd05619 74 VMEYLNGGDLMFHIQS----------------------------------------------CHKFDLPRATFYAAEIIC 107 (316)
T ss_pred EEeCCCCCcHHHHHHH----------------------------------------------cCCCCHHHHHHHHHHHHH
Confidence 9999999888665542 336888899999999999
Q ss_pred HHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 227 AVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 227 ~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
||+|||++|++||||||+||+++.++.+||+|||+|+.
T Consensus 108 al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05619 108 GLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKE 145 (316)
T ss_pred HHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence 99999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=212.53 Aligned_cols=148 Identities=30% Similarity=0.375 Sum_probs=128.0
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-C-----Cceeeeeee
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-H-----PNIIRLYEV 137 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h-----pnIv~~~~~ 137 (267)
+|++++.||+|+||.|-+|.+. .+++.||||+++... ....+...|+.+|..|+ | -|+|+++++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~-------~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDH-------KTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred EEEEEEEecccccceeEEEEec-------CCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 5899999999999999999998 556999999997653 44466778999999996 3 399999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
|...+++|||+|++.. +|+++++.+. ...++...+
T Consensus 257 F~fr~HlciVfELL~~-NLYellK~n~--------------------------------------------f~Glsl~~i 291 (586)
T KOG0667|consen 257 FYFRNHLCIVFELLST-NLYELLKNNK--------------------------------------------FRGLSLPLV 291 (586)
T ss_pred cccccceeeeehhhhh-hHHHHHHhcC--------------------------------------------CCCCCHHHH
Confidence 9999999999998864 6777776542 236899999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC--ceEEeccccccccC
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG--IVKLGDLGFSTKLQ 266 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~--~~kl~DFGla~~l~ 266 (267)
+.++.||+.||.+||+.||||+||||+||||...+ .+||+|||.|+...
T Consensus 292 r~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 292 RKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred HHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 99999999999999999999999999999997654 79999999998653
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-27 Score=199.11 Aligned_cols=171 Identities=23% Similarity=0.337 Sum_probs=135.8
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
+..|++.+.||+|+||.||+|.+...+ ...+..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~---~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPG---MDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCC---CCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 456999999999999999999875332 1345789999997543 334456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|++|||+.+++|.+++......... +......-.....+++..+..++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~~~i~ 130 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDV-----------------------------GCSSDEDGTVKSSLDHGDFLHIA 130 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCcc-----------------------------ccccccccccccccCHHHHHHHH
Confidence 9999999999999999888543211000 00000000112357889999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++|++||||||+||+++.++.++|+|||+++.+
T Consensus 131 ~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (283)
T cd05090 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREI 174 (283)
T ss_pred HHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccc
Confidence 99999999999999999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-27 Score=199.22 Aligned_cols=150 Identities=25% Similarity=0.362 Sum_probs=125.2
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec--C
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF--G 142 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~--~ 142 (267)
|++.+.||+|+||.||++...... ...+..||+|++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPAN---DGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred ceeceecccCCCcEEEEeeEcccc---CCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 489999999999999998654221 2456789999997653 334456788999999999999999999987653 3
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++|||+.+++|.+++.. ..+++..+..++.
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~-----------------------------------------------~~l~~~~~~~i~~ 114 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK-----------------------------------------------HKLNLAQLLLFAQ 114 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH-----------------------------------------------cCCCHHHHHHHHH
Confidence 57888888888777665532 2589999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++|++||||||+||+++.++.++|+|||+++.+
T Consensus 115 ~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 115 QICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred HHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=201.53 Aligned_cols=172 Identities=27% Similarity=0.363 Sum_probs=137.3
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~ 141 (267)
++|.+.+.||+|+||.||+|.+.........+...+|+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 569999999999999999998754332222344679999997643 344456788999999999 899999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|++|||+.+|+|.+++........ +.+ ..........+++..+..++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~--------------------------~~~----~~~~~~~~~~l~~~~~~~~~ 146 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGM--------------------------EYC----YNPTQVPEEQLSFKDLVSCA 146 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCccc--------------------------ccc----cccccCccccCCHHHHHHHH
Confidence 999999999999999998876432100 000 00001123358889999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++|++||||||+||+++.++.++|+|||+|+.+
T Consensus 147 ~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~ 190 (307)
T cd05098 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190 (307)
T ss_pred HHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccc
Confidence 99999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=208.23 Aligned_cols=149 Identities=28% Similarity=0.415 Sum_probs=123.5
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++.+.||+|+||.||+|.+. ..++.||||++............+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~ 94 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDA-------ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP 94 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEEC-------CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecc
Confidence 3567999999999999999999986 445889999997655455556778899999999999999999998754
Q ss_pred c------CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCCh
Q psy2579 141 F------GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214 (267)
Q Consensus 141 ~------~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~ 214 (267)
. ...|+||||+.+ ++. +.+. ..+++
T Consensus 95 ~~~~~~~~~~~lv~e~~~~-~l~----------------------------------------------~~~~--~~~~~ 125 (364)
T cd07875 95 QKSLEEFQDVYIVMELMDA-NLC----------------------------------------------QVIQ--MELDH 125 (364)
T ss_pred cccccccCeEEEEEeCCCC-CHH----------------------------------------------HHHH--hcCCH
Confidence 3 246777777754 232 2221 24778
Q ss_pred hHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+|+..
T Consensus 126 ~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 126 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred HHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 889999999999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=209.48 Aligned_cols=156 Identities=45% Similarity=0.729 Sum_probs=139.8
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
|+..+-|.+.+.||+|-|+.|-+|++- -+|..||||++++.+++......+.+|++.|+.++|||||++|.+.
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHV-------FTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi 86 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHV-------FTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI 86 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhh-------cccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh
Confidence 455677999999999999999999996 4569999999999998887788899999999999999999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
.++..+|+|+|+-.+|+|++++... ...+.+..+.
T Consensus 87 DTQTKlyLiLELGD~GDl~DyImKH---------------------------------------------e~Gl~E~La~ 121 (864)
T KOG4717|consen 87 DTQTKLYLILELGDGGDLFDYIMKH---------------------------------------------EEGLNEDLAK 121 (864)
T ss_pred cccceEEEEEEecCCchHHHHHHhh---------------------------------------------hccccHHHHH
Confidence 9999999999998888888777543 3368999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEe-ecCCceEEeccccccccC
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFL-SVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll-~~~~~~kl~DFGla~~l~ 266 (267)
.++.||+.|+.|+|...+|||||||+|+++ ..-|.+||+|||++-.++
T Consensus 122 kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 122 KYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred HHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999999999999999999999987 557899999999997764
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=199.59 Aligned_cols=150 Identities=30% Similarity=0.453 Sum_probs=130.0
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++...||+|+||.||+|.+. .+++.||+|++..........+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNR-------ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEEC-------CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC
Confidence 35999999999999999999986 44689999998765433334456789999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++|||++++++..... ....+++..+..++.
T Consensus 74 ~~~~v~e~~~~~~l~~~~~----------------------------------------------~~~~~~~~~~~~~~~ 107 (286)
T cd07847 74 KLHLVFEYCDHTVLNELEK----------------------------------------------NPRGVPEHLIKKIIW 107 (286)
T ss_pred EEEEEEeccCccHHHHHHh----------------------------------------------CCCCCCHHHHHHHHH
Confidence 9999999998866654432 233588999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++|++|+||||+||+++.++.++|+|||++..+
T Consensus 108 ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07847 108 QTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL 150 (286)
T ss_pred HHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceec
Confidence 9999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=200.15 Aligned_cols=150 Identities=27% Similarity=0.413 Sum_probs=129.4
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
|++.+.||+|+||.||+|.+. .+++.||+|.+....... .....+.+|+.+++.++|+||+.+++.+...+.
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~ 74 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVR-------ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDA 74 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEc-------CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCE
Confidence 788889999999999999987 456899999987654332 234567789999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.|++|||+.+++|.+++... ....+++..+..++.|
T Consensus 75 ~~lv~e~~~g~~L~~~l~~~--------------------------------------------~~~~l~~~~~~~~~~q 110 (285)
T cd05630 75 LCLVLTLMNGGDLKFHIYHM--------------------------------------------GEAGFEEGRAVFYAAE 110 (285)
T ss_pred EEEEEEecCCCcHHHHHHHh--------------------------------------------cccCCCHHHHHHHHHH
Confidence 99999999999987766432 1125888999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||.|||+.|++||||||+||+++.++.++|+|||++..+
T Consensus 111 i~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05630 111 ICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHV 152 (285)
T ss_pred HHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence 999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=200.95 Aligned_cols=150 Identities=34% Similarity=0.623 Sum_probs=131.6
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||.||+|.+. .+++.||+|++...... ......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHK-------GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD 73 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEc-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC
Confidence 35999999999999999999986 45689999999765432 34457788999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|++|||+.+++|.+.+.. ...+++..+..++
T Consensus 74 ~~~~~v~e~~~~~~L~~~~~~----------------------------------------------~~~l~~~~~~~~~ 107 (290)
T cd05580 74 SNLYLVMEYVPGGELFSHLRK----------------------------------------------SGRFPEPVARFYA 107 (290)
T ss_pred CeEEEEEecCCCCCHHHHHHH----------------------------------------------cCCCCHHHHHHHH
Confidence 999999999988777665543 3468899999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++.+
T Consensus 108 ~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 151 (290)
T cd05580 108 AQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV 151 (290)
T ss_pred HHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence 99999999999999999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=201.78 Aligned_cols=172 Identities=26% Similarity=0.333 Sum_probs=138.1
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~ 139 (267)
...+|++.+.||+|+||.||+|.+..........+..||+|.+.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34569999999999999999998754322222345689999987543 334456789999999999 8999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhh--cccCCCChhHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKI--TTEGRLSEDDA 217 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~--~~~~~~~~~~~ 217 (267)
..+..|++|||+.+|+|.+++........ .....+ .....+++..+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--------------------------------~~~~~~~~~~~~~~~~~~~ 139 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGM--------------------------------EYSYDIARVPDEQMTFKDL 139 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCccc--------------------------------ccccccccCCcccccHHHH
Confidence 99999999999999999998876432110 000000 12236888999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..++.|++.||.|||++|++||||||+||+++.++.++|+|||+|+.+
T Consensus 140 ~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~ 187 (304)
T cd05101 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187 (304)
T ss_pred HHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceec
Confidence 999999999999999999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=201.08 Aligned_cols=167 Identities=25% Similarity=0.357 Sum_probs=135.1
Q ss_pred cceEEecccCccCceeEEEeEEeeccc---------ccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVP---------ILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIR 133 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~ 133 (267)
++|++.+.||+|+||.||+|.+..... ........||+|++.... .......+.+|+.+++.++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 469999999999999999997543211 011234579999987543 3445678899999999999999999
Q ss_pred eeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCC
Q psy2579 134 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLS 213 (267)
Q Consensus 134 ~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~ 213 (267)
+++++...+..+++||++.+|+|.+++........ ........++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----------------------------------~~~~~~~~~~ 128 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEA-----------------------------------AEKADVVTIS 128 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccc-----------------------------------cccccccccC
Confidence 99999999999999999999999988875422100 0011223578
Q ss_pred hhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 214 EDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 214 ~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||+|+.+
T Consensus 129 ~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 180 (296)
T cd05095 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180 (296)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccc
Confidence 8999999999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-27 Score=200.41 Aligned_cols=157 Identities=27% Similarity=0.474 Sum_probs=136.1
Q ss_pred hhccccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCcee
Q psy2579 53 QHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNII 132 (267)
Q Consensus 53 ~~~~~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv 132 (267)
......++...+|++.+.||+|+||.||+|.+. .++..||+|.+...... ....+.+|+.+++.+.||||+
T Consensus 10 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~ 80 (296)
T cd06654 10 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDV-------ATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIV 80 (296)
T ss_pred HhccccCCcccceeeEEEecCCCCeEEEEEEEC-------CCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEe
Confidence 344567777788999999999999999999875 45588999998765432 346688999999999999999
Q ss_pred eeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCC
Q psy2579 133 RLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRL 212 (267)
Q Consensus 133 ~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~ 212 (267)
++++.+...+..|+||||+.+++|.+++.. ..+
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----------------------------------------------~~~ 113 (296)
T cd06654 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----------------------------------------------TCM 113 (296)
T ss_pred eEEEEEEeCCEEEEeecccCCCCHHHHHHh-----------------------------------------------cCC
Confidence 999999999999999999999888766542 257
Q ss_pred ChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 213 SEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 213 ~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.++..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||+++.+
T Consensus 114 ~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 114 DEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (296)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence 88889999999999999999999999999999999999999999999988753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=198.40 Aligned_cols=148 Identities=28% Similarity=0.427 Sum_probs=129.1
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|++.+.||+|+||.||+|.+. .+++.||+|++..... .....+.+|+.+++.++||||+++++++...+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~-------~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~ 79 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNL-------HTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE 79 (267)
T ss_pred hhcchhheeecCCCeEEEEEEEC-------CCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Confidence 45999999999999999999986 4458899999965432 23356789999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++|||+.+++|.+.+. ...++++..+..++.
T Consensus 80 ~~~iv~e~~~~~~L~~~~~----------------------------------------------~~~~~~~~~~~~~~~ 113 (267)
T cd06646 80 KLWICMEYCGGGSLQDIYH----------------------------------------------VTGPLSELQIAYVCR 113 (267)
T ss_pred EEEEEEeCCCCCcHHHHHH----------------------------------------------hcCCCCHHHHHHHHH
Confidence 9999999999877766553 233688899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||+.|++||||+|+||+++.++.++|+|||+++.+
T Consensus 114 qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 114 ETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKI 156 (267)
T ss_pred HHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceee
Confidence 9999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=194.50 Aligned_cols=150 Identities=33% Similarity=0.582 Sum_probs=130.8
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++.+.||.|+||.||++.+. .++..+|+|.+.... .....+.+.+|+.+++.++||||+++++.+...+.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~-------~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 72 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHV-------NSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGH 72 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEc-------CCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE
Confidence 4899999999999999999886 446889999986543 23445678899999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.|++|||+++|++.+++... ....+++..+..++.|
T Consensus 73 ~~lv~e~~~~~~l~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~~ 108 (255)
T cd08219 73 LYIVMEYCDGGDLMQKIKLQ--------------------------------------------RGKLFPEDTILQWFVQ 108 (255)
T ss_pred EEEEEeeCCCCcHHHHHHhc--------------------------------------------cCCCCCHHHHHHHHHH
Confidence 99999999998887766432 1225788999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||.|||++|++|+||||+||+++.++.++|+|||+++.+
T Consensus 109 i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 150 (255)
T cd08219 109 MCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150 (255)
T ss_pred HHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceee
Confidence 999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=204.33 Aligned_cols=146 Identities=23% Similarity=0.347 Sum_probs=127.3
Q ss_pred EecccCcc--CceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeE
Q psy2579 67 LQNELGRG--NFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKI 144 (267)
Q Consensus 67 ~~~~iG~G--~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 144 (267)
++++||+| +||+||++.+. .+++.||+|.+............+.+|+.+++.++||||+++++++..++..
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 74 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYK-------PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 74 (327)
T ss_pred hhhhccccccceEEEEEEeec-------ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEE
Confidence 56789999 78999999987 5569999999977655555567788999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHH
Q psy2579 145 FLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 224 (267)
Q Consensus 145 ~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql 224 (267)
|+||||+++|+|.+++... ....+++..+..++.|+
T Consensus 75 ~lv~e~~~~~~l~~~~~~~--------------------------------------------~~~~l~~~~~~~i~~qi 110 (327)
T cd08227 75 WVVTSFMAYGSAKDLICTH--------------------------------------------FMDGMSELAIAYILQGV 110 (327)
T ss_pred EEEEeccCCCcHHHHHHhh--------------------------------------------ccCCCCHHHHHHHHHHH
Confidence 9999999998888776432 11258889999999999
Q ss_pred HHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccc
Q psy2579 225 LSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 225 ~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 263 (267)
+.||+|||++|++||||||+||+++.++.++++|||.+.
T Consensus 111 ~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 111 LKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred HHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhh
Confidence 999999999999999999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-27 Score=198.70 Aligned_cols=144 Identities=29% Similarity=0.389 Sum_probs=126.6
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 73 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHL-------LTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENR 73 (279)
T ss_pred cchheeeeccCCCeEEEEEEEc-------CCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCE
Confidence 4888999999999999999886 456889999986543 34455678999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.+++|||+.+++|..+ ..+++..+..++.|
T Consensus 74 ~~lv~e~~~~~~l~~~--------------------------------------------------~~~~~~~~~~~~~q 103 (279)
T cd06619 74 ISICTEFMDGGSLDVY--------------------------------------------------RKIPEHVLGRIAVA 103 (279)
T ss_pred EEEEEecCCCCChHHh--------------------------------------------------hcCCHHHHHHHHHH
Confidence 9999999998777421 14678888999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||+|||+.|++|+||||+||+++.++.++|+|||++..+
T Consensus 104 i~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~ 145 (279)
T cd06619 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145 (279)
T ss_pred HHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceec
Confidence 999999999999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-27 Score=198.99 Aligned_cols=171 Identities=27% Similarity=0.366 Sum_probs=138.7
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 140 (267)
.++|++.+.||+|+||.||+|.+..... ......+|+|.+.... .......+.+|+.++..+ +||||+++++++..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~--~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDN--PNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCC--CCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3569999999999999999998864321 1334789999997653 334456788999999999 89999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..+++|||+.+|+|..++......... ..+.........+++..+..+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~------------------------------~~~~~~~~~~~~l~~~~~~~i 137 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEY------------------------------ASPDDPRPPEETLTQKDLVSF 137 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccc------------------------------cccccccccccccCHHHHHHH
Confidence 99999999999999999988764321110 011112223457899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.+
T Consensus 138 ~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 182 (293)
T cd05053 138 AYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI 182 (293)
T ss_pred HHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCcccccccc
Confidence 999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-27 Score=201.16 Aligned_cols=167 Identities=26% Similarity=0.368 Sum_probs=133.6
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 140 (267)
.++|++.+.||+|+||.||+|.+..++ ....+|+|.+.... +......+.+|+.++..+ +||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~-----~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~ 79 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDG-----LRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 79 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCC-----ceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence 457999999999999999999986321 12456888775432 344556788999999999 89999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|++|||+.+|+|.+++.......... ...........+++..+..+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~------------------------------~~~~~~~~~~~l~~~~~~~~ 129 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDP------------------------------AFAIANSTASTLSSQQLLHF 129 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccc------------------------------cccccccccCcCCHHHHHHH
Confidence 999999999999999999887653221100 00000112236889999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
+.|++.||+|||++|++||||||+|||++.++.++|+|||+++.
T Consensus 130 ~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~ 173 (303)
T cd05088 130 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG 173 (303)
T ss_pred HHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcc
Confidence 99999999999999999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=204.99 Aligned_cols=143 Identities=31% Similarity=0.535 Sum_probs=123.2
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhc-CCCceeeeeeeeeecCeEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESV-HHPNIIRLYEVLETFGKIFL 146 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~i 146 (267)
+.||+|+||.||+|.+. .++..||+|++...... ......+.+|+.+++.+ +||||+++++++...+..|+
T Consensus 1 ~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~l 73 (318)
T cd05570 1 KVLGKGSFGKVLLAELK-------GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFF 73 (318)
T ss_pred CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEE
Confidence 36999999999999986 44588999999765422 23456677899999888 79999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS 226 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~ 226 (267)
||||+.+|+|...+. ..+.+++..+..++.|++.
T Consensus 74 v~e~~~~~~L~~~~~----------------------------------------------~~~~l~~~~~~~~~~qi~~ 107 (318)
T cd05570 74 VMEYVNGGDLMFHIQ----------------------------------------------RSGRFDEPRARFYAAEIVL 107 (318)
T ss_pred EEcCCCCCCHHHHHH----------------------------------------------HcCCCCHHHHHHHHHHHHH
Confidence 999999877765553 3346899999999999999
Q ss_pred HHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 227 AVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 227 ~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
||.|||++|++||||||+||+++.++.++|+|||+++.
T Consensus 108 ~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 145 (318)
T cd05570 108 GLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE 145 (318)
T ss_pred HHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCee
Confidence 99999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-27 Score=198.80 Aligned_cols=164 Identities=19% Similarity=0.272 Sum_probs=132.6
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|++.+.||+|+||.||+|.++.... ...+..||+|.+.... .......+.+|+.+++.++||||+++++++...+
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIK--GEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCC--CCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 569999999999999999997653211 1234689999986543 2334456789999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++|||+.+|+|.+++....... ........++...+..++.
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~------------------------------------~~~~~~~~~~~~~~~~~~~ 126 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEA------------------------------------ENNPGRPPPTLQEMIQMAA 126 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhcccc------------------------------------ccCCCCCCCCHHHHHHHHH
Confidence 9999999999999999886532110 0001123467778899999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++|++||||||+||+++.++.++|+|||+++.+
T Consensus 127 ~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~ 169 (288)
T cd05061 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 169 (288)
T ss_pred HHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccc
Confidence 9999999999999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-27 Score=198.06 Aligned_cols=152 Identities=27% Similarity=0.428 Sum_probs=126.0
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec--
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF-- 141 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~-- 141 (267)
.|++.+.||+|+||.||+|...... ..++..||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQ---DNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCc---CCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 5999999999999999999753211 145688999998654 334456789999999999999999999986543
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
...++++||+.+++|.+++... ...+++..+..++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~l~~~~~~~~~ 114 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKH---------------------------------------------RERLDHRKLLLYA 114 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhc---------------------------------------------CcCCCHHHHHHHH
Confidence 4578888888887777665432 2357889999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++|++||||||+||+++.++.++|+|||+++.+
T Consensus 115 ~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 115 SQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred HHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=224.31 Aligned_cols=161 Identities=24% Similarity=0.371 Sum_probs=138.0
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
..-++.+.||+|+||.||.|......... ....||||.+.... +.+....|.+|..+|+.++|||||+++|.+.+.+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~--~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSV--SPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCc--cceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 45788899999999999999886433111 13468999886653 5667789999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+|++|||++|+|..+|+..+.... ....++..+...++.
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~---------------------------------------~~~~L~~~dLl~~a~ 809 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPF---------------------------------------QPSNLSMRDLLAFAL 809 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccC---------------------------------------CCCCCCHHHHHHHHH
Confidence 99999999999999999987633110 133688999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
||++|+.||+++++|||||..+|+|++....+||+|||+|+++
T Consensus 810 dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDi 852 (1025)
T KOG1095|consen 810 DVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDI 852 (1025)
T ss_pred HHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhh
Confidence 9999999999999999999999999999999999999999965
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=197.66 Aligned_cols=149 Identities=23% Similarity=0.343 Sum_probs=123.5
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVV 148 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 148 (267)
+.||+|+||.||+|..... .....+|+|.+.... .......+.+|+.+++.++||||+++++.+...+..|++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-----~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~ 74 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-----MSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVL 74 (269)
T ss_pred CcCCccCCceEEEEEEecC-----CCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEE
Confidence 3699999999999975321 234678999876543 3344567889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHH
Q psy2579 149 EYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAV 228 (267)
Q Consensus 149 e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L 228 (267)
||+.+|+|.+++...... .....++..+..++.|++.||
T Consensus 75 e~~~~g~L~~~l~~~~~~-----------------------------------------~~~~~~~~~~~~~~~qi~~~l 113 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGM-----------------------------------------VAQMAQKDVLQRMACEVASGL 113 (269)
T ss_pred EeCCCCcHHHHHHhcccc-----------------------------------------ccccccHHHHHHHHHHHHHHH
Confidence 999999998887654210 012356778889999999999
Q ss_pred HHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 229 KHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 229 ~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
+|||++|++||||||+||+++.++.+||+|||+++.
T Consensus 114 ~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 149 (269)
T cd05042 114 LWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALE 149 (269)
T ss_pred HHHHhcCEecccccHhheEecCCCcEEEeccccccc
Confidence 999999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-27 Score=196.35 Aligned_cols=152 Identities=31% Similarity=0.484 Sum_probs=128.0
Q ss_pred EEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEE
Q psy2579 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIF 145 (267)
Q Consensus 66 ~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 145 (267)
++.+.||.|+||.||+|.+.... ...+..|+||+++.. ......+.+.+|+..++.++||||+++++++...+..+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~---~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKD---NDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTT---TSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EEeeEEccCCCcEEEEEEEEccc---CCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccccccc
Confidence 46788999999999999997311 245689999999653 34455788999999999999999999999999888899
Q ss_pred EEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHH
Q psy2579 146 LVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 225 (267)
Q Consensus 146 iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~ 225 (267)
+|+|||.+|+|.+++... ....+++.....++.|++
T Consensus 78 lv~e~~~~g~L~~~L~~~--------------------------------------------~~~~~~~~~~~~i~~~i~ 113 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSK--------------------------------------------NKEPLSEQQRLSIAIQIA 113 (259)
T ss_dssp EEEE--TTEBHHHHHHHT--------------------------------------------CTTTSBHHHHHHHHHHHH
T ss_pred cccccccccccccccccc--------------------------------------------cccccccccccccccccc
Confidence 999999998888877653 123688999999999999
Q ss_pred HHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 226 SAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 226 ~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.||.|||+++++|+||+|+||+++.++.+||+|||+++..
T Consensus 114 ~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 114 EALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp HHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred cccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999999999999998765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-27 Score=196.42 Aligned_cols=150 Identities=25% Similarity=0.429 Sum_probs=129.6
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
..+|++.++||+|+||.||+|.+. .+..||+|.+.... ...+.+.+|+.+++.++||||+++++.+...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~--------~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN--------NSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec--------CCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 356999999999999999999863 23679999986543 2346788999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..+++||++.+++|.+++... ....+++..+..++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~--------------------------------------------~~~~~~~~~~~~~~ 109 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSD--------------------------------------------EGGKVLLPKLIDFS 109 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHh--------------------------------------------cCCCCCHHHHHHHH
Confidence 9999999999998888776532 12357888899999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.|++.||+|||+.|++||||||+||+++.++.++|+|||+++.+.
T Consensus 110 ~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 110 AQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE 154 (261)
T ss_pred HHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecC
Confidence 999999999999999999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-27 Score=195.78 Aligned_cols=147 Identities=26% Similarity=0.411 Sum_probs=126.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|++.+.||+|+||.||.|.+. .+..+|+|.+...... .+.+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~--------~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR--------GQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec--------CCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 45999999999999999999764 2356999998754332 356889999999999999999999999888
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++|||+.+|+|.+++... ...+++..+..++.
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~---------------------------------------------~~~~~~~~~~~~~~ 107 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREH---------------------------------------------GKRFQPSQLLEMCK 107 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhc---------------------------------------------CCCCCHHHHHHHHH
Confidence 899999999988887666432 12578899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||+.|++|+||||+||+++.++.+||+|||+++.+
T Consensus 108 ~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~ 150 (256)
T cd05113 108 DVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV 150 (256)
T ss_pred HHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceec
Confidence 9999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=200.31 Aligned_cols=150 Identities=29% Similarity=0.406 Sum_probs=119.5
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc---CCCceeeeeeeeee
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV---HHPNIIRLYEVLET 140 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~~~~~~~~ 140 (267)
+|++.+.||+|+||.||+|.+. .+++.||+|.+............+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~ 73 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDP-------HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCAT 73 (288)
T ss_pred CceEeeEEeecCCeEEEEEEEC-------CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeecc
Confidence 4899999999999999999987 4568999999876433322223456677777665 79999999998764
Q ss_pred c-----CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 141 F-----GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 141 ~-----~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
. ...++++|++.+ +|..++... ....+++.
T Consensus 74 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~--------------------------------------------~~~~~~~~ 108 (288)
T cd07863 74 SRTDRETKVTLVFEHVDQ-DLRTYLDKV--------------------------------------------PPPGLPAE 108 (288)
T ss_pred ccCCCCceEEEEEccccc-CHHHHHHhc--------------------------------------------CCCCCCHH
Confidence 2 347788888764 554444321 12348999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.+
T Consensus 109 ~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 109 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 99999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=196.91 Aligned_cols=164 Identities=21% Similarity=0.287 Sum_probs=135.1
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+..... ..+...||+|.+.... .......+.+|+.+++.++||||+++++++...+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVK--GEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCC--CCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 469999999999999999998863221 1345789999986543 3344567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++|||+.+|+|.+++...... .+.......+++..+..++.
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~------------------------------------~~~~~~~~~~~~~~~~~~~~ 126 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPE------------------------------------AENNPGLGPPTLQKFIQMAA 126 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccc------------------------------------hhhccCCCCCCHHHHHHHHH
Confidence 999999999999998888653210 00011233578899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||+.|++||||||+||+++.++.++|+|||+++.+
T Consensus 127 ~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~ 169 (277)
T cd05032 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI 169 (277)
T ss_pred HHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhh
Confidence 9999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=204.18 Aligned_cols=145 Identities=23% Similarity=0.243 Sum_probs=113.7
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc---chHHHHHHHHHHHHHhhcCCCceee-e
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL---TPKARKMLSREIVSMESVHHPNIIR-L 134 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~-~ 134 (267)
....++|++.+.||+|+||.||+|.+.. .+++.||||.+..... .......+.+|+.+++.++|+|++. +
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~------~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l 87 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAG------DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQL 87 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcC------CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence 3345669999999999999999998763 2356789998753311 2334667999999999999999985 4
Q ss_pred eeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCCh
Q psy2579 135 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214 (267)
Q Consensus 135 ~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~ 214 (267)
++. +..|+||||+.|++|.... ...
T Consensus 88 ~~~----~~~~LVmE~~~G~~L~~~~--------------------------------------------------~~~- 112 (365)
T PRK09188 88 LAT----GKDGLVRGWTEGVPLHLAR--------------------------------------------------PHG- 112 (365)
T ss_pred EEc----CCcEEEEEccCCCCHHHhC--------------------------------------------------ccc-
Confidence 432 5678999998887774110 000
Q ss_pred hHHHHHHHHHHHHHHHHHhCCCcccCC-CCCcEEeecCCceEEeccccccccC
Q psy2579 215 DDAKIYFLQILSAVKHLHDRDIIHRDI-KAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH~~~ivHrDl-kp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
...++.|++.||.|||++||+|||| ||+|||++.++.++|+|||+|+.+.
T Consensus 113 --~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 113 --DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred --hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 1357889999999999999999999 9999999999999999999998654
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=205.05 Aligned_cols=141 Identities=34% Similarity=0.554 Sum_probs=118.7
Q ss_pred cCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhc---CCCceeeeeeeeeecCeEEE
Q psy2579 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESV---HHPNIIRLYEVLETFGKIFL 146 (267)
Q Consensus 71 iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l---~hpnIv~~~~~~~~~~~~~i 146 (267)
||+|+||.||+|++. .++..||+|++...... .........|..++... .||||+.+++.+...+..|+
T Consensus 1 lG~G~~g~Vy~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~l 73 (330)
T cd05586 1 IGKGTFGQVYQVRKK-------DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYL 73 (330)
T ss_pred CCCCCceEEEEEEEC-------CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEE
Confidence 799999999999986 45689999999754322 22334455677777655 79999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS 226 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~ 226 (267)
||||+.+|+|...+. ..+.+++..+..++.|++.
T Consensus 74 v~e~~~~g~L~~~l~----------------------------------------------~~~~~~~~~~~~~~~qil~ 107 (330)
T cd05586 74 VTDYMSGGELFWHLQ----------------------------------------------KEGRFSEDRAKFYIAELVL 107 (330)
T ss_pred EEcCCCCChHHHHHH----------------------------------------------hcCCCCHHHHHHHHHHHHH
Confidence 999999877765553 3346889999999999999
Q ss_pred HHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 227 AVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 227 ~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
||+|||++||+||||||+|||++.++.++|+|||+++.
T Consensus 108 al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 108 ALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKA 145 (330)
T ss_pred HHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence 99999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-27 Score=200.54 Aligned_cols=148 Identities=28% Similarity=0.462 Sum_probs=129.5
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++.+.||+|+||.||+|.+. .++..+|+|.+.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~-------~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 73 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHR-------PSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGE 73 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEc-------CCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCE
Confidence 5999999999999999999886 445789999986542 34455678899999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.|++|||+.+++|.+++.. .+.+++..+..++.|
T Consensus 74 ~~lv~ey~~~~~L~~~l~~----------------------------------------------~~~~~~~~~~~~~~~ 107 (308)
T cd06615 74 ISICMEHMDGGSLDQVLKK----------------------------------------------AGRIPENILGKISIA 107 (308)
T ss_pred EEEEeeccCCCcHHHHHHh----------------------------------------------cCCCCHHHHHHHHHH
Confidence 9999999998888766643 246888999999999
Q ss_pred HHHHHHHHHh-CCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHD-RDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||.|||+ .+++|+||||+||+++.++.++|+|||++..+
T Consensus 108 i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (308)
T cd06615 108 VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 150 (308)
T ss_pred HHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccc
Confidence 9999999997 69999999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=223.21 Aligned_cols=158 Identities=27% Similarity=0.489 Sum_probs=132.7
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
...+++|++++.||.|+||.||+|.+. .++..||+|++............+.+|+.+++.++|||||+++++|
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk-------~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f 81 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHK-------RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRF 81 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEEC-------CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence 335677999999999999999999987 4458999999987766666677899999999999999999999988
Q ss_pred eec--CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 139 ETF--GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 139 ~~~--~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
... ..+|+||||+.+|+|.+++... ......+++..
T Consensus 82 ~de~~~~lyIVMEY~~gGSL~~lL~k~------------------------------------------~~~~g~L~E~~ 119 (1021)
T PTZ00266 82 LNKANQKLYILMEFCDAGDLSRNIQKC------------------------------------------YKMFGKIEEHA 119 (1021)
T ss_pred EecCCCEEEEEEeCCCCCcHHHHHHHH------------------------------------------hhccCCCCHHH
Confidence 553 5689999999998888776532 11234689999
Q ss_pred HHHHHHHHHHHHHHHHhC-------CCcccCCCCCcEEeec-----------------CCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDR-------DIIHRDIKAENVFLSV-----------------RGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~-------~ivHrDlkp~NIll~~-----------------~~~~kl~DFGla~~l 265 (267)
++.|+.||+.||+|||+. +||||||||+|||++. .+.+||+|||+++.+
T Consensus 120 Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l 192 (1021)
T PTZ00266 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192 (1021)
T ss_pred HHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccc
Confidence 999999999999999985 4999999999999964 235899999998764
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=198.31 Aligned_cols=148 Identities=27% Similarity=0.448 Sum_probs=129.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+. .++..||+|+++... ......+.+|+.+++.++||||+++++.+...+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNV-------NTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEc-------CCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 46999999999999999999886 456889999987553 233456789999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++|||+++++|.+++. ..+.+++.++..++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~----------------------------------------------~~~~~~~~~~~~~~~ 113 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYH----------------------------------------------VTGPLSESQIAYVSR 113 (267)
T ss_pred EEEEEEeccCCCcHHHHHH----------------------------------------------hcCCCCHHHHHHHHH
Confidence 9999999999877766553 334688999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++|++|+||||+||+++.++.++|+|||++..+
T Consensus 114 ~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 114 ETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQI 156 (267)
T ss_pred HHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence 9999999999999999999999999999999999999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-27 Score=195.49 Aligned_cols=150 Identities=31% Similarity=0.478 Sum_probs=129.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch---HHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP---KARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
++|++.+.||+|++|.||.|.+. .+++.||+|.+....... .....+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~-------~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 74 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDV-------DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR 74 (263)
T ss_pred CcccccceecCCCceEEEEEEEc-------CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc
Confidence 35899999999999999999876 456899999987654322 23456889999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+..++++|++.+++|.+.+. ..+.+++..+..
T Consensus 75 ~~~~~~~v~e~~~~~~l~~~~~----------------------------------------------~~~~~~~~~~~~ 108 (263)
T cd06625 75 DDETLSIFMEYMPGGSVKDQLK----------------------------------------------AYGALTETVTRK 108 (263)
T ss_pred cCCeEEEEEEECCCCcHHHHHH----------------------------------------------HhCCCCHHHHHH
Confidence 9999999999998877766554 334578889999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++.+
T Consensus 109 ~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 109 YTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred HHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=200.54 Aligned_cols=172 Identities=27% Similarity=0.319 Sum_probs=137.0
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||.||+|.+.............||+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 569999999999999999998753332222345679999987543 334456788999999999 699999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|++|||+.+|+|.+++.......... ...........+++..+..++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~------------------------------~~~~~~~~~~~l~~~~~~~~~ 140 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDY------------------------------TFDITKVPEEQLSFKDLVSCA 140 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccc------------------------------cccccCCcccccCHHHHHHHH
Confidence 99999999999999999887643211000 000001123468899999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||.|||++|++||||||+||+++.++.+||+|||+++.+
T Consensus 141 ~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~ 184 (314)
T cd05099 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGV 184 (314)
T ss_pred HHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccc
Confidence 99999999999999999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=197.23 Aligned_cols=153 Identities=28% Similarity=0.370 Sum_probs=126.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|++.+.||+|+||.||+|.+..++. .....||+|++.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~---~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGE---NVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCC---ccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 459999999999999999999864331 112368999987543 34445678899999999999999999998865 4
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++++++.+|+|.+++... .+.+++..+..++.
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~---------------------------------------------~~~~~~~~~~~~~~ 116 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVREN---------------------------------------------KDRIGSQDLLNWCV 116 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhc---------------------------------------------cCCCCHHHHHHHHH
Confidence 567888888887777665432 23588999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++|++||||||+||+++.++.+||+|||+++.+
T Consensus 117 qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred HHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 9999999999999999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=199.59 Aligned_cols=170 Identities=22% Similarity=0.302 Sum_probs=135.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
..|++.+.||+|+||.||+|.+..+.. ...+..||+|+++... .......+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAP--GEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCC--CCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 458889999999999999998753221 1335789999997543 3344567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..++++||+.+++|..++........ .+...+.......+++..+..++.
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~~~~ 131 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSD------------------------------VGSTDDDKTVKSTLEPADFVHIVT 131 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCcc------------------------------ccccccccccccccCHHHHHHHHH
Confidence 99999999999999988854321100 011111112234688899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|+|++|++||||||+||+++.++.+||+|||+++.+
T Consensus 132 ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (283)
T cd05091 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREV 174 (283)
T ss_pred HHHHHHHHHHHcCccccccchhheEecCCCceEeccccccccc
Confidence 9999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-27 Score=197.03 Aligned_cols=155 Identities=25% Similarity=0.302 Sum_probs=125.4
Q ss_pred EEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec----
Q psy2579 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF---- 141 (267)
Q Consensus 66 ~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~---- 141 (267)
.+.+.||+|+||.||+|.+.... ....||+|.++....+......+.+|+.+++.++||||+++++.+...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~-----~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDD-----SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE 76 (272)
T ss_pred ccccccCcccCceEEEeEEccCC-----CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCccc
Confidence 46678999999999999875321 124799999987655566677889999999999999999999976432
Q ss_pred --CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 142 --GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 142 --~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
...+++|||+.+|+|.+++..... -.....+++..+..
T Consensus 77 ~~~~~~~v~e~~~~~~l~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~ 116 (272)
T cd05075 77 GYPSPVVILPFMKHGDLHSFLLYSRL----------------------------------------GDCPQYLPTQMLVK 116 (272)
T ss_pred CCCCcEEEEEeCCCCcHHHHHHHhcc----------------------------------------cCCcccCCHHHHHH
Confidence 346888888888888766532210 00123588999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||+|||++|++||||||+||+++.++.++|+|||+|+.+
T Consensus 117 ~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 162 (272)
T cd05075 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI 162 (272)
T ss_pred HHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccccc
Confidence 9999999999999999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-27 Score=198.27 Aligned_cols=153 Identities=24% Similarity=0.364 Sum_probs=127.5
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec--
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF-- 141 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~-- 141 (267)
.|++++.||+|+||.||+|.+.... ..++..||+|.++... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEG---DNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCC---CCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 3789999999999999999864211 1456889999987543 344456799999999999999999999998775
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
...+++|||+++++|.+++... ...+++..+..++
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~---------------------------------------------~~~~~~~~~~~i~ 115 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRN---------------------------------------------KNKINLKQQLKYA 115 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhc---------------------------------------------cCCCCHHHHHHHH
Confidence 4578888888887776655422 1257889999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++|++||||||+||+++.++.++|+|||+++.+
T Consensus 116 ~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 116 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred HHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-27 Score=212.06 Aligned_cols=148 Identities=28% Similarity=0.335 Sum_probs=116.9
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
..+|++.+.||+|+||.||+|.+. .+++.||||.+.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~-------~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICI-------DTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEEC-------CCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeec
Confidence 356999999999999999999986 455899999885432 2245799999999999999999876432
Q ss_pred --------CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCC
Q psy2579 142 --------GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLS 213 (267)
Q Consensus 142 --------~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~ 213 (267)
..++++|||+.+ ++.+.+.. .......++
T Consensus 132 ~~~~~~~~~~l~lvmE~~~~-~l~~~~~~------------------------------------------~~~~~~~l~ 168 (440)
T PTZ00036 132 CFKKNEKNIFLNVVMEFIPQ-TVHKYMKH------------------------------------------YARNNHALP 168 (440)
T ss_pred ccccCCCceEEEEEEecCCc-cHHHHHHH------------------------------------------HhhcCCCCC
Confidence 135567777664 33332221 112345689
Q ss_pred hhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC-ceEEecccccccc
Q psy2579 214 EDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG-IVKLGDLGFSTKL 265 (267)
Q Consensus 214 ~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~l 265 (267)
+..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.+
T Consensus 169 ~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 169 LFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 999999999999999999999999999999999998665 7999999999864
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-27 Score=198.45 Aligned_cols=149 Identities=33% Similarity=0.520 Sum_probs=130.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||.|+||.||+|.+. .++..||+|++... .....+.+.+|+.+++.++||||+++++.+...+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~-------~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHK-------ETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN 75 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEc-------CCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC
Confidence 45999999999999999999886 34588999998654 3344567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++|||+.+++|..++... ...+++..+..++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~---------------------------------------------~~~l~~~~~~~~~~ 110 (280)
T cd06611 76 KLWILIEFCDGGALDSIMLEL---------------------------------------------ERGLTEPQIRYVCR 110 (280)
T ss_pred eEEEEeeccCCCcHHHHHHHh---------------------------------------------cCCCCHHHHHHHHH
Confidence 999999999998887766432 23688999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 111 ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~ 153 (280)
T cd06611 111 QMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKN 153 (280)
T ss_pred HHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhh
Confidence 9999999999999999999999999999999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=212.06 Aligned_cols=142 Identities=25% Similarity=0.293 Sum_probs=122.7
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
..|.+.+.||+|+||.||+|.+. .+++.||||.... ..+.+|+.+++.++|||||++++++...+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~-------~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~ 233 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHP-------DYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGG 233 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEEC-------CCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence 46999999999999999999986 4458999996422 23568999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++||++. ++|..++.. ....+++..+..++.
T Consensus 234 ~~~lv~e~~~-~~L~~~l~~---------------------------------------------~~~~l~~~~~~~i~~ 267 (461)
T PHA03211 234 LTCLVLPKYR-SDLYTYLGA---------------------------------------------RLRPLGLAQVTAVAR 267 (461)
T ss_pred EEEEEEEccC-CCHHHHHHh---------------------------------------------cCCCCCHHHHHHHHH
Confidence 9999999885 455554432 123689999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++||+||||||+|||++.++.++|+|||+|+.+
T Consensus 268 qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA 310 (461)
T ss_pred HHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceec
Confidence 9999999999999999999999999999999999999999754
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=196.68 Aligned_cols=153 Identities=25% Similarity=0.383 Sum_probs=129.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+..++. .....||+|.+.... .......+.+|+.+++.++||||+++++++.. +
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~---~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGE---KVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCC---CcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 569999999999999999999864331 123479999887654 24455778899999999999999999999877 7
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++|||+.+|+|.+++... ...+++..+..++.
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~---------------------------------------------~~~~~~~~~~~~~~ 116 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNH---------------------------------------------KDNIGSQYLLNWCV 116 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhc---------------------------------------------cCCCCHHHHHHHHH
Confidence 888999999888887766532 22588999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++|++||||||+||+++.++.++|+|||+++.+
T Consensus 117 qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred HHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 9999999999999999999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-27 Score=195.43 Aligned_cols=147 Identities=27% Similarity=0.443 Sum_probs=126.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|++.+.||+|+||.||+|.+. .+..+|+|++...... ...+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~--------~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR--------GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec--------CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34899999999999999999874 2367899998654432 245778999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++||++++++|.+++... ...+++..+..++.
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~i~~ 107 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRER---------------------------------------------KGKLGTEWLLDMCS 107 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhc---------------------------------------------ccCCCHHHHHHHHH
Confidence 999999999998887766532 22578899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++|++||||||+||+++.++.+||+|||+++..
T Consensus 108 qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~ 150 (256)
T cd05059 108 DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV 150 (256)
T ss_pred HHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceec
Confidence 9999999999999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=195.34 Aligned_cols=149 Identities=23% Similarity=0.397 Sum_probs=129.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
..|.+.+.||+|+||.||+|.+. .++..||+|.+.... .....+.+|+.+++.++||||+++++++...+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-------~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 75 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEe-------cCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC
Confidence 45899999999999999999986 445889999986542 33456889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++|||+.+++|.+++... ....+++..+..++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~--------------------------------------------~~~~l~~~~~~~~~~ 111 (263)
T cd05052 76 PFYIITEFMTYGNLLDYLREC--------------------------------------------NRQEVNAVVLLYMAT 111 (263)
T ss_pred CcEEEEEeCCCCcHHHHHHhC--------------------------------------------CCCCCCHHHHHHHHH
Confidence 999999999998887766432 122578888999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++|++||||||+||+++.++.++|+|||+++.+
T Consensus 112 ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~ 154 (263)
T cd05052 112 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 154 (263)
T ss_pred HHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccc
Confidence 9999999999999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-27 Score=199.02 Aligned_cols=149 Identities=28% Similarity=0.461 Sum_probs=127.4
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
+++|++.+.||+|++|.||+|.+. .+++.||+|.+...... .....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSK-------LTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEc-------CCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 467999999999999999999886 34588999998754322 2234467899999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..++||||+.+ +|.+.+... ...+++..+..++
T Consensus 76 ~~~~lv~e~~~~-~L~~~~~~~---------------------------------------------~~~~~~~~~~~~~ 109 (291)
T cd07844 76 KTLTLVFEYLDT-DLKQYMDDC---------------------------------------------GGGLSMHNVRLFL 109 (291)
T ss_pred CeEEEEEecCCC-CHHHHHHhC---------------------------------------------CCCCCHHHHHHHH
Confidence 999999999974 676555432 2257889999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
.|++.||.|||++|++||||||+||+++.++.++|+|||+++.
T Consensus 110 ~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 152 (291)
T cd07844 110 FQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARA 152 (291)
T ss_pred HHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccc
Confidence 9999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=194.88 Aligned_cols=148 Identities=26% Similarity=0.378 Sum_probs=128.6
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+.|++.+.||+|++|.||+|.+. .+..||+|.+...... ...+.+|+.+++.++||||+++++++...+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--------~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN--------NTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEE 74 (261)
T ss_pred hheeeEEEecccCCccEEEEEec--------CCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCC
Confidence 45999999999999999999863 2367999998765432 356889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++||++.+++|.+++.... ...+++..+..++.
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~--------------------------------------------~~~~~~~~~~~~~~ 110 (261)
T cd05068 75 PIYIVTELMKYGSLLEYLQGGA--------------------------------------------GRALKLPQLIDMAA 110 (261)
T ss_pred CeeeeeecccCCcHHHHHhccC--------------------------------------------CCCCCHHHHHHHHH
Confidence 9999999999988877765321 12588899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||+.|++|+||||+||+++.++.++|+|||+++.+
T Consensus 111 ~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVI 153 (261)
T ss_pred HHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence 9999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=200.63 Aligned_cols=149 Identities=27% Similarity=0.482 Sum_probs=127.6
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++.+.||+|+||.||+|.+. .++..||+|.+............+.+|+.+++.++||||+++++++.+.+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~-------~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 73 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNR-------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKK 73 (284)
T ss_pred CceeEEEecccCCeEEEEEEEC-------CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCc
Confidence 4899999999999999999986 456889999997654333334567789999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.|+++||+.+ +|.+.+.. ..+.+++..+..++.|
T Consensus 74 ~~lv~e~~~~-~l~~~~~~---------------------------------------------~~~~~~~~~~~~~~~q 107 (284)
T cd07839 74 LTLVFEYCDQ-DLKKYFDS---------------------------------------------CNGDIDPEIVKSFMFQ 107 (284)
T ss_pred eEEEEecCCC-CHHHHHHh---------------------------------------------cCCCCCHHHHHHHHHH
Confidence 9999999874 55444322 1346899999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||.|||++|++||||||+||+++.++.++|+|||+++.+
T Consensus 108 i~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 149 (284)
T cd07839 108 LLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAF 149 (284)
T ss_pred HHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhcc
Confidence 999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=197.25 Aligned_cols=154 Identities=34% Similarity=0.537 Sum_probs=132.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||.||+|.+. .++..+|||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~-------~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 74 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCL-------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED 74 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeec-------CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC
Confidence 56999999999999999999986 4458999998876443 234456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..+++||++.+++|.+++.... .....+++..+..++
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~------------------------------------------~~~~~~~~~~~~~~~ 112 (267)
T cd08229 75 NELNIVLELADAGDLSRMIKHFK------------------------------------------KQKRLIPEKTVWKYF 112 (267)
T ss_pred CeEEEEEEecCCCCHHHHHHHhh------------------------------------------ccCCCCCHHHHHHHH
Confidence 99999999999999887665321 122368899999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+
T Consensus 113 ~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 113 VQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred HHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 99999999999999999999999999999999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=198.11 Aligned_cols=148 Identities=30% Similarity=0.496 Sum_probs=129.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+.|++++.||.|+||.||+|.+. .++..||+|++... +......+.+|+.+++.++||||+++++.+...+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~-------~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNK-------ETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEEC-------CCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence 45999999999999999999886 44588999998754 3455677889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++|||+.+++|...+... ...+++..+..++.
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~---------------------------------------------~~~l~~~~~~~~~~ 117 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLEL---------------------------------------------DRGLTEPQIQVICR 117 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhh---------------------------------------------cCCCCHHHHHHHHH
Confidence 999999999998876554321 23588999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 118 ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 118 QMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred HHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCcccee
Confidence 999999999999999999999999999999999999998864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-27 Score=208.01 Aligned_cols=144 Identities=27% Similarity=0.370 Sum_probs=122.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|++++.||.|+||.||+|..... ..+..||+|.+... ....+|+.+++.++||||+++++++...+
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~-----~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGD-----EQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKS 159 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCC-----ccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence 4599999999999999999976421 34578999988643 23457999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++||++.+ +|..++ .....+++..+..++.
T Consensus 160 ~~~lv~e~~~~-~l~~~l----------------------------------------------~~~~~l~~~~~~~i~~ 192 (392)
T PHA03207 160 TVCMVMPKYKC-DLFTYV----------------------------------------------DRSGPLPLEQAITIQR 192 (392)
T ss_pred EEEEEehhcCC-CHHHHH----------------------------------------------HhcCCCCHHHHHHHHH
Confidence 99999998863 444333 3345789999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++||+||||||+|||++.++.++|+|||+|+.+
T Consensus 193 ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 193 RLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred HHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 9999999999999999999999999999999999999998764
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=196.98 Aligned_cols=171 Identities=24% Similarity=0.317 Sum_probs=136.7
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
+++|++.+.||+|+||.||+|.+..... ......||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNE--RLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCC--CcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 3569999999999999999998763321 1234689999987543 344567789999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|++|||+.+|+|.+++.......... ...........+++..+..++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~------------------------------~~~~~~~~~~~l~~~~~~~~~ 130 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVG------------------------------AESGDETVKSSLDCSDFLHIA 130 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccc------------------------------cccccccccCCCCHHHHHHHH
Confidence 99999999999999998887543211000 000001112468899999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.+
T Consensus 131 ~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~ 174 (283)
T cd05048 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI 174 (283)
T ss_pred HHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeec
Confidence 99999999999999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=197.89 Aligned_cols=168 Identities=21% Similarity=0.319 Sum_probs=137.2
Q ss_pred ecceEEecccCccCceeEEEeEEeeccccc---------ccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCcee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPIL---------CTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNII 132 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv 132 (267)
.++|++.+.||+|+||.||+|.+...+... ......||+|.+.... .......+.+|+.+++.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 356999999999999999999876433211 1234679999987654 335567899999999999999999
Q ss_pred eeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCC
Q psy2579 133 RLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRL 212 (267)
Q Consensus 133 ~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~ 212 (267)
++++++...+..+++||++.+++|..++........ ........+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----------------------------------~~~~~~~~~ 127 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETS-----------------------------------GLACNSKSL 127 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccc-----------------------------------cccccCCCC
Confidence 999999999999999999999999888865421100 001123368
Q ss_pred ChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 213 SEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 213 ~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||+++.+
T Consensus 128 ~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 180 (296)
T cd05051 128 SFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180 (296)
T ss_pred CHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeec
Confidence 99999999999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=200.99 Aligned_cols=172 Identities=26% Similarity=0.313 Sum_probs=136.1
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~ 141 (267)
.+|++.+.||+|+||.||+|.+.............||+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 359999999999999999998754332222334579999887532 344567789999999999 899999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..++++||+.+|+|.+++........ + ............+++..+..++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------------------~----~~~~~~~~~~~~l~~~~~~~~~ 140 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGM--------------------------D----YSFDTCKLPEEQLTFKDLVSCA 140 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCccc--------------------------c----cccccccCccccCCHHHHHHHH
Confidence 999999999999999998875421100 0 0000000123358888999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||.|||++|++||||||+||+++.++.++|+|||+++.+
T Consensus 141 ~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 184 (334)
T cd05100 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184 (334)
T ss_pred HHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceec
Confidence 99999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=196.84 Aligned_cols=149 Identities=28% Similarity=0.467 Sum_probs=132.1
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++.+.||.|+||.||+|.+. .++..||+|++............+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDR-------ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSG 73 (286)
T ss_pred CceEEeecccCCCcEEEEEEEC-------CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence 4899999999999999999986 446899999998765445556778999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.++|+|++ +++|.+.+... ..++++..+..++.|
T Consensus 74 ~~~v~e~~-~~~L~~~~~~~---------------------------------------------~~~~~~~~~~~~~~~ 107 (286)
T cd07832 74 FVLVMEYM-PSDLSEVLRDE---------------------------------------------ERPLPEAQVKSYMRM 107 (286)
T ss_pred eEEEeccc-CCCHHHHHHhc---------------------------------------------CCCCCHHHHHHHHHH
Confidence 99999999 88887766432 136899999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||+|||+.|++|+||||+||+++.++.++|+|||++..+
T Consensus 108 i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~ 149 (286)
T cd07832 108 LLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLF 149 (286)
T ss_pred HHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccc
Confidence 999999999999999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=199.01 Aligned_cols=149 Identities=30% Similarity=0.448 Sum_probs=129.4
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc---hHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT---PKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
+|++.+.||+|+||.||+|.+. .+++.||+|.+...... ......+..|+.+++.++||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 73 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDK-------ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH 73 (298)
T ss_pred CceeeeeeeeccccEEEEEEEC-------CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec
Confidence 4889999999999999999986 44689999999766543 2334567789999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..++||||+ +|+|.+++.... ..+++..+..+
T Consensus 74 ~~~~~lv~e~~-~~~L~~~i~~~~---------------------------------------------~~~~~~~~~~~ 107 (298)
T cd07841 74 KSNINLVFEFM-ETDLEKVIKDKS---------------------------------------------IVLTPADIKSY 107 (298)
T ss_pred CCEEEEEEccc-CCCHHHHHhccC---------------------------------------------CCCCHHHHHHH
Confidence 99999999999 877776664321 25889999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++.+
T Consensus 108 ~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 108 MLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred HHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 999999999999999999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-27 Score=205.51 Aligned_cols=141 Identities=30% Similarity=0.390 Sum_probs=121.6
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|++.+.||+|+||.||+|.+. .++..||+|+.... ....|+.+++.++||||+++++++...+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 130 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKP-------GQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGA 130 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEEC-------CCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCC
Confidence 35999999999999999999986 44588999985432 2346999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++||++. ++|..++.. ...++++..+..++.
T Consensus 131 ~~~lv~e~~~-~~l~~~l~~---------------------------------------------~~~~~~~~~~~~i~~ 164 (357)
T PHA03209 131 ITCMVLPHYS-SDLYTYLTK---------------------------------------------RSRPLPIDQALIIEK 164 (357)
T ss_pred eeEEEEEccC-CcHHHHHHh---------------------------------------------ccCCCCHHHHHHHHH
Confidence 9999999985 455554432 234689999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
|++.||.|||++||+||||||+|||++.++.++|+|||+++.
T Consensus 165 qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 206 (357)
T PHA03209 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF 206 (357)
T ss_pred HHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccc
Confidence 999999999999999999999999999999999999999874
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=192.49 Aligned_cols=151 Identities=32% Similarity=0.584 Sum_probs=129.7
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee-cC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET-FG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~-~~ 142 (267)
.|++.+.||.|++|.||+|.+. .+++.||+|.+..........+.+.+|+.+++.++|||++++++.+.. .+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHR-------TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDG 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEc-------CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCC
Confidence 4899999999999999999986 445789999997655555566778999999999999999999998764 44
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++||++.+++|.+++... ....+++.++..++.
T Consensus 74 ~~~lv~e~~~~~~l~~~l~~~--------------------------------------------~~~~l~~~~~~~~~~ 109 (257)
T cd08223 74 LLYIVMGFCEGGDLYHKLKEQ--------------------------------------------KGKLLPENQVVEWFV 109 (257)
T ss_pred EEEEEecccCCCcHHHHHHHh--------------------------------------------cCCCCCHHHHHHHHH
Confidence 688999999988887766532 123588999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||++||+.|++|+||||+||+++.++.++|+|||++..+
T Consensus 110 ~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 110 QIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152 (257)
T ss_pred HHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEe
Confidence 9999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=196.94 Aligned_cols=177 Identities=24% Similarity=0.342 Sum_probs=134.6
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++.+.||+|+||.||+|.+..... ......+|+|.+.... .......+.+|+.+++.++||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKG--RAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCC--CCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC
Confidence 47889999999999999998753221 1233579999987554 23445678899999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.++++||+.+|+|.+++........... ..+-. ..+..........+++..+..++.|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~---------------------~~~~~-~~~~~~~~~~~~~l~~~~~~~i~~~ 135 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYL---------------------GSDGN-RNSSYLDNPDERALTMGDLISFAWQ 135 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCcccccc---------------------ccccc-cccccccCccccccCHHHHHHHHHH
Confidence 9999999999999988865322110000 00000 0000001112346889999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||+|||+.|++||||||+||+++.++.++|+|||+++.+
T Consensus 136 i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~ 177 (290)
T cd05045 136 ISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177 (290)
T ss_pred HHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccc
Confidence 999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-27 Score=203.53 Aligned_cols=200 Identities=23% Similarity=0.269 Sum_probs=134.7
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||.||+|.+..... ..+++.||||++.... .......+.+|+.++..+ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDK--TATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCc--cccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 469999999999999999998643211 1345789999997543 233456788999999999 789999999987654
Q ss_pred -CeEEEEEeecCCCchhhhhhccCCCChhhHH------------HHHHHHHHHH-hhhccCeEEEEEEEccCCchhh---
Q psy2579 142 -GKIFLVVEYASGGELYNKITTEGRLSEDDAK------------IYFLQILLYE-VLETFGKIFLVVEYASGGELYN--- 204 (267)
Q Consensus 142 -~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~------------~~~~~~~~~~-~~~~~~~~~~v~e~~~~~~l~~--- 204 (267)
+..+++||||.+|+|.+++.........-.. ....+..... ........+....+.+...+.+
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 5689999999999999998764321000000 0000000000 0000000001111111111000
Q ss_pred -----hhcccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 205 -----KITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 205 -----~~~~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.......+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~ 229 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEeccccccc
Confidence 0011235788999999999999999999999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=196.92 Aligned_cols=168 Identities=26% Similarity=0.372 Sum_probs=137.0
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+.|.+.+.||+|+||.||+|.+..... ..+...||+|.+.... ..+....+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~--~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEP--ENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccC--cCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 459999999999999999998753311 1335789999987543 3335678999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++|||+.+++|.+++...+.... .+.........+++..+..++.
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~--------------------------------~~~~~~~~~~~l~~~~~~~~~~ 129 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAA--------------------------------FLKSPDSPMGELTLSQLLQIAV 129 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchh--------------------------------hhcccccccccccHHHHHHHHH
Confidence 99999999999999999876532100 0000011234688999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++|++||||||+||+++.++.++|+|||+++.+
T Consensus 130 ~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~ 172 (280)
T cd05049 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV 172 (280)
T ss_pred HHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceec
Confidence 9999999999999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=195.63 Aligned_cols=147 Identities=30% Similarity=0.495 Sum_probs=128.2
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeE
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKI 144 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 144 (267)
|++.+.||+|+||.||+|.+. .++..+++|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~-------~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 77 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNK-------ETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 77 (282)
T ss_pred HHHHhhcccCCCeEEEEEEEC-------CCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEE
Confidence 788899999999999999886 445789999986542 34456788999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHH
Q psy2579 145 FLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 224 (267)
Q Consensus 145 ~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql 224 (267)
|+++||+.+++|...+.+ ...++++..+..++.|+
T Consensus 78 ~~v~e~~~~~~l~~~~~~---------------------------------------------~~~~l~~~~~~~~~~qi 112 (282)
T cd06643 78 WILIEFCAGGAVDAVMLE---------------------------------------------LERPLTEPQIRVVCKQT 112 (282)
T ss_pred EEEEEecCCCcHHHHHHh---------------------------------------------cCCCCCHHHHHHHHHHH
Confidence 999999998887665432 12368899999999999
Q ss_pred HHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 225 LSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 225 ~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.||.|||+.|++||||||+||+++.++.++|+|||++..+
T Consensus 113 ~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 113 LEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKN 153 (282)
T ss_pred HHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccc
Confidence 99999999999999999999999999999999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-28 Score=202.49 Aligned_cols=148 Identities=28% Similarity=0.493 Sum_probs=133.0
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.-|.++.+||+|+||.||+|.++ +.|+.||||.+... ...+.+..|+.+|++++.|++|++|+.+-...
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~-------EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s 101 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHR-------ESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS 101 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHh-------ccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCC
Confidence 34889999999999999999998 67799999998654 34567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
.+|||||||..||..+.++. ...++++.++..+++
T Consensus 102 DLWIVMEYCGAGSiSDI~R~---------------------------------------------R~K~L~E~EIs~iL~ 136 (502)
T KOG0574|consen 102 DLWIVMEYCGAGSISDIMRA---------------------------------------------RRKPLSEQEISAVLR 136 (502)
T ss_pred ceEeehhhcCCCcHHHHHHH---------------------------------------------hcCCccHHHHHHHHH
Confidence 99999999999888776653 234799999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
..+.||+|||...-+|||||..|||++.+|..||+|||.|-++.
T Consensus 137 ~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 137 DTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT 180 (502)
T ss_pred HHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh
Confidence 99999999999999999999999999999999999999998763
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-27 Score=195.87 Aligned_cols=149 Identities=21% Similarity=0.365 Sum_probs=130.5
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|++.+.||.|+||.||+|.+. . +..+|+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~-------~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 75 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWK-------N-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE 75 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEec-------C-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCC
Confidence 45999999999999999999985 2 5889999987653 223456889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++|||+.+++|.+++... ....+++..+..++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~ 111 (261)
T cd05148 76 PVYIITELMEKGSLLAFLRSP--------------------------------------------EGQVLPVASLIDMAC 111 (261)
T ss_pred CeEEEEeecccCCHHHHHhcC--------------------------------------------CCCCCCHHHHHHHHH
Confidence 999999999998888777542 123578899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++|++|+||||+||+++.++.++|+|||++..+
T Consensus 112 ~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 112 QVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred HHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhc
Confidence 9999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=193.90 Aligned_cols=147 Identities=25% Similarity=0.403 Sum_probs=124.3
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.++||+|+||.||+|.+.. ...||+|.+...... ...+.+|+.+++.++||||+++++.+. .+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~--------~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~ 73 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNG--------TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS-EE 73 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecC--------CceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEEC-CC
Confidence 569999999999999999998742 246999999764433 246889999999999999999999874 45
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++||++.+|+|.+++... ....+++..+..++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~ 109 (262)
T cd05071 74 PIYIVTEYMSKGSLLDFLKGE--------------------------------------------MGKYLRLPQLVDMAA 109 (262)
T ss_pred CcEEEEEcCCCCcHHHHHhhc--------------------------------------------cccCCCHHHHHHHHH
Confidence 678999999888887766432 112578889999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|+|+.|++|+||||+||+++.++.++|+|||+++.+
T Consensus 110 ~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 110 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 152 (262)
T ss_pred HHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeec
Confidence 9999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-27 Score=195.65 Aligned_cols=149 Identities=27% Similarity=0.509 Sum_probs=131.3
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+|++.+.||.|+||.||+|.+. .++..||+|++....... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKR-------DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEc-------cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC
Confidence 4899999999999999999886 456889999997655433 45678999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..++++||+.+++|..++.. ..++++..+..++.
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~----------------------------------------------~~~l~~~~~~~~~~ 107 (258)
T cd05578 74 NMYLVVDLLLGGDLRYHLSQ----------------------------------------------KVKFSEEQVKFWIC 107 (258)
T ss_pred eEEEEEeCCCCCCHHHHHHh----------------------------------------------cCCcCHHHHHHHHH
Confidence 99999999998777665542 24688899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++|++|+||+|+||+++.++.++|+|||++..+
T Consensus 108 ~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~ 150 (258)
T cd05578 108 EIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV 150 (258)
T ss_pred HHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence 9999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=209.43 Aligned_cols=154 Identities=29% Similarity=0.395 Sum_probs=130.2
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
...++.+.||.|.||.||.|.+.... ....--||||..+... .+...+.|+.|+.+|+.++||||++++|.|.. .
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~---kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPE---KGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccc---cCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 34555678999999999999986542 1233569999987644 55668889999999999999999999999865 6
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|||||++.-|.|..++..++ ..++......++.
T Consensus 464 P~WivmEL~~~GELr~yLq~nk---------------------------------------------~sL~l~tL~ly~~ 498 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK---------------------------------------------DSLPLRTLTLYCY 498 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc---------------------------------------------ccchHHHHHHHHH
Confidence 7888888888888877776542 2688888899999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
|++.||.|||+..+|||||..+|||+.....+||+||||||-+.
T Consensus 499 Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 499 QICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred HHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 99999999999999999999999999999999999999999775
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=193.50 Aligned_cols=153 Identities=28% Similarity=0.366 Sum_probs=131.0
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|+..+.||+|+||.||+|.+.... .....+|+|.+.... .......+.+|+.+++.++||||+++.+++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~----~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPG----RKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCC----CCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 45889999999999999999986432 223579999986543 3444577899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++||++.+++|.+++... .+.+++..+..++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~---------------------------------------------~~~~~~~~~~~~~~ 114 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDH---------------------------------------------DGEFSSYQLVGMLR 114 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhc---------------------------------------------CCCCCHHHHHHHHH
Confidence 999999999998887766432 23578889999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||+.|++|+||||+||+++.++.++|+|||++..+
T Consensus 115 ~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 115 GIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred HHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=198.37 Aligned_cols=151 Identities=29% Similarity=0.451 Sum_probs=132.4
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+|++.+.||+|+||.||+|.+. .++..||+|.+....... .....+.+|+.+++.++||||+++++.+...+
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 74 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLK-------GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET 74 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEc-------CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC
Confidence 5999999999999999999886 345899999998765443 35567899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++||++.+++|.+++... ....+++..+..++.
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~--------------------------------------------~~~~l~~~~~~~~~~ 110 (316)
T cd05574 75 YLCLVMDYCPGGELFRLLQRQ--------------------------------------------PGKCLSEEVARFYAA 110 (316)
T ss_pred EEEEEEEecCCCCHHHHHHhC--------------------------------------------CCCccCHHHHHHHHH
Confidence 999999999998887766532 123588899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 111 qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 111 EVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred HHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 9999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=191.84 Aligned_cols=151 Identities=35% Similarity=0.658 Sum_probs=132.3
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++.+.||+|+||.||.+.+. .+++.||+|.+............+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSK-------EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGN 73 (256)
T ss_pred CceEEEEeccCCceEEEEEEEc-------CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCe
Confidence 4899999999999999999986 445889999997655455556788999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.|+++|++.+++|.+.+.... ...+++..+..++.|
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~ 109 (256)
T cd08218 74 LYIVMDYCEGGDLYKKINAQR--------------------------------------------GVLFPEDQILDWFVQ 109 (256)
T ss_pred EEEEEecCCCCcHHHHHHhcc--------------------------------------------CCCCCHHHHHHHHHH
Confidence 999999999988877664321 125788899999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||.|||++|++|+||+|+||+++.++.++|+|||++..+
T Consensus 110 l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~ 151 (256)
T cd08218 110 ICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151 (256)
T ss_pred HHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence 999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=197.68 Aligned_cols=156 Identities=27% Similarity=0.404 Sum_probs=131.6
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~ 141 (267)
++|.+.+.||+|+||.||+|.+..... ...+..||+|+++... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSK--SDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCC--CCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 469999999999999999998642211 1345689999987653 234456789999999999 899999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|++|||+.+|+|.+++.... ...+++.++..++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~--------------------------------------------~~~l~~~~~~~i~ 147 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR--------------------------------------------ESFLTLEDLLSFS 147 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC--------------------------------------------CCCCCHHHHHHHH
Confidence 99999999999988877765321 1137889999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++|++|+||||+||+++.++.++|+|||+|+.+
T Consensus 148 ~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 148 YQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred HHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 99999999999999999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=195.44 Aligned_cols=151 Identities=27% Similarity=0.375 Sum_probs=125.1
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHH-HhhcCCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVS-MESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~-l~~l~hpnIv~~~~~~~~~~ 142 (267)
+|++.+.||+|+||.||+|.+. .++..||+|.++....... ...+..|+.. ++.++||||+++++++...+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~ 73 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHV-------PTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREG 73 (283)
T ss_pred CceEEEEecccCCeEEEEEEEc-------CCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence 5999999999999999999986 4569999999976543333 3345556665 56679999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++|||++ |+|.+++... ......+++..+..++.
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~------------------------------------------~~~~~~~~~~~~~~~~~ 110 (283)
T cd06617 74 DVWICMEVMD-TSLDKFYKKV------------------------------------------YDKGLTIPEDILGKIAV 110 (283)
T ss_pred cEEEEhhhhc-ccHHHHHHHh------------------------------------------ccCCCCCCHHHHHHHHH
Confidence 9999999997 5665555321 11224689999999999
Q ss_pred HHHHHHHHHHhC-CCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDR-DIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++ +++||||||+||+++.++.+||+|||+++.+
T Consensus 111 qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 111 SIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred HHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999997 9999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=197.73 Aligned_cols=147 Identities=25% Similarity=0.451 Sum_probs=129.3
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+|++.+.||+|+||.||+|.+. ..++.||+|.+...... ......+.+|+.+++.++||||+++++.+...+
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHK-------ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR 74 (305)
T ss_pred CceEeeEeecCCCeeEEEEEEC-------CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC
Confidence 5999999999999999999986 45689999998765432 234567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++|||+++++|.+++.. .+.+++..+..++.
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~----------------------------------------------~~~~~~~~~~~~~~ 108 (305)
T cd05609 75 HLCMVMEYVEGGDCATLLKN----------------------------------------------IGALPVDMARMYFA 108 (305)
T ss_pred EEEEEEecCCCCcHHHHHHH----------------------------------------------cCCCCHHHHHHHHH
Confidence 99999999998887766643 34688899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 263 (267)
|++.||.|||+.|++||||||+||+++.++.++|+|||+++
T Consensus 109 ~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~ 149 (305)
T cd05609 109 ETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSK 149 (305)
T ss_pred HHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCcc
Confidence 99999999999999999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=191.99 Aligned_cols=149 Identities=30% Similarity=0.472 Sum_probs=130.5
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|++.+.||.|+||.||+|.+. .++..+|+|++..... .....+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDI-------ATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred cceEEEEEecCCCceEEEEeEec-------CCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 46999999999999999999986 3457899999976532 24577899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++||++.+++|.+++... ...+++..+..++.
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~---------------------------------------------~~~l~~~~~~~~~~ 108 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVT---------------------------------------------RGPLSELQIAYVCR 108 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhh---------------------------------------------ccCCCHHHHHHHHH
Confidence 999999999988887655432 13688999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++|++|+||+|+||+++.++.++|+|||++..+
T Consensus 109 ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 151 (262)
T cd06613 109 ETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQL 151 (262)
T ss_pred HHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhh
Confidence 9999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-28 Score=207.77 Aligned_cols=149 Identities=32% Similarity=0.510 Sum_probs=131.9
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
.|+.++.||+|+||.||+|.+. .+++.||+|++..... ....+.+.+|+.++..++++||.++|+++..+..
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~-------~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~ 85 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDN-------KTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK 85 (467)
T ss_pred ccccchhccccccceeeeeeec-------cccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence 4888899999999999999997 5568999999987653 3455778999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
+|++||||.||++.+.++. ...+++.++..++++
T Consensus 86 LwiiMey~~gGsv~~lL~~----------------------------------------------~~~~~E~~i~~ilre 119 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKS----------------------------------------------GNILDEFEIAVILRE 119 (467)
T ss_pred HHHHHHHhcCcchhhhhcc----------------------------------------------CCCCccceeeeehHH
Confidence 9999999998777665543 334588888899999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
++.||.|+|+++.+|||||+.|||+...|.+||+|||.|.+++
T Consensus 120 ~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 120 VLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLT 162 (467)
T ss_pred HHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeee
Confidence 9999999999999999999999999999999999999998765
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=192.49 Aligned_cols=148 Identities=24% Similarity=0.428 Sum_probs=129.8
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||.|+||.||+|... ++.||+|.+..... ..+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~---------~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR---------GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec---------CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence 346999999999999999999763 47899999976532 456789999999999999999999999988
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..+++||++.+++|.+++.... ...+++..+..++
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~--------------------------------------------~~~~~~~~~~~~~ 108 (256)
T cd05039 73 NPLYIVTEYMAKGSLVDYLRSRG--------------------------------------------RAVITLAQQLGFA 108 (256)
T ss_pred CCeEEEEEecCCCcHHHHHHhcC--------------------------------------------CCCCCHHHHHHHH
Confidence 99999999999988877665431 1258899999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||.|||++|++|+||||+||+++.++.++|+|||+++..
T Consensus 109 ~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~ 152 (256)
T cd05039 109 LDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEA 152 (256)
T ss_pred HHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccc
Confidence 99999999999999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=197.63 Aligned_cols=150 Identities=31% Similarity=0.494 Sum_probs=130.7
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+. .+++.||+|.+..........+.+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 73 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHK-------ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK 73 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEEC-------CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC
Confidence 35999999999999999999986 44588999998765544445567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+++||+.++++..... ....+++..+..++.
T Consensus 74 ~~~lv~e~~~~~~l~~~~~----------------------------------------------~~~~~~~~~~~~~~~ 107 (286)
T cd07846 74 RLYLVFEFVDHTVLDDLEK----------------------------------------------YPNGLDESRVRKYLF 107 (286)
T ss_pred eEEEEEecCCccHHHHHHh----------------------------------------------ccCCCCHHHHHHHHH
Confidence 9999999999877755432 223588999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||+.|++|+||+|+||+++.++.++|+|||+++.+
T Consensus 108 ~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07846 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 150 (286)
T ss_pred HHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence 9999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=196.51 Aligned_cols=154 Identities=31% Similarity=0.519 Sum_probs=133.4
Q ss_pred cccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeee
Q psy2579 56 TSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLY 135 (267)
Q Consensus 56 ~~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~ 135 (267)
...+....+|++.+.||.|+||.||+|.+. .+++.||+|.+..... ...+.+.+|+.+++.++||||++++
T Consensus 12 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~-------~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~ 82 (296)
T cd06655 12 VSIGDPKKKYTRYEKIGQGASGTVFTAIDV-------ATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFL 82 (296)
T ss_pred HhcCCCcceEEEEEEEecCCCeEEEEEEEc-------CCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeee
Confidence 345555667999999999999999999876 4568999999865432 2346788999999999999999999
Q ss_pred eeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 136 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 136 ~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
+++...+..|+++||+.+++|..++.. ..+++.
T Consensus 83 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-----------------------------------------------~~l~~~ 115 (296)
T cd06655 83 DSFLVGDELFVVMEYLAGGSLTDVVTE-----------------------------------------------TCMDEA 115 (296)
T ss_pred eeEecCceEEEEEEecCCCcHHHHHHh-----------------------------------------------cCCCHH
Confidence 999999999999999998888665532 258889
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++..+
T Consensus 116 ~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~ 165 (296)
T cd06655 116 QIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI 165 (296)
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhc
Confidence 99999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=192.28 Aligned_cols=144 Identities=31% Similarity=0.480 Sum_probs=121.0
Q ss_pred ccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEEe
Q psy2579 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVE 149 (267)
Q Consensus 70 ~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~e 149 (267)
.||+|+||.||+|.+... ..+..||+|++.... .....+.+.+|+.+++.++||||+++++++. .+..+++||
T Consensus 2 ~ig~G~~g~v~~~~~~~~-----~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMR-----KKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecC-----CCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEE
Confidence 489999999999987532 234679999997553 3445577999999999999999999999875 456788999
Q ss_pred ecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHH
Q psy2579 150 YASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVK 229 (267)
Q Consensus 150 ~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~ 229 (267)
|+++++|.+++... ...+++..+..++.|++.||.
T Consensus 75 ~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~~~~~i~~~l~ 109 (257)
T cd05115 75 MASGGPLNKFLSGK---------------------------------------------KDEITVSNVVELMHQVSMGMK 109 (257)
T ss_pred eCCCCCHHHHHHhC---------------------------------------------CCCCCHHHHHHHHHHHHHHHH
Confidence 98888887665421 236889999999999999999
Q ss_pred HHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 230 HLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 230 ~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|||++|++||||||+||+++.++.+||+|||+++.+
T Consensus 110 ~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 145 (257)
T cd05115 110 YLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145 (257)
T ss_pred HHHhcCeeecccchheEEEcCCCcEEeccCCccccc
Confidence 999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=195.32 Aligned_cols=153 Identities=22% Similarity=0.339 Sum_probs=124.3
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+.|++.+.||+|+||.||+|.+..++. .....|++|.+.... .......+..|+..++.+.||||+++++++. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~---~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~ 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGD---SIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCC---ceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence 469999999999999999999863321 112358888875432 2334466788999999999999999999875 35
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..++++|++.+|+|.+++... .+.+++..+..++.
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~---------------------------------------------~~~~~~~~~~~i~~ 116 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQH---------------------------------------------RDSLDPQRLLNWCV 116 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhc---------------------------------------------ccCCCHHHHHHHHH
Confidence 577888888888877766432 23688999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++|++||||||+||+++.++.+||+|||+++.+
T Consensus 117 qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred HHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=197.96 Aligned_cols=151 Identities=32% Similarity=0.476 Sum_probs=128.8
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||.|+||.||+|.+. .+++.+|+|.++...........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 76 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDK-------KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS 76 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEEC-------CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec
Confidence 356999999999999999999986 4458899999976654444445677899999999999999999998877
Q ss_pred --CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 142 --GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 142 --~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
+..|++|||+.+ +|.+.+... ...+++..+..
T Consensus 77 ~~~~~~lv~e~~~~-~L~~~~~~~---------------------------------------------~~~l~~~~~~~ 110 (293)
T cd07843 77 NLDKIYMVMEYVEH-DLKSLMETM---------------------------------------------KQPFLQSEVKC 110 (293)
T ss_pred CCCcEEEEehhcCc-CHHHHHHhc---------------------------------------------cCCCCHHHHHH
Confidence 889999999874 665544321 12589999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||+|||++|++|+||||+||+++.++.++|+|||+++.+
T Consensus 111 i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 111 LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred HHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 9999999999999999999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=192.26 Aligned_cols=150 Identities=31% Similarity=0.464 Sum_probs=125.6
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc---chHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL---TPKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
.+|++.+.||+|+||.||.|.+. .++..||||.+..... .......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~-------~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 74 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDA-------DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLR 74 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEc-------CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEec
Confidence 35999999999999999999886 4568999998864321 2234567889999999999999999999887
Q ss_pred ec--CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 140 TF--GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 140 ~~--~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
+. ...+++||++.+++|.+++. ....+++..+
T Consensus 75 ~~~~~~~~~v~e~~~~~~L~~~l~----------------------------------------------~~~~~~~~~~ 108 (265)
T cd06652 75 DPMERTLSIFMEHMPGGSIKDQLK----------------------------------------------SYGALTENVT 108 (265)
T ss_pred cCCCceEEEEEEecCCCcHHHHHH----------------------------------------------HcCCCCHHHH
Confidence 64 45778888887777665543 3345788889
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..++.|++.||+|||++|++|+||||+||+++.++.++|+|||+++.+
T Consensus 109 ~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 109 RKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred HHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=191.17 Aligned_cols=150 Identities=25% Similarity=0.411 Sum_probs=129.8
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. ....||+|.+...... ...+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~--------~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN--------GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc--------CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence 356999999999999999999864 2367999998765433 35688999999999999999999999988
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..+++||++++++|.+++.... ...+++..+..++
T Consensus 74 ~~~~~v~e~~~~~~L~~~i~~~~--------------------------------------------~~~~~~~~~~~~~ 109 (261)
T cd05034 74 EPIYIVTEYMSKGSLLDFLKSGE--------------------------------------------GKKLRLPQLVDMA 109 (261)
T ss_pred CceEEEEeccCCCCHHHHHhccc--------------------------------------------cCCCCHHHHHHHH
Confidence 99999999999988877765421 1258889999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.+.
T Consensus 110 ~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 110 AQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred HHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceecc
Confidence 999999999999999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=192.13 Aligned_cols=144 Identities=31% Similarity=0.465 Sum_probs=122.2
Q ss_pred ccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEEe
Q psy2579 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVE 149 (267)
Q Consensus 70 ~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~e 149 (267)
+||+|+||.||+|.+... .++..+|+|+++.........+.+.+|+.+++.++||||+++++++. ....+++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMK-----KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecC-----CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEe
Confidence 599999999999976422 34578999999766555566778999999999999999999999875 456678888
Q ss_pred ecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHH
Q psy2579 150 YASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVK 229 (267)
Q Consensus 150 ~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~ 229 (267)
++.+|+|.+++. ....+++..+..++.|++.||+
T Consensus 76 ~~~~~~L~~~l~----------------------------------------------~~~~~~~~~~~~i~~qi~~al~ 109 (257)
T cd05116 76 LAELGPLNKFLQ----------------------------------------------KNKHVTEKNITELVHQVSMGMK 109 (257)
T ss_pred cCCCCcHHHHHH----------------------------------------------hcCCCCHHHHHHHHHHHHHHHH
Confidence 888777765553 3346888999999999999999
Q ss_pred HHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 230 HLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 230 ~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|+|++|++||||||+||+++.++.++|+|||+++.+
T Consensus 110 ~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~ 145 (257)
T cd05116 110 YLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 145 (257)
T ss_pred HHHHCCEeecccchhhEEEcCCCeEEECCCcccccc
Confidence 999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=194.34 Aligned_cols=148 Identities=22% Similarity=0.233 Sum_probs=119.8
Q ss_pred ccCccCceeEEEeEEeeccccc-----------------ccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCcee
Q psy2579 70 ELGRGNFSTVKMAIHEIYVPIL-----------------CTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNII 132 (267)
Q Consensus 70 ~iG~G~fg~V~~a~~~~~~~~~-----------------~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv 132 (267)
.||+|+||.||+|......... ......||+|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 5999999999999865322100 1123569999986542 23345688899999999999999
Q ss_pred eeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCC
Q psy2579 133 RLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRL 212 (267)
Q Consensus 133 ~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~ 212 (267)
++++++...+..++||||+++|+|..++... .+.+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---------------------------------------------~~~~ 114 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKE---------------------------------------------KGRV 114 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhc---------------------------------------------CCCC
Confidence 9999999999999999999998887666432 2357
Q ss_pred ChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC-------ceEEeccccccc
Q psy2579 213 SEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG-------IVKLGDLGFSTK 264 (267)
Q Consensus 213 ~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~-------~~kl~DFGla~~ 264 (267)
++..+..++.|++.||+|||++|++||||||+||+++..+ .++++|||++..
T Consensus 115 ~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~ 173 (274)
T cd05076 115 PVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFT 173 (274)
T ss_pred CHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccc
Confidence 8889999999999999999999999999999999997654 489999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=197.71 Aligned_cols=156 Identities=24% Similarity=0.407 Sum_probs=126.3
Q ss_pred cccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeee
Q psy2579 56 TSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLY 135 (267)
Q Consensus 56 ~~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~ 135 (267)
.+.+..+++|++.+.||+|+||.||+|.+. .+++.||||.+............+.+|+.+++.++||||++++
T Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 77 (310)
T cd07865 5 FPFCDEVSKYEKLAKIGQGTFGEVFKARHK-------KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77 (310)
T ss_pred CcccchhhheEEEEEeecCCCEEEEEEEEC-------CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceE
Confidence 446667788999999999999999999986 4568999999865443333334567899999999999999999
Q ss_pred eeeeecCe--------EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhc
Q psy2579 136 EVLETFGK--------IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKIT 207 (267)
Q Consensus 136 ~~~~~~~~--------~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~ 207 (267)
+++...+. .+++|||+.+ ++. +.+.
T Consensus 78 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~----------------------------------------------~~l~ 110 (310)
T cd07865 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLA----------------------------------------------GLLS 110 (310)
T ss_pred EEEecccccccCCCceEEEEEcCCCc-CHH----------------------------------------------HHHH
Confidence 98876543 3666666643 333 3332
Q ss_pred c-cCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 208 T-EGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 208 ~-~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
. ...+++.++..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++..+
T Consensus 111 ~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 111 NKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 2 236899999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=197.01 Aligned_cols=151 Identities=25% Similarity=0.402 Sum_probs=130.5
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++++.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~-------~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHR-------PTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGA 73 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEc-------CCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCe
Confidence 5899999999999999999986 456899999886542 34445778899999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.|++|||+.+++|..++.... ....+++..+..++.|
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~-------------------------------------------~~~~~~~~~~~~~~~~ 110 (286)
T cd06622 74 VYMCMEYMDAGSLDKLYAGGV-------------------------------------------ATEGIPEDVLRRITYA 110 (286)
T ss_pred EEEEEeecCCCCHHHHHHhcc-------------------------------------------ccCCCCHHHHHHHHHH
Confidence 999999999988876664320 1236899999999999
Q ss_pred HHHHHHHHHh-CCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHD-RDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||.|||+ .|++|+||||+||+++.++.++|+|||++..+
T Consensus 111 i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 153 (286)
T cd06622 111 VVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL 153 (286)
T ss_pred HHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9999999997 59999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=192.76 Aligned_cols=161 Identities=24% Similarity=0.324 Sum_probs=132.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+..... ...+..||+|.+.... .......+.+|+.+++.++||||+++++++...+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDG--DAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCC--CCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 459999999999999999998863110 0145789999886543 3344566889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++||++.+++|.+++....... .....+++..+..++.
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~---------------------------------------~~~~~~~~~~~~~~~~ 123 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRP---------------------------------------ERPSSLTMKDLLFCAR 123 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCC---------------------------------------CCCCCCCHHHHHHHHH
Confidence 9999999999999988886543210 0122588999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCC---ceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRG---IVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~---~~kl~DFGla~~l 265 (267)
|++.||+|||+++++||||||+||+++.++ .+||+|||+|+.+
T Consensus 124 qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~ 169 (277)
T cd05036 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI 169 (277)
T ss_pred HHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcccccc
Confidence 999999999999999999999999998765 6999999999764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=195.53 Aligned_cols=150 Identities=31% Similarity=0.503 Sum_probs=130.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+. .+++.||+|.++...........+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~-------~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNK-------ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeC-------CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC
Confidence 35999999999999999999986 44589999999766545555678999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++|||+.++.+..... ....+++..+..++.
T Consensus 74 ~~~iv~e~~~~~~l~~~~~----------------------------------------------~~~~~~~~~~~~~~~ 107 (288)
T cd07833 74 RLYLVFEYVERTLLELLEA----------------------------------------------SPGGLPPDAVRSYIW 107 (288)
T ss_pred EEEEEEecCCCCHHHHHHh----------------------------------------------cCCCCCHHHHHHHHH
Confidence 9999999998755543322 234588999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++|++|+||+|+||+++.++.++|+|||+++.+
T Consensus 108 ~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~ 150 (288)
T cd07833 108 QLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARAL 150 (288)
T ss_pred HHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence 9999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=193.85 Aligned_cols=158 Identities=26% Similarity=0.462 Sum_probs=130.5
Q ss_pred cccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeee
Q psy2579 56 TSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRL 134 (267)
Q Consensus 56 ~~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~ 134 (267)
...+...++|++.+.||+|+||.||+|.+. .++..+|+|++.... .....+.+|+.+++.+ +||||+++
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~-------~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~ 80 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNK-------KNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKF 80 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEEC-------CCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeee
Confidence 345556678999999999999999999986 445889999986532 2224577899999999 79999999
Q ss_pred eeeee-----ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhccc
Q psy2579 135 YEVLE-----TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTE 209 (267)
Q Consensus 135 ~~~~~-----~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~ 209 (267)
++++. ..+..+++|||+++++|.+.+... ....
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------------------------------------~~~~ 118 (286)
T cd06638 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGF------------------------------------------LKRG 118 (286)
T ss_pred eeeeeecccCCCCeEEEEEeecCCCCHHHHHHHh------------------------------------------hccC
Confidence 99874 345689999999998887765421 1123
Q ss_pred CCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 210 GRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 210 ~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||+++.+
T Consensus 119 ~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 119 ERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred ccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 46888999999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=192.43 Aligned_cols=149 Identities=21% Similarity=0.277 Sum_probs=123.5
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVV 148 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 148 (267)
+.||+|+||.||+|.+... .+...+|+|.+..... ......+.+|+.+++.++||||+++++++......+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~-----~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 74 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSG-----YTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVM 74 (269)
T ss_pred CcccccCCceEEEEEEcCC-----CCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEE
Confidence 3599999999999986421 2346799999876542 333456889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHH
Q psy2579 149 EYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAV 228 (267)
Q Consensus 149 e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L 228 (267)
||+.+|+|.+++...... .....++..+..++.|++.||
T Consensus 75 e~~~~g~L~~~l~~~~~~-----------------------------------------~~~~~~~~~~~~~~~qi~~al 113 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKA-----------------------------------------ELMTPDPTTLQRMACEIALGL 113 (269)
T ss_pred ECCCCCcHHHHHHHhhhc-----------------------------------------ccccccHHHHHHHHHHHHHHH
Confidence 999999998877543110 112456778889999999999
Q ss_pred HHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 229 KHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 229 ~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
+|||+.|++||||||+||+++.++.++|+|||+++.
T Consensus 114 ~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~ 149 (269)
T cd05087 114 LHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHN 149 (269)
T ss_pred HHHHHCCEeccccCcceEEEcCCCcEEECCcccccc
Confidence 999999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-26 Score=193.64 Aligned_cols=166 Identities=26% Similarity=0.375 Sum_probs=134.3
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|.+.+.||+|+||.||++.+..... ..++..+|+|.+... +......+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~--~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCP--EQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCC--CCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 459999999999999999997642110 133467899988654 3345567899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++|||+.+++|.+++....... ...........+++..+..++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~---------------------------------~~~~~~~~~~~l~~~~~~~~~~ 127 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDA---------------------------------VLMAEGNRPAELTQSQMLHIAQ 127 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCcc---------------------------------ccccccCCCCCCCHHHHHHHHH
Confidence 9999999999999998886542210 0000011223589999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++|++||||||+||+++.++.++|+|||+++.+
T Consensus 128 ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 170 (288)
T cd05093 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV 170 (288)
T ss_pred HHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccc
Confidence 9999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=195.01 Aligned_cols=166 Identities=25% Similarity=0.396 Sum_probs=132.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||.||+|.+...+ ....+++|.++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 75 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDG-----LKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENR 75 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCC-----CcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC
Confidence 46999999999999999999876322 12457888886432 334456788999999999 799999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+++||+.+++|.+++.......... ...........+++..+..++
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~------------------------------~~~~~~~~~~~l~~~~~~~i~ 125 (297)
T cd05089 76 GYLYIAIEYAPYGNLLDFLRKSRVLETDP------------------------------AFAKEHGTASTLTSQQLLQFA 125 (297)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccc------------------------------ccccccCccCCCCHHHHHHHH
Confidence 99999999999999999887543211100 000000122358899999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
.|++.||+|||++|++||||||+||+++.++.+||+|||++..
T Consensus 126 ~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 168 (297)
T cd05089 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRG 168 (297)
T ss_pred HHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCcc
Confidence 9999999999999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=201.28 Aligned_cols=199 Identities=23% Similarity=0.292 Sum_probs=134.6
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec-
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETF- 141 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~- 141 (267)
+|++.+.||+|+||.||+|.+..+.. ..+++.||+|++.... .......+.+|+.++..+ +||||+++++++...
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~--~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEK--SASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HhhhhcccccCcCceEEecccccccc--ccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 59999999999999999998643221 1345789999987543 334456788999999999 899999999987654
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChh-h---HHHHH--------HHHHHHHhhhccCeEEEEEEEcc---CCchhhhh
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSED-D---AKIYF--------LQILLYEVLETFGKIFLVVEYAS---GGELYNKI 206 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~-~---~~~~~--------~~~~~~~~~~~~~~~~~v~e~~~---~~~l~~~~ 206 (267)
...+++|||+.+++|.+.+......... . ..... ...................++.. .....+.-
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5689999999999999988654221000 0 00000 00000000000000000011100 00000111
Q ss_pred cccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 207 TTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 207 ~~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
....++++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||+++.+
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~ 223 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 223 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhc
Confidence 11346899999999999999999999999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=192.39 Aligned_cols=149 Identities=27% Similarity=0.488 Sum_probs=127.9
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-------HHHHHHHHHHHHHhhcCCCceeeeeee
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-------KARKMLSREIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~Ei~~l~~l~hpnIv~~~~~ 137 (267)
|.+...||+|+||.||+|.+. .++..||+|.+....... ...+.+.+|+.+++.++||||++++++
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNA-------SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGS 74 (267)
T ss_pred ccccceeecCCCeEEEEEEec-------CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 778889999999999999986 345889999887544321 233568899999999999999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
+...+..+++|||+.+++|.+++.. .+.+++..+
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~l~~----------------------------------------------~~~l~~~~~ 108 (267)
T cd06628 75 SLDADHLNIFLEYVPGGSVAALLNN----------------------------------------------YGAFEETLV 108 (267)
T ss_pred EEeCCccEEEEEecCCCCHHHHHHh----------------------------------------------ccCccHHHH
Confidence 9999999999999988777665543 346788889
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||+++.+.
T Consensus 109 ~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 109 RNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred HHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999999999999999999999999999999999999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=192.94 Aligned_cols=148 Identities=30% Similarity=0.497 Sum_probs=129.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+.|+..+.||.|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.+.||||+++++++.+.+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDN-------RTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT 75 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEc-------cCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 45888999999999999999986 345889999987553 2344577899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++|||+.+|+|.+++.. .++++..+..++.
T Consensus 76 ~~~lv~e~~~~~~L~~~i~~-----------------------------------------------~~l~~~~~~~~~~ 108 (277)
T cd06640 76 KLWIIMEYLGGGSALDLLRA-----------------------------------------------GPFDEFQIATMLK 108 (277)
T ss_pred EEEEEEecCCCCcHHHHHhc-----------------------------------------------CCCCHHHHHHHHH
Confidence 99999999999888766542 2577888899999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|+|+.+++|+||+|+||+++.++.++|+|||++..+
T Consensus 109 ~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~ 151 (277)
T cd06640 109 EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred HHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceec
Confidence 9999999999999999999999999999999999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=194.64 Aligned_cols=149 Identities=25% Similarity=0.440 Sum_probs=124.9
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.+.|++.+.||+|+||.||+|.+. .++..||+|++..... ......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 75 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISR-------INGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTK 75 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEc-------CCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC
Confidence 356999999999999999999986 4458899999865432 22233567899999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+++||+. +++.+.+.. ....+++..+..++
T Consensus 76 ~~~~lv~e~~~-~~l~~~~~~---------------------------------------------~~~~~~~~~~~~~~ 109 (291)
T cd07870 76 ETLTFVFEYMH-TDLAQYMIQ---------------------------------------------HPGGLHPYNVRLFM 109 (291)
T ss_pred CeEEEEEeccc-CCHHHHHHh---------------------------------------------CCCCCCHHHHHHHH
Confidence 99999999996 455443322 12356778888999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++.
T Consensus 110 ~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 152 (291)
T cd07870 110 FQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA 152 (291)
T ss_pred HHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccc
Confidence 9999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=191.38 Aligned_cols=147 Identities=27% Similarity=0.443 Sum_probs=125.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+.|++.++||+|+||.||+|... .+..||+|.+...... ...+.+|+.+++.++||||+++++++ ..+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~--------~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 73 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYN--------GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVV-TQE 73 (260)
T ss_pred HHceeeeeeccCccceEEeeecC--------CCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEE-ccC
Confidence 45999999999999999999763 3578999998765433 35688999999999999999999886 456
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++||++.+++|.+++.... ...+++..+..++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~--------------------------------------------~~~~~~~~~~~i~~ 109 (260)
T cd05067 74 PIYIITEYMENGSLVDFLKTPE--------------------------------------------GIKLTINKLIDMAA 109 (260)
T ss_pred CcEEEEEcCCCCCHHHHHHhcC--------------------------------------------CCCCCHHHHHHHHH
Confidence 7899999999888877665321 22578889999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||+.|++|+||||+||+++.++.++|+|||+++.+
T Consensus 110 ~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 110 QIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLI 152 (260)
T ss_pred HHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence 9999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=197.70 Aligned_cols=151 Identities=27% Similarity=0.430 Sum_probs=118.0
Q ss_pred ecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee--cCeEE
Q psy2579 68 QNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET--FGKIF 145 (267)
Q Consensus 68 ~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~--~~~~~ 145 (267)
..+||+|+||.||+|.+... .++..||+|.+...... ..+.+|+.+++.++||||+++++++.. ....|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~-----~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDG-----KDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred ccccccCCCeEEEEEEEccC-----CCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence 35799999999999987521 34578999998755332 346789999999999999999999854 45688
Q ss_pred EEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHH
Q psy2579 146 LVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 225 (267)
Q Consensus 146 iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~ 225 (267)
+++|++.+ +|.+.+...... ........+++..+..++.|++
T Consensus 77 lv~e~~~~-~l~~~~~~~~~~-------------------------------------~~~~~~~~l~~~~~~~i~~qi~ 118 (317)
T cd07868 77 LLFDYAEH-DLWHIIKFHRAS-------------------------------------KANKKPVQLPRGMVKSLLYQIL 118 (317)
T ss_pred EEEeccCC-CHHHHHHhcccc-------------------------------------cccCCcccCCHHHHHHHHHHHH
Confidence 99999864 666555432110 0001123588999999999999
Q ss_pred HHHHHHHhCCCcccCCCCCcEEe----ecCCceEEecccccccc
Q psy2579 226 SAVKHLHDRDIIHRDIKAENVFL----SVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 226 ~~L~~lH~~~ivHrDlkp~NIll----~~~~~~kl~DFGla~~l 265 (267)
.||+|||++||+||||||+|||+ +..+.+||+|||+|+.+
T Consensus 119 ~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred HHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 99999999999999999999999 45678999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=189.86 Aligned_cols=151 Identities=33% Similarity=0.536 Sum_probs=131.9
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++.+.||+|+||.||+|.+. .++..+|+|.+.....+......+.+|+.+++.++||||+++++.+...+.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRK-------ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKA 73 (256)
T ss_pred CceEEEEecccCceEEEEEEEc-------CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCE
Confidence 4899999999999999999886 445899999998766666667789999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.+++||++.+++|.+++.... ...+++..+..++.|
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~ 109 (256)
T cd08220 74 LMIVMEYAPGGTLAEYIQKRC--------------------------------------------NSLLDEDTILHFFVQ 109 (256)
T ss_pred EEEEEecCCCCCHHHHHHHhc--------------------------------------------ccCCCHHHHHHHHHH
Confidence 999999999988887765321 125788999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecC-CceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVR-GIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DFGla~~l 265 (267)
++.||+|||++|++|+||+|+||+++.+ +.++|+|||++..+
T Consensus 110 i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 110 ILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred HHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 9999999999999999999999999755 46899999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=190.72 Aligned_cols=149 Identities=34% Similarity=0.584 Sum_probs=132.1
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++.+.||+|+||.||+|.+. .++..||+|.+............+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~ 73 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNL-------DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREK 73 (264)
T ss_pred CceeeeEeecCCCcEEEEEEEC-------CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCE
Confidence 4899999999999999999875 446899999998776555567889999999999999999999999999899
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.++++||+.+++|.+.+.. ...+++..+..++.|
T Consensus 74 ~~lv~e~~~~~~L~~~~~~----------------------------------------------~~~~~~~~~~~i~~~ 107 (264)
T cd06626 74 VYIFMEYCSGGTLEELLEH----------------------------------------------GRILDEHVIRVYTLQ 107 (264)
T ss_pred EEEEEecCCCCcHHHHHhh----------------------------------------------cCCCChHHHHHHHHH
Confidence 9999999988777665543 335788889999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+
T Consensus 108 i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~ 149 (264)
T cd06626 108 LLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL 149 (264)
T ss_pred HHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccccccccc
Confidence 999999999999999999999999999999999999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=192.66 Aligned_cols=151 Identities=29% Similarity=0.476 Sum_probs=126.5
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~ 139 (267)
.-+.|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~-------~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHV-------KTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFI 73 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEc-------CCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 3456999999999999999999886 456899999986543 2335678899999998 7999999999987
Q ss_pred ec------CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCC
Q psy2579 140 TF------GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLS 213 (267)
Q Consensus 140 ~~------~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~ 213 (267)
.. ...|++|||+.+++|.+++... ....++
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~--------------------------------------------~~~~l~ 109 (272)
T cd06637 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--------------------------------------------KGNTLK 109 (272)
T ss_pred ecCCCCCCcEEEEEEEcCCCCcHHHHHHhc--------------------------------------------cCCCCC
Confidence 53 3578888888887777666432 123588
Q ss_pred hhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 214 EDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 214 ~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||+++.+
T Consensus 110 ~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 110 EEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 8999999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=193.39 Aligned_cols=154 Identities=24% Similarity=0.386 Sum_probs=130.2
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee--c
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET--F 141 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~--~ 141 (267)
.|++.+.||+|+||.||+|.+.... ..++..||+|++...... .....+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~---~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLG---DNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCC---CCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 4888899999999999999875332 134688999999765433 355779999999999999999999999877 4
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
...+++|||+.+++|.+++... ...+++..+..++
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~---------------------------------------------~~~~~~~~~~~~~ 115 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRH---------------------------------------------RDQINLKRLLLFS 115 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhC---------------------------------------------ccccCHHHHHHHH
Confidence 5788999999888887766532 1258889999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.|++.||+|||+.|++|+||||+||+++.++.++|+|||++..+.
T Consensus 116 ~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 116 SQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred HHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 999999999999999999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-26 Score=190.37 Aligned_cols=154 Identities=29% Similarity=0.503 Sum_probs=132.6
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee--c
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET--F 141 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~--~ 141 (267)
+|++.+.||.|+||.||+|.+. .++..||+|++..........+.+..|+.+++.++||||+++++.+.. .
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRK-------SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN 73 (265)
T ss_pred CceeeeeeccCCCeEEEEeeec-------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC
Confidence 4899999999999999999886 455889999998766666667889999999999999999999998754 3
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
...|++|||+.+++|.+++.... ....++++..+..++
T Consensus 74 ~~~~~~~e~~~~~~L~~~l~~~~------------------------------------------~~~~~l~~~~~~~~~ 111 (265)
T cd08217 74 QTLYIVMEYCEGGDLAQLIQKCK------------------------------------------KERKYIEEEFIWRIL 111 (265)
T ss_pred CEEEEEehhccCCCHHHHHHHHh------------------------------------------hcccCCCHHHHHHHH
Confidence 56889999999988877765321 123468899999999
Q ss_pred HHHHHHHHHHH-----hCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 222 LQILSAVKHLH-----DRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH-----~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+.
T Consensus 112 ~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred HHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 99999999999 8999999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=191.81 Aligned_cols=147 Identities=23% Similarity=0.309 Sum_probs=121.6
Q ss_pred ccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEEe
Q psy2579 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVE 149 (267)
Q Consensus 70 ~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~e 149 (267)
.||+|+||.||+|..... .....+++|.+.... .......+.+|+.+++.++||||+++++.+......|++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~-----~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e 75 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTD-----TGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFE 75 (268)
T ss_pred cCCCCcCceEEEEEEEcC-----CCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEe
Confidence 599999999999976421 223456777776543 23456789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHH
Q psy2579 150 YASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVK 229 (267)
Q Consensus 150 ~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~ 229 (267)
|+.+|+|.+++..... .....++..+..++.|++.||+
T Consensus 76 ~~~~~~L~~~l~~~~~------------------------------------------~~~~~~~~~~~~~~~~i~~al~ 113 (268)
T cd05086 76 YCELGDLKSYLSQEQW------------------------------------------HRRNSQLLLLQRMACEIAAGVT 113 (268)
T ss_pred cCCCCcHHHHHHhhhc------------------------------------------ccccccHHHHHHHHHHHHHHHH
Confidence 9999999887764311 1124567788899999999999
Q ss_pred HHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 230 HLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 230 ~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
|||+.+++||||||+|||++.++.++|+|||++..
T Consensus 114 ~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 114 HMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred HHHHCCeeccCCccceEEEcCCccEEecccccccc
Confidence 99999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=195.32 Aligned_cols=147 Identities=32% Similarity=0.507 Sum_probs=128.5
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
.|+..+.||+|+||.||+|.+. .++..||+|.+..... ......+.+|+.+++.++||||+++++++...+.
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~-------~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDN-------RTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTK 76 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEc-------CCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCc
Confidence 4788889999999999999886 4458899999875532 3345678999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.|+||||+.+++|.+.+.. ..+++..+..++.|
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-----------------------------------------------~~~~~~~~~~~~~~ 109 (277)
T cd06642 77 LWIIMEYLGGGSALDLLKP-----------------------------------------------GPLEETYIATILRE 109 (277)
T ss_pred eEEEEEccCCCcHHHHhhc-----------------------------------------------CCCCHHHHHHHHHH
Confidence 9999999998888665532 25788899999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||.|||++|++|+||+|+||+++.++.++|+|||+++.+
T Consensus 110 i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06642 110 ILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred HHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccc
Confidence 999999999999999999999999999999999999998764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=197.19 Aligned_cols=160 Identities=28% Similarity=0.403 Sum_probs=129.8
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee-
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET- 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~- 140 (267)
+..|+++..||+|+||.||+|....++. .....+|||.++...--...-....||+.+++.++||||+.+..+|..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~---kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTND---KRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCc---ccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 3459999999999999999997765442 113589999998763221222346789999999999999999999887
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
...+|+++||.+. +|++.++..... ....++...+..+
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~-----------------------------------------~~~~lp~~mvKsi 137 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRAS-----------------------------------------KAKQLPRSMVKSI 137 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccc-----------------------------------------hhccCCHHHHHHH
Confidence 7789999999875 666666544221 1135788899999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecC----CceEEeccccccccC
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVR----GIVKLGDLGFSTKLQ 266 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~----~~~kl~DFGla~~l~ 266 (267)
+.||+.|+.|||++-|+||||||.|||+..+ |.+||+|||+|+.++
T Consensus 138 lwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~ 187 (438)
T KOG0666|consen 138 LWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFN 187 (438)
T ss_pred HHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhh
Confidence 9999999999999999999999999999877 899999999999875
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=192.39 Aligned_cols=147 Identities=31% Similarity=0.513 Sum_probs=128.5
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
-|++.+.||.|+||.||+|.+. .++..||+|++..... ......+.+|+.+++.++||||+++++++...+.
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~-------~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 76 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDN-------RTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK 76 (277)
T ss_pred hhhhheeEeecCCeEEEEEEEC-------CCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCe
Confidence 4888899999999999999875 4458999999865432 3445678899999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.|++|||+.+++|...+.. ..+++..+..++.|
T Consensus 77 ~~lv~e~~~~~~l~~~i~~-----------------------------------------------~~~~~~~~~~~~~~ 109 (277)
T cd06641 77 LWIIMEYLGGGSALDLLEP-----------------------------------------------GPLDETQIATILRE 109 (277)
T ss_pred EEEEEEeCCCCcHHHHHhc-----------------------------------------------CCCCHHHHHHHHHH
Confidence 9999999998888665532 25788999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|+.|||+.|++|+||+|+||+++.++.++|+|||++..+
T Consensus 110 l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06641 110 ILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL 151 (277)
T ss_pred HHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceec
Confidence 999999999999999999999999999999999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-26 Score=191.97 Aligned_cols=162 Identities=23% Similarity=0.307 Sum_probs=133.5
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|+++..||.|+||.||+|++..... ......||+|.+.... .......+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEE--EGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCc--CCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 459999999999999999999764321 1234789999986543 2234577999999999999999999999999989
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++||++++|+|.+++....... .......+++..+..++.
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~-------------------------------------~~~~~~~l~~~~~~~~~~ 124 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKD-------------------------------------EKLKPPPLSTKQKVALCT 124 (275)
T ss_pred cceEEEEecCCCcHHHHHHhccccc-------------------------------------ccccccCCCHHHHHHHHH
Confidence 9999999999999988876542100 001122589999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
|++.||+|||++|++||||||+||+++.++.++++|||+++.
T Consensus 125 ~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~ 166 (275)
T cd05046 125 QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKD 166 (275)
T ss_pred HHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccc
Confidence 999999999999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-26 Score=198.91 Aligned_cols=149 Identities=27% Similarity=0.389 Sum_probs=123.4
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .++..||+|.+............+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDR-------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPD 86 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEEC-------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCC
Confidence 355999999999999999999886 4568999999865544444556788999999999999999999998755
Q ss_pred C------eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 142 G------KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 142 ~------~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
+ ..+++||++ +++|.. .+. ...+++.
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~l~~----------------------------------------------~~~-~~~l~~~ 118 (343)
T cd07880 87 LSLDRFHDFYLVMPFM-GTDLGK----------------------------------------------LMK-HEKLSED 118 (343)
T ss_pred ccccccceEEEEEecC-CCCHHH----------------------------------------------HHh-cCCCCHH
Confidence 4 246666666 334433 332 2368899
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++..+
T Consensus 119 ~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 119 RIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 99999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=191.14 Aligned_cols=148 Identities=20% Similarity=0.299 Sum_probs=120.5
Q ss_pred cccCccCceeEEEeEEeecccc---cccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPI---LCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIF 145 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~---~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 145 (267)
+.||+|+||.||+|.+...... .......|++|++..... ....+.+|+.+++.++||||+++++++.. +..+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 3699999999999998743200 001124688888764432 15678899999999999999999999887 7789
Q ss_pred EEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHH
Q psy2579 146 LVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 225 (267)
Q Consensus 146 iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~ 225 (267)
++|||+.+|+|.+++.... ..+++..+..++.|++
T Consensus 77 lv~e~~~~~~L~~~l~~~~---------------------------------------------~~~~~~~~~~~~~~i~ 111 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREK---------------------------------------------NNVSLHWKLDVAKQLA 111 (259)
T ss_pred EEEEcCCCCcHHHHHHhhc---------------------------------------------cCCCHHHHHHHHHHHH
Confidence 9999999988877665421 1578889999999999
Q ss_pred HHHHHHHhCCCcccCCCCCcEEeecCC-------ceEEecccccccc
Q psy2579 226 SAVKHLHDRDIIHRDIKAENVFLSVRG-------IVKLGDLGFSTKL 265 (267)
Q Consensus 226 ~~L~~lH~~~ivHrDlkp~NIll~~~~-------~~kl~DFGla~~l 265 (267)
.||+|||++|++||||||+||+++.++ .++|+|||+++.+
T Consensus 112 ~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~ 158 (259)
T cd05037 112 SALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV 158 (259)
T ss_pred HHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence 999999999999999999999999887 7999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-26 Score=190.57 Aligned_cols=147 Identities=23% Similarity=0.403 Sum_probs=125.2
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+. .+..||+|.+....... +.+.+|+.+++.++|||++++++++. .+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~--------~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~-~~ 73 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN--------GNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVS-EE 73 (260)
T ss_pred HHhhhhheeccccCceEEEEEec--------CCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEEC-CC
Confidence 45999999999999999999763 34679999997655432 46889999999999999999999875 45
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++||++.+++|.+++... ....+++..+..++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~ 109 (260)
T cd05070 74 PIYIVTEYMSKGSLLDFLKDG--------------------------------------------EGRALKLPNLVDMAA 109 (260)
T ss_pred CcEEEEEecCCCcHHHHHHhc--------------------------------------------CCCCCCHHHHHHHHH
Confidence 688999999888887766432 123578899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||+.|++||||||+||+++.++.++|+|||++..+
T Consensus 110 ~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 110 QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred HHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeec
Confidence 9999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=191.83 Aligned_cols=157 Identities=24% Similarity=0.348 Sum_probs=128.8
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC--
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG-- 142 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~-- 142 (267)
|++.+.||+|+||.||+|.+.... .++..||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSED----GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAK 76 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccC----CCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCC
Confidence 677889999999999999876432 45689999999776655666778899999999999999999999876542
Q ss_pred ----eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 143 ----KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 143 ----~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
..+++++|+.+|+|..++...... .....+++..+.
T Consensus 77 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~----------------------------------------~~~~~l~~~~~~ 116 (273)
T cd05074 77 GRLPIPMVILPFMKHGDLHTFLLMSRIG----------------------------------------EEPFTLPLQTLV 116 (273)
T ss_pred CcccceEEEEecCCCCcHHHHHHHhccc----------------------------------------CCCCCCCHHHHH
Confidence 247888898888887665422100 011247888999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||+|||+.|++||||||+||+++.++.++|+|||+++.+
T Consensus 117 ~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~ 163 (273)
T cd05074 117 RFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKI 163 (273)
T ss_pred HHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccc
Confidence 99999999999999999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-26 Score=189.84 Aligned_cols=147 Identities=30% Similarity=0.466 Sum_probs=125.8
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVV 148 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 148 (267)
+.||+|++|.||+|.+...+ .....||||.+...... ...+.+.+|+.+++.++||||+++++.+.. ...+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~----~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSG----GKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCC----CCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEE
Confidence 36899999999999986422 23357999999876544 556789999999999999999999999888 8899999
Q ss_pred eecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHH
Q psy2579 149 EYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAV 228 (267)
Q Consensus 149 e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L 228 (267)
|++.+++|.+.+.... ...+++..+..++.|++.||
T Consensus 75 e~~~~~~L~~~l~~~~--------------------------------------------~~~~~~~~~~~~~~qi~~~L 110 (257)
T cd05040 75 ELAPLGSLLDRLRKDA--------------------------------------------LGHFLISTLCDYAVQIANGM 110 (257)
T ss_pred EecCCCcHHHHHHhcc--------------------------------------------cccCcHHHHHHHHHHHHHHH
Confidence 9999888877665421 02588999999999999999
Q ss_pred HHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 229 KHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 229 ~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+|||++|++|+||||+||+++.++.+||+|||+++.+
T Consensus 111 ~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 111 RYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147 (257)
T ss_pred HHHHhCCccccccCcccEEEecCCEEEeccccccccc
Confidence 9999999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=191.92 Aligned_cols=148 Identities=31% Similarity=0.527 Sum_probs=130.4
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++.+.||.|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.++||||+++++++.....
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDK-------RTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSK 73 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEEC-------CCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCe
Confidence 5889999999999999999986 456899999987553 33445668899999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.|+++|++.+++|.+++.. .++++..+..++.|
T Consensus 74 ~~~v~e~~~~~~L~~~~~~-----------------------------------------------~~~~~~~~~~~~~q 106 (274)
T cd06609 74 LWIIMEYCGGGSCLDLLKP-----------------------------------------------GKLDETYIAFILRE 106 (274)
T ss_pred EEEEEEeeCCCcHHHHHhh-----------------------------------------------cCCCHHHHHHHHHH
Confidence 9999999998888765532 16889999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
++.||.|||+++++|+||+|+||+++.++.++|+|||+++.+.
T Consensus 107 l~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 149 (274)
T cd06609 107 VLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT 149 (274)
T ss_pred HHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeec
Confidence 9999999999999999999999999999999999999997653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=194.81 Aligned_cols=150 Identities=25% Similarity=0.453 Sum_probs=128.8
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++++.||.|+||.||+|.+. .++..||||.+............+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 73 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 73 (284)
T ss_pred CceeeeeecCCCceEEEEEEEC-------CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCc
Confidence 4899999999999999999986 456899999987654444445678899999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.+++|||+. ++|..++... ....+++..+..++.|
T Consensus 74 ~~~v~e~~~-~~l~~~~~~~--------------------------------------------~~~~l~~~~~~~~~~~ 108 (284)
T cd07860 74 LYLVFEFLH-QDLKKFMDAS--------------------------------------------PLSGIPLPLIKSYLFQ 108 (284)
T ss_pred EEEEeeccc-cCHHHHHHhC--------------------------------------------CCCCCCHHHHHHHHHH
Confidence 999999985 4665554321 1236889999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||+|||+.|++|+||+|+||+++.++.++|+|||+++.+
T Consensus 109 i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~ 150 (284)
T cd07860 109 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF 150 (284)
T ss_pred HHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence 999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=191.93 Aligned_cols=149 Identities=28% Similarity=0.435 Sum_probs=127.9
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc----hHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT----PKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
+|+..+.||+|++|.||+|.+. .++..||+|++...... ......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 73 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDV-------KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC 73 (268)
T ss_pred CccccceecCcCceEEEEEEEc-------CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec
Confidence 3788899999999999999876 44689999999754422 123577899999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+..++++||+.+++|.+++.. .+++++..+..
T Consensus 74 ~~~~~~~v~e~~~~~~L~~~l~~----------------------------------------------~~~~~~~~~~~ 107 (268)
T cd06630 74 EDSHFNLFVEWMAGGSVSHLLSK----------------------------------------------YGAFKEAVIIN 107 (268)
T ss_pred cCCeEEEEEeccCCCcHHHHHHH----------------------------------------------hCCCCHHHHHH
Confidence 99999999999998877665542 33688899999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC-ceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG-IVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~l 265 (267)
++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++..+
T Consensus 108 ~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 108 YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred HHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999999999999999999998776 6999999998654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=192.61 Aligned_cols=151 Identities=24% Similarity=0.413 Sum_probs=126.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|++|.||+|.+. .+++.||+|.+............+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDR-------VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK 74 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEec-------CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC
Confidence 56999999999999999999986 44588999998765444444567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+||||+.+ ++...+... ....+++..+..++.
T Consensus 75 ~~~lv~e~~~~-~l~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~ 109 (294)
T PLN00009 75 RLYLVFEYLDL-DLKKHMDSS--------------------------------------------PDFAKNPRLIKTYLY 109 (294)
T ss_pred eEEEEEecccc-cHHHHHHhC--------------------------------------------CCCCcCHHHHHHHHH
Confidence 99999999964 555544321 111357788889999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeec-CCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSV-RGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~l 265 (267)
|++.||+|||++|++|+||+|+||+++. ++.+||+|||++..+
T Consensus 110 qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred HHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 9999999999999999999999999985 457999999998754
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=189.02 Aligned_cols=151 Identities=32% Similarity=0.485 Sum_probs=131.9
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++.+.||.|+||.||+|.+. .++..+|+|++....... ....+.+|+.+++.++||||+++++.+...+.
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICL-------PNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE 73 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEc-------CCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCE
Confidence 5999999999999999999875 445889999997655443 55778999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.|+++|++.+++|.+.+.... ....+++..+..++.|
T Consensus 74 ~~iv~e~~~~~~l~~~~~~~~-------------------------------------------~~~~~~~~~~~~~~~q 110 (267)
T cd06610 74 LWLVMPYLSGGSLLDIMKSSY-------------------------------------------PRGGLDEAIIATVLKE 110 (267)
T ss_pred EEEEEeccCCCcHHHHHHHhc-------------------------------------------ccCCCCHHHHHHHHHH
Confidence 999999999988877765321 0135889999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||+|||++|++|+||+|+||+++.++.++|+|||++..+
T Consensus 111 l~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~ 152 (267)
T cd06610 111 VLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASL 152 (267)
T ss_pred HHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence 999999999999999999999999999999999999998654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=189.49 Aligned_cols=150 Identities=33% Similarity=0.503 Sum_probs=125.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccc---cchHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAK---LTPKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
.+|++.+.||+|+||.||+|.+. .++..||+|.+.... ........+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~ 74 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDA-------DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLR 74 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEc-------CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEE
Confidence 35999999999999999999986 456899999875432 12345567889999999999999999999986
Q ss_pred ec--CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 140 TF--GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 140 ~~--~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
+. +..++++|++.+++|.+.+. ....+++..+
T Consensus 75 ~~~~~~~~~v~e~~~~~~L~~~~~----------------------------------------------~~~~l~~~~~ 108 (264)
T cd06653 75 DPEEKKLSIFVEYMPGGSIKDQLK----------------------------------------------AYGALTENVT 108 (264)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHH----------------------------------------------HcCCCCHHHH
Confidence 64 45778888887766655443 3346788899
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.+
T Consensus 109 ~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 109 RRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred HHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 999999999999999999999999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-26 Score=190.55 Aligned_cols=152 Identities=28% Similarity=0.417 Sum_probs=127.1
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|++.+.||+|+||.||+|.+.... .....||||...... .....+.+.+|+.+++.++||||+++++++.. +
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPE----NEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCC----CCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 34899999999999999999875321 223578999886543 24456788999999999999999999998865 5
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++||++.+|+|.+++... ...+++..+..++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~~~~ 114 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVN---------------------------------------------KYSLDLASLILYSY 114 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhC---------------------------------------------CCCCCHHHHHHHHH
Confidence 578899998888887766432 12578899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++|++|+||||+||+++.++.++|+|||+++.+
T Consensus 115 ~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 115 QLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred HHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 9999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=195.84 Aligned_cols=152 Identities=30% Similarity=0.450 Sum_probs=126.6
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
.+.+|++.+.||+|+||.||+|.+. .++..||+|.+............+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDT-------TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG 77 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEEC-------CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec
Confidence 4567999999999999999999986 456899999987654333333446689999999999999999999875
Q ss_pred c--CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 141 F--GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 141 ~--~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
. +..++|||++.+ +|.+.+... ...+++..+.
T Consensus 78 ~~~~~~~lv~e~~~~-~l~~~l~~~---------------------------------------------~~~l~~~~~~ 111 (309)
T cd07845 78 KHLDSIFLVMEYCEQ-DLASLLDNM---------------------------------------------PTPFSESQVK 111 (309)
T ss_pred CCCCeEEEEEecCCC-CHHHHHHhc---------------------------------------------ccCCCHHHHH
Confidence 5 568899998864 554444321 2468999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||+|||+.|++||||||+||+++.++.++|+|||+++.+
T Consensus 112 ~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 112 CLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 99999999999999999999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=210.48 Aligned_cols=156 Identities=26% Similarity=0.457 Sum_probs=118.0
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEE--------------ee-cccccchHHHHHHHHHHHHHhhc
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIK--------------IL-DKAKLTPKARKMLSREIVSMESV 126 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK--------------~~-~~~~~~~~~~~~~~~Ei~~l~~l 126 (267)
.++|++++.||+|+||.||+|..+... +..++.| .+ +...........+.+|+.+++.+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l 220 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRAST------EEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL 220 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccc------hhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC
Confidence 467999999999999999999775321 1111111 11 11111223456688999999999
Q ss_pred CCCceeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhh
Q psy2579 127 HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKI 206 (267)
Q Consensus 127 ~hpnIv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~ 206 (267)
+||||+++++++...+..|++++++.+ ++..++.... +
T Consensus 221 ~HpnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-----------------------------------------~ 258 (501)
T PHA03210 221 NHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEA-----------------------------------------F 258 (501)
T ss_pred CCCCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhcc-----------------------------------------c
Confidence 999999999999999999999999864 4444433210 0
Q ss_pred cccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 207 TTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 207 ~~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..........+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 259 ~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 317 (501)
T PHA03210 259 DWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF 317 (501)
T ss_pred cccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceec
Confidence 01122345678889999999999999999999999999999999999999999999765
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-26 Score=193.00 Aligned_cols=175 Identities=22% Similarity=0.307 Sum_probs=137.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+....+ ..++..||+|++.... .......+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLP--YEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred HhceecccccccccccEEEEEEcccCC--CCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 469999999999999999998753111 1345789999987543 3445577899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..++++|++.+|+|.+++............ ...............+++..+..++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~l~~~~~~~~~~ 137 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLS------------------------HSTSSARKCGLNPLPLSCTEQLCIAK 137 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCcccccccc------------------------ccccccccccccccccCHHHHHHHHH
Confidence 999999999999999988754321110000 00011111222334588999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
|++.||+|||++|++||||||+||+++.++.++|+|||+++.
T Consensus 138 ~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 179 (288)
T cd05050 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 179 (288)
T ss_pred HHHHHHHHHHhCCeecccccHhheEecCCCceEECcccccee
Confidence 999999999999999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=189.61 Aligned_cols=149 Identities=30% Similarity=0.458 Sum_probs=125.6
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc---hHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT---PKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
+|+..+.||+|+||.||+|.+. .++..||+|.+...... ......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 75 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDV-------DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD 75 (266)
T ss_pred CccccceecCCCCEEEEEEEEc-------CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc
Confidence 5899999999999999999886 44689999998754322 2345678899999999999999999998865
Q ss_pred c--CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 141 F--GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 141 ~--~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
. +..++++|++.+++|.+.+. ....+++....
T Consensus 76 ~~~~~~~l~~e~~~~~~L~~~l~----------------------------------------------~~~~l~~~~~~ 109 (266)
T cd06651 76 RAEKTLTIFMEYMPGGSVKDQLK----------------------------------------------AYGALTESVTR 109 (266)
T ss_pred CCCCEEEEEEeCCCCCcHHHHHH----------------------------------------------HcCCCCHHHHH
Confidence 3 56778888887766665553 33457888899
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||+++.+
T Consensus 110 ~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 110 KYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred HHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 99999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=188.07 Aligned_cols=156 Identities=26% Similarity=0.406 Sum_probs=130.1
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVV 148 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 148 (267)
+.||+|+||.||+|.+.... ..+..||+|++....... ....+.+|+..++.++||||+++++++...+..+++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~----~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD----GKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCC----CCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEE
Confidence 36999999999999986321 225889999997665433 5678899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHH
Q psy2579 149 EYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAV 228 (267)
Q Consensus 149 e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L 228 (267)
||+.+++|.+++....... .......+++..+..++.|++.||
T Consensus 76 e~~~~~~L~~~l~~~~~~~-------------------------------------~~~~~~~~~~~~~~~~~~~l~~al 118 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVF-------------------------------------PSPEKSTLSLKDLLSFAIQIAKGM 118 (262)
T ss_pred EeccCCcHHHHHhhccccc-------------------------------------cccccccCCHHHHHHHHHHHHHHH
Confidence 9999988888776531100 001124689999999999999999
Q ss_pred HHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 229 KHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 229 ~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+|||++|++|+||+|+||+++.++.++|+|||.++.+.
T Consensus 119 ~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred HHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-27 Score=205.42 Aligned_cols=153 Identities=32% Similarity=0.533 Sum_probs=133.5
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc------hHHHHHHHHHHHHHhhcC---CCce
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT------PKARKMLSREIVSMESVH---HPNI 131 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~Ei~~l~~l~---hpnI 131 (267)
....|..++.+|.|+||.|+.|.++ .+...|+||.+.+.+.- ......+--||+||+.++ |+||
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K-------~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHK-------ENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI 631 (772)
T ss_pred ccccceeeeeccccccceEEEeeec-------ccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence 4556999999999999999999997 44589999999876531 122234567999999997 9999
Q ss_pred eeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCC
Q psy2579 132 IRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGR 211 (267)
Q Consensus 132 v~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~ 211 (267)
++++++|++++..|++||--.. |.+|.+++.-...
T Consensus 632 lKlLdfFEddd~yyl~te~hg~---------------------------------------------gIDLFd~IE~kp~ 666 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGE---------------------------------------------GIDLFDFIEFKPR 666 (772)
T ss_pred hhhhheeecCCeeEEEecCCCC---------------------------------------------CcchhhhhhccCc
Confidence 9999999999999999996543 4577888888889
Q ss_pred CChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 212 LSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 212 ~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+++.++..+++|++.|+++||++||||||||-+|+.++.+|.+||+|||.|...
T Consensus 667 m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 667 MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred cchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 999999999999999999999999999999999999999999999999998754
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=188.54 Aligned_cols=147 Identities=24% Similarity=0.341 Sum_probs=120.3
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeee-ecCeEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLE-TFGKIFLV 147 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~-~~~~~~iv 147 (267)
+.||+|+||.||+|.+.... .....||+|.+.... .......+.+|+.+++.++||||+++++++. ..+..+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~----~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSD----GQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCC----CceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEE
Confidence 36899999999999875322 234689999986432 3344567889999999999999999999765 45568899
Q ss_pred EeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHH
Q psy2579 148 VEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSA 227 (267)
Q Consensus 148 ~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~ 227 (267)
|||+.+|+|.+++... ....++..+..++.|++.|
T Consensus 76 ~e~~~~~~L~~~~~~~---------------------------------------------~~~~~~~~~~~~~~~i~~~ 110 (262)
T cd05058 76 LPYMKHGDLRNFIRSE---------------------------------------------THNPTVKDLIGFGLQVAKG 110 (262)
T ss_pred EecCCCCCHHHHHHhc---------------------------------------------CCCCCHHHHHHHHHHHHHH
Confidence 9999988887776532 1235667788899999999
Q ss_pred HHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 228 VKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 228 L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|.|||+.|++||||||+||+++.++.+||+|||+++.+
T Consensus 111 l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 111 MEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDI 148 (262)
T ss_pred HHHHHhCCccccccCcceEEEcCCCcEEECCccccccc
Confidence 99999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=184.31 Aligned_cols=141 Identities=21% Similarity=0.263 Sum_probs=105.3
Q ss_pred ecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHH------------------------HHHHHHHHHHH
Q psy2579 68 QNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKA------------------------RKMLSREIVSM 123 (267)
Q Consensus 68 ~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~------------------------~~~~~~Ei~~l 123 (267)
...||+|+||.||+|.+. +++.||||+++....+... .....+|+.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 73 (190)
T cd05147 2 NGCISTGKEANVYHATTA--------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNL 73 (190)
T ss_pred CCccccccceEEEEEECC--------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHH
Confidence 457999999999999873 3589999999765322111 12234599999
Q ss_pred hhcCCCceeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchh
Q psy2579 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELY 203 (267)
Q Consensus 124 ~~l~hpnIv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~ 203 (267)
..+.++++....... ....++||||++++++..
T Consensus 74 ~~l~~~~v~~p~~~~--~~~~~iVmE~i~g~~l~~--------------------------------------------- 106 (190)
T cd05147 74 KRLVTAGIPCPEPIL--LKSHVLVMEFIGDDGWAA--------------------------------------------- 106 (190)
T ss_pred HHHHHCCCCCCcEEE--ecCCEEEEEEeCCCCCcc---------------------------------------------
Confidence 999887764433321 122378888877654432
Q ss_pred hhhcccCCCChhHHHHHHHHHHHHHHHH-HhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 204 NKITTEGRLSEDDAKIYFLQILSAVKHL-HDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~ql~~~L~~l-H~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
......++++..+..++.|++.+|.++ |+.||+||||||+|||++ ++.++|+|||+|...
T Consensus 107 -~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 107 -PRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred -hhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 112234688899999999999999999 799999999999999998 588999999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-26 Score=193.31 Aligned_cols=154 Identities=30% Similarity=0.503 Sum_probs=132.4
Q ss_pred cccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeee
Q psy2579 56 TSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLY 135 (267)
Q Consensus 56 ~~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~ 135 (267)
...+...++|++.+.||+|+||.||+|.+. .++..||+|.+.... ....+.+.+|+.+++.++||||++++
T Consensus 12 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~-------~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~ 82 (293)
T cd06647 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDV-------ATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYL 82 (293)
T ss_pred eeccCchhhceeeeEecCCCCeEEEEEEEc-------CCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehh
Confidence 345666678999999999999999999875 345789999986543 23346688999999999999999999
Q ss_pred eeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 136 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 136 ~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
+.+...+..|+|+||+.+++|.+++.+ ..+++.
T Consensus 83 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-----------------------------------------------~~l~~~ 115 (293)
T cd06647 83 DSYLVGDELWVVMEYLAGGSLTDVVTE-----------------------------------------------TCMDEG 115 (293)
T ss_pred heeeeCCcEEEEEecCCCCcHHHHHhh-----------------------------------------------cCCCHH
Confidence 999999999999999999888766542 246788
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..+
T Consensus 116 ~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 116 QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (293)
T ss_pred HHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence 89999999999999999999999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=187.19 Aligned_cols=142 Identities=23% Similarity=0.411 Sum_probs=122.2
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVV 148 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 148 (267)
+.||+|+||.||+|... .+..||+|.+.... .......+.+|+.+++.++||||+++++++...+..+++|
T Consensus 1 ~~ig~g~~g~vy~~~~~--------~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 71 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK--------DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVM 71 (250)
T ss_pred CccCCCCCceEEEEEec--------CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEE
Confidence 36999999999999753 34789999986543 3344456889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHH
Q psy2579 149 EYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAV 228 (267)
Q Consensus 149 e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L 228 (267)
||+.+++|.+++... ...+++..+..++.|++.||
T Consensus 72 e~~~~~~L~~~~~~~---------------------------------------------~~~~~~~~~~~~~~~i~~~l 106 (250)
T cd05085 72 ELVPGGDFLSFLRKK---------------------------------------------KDELKTKQLVKFALDAAAGM 106 (250)
T ss_pred ECCCCCcHHHHHHhc---------------------------------------------CCCCCHHHHHHHHHHHHHHH
Confidence 999998887665432 22578889999999999999
Q ss_pred HHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 229 KHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 229 ~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
.|+|++|++|+||||+||+++.++.++|+|||++..
T Consensus 107 ~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 142 (250)
T cd05085 107 AYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQ 142 (250)
T ss_pred HHHHhCCeeecccChheEEEcCCCeEEECCCcccee
Confidence 999999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-26 Score=189.72 Aligned_cols=148 Identities=29% Similarity=0.425 Sum_probs=127.2
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc----chHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL----TPKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
+|++.+.||+|+||.||+|.. .++..+|+|.+..... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~--------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 72 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT--------NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL 72 (265)
T ss_pred CccccceEeccCCeEEEEEEE--------cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee
Confidence 378889999999999999975 3457899999875432 1233466889999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+..++++||+.+++|.+++.+ ..++++..+..
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~----------------------------------------------~~~~~~~~~~~ 106 (265)
T cd06631 73 DDNTISIFMEFVPGGSISSILNR----------------------------------------------FGPLPEPVFCK 106 (265)
T ss_pred cCCeEEEEEecCCCCcHHHHHHh----------------------------------------------cCCCCHHHHHH
Confidence 99999999999998777666543 23578889999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||+++.+
T Consensus 107 ~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 107 YTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred HHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999999999999999999999999999999999998753
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=190.79 Aligned_cols=147 Identities=29% Similarity=0.499 Sum_probs=128.0
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC---CCceeeeeeeeee
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH---HPNIIRLYEVLET 140 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~~~~~~~~ 140 (267)
.|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++ |||++++++++..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~-------~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~ 73 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHV-------PTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK 73 (277)
T ss_pred hhhhhhheeccCCceEEEEEEc-------CCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee
Confidence 4888999999999999999986 456899999987543 3344567889999999996 9999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|++|||+.+++|.+++.. ..+++..+..+
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~-----------------------------------------------~~l~~~~~~~i 106 (277)
T cd06917 74 GPRLWIIMEYAEGGSVRTLMKA-----------------------------------------------GPIAEKYISVI 106 (277)
T ss_pred CCEEEEEEecCCCCcHHHHHHc-----------------------------------------------cCCCHHHHHHH
Confidence 9999999999998887665532 26888999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+
T Consensus 107 ~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 107 IREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred HHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 999999999999999999999999999999999999999998764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.5e-26 Score=198.02 Aligned_cols=148 Identities=29% Similarity=0.415 Sum_probs=122.7
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .++..||+|.+............+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDT-------VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQ 87 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEEC-------CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccC
Confidence 356999999999999999999986 4568999999876544445556788999999999999999999987644
Q ss_pred C------eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 142 G------KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 142 ~------~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
. ..|+||||+.+ +|. +.+.. .+++.
T Consensus 88 ~~~~~~~~~~lv~e~~~~-~l~----------------------------------------------~~~~~--~l~~~ 118 (353)
T cd07850 88 KSLEEFQDVYLVMELMDA-NLC----------------------------------------------QVIQM--DLDHE 118 (353)
T ss_pred CCccccCcEEEEEeccCC-CHH----------------------------------------------HHHhh--cCCHH
Confidence 2 45777777753 333 32222 27888
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++..
T Consensus 119 ~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 119 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 89999999999999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=188.15 Aligned_cols=149 Identities=29% Similarity=0.513 Sum_probs=128.5
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc---chHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL---TPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
+|+..+.||+|+||.||+|.+. .++..|++|.+..... ..+..+.+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 73 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNL-------DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE 73 (258)
T ss_pred CccccceeeecCCceEEEEEEc-------CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec
Confidence 3778889999999999999885 3468999999876442 23455778999999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..++++||+.+++|.+.+.+ ...+++..+..+
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~----------------------------------------------~~~~~~~~~~~~ 107 (258)
T cd06632 74 EDNLYIFLELVPGGSLAKLLKK----------------------------------------------YGSFPEPVIRLY 107 (258)
T ss_pred CCeEEEEEEecCCCcHHHHHHh----------------------------------------------cCCCCHHHHHHH
Confidence 8999999999988777665542 335788899999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++..+
T Consensus 108 ~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 108 TRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-26 Score=192.61 Aligned_cols=152 Identities=31% Similarity=0.497 Sum_probs=128.8
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc--hHHHHHHHHHHHHHhhc-CCCceeeeeeeeee
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT--PKARKMLSREIVSMESV-HHPNIIRLYEVLET 140 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 140 (267)
+|++.+.||.|+||.||+|.+.... .++..||+|++...... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~----~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGH----DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCC----CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 4889999999999999999875321 35688999999754322 22346678999999999 69999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+++||+.+++|.+++.. ...+++..+..+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~----------------------------------------------~~~l~~~~~~~~ 110 (290)
T cd05613 77 DTKLHLILDYINGGELFTHLSQ----------------------------------------------RERFKEQEVQIY 110 (290)
T ss_pred CCeEEEEEecCCCCcHHHHHHH----------------------------------------------cCCCCHHHHHHH
Confidence 8999999999998777666543 335788899999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++.+
T Consensus 111 ~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 111 SGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred HHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-25 Score=190.38 Aligned_cols=160 Identities=29% Similarity=0.515 Sum_probs=133.1
Q ss_pred hccccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCcee
Q psy2579 54 HETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNII 132 (267)
Q Consensus 54 ~~~~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv 132 (267)
....+++..++|++.+.||+|+||.||+|.+. .+++.+|+|++.... .....+.+|+.+++.+ +|||++
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~-------~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~ 82 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNK-------KDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVV 82 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEEC-------CCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeE
Confidence 34566777888999999999999999999886 456899999986542 2235577899999998 899999
Q ss_pred eeeeeeeec-----CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhc
Q psy2579 133 RLYEVLETF-----GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKIT 207 (267)
Q Consensus 133 ~~~~~~~~~-----~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~ 207 (267)
++++++... +..|++|||+.+|+|.++++.. ..
T Consensus 83 ~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~------------------------------------------~~ 120 (291)
T cd06639 83 KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL------------------------------------------LI 120 (291)
T ss_pred EEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHh------------------------------------------hh
Confidence 999998754 3588999999888887766421 11
Q ss_pred ccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 208 TEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 208 ~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++.+
T Consensus 121 ~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 121 CGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178 (291)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence 2346889999999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=188.13 Aligned_cols=147 Identities=23% Similarity=0.373 Sum_probs=123.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+.. +..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. .+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~--------~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 73 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG--------TTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EE 73 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC--------CceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CC
Confidence 459999999999999999998742 24689998865432 2356888999999999999999999875 45
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++||++.+++|.+++.... ...+++..+..++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~--------------------------------------------~~~~~~~~~~~~~~ 109 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGD--------------------------------------------GKYLKLPQLVDMAA 109 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCC--------------------------------------------CCCCCHHHHHHHHH
Confidence 6889999998888877665321 12478889999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||+.|++|+||||+||+++.++.++|+|||+++.+
T Consensus 110 ~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLI 152 (260)
T ss_pred HHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEc
Confidence 9999999999999999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=184.29 Aligned_cols=152 Identities=28% Similarity=0.381 Sum_probs=128.7
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|++.+++|.|||+-||++... .++..+|+|.+.... .+..+..++|+...++++||||+++++....+.
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~-------s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGL-------STGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE 91 (302)
T ss_pred ceEEEeeeecCCCceeeeeeccc-------Ccccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence 45999999999999999999865 556889999987653 466788999999999999999999998875443
Q ss_pred -----eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 143 -----KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 143 -----~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
..|++++|...|||.+.+.... ..+..+++.++
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k------------------------------------------~kg~~~sE~~i 129 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLK------------------------------------------IKGNFVSEAQI 129 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHh------------------------------------------hcCCccCHHHH
Confidence 3788888888777776654321 12336899999
Q ss_pred HHHHHHHHHHHHHHHhCC--CcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRD--IIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|+.++++||++||+.. ++||||||.|||+++.+.++|.|||.++..
T Consensus 130 L~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 130 LWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred HHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 999999999999999998 999999999999999999999999998764
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=191.06 Aligned_cols=150 Identities=30% Similarity=0.504 Sum_probs=128.1
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++.+.||.|++|.||+|.+. .++..||||++..... ......+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 72 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNR-------TTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENK 72 (284)
T ss_pred CceEeeeeccCCceEEEEEEEC-------CCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc
Confidence 4899999999999999999986 4568999999976542 2234567789999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.+++|||+.+ +|.+++.... ....+++..+..++.|
T Consensus 73 ~~lv~e~~~~-~l~~~~~~~~-------------------------------------------~~~~~~~~~~~~~~~q 108 (284)
T cd07836 73 LMLVFEYMDK-DLKKYMDTHG-------------------------------------------VRGALDPNTVKSFTYQ 108 (284)
T ss_pred EEEEEecCCc-cHHHHHHhcC-------------------------------------------CCCCcCHHHHHHHHHH
Confidence 9999999985 6665554321 1235899999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||+|||+.|++|+||||+||+++.++.++|+|||+++.+
T Consensus 109 i~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 109 LLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAF 150 (284)
T ss_pred HHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence 999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=197.29 Aligned_cols=142 Identities=26% Similarity=0.426 Sum_probs=117.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc--CCCceeeeeeeeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV--HHPNIIRLYEVLET 140 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l--~hpnIv~~~~~~~~ 140 (267)
...++.+.||+|.||+||+|.|+ |+.||||++... ....+.||.++.+.. +|+||+.++++-..
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr---------Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~ 276 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR---------GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNK 276 (513)
T ss_pred heeEEEEEecCccccceeecccc---------CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence 34889999999999999999997 689999999543 335688999998874 99999999987544
Q ss_pred cC----eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 141 FG----KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 141 ~~----~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
++ .+|+|++|-+.|||+++|.+ ..++...
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r-----------------------------------------------~tv~~~~ 309 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNR-----------------------------------------------NTVTTEG 309 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhh-----------------------------------------------ccCCHHH
Confidence 32 36666666666666666544 3789999
Q ss_pred HHHHHHHHHHHHHHHHhC--------CCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDR--------DIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~--------~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..+++..++.||++||.. .|.|||||+.|||+..+|.+.|+|+|||...
T Consensus 310 ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h 366 (513)
T KOG2052|consen 310 MLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 366 (513)
T ss_pred HHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence 999999999999999953 4999999999999999999999999999754
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-26 Score=192.95 Aligned_cols=154 Identities=25% Similarity=0.430 Sum_probs=126.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||.||+|.+. .+++.||+|.+............+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~-------~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 73 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDK-------NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVE 73 (295)
T ss_pred CCceEeeEecccCCeEEEEEEEC-------CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeec
Confidence 35999999999999999999986 4568999999876543333345678899999999 569999999998876
Q ss_pred Ce-----EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 142 GK-----IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 142 ~~-----~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
.. .|++|||+.+ ++.+++..... .....+++..
T Consensus 74 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-----------------------------------------~~~~~~~~~~ 111 (295)
T cd07837 74 EKNGKPSLYLVFEYLDS-DLKKFMDSNGR-----------------------------------------GPGRPLPAKT 111 (295)
T ss_pred CCCCCceEEEEeeccCc-CHHHHHHHhcc-----------------------------------------cCCCCCCHHH
Confidence 65 8899999885 66665543211 0123589999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeec-CCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSV-RGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~l 265 (267)
+..++.|++.||.|||++|++||||+|+||+++. ++.++|+|||+++.+
T Consensus 112 ~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~ 161 (295)
T cd07837 112 IKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161 (295)
T ss_pred HHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceec
Confidence 9999999999999999999999999999999998 889999999998753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=194.94 Aligned_cols=150 Identities=31% Similarity=0.497 Sum_probs=133.6
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
.++|..++.||+|.||.|-+++.+ .+++.+|+|++++.-.. ...+.-...|-++|+..+||.+..+...|..
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEK-------at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREK-------ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeec-------ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence 467999999999999999999987 66799999999876543 3445567789999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+++|+||||..||.|..++.++ ..+++..++.+
T Consensus 240 ~drlCFVMeyanGGeLf~HLsre----------------------------------------------r~FsE~RtRFY 273 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRE----------------------------------------------RVFSEDRTRFY 273 (516)
T ss_pred CceEEEEEEEccCceEeeehhhh----------------------------------------------hcccchhhhhh
Confidence 99999999999998887666543 35888889999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
...|+.||.|||+++||.||||.+|+|++.+|++||+|||||+.
T Consensus 274 GaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 274 GAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred hHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh
Confidence 99999999999999999999999999999999999999999975
|
|
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=194.26 Aligned_cols=156 Identities=30% Similarity=0.466 Sum_probs=132.3
Q ss_pred ccccCceecceEEe-cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCcee
Q psy2579 55 ETSLGKRVALYKLQ-NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNII 132 (267)
Q Consensus 55 ~~~~~~~~~~y~~~-~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv 132 (267)
.+-.|....-|++. +.||+|+++.|--|..- .++.++|||++.+. ....+.++.||++++... .|+||+
T Consensus 69 ss~~g~F~d~YkLt~e~LGeGAyasVqtcv~i-------~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nil 139 (463)
T KOG0607|consen 69 SSLSGKFEDMYKLTSELLGEGAYASVQTCVSI-------QTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNIL 139 (463)
T ss_pred ccccchHHHHHHhHHHHhcCccceeeeeeeee-------ccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHH
Confidence 33334444557775 57999999999999876 45689999999876 345678899999999999 699999
Q ss_pred eeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCC
Q psy2579 133 RLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRL 212 (267)
Q Consensus 133 ~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~ 212 (267)
+++++|++....|+|||.+.||+|..++. ....+
T Consensus 140 qLiefFEdd~~FYLVfEKm~GGplLshI~----------------------------------------------~~~~F 173 (463)
T KOG0607|consen 140 QLIEFFEDDTRFYLVFEKMRGGPLLSHIQ----------------------------------------------KRKHF 173 (463)
T ss_pred HHHHHhcccceEEEEEecccCchHHHHHH----------------------------------------------Hhhhc
Confidence 99999999999999999999977766654 34479
Q ss_pred ChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC---ceEEecccccccc
Q psy2579 213 SEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG---IVKLGDLGFSTKL 265 (267)
Q Consensus 213 ~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~---~~kl~DFGla~~l 265 (267)
++.++.++...|+.||.|||.+||.|||+||+|||-.... -+|||||.|+.-+
T Consensus 174 ~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 174 NEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred cHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence 9999999999999999999999999999999999986554 5899999987654
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=187.64 Aligned_cols=145 Identities=30% Similarity=0.425 Sum_probs=121.8
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVV 148 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 148 (267)
++||+|+||.||+|.+...+ .....+|+|.+...... ...+.+.+|+.+++.++||||+++++++. .+..+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~----~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKS----GKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccC----CCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEE
Confidence 46999999999999876432 23478999999766543 44567899999999999999999999875 44578888
Q ss_pred eecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHH
Q psy2579 149 EYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAV 228 (267)
Q Consensus 149 e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L 228 (267)
|++.+|+|.+++. ....+++..+..++.|++.||
T Consensus 75 e~~~~~~L~~~l~----------------------------------------------~~~~~~~~~~~~~~~qi~~~l 108 (257)
T cd05060 75 ELAPLGPLLKYLK----------------------------------------------KRREIPVSDLKELAHQVAMGM 108 (257)
T ss_pred EeCCCCcHHHHHH----------------------------------------------hCCCCCHHHHHHHHHHHHHHH
Confidence 8888777766554 333688999999999999999
Q ss_pred HHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 229 KHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 229 ~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+|||++|++|+||||+||+++.++.++|+|||+++.+
T Consensus 109 ~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~ 145 (257)
T cd05060 109 AYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145 (257)
T ss_pred HHHhhcCeeccCcccceEEEcCCCcEEecccccccee
Confidence 9999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-25 Score=186.72 Aligned_cols=147 Identities=24% Similarity=0.415 Sum_probs=127.0
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
..|++.+.||+|+||.||+|.+. .+..+|+|.+....... ..+.+|+.+++.++|||++++++++....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~--------~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL--------EKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe--------CCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 45999999999999999999874 23679999987654432 45788999999999999999999999989
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..++++||+.+++|.+++... .+.+++..+..++.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~---------------------------------------------~~~~~~~~~~~~~~ 107 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQ---------------------------------------------RGKFSQETLLGMCL 107 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhC---------------------------------------------ccCCCHHHHHHHHH
Confidence 999999999988887665432 23578899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||+.|++|+||||+||+++.++.++|+|||+++.+
T Consensus 108 ~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 150 (256)
T cd05112 108 DVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFV 150 (256)
T ss_pred HHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeec
Confidence 9999999999999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=193.68 Aligned_cols=153 Identities=29% Similarity=0.384 Sum_probs=125.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|+..+.||+|+||.||+|.+..++. .....||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~---~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGE---TVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCC---cceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 458899999999999999999864331 112468999986543 234445688999999999999999999998654
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..++++|++.+|+|.+.+... ...+++..+..++.
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~---------------------------------------------~~~~~~~~~~~~~~ 116 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEH---------------------------------------------KDNIGSQLLLNWCV 116 (303)
T ss_pred CceeeehhcCCCCHHHHHHhc---------------------------------------------ccCCCHHHHHHHHH
Confidence 467888888887776655432 22578889999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++|++||||||+||+++.++.+||+|||+++.+
T Consensus 117 qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred HHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 9999999999999999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=187.58 Aligned_cols=147 Identities=28% Similarity=0.493 Sum_probs=129.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+. .++..+|+|.+..... .+.+.+|+.+++.++||||+++++.+....
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHK-------ETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEc-------CCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 46999999999999999999986 3458899999865421 567899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+++|++.+++|.+.+... ...+++..+..++.
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~---------------------------------------------~~~l~~~~~~~~~~ 106 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKIT---------------------------------------------NKTLTEEEIAAILY 106 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhC---------------------------------------------ccCCCHHHHHHHHH
Confidence 999999999988887766432 23688999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+
T Consensus 107 ~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~ 149 (256)
T cd06612 107 QTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL 149 (256)
T ss_pred HHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhc
Confidence 9999999999999999999999999999999999999998764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-25 Score=187.53 Aligned_cols=148 Identities=22% Similarity=0.414 Sum_probs=126.1
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.+.|++.+.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|+.+++.++|+||+++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~--------~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN--------KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec--------CCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 356999999999999999999753 23669999886532 334678899999999999999999999877
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..+++|||+.+++|.+++.... ...+++..+..++
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~--------------------------------------------~~~~~~~~~~~~~ 108 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDE--------------------------------------------GSKQPLPKLIDFS 108 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCC--------------------------------------------ccccCHHHHHHHH
Confidence 77899999999888877765421 1247788899999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++.+
T Consensus 109 ~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 109 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred HHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeec
Confidence 99999999999999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=191.06 Aligned_cols=168 Identities=26% Similarity=0.362 Sum_probs=135.1
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|.+.+.||+|+||.||+|.+..... ......+++|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSP--TKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCC--CCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 3569999999999999999998753321 1334678999986543 34446788999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchh--hhhcccCCCChhHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELY--NKITTEGRLSEDDAKI 219 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~--~~~~~~~~~~~~~~~~ 219 (267)
+..+++|||+.+++|.+++....... ..+. +.......+++..++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~--------------------------------~~~~~~~~~~~~~~~~~~~~~~ 127 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDA--------------------------------MILVDGQPRQAKGELGLSQMLH 127 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCccc--------------------------------ccccccccccCcCCCCHHHHHH
Confidence 99999999999999999887643210 0000 0001223588999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||+|||++|++||||||+||+++.++.++|+|||+++..
T Consensus 128 i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~ 173 (291)
T cd05094 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV 173 (291)
T ss_pred HHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCccccc
Confidence 9999999999999999999999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=199.39 Aligned_cols=159 Identities=30% Similarity=0.463 Sum_probs=139.2
Q ss_pred cCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeee
Q psy2579 58 LGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYE 136 (267)
Q Consensus 58 ~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~ 136 (267)
..-..+.|...+.||+|+||.|+.+.-+ ++|+.+|.|.+.+..... ......++|-.+|.+++.|.||.+-.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvr-------aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaY 252 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVR-------ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAY 252 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEe-------cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEee
Confidence 3334466888889999999999999887 667899999997766433 34466789999999999999999999
Q ss_pred eeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 137 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 137 ~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
+|++++.+|+|+..|.||+|..++.+.+ .+.+++..
T Consensus 253 AfeTkd~LClVLtlMNGGDLkfHiyn~g--------------------------------------------~~gF~e~r 288 (591)
T KOG0986|consen 253 AFETKDALCLVLTLMNGGDLKFHIYNHG--------------------------------------------NPGFDEQR 288 (591)
T ss_pred eecCCCceEEEEEeecCCceeEEeeccC--------------------------------------------CCCCchHH
Confidence 9999999999999999999987776542 23699999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccCC
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~~ 267 (267)
++.++.+|+.||++||+.+||.||+||+|||+|+.|++.|+|+|||..+.+
T Consensus 289 a~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 289 ARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred HHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999999999999999999999999999999999999998764
|
|
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-27 Score=211.16 Aligned_cols=148 Identities=28% Similarity=0.500 Sum_probs=128.6
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
..|.|+..||.|+||.||+|..+ .++-..|-|++... +.+..+.+.-||.||+.++||+||+++++|...+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nk-------et~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNK-------ETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcc-------cchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence 44899999999999999999887 33466688887544 4566788999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
.+||..|||.||-....+-. -...+++.++..+++
T Consensus 103 kLwiliEFC~GGAVDaimlE---------------------------------------------L~r~LtE~QIqvvc~ 137 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLE---------------------------------------------LGRVLTEDQIQVVCY 137 (1187)
T ss_pred ceEEEEeecCCchHhHHHHH---------------------------------------------hccccchHHHHHHHH
Confidence 99999999998766543321 234799999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
|+|.||.|||+++|||||||..|||++-+|.++|+|||.+..
T Consensus 138 q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 138 QVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred HHHHHHHHHhhcchhhhhccccceEEEecCcEeeeccccccc
Confidence 999999999999999999999999999999999999998764
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=190.40 Aligned_cols=144 Identities=35% Similarity=0.500 Sum_probs=124.0
Q ss_pred cCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEEe
Q psy2579 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVE 149 (267)
Q Consensus 71 iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~e 149 (267)
||+|+||.||+|.+. .+++.||+|++....... .....+.+|+.+++.++||||+++++.+...+..|++||
T Consensus 1 lg~g~~g~vy~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 73 (277)
T cd05577 1 LGKGGFGEVCACQVK-------ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMT 73 (277)
T ss_pred CCCCCceeEEEEEEc-------CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEe
Confidence 699999999999886 456899999997654332 234566789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHH
Q psy2579 150 YASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVK 229 (267)
Q Consensus 150 ~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~ 229 (267)
|+.+++|.+++.... ...+++..+..++.|++.||.
T Consensus 74 ~~~~~~L~~~l~~~~--------------------------------------------~~~~~~~~~~~~~~ql~~~l~ 109 (277)
T cd05577 74 LMNGGDLKYHIYNVG--------------------------------------------EPGFPEARAIFYAAQIICGLE 109 (277)
T ss_pred cCCCCcHHHHHHHcC--------------------------------------------cCCCCHHHHHHHHHHHHHHHH
Confidence 999988877665431 125889999999999999999
Q ss_pred HHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 230 HLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 230 ~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|||+.|++|+||+|+||+++.++.++|+|||++..+
T Consensus 110 ~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~ 145 (277)
T cd05577 110 HLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL 145 (277)
T ss_pred HHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhh
Confidence 999999999999999999999999999999988754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=189.83 Aligned_cols=168 Identities=26% Similarity=0.352 Sum_probs=134.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|.+.++||+|+||.||+|....... ..++..+|+|.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLP--EQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCC--CCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 358889999999999999997643211 134568999988654 3445567999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++|||+.+++|.+++.......... ..........+++..+..++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~-------------------------------~~~~~~~~~~l~~~~~~~~~~ 129 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKIL-------------------------------AGGEDVAPGQLTLGQMLAIAS 129 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhh-------------------------------cccccCCccccCHHHHHHHHH
Confidence 9999999999999999887653210000 000011223588999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++|++||||||+||+++.++.++|+|||+++.+
T Consensus 130 qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~ 172 (280)
T cd05092 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI 172 (280)
T ss_pred HHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEc
Confidence 9999999999999999999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=187.32 Aligned_cols=146 Identities=25% Similarity=0.449 Sum_probs=124.1
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeee-ec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLE-TF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~-~~ 141 (267)
.+|++.+.||+|+||.||+|... +..||+|.+.... ..+.+.+|+.+++.++|||++++++++. ..
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR---------GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc---------CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 46999999999999999999653 4779999986432 2356889999999999999999999754 45
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..+++|||+.+++|.+++.... ...+++..+..++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~--------------------------------------------~~~~~~~~~~~~~ 108 (256)
T cd05082 73 GGLYIVTEYMAKGSLVDYLRSRG--------------------------------------------RSVLGGDCLLKFS 108 (256)
T ss_pred CceEEEEECCCCCcHHHHHHhcC--------------------------------------------CCCCCHHHHHHHH
Confidence 67899999999888877665321 1247888999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++|++||||||+||+++.++.+||+|||+++..
T Consensus 109 ~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 109 LDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152 (256)
T ss_pred HHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceec
Confidence 99999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=185.19 Aligned_cols=150 Identities=34% Similarity=0.592 Sum_probs=132.7
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++.+.||+|++|.||+|.+. ..+..||+|.+............+.+|+.+++.++|||++++++++...+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNL-------ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDS 73 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEc-------CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Confidence 4889999999999999999886 445889999998776555666789999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.+++||++.+++|.+.+. ....+++..+..++.|
T Consensus 74 ~~~v~e~~~~~~L~~~~~----------------------------------------------~~~~l~~~~~~~~~~~ 107 (254)
T cd06627 74 LYIILEYAENGSLRQIIK----------------------------------------------KFGPFPESLVAVYVYQ 107 (254)
T ss_pred EEEEEecCCCCcHHHHHH----------------------------------------------hccCCCHHHHHHHHHH
Confidence 999999998877766553 2346889999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+.
T Consensus 108 i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 150 (254)
T cd06627 108 VLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLN 150 (254)
T ss_pred HHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecC
Confidence 9999999999999999999999999999999999999988653
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-27 Score=207.91 Aligned_cols=146 Identities=27% Similarity=0.384 Sum_probs=126.6
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccc-cchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAK-LTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
|.=++.||.|+||.||.|++. .+.+.||||.++-+. .+.+.-..+..|+..|+.++|||++.+.++|.....
T Consensus 28 f~dLrEIGHGSFGAVYfArd~-------~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T 100 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDV-------RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT 100 (948)
T ss_pred HHHHHHhcCCccceeEEeecc-------CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch
Confidence 666788999999999999997 445889999997544 344556789999999999999999999999998888
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcc-cCCCChhHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITT-EGRLSEDDAKIYFL 222 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~ 222 (267)
.|+|||||-| +..|++.- ..++.+.++..++.
T Consensus 101 aWLVMEYClG-----------------------------------------------SAsDlleVhkKplqEvEIAAi~~ 133 (948)
T KOG0577|consen 101 AWLVMEYCLG-----------------------------------------------SASDLLEVHKKPLQEVEIAAITH 133 (948)
T ss_pred HHHHHHHHhc-----------------------------------------------cHHHHHHHHhccchHHHHHHHHH
Confidence 8999998864 33343332 45899999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
+.+.||+|||+.+.||||||..|||+++.|.+||+|||.|..
T Consensus 134 gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi 175 (948)
T KOG0577|consen 134 GALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASI 175 (948)
T ss_pred HHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhh
Confidence 999999999999999999999999999999999999999875
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=189.64 Aligned_cols=149 Identities=28% Similarity=0.466 Sum_probs=127.3
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc--------hHHHHHHHHHHHHHhhcCCCceeeee
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT--------PKARKMLSREIVSMESVHHPNIIRLY 135 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~Ei~~l~~l~hpnIv~~~ 135 (267)
+|.+.+.||.|+||.||+|.+. .++..||+|.+...... ....+.+.+|+.+++.++||||++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 74 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNV-------TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYL 74 (272)
T ss_pred ceeecceecccCceEEEEEeec-------CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEE
Confidence 4888999999999999999876 44689999988643211 11235678899999999999999999
Q ss_pred eeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 136 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 136 ~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
+++...+..++||||+.+++|.+.+.. .+.+++.
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----------------------------------------------~~~l~~~ 108 (272)
T cd06629 75 GFETTEEYLSIFLEYVPGGSIGSCLRT----------------------------------------------YGRFEEQ 108 (272)
T ss_pred EEeccCCceEEEEecCCCCcHHHHHhh----------------------------------------------ccCCCHH
Confidence 999999999999999998888766543 2368888
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++..
T Consensus 109 ~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 109 LVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred HHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 89999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-26 Score=193.64 Aligned_cols=151 Identities=26% Similarity=0.431 Sum_probs=124.3
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .+++.||+|+++...........+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~ 78 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDK-------DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDK 78 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEEC-------CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCc
Confidence 466999999999999999999986 4458899999976543333345677899999999999999999998765
Q ss_pred C----------eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCC
Q psy2579 142 G----------KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGR 211 (267)
Q Consensus 142 ~----------~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~ 211 (267)
. ..|+++||+.+ ++...+.. ....
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---------------------------------------------~~~~ 112 (302)
T cd07864 79 QDALDFKKDKGAFYLVFEYMDH-DLMGLLES---------------------------------------------GLVH 112 (302)
T ss_pred chhhhccccCCcEEEEEcccCc-cHHHHHhc---------------------------------------------CCCC
Confidence 4 57777777764 33332221 1236
Q ss_pred CChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 212 LSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 212 ~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++..+
T Consensus 113 ~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 166 (302)
T cd07864 113 FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166 (302)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccc
Confidence 899999999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=190.63 Aligned_cols=141 Identities=13% Similarity=0.185 Sum_probs=118.8
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeeeeeee----cCe
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYEVLET----FGK 143 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~----~~~ 143 (267)
..||+|++|.||+|.+. ++.||||.++...... ...+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 26 ~~i~~g~~~~v~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~ 96 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN---------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPR 96 (283)
T ss_pred eEEeeCCceEEEEEEEC---------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCc
Confidence 45999999999999863 4789999997654333 234678899999999999999999999876 346
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.+++|||+.+|+|.+++. ....+++.....++.|
T Consensus 97 ~~lv~Ey~~~g~L~~~l~----------------------------------------------~~~~~~~~~~~~i~~~ 130 (283)
T PHA02988 97 LSLILEYCTRGYLREVLD----------------------------------------------KEKDLSFKTKLDMAID 130 (283)
T ss_pred eEEEEEeCCCCcHHHHHh----------------------------------------------hCCCCChhHHHHHHHH
Confidence 778888888877766554 3346788889999999
Q ss_pred HHHHHHHHHh-CCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 224 ILSAVKHLHD-RDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 224 l~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
++.||.|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 131 i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~ 172 (283)
T PHA02988 131 CCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKI 172 (283)
T ss_pred HHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhh
Confidence 9999999998 5999999999999999999999999999875
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-26 Score=198.19 Aligned_cols=149 Identities=27% Similarity=0.490 Sum_probs=124.6
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee--
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET-- 140 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~-- 140 (267)
.+|++.+.||.|+||.||+|.+. .++..||+|.+............+.+|+.+++.++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~-------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 77 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDT-------RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG 77 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEc-------CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC
Confidence 45999999999999999999886 456899999997654444455678899999999999999999998753
Q ss_pred --cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 141 --FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 141 --~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
....|++|||+. ++|. +.+...+.+++..+.
T Consensus 78 ~~~~~~~lv~e~~~-~~l~----------------------------------------------~~~~~~~~~~~~~~~ 110 (334)
T cd07855 78 ADFKDVYVVMDLME-SDLH----------------------------------------------HIIHSDQPLTEEHIR 110 (334)
T ss_pred CCCceEEEEEehhh-hhHH----------------------------------------------HHhccCCCCCHHHHH
Confidence 245677777774 3443 444444568999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.+
T Consensus 111 ~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 111 YFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred HHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=189.34 Aligned_cols=153 Identities=29% Similarity=0.387 Sum_probs=129.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec-
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF- 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~- 141 (267)
++|+..+.||.|++|.||+|.+. .+++.+|+|.+..... ......+.+|+++++.++||||+++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 72 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLK-------NTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDES 72 (287)
T ss_pred CceEEEEEeccCCceEEEEEEEC-------CCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC
Confidence 35899999999999999999986 4458899999976532 34557789999999999999999999988653
Q ss_pred -CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 142 -GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 142 -~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
+..|++|||+++++|.+++... ......+++..+..+
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~------------------------------------------~~~~~~l~~~~~~~i 110 (287)
T cd06621 73 SSSIGIAMEYCEGGSLDSIYKKV------------------------------------------KKRGGRIGEKVLGKI 110 (287)
T ss_pred CCeEEEEEEecCCCCHHHHHHHH------------------------------------------HhcCCCCCHHHHHHH
Confidence 4689999999998887665421 112346888999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+
T Consensus 111 ~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 111 AESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 999999999999999999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=188.10 Aligned_cols=159 Identities=26% Similarity=0.388 Sum_probs=126.7
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeecCeEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETFGKIFLV 147 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~iv 147 (267)
+.||+|+||.||+|.+..++ ....+|+|.+.... .......+.+|+.+++.+ +||||+++++++...+..|++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~-----~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 74 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDG-----LRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 74 (270)
T ss_pred CcCCCCCCceEEEEEEcCCC-----CeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEE
Confidence 35999999999999886322 12467899886432 334456788999999999 899999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHH
Q psy2579 148 VEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSA 227 (267)
Q Consensus 148 ~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~ 227 (267)
|||+.+|+|.+++.......... ...........+++..+..++.|++.|
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~------------------------------~~~~~~~~~~~l~~~~~~~~~~~i~~a 124 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDP------------------------------AFAIANSTASTLSSQQLLHFAADVARG 124 (270)
T ss_pred EEeCCCCcHHHHHHhcccccccc------------------------------ccccccCCcCCCCHHHHHHHHHHHHHH
Confidence 99999999999887653211100 000001122358899999999999999
Q ss_pred HHHHHhCCCcccCCCCCcEEeecCCceEEecccccc
Q psy2579 228 VKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 228 L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 263 (267)
|+|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 125 l~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 125 MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred HHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 999999999999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-26 Score=195.00 Aligned_cols=149 Identities=28% Similarity=0.506 Sum_probs=127.5
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
....|.....||+|+||.||+|.+. ..+..||+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~~~~~~~~ig~g~~g~v~~~~~~-------~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~ 89 (297)
T cd06659 19 PRSLLENYIKIGEGSTGIVCIAREK-------HSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLV 89 (297)
T ss_pred chhhHHhhhhcCCCCceeEEEEEEc-------CCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheee
Confidence 3344666678999999999999886 3458999999865432 234668899999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+++||+.+++|...+.. ..+++..+..+
T Consensus 90 ~~~~~iv~e~~~~~~L~~~~~~-----------------------------------------------~~~~~~~~~~~ 122 (297)
T cd06659 90 GEELWVLMEFLQGGALTDIVSQ-----------------------------------------------TRLNEEQIATV 122 (297)
T ss_pred CCeEEEEEecCCCCCHHHHHhh-----------------------------------------------cCCCHHHHHHH
Confidence 9999999999998887654432 25788999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||++|++||||||+||+++.++.++|+|||++..+
T Consensus 123 ~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 123 CESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 999999999999999999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=188.43 Aligned_cols=150 Identities=23% Similarity=0.274 Sum_probs=120.5
Q ss_pred cccCccCceeEEEeEEeecccc-----cccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPI-----LCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+.||+|+||.||+|........ .......||+|++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 3699999999999986421100 00223568999986543 2334568889999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.+++|||+.+|+|..++... ...+++..+..++.|
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~---------------------------------------------~~~~~~~~~~~i~~q 113 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRK---------------------------------------------SDVLTTPWKFKVAKQ 113 (262)
T ss_pred CEEEEecccCCCHHHHHHhc---------------------------------------------CCCCCHHHHHHHHHH
Confidence 99999999998886655432 235888999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCc-------eEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGI-------VKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~-------~kl~DFGla~~l 265 (267)
++.||+|||++|++||||||+|||++.++. ++++|||++..+
T Consensus 114 i~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~ 162 (262)
T cd05077 114 LASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV 162 (262)
T ss_pred HHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccc
Confidence 999999999999999999999999987664 899999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=192.98 Aligned_cols=150 Identities=27% Similarity=0.438 Sum_probs=117.5
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee--cCeEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET--FGKIFL 146 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~--~~~~~i 146 (267)
.+||+|+||.||+|.+... .++..||+|.+...... ..+.+|+.+++.++||||+++++++.. ....|+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~-----~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDG-----KDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred eEeccCCCeeEEEEEecCC-----CccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 5799999999999987532 34578999998754322 346789999999999999999999854 467899
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS 226 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~ 226 (267)
++||+.+ +|.+.+...... ........+++..+..++.|++.
T Consensus 78 v~e~~~~-~l~~~~~~~~~~-------------------------------------~~~~~~~~l~~~~~~~i~~qi~~ 119 (317)
T cd07867 78 LFDYAEH-DLWHIIKFHRAS-------------------------------------KANKKPMQLPRSMVKSLLYQILD 119 (317)
T ss_pred EEeeeCC-cHHHHHHhhhcc-------------------------------------ccCCCCccCCHHHHHHHHHHHHH
Confidence 9999875 565555322100 00011235888999999999999
Q ss_pred HHHHHHhCCCcccCCCCCcEEe----ecCCceEEecccccccc
Q psy2579 227 AVKHLHDRDIIHRDIKAENVFL----SVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 227 ~L~~lH~~~ivHrDlkp~NIll----~~~~~~kl~DFGla~~l 265 (267)
||.|||++|++||||||+||++ +.++.+||+|||+|+.+
T Consensus 120 aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred HHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 9999999999999999999999 45679999999999764
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=187.96 Aligned_cols=145 Identities=25% Similarity=0.410 Sum_probs=122.9
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
..+|++.+.||+|+||.||+|.. ++..||+|.+.... ....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~---------~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY---------TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN 71 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc---------CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence 35699999999999999999864 24779999986532 235688999999999999999999998654
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
..+++|||+.+++|.+++.... ...+++..+..++
T Consensus 72 -~~~~v~e~~~~~~L~~~l~~~~--------------------------------------------~~~~~~~~~~~~~ 106 (254)
T cd05083 72 -GLYIVMELMSKGNLVNFLRTRG--------------------------------------------RALVSVIQLLQFS 106 (254)
T ss_pred -CcEEEEECCCCCCHHHHHHhcC--------------------------------------------cCCCCHHHHHHHH
Confidence 4689999998888877665321 1257888999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.
T Consensus 107 ~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~ 149 (254)
T cd05083 107 LDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV 149 (254)
T ss_pred HHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCcccee
Confidence 9999999999999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-27 Score=220.55 Aligned_cols=152 Identities=30% Similarity=0.461 Sum_probs=132.6
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..+|++++.||+|+||.|..++++ .+++.+|+|++++-... ......|..|-.+|...+.+.|++++.+|.+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k-------~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHK-------STEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEee-------ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 456999999999999999999998 45588999999874433 2234568899999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
..++|+||||+.||+|..++.+ ..++++.-++.+
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk----------------------------------------------~~~~pE~~ArFY 180 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSK----------------------------------------------FDRLPEDWARFY 180 (1317)
T ss_pred ccceEEEEecccCchHHHHHhh----------------------------------------------cCCChHHHHHHH
Confidence 9999999999998888665543 346889999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+..++.||.-||+.|+|||||||+|||++..|++||+|||.|-.+.
T Consensus 181 ~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 181 TAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred HHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 9999999999999999999999999999999999999999987664
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=194.20 Aligned_cols=155 Identities=28% Similarity=0.440 Sum_probs=126.6
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeeec-
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLETF- 141 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~- 141 (267)
+|++.+.||+|+||.||+|.+... ..+..||+|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-----~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-----KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-----CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 388999999999999999998631 1568999999987431 122235678899999999999999999999988
Q ss_pred -CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 142 -GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 142 -~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
+..|+|||++++ ++.+.+..... .....+++..+..+
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~i 113 (316)
T cd07842 76 DKSVYLLFDYAEH-DLWQIIKFHRQ-----------------------------------------AKRVSIPPSMVKSL 113 (316)
T ss_pred CceEEEEEeCCCc-CHHHHHHhhcc-----------------------------------------CCCcCcCHHHHHHH
Confidence 789999999875 44443322100 01236889999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeec----CCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSV----RGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~----~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||+.|++||||||+||+++. ++.+||+|||+++.+
T Consensus 114 ~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~ 162 (316)
T cd07842 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162 (316)
T ss_pred HHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccccc
Confidence 999999999999999999999999999999 899999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=194.31 Aligned_cols=147 Identities=29% Similarity=0.532 Sum_probs=126.7
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
..|.....||+|+||.||++.+. .++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~-------~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~ 92 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEK-------HTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD 92 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEEC-------CCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC
Confidence 44666678999999999999875 445889999986542 344567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++|||+.+++|.+++.. +.+++..+..++.
T Consensus 93 ~~~lv~e~~~~~~L~~~~~~-----------------------------------------------~~l~~~~~~~~~~ 125 (292)
T cd06658 93 ELWVVMEFLEGGALTDIVTH-----------------------------------------------TRMNEEQIATVCL 125 (292)
T ss_pred eEEEEEeCCCCCcHHHHHhc-----------------------------------------------CCCCHHHHHHHHH
Confidence 99999999998877665432 2578889999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++|++||||||+||+++.++.++|+|||++..+
T Consensus 126 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 126 SVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168 (292)
T ss_pred HHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence 9999999999999999999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=184.81 Aligned_cols=153 Identities=36% Similarity=0.645 Sum_probs=134.9
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++.+.||.|+||.||+|.+. .++..||+|++............+.+|+++++.++|||++++.+.+...+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 73 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRK-------SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGK 73 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEc-------CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCE
Confidence 4899999999999999999986 345899999998776655667789999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.++++|++++++|.+.+.... .....+++..+..++.|
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~------------------------------------------~~~~~~~~~~~~~i~~~ 111 (258)
T cd08215 74 LCIVMEYADGGDLSQKIKKQK------------------------------------------KEGKPFPEEQILDWFVQ 111 (258)
T ss_pred EEEEEEecCCCcHHHHHHHhh------------------------------------------ccCCCcCHHHHHHHHHH
Confidence 999999999988877765421 01246899999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 112 i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 153 (258)
T cd08215 112 LCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL 153 (258)
T ss_pred HHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeec
Confidence 999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=187.30 Aligned_cols=151 Identities=34% Similarity=0.682 Sum_probs=130.9
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++.+.||+|+||.||+|.+. ..+..||+|.+..........+.+.+|+.+++.++||||+++++.+...+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~ 73 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAK-------SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGR 73 (257)
T ss_pred CceEEEEecCCCcceEEEEEEc-------CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCe
Confidence 4899999999999999999986 445889999997765544556678899999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.++++||+.+++|.+.+.... ...+++..+..++.|
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~ 109 (257)
T cd08225 74 LFIVMEYCDGGDLMKRINRQR--------------------------------------------GVLFSEDQILSWFVQ 109 (257)
T ss_pred EEEEEecCCCCcHHHHHHhcc--------------------------------------------CCCCCHHHHHHHHHH
Confidence 999999999988877665321 124788999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCC-ceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRG-IVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~l 265 (267)
++.||.|||+.+++|+||||+||+++.++ .++|+|||.+..+
T Consensus 110 l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 110 ISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred HHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 99999999999999999999999998886 5699999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=186.75 Aligned_cols=154 Identities=28% Similarity=0.421 Sum_probs=129.5
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeE
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKI 144 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 144 (267)
+++.+.||.|+||.||+|.+..... .....||+|++.... .......+..|+..+..++||||+++++++...+..
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~---~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSG---EKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL 76 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCC---CCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence 3567889999999999999863221 224889999996553 223567889999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHH
Q psy2579 145 FLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 224 (267)
Q Consensus 145 ~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql 224 (267)
+++||++.+++|.+.+..... ..+++..+..++.|+
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~--------------------------------------------~~~~~~~~~~~~~ql 112 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRP--------------------------------------------KELSLSDLLSFALQI 112 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhh--------------------------------------------ccCCHHHHHHHHHHH
Confidence 999999999888776653210 128899999999999
Q ss_pred HHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 225 LSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 225 ~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+.||+|||+.|++|+||||+||+++.++.++|+|||+++...
T Consensus 113 ~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 113 ARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred HHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 999999999999999999999999999999999999997643
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=195.24 Aligned_cols=148 Identities=26% Similarity=0.418 Sum_probs=122.0
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec-
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF- 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~- 141 (267)
++|++.+.||+|+||.||+|.+. .+++.||+|.+.....+......+.+|+.+++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDT-------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEc-------CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 55999999999999999999886 4568999999976544444456788999999999999999999987643
Q ss_pred -----CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 142 -----GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 142 -----~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
+..|++++++ +++|.+.+ . ...+++..
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~----------------------------------------------~-~~~l~~~~ 121 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIV----------------------------------------------K-CQKLTDDH 121 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHH----------------------------------------------h-cCCCCHHH
Confidence 2356666655 44443332 2 23588999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++..
T Consensus 122 ~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 122 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred HHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 9999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=189.16 Aligned_cols=149 Identities=29% Similarity=0.465 Sum_probs=130.9
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++.+.||.|+||.||+|.+. .+++.||+|.+..... ......+.+|+.+++.++||||+++++.+...+.
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHR-------PTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGD 73 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEc-------CCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCE
Confidence 5888999999999999999986 4568899999876543 3556778999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.++++|++.+++|.+++... ...+++..+..++.|
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~---------------------------------------------~~~~~~~~~~~~~~~ 108 (265)
T cd06605 74 ISICMEYMDGGSLDKILKEV---------------------------------------------QGRIPERILGKIAVA 108 (265)
T ss_pred EEEEEEecCCCcHHHHHHHc---------------------------------------------cCCCCHHHHHHHHHH
Confidence 99999999988887666432 146888999999999
Q ss_pred HHHHHHHHHh-CCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHD-RDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||+|+|+ .|++|+||||+||+++.++.++|+|||++..+
T Consensus 109 l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~ 151 (265)
T cd06605 109 VLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL 151 (265)
T ss_pred HHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhh
Confidence 9999999999 99999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=185.56 Aligned_cols=148 Identities=31% Similarity=0.458 Sum_probs=131.5
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++.+.||.|++|.||+|.+. .+++.||+|++...... .....+.+|+..++.++||||+++++++...+.
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~-------~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHK-------PTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGE 73 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEc-------CCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCe
Confidence 5899999999999999999987 45689999999766432 455779999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.++++||+.+++|.+++.. ...+++..+..++.|
T Consensus 74 ~~lv~e~~~~~~L~~~l~~----------------------------------------------~~~l~~~~~~~~~~~ 107 (264)
T cd06623 74 ISIVLEYMDGGSLADLLKK----------------------------------------------VGKIPEPVLAYIARQ 107 (264)
T ss_pred EEEEEEecCCCcHHHHHHH----------------------------------------------cCCCCHHHHHHHHHH
Confidence 9999999998887766643 246889999999999
Q ss_pred HHHHHHHHHh-CCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHD-RDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||+|||+ .|++|+||+|+||+++.++.++|+|||++..+
T Consensus 108 l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~ 150 (264)
T cd06623 108 ILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL 150 (264)
T ss_pred HHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceec
Confidence 9999999999 99999999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=190.64 Aligned_cols=151 Identities=26% Similarity=0.373 Sum_probs=127.8
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
...|++.+.||+|+||.||+|.+. .+++.||+|.+..... .......+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~ 86 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDV-------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR 86 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEc-------CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe
Confidence 345999999999999999999886 4468999999865432 33445678899999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+++||+.+ ++.+.+.. ...++++..+..+
T Consensus 87 ~~~~~lv~e~~~g-~l~~~~~~---------------------------------------------~~~~l~~~~~~~~ 120 (307)
T cd06607 87 EHTAWLVMEYCLG-SASDILEV---------------------------------------------HKKPLQEVEIAAI 120 (307)
T ss_pred CCeEEEEHHhhCC-CHHHHHHH---------------------------------------------cccCCCHHHHHHH
Confidence 9999999999874 44333321 1236889999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 121 ~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 121 CHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred HHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceec
Confidence 999999999999999999999999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-26 Score=190.41 Aligned_cols=150 Identities=21% Similarity=0.244 Sum_probs=121.9
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVV 148 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 148 (267)
+.||.|+||.||+|.+...+.........||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 369999999999998864321111234568999886432 234467889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHH
Q psy2579 149 EYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAV 228 (267)
Q Consensus 149 e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L 228 (267)
||+.+|+|..++... ...+++..+..++.|++.||
T Consensus 79 e~~~~g~L~~~l~~~---------------------------------------------~~~~~~~~~~~~~~qi~~~l 113 (258)
T cd05078 79 EYVKFGSLDTYLKKN---------------------------------------------KNLINISWKLEVAKQLAWAL 113 (258)
T ss_pred ecCCCCcHHHHHhcC---------------------------------------------CCCCCHHHHHHHHHHHHHHH
Confidence 999998887776543 12578888999999999999
Q ss_pred HHHHhCCCcccCCCCCcEEeecCCc--------eEEecccccccc
Q psy2579 229 KHLHDRDIIHRDIKAENVFLSVRGI--------VKLGDLGFSTKL 265 (267)
Q Consensus 229 ~~lH~~~ivHrDlkp~NIll~~~~~--------~kl~DFGla~~l 265 (267)
+|||++|++||||||+||+++.++. ++++|||++...
T Consensus 114 ~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 114 HFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred HHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 9999999999999999999987764 699999988643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=190.90 Aligned_cols=149 Identities=25% Similarity=0.379 Sum_probs=129.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~-------~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 76 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHI-------PTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN 76 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEc-------CCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC
Confidence 46999999999999999999986 445889999986543 3445678899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++|||+.+++|...+.. .+.+++..+..++.
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~----------------------------------------------~~~~~~~~~~~~~~ 110 (284)
T cd06620 77 NICMCMEFMDCGSLDRIYKK----------------------------------------------GGPIPVEILGKIAV 110 (284)
T ss_pred EEEEEEecCCCCCHHHHHHh----------------------------------------------ccCCCHHHHHHHHH
Confidence 99999999998877665532 34688899999999
Q ss_pred HHHHHHHHHHh-CCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHD-RDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||+ .|++||||+|+||+++.++.++|+|||++..+
T Consensus 111 ~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 111 AVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred HHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 99999999997 69999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=204.55 Aligned_cols=147 Identities=34% Similarity=0.510 Sum_probs=122.6
Q ss_pred EecccCccCceeEEEeEEeecccccccccceEEEEeeccccc--chHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe-
Q psy2579 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL--TPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK- 143 (267)
Q Consensus 67 ~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~- 143 (267)
....||+|+|-+||+|.|. .+|-.||.-.++..+. ++...+++..|+++|+.|+||||+++|++|.+...
T Consensus 44 ~~evLGrGafKtVYka~De-------~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~ 116 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDE-------EEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK 116 (632)
T ss_pred hhhhcccccceeeeecccc-------ccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc
Confidence 3457999999999999997 5567888777665554 34556899999999999999999999999998765
Q ss_pred -EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 144 -IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 144 -~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
.-+|+|++..|+|. .+....+.++...+..|++
T Consensus 117 ~in~iTEL~TSGtLr----------------------------------------------~Y~kk~~~vn~kaik~W~R 150 (632)
T KOG0584|consen 117 TINFITELFTSGTLR----------------------------------------------EYRKKHRRVNIKAIKSWCR 150 (632)
T ss_pred eeeeeeecccCCcHH----------------------------------------------HHHHHhccCCHHHHHHHHH
Confidence 66666766665554 4444556788999999999
Q ss_pred HHHHHHHHHHhCC--CcccCCCCCcEEeec-CCceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRD--IIHRDIKAENVFLSV-RGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~--ivHrDlkp~NIll~~-~~~~kl~DFGla~~l~ 266 (267)
||+.||.|||++. |||||||-+||+|+. .|.+||+|+|||+.++
T Consensus 151 QILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 151 QILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred HHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 9999999999994 999999999999964 5899999999998765
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=189.91 Aligned_cols=149 Identities=37% Similarity=0.563 Sum_probs=131.0
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcC-CCceeeeeeeeeec
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVH-HPNIIRLYEVLETF 141 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~ 141 (267)
+|++.+.||+|+||.||+|.+. .++..||+|++...... ......+.+|+.+++.++ ||||+++++++...
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 74 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEK-------ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE 74 (280)
T ss_pred CceEeeeecCCCceEEEEEEEc-------CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC
Confidence 5999999999999999999986 45689999999775432 344567889999999998 99999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..+++||++.+++|.+.+.. .+.+++..+..++
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~----------------------------------------------~~~l~~~~~~~i~ 108 (280)
T cd05581 75 ENLYFVLEYAPNGELLQYIRK----------------------------------------------YGSLDEKCTRFYA 108 (280)
T ss_pred ceEEEEEcCCCCCcHHHHHHH----------------------------------------------cCCCCHHHHHHHH
Confidence 999999999988777665543 3368999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+
T Consensus 109 ~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 109 AEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred HHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 99999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=186.46 Aligned_cols=145 Identities=31% Similarity=0.449 Sum_probs=123.4
Q ss_pred EecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEE
Q psy2579 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFL 146 (267)
Q Consensus 67 ~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~i 146 (267)
....||+|+||.||+|.+. .++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 12 ~~~~lg~g~~g~v~~~~~~-------~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDL-------STQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ceEEEecCCceEEEEeEec-------CCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3347999999999999886 445889999886543 3345678999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCC--ChhHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRL--SEDDAKIYFLQI 224 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~ql 224 (267)
++|++.+++|.+++.... .++ ++..+..++.|+
T Consensus 83 v~e~~~~~~L~~~l~~~~---------------------------------------------~~~~~~~~~~~~~~~qi 117 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW---------------------------------------------GPLKDNEQTIIFYTKQI 117 (268)
T ss_pred EEecCCCCCHHHHHHHhc---------------------------------------------ccCCCcHHHHHHHHHHH
Confidence 999999988887775421 133 677888899999
Q ss_pred HHHHHHHHhCCCcccCCCCCcEEeec-CCceEEecccccccc
Q psy2579 225 LSAVKHLHDRDIIHRDIKAENVFLSV-RGIVKLGDLGFSTKL 265 (267)
Q Consensus 225 ~~~L~~lH~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~l 265 (267)
+.||+|||++|++||||||+||+++. ++.++|+|||++..+
T Consensus 118 ~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 118 LEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred HHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 99999999999999999999999976 679999999998654
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-25 Score=186.90 Aligned_cols=154 Identities=28% Similarity=0.467 Sum_probs=129.1
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVL 138 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~ 138 (267)
+..++|++.+.||+|+||.||+|.+. .+++.+++|++.... ...+.+.+|+.+++.+ .||||+++++++
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 72 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHK-------KTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAF 72 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEEC-------CCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEE
Confidence 34577999999999999999999986 345889999987543 2346788999999999 799999999999
Q ss_pred eecC------eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCC
Q psy2579 139 ETFG------KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRL 212 (267)
Q Consensus 139 ~~~~------~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~ 212 (267)
.... ..|++|||+.+++|.+++.... .....+
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------------------------------------~~~~~~ 110 (275)
T cd06608 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLR------------------------------------------KKGKRL 110 (275)
T ss_pred EecCCCCcceEEEEEEEcCCCCcHHHHHHHHh------------------------------------------hcCCCC
Confidence 7654 3788888888888776654321 113468
Q ss_pred ChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 213 SEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 213 ~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..+
T Consensus 111 ~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 111 KEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred CHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 89999999999999999999999999999999999999999999999988653
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=195.33 Aligned_cols=149 Identities=25% Similarity=0.406 Sum_probs=124.3
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|++.+.||+|+||.||+|.+. .++..||||.+............+.+|+.+++.++||||+++++++....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~ 77 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNS-------ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPH 77 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEec-------CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccc
Confidence 35999999999999999999986 45689999998765434444566789999999999999999999876542
Q ss_pred -----eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 143 -----KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 143 -----~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
..|+++||+. ++| .+.+...+.+++..+
T Consensus 78 ~~~~~~~~lv~e~~~-~~L----------------------------------------------~~~~~~~~~l~~~~~ 110 (337)
T cd07858 78 REAFNDVYIVYELMD-TDL----------------------------------------------HQIIRSSQTLSDDHC 110 (337)
T ss_pred ccccCcEEEEEeCCC-CCH----------------------------------------------HHHHhcCCCCCHHHH
Confidence 3677777764 334 344444557899999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++..
T Consensus 111 ~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 111 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred HHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=184.41 Aligned_cols=143 Identities=24% Similarity=0.421 Sum_probs=124.4
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVV 148 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 148 (267)
+.||+|+||.||+|.+. . ++.||+|.+...... .....+.+|+.+++.++||||+++++++...+..+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~-------~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 71 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK-------G-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVM 71 (251)
T ss_pred CccccCCCceEEEEEEe-------C-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEE
Confidence 36999999999999875 3 589999998765433 45677899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHH
Q psy2579 149 EYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAV 228 (267)
Q Consensus 149 e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L 228 (267)
|++.+++|.+++... ...+++..+..++.|++.||
T Consensus 72 e~~~~~~l~~~l~~~---------------------------------------------~~~~~~~~~~~~~~~~~~~l 106 (251)
T cd05041 72 ELVPGGSLLTFLRKK---------------------------------------------KNRLTVKKLLQMSLDAAAGM 106 (251)
T ss_pred EcCCCCcHHHHHHhc---------------------------------------------CCCCCHHHHHHHHHHHHHHH
Confidence 999988887666432 22578888999999999999
Q ss_pred HHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 229 KHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 229 ~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+|||++|++||||+|+||+++.++.++|+|||+++..
T Consensus 107 ~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 143 (251)
T cd05041 107 EYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREE 143 (251)
T ss_pred HHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccc
Confidence 9999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=207.15 Aligned_cols=154 Identities=29% Similarity=0.396 Sum_probs=134.3
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+..++.++||+|.||.|++|.|...+ .+.-.||||.+....... ..+.|++|+.+|.+|+|||++++||...+ .
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~ps----gk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPS----GKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCC----CcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 34677788999999999999998643 455789999998776654 67889999999999999999999999877 7
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
...+|+|++..|||.+.|+.. ....+-......++.
T Consensus 184 p~mMV~ELaplGSLldrLrka--------------------------------------------~~~~llv~~Lcdya~ 219 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKA--------------------------------------------KKAILLVSRLCDYAM 219 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhc--------------------------------------------cccceeHHHHHHHHH
Confidence 788999999999998888752 123566677888999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
||+.||.||.++++|||||..+|+|+.....+||+||||.+-+.
T Consensus 220 QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 220 QIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred HHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 99999999999999999999999999999999999999999875
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=193.75 Aligned_cols=143 Identities=27% Similarity=0.388 Sum_probs=124.6
Q ss_pred cccCcc--CceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEE
Q psy2579 69 NELGRG--NFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFL 146 (267)
Q Consensus 69 ~~iG~G--~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~i 146 (267)
..||+| +||.||+|.+. .+++.||+|++..........+.+.+|+.+++.++||||++++++|...+..|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~ 76 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHT-------PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWV 76 (328)
T ss_pred HHhCCcccCceeEEEEEEc-------CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEE
Confidence 457777 99999999986 456999999998766555566789999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS 226 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~ 226 (267)
++|++.++++.+.+.... ...+++..+..++.|++.
T Consensus 77 v~e~~~~~~l~~~l~~~~--------------------------------------------~~~~~~~~~~~~~~qi~~ 112 (328)
T cd08226 77 ISPFMAYGSANSLLKTYF--------------------------------------------PEGMSEALIGNILFGALR 112 (328)
T ss_pred EEecccCCCHHHHHHhhc--------------------------------------------ccCCCHHHHHHHHHHHHH
Confidence 999999988877665421 124788999999999999
Q ss_pred HHHHHHhCCCcccCCCCCcEEeecCCceEEeccccc
Q psy2579 227 AVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262 (267)
Q Consensus 227 ~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla 262 (267)
||+|||++|++||||||+||+++.++.++++|||.+
T Consensus 113 aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~ 148 (328)
T cd08226 113 GLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHL 148 (328)
T ss_pred HHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHH
Confidence 999999999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=194.96 Aligned_cols=147 Identities=26% Similarity=0.432 Sum_probs=121.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec-
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF- 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~- 141 (267)
++|++.+.||+|+||.||+|.+. .++..||+|.++... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~-------~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHK-------PTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPS 76 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEc-------CCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence 46999999999999999999986 456899999986432 223446678899999999999999999886543
Q ss_pred ----CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 142 ----GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 142 ----~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
...|+++|++.+ ++... + ....+++..+
T Consensus 77 ~~~~~~~~lv~e~~~~-~l~~~----------------------------------------------~-~~~~l~~~~~ 108 (336)
T cd07849 77 FESFNDVYIVQELMET-DLYKL----------------------------------------------I-KTQHLSNDHI 108 (336)
T ss_pred ccccceEEEEehhccc-CHHHH----------------------------------------------H-hcCCCCHHHH
Confidence 346777777753 33332 2 2236899999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..++.|++.||+|||+.|++||||||+||+++.++.++|+|||+++..
T Consensus 109 ~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 109 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred HHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-27 Score=192.47 Aligned_cols=147 Identities=26% Similarity=0.429 Sum_probs=122.7
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC--
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG-- 142 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~-- 142 (267)
.+..+.||.|+||.||...+. ..++.||+|.+..-..+-...+++.+|+.++..++|.|++..++...-..
T Consensus 55 i~PDRPIGYGAFGVVWsVTDP-------RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d 127 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDP-------RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS 127 (449)
T ss_pred CCCCCcccccceeEEEeccCC-------CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence 445567999999999999886 55699999988665544455678999999999999999999988764332
Q ss_pred ---eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 143 ---KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 143 ---~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
.+|+++|++. .+|+.++.+..+++...+..
T Consensus 128 fFqEiYV~TELmQ-----------------------------------------------SDLHKIIVSPQ~Ls~DHvKV 160 (449)
T KOG0664|consen 128 FFQELYVLTELMQ-----------------------------------------------SDLHKIIVSPQALTPDHVKV 160 (449)
T ss_pred HHHHHHHHHHHHH-----------------------------------------------hhhhheeccCCCCCcchhhh
Confidence 1333333332 47888888999999999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+++||++||.|||+.||+||||||.|+|++.+..+||||||+|+.-
T Consensus 161 FlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 161 FVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred hHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEeccccccccc
Confidence 9999999999999999999999999999999999999999999853
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=191.95 Aligned_cols=149 Identities=26% Similarity=0.376 Sum_probs=125.2
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee-
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET- 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~- 140 (267)
.++|++.+.||.|+||.||+|.+. .++..||+|.+............+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 81 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQ-------LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP 81 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEEC-------CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence 456999999999999999999986 456899999886544344445678899999999999999999999865
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
....|+++|++. ++|...+. ..++++..+..+
T Consensus 82 ~~~~~lv~e~~~-~~L~~~~~-----------------------------------------------~~~~~~~~~~~~ 113 (328)
T cd07856 82 LEDIYFVTELLG-TDLHRLLT-----------------------------------------------SRPLEKQFIQYF 113 (328)
T ss_pred CCcEEEEeehhc-cCHHHHHh-----------------------------------------------cCCCCHHHHHHH
Confidence 457889999874 45544332 235778888899
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++..
T Consensus 114 ~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 114 LYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred HHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-25 Score=186.45 Aligned_cols=161 Identities=21% Similarity=0.196 Sum_probs=132.7
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee-c
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET-F 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~-~ 141 (267)
.+|++.+.||+|+||.||+|.+.... ...+..||+|.+.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~---~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEK---PGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCC---CCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 46999999999999999999986422 1235789999986432 44556778999999999999999999998765 4
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
...+++++++.+|+|.+++....... ......+++..+..++
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~--------------------------------------~~~~~~l~~~~~~~i~ 123 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGE--------------------------------------ANNPQALSTQQLVHMA 123 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccc--------------------------------------cccccCCCHHHHHHHH
Confidence 77899999999999988775432100 0012468999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.+
T Consensus 124 ~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~ 167 (280)
T cd05043 124 IQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDL 167 (280)
T ss_pred HHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccc
Confidence 99999999999999999999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=192.41 Aligned_cols=150 Identities=25% Similarity=0.392 Sum_probs=121.1
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec-
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETF- 141 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~- 141 (267)
+|++.+.||+|+||.||+|.+... ..+..||+|.+............+.+|+.+++.+ +||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 75 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAET-----SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP 75 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCC-----CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc
Confidence 489999999999999999998632 1157899999875433333456788999999999 699999999875432
Q ss_pred ---CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 142 ---GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 142 ---~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
...|++++++.+ +|.+.+.....+++..+.
T Consensus 76 ~~~~~~~~~~e~~~~-----------------------------------------------~L~~~l~~~~~~~~~~~~ 108 (332)
T cd07857 76 GNFNELYLYEELMEA-----------------------------------------------DLHQIIRSGQPLTDAHFQ 108 (332)
T ss_pred ccCCcEEEEEecccC-----------------------------------------------CHHHHHhcCCCCCHHHHH
Confidence 345666666542 344444445578999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||+|||++|++||||||+||+++.++.++|+|||+|+.+
T Consensus 109 ~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 109 SFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred HHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 99999999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=204.34 Aligned_cols=143 Identities=31% Similarity=0.501 Sum_probs=126.8
Q ss_pred ccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEEe
Q psy2579 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVE 149 (267)
Q Consensus 70 ~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~e 149 (267)
.||+|+||+||.|++. .+....|||.+.... .+..+-+..||.+.+.|+|.|||+++|++...|..-|.||
T Consensus 582 VLGKGTYG~VYA~RD~-------~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDM-------DTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME 652 (1226)
T ss_pred EeecCceeEEEeeccc-------cceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence 6999999999999998 455889999996553 3445668899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCC--ChhHHHHHHHHHHHH
Q psy2579 150 YASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRL--SEDDAKIYFLQILSA 227 (267)
Q Consensus 150 ~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~ql~~~ 227 (267)
-++||||...+++.+ +++ .+..+-.+.+||+.|
T Consensus 653 qVPGGSLSsLLrskW---------------------------------------------GPlKDNEstm~fYtkQILeG 687 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKW---------------------------------------------GPLKDNESTMNFYTKQILEG 687 (1226)
T ss_pred cCCCCcHHHHHHhcc---------------------------------------------CCCccchhHHHHHHHHHHHH
Confidence 999999988887653 355 778888899999999
Q ss_pred HHHHHhCCCcccCCCCCcEEee-cCCceEEeccccccccC
Q psy2579 228 VKHLHDRDIIHRDIKAENVFLS-VRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 228 L~~lH~~~ivHrDlkp~NIll~-~~~~~kl~DFGla~~l~ 266 (267)
|.|||.+.|||||||.+|+|++ ..|.+||+|||.|+++.
T Consensus 688 LkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 688 LKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred hhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc
Confidence 9999999999999999999995 58999999999999864
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=187.69 Aligned_cols=148 Identities=29% Similarity=0.521 Sum_probs=126.8
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec--C
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF--G 142 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~--~ 142 (267)
|++.+.||.|+||.||+|.+. .++..+|+|.+............+.+|+.+++.++|||++++++++... +
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 73 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNK-------KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKG 73 (287)
T ss_pred CeeeEEeccCCCeEEEEEEEC-------CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCC
Confidence 678899999999999999986 4458999999987653334456688999999999999999999999888 7
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..++++||+.+ +|...+... ...+++..+..++.
T Consensus 74 ~~~lv~e~~~~-~l~~~~~~~---------------------------------------------~~~~~~~~~~~i~~ 107 (287)
T cd07840 74 SIYMVFEYMDH-DLTGLLDSP---------------------------------------------EVKFTESQIKCYMK 107 (287)
T ss_pred cEEEEeccccc-cHHHHHhcc---------------------------------------------CCCCCHHHHHHHHH
Confidence 89999998864 555444321 13688999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||+.|++|+||+|+||+++.++.++|+|||++..+
T Consensus 108 ~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~ 150 (287)
T cd07840 108 QLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPY 150 (287)
T ss_pred HHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeec
Confidence 9999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=203.11 Aligned_cols=148 Identities=24% Similarity=0.415 Sum_probs=131.8
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeE
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKI 144 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 144 (267)
..+..+||-|.||.||.|.|+.+. -.||||.++... -..++|+.|+.+|+.++|||+|+++++|.....+
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkys-------lTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYS-------LTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccc-------eeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 667789999999999999998554 679999996543 3457899999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHH
Q psy2579 145 FLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 224 (267)
Q Consensus 145 ~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql 224 (267)
|||+|||.+|+|.++|+...+ ..++.-..+.++.||
T Consensus 339 YIiTEfM~yGNLLdYLRecnr--------------------------------------------~ev~avvLlyMAtQI 374 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNR--------------------------------------------SEVPAVVLLYMATQI 374 (1157)
T ss_pred EEEEecccCccHHHHHHHhch--------------------------------------------hhcchhHHHHHHHHH
Confidence 999999999999999876422 246667788899999
Q ss_pred HHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 225 LSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 225 ~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
..||+||..+++|||||..+|+|+.++..+|++||||++.+.
T Consensus 375 sSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 375 SSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred HHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 999999999999999999999999999999999999999763
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=185.32 Aligned_cols=153 Identities=32% Similarity=0.528 Sum_probs=133.6
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+|++.+.||.|+||.||++.+. .++..+|+|.+............+.+|+.+++.++||||+++++++.....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRL-------SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNK 73 (256)
T ss_pred CceEeeeecCCCceeEEEEEEC-------CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCE
Confidence 4899999999999999999876 445889999998766555666778899999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.|+++|++.+++|..++.... .....+++..+..++.|
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~------------------------------------------~~~~~~~~~~~~~~~~~ 111 (256)
T cd08530 74 LCIVMEYAPFGDLSKAISKRK------------------------------------------KKRKLIPEQEIWRIFIQ 111 (256)
T ss_pred EEEEehhcCCCCHHHHHHHHH------------------------------------------hhcCCCCHHHHHHHHHH
Confidence 999999999988877665321 11246889999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||+|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 112 l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~ 153 (256)
T cd08530 112 LLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVL 153 (256)
T ss_pred HHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhh
Confidence 999999999999999999999999999999999999988754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-25 Score=187.08 Aligned_cols=143 Identities=26% Similarity=0.481 Sum_probs=117.3
Q ss_pred ccCccCceeEEEeEEeecccccccccceEEEEeecccccchH-HHHHHHHHHHHHh---hcCCCceeeeeeeeeecCeEE
Q psy2579 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPK-ARKMLSREIVSME---SVHHPNIIRLYEVLETFGKIF 145 (267)
Q Consensus 70 ~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~Ei~~l~---~l~hpnIv~~~~~~~~~~~~~ 145 (267)
.||+|+||.||+|.+. .+++.+|+|.+........ ......+|..+++ ..+||||+.+++.+...+..+
T Consensus 1 ~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 73 (279)
T cd05633 1 IIGRGGFGEVYGCRKA-------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLC 73 (279)
T ss_pred CcccCCCeEEEEEEEC-------CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEE
Confidence 4899999999999986 4468999999976543322 2233445544443 347999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHH
Q psy2579 146 LVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 225 (267)
Q Consensus 146 iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~ 225 (267)
+||||+.+|+|.+++. ..+.+++..+..++.|++
T Consensus 74 lv~e~~~~~~L~~~i~----------------------------------------------~~~~l~~~~~~~i~~qi~ 107 (279)
T cd05633 74 FILDLMNGGDLHYHLS----------------------------------------------QHGVFSEKEMRFYATEII 107 (279)
T ss_pred EEEecCCCCCHHHHHH----------------------------------------------hcCCCCHHHHHHHHHHHH
Confidence 9999999988866554 234689999999999999
Q ss_pred HHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 226 SAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 226 ~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.||+|||++|++||||||+||+++.++.++|+|||++..+
T Consensus 108 ~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~ 147 (279)
T cd05633 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (279)
T ss_pred HHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence 9999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-25 Score=187.24 Aligned_cols=151 Identities=29% Similarity=0.464 Sum_probs=126.4
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~ 139 (267)
..+.|++.+.||.|+||.||+|.+. .+++.||+|++... ......+..|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHV-------KTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEc-------CCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 4467999999999999999999986 44589999998653 23345688899999998 7999999999985
Q ss_pred e------cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCC
Q psy2579 140 T------FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLS 213 (267)
Q Consensus 140 ~------~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~ 213 (267)
. .+..|++|||+.+|+|.+++.... ...++
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--------------------------------------------~~~~~ 119 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--------------------------------------------GNALK 119 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHcc--------------------------------------------CCCCC
Confidence 3 356788888888888877664321 12477
Q ss_pred hhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 214 EDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 214 ~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++.+
T Consensus 120 ~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 120 EDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 8888999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=178.07 Aligned_cols=142 Identities=18% Similarity=0.220 Sum_probs=108.4
Q ss_pred ecccCccCceeEEEeEEeecccccccccceEEEEeecccccchH------------------------HHHHHHHHHHHH
Q psy2579 68 QNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPK------------------------ARKMLSREIVSM 123 (267)
Q Consensus 68 ~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~------------------------~~~~~~~Ei~~l 123 (267)
.+.||+|+||.||+|.+. +++.||||++........ ....+.+|...+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 73 (190)
T cd05145 2 NGCISTGKEANVYHARTG--------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNL 73 (190)
T ss_pred CceeecCCCcEEEEEEcC--------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHH
Confidence 467999999999999873 458999999986532100 022346899999
Q ss_pred hhcCCCceeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchh
Q psy2579 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELY 203 (267)
Q Consensus 124 ~~l~hpnIv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~ 203 (267)
..+.|+++.....+... ..++||||++++++...
T Consensus 74 ~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~-------------------------------------------- 107 (190)
T cd05145 74 KRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAP-------------------------------------------- 107 (190)
T ss_pred HHHHhCCCCCceEEEec--CCEEEEEEecCCCchhh--------------------------------------------
Confidence 99999987544443322 23788888877543211
Q ss_pred hhhcccCCCChhHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 204 NKITTEGRLSEDDAKIYFLQILSAVKHLHD-RDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.....+++...+..++.|++.+|.++|+ +|++||||||+||+++ ++.++|+|||+|+.+.
T Consensus 108 --~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 108 --RLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred --hhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 1122357788999999999999999999 9999999999999999 8999999999998765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-24 Score=181.30 Aligned_cols=150 Identities=33% Similarity=0.538 Sum_probs=131.3
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec--
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF-- 141 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~-- 141 (267)
+|++.+.||+|++|.||+|.+. .++..|++|++..........+.+.+|+.+++.++||||+++++.+...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDK-------DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK 73 (260)
T ss_pred CceeeeEeeecCceEEEEEEEC-------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC
Confidence 3888899999999999999886 4568999999987765556678899999999999999999999999888
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..++++|++.+++|.+++. ....+++..+..++
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~----------------------------------------------~~~~~~~~~~~~~~ 107 (260)
T cd06606 74 NTLNIFLEYVSGGSLSSLLK----------------------------------------------KFGKLPEPVIRKYT 107 (260)
T ss_pred CeEEEEEEecCCCcHHHHHH----------------------------------------------HcCCCCHHHHHHHH
Confidence 78888888888766665553 33378999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+..+.
T Consensus 108 ~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 108 RQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred HHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 999999999999999999999999999999999999999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=188.24 Aligned_cols=149 Identities=26% Similarity=0.448 Sum_probs=127.9
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeE
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKI 144 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 144 (267)
|++.+.||.|++|.||+|.+. .++..||+|++............+.+|+.+++.++|||++++++++...+..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~ 73 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDK-------LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKL 73 (283)
T ss_pred CchheEecCCCCeEEEEEEEc-------CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeE
Confidence 678889999999999999986 4568999999976654444446688999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHH
Q psy2579 145 FLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 224 (267)
Q Consensus 145 ~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql 224 (267)
|+++||++ ++|.+++.... ...+++..+..++.|+
T Consensus 74 ~iv~e~~~-~~l~~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~i 108 (283)
T cd07835 74 YLVFEFLD-LDLKKYMDSSP--------------------------------------------LTGLDPPLIKSYLYQL 108 (283)
T ss_pred EEEEeccC-cCHHHHHhhCC--------------------------------------------CCCCCHHHHHHHHHHH
Confidence 99999985 46665554321 1258899999999999
Q ss_pred HHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 225 LSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 225 ~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.||+|||+++++|+||+|+||+++.++.++|+|||+++.+
T Consensus 109 ~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~ 149 (283)
T cd07835 109 LQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF 149 (283)
T ss_pred HHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence 99999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-25 Score=183.78 Aligned_cols=143 Identities=33% Similarity=0.574 Sum_probs=125.0
Q ss_pred cCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEEe
Q psy2579 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVE 149 (267)
Q Consensus 71 iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~e 149 (267)
||.|+||.||+|.+. .++..||+|++...... ......+.+|+.+++.++||||+++++.+...+..|+++|
T Consensus 1 lg~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 73 (262)
T cd05572 1 LGVGGFGRVELVKVK-------SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLME 73 (262)
T ss_pred CCCCCceEEEEEEEC-------CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEe
Confidence 799999999999986 34589999999765543 2445779999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHH
Q psy2579 150 YASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVK 229 (267)
Q Consensus 150 ~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~ 229 (267)
|+.+++|.+++.+ ...+++..+..++.|++.||.
T Consensus 74 ~~~~~~L~~~l~~----------------------------------------------~~~l~~~~~~~~~~~i~~~l~ 107 (262)
T cd05572 74 YCLGGELWTILRD----------------------------------------------RGLFDEYTARFYIACVVLAFE 107 (262)
T ss_pred cCCCCcHHHHHhh----------------------------------------------cCCCCHHHHHHHHHHHHHHHH
Confidence 9998888766643 235788899999999999999
Q ss_pred HHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 230 HLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 230 ~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
|||++|++|+||+|+||+++.++.++|+|||+++.+.
T Consensus 108 ~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~ 144 (262)
T cd05572 108 YLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK 144 (262)
T ss_pred HHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccC
Confidence 9999999999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.9e-26 Score=194.44 Aligned_cols=144 Identities=23% Similarity=0.363 Sum_probs=122.5
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhh--cCCCceeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES--VHHPNIIRLYEVLE 139 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~~~~~~~ 139 (267)
+...++.+.||+|.||.||+|... ++.||||++. .+....|..|-.|.+. ++|+||++++++-.
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~---------~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ek 274 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD---------NRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEK 274 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc---------CceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhc
Confidence 455788899999999999999764 4899999984 4566778888888876 48999999999865
Q ss_pred ecC----eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 140 TFG----KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 140 ~~~----~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
... ..|+|++|.+.|||.++|..+ .++|.
T Consensus 275 r~t~~~~eywLVt~fh~kGsL~dyL~~n-----------------------------------------------tisw~ 307 (534)
T KOG3653|consen 275 RGTADRMEYWLVTEFHPKGSLCDYLKAN-----------------------------------------------TISWN 307 (534)
T ss_pred cCCccccceeEEeeeccCCcHHHHHHhc-----------------------------------------------cccHH
Confidence 544 577888888887777777654 68999
Q ss_pred HHHHHHHHHHHHHHHHHhC---------CCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 216 DAKIYFLQILSAVKHLHDR---------DIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~---------~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
...+++..+++||+|||+- .|+|||||++|||+..++++.|+|||||.++.
T Consensus 308 ~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 308 SLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred HHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 9999999999999999953 59999999999999999999999999998764
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.7e-25 Score=185.68 Aligned_cols=143 Identities=25% Similarity=0.457 Sum_probs=117.0
Q ss_pred ccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHH---HHHhhcCCCceeeeeeeeeecCeEE
Q psy2579 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREI---VSMESVHHPNIIRLYEVLETFGKIF 145 (267)
Q Consensus 70 ~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei---~~l~~l~hpnIv~~~~~~~~~~~~~ 145 (267)
.||+|+||.||+|.+. .+++.||+|.+....... ........|. ..++...||||+.+++.+...+..|
T Consensus 1 ~ig~g~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 73 (278)
T cd05606 1 IIGRGGFGEVYGCRKA-------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 73 (278)
T ss_pred CcccCCCeEEEEEEEe-------cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEE
Confidence 3899999999999886 456899999987654322 1122233343 4455568999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHH
Q psy2579 146 LVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 225 (267)
Q Consensus 146 iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~ 225 (267)
+||||+.+|+|...+. ..+.+++..+..++.|++
T Consensus 74 ~v~e~~~g~~L~~~l~----------------------------------------------~~~~l~~~~~~~~~~ql~ 107 (278)
T cd05606 74 FILDLMNGGDLHYHLS----------------------------------------------QHGVFSEAEMRFYAAEII 107 (278)
T ss_pred EEEecCCCCcHHHHHH----------------------------------------------hcCCCCHHHHHHHHHHHH
Confidence 9999999887765543 234689999999999999
Q ss_pred HHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 226 SAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 226 ~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.||.|||+.+++||||||+||+++.++.++|+|||+++.+
T Consensus 108 ~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~ 147 (278)
T cd05606 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (278)
T ss_pred HHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence 9999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.2e-28 Score=192.59 Aligned_cols=152 Identities=25% Similarity=0.401 Sum_probs=122.6
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
...+.|+-..+||+|.||+||+|+.. ++++.||+|..-.............+|+.+|..++|+|++.++..|.
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~-------n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~ 86 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSK-------NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 86 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhc-------CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence 34566888999999999999999987 55688999876443222222345679999999999999999998875
Q ss_pred ecC--------eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhccc-C
Q psy2579 140 TFG--------KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTE-G 210 (267)
Q Consensus 140 ~~~--------~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~ 210 (267)
+.. .+|+|+.+|+. +|.-++... .
T Consensus 87 tk~Tp~~r~r~t~ylVf~~ceh-----------------------------------------------DLaGlLsn~~v 119 (376)
T KOG0669|consen 87 TKATPTNRDRATFYLVFDFCEH-----------------------------------------------DLAGLLSNRKV 119 (376)
T ss_pred hccCCcccccceeeeeHHHhhh-----------------------------------------------hHHHHhcCccc
Confidence 542 25666666653 444444443 5
Q ss_pred CCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 211 RLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 211 ~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+++..++..++.+++.||.|+|+..|+|||+||.|+||+.+|.+||+|||+|+.+
T Consensus 120 r~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 120 RFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred cccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 7999999999999999999999999999999999999999999999999999865
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.7e-25 Score=185.40 Aligned_cols=146 Identities=36% Similarity=0.545 Sum_probs=121.8
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec--
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETF-- 141 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~-- 141 (267)
|++.+.||+|+||.||+|.+. .++..||+|.++....+... ....+|+..+..+ +||||+++++++.+.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~-------~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 72 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSR-------KTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKT 72 (282)
T ss_pred CceEeeccccccceEEEEEEc-------CCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCC
Confidence 678899999999999999986 44588999998765333222 3345789999988 599999999999887
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..+++|||+.+ ++.+.+... ...+++..+..++
T Consensus 73 ~~~~lv~e~~~~-~l~~~l~~~---------------------------------------------~~~~~~~~~~~~~ 106 (282)
T cd07831 73 GRLALVFELMDM-NLYELIKGR---------------------------------------------KRPLPEKRVKSYM 106 (282)
T ss_pred CcEEEEEecCCc-cHHHHHHhc---------------------------------------------cCCCCHHHHHHHH
Confidence 889999999874 555444321 2368999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||+.|++||||+|+||+++. +.++|+|||+++.+
T Consensus 107 ~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~ 149 (282)
T cd07831 107 YQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGI 149 (282)
T ss_pred HHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccc
Confidence 99999999999999999999999999999 99999999999765
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=192.88 Aligned_cols=149 Identities=30% Similarity=0.497 Sum_probs=124.0
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 140 (267)
.++|++.+.||+|+||.||+|.+. .++..||+|.+............+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~ 78 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDR-------RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA 78 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEc-------CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc
Confidence 356999999999999999999886 3458899998865443444456678899999999 99999999998865
Q ss_pred c--CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 141 F--GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 141 ~--~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
. ...|+|||++.+ +|...+. .. .+++....
T Consensus 79 ~~~~~~~lv~e~~~~-~L~~~~~----------------------------------------------~~-~~~~~~~~ 110 (337)
T cd07852 79 ENDKDIYLVFEYMET-DLHAVIR----------------------------------------------AN-ILEDVHKR 110 (337)
T ss_pred CCCceEEEEeccccc-CHHHHHh----------------------------------------------cC-CCCHHHHH
Confidence 4 357888888863 5544432 22 57788888
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||+|||+.|++||||||+||+++.++.++|+|||+++.+
T Consensus 111 ~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 111 YIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred HHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=190.12 Aligned_cols=150 Identities=27% Similarity=0.464 Sum_probs=121.9
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .+++.||+|.+............+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQI-------KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVER 79 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEEC-------CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecc
Confidence 567999999999999999999986 4568899999876543333334567899999999999999999987543
Q ss_pred C--------eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhc-ccCCC
Q psy2579 142 G--------KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKIT-TEGRL 212 (267)
Q Consensus 142 ~--------~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~-~~~~~ 212 (267)
. ..++++||+.+ ++ ...+. ....+
T Consensus 80 ~~~~~~~~~~~~lv~~~~~~-~l----------------------------------------------~~~~~~~~~~~ 112 (311)
T cd07866 80 PDKSKRKRGSVYMVTPYMDH-DL----------------------------------------------SGLLENPSVKL 112 (311)
T ss_pred cccccccCceEEEEEecCCc-CH----------------------------------------------HHHHhccccCC
Confidence 3 35667776653 22 22222 23468
Q ss_pred ChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 213 SEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 213 ~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||+++..
T Consensus 113 ~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 113 TESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 99999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-25 Score=187.14 Aligned_cols=152 Identities=30% Similarity=0.492 Sum_probs=128.5
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc--hHHHHHHHHHHHHHhhc-CCCceeeeeeeeee
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT--PKARKMLSREIVSMESV-HHPNIIRLYEVLET 140 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 140 (267)
+|++.+.||+|+||.||+|.+.... .++..||||++...... ....+.+.+|+.++..+ +||||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~----~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGH----DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccc----cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 3889999999999999999875322 34678999998754322 23346688999999999 69999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+||||+.+|+|...+. ....+++..+..+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~----------------------------------------------~~~~~~~~~~~~~ 110 (288)
T cd05583 77 DTKLHLILDYVNGGELFTHLY----------------------------------------------QREHFTESEVRVY 110 (288)
T ss_pred CCEEEEEEecCCCCcHHHHHh----------------------------------------------hcCCcCHHHHHHH
Confidence 999999999999877766553 2235788899999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++.+
T Consensus 111 ~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 111 IAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred HHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.2e-25 Score=199.02 Aligned_cols=146 Identities=25% Similarity=0.351 Sum_probs=113.9
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC------CCceeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH------HPNIIRLY 135 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~------hpnIv~~~ 135 (267)
.++|++.+.||+|+||.||+|.+. .++..||||+++... ........|+.++..++ |++++.++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~-------~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDR-------KRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEc-------CCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 367999999999999999999986 445889999996432 22234556777776665 45588888
Q ss_pred eeeeec-CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCCh
Q psy2579 136 EVLETF-GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214 (267)
Q Consensus 136 ~~~~~~-~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~ 214 (267)
+++... +..|++|+++ +++|. +.+...+.+++
T Consensus 198 ~~~~~~~~~~~iv~~~~-g~~l~----------------------------------------------~~l~~~~~l~~ 230 (467)
T PTZ00284 198 RYFQNETGHMCIVMPKY-GPCLL----------------------------------------------DWIMKHGPFSH 230 (467)
T ss_pred EEEEcCCceEEEEEecc-CCCHH----------------------------------------------HHHHHcCCCCH
Confidence 887654 4678888876 33443 33334457899
Q ss_pred hHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEeecCC----------------ceEEeccccccc
Q psy2579 215 DDAKIYFLQILSAVKHLHD-RDIIHRDIKAENVFLSVRG----------------IVKLGDLGFSTK 264 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH~-~~ivHrDlkp~NIll~~~~----------------~~kl~DFGla~~ 264 (267)
..+..++.|++.||+|||+ .|||||||||+|||++.++ .+||+|||++..
T Consensus 231 ~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~ 297 (467)
T PTZ00284 231 RHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCD 297 (467)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCcccc
Confidence 9999999999999999998 5999999999999998765 499999998764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=193.23 Aligned_cols=149 Identities=27% Similarity=0.412 Sum_probs=125.3
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++...||+|+||.||+|.+. .++..||+|++.....+......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDT-------KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPA 86 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEEC-------CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcc
Confidence 356999999999999999999986 4568899999876544444556788999999999999999999987665
Q ss_pred Ce------EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 142 GK------IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 142 ~~------~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
+. .++++|++ +++|.+.+ .. .++++.
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~L~~~~----------------------------------------------~~-~~l~~~ 118 (343)
T cd07851 87 SSLEDFQDVYLVTHLM-GADLNNIV----------------------------------------------KC-QKLSDD 118 (343)
T ss_pred ccccccccEEEEEecC-CCCHHHHH----------------------------------------------hc-CCCCHH
Confidence 54 77888876 33554433 22 368999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++..+
T Consensus 119 ~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 119 HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 99999999999999999999999999999999999999999999999765
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-25 Score=192.51 Aligned_cols=148 Identities=27% Similarity=0.449 Sum_probs=126.1
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC-
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG- 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~- 142 (267)
+|++.+.||.|+||.||+|.+. .++..||||.+..........+.+.+|+.+++.++||||+++++++...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDK-------RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSP 73 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeC-------CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc
Confidence 4899999999999999999986 44689999999765433455577899999999999999999999987765
Q ss_pred ----eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 143 ----KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 143 ----~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
..|++||++.+ +|. +.+....++++..+.
T Consensus 74 ~~~~~~~lv~e~~~~-~l~----------------------------------------------~~l~~~~~l~~~~~~ 106 (330)
T cd07834 74 EDFNDVYIVTELMET-DLH----------------------------------------------KVIKSPQPLTDDHIQ 106 (330)
T ss_pred ccccceEEEecchhh-hHH----------------------------------------------HHHhCCCCCCHHHHH
Confidence 67788887763 443 334344478999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 107 ~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 107 YFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=184.71 Aligned_cols=141 Identities=30% Similarity=0.548 Sum_probs=123.5
Q ss_pred cCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEEe
Q psy2579 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVE 149 (267)
Q Consensus 71 iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~e 149 (267)
||.|+||.||+|.+. .+++.||+|++...... ......+.+|+.+++.++||||+++++.+...+..|+++|
T Consensus 1 lg~g~~~~vy~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 73 (265)
T cd05579 1 ISKGAYGRVFLAKKK-------STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVME 73 (265)
T ss_pred CCCCCceEEEEEEEC-------CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEe
Confidence 689999999999986 44689999999765432 2445778999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHH
Q psy2579 150 YASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVK 229 (267)
Q Consensus 150 ~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~ 229 (267)
++.+++|.+.+.+ .+.+++..+..++.|++.||+
T Consensus 74 ~~~~~~L~~~l~~----------------------------------------------~~~~~~~~~~~i~~qi~~~L~ 107 (265)
T cd05579 74 YLPGGDLASLLEN----------------------------------------------VGSLDEDVARIYIAEIVLALE 107 (265)
T ss_pred cCCCCcHHHHHHH----------------------------------------------cCCCCHHHHHHHHHHHHHHHH
Confidence 9998787666543 236889999999999999999
Q ss_pred HHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 230 HLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 230 ~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus 108 ~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~ 142 (265)
T cd05579 108 YLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKV 142 (265)
T ss_pred HHHHcCeecCCCCHHHeEEcCCCCEEEEecccchh
Confidence 99999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=186.77 Aligned_cols=150 Identities=27% Similarity=0.376 Sum_probs=127.1
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
..|+..+.||+|+||.||+|.+. .++..||+|.+..... .......+.+|+.+++.++|||++++++++...
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~-------~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 97 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDV-------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE 97 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEc-------CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 34888999999999999999986 4458999999875432 234456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|++|||+.+ ++.+.+.. ...++++..+..++
T Consensus 98 ~~~~lv~e~~~g-~l~~~~~~---------------------------------------------~~~~l~~~~~~~i~ 131 (317)
T cd06635 98 HTAWLVMEYCLG-SASDLLEV---------------------------------------------HKKPLQEVEIAAIT 131 (317)
T ss_pred CeEEEEEeCCCC-CHHHHHHH---------------------------------------------hcCCCCHHHHHHHH
Confidence 999999999964 55444322 12368899999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 132 ~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 132 HGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA 175 (317)
T ss_pred HHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence 99999999999999999999999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=196.39 Aligned_cols=136 Identities=25% Similarity=0.384 Sum_probs=120.2
Q ss_pred EecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEE
Q psy2579 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFL 146 (267)
Q Consensus 67 ~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~i 146 (267)
-++-||.|+-|.||+|+.. ++.||||.++. .-..+|+-|++|+||||+.+.|+|....-.||
T Consensus 128 ELeWlGSGaQGAVF~Grl~---------netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCI 189 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH---------NETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCI 189 (904)
T ss_pred hhhhhccCcccceeeeecc---------CceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence 3456999999999999875 37899997632 23468999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS 226 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~ 226 (267)
|||||..|.|+..|+. ..+++......|..+|+.
T Consensus 190 iMEfCa~GqL~~VLka----------------------------------------------~~~itp~llv~Wsk~IA~ 223 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKA----------------------------------------------GRPITPSLLVDWSKGIAG 223 (904)
T ss_pred eeeccccccHHHHHhc----------------------------------------------cCccCHHHHHHHHHHhhh
Confidence 9999999888877764 346888899999999999
Q ss_pred HHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 227 AVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 227 ~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
||.|||.+.|||||||.-||||+.+..+||+|||.++.+.
T Consensus 224 GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 224 GMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred hhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh
Confidence 9999999999999999999999999999999999998754
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=177.93 Aligned_cols=149 Identities=31% Similarity=0.547 Sum_probs=130.6
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
.|++.+.||+|++|.||+|.+. .++..+++|++..... .....+.+|+..++.++|||++++++++...+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHK-------RTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEEC-------CCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 3888999999999999999986 3458899999976543 355778999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.++++|++.+++|.+++... ...+++..+..++.|
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~---------------------------------------------~~~~~~~~~~~i~~~ 106 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKST---------------------------------------------NQTLTESQIAYVCKE 106 (253)
T ss_pred EEEEEecCCCCcHHHHHhhc---------------------------------------------CCCCCHHHHHHHHHH
Confidence 99999999988877665432 136899999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
++.||.+||++|++|+||+|+||+++.++.++|+|||.+..+.
T Consensus 107 i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 149 (253)
T cd05122 107 LLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149 (253)
T ss_pred HHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccc
Confidence 9999999999999999999999999999999999999987653
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=184.02 Aligned_cols=145 Identities=31% Similarity=0.551 Sum_probs=124.5
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeE
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKI 144 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 144 (267)
|.-.+.||+|++|.||+|.+. .+++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~-------~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~ 91 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDK-------STGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDEL 91 (285)
T ss_pred hhcceEeccCCCeEEEEEEEC-------CCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeE
Confidence 444567999999999999876 445889999886432 23446688999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHH
Q psy2579 145 FLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 224 (267)
Q Consensus 145 ~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql 224 (267)
++++||+.+++|.+.+.. .++++..+..++.|+
T Consensus 92 ~~v~e~~~~~~L~~~~~~-----------------------------------------------~~~~~~~~~~~~~ql 124 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH-----------------------------------------------TRMNEEQIATVCLAV 124 (285)
T ss_pred EEEEeccCCCCHHHHHHh-----------------------------------------------CCCCHHHHHHHHHHH
Confidence 999999988777665532 357888999999999
Q ss_pred HHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 225 LSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 225 ~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.||+|||++|++||||+|+||+++.++.++|+|||++..+
T Consensus 125 ~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~ 165 (285)
T cd06648 125 LKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165 (285)
T ss_pred HHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence 99999999999999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=189.85 Aligned_cols=149 Identities=28% Similarity=0.433 Sum_probs=124.0
Q ss_pred cceEE-ecccCccCceeEEEeEEeecccccccccceEEEEeecccccchH------------HHHHHHHHHHHHhhcCCC
Q psy2579 63 ALYKL-QNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPK------------ARKMLSREIVSMESVHHP 129 (267)
Q Consensus 63 ~~y~~-~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~~Ei~~l~~l~hp 129 (267)
++|.. .+.||.|+||.||+|.+. ..++.||||.+........ ....+.+|+.+++.++||
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 80 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDT-------LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHE 80 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEEC-------CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCc
Confidence 34654 467999999999999986 4468999999875543220 012477999999999999
Q ss_pred ceeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhccc
Q psy2579 130 NIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTE 209 (267)
Q Consensus 130 nIv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~ 209 (267)
||+++++++...+..+++||++. |+|.+.+. ..
T Consensus 81 ~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~----------------------------------------------~~ 113 (335)
T PTZ00024 81 NIMGLVDVYVEGDFINLVMDIMA-SDLKKVVD----------------------------------------------RK 113 (335)
T ss_pred ceeeeeEEEecCCcEEEEEeccc-cCHHHHHH----------------------------------------------hc
Confidence 99999999999999999999986 45554443 33
Q ss_pred CCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 210 GRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 210 ~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||+++.+
T Consensus 114 ~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~ 169 (335)
T PTZ00024 114 IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRY 169 (335)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeec
Confidence 46889999999999999999999999999999999999999999999999998754
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=181.11 Aligned_cols=144 Identities=34% Similarity=0.544 Sum_probs=118.8
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHH-hhcCCCceeeeeeeeeecCeEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSM-ESVHHPNIIRLYEVLETFGKIFL 146 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l-~~l~hpnIv~~~~~~~~~~~~~i 146 (267)
+.||.|+||.||+|.+. .+++.||+|++....... .....+..|..++ ...+|||++++++++...+..|+
T Consensus 2 ~~l~~g~~~~v~~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~l 74 (260)
T cd05611 2 KPISKGAFGSVYLAKKR-------STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYL 74 (260)
T ss_pred ccCCcCCCeeEEEEEec-------CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEE
Confidence 46999999999999886 445899999997654322 2223344555444 44589999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS 226 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~ 226 (267)
++||+.+++|..++.. ...+++..+..++.|++.
T Consensus 75 v~e~~~~~~L~~~l~~----------------------------------------------~~~~~~~~~~~i~~qi~~ 108 (260)
T cd05611 75 VMEYLNGGDCASLIKT----------------------------------------------LGGLPEDWAKQYIAEVVL 108 (260)
T ss_pred EEeccCCCCHHHHHHH----------------------------------------------cCCCCHHHHHHHHHHHHH
Confidence 9999999888766542 236888999999999999
Q ss_pred HHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 227 AVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 227 ~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
||.|||+.|++|+||+|+||+++.++.++|+|||+++..
T Consensus 109 aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 109 GVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147 (260)
T ss_pred HHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceec
Confidence 999999999999999999999999999999999988753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=183.15 Aligned_cols=151 Identities=32% Similarity=0.524 Sum_probs=131.4
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
.....|++.+.||+|+||.||+|.+. ..+..||+|++..... ....+.+|+..++.++||||+++++.+.
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 85 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDR-------ATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYL 85 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEc-------cCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEE
Confidence 34556999999999999999999986 3458899999976532 4567889999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+..|+++||+.+++|.+++.... ..+++..+..
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------~~l~~~~~~~ 120 (286)
T cd06614 86 VGDELWVVMEYMDGGSLTDIITQNF---------------------------------------------VRMNEPQIAY 120 (286)
T ss_pred ECCEEEEEEeccCCCcHHHHHHHhc---------------------------------------------cCCCHHHHHH
Confidence 9999999999999888877665421 2688899999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+
T Consensus 121 i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 121 VCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred HHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 9999999999999999999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=185.56 Aligned_cols=145 Identities=29% Similarity=0.517 Sum_probs=124.8
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeE
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKI 144 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 144 (267)
|+-...||+|+||.||+|.+. .++..||+|.+... .......+.+|+.+++.++||||+++++.+...+..
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~-------~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVK-------SSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 92 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEc-------CCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEE
Confidence 444467999999999999886 45689999988543 233456789999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHH
Q psy2579 145 FLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 224 (267)
Q Consensus 145 ~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql 224 (267)
+++|||+.+++|.+.+. ...+++..+..++.|+
T Consensus 93 ~lv~e~~~~~~L~~~~~-----------------------------------------------~~~~~~~~~~~~~~ql 125 (292)
T cd06657 93 WVVMEFLEGGALTDIVT-----------------------------------------------HTRMNEEQIAAVCLAV 125 (292)
T ss_pred EEEEecCCCCcHHHHHh-----------------------------------------------cCCCCHHHHHHHHHHH
Confidence 99999999888765442 2257888999999999
Q ss_pred HHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 225 LSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 225 ~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.||+|||+.|++|+||+|+||+++.++.++|+|||++..+
T Consensus 126 ~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~ 166 (292)
T cd06657 126 LKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166 (292)
T ss_pred HHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceec
Confidence 99999999999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=181.81 Aligned_cols=154 Identities=23% Similarity=0.427 Sum_probs=127.9
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccc--------cchHHHHHHHHHHHHHhh-cCCCceeee
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAK--------LTPKARKMLSREIVSMES-VHHPNIIRL 134 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~~Ei~~l~~-l~hpnIv~~ 134 (267)
.|++.+.||+|+||.||+|.+.. ..+..+|+|.+.... ........+.+|+.++.. ++||||+++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~ 74 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKN------NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRY 74 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcC------CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeE
Confidence 38889999999999999999863 245889999886432 123344567789998875 699999999
Q ss_pred eeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCCh
Q psy2579 135 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214 (267)
Q Consensus 135 ~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~ 214 (267)
++++...+..+++|||+++++|.+.+... ......+++
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~------------------------------------------~~~~~~~~~ 112 (269)
T cd08528 75 YKTFLENDRLYIVMDLIEGAPLGEHFNSL------------------------------------------KEKKQRFTE 112 (269)
T ss_pred EeeEccCCeEEEEEecCCCCcHHHHHHHH------------------------------------------HhccCCCCH
Confidence 99999999999999999999887765321 112336888
Q ss_pred hHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 215 DDAKIYFLQILSAVKHLHD-RDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++...
T Consensus 113 ~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 164 (269)
T cd08528 113 ERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK 164 (269)
T ss_pred HHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeec
Confidence 9999999999999999996 78999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-26 Score=195.10 Aligned_cols=151 Identities=28% Similarity=0.468 Sum_probs=129.7
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhc-CCCceeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESV-HHPNIIRLYEVL 138 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~ 138 (267)
+..+|.++..||+|+||.|.+|..+ .+.+.+|||++++.-... ...+-.+.|-++|... +-|.+++++.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerk-------gtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF 419 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERK-------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF 419 (683)
T ss_pred eecccceEEEeccCccceeeeeccc-------CcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh
Confidence 4567999999999999999999887 445889999998765432 2344556788888876 788999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
.+-+++|+||||+.||+|...+.. -+++.+..+.
T Consensus 420 QTmDRLyFVMEyvnGGDLMyhiQQ----------------------------------------------~GkFKEp~Av 453 (683)
T KOG0696|consen 420 QTMDRLYFVMEYVNGGDLMYHIQQ----------------------------------------------VGKFKEPVAV 453 (683)
T ss_pred hhhhheeeEEEEecCchhhhHHHH----------------------------------------------hcccCCchhh
Confidence 999999999999999888766543 3578889999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
.++.+|+-||-|||++||+.||||.+|+|++.+|++||+|||+|+.
T Consensus 454 FYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 454 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred hhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc
Confidence 9999999999999999999999999999999999999999999974
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=183.63 Aligned_cols=148 Identities=32% Similarity=0.549 Sum_probs=126.0
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-CCceeeeeeeeeecCe
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-HPNIIRLYEVLETFGK 143 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~ 143 (267)
|++.+.||+|+||.||+|.+. .+++.||||.+...... .......+|+..++.++ ||||+++++++...+.
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~-------~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 72 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNK-------ETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDE 72 (283)
T ss_pred CeeheeeccCCceEEEEEEEC-------CCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCc
Confidence 678899999999999999986 34588999998765432 22334567999999998 9999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.+++||++ +|++.+.+.... ...+++..+..++.|
T Consensus 73 ~~lv~e~~-~~~l~~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~ 107 (283)
T cd07830 73 LYFVFEYM-EGNLYQLMKDRK--------------------------------------------GKPFSESVIRSIIYQ 107 (283)
T ss_pred EEEEEecC-CCCHHHHHHhcc--------------------------------------------cccCCHHHHHHHHHH
Confidence 99999999 777776664321 136789999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.+|.|||++|++|+||+|+||+++.++.++|+|||+++.+
T Consensus 108 l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~ 149 (283)
T cd07830 108 ILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREI 149 (283)
T ss_pred HHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceec
Confidence 999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=184.87 Aligned_cols=150 Identities=26% Similarity=0.369 Sum_probs=124.1
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-CCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-HPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~ 142 (267)
+|+..+.||+|+||.||++.+. .++..||+|.+...... .....+.+|+.++.++. ||||+++++++..++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~-------~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~ 76 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHK-------PSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG 76 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEEC-------CCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC
Confidence 4777889999999999999986 45689999998765433 44567889999999995 999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhh--cccCCCChhHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKI--TTEGRLSEDDAKIY 220 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~--~~~~~~~~~~~~~~ 220 (267)
..+++||++.. ++.++. ..+ .....+++..+..+
T Consensus 77 ~~~~~~e~~~~-~l~~l~-------------------------------------------~~~~~~~~~~l~~~~~~~i 112 (288)
T cd06616 77 DCWICMELMDI-SLDKFY-------------------------------------------KYVYEVLKSVIPEEILGKI 112 (288)
T ss_pred cEEEEEecccC-CHHHHH-------------------------------------------HHHHHhhcCCCCHHHHHHH
Confidence 99999999864 332211 111 12346899999999
Q ss_pred HHHHHHHHHHHHhC-CCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDR-DIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||+|||+. |++||||||+||+++.++.++|+|||+|+.+
T Consensus 113 ~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 113 AVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred HHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 99999999999974 9999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=182.72 Aligned_cols=155 Identities=25% Similarity=0.355 Sum_probs=126.3
Q ss_pred ccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEEe
Q psy2579 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVE 149 (267)
Q Consensus 70 ~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~e 149 (267)
.||+|+||.||+|.+...... ...+..+|+|.+.... .......+.+|+.+++.++||||+++++++...+..+++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~-~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGP-GSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccC-cccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 599999999999988643211 1234689999886542 23445678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHH
Q psy2579 150 YASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVK 229 (267)
Q Consensus 150 ~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~ 229 (267)
++.+++|.+++....... .....+++..+..++.|++.||.
T Consensus 80 ~~~~~~L~~~l~~~~~~~---------------------------------------~~~~~~~~~~~~~~~~~l~~~l~ 120 (269)
T cd05044 80 LMEGGDLLSYLRDARVER---------------------------------------FGPPLLTLKELLDICLDVAKGCV 120 (269)
T ss_pred ccCCCcHHHHHHHhhhcc---------------------------------------cCCccccHHHHHHHHHHHHHHHH
Confidence 999999988876431100 01234788999999999999999
Q ss_pred HHHhCCCcccCCCCCcEEeecCC-----ceEEecccccccc
Q psy2579 230 HLHDRDIIHRDIKAENVFLSVRG-----IVKLGDLGFSTKL 265 (267)
Q Consensus 230 ~lH~~~ivHrDlkp~NIll~~~~-----~~kl~DFGla~~l 265 (267)
|||+.+++|+||||+||+++.++ .++|+|||+++.+
T Consensus 121 ~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~ 161 (269)
T cd05044 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI 161 (269)
T ss_pred HHHhCCcccCCCChheEEEecCCCCCCcceEECCccccccc
Confidence 99999999999999999999877 8999999998754
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-26 Score=215.37 Aligned_cols=151 Identities=30% Similarity=0.518 Sum_probs=133.7
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
-+|+-...||.|.||.||-|.+. ++|.-.|+|.+............+.+|..++..++|||+|+++++-....
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~-------~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNL-------DTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE 1307 (1509)
T ss_pred eeeccccccCCcceeeeEEeecC-------CccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH
Confidence 34777889999999999999986 66788999999877766666677899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
.++|.||||++|+|.+.+.. .+..++.....+..
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~----------------------------------------------gri~dE~vt~vyt~ 1341 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEH----------------------------------------------GRIEDEMVTRVYTK 1341 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHh----------------------------------------------cchhhhhHHHHHHH
Confidence 99999999999888765543 33567778888999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
|++.|+.|||++|||||||||.||+++.+|.+|++|||.|..+.
T Consensus 1342 qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1342 QLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEec
Confidence 99999999999999999999999999999999999999998764
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=185.89 Aligned_cols=146 Identities=23% Similarity=0.348 Sum_probs=120.9
Q ss_pred EecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEE
Q psy2579 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFL 146 (267)
Q Consensus 67 ~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~i 146 (267)
+.+.+|.|++ ||.++.. .+++.||+|++............+.+|+.+++.++||||+++++++...+..++
T Consensus 6 i~~~~~~~~~--v~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (314)
T cd08216 6 IGKCFEDLMI--VHLAKHK-------PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYV 76 (314)
T ss_pred hhHhhcCCce--EEEEEec-------CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEE
Confidence 3344444444 5555543 346899999998765556667889999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS 226 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~ 226 (267)
+|||+.+|++.+++.... ...+++..+..++.|++.
T Consensus 77 ~~e~~~~~~l~~~l~~~~--------------------------------------------~~~~~~~~~~~~~~~l~~ 112 (314)
T cd08216 77 VSPLMAYGSCEDLLKTHF--------------------------------------------PEGLPELAIAFILKDVLN 112 (314)
T ss_pred EEeccCCCCHHHHHHHhc--------------------------------------------ccCCCHHHHHHHHHHHHH
Confidence 999999988877765321 124788889999999999
Q ss_pred HHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 227 AVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 227 ~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
||+|||++||+||||||+||+++.++.++|+|||.+..+
T Consensus 113 ~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~ 151 (314)
T cd08216 113 ALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSM 151 (314)
T ss_pred HHHHHHHCCeecCCCCcceEEEecCCceEEecCccceee
Confidence 999999999999999999999999999999999988643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=184.02 Aligned_cols=148 Identities=30% Similarity=0.536 Sum_probs=127.7
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeE
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKI 144 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 144 (267)
|++.+.||+|++|.||+|.+. .++..+|+|.+......+.....+.+|+.+++.++||||+++++++...+..
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 73 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDK-------LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDL 73 (283)
T ss_pred CccceeeecCCCceEEEEEcC-------CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCE
Confidence 667889999999999999985 4568899999877655544567788999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHH
Q psy2579 145 FLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 224 (267)
Q Consensus 145 ~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql 224 (267)
++++||+.+ ++.+.+... ...+++..+..++.|+
T Consensus 74 ~~v~e~~~~-~l~~~l~~~---------------------------------------------~~~~~~~~~~~~~~~i 107 (283)
T cd05118 74 YLVFEFMDT-DLYKLIKDR---------------------------------------------QRGLPESLIKSYLYQL 107 (283)
T ss_pred EEEEeccCC-CHHHHHHhh---------------------------------------------cccCCHHHHHHHHHHH
Confidence 999999875 555444321 2368999999999999
Q ss_pred HHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 225 LSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 225 ~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.||.|||++|++|+||+|+||+++.++.++|+|||.+..+
T Consensus 108 ~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~ 148 (283)
T cd05118 108 LQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSF 148 (283)
T ss_pred HHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence 99999999999999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=188.58 Aligned_cols=147 Identities=27% Similarity=0.406 Sum_probs=120.5
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|.+.+.||+|+||.||+|.+. .+++.||+|.+............+.+|+.+++.++||||+++++++....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 87 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDK-------RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV 87 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeC-------CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence 45999999999999999999986 45689999998765433444456889999999999999999999987543
Q ss_pred ------eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 143 ------KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 143 ------~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
..|+++|++.. ++.+.. ...+++..
T Consensus 88 ~~~~~~~~~lv~e~~~~-----------------------------------------------~l~~~~--~~~~~~~~ 118 (342)
T cd07879 88 SGDEFQDFYLVMPYMQT-----------------------------------------------DLQKIM--GHPLSEDK 118 (342)
T ss_pred cCCCCceEEEEeccccc-----------------------------------------------CHHHHH--cCCCCHHH
Confidence 34666666532 222222 23588899
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||+++..
T Consensus 119 ~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 119 VQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 9999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-24 Score=181.37 Aligned_cols=149 Identities=28% Similarity=0.409 Sum_probs=122.6
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc---CCCceeeeeeeeeec
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV---HHPNIIRLYEVLETF 141 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~~~~~~~~~ 141 (267)
|++.+.||+|+||.||+|.+. .++..||+|.+............+.+|+.+++.+ +||||+++++++...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 73 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDL-------NTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGP 73 (287)
T ss_pred CeEEEEecccCceEEEEEEEC-------CCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeec
Confidence 688999999999999999986 3458999999976544333345566788877666 599999999999887
Q ss_pred Ce-----EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 142 GK-----IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 142 ~~-----~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
+. .+++||++.+ +|.+++... ....+++..
T Consensus 74 ~~~~~~~~~l~~e~~~~-~l~~~l~~~--------------------------------------------~~~~l~~~~ 108 (287)
T cd07838 74 RTDRELKLTLVFEHVDQ-DLATYLSKC--------------------------------------------PKPGLPPET 108 (287)
T ss_pred cCCCCceeEEEehhccc-CHHHHHHHc--------------------------------------------cCCCCCHHH
Confidence 76 8888888864 555544321 112588999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+
T Consensus 109 ~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 109 IKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred HHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 9999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=188.33 Aligned_cols=160 Identities=29% Similarity=0.511 Sum_probs=120.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||.|+||.||+|.+. .++..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~-------~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~ 75 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDS-------DCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSG 75 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEEC-------CCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccc
Confidence 56999999999999999999986 4568999999866543 34466889999999999999999998776543
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
.... + .+ .........+++||+++ +++.+.+. ...+++..+..++.
T Consensus 76 ~~~~--~-----~~-------------------------~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~ 121 (342)
T cd07854 76 SDLT--E-----DV-------------------------GSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMY 121 (342)
T ss_pred cccc--c-----cc-------------------------ccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHH
Confidence 2100 0 00 00011223455555554 24444443 34689999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeec-CCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSV-RGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~l 265 (267)
|++.||.|||+.|++||||||+||+++. ++.++|+|||+++.+
T Consensus 122 qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~ 165 (342)
T cd07854 122 QLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV 165 (342)
T ss_pred HHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceec
Confidence 9999999999999999999999999974 557899999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=190.68 Aligned_cols=151 Identities=32% Similarity=0.466 Sum_probs=127.2
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHH-----HHHHHHHHHHHhhcCCCceeeeeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKA-----RKMLSREIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~-----~~~~~~Ei~~l~~l~hpnIv~~~~~ 137 (267)
.+|-++..||+|||++||+|.+. ...++||+|+-..++...+. .+-..+|..|.+.|+||-||++|++
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl-------~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy 535 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDL-------TEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY 535 (775)
T ss_pred HHHHHHHHhccccHHHHHHhccc-------chhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence 45999999999999999999996 55699999998776644322 2446799999999999999999999
Q ss_pred eeec-CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 138 LETF-GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 138 ~~~~-~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
|.-+ +.+|-|+|||+|.+|..+++. ..-+++.+
T Consensus 536 fslDtdsFCTVLEYceGNDLDFYLKQ----------------------------------------------hklmSEKE 569 (775)
T KOG1151|consen 536 FSLDTDSFCTVLEYCEGNDLDFYLKQ----------------------------------------------HKLMSEKE 569 (775)
T ss_pred eeeccccceeeeeecCCCchhHHHHh----------------------------------------------hhhhhHHH
Confidence 8754 568888999888777666654 34589999
Q ss_pred HHHHHHHHHHHHHHHHhC--CCcccCCCCCcEEeec---CCceEEeccccccccC
Q psy2579 217 AKIYFLQILSAVKHLHDR--DIIHRDIKAENVFLSV---RGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~--~ivHrDlkp~NIll~~---~~~~kl~DFGla~~l~ 266 (267)
++.|+-||+.||.||... .|||-||||.|||+-. .|.+||+||||++.+.
T Consensus 570 ARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMd 624 (775)
T KOG1151|consen 570 ARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMD 624 (775)
T ss_pred HHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhcc
Confidence 999999999999999976 6999999999999943 4689999999999875
|
|
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-25 Score=181.59 Aligned_cols=146 Identities=30% Similarity=0.464 Sum_probs=115.7
Q ss_pred cceEEe-cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeee
Q psy2579 63 ALYKLQ-NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLET 140 (267)
Q Consensus 63 ~~y~~~-~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 140 (267)
.+|++- +.||-|-.|.|..|.++ .+++.+|+|++..+ ...++|+++.-.. .|||||+++++++.
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k-------~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHK-------RTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hhheehhhhhccccCCceEEEEec-------cchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 446664 57999999999999998 55689999998543 2345788776555 79999999999864
Q ss_pred c----CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 141 F----GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 141 ~----~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
. ..+.+|||.++||.|.+.+... ...++++.+
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~--------------------------------------------g~~afTEre 162 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDR--------------------------------------------GDQAFTERE 162 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHc--------------------------------------------ccccchHHH
Confidence 3 3456677777766665555433 123699999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecC---CceEEeccccccccC
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVR---GIVKLGDLGFSTKLQ 266 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~---~~~kl~DFGla~~l~ 266 (267)
+..++.||+.|+.|||+.+|.||||||+|+|.... ..+||+|||+|+.-+
T Consensus 163 a~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 163 ASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred HHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence 99999999999999999999999999999999654 479999999998754
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=182.92 Aligned_cols=148 Identities=28% Similarity=0.485 Sum_probs=127.9
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeE
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKI 144 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 144 (267)
|++.+.||+|+||.||+|.+. .+++.||+|++............+.+|+.+++.++|||++++++++...+..
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 73 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDK-------KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKL 73 (282)
T ss_pred CeeehcccccCcceEEEeeec-------CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCce
Confidence 677889999999999999986 4468999999987653334446678899999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHH
Q psy2579 145 FLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 224 (267)
Q Consensus 145 ~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql 224 (267)
++++|++.+ +|.+.+... ...+++..+..++.|+
T Consensus 74 ~~v~e~~~~-~l~~~i~~~---------------------------------------------~~~~~~~~~~~~~~~i 107 (282)
T cd07829 74 YLVFEYCDM-DLKKYLDKR---------------------------------------------PGPLSPNLIKSIMYQL 107 (282)
T ss_pred EEEecCcCc-CHHHHHHhh---------------------------------------------ccCCCHHHHHHHHHHH
Confidence 999999874 676655432 1368999999999999
Q ss_pred HHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 225 LSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 225 ~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.||+|||++|++|+||+|+||+++.++.++|+|||+++.+
T Consensus 108 ~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~ 148 (282)
T cd07829 108 LRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAF 148 (282)
T ss_pred HHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCccccc
Confidence 99999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=182.07 Aligned_cols=147 Identities=27% Similarity=0.400 Sum_probs=124.7
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
|...+.||+|+||.||+|.+. .++..||+|.+..... .......+.+|+.+++.++|||++++++++.+...
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~-------~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 95 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNS-------HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT 95 (313)
T ss_pred hhcceeeccCCCeEEEEEEEC-------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence 777788999999999999885 4568999999875433 23344678899999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.|++|||+.+ ++.+.+.. ...++++..+..++.|
T Consensus 96 ~~lv~e~~~~-~l~~~l~~---------------------------------------------~~~~l~~~~~~~~~~q 129 (313)
T cd06633 96 AWLVMEYCLG-SASDLLEV---------------------------------------------HKKPLQEVEIAAITHG 129 (313)
T ss_pred EEEEEecCCC-CHHHHHHh---------------------------------------------cCCCCCHHHHHHHHHH
Confidence 9999999864 55444322 1236888999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
++.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus 130 i~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~ 170 (313)
T cd06633 130 ALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK 170 (313)
T ss_pred HHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcc
Confidence 99999999999999999999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=180.67 Aligned_cols=152 Identities=31% Similarity=0.535 Sum_probs=124.1
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccc---ccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKA---KLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
+|.+.+.||+|+||.||+|.+... +..+++|+++.. .........+.+|+.+++.++||||+++++++..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKA-------VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE 73 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCC-------CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc
Confidence 489999999999999999988632 344556665432 2233344567789999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
....++++||+.+++|.+.+.... .....+++..+..+
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~~~------------------------------------------~~~~~~~~~~~~~~ 111 (260)
T cd08222 74 RDAFCIITEYCEGRDLDCKLEELK------------------------------------------HTGKTLSENQVCEW 111 (260)
T ss_pred CCceEEEEEeCCCCCHHHHHHHHh------------------------------------------hcccccCHHHHHHH
Confidence 999999999999988877664321 12346899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||+.|++|+||+|+||+++. +.++|+|||+++.+
T Consensus 112 ~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred HHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeec
Confidence 999999999999999999999999999974 67999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=182.06 Aligned_cols=152 Identities=16% Similarity=0.147 Sum_probs=108.6
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch--HH-------HHHHHHHHHHHhhcCCCceee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP--KA-------RKMLSREIVSMESVHHPNIIR 133 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~-------~~~~~~Ei~~l~~l~hpnIv~ 133 (267)
++|++.+.||+|+||.||+|.+..+. .....+|+|+........ +. ......+...+..+.|+|+++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~----~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDH----CINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCc----ccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 46999999999999999999876331 114567888654332111 00 011223445566679999999
Q ss_pred eeeeeeecC----eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhccc
Q psy2579 134 LYEVLETFG----KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTE 209 (267)
Q Consensus 134 ~~~~~~~~~----~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~ 209 (267)
+++++.... ..+++++++.. ++.+.+...
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~ 120 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVE-----------------------------------------------NTKEIFKRI 120 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhcc-----------------------------------------------CHHHHHHhh
Confidence 998765443 23455554322 223333333
Q ss_pred CCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 210 GRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 210 ~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
...++..+..++.|++.||+|||+++++||||||+|||++.++.++|+|||+|+.+
T Consensus 121 ~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~ 176 (294)
T PHA02882 121 KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHF 176 (294)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceee
Confidence 34678889999999999999999999999999999999999999999999999764
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=182.87 Aligned_cols=149 Identities=28% Similarity=0.418 Sum_probs=125.8
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.|+..+.||.|+||.||+|++. .++..||+|.+..... .......+.+|+.+++.++|||++++++++...+
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 88 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDV-------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEc-------CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence 3888889999999999999986 3458899999865332 3344567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+|+||+. |++.+.+.. ...++++..+..++.
T Consensus 89 ~~~lv~e~~~-~~l~~~~~~---------------------------------------------~~~~l~~~~~~~~~~ 122 (308)
T cd06634 89 TAWLVMEYCL-GSASDLLEV---------------------------------------------HKKPLQEVEIAAVTH 122 (308)
T ss_pred eeEEEEEccC-CCHHHHHHH---------------------------------------------cCCCCCHHHHHHHHH
Confidence 9999999986 455544322 123588899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++|++||||+|+||+++.++.++|+|||++..+
T Consensus 123 ~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 123 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred HHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceee
Confidence 9999999999999999999999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=194.82 Aligned_cols=157 Identities=29% Similarity=0.511 Sum_probs=130.7
Q ss_pred cccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeee
Q psy2579 56 TSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRL 134 (267)
Q Consensus 56 ~~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~ 134 (267)
.+..++.+-|+|.+.||.|.+|.||+++.+ .+++.+|+|++.... ...+++..|..+++.. .|||++.+
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~-------~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~f 81 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHV-------KTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATF 81 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeee-------ecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceE
Confidence 344556667999999999999999999998 445889999987653 3335677789999888 89999999
Q ss_pred eeeeeec-----CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhccc
Q psy2579 135 YEVLETF-----GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTE 209 (267)
Q Consensus 135 ~~~~~~~-----~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~ 209 (267)
+++|... +.+|+|||||.+||.-+.+++.. .
T Consensus 82 yg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--------------------------------------------g 117 (953)
T KOG0587|consen 82 YGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--------------------------------------------G 117 (953)
T ss_pred EEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--------------------------------------------c
Confidence 9998654 45777777777777766555321 4
Q ss_pred CCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 210 GRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 210 ~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.++.|..+..|++.++.||.+||...++|||||-.|||++.++.+||+|||++.++.
T Consensus 118 ~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 118 NRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred cchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 579999999999999999999999999999999999999999999999999998764
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=178.39 Aligned_cols=144 Identities=28% Similarity=0.477 Sum_probs=118.1
Q ss_pred ecceEEeccc--CccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeee
Q psy2579 62 VALYKLQNEL--GRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVL 138 (267)
Q Consensus 62 ~~~y~~~~~i--G~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~ 138 (267)
.++|++.+.+ |+|+||.||++.+. .++..+|+|++........ |+.....+ +||||+++++.+
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~-------~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~ 78 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHK-------PTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSV 78 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEc-------CCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEE
Confidence 3457777776 99999999999886 4558899999875433221 22222223 799999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
...+..|+||||+++++|.+++.. ...+++.++.
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~----------------------------------------------~~~l~~~~~~ 112 (267)
T PHA03390 79 TTLKGHVLIMDYIKDGDLFDLLKK----------------------------------------------EGKLSEAEVK 112 (267)
T ss_pred ecCCeeEEEEEcCCCCcHHHHHHh----------------------------------------------cCCCCHHHHH
Confidence 999999999999998877766543 2368999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC-ceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG-IVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~l 265 (267)
.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||+++.+
T Consensus 113 ~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 113 KIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred HHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 9999999999999999999999999999999988 9999999998754
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=175.56 Aligned_cols=142 Identities=37% Similarity=0.620 Sum_probs=124.0
Q ss_pred cCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEEe
Q psy2579 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVE 149 (267)
Q Consensus 71 iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~e 149 (267)
||.|+||.||+|.+. .+++.+|+|++...... ......+.+|+.+++.++||||+++++.+...+..|++||
T Consensus 1 lg~G~~~~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 73 (250)
T cd05123 1 LGKGSFGKVLLVRKK-------DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLE 73 (250)
T ss_pred CCCCCceEEEEEEEC-------CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEe
Confidence 799999999999886 34589999998766433 2345678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHH
Q psy2579 150 YASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVK 229 (267)
Q Consensus 150 ~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~ 229 (267)
++.+++|.+++.. ...+++..+..++.|++.||.
T Consensus 74 ~~~~~~L~~~l~~----------------------------------------------~~~l~~~~~~~~~~qi~~~l~ 107 (250)
T cd05123 74 YAPGGELFSHLSK----------------------------------------------EGRFSEERARFYAAEIVLALE 107 (250)
T ss_pred cCCCCcHHHHHHh----------------------------------------------cCCCCHHHHHHHHHHHHHHHH
Confidence 9988777666543 235888999999999999999
Q ss_pred HHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 230 HLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 230 ~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|+|+++++|+||+|+||+++.++.++|+|||++...
T Consensus 108 ~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 143 (250)
T cd05123 108 YLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKEL 143 (250)
T ss_pred HHHHCCceecCCCcceEEEcCCCcEEEeecCcceec
Confidence 999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=180.27 Aligned_cols=151 Identities=24% Similarity=0.345 Sum_probs=123.9
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~ 139 (267)
..++|++.+.||+|+||.||+|.+. .++..||||.++..... .....+.+|+.++... .||||+++++++.
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFK-------KTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEEC-------CCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence 4567999999999999999999986 44689999999765433 3345566777777666 5999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+..|++||++.+ ++.+.... ....+++..+..
T Consensus 85 ~~~~~~~v~e~~~~-~l~~l~~~---------------------------------------------~~~~l~~~~~~~ 118 (296)
T cd06618 85 TDSDVFICMELMST-CLDKLLKR---------------------------------------------IQGPIPEDILGK 118 (296)
T ss_pred cCCeEEEEeeccCc-CHHHHHHH---------------------------------------------hcCCCCHHHHHH
Confidence 99999999999753 44332221 123688899999
Q ss_pred HHHHHHHHHHHHHh-CCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHD-RDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||+|||+ .|++||||+|+||+++.++.++|+|||++..+
T Consensus 119 i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 119 MTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred HHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 99999999999997 59999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=189.21 Aligned_cols=183 Identities=19% Similarity=0.239 Sum_probs=126.1
Q ss_pred eecceEEecccCccCceeEEEeEEeeccc---------ccccccceEEEEeecccccchH------------HHHHHHHH
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVP---------ILCTYISYLAIKILDKAKLTPK------------ARKMLSRE 119 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~---------~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~~E 119 (267)
..++|++.++||+|+||.||+|.+...+. .....++.||||.+........ ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 35679999999999999999997632221 0113356899999865421100 11223457
Q ss_pred HHHHhhcCCCce-----eeeeeeeee--------cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhc
Q psy2579 120 IVSMESVHHPNI-----IRLYEVLET--------FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLET 186 (267)
Q Consensus 120 i~~l~~l~hpnI-----v~~~~~~~~--------~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (267)
+..+..++|.++ ++++++|.. .+..|+|+||+.+++|.++++.........-
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L--------------- 287 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCL--------------- 287 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchH---------------
Confidence 777777766544 667777653 3568999999999999999975422111000
Q ss_pred cCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 187 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 187 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+++..+...........+++..+..++.|++.||.|+|+++++||||||+||+++.++.+||+|||+|+.+
T Consensus 288 -------~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~ 359 (507)
T PLN03224 288 -------EEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDM 359 (507)
T ss_pred -------HHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCcccc
Confidence 001111111111112335778899999999999999999999999999999999999999999999998754
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-25 Score=174.63 Aligned_cols=142 Identities=28% Similarity=0.447 Sum_probs=119.0
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-CCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-HPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~ 140 (267)
..+|++.+++|+|.+++||.|+.- .+.+.++||++++ -....+.||+.+|..|. ||||+.+++...+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~-------~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINI-------TNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred cchHHHHHHHcCccHhhHhccccc-------CCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 456999999999999999999875 4458999999964 33466889999999995 9999999999876
Q ss_pred cC--eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 141 FG--KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 141 ~~--~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
+. .+.+++|+..+.+..... ..++..+++
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly-------------------------------------------------~tl~d~dIr 135 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLY-------------------------------------------------PTLTDYDIR 135 (338)
T ss_pred ccccCchhHhhhhccccHHHHh-------------------------------------------------hhhchhhHH
Confidence 63 466788877765543222 257788999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC-ceEEeccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG-IVKLGDLGFSTK 264 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~ 264 (267)
.++.|++.||.|+||.||+|||+||.|++|+... .++|+|+|||..
T Consensus 136 yY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 136 YYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhh
Confidence 9999999999999999999999999999998765 699999999853
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-24 Score=198.20 Aligned_cols=152 Identities=30% Similarity=0.382 Sum_probs=129.4
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeE
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKI 144 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 144 (267)
.+..++||+|+||+||+|.|-..+ ..-.-+||||++.... ..+.-..+++|+.+|..++|||++++++++.... +
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Peg---e~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEG---ENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCC---ceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 334567999999999999986432 2334689999996543 4555678999999999999999999999998766 8
Q ss_pred EEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHH
Q psy2579 145 FLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 224 (267)
Q Consensus 145 ~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql 224 (267)
.||++|+..|+|.++++.+ +.++.....+.|..||
T Consensus 773 qlvtq~mP~G~LlDyvr~h---------------------------------------------r~~igsq~lLnw~~QI 807 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREH---------------------------------------------RDNIGSQDLLNWCYQI 807 (1177)
T ss_pred HHHHHhcccchHHHHHHHh---------------------------------------------hccccHHHHHHHHHHH
Confidence 8889999988888877654 3478889999999999
Q ss_pred HHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 225 LSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 225 ~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
++||.|||.++++||||..+|+|+.....+||+|||+|+.+.
T Consensus 808 AkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 808 AKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 999999999999999999999999999999999999998763
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=194.91 Aligned_cols=169 Identities=25% Similarity=0.408 Sum_probs=137.0
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeecCe
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETFGK 143 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~ 143 (267)
.++.+.||.|+||.|++|.-.............||||.++..... ...+.+..|+.+|+.+ +||||+.+++++...+.
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 456668999999999999865433221122578999999877655 6778899999999999 79999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhccc-CCCChhHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTE-GRLSEDDAKIYFL 222 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~ 222 (267)
.++|+|||..|+|..+++..+... -..+.. ..... ..++..+...++.
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~----------------------------~~~~~~---~~~~~~~~L~~~dLlsfa~ 425 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTE----------------------------SIDGSG---VFPNERDALTTKDLLSFAY 425 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccc----------------------------cccccC---CCccccCCcCHHHHHHHHH
Confidence 999999999999999998875000 000000 00011 3589999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
||+.|++||++..+|||||..+|||+..+..+||+|||+|+..
T Consensus 426 QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~ 468 (609)
T KOG0200|consen 426 QIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDH 468 (609)
T ss_pred HHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceecc
Confidence 9999999999999999999999999999999999999999853
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=164.57 Aligned_cols=152 Identities=24% Similarity=0.365 Sum_probs=125.9
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~ 142 (267)
...-+..||+|++|.|-+-++. .+|.-.|+|.+...- +.+...++.+|+.+.... ..|.+|.+||..-..+
T Consensus 47 ~L~~i~elGrGayG~vekmrh~-------~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHI-------QSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred hhhhhhhhcCCccchhhheeec-------cCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 3445678999999999888886 456889999997665 445567788899887766 8999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..||.||.|.. ||..+. .+.+...+.+++..+-.++.
T Consensus 119 dvwIcME~M~t-Sldkfy------------------------------------------~~v~~~g~~ipE~vlGkIa~ 155 (282)
T KOG0984|consen 119 DVWICMELMDT-SLDKFY------------------------------------------RKVLKKGGTIPEDVLGKIAV 155 (282)
T ss_pred cEEEeHHHhhh-hHHHHH------------------------------------------HHHHhcCCcCchHHhhHhHH
Confidence 99999998853 222111 13344567899999999999
Q ss_pred HHHHHHHHHHhC-CCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 223 QILSAVKHLHDR-DIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.+..||.|||++ .++|||+||+|||++.+|++|+||||.|-.+.
T Consensus 156 Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 156 SVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 999999999987 89999999999999999999999999998764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=167.47 Aligned_cols=135 Identities=21% Similarity=0.244 Sum_probs=99.6
Q ss_pred ecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-----CCCceeeeeeeeeecC
Q psy2579 68 QNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-----HHPNIIRLYEVLETFG 142 (267)
Q Consensus 68 ~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-----~hpnIv~~~~~~~~~~ 142 (267)
.+.||+|+||.||. +. .+... +||++..... ...+.+.+|+.+++.+ .||||+++++++++..
T Consensus 7 ~~~LG~G~~~~Vy~--hp-------~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~ 74 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HP-------EDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC 74 (210)
T ss_pred cceecCCCceEEEE--CC-------CCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC
Confidence 35699999999995 43 22234 6998866432 2346789999999999 5799999999998873
Q ss_pred ---eEE-EEEee--cCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 143 ---KIF-LVVEY--ASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 143 ---~~~-iv~e~--~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
.++ +|+|| +.+|+|.+++.+ ..+++.
T Consensus 75 g~g~v~~~I~e~~G~~~~tL~~~l~~-----------------------------------------------~~~~e~- 106 (210)
T PRK10345 75 GTGYVYDVIADFDGKPSITLTEFAEQ-----------------------------------------------CRYEED- 106 (210)
T ss_pred CCeEEEEEEecCCCCcchhHHHHHHc-----------------------------------------------ccccHh-
Confidence 433 67888 335666555532 234444
Q ss_pred HHHHHHHHHHHH-HHHHhCCCcccCCCCCcEEeecC----CceEEecccccc
Q psy2579 217 AKIYFLQILSAV-KHLHDRDIIHRDIKAENVFLSVR----GIVKLGDLGFST 263 (267)
Q Consensus 217 ~~~~~~ql~~~L-~~lH~~~ivHrDlkp~NIll~~~----~~~kl~DFGla~ 263 (267)
..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.++
T Consensus 107 -~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 107 -VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred -HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 35678888888 99999999999999999999743 379999944443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=193.24 Aligned_cols=171 Identities=20% Similarity=0.231 Sum_probs=113.5
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeee--
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEV-- 137 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~-- 137 (267)
...++|++.+.||+|+||.||+|.+..+.. ..+..||+|.+...... +....| .+....+.++..+...
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~---~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQS---KKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFL 199 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCcc---ccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhh
Confidence 356789999999999999999999864311 22688999987643211 111111 1111222222222221
Q ss_pred ----eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCC
Q psy2579 138 ----LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLS 213 (267)
Q Consensus 138 ----~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~ 213 (267)
....+..++++||+.+++|.+++..... .+.+++++.+. . ..+.......
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~------------------------~~~v~~~l~~~-~-~~l~~~~~r~ 253 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEF------------------------PYNVEPYLLGK-V-QDLPKGLERE 253 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCC------------------------chhHHHHhccc-h-hhccccchhh
Confidence 2455679999999999999988865421 12222232221 1 1111112234
Q ss_pred hhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeec-CCceEEecccccccc
Q psy2579 214 EDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSV-RGIVKLGDLGFSTKL 265 (267)
Q Consensus 214 ~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~l 265 (267)
...+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+.+
T Consensus 254 ~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l 306 (566)
T PLN03225 254 NKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADL 306 (566)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCcccc
Confidence 5567789999999999999999999999999999986 579999999999864
|
|
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-24 Score=172.31 Aligned_cols=151 Identities=22% Similarity=0.311 Sum_probs=125.5
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~ 139 (267)
.++..+++..||.|+.|.||+++++ .++...|||.+..+.. .+..++++..+.++... +.|.||+.+|+|.
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~r-------s~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFR-------STGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEc-------ccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 3556778889999999999999998 4558899999988763 45567788888888776 4899999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhc-ccCCCChhHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKIT-TEGRLSEDDAK 218 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~ 218 (267)
....+++.||.|.. ....++. ..+++++.-+-
T Consensus 162 ~n~dV~IcMelMs~-----------------------------------------------C~ekLlkrik~piPE~ilG 194 (391)
T KOG0983|consen 162 TNTDVFICMELMST-----------------------------------------------CAEKLLKRIKGPIPERILG 194 (391)
T ss_pred eCchHHHHHHHHHH-----------------------------------------------HHHHHHHHhcCCchHHhhh
Confidence 99999999998742 1111121 24579999999
Q ss_pred HHHHHHHHHHHHHHh-CCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 219 IYFLQILSAVKHLHD-RDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.+...+..||.||-. +||+|||+||+|||+|..|++||||||.|-++-
T Consensus 195 k~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 195 KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred hhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee
Confidence 999999999999995 589999999999999999999999999987653
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-23 Score=164.15 Aligned_cols=148 Identities=23% Similarity=0.273 Sum_probs=121.6
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-CCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-HPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~ 139 (267)
+.+.|+++++||.|+||.+|.|..- ..++.||||+-+...-. ..+..|..+...|+ -++|+.+..++.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i-------~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISI-------TSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eccceEEEEeecCCchhheeeeeec-------cCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhcc
Confidence 4567999999999999999999886 56799999998655433 34678999999995 578888888888
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhc-ccCCCChhHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKIT-TEGRLSEDDAK 218 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~ 218 (267)
+.....+||+++. +| |.+++. ...+++..+++
T Consensus 82 e~~ynvlVMdLLG-Ps----------------------------------------------LEdLfnfC~R~ftmkTvL 114 (341)
T KOG1163|consen 82 EKDYNVLVMDLLG-PS----------------------------------------------LEDLFNFCSRRFTMKTVL 114 (341)
T ss_pred ccccceeeeeccC-cc----------------------------------------------HHHHHHHHhhhhhHHhHH
Confidence 8888889998773 33 333332 23479999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecC---CceEEeccccccccC
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVR---GIVKLGDLGFSTKLQ 266 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~---~~~kl~DFGla~~l~ 266 (267)
.++-|++.-++|+|.++++||||||+|+|..-+ ..+.++|||||+...
T Consensus 115 MLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 115 MLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred HHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 999999999999999999999999999998543 469999999998753
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.3e-23 Score=169.91 Aligned_cols=132 Identities=24% Similarity=0.386 Sum_probs=111.6
Q ss_pred cCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEEeecCC
Q psy2579 74 GNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASG 153 (267)
Q Consensus 74 G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~e~~~~ 153 (267)
|.+|.||+|++. .+++.||+|.+.... ...+|...+....||||+++++++...+..|++|||+.+
T Consensus 4 g~~~~v~~~~~~-------~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 69 (237)
T cd05576 4 GVIDKVLLVMDT-------RTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69 (237)
T ss_pred cccceEEEEEEc-------cCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence 899999999997 556899999986542 123455555556799999999999999999999999998
Q ss_pred CchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHHHHHh
Q psy2579 154 GELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHD 233 (267)
Q Consensus 154 gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~ 233 (267)
|+|.+.+.. ...+++..+..++.|++.||+|+|+
T Consensus 70 ~~L~~~l~~----------------------------------------------~~~l~~~~~~~~~~ql~~~l~~lH~ 103 (237)
T cd05576 70 GKLWSHISK----------------------------------------------FLNIPEECVKRWAAEMVVALDALHR 103 (237)
T ss_pred CCHHHHHHH----------------------------------------------hcCCCHHHHHHHHHHHHHHHHHHHh
Confidence 887665542 2358899999999999999999999
Q ss_pred CCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 234 RDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 234 ~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+|++||||||+||+++.++.++++|||++..+
T Consensus 104 ~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~ 135 (237)
T cd05576 104 EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEV 135 (237)
T ss_pred CCeeccCCCHHHEEEcCCCCEEEecccchhcc
Confidence 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-24 Score=193.46 Aligned_cols=150 Identities=29% Similarity=0.426 Sum_probs=131.5
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
.-.+|+++..+|.|++|.||+|++.. +++..|+|+++...- .....++.|+-+++..+|||||.+++.+..
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~-------s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr 83 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKR-------SGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLR 83 (829)
T ss_pred CccchhheeeecCCcccchhhhcccc-------cCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhh
Confidence 34569999999999999999999974 458899999987643 334567889999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
...+|+.||||.+|+|.+..+ .-+++++.++...
T Consensus 84 ~dklwicMEycgggslQdiy~----------------------------------------------~Tgplselqiayv 117 (829)
T KOG0576|consen 84 RDKLWICMEYCGGGSLQDIYH----------------------------------------------VTGPLSELQIAYV 117 (829)
T ss_pred hcCcEEEEEecCCCcccceee----------------------------------------------ecccchhHHHHHH
Confidence 999999999999988765433 3357999999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++..+.||+|+|++|-+|||||-.||++++.|.+|+.|||.+.++
T Consensus 118 cRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 118 CRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred HhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhh
Confidence 999999999999999999999999999999999999999998765
|
|
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-22 Score=178.80 Aligned_cols=148 Identities=26% Similarity=0.385 Sum_probs=122.6
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~ 142 (267)
.|+++++||+||.+.||++... ...-+|+|.+.....+.+..+.+.+|+.+|.+| .|.+||+++++-..++
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s--------~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNS--------DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecC--------CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 4999999999999999999763 235567776666556777889999999999999 6999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
.+|+|||+ +..+|...|..... .++...+..+-.
T Consensus 434 ~lYmvmE~-Gd~DL~kiL~k~~~---------------------------------------------~~~~~~lk~ywk 467 (677)
T KOG0596|consen 434 YLYMVMEC-GDIDLNKILKKKKS---------------------------------------------IDPDWFLKFYWK 467 (677)
T ss_pred eEEEEeec-ccccHHHHHHhccC---------------------------------------------CCchHHHHHHHH
Confidence 99999995 44455555543321 233347788889
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
|++.++.++|..||||.||||.|+|+- .|.+||+|||.|..++
T Consensus 468 qML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 468 QMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred HHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 999999999999999999999999985 7999999999998875
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.3e-24 Score=171.00 Aligned_cols=153 Identities=26% Similarity=0.369 Sum_probs=121.9
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~ 142 (267)
+.+-+..||.|+||+|++-.++ ..++..|||.+..... .....+++.|.....+- +.||||++||+.-..+
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk-------~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHK-------PSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG 136 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcC-------ccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence 3455678999999999999997 5568999999977653 45567788888776655 8999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..||.||+|.- |+..+.+. -+......+++.-+-.+..
T Consensus 137 dcWiCMELMd~-SlDklYk~-----------------------------------------vy~vq~~~ipE~Ilg~Itv 174 (361)
T KOG1006|consen 137 DCWICMELMDI-SLDKLYKR-----------------------------------------VYSVQKSRIPENILGHITV 174 (361)
T ss_pred ceeeeHHHHhh-hHHHHHHH-----------------------------------------HHHHHhccCcHhhhhheee
Confidence 99999999853 22211110 0111234688888888888
Q ss_pred HHHHHHHHHHh-CCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 223 QILSAVKHLHD-RDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
-.+.||+||-. ..|||||+||+|||++..|.+||||||.|-.+.
T Consensus 175 atV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 175 ATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred eehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 88999999985 489999999999999999999999999998764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=166.32 Aligned_cols=145 Identities=19% Similarity=0.241 Sum_probs=109.2
Q ss_pred ceEEecccCccCceeEEEeE-EeecccccccccceEEEEeecccccch----------------------HHHHHHHHHH
Q psy2579 64 LYKLQNELGRGNFSTVKMAI-HEIYVPILCTYISYLAIKILDKAKLTP----------------------KARKMLSREI 120 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~-~~~~~~~~~~~~~~vaiK~~~~~~~~~----------------------~~~~~~~~Ei 120 (267)
.|++.+.||+|+||.||+|. +. .+++.||+|++....... .....+.+|+
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~-------~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 101 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFD-------GSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEF 101 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecC-------CCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHH
Confidence 48899999999999999998 43 356899999997543210 0123467899
Q ss_pred HHHhhcCCC--ceeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEcc
Q psy2579 121 VSMESVHHP--NIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYAS 198 (267)
Q Consensus 121 ~~l~~l~hp--nIv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~ 198 (267)
.++..+.+. .++++++. +..++|||++.++++....
T Consensus 102 ~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~-------------------------------------- 139 (237)
T smart00090 102 RNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPR-------------------------------------- 139 (237)
T ss_pred HHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccc--------------------------------------
Confidence 999999753 34444432 2347888888776653321
Q ss_pred CCchhhhhcccCCCChhHHHHHHHHHHHHHHHHHhCC-CcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 199 GGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRD-IIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 199 ~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~~~-ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.....+....+..++.|++.++.+||++| ++||||||+||+++ ++.++|+|||.|+...
T Consensus 140 --------~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 140 --------LKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred --------cccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 12234556677889999999999999999 99999999999999 8899999999998654
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-24 Score=185.73 Aligned_cols=153 Identities=30% Similarity=0.491 Sum_probs=130.4
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
.+.+.+.+..||-|+||.|-++..... ...+|+|++++.... ....+-+..|-.+|..++.|.||++|..|.
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~-------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr 490 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQ-------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR 490 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEeccc-------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc
Confidence 456688899999999999998876421 134899999876643 345567889999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
+...+|+.||-|-||.++. .+...+.++...+..
T Consensus 491 d~kyvYmLmEaClGGElWT----------------------------------------------iLrdRg~Fdd~tarF 524 (732)
T KOG0614|consen 491 DSKYVYMLMEACLGGELWT----------------------------------------------ILRDRGSFDDYTARF 524 (732)
T ss_pred cchhhhhhHHhhcCchhhh----------------------------------------------hhhhcCCcccchhhh
Confidence 9998888888887765554 445566788999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
++..++.|++|||++|||.|||||+|++++.+|.+||.|||+|+.+.
T Consensus 525 ~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 525 YVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 99999999999999999999999999999999999999999999864
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.2e-22 Score=160.77 Aligned_cols=139 Identities=17% Similarity=0.168 Sum_probs=106.2
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchH-HHHH------HHHHHHHHhhcCCCceeeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPK-ARKM------LSREIVSMESVHHPNIIRLY 135 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~------~~~Ei~~l~~l~hpnIv~~~ 135 (267)
++|++.+.+|.|+||.||++.. ++..+|||++.+.....+ ...+ +.+|+..+.++.||+|..+.
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~---------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~ 101 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT---------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLN 101 (232)
T ss_pred CceEEEEEecCCCceEEEEEec---------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcce
Confidence 5699999999999999998643 135799999976654332 2233 67999999999999999998
Q ss_pred eeeeec--------CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhc
Q psy2579 136 EVLETF--------GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKIT 207 (267)
Q Consensus 136 ~~~~~~--------~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~ 207 (267)
+++... +..+++|||++|.+| .+..
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL----------------------------------------------~~~~- 134 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVEL----------------------------------------------NDMP- 134 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccH----------------------------------------------HHhh-
Confidence 886643 235555555555444 3331
Q ss_pred ccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 208 TEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 208 ~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+++ ....+++.+|..+|+.|++|+|++|+||+++.+| ++|+|||.++..
T Consensus 135 ---~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~ 184 (232)
T PRK10359 135 ---EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCT 184 (232)
T ss_pred ---hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccc
Confidence 1222 2456899999999999999999999999999988 999999988765
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=159.06 Aligned_cols=148 Identities=40% Similarity=0.729 Sum_probs=128.0
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeE
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKI 144 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~ 144 (267)
|++.+.||.|++|.||+|.+. .++..+|+|.+...... .....+.+|+..++.++|+|++++++++......
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDK-------GTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPL 72 (225)
T ss_pred CceeeEeecCCCeEEEEEEEc-------CCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCce
Confidence 567889999999999999886 34588999999765433 2467889999999999999999999999988899
Q ss_pred EEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCC-CChhHHHHHHHH
Q psy2579 145 FLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGR-LSEDDAKIYFLQ 223 (267)
Q Consensus 145 ~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~q 223 (267)
++++|++.+++|.+++... .. +++..+..++.+
T Consensus 73 ~~v~e~~~~~~L~~~~~~~----------------------------------------------~~~~~~~~~~~~~~~ 106 (225)
T smart00221 73 YLVMEYCEGGDLFDYLRKK----------------------------------------------GGKLSEEEARFYLRQ 106 (225)
T ss_pred EEEEeccCCCCHHHHHHhc----------------------------------------------ccCCCHHHHHHHHHH
Confidence 9999999887777665432 23 788899999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
++.++.+||+++++|+|++|+||+++.++.++|+|||++..+.
T Consensus 107 l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 107 ILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIH 149 (225)
T ss_pred HHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence 9999999999999999999999999999999999999987653
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-22 Score=184.58 Aligned_cols=145 Identities=31% Similarity=0.431 Sum_probs=113.8
Q ss_pred eEEecccCccCcee-EEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeecC
Q psy2579 65 YKLQNELGRGNFST-VKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETFG 142 (267)
Q Consensus 65 y~~~~~iG~G~fg~-V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~ 142 (267)
|.--+.+|.|+.|+ ||+|... ++.||||.+- .+..+...+||..|+.- .|||||++++.-.+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye---------~R~VAVKrll-----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q 576 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE---------GREVAVKRLL-----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQ 576 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC---------CceehHHHHh-----hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCc
Confidence 33446789999986 8999874 5899999884 34456788999999998 7999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..||..|+|.. +|.+++..... .......-..+..+.
T Consensus 577 F~YIalELC~~-sL~dlie~~~~------------------------------------------d~~~~~~i~~~~~l~ 613 (903)
T KOG1027|consen 577 FLYIALELCAC-SLQDLIESSGL------------------------------------------DVEMQSDIDPISVLS 613 (903)
T ss_pred eEEEEehHhhh-hHHHHHhcccc------------------------------------------chhhcccccHHHHHH
Confidence 99999999976 44444432100 000111145677889
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeec---CC--ceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSV---RG--IVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~---~~--~~kl~DFGla~~l~ 266 (267)
|++.||++||+.+||||||||.||||+. ++ .++|+|||+|++++
T Consensus 614 q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 614 QIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred HHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 9999999999999999999999999976 33 79999999999875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=6e-21 Score=153.46 Aligned_cols=142 Identities=42% Similarity=0.675 Sum_probs=123.1
Q ss_pred cCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEEee
Q psy2579 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEY 150 (267)
Q Consensus 71 iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~e~ 150 (267)
||+|++|.||++.+. .++..+++|++....... ....+.+|+..++.++|++|+++++++......++++|+
T Consensus 1 l~~g~~~~v~~~~~~-------~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~ 72 (215)
T cd00180 1 LGEGGFGTVYLARDK-------KTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEY 72 (215)
T ss_pred CCcCCceEEEEEEec-------CCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEec
Confidence 689999999999885 346889999997654321 346789999999999999999999999998999999999
Q ss_pred cCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHHH
Q psy2579 151 ASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKH 230 (267)
Q Consensus 151 ~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~~ 230 (267)
+.+++|.+++... ...+++..+..++.+++.++.+
T Consensus 73 ~~~~~l~~~~~~~---------------------------------------------~~~~~~~~~~~~~~~l~~~l~~ 107 (215)
T cd00180 73 CEGGSLKDLLKEN---------------------------------------------EGKLSEDEILRILLQILEGLEY 107 (215)
T ss_pred CCCCcHHHHHHhc---------------------------------------------cCCCCHHHHHHHHHHHHHHHHH
Confidence 9887877665432 0368889999999999999999
Q ss_pred HHhCCCcccCCCCCcEEeec-CCceEEecccccccc
Q psy2579 231 LHDRDIIHRDIKAENVFLSV-RGIVKLGDLGFSTKL 265 (267)
Q Consensus 231 lH~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~l 265 (267)
||+.|++|+||+|.||+++. ++.++|+|||.+...
T Consensus 108 lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~ 143 (215)
T cd00180 108 LHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLL 143 (215)
T ss_pred HHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence 99999999999999999999 899999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-22 Score=163.73 Aligned_cols=147 Identities=29% Similarity=0.512 Sum_probs=120.0
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeee-ee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEV-LE 139 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~-~~ 139 (267)
...|.|.+.+|+|.||.+-+|+|+. ....+++|.+.... .....|.+|...--.| .|.||+.-|+. |.
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~-------s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq 92 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQ-------SKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQ 92 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccC-------CceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhh
Confidence 3559999999999999999999984 44899999987654 2346788998877777 69999987754 77
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
+.+...+++||++.|+|..-+.. ..+.+.....
T Consensus 93 t~d~YvF~qE~aP~gdL~snv~~-----------------------------------------------~GigE~~~K~ 125 (378)
T KOG1345|consen 93 TSDAYVFVQEFAPRGDLRSNVEA-----------------------------------------------AGIGEANTKK 125 (378)
T ss_pred cCceEEEeeccCccchhhhhcCc-----------------------------------------------ccccHHHHHH
Confidence 77878888888888777543321 2477888899
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecC--CceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVR--GIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~--~~~kl~DFGla~~l 265 (267)
++.|+++|++|||+.++||||||.+||||-.. -.+||||||+.+..
T Consensus 126 v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 126 VFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred HHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999999999999999999999999443 38999999998753
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-22 Score=179.48 Aligned_cols=146 Identities=33% Similarity=0.520 Sum_probs=122.3
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~ 139 (267)
....|++...+|.|+||.|-.+.+. .+.+..++|++.... ....+|+.++... +||||+++.+.+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~-------~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~ 386 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESS-------PTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYE 386 (612)
T ss_pred cchhhccccccCCCCccceeeeecc-------ccccchhheeccccc------cccccccchhhhhcCCCcceeecceec
Confidence 3566999999999999999999997 445888999997662 2234577666555 8999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
+....|+|||++.++-+.+.+... ..+. .++..
T Consensus 387 ~~~~~~~v~e~l~g~ell~ri~~~----------------------------------------------~~~~-~e~~~ 419 (612)
T KOG0603|consen 387 DGKEIYLVMELLDGGELLRRIRSK----------------------------------------------PEFC-SEASQ 419 (612)
T ss_pred CCceeeeeehhccccHHHHHHHhc----------------------------------------------chhH-HHHHH
Confidence 999999999999987766555432 2233 78888
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEe-ecCCceEEeccccccccC
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFL-SVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll-~~~~~~kl~DFGla~~l~ 266 (267)
|++|++.|+.|||++|+|||||||+|||+ +..|+++|+|||.++.++
T Consensus 420 w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 420 WAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred HHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999999999999999999999999999 689999999999998765
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-22 Score=167.70 Aligned_cols=153 Identities=28% Similarity=0.510 Sum_probs=132.4
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhc-CCCceeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESV-HHPNIIRLYE 136 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l-~hpnIv~~~~ 136 (267)
+.-+++|.+++.||+|+|+.|-.+++. .+.+-+|+|++++.-.+. +..+-++.|-.+.... +||.+|-++.
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~-------~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhs 318 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLK-------KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHS 318 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehc-------ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhh
Confidence 334678999999999999999999987 445889999998876543 3455577888888776 8999999999
Q ss_pred eeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 137 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 137 ~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
+|.+..++++|.||..||+|.-.. ..+..++++.
T Consensus 319 cfqtesrlffvieyv~ggdlmfhm----------------------------------------------qrqrklpeeh 352 (593)
T KOG0695|consen 319 CFQTESRLFFVIEYVNGGDLMFHM----------------------------------------------QRQRKLPEEH 352 (593)
T ss_pred hhcccceEEEEEEEecCcceeeeh----------------------------------------------hhhhcCcHHH
Confidence 999999999999999887775443 3455799999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
++.+...|+.||.|||++||+.||||.+|+|++..|++||+|+|+|+.
T Consensus 353 arfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 353 ARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred hhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc
Confidence 999999999999999999999999999999999999999999999974
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.7e-21 Score=153.47 Aligned_cols=134 Identities=18% Similarity=0.231 Sum_probs=102.7
Q ss_pred EEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc--hHHHHHHHHHHHHHhhc-CCCceeeeeeeeeecC
Q psy2579 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT--PKARKMLSREIVSMESV-HHPNIIRLYEVLETFG 142 (267)
Q Consensus 66 ~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~ 142 (267)
.+...|++|+||+|+.+.. .+.+++.+.+...... .-....+.+|+++|+.+ +|+++++++++ +
T Consensus 5 ~~~~~l~~~~f~~v~~~~~---------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~ 71 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG---------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----D 71 (218)
T ss_pred ccceeecCCCcceEEEeec---------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----c
Confidence 3556799999999997653 3477777777554431 12234688999999999 56889999886 4
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++|||+.|.+|..... . ....++.
T Consensus 72 ~~~lvmeyI~G~~L~~~~~----------------------------------------------------~-~~~~~~~ 98 (218)
T PRK12274 72 GRHLDRSYLAGAAMYQRPP----------------------------------------------------R-GDLAYFR 98 (218)
T ss_pred CEEEEEeeecCccHHhhhh----------------------------------------------------h-hhHHHHH
Confidence 4688899888766643110 0 1134678
Q ss_pred HHHHHHHHHHhCCCcccCC-CCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDI-KAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDl-kp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.+|.++|++||+|||| ||+|||++.++.++|+|||+|...
T Consensus 99 qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~ 142 (218)
T PRK12274 99 AARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRG 142 (218)
T ss_pred HHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence 9999999999999999999 799999999999999999999854
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.7e-21 Score=155.00 Aligned_cols=136 Identities=21% Similarity=0.205 Sum_probs=109.0
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccch------HHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP------KARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+.||+|++|.||+|.+. +..|++|+........ .....+.+|+.++..+.|++|+....++...+
T Consensus 2 ~~l~~G~~~~vy~~~~~---------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 72 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL---------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE 72 (211)
T ss_pred cccccCceEEEEEEeeC---------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC
Confidence 56999999999999863 3678999865433211 12356889999999999999887777777777
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++|||++|++|.+.+.. . .+ ....++.
T Consensus 73 ~~~lv~e~~~G~~L~~~~~~----------------------------------------------~---~~-~~~~i~~ 102 (211)
T PRK14879 73 NFIIVMEYIEGEPLKDLINS----------------------------------------------N---GM-EELELSR 102 (211)
T ss_pred CCEEEEEEeCCcCHHHHHHh----------------------------------------------c---cH-HHHHHHH
Confidence 78888888888777654421 1 11 7778899
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
+++.+|.++|+.|++|+|++|+||+++ ++.++|+|||+|+.
T Consensus 103 ~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 103 EIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred HHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999999999999999999999 88999999999874
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=164.40 Aligned_cols=149 Identities=23% Similarity=0.337 Sum_probs=122.7
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC--CC----ceeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH--HP----NIIRLY 135 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~--hp----nIv~~~ 135 (267)
.++|+++..+|+|+||.|-.+.++ .++..||||+++. ....++...-|+.++.++. .| -+|.+.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~-------~~~~~vAlKIik~---V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDR-------ETKEHVALKIIKN---VDKYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred ccceehhhhhcCCcccceEEEeec-------CCCceehHHHHHH---HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 467999999999999999999997 3468999999964 3455667788999999993 22 377888
Q ss_pred eeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 136 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 136 ~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
++|...++.|||+|.++ .|+++++..+ ...+++..
T Consensus 158 ~wFdyrghiCivfellG-~S~~dFlk~N--------------------------------------------~y~~fpi~ 192 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELLG-LSTFDFLKEN--------------------------------------------NYIPFPID 192 (415)
T ss_pred hhhhccCceEEEEeccC-hhHHHHhccC--------------------------------------------CccccchH
Confidence 89999999999999873 3555655543 12379999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecC--------------------CceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVR--------------------GIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~--------------------~~~kl~DFGla~~l 265 (267)
.++.++.|++.+++|||+.+++|-||||+|||+... ..++++|||.|+.-
T Consensus 193 ~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~ 262 (415)
T KOG0671|consen 193 HIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFD 262 (415)
T ss_pred HHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCccee
Confidence 999999999999999999999999999999998432 25899999999754
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=189.66 Aligned_cols=137 Identities=20% Similarity=0.309 Sum_probs=114.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
..|+..+.||+|+||.||+|.+. .++..||+|.+...... ...|+..++.++|||||++++++...+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~ 756 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSI-------KNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEK 756 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEEC-------CCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence 34667788999999999999886 44589999998644321 124688999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+||||+++|+|.++++ .+++.....++.
T Consensus 757 ~~~lv~Ey~~~g~L~~~l~-------------------------------------------------~l~~~~~~~i~~ 787 (968)
T PLN00113 757 GAYLIHEYIEGKNLSEVLR-------------------------------------------------NLSWERRRKIAI 787 (968)
T ss_pred CCEEEEeCCCCCcHHHHHh-------------------------------------------------cCCHHHHHHHHH
Confidence 9999999999988876653 377888999999
Q ss_pred HHHHHHHHHH---hCCCcccCCCCCcEEeecCCceEEeccccc
Q psy2579 223 QILSAVKHLH---DRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262 (267)
Q Consensus 223 ql~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFGla 262 (267)
|++.||+||| +.+++||||||+||+++.++..++. ||.+
T Consensus 788 ~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~ 829 (968)
T PLN00113 788 GIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829 (968)
T ss_pred HHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence 9999999999 6699999999999999988887765 5544
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.7e-21 Score=154.07 Aligned_cols=138 Identities=20% Similarity=0.257 Sum_probs=104.6
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch--------------------HHHHHHHHHHHHHh
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP--------------------KARKMLSREIVSME 124 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~--------------------~~~~~~~~Ei~~l~ 124 (267)
|.+.+.||+|+||.||+|.+. +++.||||++....... .......+|+.++.
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP--------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred hhcCCccccCcceEEEEEEcC--------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 788899999999999999763 46899999876533110 11223678999999
Q ss_pred hcCCCc--eeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCch
Q psy2579 125 SVHHPN--IIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGEL 202 (267)
Q Consensus 125 ~l~hpn--Iv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l 202 (267)
.+.|++ ++..++ .+..+++|||+++++|....
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~------------------------------------------ 122 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVR------------------------------------------ 122 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcc------------------------------------------
Confidence 997774 444443 24557888888876663211
Q ss_pred hhhhcccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 203 YNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
. ......++.+++.++.++|+.|++|+||||+||+++.++.++|+|||+|..+.
T Consensus 123 ----~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 123 ----V------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ----c------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 0 13456788899999999999999999999999999999999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=162.91 Aligned_cols=146 Identities=25% Similarity=0.327 Sum_probs=117.1
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCC----Cceeeeeeee-
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHH----PNIIRLYEVL- 138 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h----pnIv~~~~~~- 138 (267)
.|++.++||+|+||.||.|.+.... ...+|+|+......... ..+..|+.++..+.. +++..+++.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~------~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK------NKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC------CeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 6999999999999999999986321 35789998876432211 156778888888863 6899999998
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcc--cCCCChhH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITT--EGRLSEDD 216 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~ 216 (267)
......|+||+.+. . +|.++... .+.++...
T Consensus 91 ~~~~~~~iVM~l~G-~----------------------------------------------sL~dl~~~~~~~~fs~~T 123 (322)
T KOG1164|consen 91 STEDFNFIVMSLLG-P----------------------------------------------SLEDLRKRNPPGRFSRKT 123 (322)
T ss_pred CCCceeEEEEeccC-c----------------------------------------------cHHHHHHhCCCCCcCHhH
Confidence 57778899988763 3 44443322 35799999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecC-----CceEEeccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVR-----GIVKLGDLGFSTK 264 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~-----~~~kl~DFGla~~ 264 (267)
+..++.|++.+|+++|+.|++||||||+|+++... ..+.|.|||+|+.
T Consensus 124 ~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 124 VLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred HHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 99999999999999999999999999999999765 3699999999983
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=157.57 Aligned_cols=146 Identities=20% Similarity=0.341 Sum_probs=121.1
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~ 141 (267)
-.|++.++||+|+||.++.|....+ +++||||.-....-.+ ++..|....+.| ..++|...|.+....
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~n-------ne~VAIKfEPrkS~AP----QLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYN-------NEPVAIKFEPRKSEAP----QLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred ccceeccccccCcceeeeccccccc-------CceEEEEeccccCCcc----hHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 4599999999999999999998744 4999999876554344 466788888888 689999999998888
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcc-cCCCChhHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITT-EGRLSEDDAKIY 220 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~ 220 (267)
-...+|+|++. .+|.|++.- ..+|+...+.++
T Consensus 97 ~~NiLVidLLG-----------------------------------------------PSLEDLFD~CgR~FSvKTV~mi 129 (449)
T KOG1165|consen 97 KYNILVIDLLG-----------------------------------------------PSLEDLFDLCGRRFSVKTVAMI 129 (449)
T ss_pred chhhhhhhhhC-----------------------------------------------cCHHHHHHHhcCcccHHhHHHH
Confidence 88888888763 344443332 447999999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCC-----ceEEeccccccccC
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRG-----IVKLGDLGFSTKLQ 266 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~-----~~kl~DFGla~~l~ 266 (267)
+.|++.-++|+|++.+|.|||||+|+||...+ .+.++|||+|+.-.
T Consensus 130 A~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 130 AKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred HHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 99999999999999999999999999997654 59999999998643
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-20 Score=153.07 Aligned_cols=137 Identities=45% Similarity=0.766 Sum_probs=118.6
Q ss_pred CceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEEeecCCC
Q psy2579 75 NFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGG 154 (267)
Q Consensus 75 ~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~e~~~~g 154 (267)
+||.||+|.+. .++..+|+|++........ .+.+.+|+..++.++|+||+++++++......++++|++.++
T Consensus 1 ~~g~v~~~~~~-------~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 72 (244)
T smart00220 1 SFGKVYLARDK-------KTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGG 72 (244)
T ss_pred CceEEEEEEEC-------CCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCC
Confidence 58999999986 3458999999976543321 578899999999999999999999999989999999999887
Q ss_pred chhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHHHHHhC
Q psy2579 155 ELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR 234 (267)
Q Consensus 155 sl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~~ 234 (267)
+|..++.. ...+++..+..++.+++.++.+||+.
T Consensus 73 ~L~~~~~~----------------------------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~ 106 (244)
T smart00220 73 DLFDLLKK----------------------------------------------RGRLSEDEARFYARQILSALEYLHSN 106 (244)
T ss_pred CHHHHHHh----------------------------------------------ccCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 77665543 22378889999999999999999999
Q ss_pred CCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 235 DIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 235 ~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++|+||+|+||+++.++.++|+|||++..+
T Consensus 107 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~ 137 (244)
T smart00220 107 GIIHRDLKPENILLDEDGHVKLADFGLARQL 137 (244)
T ss_pred CeecCCcCHHHeEECCCCcEEEccccceeee
Confidence 9999999999999999999999999998764
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-20 Score=150.53 Aligned_cols=133 Identities=17% Similarity=0.135 Sum_probs=103.1
Q ss_pred ccCccCceeEEEeEEeecccccccccceEEEEeecccccch------HHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP------KARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 70 ~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
.||+|+||.||+|.+. +..|++|......... ....++.+|+.+++.+.|+++.....++...+.
T Consensus 1 ~ig~G~~~~vy~~~~~---------~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 71 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL---------GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN 71 (199)
T ss_pred CCCCCceEEEEEeecC---------CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC
Confidence 3899999999999853 3779999865432111 123667899999999988876655555556666
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.+++||+++|++|.+.+... .. .++.|
T Consensus 72 ~~lv~e~~~g~~l~~~~~~~----------------------------------------------~~-------~~~~~ 98 (199)
T TIGR03724 72 KTIVMEYIEGKPLKDVIEEG----------------------------------------------ND-------ELLRE 98 (199)
T ss_pred CEEEEEEECCccHHHHHhhc----------------------------------------------HH-------HHHHH
Confidence 78888888887775544211 00 67889
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.+|.++|+.|++|+|++|+||+++ ++.++++|||+|+..
T Consensus 99 i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 99 IGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred HHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999999999999999999999999 899999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.4e-20 Score=171.21 Aligned_cols=138 Identities=15% Similarity=0.105 Sum_probs=107.4
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-----c-hHHHHHHHHHHHHHhhcCCCceeeeeee
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-----T-PKARKMLSREIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-----~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~ 137 (267)
.|...+.||+|+||.||+|.+.. ..+++|+...... . .....++.+|+.+++.++|++++....+
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~---------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~ 404 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLG---------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIY 404 (535)
T ss_pred ccCccceeccCCcEEEEEEeecC---------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEE
Confidence 35677899999999999998742 2334443222111 1 1224668899999999999999988777
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
+......+++|||+++++|.+.+. ..
T Consensus 405 ~~~~~~~~lv~E~~~g~~L~~~l~------------------------------------------------------~~ 430 (535)
T PRK09605 405 DVDPEEKTIVMEYIGGKDLKDVLE------------------------------------------------------GN 430 (535)
T ss_pred EEeCCCCEEEEEecCCCcHHHHHH------------------------------------------------------HH
Confidence 777777888999988877755431 24
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..++.|++.+|.+||+.|++||||||+||++ .++.++|+|||+|+..
T Consensus 431 ~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 431 PELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred HHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 5688999999999999999999999999999 6789999999999854
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-21 Score=160.02 Aligned_cols=146 Identities=29% Similarity=0.417 Sum_probs=119.9
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
..+|.-+..+|.|+- .|-.|.+.. .+++||+|.+.....+....++..+|..++..+.|+||++++.+|.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v-------~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~ 87 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQV-------LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQ 87 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhh-------ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcc
Confidence 345888889999998 787887763 458999999877765555667889999999999999999999998644
Q ss_pred C------eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 142 G------KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 142 ~------~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
. ..|+|||++.. ++.+.+. -.++-.
T Consensus 88 ~~l~~~~e~y~v~e~m~~-----------------------------------------------nl~~vi~--~elDH~ 118 (369)
T KOG0665|consen 88 KTLEEFQEVYLVMELMDA-----------------------------------------------NLCQVIL--MELDHE 118 (369)
T ss_pred ccHHHHHhHHHHHHhhhh-----------------------------------------------HHHHHHH--HhcchH
Confidence 3 36666666642 4444433 246778
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
.+..++.|++.|+.|+|+.||+||||||+||++..++.+||.|||+|+.
T Consensus 119 tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 119 TISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence 8999999999999999999999999999999999999999999999975
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.5e-21 Score=163.72 Aligned_cols=144 Identities=26% Similarity=0.396 Sum_probs=123.6
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~ 141 (267)
+.|.++++||.|.|++||+|.+... .....+||+|.+.... ...++.+|++.|..+ .+.||+++.+++...
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~----~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQ----DTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhh----ccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 4599999999999999999988642 1356899999987653 235688999999999 799999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+...+|+||.+.-+..++.. .++..++..++
T Consensus 108 d~v~ivlp~~~H~~f~~l~~-------------------------------------------------~l~~~~i~~Yl 138 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR-------------------------------------------------SLSLAEIRWYL 138 (418)
T ss_pred CeeEEEecccCccCHHHHHh-------------------------------------------------cCCHHHHHHHH
Confidence 99999999998755554443 46788999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeec-CCceEEecccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSV-RGIVKLGDLGFST 263 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~ 263 (267)
+.++.||.++|.+|||||||||+|+|.+. .+.-.|+|||||.
T Consensus 139 ~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 139 RNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred HHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 99999999999999999999999999975 4678999999996
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-20 Score=163.28 Aligned_cols=147 Identities=27% Similarity=0.364 Sum_probs=121.2
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC------CCceeeeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH------HPNIIRLYE 136 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~------hpnIv~~~~ 136 (267)
++|.+....|+|-||+|-+|.+. ..+..||||++..+.. ....=++|+.+|.+|+ --|+++++.
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~-------~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQ-------ARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred ceeEEEeccccceeeeeeecccc-------CCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 45999999999999999999997 4557999999976542 2344568999999995 348999999
Q ss_pred eeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccC---CCC
Q psy2579 137 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEG---RLS 213 (267)
Q Consensus 137 ~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~---~~~ 213 (267)
.|...+++|+|+|-+. .+|.+.+...+ .+.
T Consensus 502 ~F~hknHLClVFE~Ls-----------------------------------------------lNLRevLKKyG~nvGL~ 534 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPLS-----------------------------------------------LNLREVLKKYGRNVGLH 534 (752)
T ss_pred HhhhcceeEEEehhhh-----------------------------------------------chHHHHHHHhCccccee
Confidence 9999999999998653 23444444332 477
Q ss_pred hhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC-ceEEeccccccccC
Q psy2579 214 EDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG-IVKLGDLGFSTKLQ 266 (267)
Q Consensus 214 ~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~l~ 266 (267)
...+..++.|+..||..|-.+||+|.||||+|||+++.. .+||||||.|....
T Consensus 535 ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ 588 (752)
T KOG0670|consen 535 IKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFAS 588 (752)
T ss_pred ehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccc
Confidence 889999999999999999999999999999999998765 79999999987653
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=157.38 Aligned_cols=139 Identities=28% Similarity=0.398 Sum_probs=111.0
Q ss_pred cccCcee--cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC------
Q psy2579 56 TSLGKRV--ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH------ 127 (267)
Q Consensus 56 ~~~~~~~--~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~------ 127 (267)
-.+|+.. ++|.+.++||-|-|++||+|.+.. ..+.||+|+.+.. ....+....||.+|+.++
T Consensus 69 V~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq-------~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~ 138 (590)
T KOG1290|consen 69 VRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQ-------NKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPND 138 (590)
T ss_pred eeccccccCceEEEEEeccccccceeEEEeecc-------CCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCC
Confidence 3455543 579999999999999999999984 4499999998643 344567789999999883
Q ss_pred --CCceeeeeeeeeecC----eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCc
Q psy2579 128 --HPNIIRLYEVLETFG----KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGE 201 (267)
Q Consensus 128 --hpnIv~~~~~~~~~~----~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~ 201 (267)
-.+||++++.|...+ ++|+|+|++.. +
T Consensus 139 ~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGd-----------------------------------------------n 171 (590)
T KOG1290|consen 139 PGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGD-----------------------------------------------N 171 (590)
T ss_pred CCCceeeeeeccceecCCCCcEEEEEehhhhh-----------------------------------------------H
Confidence 247999999997654 58888887743 4
Q ss_pred hhhhhcc--cCCCChhHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEeecC
Q psy2579 202 LYNKITT--EGRLSEDDAKIYFLQILSAVKHLHD-RDIIHRDIKAENVFLSVR 251 (267)
Q Consensus 202 l~~~~~~--~~~~~~~~~~~~~~ql~~~L~~lH~-~~ivHrDlkp~NIll~~~ 251 (267)
|..+|.. .+.++...+..|++||+.||.|||. +||||-||||+|||+...
T Consensus 172 LLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 172 LLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST 224 (590)
T ss_pred HHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence 4444433 3469999999999999999999995 599999999999999654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-19 Score=143.77 Aligned_cols=139 Identities=20% Similarity=0.323 Sum_probs=93.9
Q ss_pred ecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHH----------------------HHHHHHHHhh
Q psy2579 68 QNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKM----------------------LSREIVSMES 125 (267)
Q Consensus 68 ~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~----------------------~~~Ei~~l~~ 125 (267)
.+.||+|+||.||+|.+. +++.||||++............ ...|...+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~--------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 73 (187)
T cd05119 2 GGPIGTGKEADVYLALDG--------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKR 73 (187)
T ss_pred CcccccccceeEEEEECC--------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHH
Confidence 457999999999999864 3588999998765432222111 1345555555
Q ss_pred cCCCc--eeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchh
Q psy2579 126 VHHPN--IIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELY 203 (267)
Q Consensus 126 l~hpn--Iv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~ 203 (267)
+.+.+ +.+.+++ ...+++|||+.++++.. ..+.
T Consensus 74 l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~-----------------------------------------~~l~ 108 (187)
T cd05119 74 LYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPA-----------------------------------------PRLK 108 (187)
T ss_pred HHHcCCCCCceEec----CCCEEEEEEeCCCCccC-----------------------------------------hhhh
Confidence 53332 3333332 23467777766644311 1111
Q ss_pred hhhcccCCCChhHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 204 NKITTEGRLSEDDAKIYFLQILSAVKHLHD-RDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+.. . ...+..++.+++.++.++|+ +|++|+||||+||+++ ++.++|+|||.|....
T Consensus 109 ~~~-----~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 109 DVR-----L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred hhh-----h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence 110 1 16678899999999999999 9999999999999999 9999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.9e-18 Score=144.85 Aligned_cols=148 Identities=41% Similarity=0.695 Sum_probs=126.2
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchH-HHHHHHHHHHHHhhcCCC-ceeeeeeeeeecC
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPK-ARKMLSREIVSMESVHHP-NIIRLYEVLETFG 142 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~Ei~~l~~l~hp-nIv~~~~~~~~~~ 142 (267)
|.+...||.|+||.||++.+. ..+++|.+........ ....+.+|+.+++.+.|+ +|+++.+.+...+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~----------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 71 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR----------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG 71 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec----------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC
Confidence 788899999999999999885 6789999987765443 567899999999999888 7999999998777
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++++++.++++.+.+..... ...++......++.
T Consensus 72 ~~~~~~~~~~~~~l~~~~~~~~~-------------------------------------------~~~~~~~~~~~~~~ 108 (384)
T COG0515 72 SLYLVMEYVDGGSLEDLLKKIGR-------------------------------------------KGPLSESEALFILA 108 (384)
T ss_pred EEEEEEecCCCCcHHHHHHhccc-------------------------------------------ccCCCHHHHHHHHH
Confidence 78999999998888644433210 02688899999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCC-ceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRG-IVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~l 265 (267)
|++.++.|+|+.|++|||+||+||+++..+ .++++|||+++.+
T Consensus 109 ~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 109 QILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred HHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 999999999999999999999999999988 7999999998743
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.7e-18 Score=141.14 Aligned_cols=135 Identities=19% Similarity=0.203 Sum_probs=95.4
Q ss_pred ccC-ccCceeEEEeEEeecccccccccceEEEEeeccccc-----------chHHHHHHHHHHHHHhhcCCCce--eeee
Q psy2579 70 ELG-RGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-----------TPKARKMLSREIVSMESVHHPNI--IRLY 135 (267)
Q Consensus 70 ~iG-~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~~~Ei~~l~~l~hpnI--v~~~ 135 (267)
.|| .||.|+||.+... +..++||.+..... +.....++.+|+.++..+.|++| +..+
T Consensus 38 ~lg~~~g~gtv~~v~~~---------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl 108 (239)
T PRK01723 38 VVGSAKGRGTTWFVQTP---------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPI 108 (239)
T ss_pred eeecCCCCccEEEEEeC---------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeE
Confidence 366 7788888887542 36788888754221 11234668899999999998875 6666
Q ss_pred eeeeec-C---eEEEEEeecCC-CchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccC
Q psy2579 136 EVLETF-G---KIFLVVEYASG-GELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEG 210 (267)
Q Consensus 136 ~~~~~~-~---~~~iv~e~~~~-gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~ 210 (267)
++.... + ..++|||++++ .+|.+.+ .. .
T Consensus 109 ~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l----------------------------------------------~~-~ 141 (239)
T PRK01723 109 AARVVRHGLFYRADILIERIEGARDLVALL----------------------------------------------QE-A 141 (239)
T ss_pred eeeeeecCcceeeeEEEEecCCCCCHHHHH----------------------------------------------hc-C
Confidence 654332 1 12466666665 3444333 22 2
Q ss_pred CCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 211 RLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 211 ~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
++++. .+.|++.+|.+||++||+||||||+|||++.++.++|+|||.++.
T Consensus 142 ~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 142 PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 34433 256899999999999999999999999999989999999998874
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.9e-17 Score=125.80 Aligned_cols=132 Identities=17% Similarity=0.189 Sum_probs=108.5
Q ss_pred EecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCC--CceeeeeeeeeecCeE
Q psy2579 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHH--PNIIRLYEVLETFGKI 144 (267)
Q Consensus 67 ~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~~~~~~~~~~~~ 144 (267)
+++.||.|.++.||++... +..+++|....... ...+.+|+.++..++| +++++++.+....+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~---------~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~ 68 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK---------DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWS 68 (155)
T ss_pred cceecccccccceEEEEec---------CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence 4567999999999999864 26789999865432 4568899999999976 5899999988887888
Q ss_pred EEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHH
Q psy2579 145 FLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 224 (267)
Q Consensus 145 ~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql 224 (267)
+++||++.++++.. ++......++.++
T Consensus 69 ~~v~e~~~g~~~~~-----------------------------------------------------~~~~~~~~~~~~~ 95 (155)
T cd05120 69 YLLMEWIEGETLDE-----------------------------------------------------VSEEEKEDIAEQL 95 (155)
T ss_pred EEEEEecCCeeccc-----------------------------------------------------CCHHHHHHHHHHH
Confidence 99999887755421 1445666788899
Q ss_pred HHHHHHHHhC---CCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 225 LSAVKHLHDR---DIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 225 ~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
+.+|+++|.. +++|+|++|+||+++..+.++++|||.++.
T Consensus 96 ~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 96 AELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred HHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999999985 799999999999999989999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.2e-18 Score=144.17 Aligned_cols=161 Identities=20% Similarity=0.220 Sum_probs=132.8
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec-C
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF-G 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~-~ 142 (267)
++++...+-+|+||.||+|.|+..+ ...+.+.|-+|.++... ++-+...+..|.-.+..+.|||+.++.+.+... .
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEd--t~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREED--TYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred heechhhhhcCchhheeeeeecccC--CcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 4788889999999999999887432 22445778889886654 667788999999999999999999999987654 5
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
.++.+..++..|+|..++.-.+.-. -...+.++..+...++.
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~--------------------------------------~~~aqtvtt~qlV~mas 403 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDD--------------------------------------PSYAQTVTTIQLVLMAS 403 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCC--------------------------------------CccccchhHHHHHHHHH
Confidence 6888999999999998887322100 01123577889999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.|++|||+.|+||.||..+|++|++.-++||+|=.++|.+
T Consensus 404 Qla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDL 446 (563)
T KOG1024|consen 404 QLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDL 446 (563)
T ss_pred HHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhcccc
Confidence 9999999999999999999999999999999999999999875
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.7e-17 Score=156.17 Aligned_cols=147 Identities=25% Similarity=0.309 Sum_probs=107.4
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHH-HHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKA-RKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
...|.|...||+|+||.||+|.+. +++.||+|+-++....+-. ..+++..+. .. --+.|..+..+...
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~--------~~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~--~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHS--------NGKLVALKVEKPPNPWEFYICLQVMERLK-PQ--MLPSIMHISSAHVF 765 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecC--------CCcEEEEEeecCCCceeeeehHHHHHhhc-hh--hhcchHHHHHHHcc
Confidence 345999999999999999999985 2799999999877654311 122222222 11 12445555555555
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+...+|+||... |+|.+++...+.+++..+..+
T Consensus 766 ~~~S~lv~ey~~~----------------------------------------------Gtlld~~N~~~~m~e~lv~~~ 799 (974)
T KOG1166|consen 766 QNASVLVSEYSPY----------------------------------------------GTLLDLINTNKVMDEYLVMFF 799 (974)
T ss_pred CCcceeeeecccc----------------------------------------------ccHHHhhccCCCCCchhhhHH
Confidence 5555666666555 455555556667999999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecC-------CceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVR-------GIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~-------~~~kl~DFGla~~l 265 (267)
..|++.-++.||..+|||+||||+|+||... .-++|+|||.|-.+
T Consensus 800 ~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 800 SCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred HHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 9999999999999999999999999999542 35999999988654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.9e-15 Score=135.90 Aligned_cols=142 Identities=19% Similarity=0.226 Sum_probs=91.2
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccch--------------------------------HHHH--
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP--------------------------------KARK-- 114 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~--------------------------------~~~~-- 114 (267)
+.||.|++|.||+|+.. +|+.||||+..+.-... +...
T Consensus 123 ~plasaSigQVh~A~l~--------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l 194 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV--------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTL 194 (437)
T ss_pred cceeeeehhheEEEEec--------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHH
Confidence 56999999999999863 46899999987642100 0000
Q ss_pred ----HHHHHHHHHhhcC-----CCceeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhh
Q psy2579 115 ----MLSREIVSMESVH-----HPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185 (267)
Q Consensus 115 ----~~~~Ei~~l~~l~-----hpnIv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (267)
.+.+|+..+..+. ++++.-..-++...+..+++|||++|+++.+.....
T Consensus 195 ~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---------------------- 252 (437)
T TIGR01982 195 RRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---------------------- 252 (437)
T ss_pred HHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH----------------------
Confidence 2445555555542 333322222222234467777777776665443211
Q ss_pred ccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH-HHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS-AVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 186 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~-~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
.... ....++.+++. .+..+|..|++|+|++|.||+++.++.++++|||++..
T Consensus 253 -----------------------~~~~---~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 253 -----------------------EAGL---DRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred -----------------------hcCC---CHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 0011 12335555554 46789999999999999999999999999999999987
Q ss_pred cC
Q psy2579 265 LQ 266 (267)
Q Consensus 265 l~ 266 (267)
+.
T Consensus 307 l~ 308 (437)
T TIGR01982 307 LS 308 (437)
T ss_pred CC
Confidence 64
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.3e-16 Score=133.75 Aligned_cols=181 Identities=23% Similarity=0.282 Sum_probs=116.4
Q ss_pred CceecceEEecccCccCceeEEEeEEeeccccccc----------------------------ccceEEEEeeccccc--
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCT----------------------------YISYLAIKILDKAKL-- 108 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~----------------------------~~~~vaiK~~~~~~~-- 108 (267)
+..+++|+|.+.||+|..+.||.|.....+..... ..-+.|||++-.-..
T Consensus 153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s 232 (598)
T KOG4158|consen 153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS 232 (598)
T ss_pred ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence 34567799999999999999999976532211100 012578887743222
Q ss_pred -chHHHHHHHHHHH-------H-------Hh-------h-cCCCceeeeeeeeeecCeEE--EEEeecCCCchhhhhhcc
Q psy2579 109 -TPKARKMLSREIV-------S-------ME-------S-VHHPNIIRLYEVLETFGKIF--LVVEYASGGELYNKITTE 163 (267)
Q Consensus 109 -~~~~~~~~~~Ei~-------~-------l~-------~-l~hpnIv~~~~~~~~~~~~~--iv~e~~~~gsl~~~l~~~ 163 (267)
+....+.+.+|.. . .+ + -+|||||++.++|.+.-... -+..|.. -+-..+.
T Consensus 233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPd--alp~R~~-- 308 (598)
T KOG4158|consen 233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPD--ALPARWY-- 308 (598)
T ss_pred chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcc--cccceec--
Confidence 1222344444431 0 01 1 25999999999987653211 0000000 0000110
Q ss_pred CCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q psy2579 164 GRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243 (267)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp 243 (267)
-+......++|+||...+ -+|.+++... ..+......++.|+++|+.|||.+||.|||+|+
T Consensus 309 -----------------p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKS 369 (598)
T KOG4158|consen 309 -----------------PSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKS 369 (598)
T ss_pred -----------------ccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccc
Confidence 112234468899999886 5788887665 466777888999999999999999999999999
Q ss_pred CcEEee--cCC--ceEEeccccc
Q psy2579 244 ENVFLS--VRG--IVKLGDLGFS 262 (267)
Q Consensus 244 ~NIll~--~~~--~~kl~DFGla 262 (267)
+|||+. +++ .+.++|||+|
T Consensus 370 DNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 370 DNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred cceEEEecCCCCcEEEEccccee
Confidence 999994 333 5788999976
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.6e-16 Score=140.36 Aligned_cols=48 Identities=25% Similarity=0.447 Sum_probs=38.0
Q ss_pred CChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC----ceEEeccccccccC
Q psy2579 212 LSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG----IVKLGDLGFSTKLQ 266 (267)
Q Consensus 212 ~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~----~~kl~DFGla~~l~ 266 (267)
+.+..+..++.|+ ...|++|+|++|.||+++.+| .++++|||++..+.
T Consensus 264 la~~~v~~~~~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 264 LAERGVEVFFTQV-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHHHHHHHHHH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3344444555555 368999999999999999888 99999999998764
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.4e-16 Score=142.87 Aligned_cols=151 Identities=26% Similarity=0.458 Sum_probs=107.2
Q ss_pred EEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEE
Q psy2579 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIF 145 (267)
Q Consensus 66 ~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~ 145 (267)
.....+|.|++|.|+.+......+.. ..+.+++| .............+..|..+-..+.|||++..+..+......+
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~--~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~ 397 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSF--PEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGIL 397 (601)
T ss_pred CccceeeecccCceEEEEecCCCccc--hhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccch
Confidence 45667999999988877765433211 11222333 1122111222233778888888899999987776655544444
Q ss_pred EEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHH
Q psy2579 146 LVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 225 (267)
Q Consensus 146 iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~ 225 (267)
-.||||++ +|. ..+...+.+...++..++.|++
T Consensus 398 ~~mE~~~~-Dlf----------------------------------------------~~~~~~~~~~~~e~~c~fKqL~ 430 (601)
T KOG0590|consen 398 QSMEYCPY-DLF----------------------------------------------SLVMSNGKLTPLEADCFFKQLL 430 (601)
T ss_pred hhhhcccH-HHH----------------------------------------------HHHhcccccchhhhhHHHHHHH
Confidence 44666655 554 4444555788999999999999
Q ss_pred HHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 226 SAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 226 ~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.|+.|+|+.|+.|||+||+|+++..+|.+||+|||.+..+.
T Consensus 431 ~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 431 RGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred HHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeec
Confidence 99999999999999999999999999999999999987653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=7.2e-14 Score=111.75 Aligned_cols=145 Identities=19% Similarity=0.255 Sum_probs=99.5
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccc--------------------hHHHHHHH----HHHHHHh
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT--------------------PKARKMLS----REIVSME 124 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~--------------------~~~~~~~~----~Ei~~l~ 124 (267)
..||.|--+.||.|....... ....+..+|||+.+.+..+ ...+..+. +|+..|+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~-~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 3 GCISTGKESVVLHANGGSNET-EQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CccccCcceEEEEEecCcccc-cccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 469999999999997542100 0013478999998643210 01122333 8999999
Q ss_pred hcC--CCceeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCch
Q psy2579 125 SVH--HPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGEL 202 (267)
Q Consensus 125 ~l~--hpnIv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l 202 (267)
++. ..+++.++++ ...++||||++++.+.. ..+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~-----------------------------------------~~L 116 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPA-----------------------------------------PKL 116 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccc-----------------------------------------hhh
Confidence 984 3566777764 56788888887643311 011
Q ss_pred hhhhcccCCCChhHHHHHHHHHHHHHHHH-HhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 203 YNKITTEGRLSEDDAKIYFLQILSAVKHL-HDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~ql~~~L~~l-H~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
....+++..+..+..|++.+|..+ |..|++|+||+|.||+++ ++.+.|+|||.|...
T Consensus 117 -----kd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 117 -----KDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred -----hccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 111344556677789999999998 899999999999999997 578999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.4e-14 Score=109.36 Aligned_cols=128 Identities=18% Similarity=0.167 Sum_probs=91.8
Q ss_pred ecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCce-eeeeeeeeecCeEEE
Q psy2579 68 QNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNI-IRLYEVLETFGKIFL 146 (267)
Q Consensus 68 ~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~~~~~~~~~~~~~i 146 (267)
++.|+.|.++.||++... +..|++|+...... ....+.+|+.+++.+.+.++ ++++.+.. ...++
T Consensus 3 ~~~l~~G~~~~vy~~~~~---------~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~l 68 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA---------NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVL 68 (170)
T ss_pred eeecCCcccCceEEEEEC---------CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeE
Confidence 356899999999998753 47799999865431 11235689999998855444 44554432 33467
Q ss_pred EEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHH
Q psy2579 147 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILS 226 (267)
Q Consensus 147 v~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~ 226 (267)
+||+++|.++... .......+.+++.
T Consensus 69 v~e~i~G~~l~~~------------------------------------------------------~~~~~~~~~~l~~ 94 (170)
T cd05151 69 ITEFIEGSELLTE------------------------------------------------------DFSDPENLEKIAK 94 (170)
T ss_pred EEEecCCCccccc------------------------------------------------------cccCHHHHHHHHH
Confidence 8888877554211 0111235678999
Q ss_pred HHHHHHhCCC-----cccCCCCCcEEeecCCceEEeccccccc
Q psy2579 227 AVKHLHDRDI-----IHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 227 ~L~~lH~~~i-----vHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
+|..||+.++ +|+|++|.||+++ ++.++++|||.|..
T Consensus 95 ~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 95 LLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred HHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9999999985 9999999999999 67899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=7e-15 Score=141.99 Aligned_cols=48 Identities=17% Similarity=0.202 Sum_probs=41.5
Q ss_pred CCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEe
Q psy2579 210 GRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLG 257 (267)
Q Consensus 210 ~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~ 257 (267)
..+++.++..++.||+.||+|||++||+||||||+|||++..+.+|++
T Consensus 75 ~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~ 122 (793)
T PLN00181 75 RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFI 122 (793)
T ss_pred ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEe
Confidence 468999999999999999999999999999999999999654433333
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.4e-15 Score=133.94 Aligned_cols=146 Identities=31% Similarity=0.516 Sum_probs=119.6
Q ss_pred ccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-CCceeeeeeeeeecCeEEEEE
Q psy2579 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-HPNIIRLYEVLETFGKIFLVV 148 (267)
Q Consensus 70 ~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~iv~ 148 (267)
.+|+|+||.|++++--.. ...+.-+|+|++.+.......+.....|..++...+ ||.+|+++.++..++..++++
T Consensus 1 vlg~g~~gkvfLvrk~~g----~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGG----ADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHhcc----ccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhh
Confidence 379999999998753211 144678899999876654443345667888888885 999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHH
Q psy2579 149 EYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAV 228 (267)
Q Consensus 149 e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L 228 (267)
++..+|++...+. ....+.+.....+...++.++
T Consensus 77 d~~rgg~lft~l~----------------------------------------------~~~~f~~~~~~~~~aelaLal 110 (612)
T KOG0603|consen 77 DFLRGGDLFTRLS----------------------------------------------KEVMFDELDVAFYLAELALAL 110 (612)
T ss_pred hhcccchhhhccc----------------------------------------------cCCchHHHHHHHHHHHHHHHH
Confidence 9988877755443 334567778888889999999
Q ss_pred HHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 229 KHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 229 ~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+++|+.++++||+|++||+++.+|++++.|||+++.+
T Consensus 111 d~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~ 147 (612)
T KOG0603|consen 111 DHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEA 147 (612)
T ss_pred hhcchhHHHHhcccccceeecccCccccCCchhhhHh
Confidence 9999999999999999999999999999999999865
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.5e-12 Score=100.15 Aligned_cols=133 Identities=17% Similarity=0.154 Sum_probs=97.1
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeeccccc-----chH-HHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-----TPK-ARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~-~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
..+++|+-+.++.+.+. +.++.+|.-.+... +.. .+.+..+|+.+++.++--+|....-+..+++
T Consensus 2 ~~i~~GAEa~i~~~~~~---------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL---------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD 72 (204)
T ss_pred chhhCCcceeEEeeecc---------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC
Confidence 35889999999999653 24566665443332 222 2467889999999997666666555666777
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
...|+|||.+|..|.+.+. .. ...++.
T Consensus 73 ~~~I~me~I~G~~lkd~l~----------------------------------------------~~-------~~~~~r 99 (204)
T COG3642 73 NGLIVMEYIEGELLKDALE----------------------------------------------EA-------RPDLLR 99 (204)
T ss_pred CCEEEEEEeCChhHHHHHH----------------------------------------------hc-------chHHHH
Confidence 7788888888766554443 21 134566
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
.+-.-+.-||..||+|+||.++||++..++ +.++||||+..
T Consensus 100 ~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 100 EVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred HHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 677778889999999999999999998655 99999999874
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.2e-12 Score=108.62 Aligned_cols=169 Identities=21% Similarity=0.237 Sum_probs=92.5
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCC---------
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHH--------- 128 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h--------- 128 (267)
+...-.....+.||.|+++.||++.+. ++++++|+|+...... +....+.+.+|......+.+
T Consensus 8 ~~~~r~l~~~~~i~~g~~~~v~~v~d~-------~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~ 80 (288)
T PF14531_consen 8 GQRPRTLVRGRIIGKGGFSIVFEVTDV-------ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYR 80 (288)
T ss_dssp S--EEEEEEEEEEEEETTEEEEEEEET-------TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHH
T ss_pred CCCceEEEEccccccCCceEEEEEEEc-------cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHH
Confidence 333345677889999999999999996 6679999999865542 23456777778766655432
Q ss_pred -CceeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhc
Q psy2579 129 -PNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKIT 207 (267)
Q Consensus 129 -pnIv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~ 207 (267)
-.++-.++...-.+..-.+-.-... + ...-...+++|+... .+|.+.+.
T Consensus 81 ~~r~l~P~d~~~i~~~~~~~~~~~~~-~----------------------------~~~v~n~~~l~P~~~-~dL~~~~~ 130 (288)
T PF14531_consen 81 HLRFLVPLDLLRIPGKPPFFERGPGQ-S----------------------------IYWVLNRFLLMPRAQ-GDLQDLVE 130 (288)
T ss_dssp HH-B---SEEEEETTS-SEEEECETT-E----------------------------EEEEESEEEEEE--S-EEHHHHHH
T ss_pred hceEEeeeEEEEEcCCCcceecCCCC-c----------------------------cceeehhhhccchhh-hcHHHHHH
Confidence 1222223322211110000000000 0 000001223333331 23333322
Q ss_pred ---ccCCC----ChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 208 ---TEGRL----SEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 208 ---~~~~~----~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
..... .......+..|++..++++|+.|++|+||+|+|++++.+|.+.|+||+....
T Consensus 131 ~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r 194 (288)
T PF14531_consen 131 ALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVR 194 (288)
T ss_dssp HHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEE
T ss_pred HHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHee
Confidence 21111 1222344558999999999999999999999999999999999999987654
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.38 E-value=8.4e-14 Score=131.66 Aligned_cols=142 Identities=25% Similarity=0.321 Sum_probs=109.0
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccc--cchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAK--LTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.|...+.||++.|=.|.+|.++ .| .|+||++-+.+ .+-....+-.+|++ ...+++||++++-.+.+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~--------eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~ 93 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR--------EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD 93 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC--------Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhh
Confidence 5888999999999999999885 23 38999986654 22223334445565 5556999999887765544
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
.-.|+|-+|.. -+|.|.+..++-+..-+-..++
T Consensus 94 kAAylvRqyvk-----------------------------------------------hnLyDRlSTRPFL~~iEKkWia 126 (1431)
T KOG1240|consen 94 KAAYLVRQYVK-----------------------------------------------HNLYDRLSTRPFLVLIEKKWIA 126 (1431)
T ss_pred HHHHHHHHHHh-----------------------------------------------hhhhhhhccchHHHHHHHHHHH
Confidence 44444433332 3666777676667888999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla 262 (267)
.|++.||..+|..||+|+|||.+||||+..+.+.|+||..-
T Consensus 127 FQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsF 167 (1431)
T KOG1240|consen 127 FQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASF 167 (1431)
T ss_pred HHHHHHHHHHHHcCccccccccceEEEeeechhhhhccccc
Confidence 99999999999999999999999999999999999999753
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.38 E-value=7.3e-12 Score=97.31 Aligned_cols=145 Identities=19% Similarity=0.162 Sum_probs=105.4
Q ss_pred EecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-----ch-HHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-----TP-KARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 67 ~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
.+..|-+|+-+.|+++.+. |+...||.-..... +. -.+.+..+|++++.++.--+|.-..-++.+
T Consensus 11 ~l~likQGAEArv~~~~~~---------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D 81 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS---------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID 81 (229)
T ss_pred cceeeeccceeeEeeeccC---------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe
Confidence 4566889999999999875 45666665443332 22 235778999999999976677766667777
Q ss_pred cCeEEEEEeecCC-CchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 141 FGKIFLVVEYASG-GELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 141 ~~~~~iv~e~~~~-gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
...-.++|||..| .++.+++.... ...........
T Consensus 82 ~~~~~i~ME~~~g~~~vk~~i~~~~--------------------------------------------~~~~~d~~~~~ 117 (229)
T KOG3087|consen 82 TYGGQIYMEFIDGASTVKDFILSTM--------------------------------------------EDESEDEGLAE 117 (229)
T ss_pred cCCCeEEEEeccchhHHHHHHHHHc--------------------------------------------cCcccchhHHH
Confidence 8888889999876 34444433221 11223333478
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC---ceEEeccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG---IVKLGDLGFSTK 264 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~---~~kl~DFGla~~ 264 (267)
++.++-..+.-||..+++|+||..+||++..++ .+.++|||++..
T Consensus 118 ~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 118 LARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred HHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 889999999999999999999999999997665 458999999864
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.3e-13 Score=112.65 Aligned_cols=143 Identities=17% Similarity=0.270 Sum_probs=121.3
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.+...++.+|...-.|+.|+|+|.. ..++.|++.....+...-+.|..|.-.|+.+.||||+.++++|.++
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwqg---------ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp 259 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQG---------NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP 259 (448)
T ss_pred hhhhhhhhhhccCCCcccccccccC---------cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC
Confidence 4446677789999999999999973 5578899988877777778899999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
..+.++..|++.|||+..++.... -..+..++.+++
T Consensus 260 pnlv~isq~mp~gslynvlhe~t~--------------------------------------------vvvd~sqav~fa 295 (448)
T KOG0195|consen 260 PNLVIISQYMPFGSLYNVLHEQTS--------------------------------------------VVVDHSQAVRFA 295 (448)
T ss_pred CCceEeeeeccchHHHHHHhcCcc--------------------------------------------EEEecchHHHHH
Confidence 999999999999999998876421 135678899999
Q ss_pred HHHHHHHHHHHhCC--CcccCCCCCcEEeecCCceEEe
Q psy2579 222 LQILSAVKHLHDRD--IIHRDIKAENVFLSVRGIVKLG 257 (267)
Q Consensus 222 ~ql~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~ 257 (267)
.++++|++|||+.. |..--|.+..++++++-+.+|+
T Consensus 296 ldiargmaflhslep~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 296 LDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred HHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee
Confidence 99999999999985 4455788999999998776653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.7e-11 Score=99.03 Aligned_cols=84 Identities=15% Similarity=0.180 Sum_probs=62.3
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCC--Cceeeeeeeeeec---Ce
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHH--PNIIRLYEVLETF---GK 143 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~~~~~~~~~---~~ 143 (267)
+.||.|..+.||++... ++..+++|+....... .....+.+|+.+++.+.+ ..+++++.+.... +.
T Consensus 4 ~~l~~G~~n~~~~v~~~--------~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~ 74 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG--------GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGT 74 (223)
T ss_pred eecCCCccceEEEEEec--------CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCC
Confidence 45899999999999763 2468999998654321 123567899999999965 4457777776654 36
Q ss_pred EEEEEeecCCCchhhhhh
Q psy2579 144 IFLVVEYASGGELYNKIT 161 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~ 161 (267)
.+++||+++|.++...+.
T Consensus 75 ~~~v~e~i~G~~l~~~~~ 92 (223)
T cd05154 75 PFYVMERVDGRVLRDRLL 92 (223)
T ss_pred ceEEEEEeCCEecCCCCC
Confidence 799999999998877653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.2e-12 Score=121.68 Aligned_cols=153 Identities=27% Similarity=0.441 Sum_probs=123.6
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-CCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-HPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~ 141 (267)
..|.+.+.||+|+|+.|-.+.... .....+|.|.+.....+.........|..+-..+. |+|++.+++.....
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~------~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~ 93 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSR------DPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP 93 (601)
T ss_pred ccccccccccccccchhhhhhhcC------CCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC
Confidence 448889999999999998886642 33466788877665433444455667888888886 99999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccC-CCChhHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEG-RLSEDDAKIY 220 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~ 220 (267)
...++++++..++++...+. .... ..+...+..+
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~---------------------------------------------~~~~~~~~~~~~~~~ 128 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKIS---------------------------------------------HPDSTGTSSSSASRY 128 (601)
T ss_pred cccccccCcccccccccccc---------------------------------------------cCCccCCCCcchhhh
Confidence 99999999988877765541 1122 4677788889
Q ss_pred HHHHHHHHHHHH-hCCCcccCCCCCcEEeecCC-ceEEeccccccccC
Q psy2579 221 FLQILSAVKHLH-DRDIIHRDIKAENVFLSVRG-IVKLGDLGFSTKLQ 266 (267)
Q Consensus 221 ~~ql~~~L~~lH-~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~l~ 266 (267)
+.|+..++.|+| ..++.|||+||+|.+++..+ .++++|||+|..+.
T Consensus 129 ~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 129 LPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred hhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 999999999999 99999999999999999999 99999999998653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=4.1e-10 Score=94.81 Aligned_cols=124 Identities=14% Similarity=0.082 Sum_probs=83.4
Q ss_pred cceEEEEeecccccchHHH----------HHHHHHHHHHhhcCCCce--eeeeeeeee-----cCeEEEEEeecCCC-ch
Q psy2579 95 ISYLAIKILDKAKLTPKAR----------KMLSREIVSMESVHHPNI--IRLYEVLET-----FGKIFLVVEYASGG-EL 156 (267)
Q Consensus 95 ~~~vaiK~~~~~~~~~~~~----------~~~~~Ei~~l~~l~hpnI--v~~~~~~~~-----~~~~~iv~e~~~~g-sl 156 (267)
++.+.||........ +.. ..+.+|...+..+..-+| +....+++. ....++|||++++. +|
T Consensus 45 g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL 123 (268)
T PRK15123 45 GKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL 123 (268)
T ss_pred CEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence 467888876433211 111 137789999988843333 334445433 23466777777663 44
Q ss_pred hhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHHHHHhCCC
Q psy2579 157 YNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDI 236 (267)
Q Consensus 157 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~~~i 236 (267)
.+++... ...+.+......++.+++..+.-||..|+
T Consensus 124 ~~~~~~~--------------------------------------------~~~~~~~~~~~~ll~~la~~i~~LH~~Gi 159 (268)
T PRK15123 124 EDYCADW--------------------------------------------ATNPPDPRLKRMLIKRVATMVRDMHAAGI 159 (268)
T ss_pred HHHHHhh--------------------------------------------cccCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence 4443211 02245566778899999999999999999
Q ss_pred cccCCCCCcEEeec-------CCceEEecccccc
Q psy2579 237 IHRDIKAENVFLSV-------RGIVKLGDLGFST 263 (267)
Q Consensus 237 vHrDlkp~NIll~~-------~~~~kl~DFGla~ 263 (267)
+|+|++++|||++. ++.+.++||+.++
T Consensus 160 ~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 160 NHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred ccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99999999999975 4589999999885
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.19 E-value=4.4e-10 Score=89.58 Aligned_cols=126 Identities=22% Similarity=0.317 Sum_probs=78.8
Q ss_pred EEEeEEeecccccccccceEEEEeeccccc----------------------c--hHHHHHHHHHHHHHhhcCCC--cee
Q psy2579 79 VKMAIHEIYVPILCTYISYLAIKILDKAKL----------------------T--PKARKMLSREIVSMESVHHP--NII 132 (267)
Q Consensus 79 V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~----------------------~--~~~~~~~~~Ei~~l~~l~hp--nIv 132 (267)
||.|.. ..+..+|+|+...... . ........+|...|..+..- +++
T Consensus 2 Vy~~~~--------~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP 73 (188)
T PF01163_consen 2 VYHAID--------PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVP 73 (188)
T ss_dssp EEEEEE--------CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS-
T ss_pred EEEEEC--------CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence 777765 3457899998864211 0 11235578999999999655 566
Q ss_pred eeeeeeeecCeEEEEEeecC--CCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccC
Q psy2579 133 RLYEVLETFGKIFLVVEYAS--GGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEG 210 (267)
Q Consensus 133 ~~~~~~~~~~~~~iv~e~~~--~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~ 210 (267)
+++++. ...+||||++ |..+.. +. ..
T Consensus 74 ~p~~~~----~~~ivME~I~~~G~~~~~-l~---------------------------------------------~~-- 101 (188)
T PF01163_consen 74 KPYDYN----RNVIVMEYIGEDGVPLPR-LK---------------------------------------------DV-- 101 (188)
T ss_dssp -EEEEE----TTEEEEE--EETTEEGGC-HH---------------------------------------------HC--
T ss_pred cEEEEe----CCEEEEEecCCCccchhh-HH---------------------------------------------hc--
Confidence 666542 3457777776 322211 11 11
Q ss_pred CCChhHHHHHHHHHHHHHHH-HHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 211 RLSEDDAKIYFLQILSAVKH-LHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 211 ~~~~~~~~~~~~ql~~~L~~-lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++......++.+++..+.. +|+.|++|+|+.+.||+++.+ .+.|+|||.|...
T Consensus 102 ~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 102 DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence 12245667778888885555 579999999999999999877 9999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.4e-10 Score=102.44 Aligned_cols=98 Identities=22% Similarity=0.366 Sum_probs=87.1
Q ss_pred HhhcCCCceeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCch
Q psy2579 123 MESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGEL 202 (267)
Q Consensus 123 l~~l~hpnIv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l 202 (267)
|+.+.|.|+.++++.+.+++..++|.+||..|+|.+.+...
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--------------------------------------- 41 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--------------------------------------- 41 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---------------------------------------
Confidence 35689999999999999999999999999999998877653
Q ss_pred hhhhcccCCCChhHHHHHHHHHHHHHHHHHhCCC-cccCCCCCcEEeecCCceEEecccccccc
Q psy2579 203 YNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDI-IHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~~~i-vHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
...+++.....+++.++.||+|+|.-.| .|..+++.|++++....+||+|||+....
T Consensus 42 ------~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~ 99 (484)
T KOG1023|consen 42 ------DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLL 99 (484)
T ss_pred ------ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcccc
Confidence 2257888888999999999999998766 89999999999999999999999998765
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.07 E-value=9.4e-11 Score=105.32 Aligned_cols=153 Identities=23% Similarity=0.259 Sum_probs=124.3
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVL 138 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~ 138 (267)
....+|.++..||.|.|+.|+....+. .++..+++|.+............-..|+.+...+ .|.+++.+...|
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~------~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRP------EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecC------CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc
Confidence 346779999999999999999987441 3457889998877665544444456777777777 799999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
......|+-.|||+++++...+. ....+++...+
T Consensus 336 ~~~r~~~ip~e~~~~~s~~l~~~----------------------------------------------~~~~~d~~~~~ 369 (524)
T KOG0601|consen 336 SQLRQGYIPLEFCEGGSSSLRSV----------------------------------------------TSQMLDEDPRL 369 (524)
T ss_pred cccccccCchhhhcCcchhhhhH----------------------------------------------HHHhcCcchhh
Confidence 99999999999999988754331 12247788889
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecC-CceEEeccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVR-GIVKLGDLGFSTK 264 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DFGla~~ 264 (267)
.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||+++.
T Consensus 370 ~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 370 RLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred hhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence 999999999999999999999999999999886 7889999998864
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.5e-10 Score=109.75 Aligned_cols=40 Identities=43% Similarity=0.737 Sum_probs=38.1
Q ss_pred HHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 225 LSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 225 ~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
+.+++|+|+-||+|||+||+|.+|..-|++|++|||+++.
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKK 192 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhh
Confidence 6699999999999999999999999999999999999874
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.1e-10 Score=104.80 Aligned_cols=151 Identities=25% Similarity=0.299 Sum_probs=119.3
Q ss_pred ceEEecccCc--cCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeee
Q psy2579 64 LYKLQNELGR--GNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLET 140 (267)
Q Consensus 64 ~y~~~~~iG~--G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 140 (267)
.+.+...+|. |.+|.||.+.... ......+|+|.-+.....+....+-.+|+...+.+ .|+|.++.+..|+.
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~-----~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTN-----SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hcccccccccCCCCCceeecccCCc-----ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 3777788999 9999999997622 14457889998655443344445556788888877 69999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCC-CChhHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGR-LSEDDAKI 219 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~-~~~~~~~~ 219 (267)
.+..++-+|+|.. ++. .++....+ ++...++.
T Consensus 190 ~~~lfiqtE~~~~-sl~----------------------------------------------~~~~~~~~~~p~~~l~~ 222 (524)
T KOG0601|consen 190 SGILFIQTELCGE-SLQ----------------------------------------------SYCHTPCNFLPDNLLWN 222 (524)
T ss_pred CCcceeeeccccc-hhH----------------------------------------------HhhhcccccCCchhhhh
Confidence 9999999999873 333 33333333 67778888
Q ss_pred HHHHHHH----HHHHHHhCCCcccCCCCCcEEeecC-CceEEeccccccccC
Q psy2579 220 YFLQILS----AVKHLHDRDIIHRDIKAENVFLSVR-GIVKLGDLGFSTKLQ 266 (267)
Q Consensus 220 ~~~ql~~----~L~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DFGla~~l~ 266 (267)
...+... ||.++|+.+++|-|+||.||+...+ ..++++|||+...+.
T Consensus 223 ~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~ 274 (524)
T KOG0601|consen 223 SLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKIS 274 (524)
T ss_pred HHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEcc
Confidence 8888888 9999999999999999999999888 789999999987764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=5.7e-09 Score=84.82 Aligned_cols=73 Identities=21% Similarity=0.283 Sum_probs=57.3
Q ss_pred EEEEEccC-CchhhhhcccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC---ceEEeccccccc
Q psy2579 192 LVVEYASG-GELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG---IVKLGDLGFSTK 264 (267)
Q Consensus 192 ~v~e~~~~-~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~---~~kl~DFGla~~ 264 (267)
+++|.+++ .+|.+.+......+......++.+++..+.-||.+|++|+|++|.|||++.++ .+.++||+.++.
T Consensus 94 lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 94 LITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred EEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 34444433 24555555433467777888999999999999999999999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.1e-09 Score=99.83 Aligned_cols=119 Identities=23% Similarity=0.427 Sum_probs=96.7
Q ss_pred cccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHH
Q psy2579 93 TYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 172 (267)
Q Consensus 93 ~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~ 172 (267)
.++.+|.|...+.... ...+...+-++-|+.++||||+++++.++..+..|+|+|.+..-. .
T Consensus 35 ~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~--~-------------- 96 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLE--T-------------- 96 (690)
T ss_pred ccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHH--H--------------
Confidence 5568899999876543 334567788999999999999999999999999999999875411 1
Q ss_pred HHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHHHHH-hCCCcccCCCCCcEEeecC
Q psy2579 173 IYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLH-DRDIIHRDIKAENVFLSVR 251 (267)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH-~~~ivHrDlkp~NIll~~~ 251 (267)
.+. .++...+..-+.||+.||.||| .++++|.+|--+.++++..
T Consensus 97 --------------------------------~lk---~l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~ 141 (690)
T KOG1243|consen 97 --------------------------------VLK---ELGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNES 141 (690)
T ss_pred --------------------------------HHH---HhHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCC
Confidence 111 2335667777899999999997 6789999999999999999
Q ss_pred CceEEeccccccc
Q psy2579 252 GIVKLGDLGFSTK 264 (267)
Q Consensus 252 ~~~kl~DFGla~~ 264 (267)
|..||.+|-++..
T Consensus 142 GeWkLggle~v~~ 154 (690)
T KOG1243|consen 142 GEWKLGGLELVSK 154 (690)
T ss_pred CcEEEeeeEEEec
Confidence 9999999987754
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.1e-11 Score=106.81 Aligned_cols=75 Identities=27% Similarity=0.391 Sum_probs=67.1
Q ss_pred eEEEEEEEccCCchhhhhcccC---CCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 189 KIFLVVEYASGGELYNKITTEG---RLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 189 ~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+|+.|..|...+|.+++.... ..++.....++.|++.|++| +|.+|||+||.||+...+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 4789999999999999997544 36778899999999999999 99999999999999999999999999998754
Q ss_pred C
Q psy2579 266 Q 266 (267)
Q Consensus 266 ~ 266 (267)
.
T Consensus 407 ~ 407 (516)
T KOG1033|consen 407 D 407 (516)
T ss_pred c
Confidence 3
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.1e-09 Score=86.50 Aligned_cols=137 Identities=22% Similarity=0.279 Sum_probs=97.8
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccc------------------cc--hHHHHHHHHHHHHHh
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAK------------------LT--PKARKMLSREIVSME 124 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~------------------~~--~~~~~~~~~Ei~~l~ 124 (267)
+.+...||-|.-|.||.|.+ ..+.++|||.=.... .+ ...+....+|..+|.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~--------~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~ 164 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID--------PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQ 164 (304)
T ss_pred HhhccccccCccceEEEEEC--------CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHH
Confidence 56677899999999999987 346899999654321 11 122445679999999
Q ss_pred hcCCC--ceeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCch
Q psy2579 125 SVHHP--NIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGEL 202 (267)
Q Consensus 125 ~l~hp--nIv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l 202 (267)
.|... .|++.+++ ++..+|||+.+|-.|+..
T Consensus 165 ~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~------------------------------------------- 197 (304)
T COG0478 165 RLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRL------------------------------------------- 197 (304)
T ss_pred HhhhcCCCCCCcccc----ccceeeeehcccceeecc-------------------------------------------
Confidence 99655 67776665 667788888777444221
Q ss_pred hhhhcccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 203 YNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
+++...+..++..|+.-+.-+-..|+||+|+.+=||+++.+|.+.++||=-+..
T Consensus 198 --------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 198 --------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred --------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCccccc
Confidence 123444455555566655555589999999999999999999999999965543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=6.6e-08 Score=77.90 Aligned_cols=140 Identities=16% Similarity=0.161 Sum_probs=94.2
Q ss_pred cCccCceeEEEeEEeecccccccccceEEEEeeccccc-c---hHHHHHHHHHHHHHhhcCC--Cceeeeeeeeeec---
Q psy2579 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-T---PKARKMLSREIVSMESVHH--PNIIRLYEVLETF--- 141 (267)
Q Consensus 71 iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~---~~~~~~~~~Ei~~l~~l~h--pnIv~~~~~~~~~--- 141 (267)
-|+||.|-|++.... +..+-+|.-...-. + +-.+..|.+|+..+..|.. -.+++...+....
T Consensus 26 ~~rgG~SgV~r~~~~---------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~ 96 (216)
T PRK09902 26 YRRNGMSGVQCVERN---------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEG 96 (216)
T ss_pred cCCCCcceEEEEEeC---------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCC
Confidence 567888889887542 23567776542110 1 3355779999999999843 3344444222111
Q ss_pred -CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcc--cCCCChhHHH
Q psy2579 142 -GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITT--EGRLSEDDAK 218 (267)
Q Consensus 142 -~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~ 218 (267)
-.-++|+|-+++ -.+|.+.+.. ..+.+...-.
T Consensus 97 ~~rA~LVTe~L~g---------------------------------------------~~~L~~~l~~~~~~~~~~~~k~ 131 (216)
T PRK09902 97 EWRALLVTEDMAG---------------------------------------------FISIADWYAQHAVSPYSDEVRQ 131 (216)
T ss_pred ceEEEEEEEeCCC---------------------------------------------CccHHHHHhcCCcCCcchHHHH
Confidence 125677775543 1234444433 2245677778
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCc--eEEeccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGI--VKLGDLGFSTK 264 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFGla~~ 264 (267)
.+..+++..+.-||+.|+.|+|+.+.||+++.+|. ++++||--++.
T Consensus 132 ~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 132 AMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 89999999999999999999999999999987776 99999976653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.2e-08 Score=80.36 Aligned_cols=58 Identities=28% Similarity=0.350 Sum_probs=51.5
Q ss_pred Cchhhhhcc-cCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 200 GELYNKITT-EGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 200 ~~l~~~~~~-~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|+|.+.+.. ..++++.+++.++.|++.||.|||+++ ||+||+++.++.+++ ||+++..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~ 59 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFK 59 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEee
Confidence 467777766 456999999999999999999999999 999999999999999 9998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=9.4e-08 Score=87.21 Aligned_cols=143 Identities=16% Similarity=0.244 Sum_probs=87.3
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccc---------------------------cchH-----HHHH-
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAK---------------------------LTPK-----ARKM- 115 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~---------------------------~~~~-----~~~~- 115 (267)
..|+.++-|.||+|+.. +|+.||||+..+.- .+.. ..+.
T Consensus 131 ~PiAsASIaQVH~A~L~--------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l 202 (517)
T COG0661 131 EPIASASIAQVHRAVLK--------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRL 202 (517)
T ss_pred CchhhhhHhhheeEEec--------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHH
Confidence 45999999999999884 37999999987521 1110 0111
Q ss_pred -----HHHHHHHHhhc-----CCCceeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhh
Q psy2579 116 -----LSREIVSMESV-----HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185 (267)
Q Consensus 116 -----~~~Ei~~l~~l-----~hpnIv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (267)
+.+|+..+..+ +.|++.-..-+++-.+.-.++|||+.|..+.+...
T Consensus 203 ~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~------------------------ 258 (517)
T COG0661 203 REELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAA------------------------ 258 (517)
T ss_pred HHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHH------------------------
Confidence 34555555443 23443333333344455556666666644443321
Q ss_pred ccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 186 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.. ...+...+.....++ -+..+=..|+.|.|..|.||+++.+|.+.+.|||+...+
T Consensus 259 --------------------l~~-~g~d~k~ia~~~~~~--f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 259 --------------------LKS-AGIDRKELAELLVRA--FLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred --------------------HHh-cCCCHHHHHHHHHHH--HHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 111 234433333333333 233334589999999999999999999999999998876
Q ss_pred C
Q psy2579 266 Q 266 (267)
Q Consensus 266 ~ 266 (267)
.
T Consensus 316 ~ 316 (517)
T COG0661 316 D 316 (517)
T ss_pred C
Confidence 5
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.7e-07 Score=74.83 Aligned_cols=53 Identities=15% Similarity=0.324 Sum_probs=45.4
Q ss_pred CChhHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 212 LSEDDAKIYFLQILSAVKHLHD-RDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 212 ~~~~~~~~~~~ql~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+...++..+..+++..+.-|-. .|+||.||..=|||+. ++.+.++|||-|...
T Consensus 163 ~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 163 LELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred cCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence 3444788888889888888776 8999999999999999 999999999988654
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.6e-07 Score=83.81 Aligned_cols=149 Identities=13% Similarity=0.164 Sum_probs=106.8
Q ss_pred CceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec----CeEEEEEee
Q psy2579 75 NFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF----GKIFLVVEY 150 (267)
Q Consensus 75 ~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~----~~~~iv~e~ 150 (267)
.-.+.|+|... .+|..|.+|.++....-.. .....-++.++++.|+|+|++.++|.+. ..+++|.+|
T Consensus 288 ~~~Ttyk~~s~-------~DG~~YvLkRlhg~r~~~~--nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDY 358 (655)
T KOG3741|consen 288 FSITTYKATSN-------VDGNAYVLKRLHGDRDQST--NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDY 358 (655)
T ss_pred ccceeEeeeec-------cCCceeeeeeeccccccCc--ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEec
Confidence 34568888775 5568899999943321111 1122357788999999999999998733 458899999
Q ss_pred cCC-CchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHH
Q psy2579 151 ASG-GELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVK 229 (267)
Q Consensus 151 ~~~-gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~ 229 (267)
.++ ++|+++-......+.. +-..........++..+|.++.|+..||.
T Consensus 359 yP~s~TL~d~~F~~~~~t~~-------------------------------~n~~~~~~~~~~~e~~lW~y~~QLtaaL~ 407 (655)
T KOG3741|consen 359 YPSSPTLYDLYFANPPFTKR-------------------------------TNSFYPSQNLKAPEEVLWSYISQLTAALY 407 (655)
T ss_pred CCCCchHHHHHccCCccccc-------------------------------cccccccCCCCchHHHHHHHHHHHHHHHH
Confidence 764 7777766544332211 11112223446889999999999999999
Q ss_pred HHHhCCCcccCCCCCcEEeecCCceEEecccccc
Q psy2579 230 HLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 230 ~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 263 (267)
++|+.|+.-+-|.|.+|+++.+.+++|+.-|..-
T Consensus 408 sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 408 SIHSSGLACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred HHHhcCceeecccHhHeEeeCcceEEEeccccee
Confidence 9999999999999999999988788887655543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.68 E-value=7.6e-07 Score=72.12 Aligned_cols=66 Identities=27% Similarity=0.368 Sum_probs=47.7
Q ss_pred EEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 190 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
.+++|||++|..+.+.. .+++ .+...+..++.-+|+.|+.|+|..|.|++++.++ ++++||+..+.
T Consensus 118 ~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 118 YVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred EEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECccccc
Confidence 34666777666554432 1222 2445677789999999999999999999998544 89999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.5e-07 Score=75.38 Aligned_cols=72 Identities=15% Similarity=0.222 Sum_probs=52.9
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCC--ceeeeeeeeeecCeEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHP--NIIRLYEVLETFGKIFL 146 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~~~~~~~~~~~~~i 146 (267)
..||+|..+.||+.. +..+++|...... . ...+.+|.++++.+..- .+++.+++....+...+
T Consensus 7 ~~i~~G~t~~~y~~~-----------~~~~VlR~~~~~~-~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl 71 (226)
T TIGR02172 7 TQTGEGGNGESYTHK-----------TGKWMLKLYNPGF-D---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL 71 (226)
T ss_pred eeecCCCCcceeEec-----------CCCEEEEeCCCCC-C---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence 458999999999841 1356788876532 1 23468899999888533 34677888777888899
Q ss_pred EEeecCCCc
Q psy2579 147 VVEYASGGE 155 (267)
Q Consensus 147 v~e~~~~gs 155 (267)
+||+++|.+
T Consensus 72 v~e~i~G~~ 80 (226)
T TIGR02172 72 IYELIVGKR 80 (226)
T ss_pred eeeecCCcc
Confidence 999999963
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.49 E-value=4.8e-06 Score=68.24 Aligned_cols=78 Identities=21% Similarity=0.239 Sum_probs=55.6
Q ss_pred ecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCC--ceeeeeeee---eecC
Q psy2579 68 QNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHP--NIIRLYEVL---ETFG 142 (267)
Q Consensus 68 ~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~~~~~~---~~~~ 142 (267)
++.|+.|..+.||+.... + ..+++|..... .....+.+|..+++.+... .+++++... ...+
T Consensus 2 i~~l~~G~~n~~~~v~~~--------~-~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~ 68 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD--------D-GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNG 68 (239)
T ss_dssp EEEEEESSSSEEEEEEET--------T-SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETS
T ss_pred CccCCCCCeeeEEEEEEC--------C-cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccc
Confidence 456899999999999753 2 58899997543 3456678899998888432 356666643 3335
Q ss_pred eEEEEEeecCCCchhh
Q psy2579 143 KIFLVVEYASGGELYN 158 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~ 158 (267)
..+++|+++++.++..
T Consensus 69 ~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 69 FPYLLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEEEEESSEEHHH
T ss_pred cceEEEEEeccccccc
Confidence 6899999999988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.49 E-value=5.1e-06 Score=66.84 Aligned_cols=142 Identities=21% Similarity=0.255 Sum_probs=96.7
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccc--------------cchHHHHHHHHHHHHHhhcC------C
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAK--------------LTPKARKMLSREIVSMESVH------H 128 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~Ei~~l~~l~------h 128 (267)
..||+|+.-.||.--+. ....||++.... .......+..+|+.....+. +
T Consensus 7 ~~i~~G~~R~cy~HP~d----------p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~ 76 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPDD----------PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDW 76 (199)
T ss_pred cccccCCCceEEECCCC----------CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcc
Confidence 45999999999976332 456899987765 11122456677777766665 8
Q ss_pred CceeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcc
Q psy2579 129 PNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITT 208 (267)
Q Consensus 129 pnIv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~ 208 (267)
.+|.+++|+.+++.-+-+|+|...+.+-. ...+|.+++..
T Consensus 77 ~~i~r~~G~veT~~G~Glv~e~I~d~dG~----------------------------------------~s~TL~~~l~~ 116 (199)
T PF10707_consen 77 SHIPRFYGFVETNLGLGLVVELIRDADGN----------------------------------------ISPTLEDYLKE 116 (199)
T ss_pred cccccEeEEEecCCceEEEEEEEECCCCC----------------------------------------cCccHHHHHHc
Confidence 89999999999998889999987542210 01356666633
Q ss_pred cCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC----ceEEec-ccccccc
Q psy2579 209 EGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG----IVKLGD-LGFSTKL 265 (267)
Q Consensus 209 ~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~----~~kl~D-FGla~~l 265 (267)
+.+++ ..... +-.-..||-+.+|+.+|++|.||++.... .+.|+| ||-...+
T Consensus 117 -~~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~~~i 173 (199)
T PF10707_consen 117 -GGLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEKELI 173 (199)
T ss_pred -CCccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCCCCcccc
Confidence 34555 33333 33345677899999999999999996543 578888 7765443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.8e-06 Score=69.30 Aligned_cols=75 Identities=16% Similarity=0.084 Sum_probs=53.4
Q ss_pred cCccCc-eeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeecCeEEEEE
Q psy2579 71 LGRGNF-STVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETFGKIFLVV 148 (267)
Q Consensus 71 iG~G~f-g~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~iv~ 148 (267)
|-.|.. +.||+.... +..+.+|+..... ...+.+|+.+++.+ .+--+++++++....+..+++|
T Consensus 6 ~~~g~~~~~v~~~~~~---------~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 71 (244)
T cd05150 6 VTEGQSGATVYRLDGK---------NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT 71 (244)
T ss_pred cCCCCCcCeEEEEcCC---------CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence 555555 778988532 2578888875432 23466799998888 3455677888877777889999
Q ss_pred eecCCCchhhh
Q psy2579 149 EYASGGELYNK 159 (267)
Q Consensus 149 e~~~~gsl~~~ 159 (267)
|+++|.++...
T Consensus 72 e~i~G~~l~~~ 82 (244)
T cd05150 72 SAVPGVPAAAL 82 (244)
T ss_pred EeeCCccHhHh
Confidence 99999888644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.8e-07 Score=77.91 Aligned_cols=93 Identities=25% Similarity=0.478 Sum_probs=78.4
Q ss_pred HhhcCCCceeeeeeeeeecC-----eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEc
Q psy2579 123 MESVHHPNIIRLYEVLETFG-----KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYA 197 (267)
Q Consensus 123 l~~l~hpnIv~~~~~~~~~~-----~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~ 197 (267)
+-.+.|-|||+++.+|.+.. +..+++||+..|++..+|++.+.
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-------------------------------- 168 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-------------------------------- 168 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH--------------------------------
Confidence 33456999999999997653 47889999999999999886533
Q ss_pred cCCchhhhhcccCCCChhHHHHHHHHHHHHHHHHHhC--CCcccCCCCCcEEeecCCceEEe
Q psy2579 198 SGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR--DIIHRDIKAENVFLSVRGIVKLG 257 (267)
Q Consensus 198 ~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~~--~ivHrDlkp~NIll~~~~~~kl~ 257 (267)
.+..+......+|+.||+.||.|||+. -++|.++..+-|++..+|.+|+.
T Consensus 169 ----------~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 169 ----------NQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred ----------hhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEec
Confidence 233678889999999999999999988 49999999999999999998874
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.30 E-value=7.4e-06 Score=74.85 Aligned_cols=54 Identities=15% Similarity=0.247 Sum_probs=39.3
Q ss_pred CCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeec----CCceEEeccccccccC
Q psy2579 211 RLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSV----RGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 211 ~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~----~~~~kl~DFGla~~l~ 266 (267)
.++...+..-+.+.. ++-|=..|++|.|-.|.||++.. ++.+.+-|||+.+.+.
T Consensus 299 gi~~~~i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 299 GISPHDILNKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CCCHHHHHHHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 466665555554442 33344678999999999999984 5689999999988764
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.1e-05 Score=78.60 Aligned_cols=84 Identities=15% Similarity=0.272 Sum_probs=57.5
Q ss_pred ecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-CCce--eeeeeeeeec---
Q psy2579 68 QNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-HPNI--IRLYEVLETF--- 141 (267)
Q Consensus 68 ~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnI--v~~~~~~~~~--- 141 (267)
+..++.|.+..+|+...... .....+++|+....... .....+.+|+.+++.+. |+++ ++++.++.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~-----~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~ 116 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNG-----GSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVI 116 (822)
T ss_pred EEEeCCCCcCceEEEEECCC-----CcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcC
Confidence 45689999999998765311 11135777776543221 12346789999999995 6665 7777777654
Q ss_pred CeEEEEEeecCCCchh
Q psy2579 142 GKIFLVVEYASGGELY 157 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~ 157 (267)
+..|+|||+++|..+.
T Consensus 117 G~~flVME~v~G~~~~ 132 (822)
T PLN02876 117 GTAFYIMEYLEGRIFV 132 (822)
T ss_pred CCceEEEEecCCcccC
Confidence 5789999999986554
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.1e-05 Score=62.93 Aligned_cols=127 Identities=21% Similarity=0.254 Sum_probs=82.1
Q ss_pred EecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCcee-eeeeeeeecCeEE
Q psy2579 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNII-RLYEVLETFGKIF 145 (267)
Q Consensus 67 ~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv-~~~~~~~~~~~~~ 145 (267)
..+.||+|.+|.||+|.|+ +.++|+|+-... ..+..+..|++++..+.-.++. +++.+ +.-+
T Consensus 26 v~~~L~KG~~s~Vyl~~~~---------~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~ 88 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR---------GGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFY----GEDF 88 (201)
T ss_pred hhhhhhcccccEEEEeecc---------CceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEe----chhh
Confidence 4567999999999999986 368999986543 3456788999999988766554 34443 2233
Q ss_pred EEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHH
Q psy2579 146 LVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 225 (267)
Q Consensus 146 iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~ 225 (267)
+.|||..|..|..... . .+..++ ..++
T Consensus 89 i~me~i~G~~L~~~~~----------------------------------------------~---~~rk~l----~~vl 115 (201)
T COG2112 89 IRMEYIDGRPLGKLEI----------------------------------------------G---GDRKHL----LRVL 115 (201)
T ss_pred hhhhhhcCcchhhhhh----------------------------------------------c---ccHHHH----HHHH
Confidence 4477776644432111 0 011222 2333
Q ss_pred HHHHHHHhCCCcccCCC-CCcEEeecCCceEEecccccc
Q psy2579 226 SAVKHLHDRDIIHRDIK-AENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 226 ~~L~~lH~~~ivHrDlk-p~NIll~~~~~~kl~DFGla~ 263 (267)
..---|-..||-|..|. |..+++..++.+.|+||..|+
T Consensus 116 E~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 116 EKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred HHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 33223446788898885 556666666699999999887
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.15 E-value=4.9e-05 Score=60.95 Aligned_cols=145 Identities=17% Similarity=0.122 Sum_probs=93.1
Q ss_pred cceEEecccCccCc-eeEEEeEEeecccccccccceEEEEeecc---cc-------cch---------HHHHHHHHHHHH
Q psy2579 63 ALYKLQNELGRGNF-STVKMAIHEIYVPILCTYISYLAIKILDK---AK-------LTP---------KARKMLSREIVS 122 (267)
Q Consensus 63 ~~y~~~~~iG~G~f-g~V~~a~~~~~~~~~~~~~~~vaiK~~~~---~~-------~~~---------~~~~~~~~Ei~~ 122 (267)
..++.++.||.|+- |.||++... ++.+|+|+... .. ... ...+-|..|.+.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~---------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRA 107 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID---------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRA 107 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC---------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHh
Confidence 55999999999999 999999864 57899999321 10 000 122457788888
Q ss_pred HhhcC---CCce--eeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEc
Q psy2579 123 MESVH---HPNI--IRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYA 197 (267)
Q Consensus 123 l~~l~---hpnI--v~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~ 197 (267)
..+|+ +.++ |+++|+..-... +..... .. -..........-||.|++
T Consensus 108 fgRLke~~~e~~~Avkc~Gyl~L~~~--------------~q~~~~------------~~--~~~~~~~~~~~aIVKD~v 159 (207)
T PF13095_consen 108 FGRLKEAGREGLWAVKCHGYLLLTED--------------QQFEQL------------RQ--RGSDHRPLPIRAIVKDFV 159 (207)
T ss_pred hHHHHhccccCceEEEeeEEEEEchH--------------HHHHHh------------hc--ccccCCCCccEEEEEeec
Confidence 88774 4455 888887532100 000000 00 012223334557888887
Q ss_pred cCCchhhhhcccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccc
Q psy2579 198 SGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262 (267)
Q Consensus 198 ~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla 262 (267)
+... .++ ..-+.++.+-|..+|..||+-+|+++.|.. .-+|+|||.+
T Consensus 160 ~~~~---------~~~----~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 160 PDDP---------PLQ----IRDIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CCcc---------ccc----hhHHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 6432 222 233457777899999999999999999986 3578899975
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.11 E-value=3.8e-05 Score=63.59 Aligned_cols=75 Identities=8% Similarity=-0.024 Sum_probs=47.8
Q ss_pred cccCccCcee-EEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCC---ceeeeeeeeeec---
Q psy2579 69 NELGRGNFST-VKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHP---NIIRLYEVLETF--- 141 (267)
Q Consensus 69 ~~iG~G~fg~-V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hp---nIv~~~~~~~~~--- 141 (267)
+.|+.|+... ||+.. ..+.+|+..... ....+.+|..++..+... .+..+++.....
T Consensus 3 ~~~~~gG~~n~vy~~~------------~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~ 66 (235)
T cd05155 3 EPVDSGGTDNATFRLG------------DDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGY 66 (235)
T ss_pred eeccCCCcccceEEcC------------CceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCC
Confidence 4578777764 88752 235778754321 234688899999887421 344555544332
Q ss_pred CeEEEEEeecCCCchhhh
Q psy2579 142 GKIFLVVEYASGGELYNK 159 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~ 159 (267)
+..|++|++++|.++...
T Consensus 67 ~~~~~l~~~i~G~~l~~~ 84 (235)
T cd05155 67 PWPWSVYRWLEGETATAA 84 (235)
T ss_pred CcceEEEEeecCCCCCcc
Confidence 245899999999888654
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00027 Score=60.51 Aligned_cols=167 Identities=15% Similarity=0.158 Sum_probs=85.8
Q ss_pred ecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCC--ceeeeeee------ee
Q psy2579 68 QNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHP--NIIRLYEV------LE 139 (267)
Q Consensus 68 ~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hp--nIv~~~~~------~~ 139 (267)
++.|..|....+|+... .+..+++|+.... + ...+..|+.++..+.+- .+++++.. ..
T Consensus 19 i~~i~~G~~n~~y~v~~---------~~~~~vLr~~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~ 84 (296)
T cd05153 19 FEGISAGIENTNYFVTT---------DSGRYVLTLFEKV--S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE 84 (296)
T ss_pred eecccCccccceEEEEe---------CCCcEEEEEcCCC--C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence 45688888889998743 1246888987541 1 23466788888777432 24444432 23
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHH--HHHHHhhhccCeEEEEEEEccCCchhhhhcc--cCCCChh
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ--ILLYEVLETFGKIFLVVEYASGGELYNKITT--EGRLSED 215 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~--~~~~~~~ 215 (267)
..+..+.++++++|..+.. ..+.... .... ..+......+... ............... ...+...
T Consensus 85 ~~~~~~~l~~~i~G~~~~~-------~~~~~~~-~lg~~La~lH~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~~ 153 (296)
T cd05153 85 LAGKPAALVEFLAGEHLTR-------PTAAHCR-QIGEALARLHLAAQSFPGE---RNNLRGLAWIRELGKDLLPLLSAE 153 (296)
T ss_pred eCCceEEEEEeCCCCCCCC-------CCHHHHH-HHHHHHHHHHHHhccCCcc---CCCcCCcHHHHHHHHHhccccCHH
Confidence 3466789999999977643 0111111 1111 1122222111111 000000000000000 0111211
Q ss_pred HHHHHHHHHHHHHHHHH-------hCCCcccCCCCCcEEeecCCceEEecccccc
Q psy2579 216 DAKIYFLQILSAVKHLH-------DRDIIHRDIKAENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH-------~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 263 (267)
.... +..++.++. ..+++|+|+.|.||+++.++.+.|+||+.|.
T Consensus 154 -~~~~---~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 154 -DRAL---LADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred -HHHH---HHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 1111 222233333 2479999999999999988778999998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.87 E-value=7.9e-05 Score=59.55 Aligned_cols=100 Identities=23% Similarity=0.258 Sum_probs=75.7
Q ss_pred HHHHHHHhhcCC-CceeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEE
Q psy2579 117 SREIVSMESVHH-PNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVE 195 (267)
Q Consensus 117 ~~Ei~~l~~l~h-pnIv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e 195 (267)
..|..+++.+++ +++++++|+| |+ ++++|+...++++...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C---G~-~~v~E~~~~~~~~~~~----------------------------------- 47 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC---GR-FYVVEYVGAGSLYGIY----------------------------------- 47 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC---CC-EEEEEeecCccccccc-----------------------------------
Confidence 358888998965 6999999997 32 5577887765553210
Q ss_pred EccCCchhhhhcccCCCChhHHHHHHHHHHHHHHHHHh---CCCcccCCCCCcEEeecCCceEEecccccc
Q psy2579 196 YASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHD---RDIIHRDIKAENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 196 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 263 (267)
..+ ......+|.....++.+++..+++++. ..+.-.|++|+|+.++.+|.+|++|...+.
T Consensus 48 ----~~l----~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 48 ----RPL----SQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred ----ccc----ccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 011 111257899999999999999999997 347779999999999999999999987543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00043 Score=57.09 Aligned_cols=76 Identities=12% Similarity=0.101 Sum_probs=46.5
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCC-CceeeeeeeeeecCeEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHH-PNIIRLYEVLETFGKIFLV 147 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~~~~~~~~~~~~~iv 147 (267)
+.|..|-...+|+..... ..+..|++|+....... .-...+|+.+++.+.. .-.++++..+. ..++
T Consensus 4 ~~l~gG~tN~~~~v~~~~------~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l 70 (235)
T cd05157 4 KRFTGGITNKLVKVSNKE------DNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLI 70 (235)
T ss_pred EEcCCcccceEEEEEcCC------CCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEE
Confidence 457888888999885320 01467889987543211 1122468888888843 33444444432 2489
Q ss_pred EeecCCCchh
Q psy2579 148 VEYASGGELY 157 (267)
Q Consensus 148 ~e~~~~gsl~ 157 (267)
|||++|.++.
T Consensus 71 ~e~i~G~~l~ 80 (235)
T cd05157 71 YEFIPGRTLE 80 (235)
T ss_pred EEeeCCCcCC
Confidence 9999997764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00027 Score=62.92 Aligned_cols=86 Identities=15% Similarity=0.050 Sum_probs=57.7
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeeccccc-----chHHHHHHHHHHHHHhhc-C--CCceeeeeeeeee
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-----TPKARKMLSREIVSMESV-H--HPNIIRLYEVLET 140 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~Ei~~l~~l-~--hpnIv~~~~~~~~ 140 (267)
+.||.|.+..||++... ..++.|.||.-.+... .+-..++...|...|..+ . ..++++++.+ +
T Consensus 32 ~elggGn~N~VyrV~~~-------~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D 102 (401)
T PRK09550 32 REIGDGNLNLVFRVSDT-------EGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--D 102 (401)
T ss_pred eEcCCCceEEEEEEEeC-------CCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--C
Confidence 46999999999999874 2225799998542210 122346677888888876 2 3467778877 4
Q ss_pred cCeEEEEEeecCCCc-hhhhhhcc
Q psy2579 141 FGKIFLVVEYASGGE-LYNKITTE 163 (267)
Q Consensus 141 ~~~~~iv~e~~~~gs-l~~~l~~~ 163 (267)
.+..++|||++++.. +...+...
T Consensus 103 ~~~~~lVME~L~~~~~lr~~Ll~g 126 (401)
T PRK09550 103 EELAVTVMEDLSDHKILRKGLIDG 126 (401)
T ss_pred CCCCEEEEecCCCccHHHHHHhcC
Confidence 466889999998755 43444433
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00015 Score=60.76 Aligned_cols=73 Identities=15% Similarity=0.041 Sum_probs=44.6
Q ss_pred ccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCce-eeeeeeeeecCeEEEEE
Q psy2579 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNI-IRLYEVLETFGKIFLVV 148 (267)
Q Consensus 70 ~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~~~~~~~~~~~~~iv~ 148 (267)
.+..|-.+.+|+... .+..+++|+........ . -...+|..+++.+...++ ++++.... -++|+
T Consensus 3 ~~~~G~tn~~y~~~~---------~~~~~vlR~~~~~~~~~-~-~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~ 67 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH---------PGISFVWRPQSPVCKAL-G-VDRQREYQILQALSALGLAPKPILVNE----HWLLV 67 (256)
T ss_pred cCCCcCcCCeEEEEe---------CCccEEEeeCCcccccc-c-CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEE
Confidence 356777888998752 23578888765432111 0 124678888888853333 34444322 37899
Q ss_pred eecCCCchh
Q psy2579 149 EYASGGELY 157 (267)
Q Consensus 149 e~~~~gsl~ 157 (267)
||++|..+.
T Consensus 68 e~i~G~~~~ 76 (256)
T TIGR02721 68 EWLEGEVIT 76 (256)
T ss_pred EeccCcccc
Confidence 999987664
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00064 Score=58.86 Aligned_cols=30 Identities=27% Similarity=0.433 Sum_probs=26.3
Q ss_pred CCCcccCCCCCcEEeecCCceEEecccccc
Q psy2579 234 RDIIHRDIKAENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 234 ~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 263 (267)
.|+||+|+.|.||+++.+...-|+||+.|.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 489999999999999966666899999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.0011 Score=57.11 Aligned_cols=30 Identities=27% Similarity=0.455 Sum_probs=27.3
Q ss_pred CCCcccCCCCCcEEeecCCceEEecccccc
Q psy2579 234 RDIIHRDIKAENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 234 ~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 263 (267)
.+++|+|+.+.|++++.++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 689999999999999988877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0022 Score=55.12 Aligned_cols=78 Identities=9% Similarity=0.070 Sum_probs=56.2
Q ss_pred ecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCC---Cceeeeeeeeee---c
Q psy2579 68 QNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHH---PNIIRLYEVLET---F 141 (267)
Q Consensus 68 ~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h---pnIv~~~~~~~~---~ 141 (267)
.+.||.|..+.||+.... . ..+.+|..+. . . ....+.+|...++.+.- ..++++++++.. .
T Consensus 19 ~~~i~~G~~~~vy~~~~~--------~-~~~~~k~~~~-~-~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~ 85 (297)
T PRK10593 19 VECISEQPYAALWALYDS--------Q-GNPMPLMARS-F-S--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSP 85 (297)
T ss_pred eeecCCccceeEEEEEcC--------C-CCEEEEEecc-c-c--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcC
Confidence 456999999999998542 1 3467777432 1 1 12468889999988842 467888877654 4
Q ss_pred CeEEEEEeecCCCchhh
Q psy2579 142 GKIFLVVEYASGGELYN 158 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~ 158 (267)
+..++|||+++++++.+
T Consensus 86 g~~~LVmE~i~G~~~~~ 102 (297)
T PRK10593 86 GPDVLLLERLRGVSVEA 102 (297)
T ss_pred CCeEEEEeccCCEecCC
Confidence 77999999999988765
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=97.64 E-value=6.6e-06 Score=79.05 Aligned_cols=149 Identities=19% Similarity=0.242 Sum_probs=105.3
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
...+.+.+-+-+|++|.++.+.-. ..+...++|+......-. ...+....+-.++-.-.+|-++.....+..
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa-------~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~ 875 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPA-------GSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC 875 (1205)
T ss_pred CccceecccccCCCCcccccCCcc-------ccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC
Confidence 455888889999999999988664 223334444443222111 112233334444444456777776666677
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
....+++++++.++++...++.-+ +.+..-++.+
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~----------------------------------------------~~saepaRs~ 909 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSG----------------------------------------------CLSAEPARSP 909 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCC----------------------------------------------Ccccccccch
Confidence 788999999998888877776542 3455555666
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 263 (267)
...+..++++||+..+.|||++|.|+++..+|..+++|||+..
T Consensus 910 i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 910 ILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred hHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccc
Confidence 6778889999999999999999999999999999999999543
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00011 Score=62.86 Aligned_cols=133 Identities=15% Similarity=0.192 Sum_probs=86.4
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc------------------chHH--HHHHHHHHHHH
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL------------------TPKA--RKMLSREIVSM 123 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~------------------~~~~--~~~~~~Ei~~l 123 (267)
-+.+.++||-|.-+.||.+.+ ..|.+.++|+-..... ++-. +-...+|...|
T Consensus 93 v~svGnqIGVGKESDIY~v~d--------~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafm 164 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD--------EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFM 164 (465)
T ss_pred hhhhccccccccccceEEEec--------CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHH
Confidence 477788999999999999987 3456777775432211 1111 22346888888
Q ss_pred hhcCC-C-ceeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCc
Q psy2579 124 ESVHH-P-NIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGE 201 (267)
Q Consensus 124 ~~l~h-p-nIv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~ 201 (267)
+.|.. . -|+..++ .++.++|||++.+-.|.+.-+
T Consensus 165 kaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~---------------------------------------- 200 (465)
T KOG2268|consen 165 KALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRH---------------------------------------- 200 (465)
T ss_pred HHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeee----------------------------------------
Confidence 88843 2 2333333 367788888887744432111
Q ss_pred hhhhhcccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccc
Q psy2579 202 LYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLG 260 (267)
Q Consensus 202 l~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG 260 (267)
.. .+..+...+..-+--|..+|+||+|..-=||++..++.++++||=
T Consensus 201 ---------v~---d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFP 247 (465)
T KOG2268|consen 201 ---------VE---DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFP 247 (465)
T ss_pred ---------cC---ChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeech
Confidence 11 122223333333445678999999999999999999999999995
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0033 Score=54.96 Aligned_cols=143 Identities=20% Similarity=0.261 Sum_probs=89.9
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc----------------------chH-HHHH-HHHHH
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL----------------------TPK-ARKM-LSREI 120 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~----------------------~~~-~~~~-~~~Ei 120 (267)
-.|-..|..|.-+.||.|.. ..|..+|||+++-+-+ ++. .... ...|+
T Consensus 146 ~~inGCiSTGKEANVYHat~--------~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~ 217 (520)
T KOG2270|consen 146 VEINGCISTGKEANVYHATE--------EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEM 217 (520)
T ss_pred eecccccccCccceeEeeec--------CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHH
Confidence 34455788999999999865 5678899999864221 111 1111 34677
Q ss_pred HHHhhcCCCceeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCC
Q psy2579 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGG 200 (267)
Q Consensus 121 ~~l~~l~hpnIv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~ 200 (267)
+-|.+++..+|...--... ....+||+|+.....
T Consensus 218 RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw-------------------------------------------- 251 (520)
T KOG2270|consen 218 RNLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGW-------------------------------------------- 251 (520)
T ss_pred HHHHHHHhcCCCCCCceee--ecceEeeeeccCCCC--------------------------------------------
Confidence 7888776666543221111 223467777653111
Q ss_pred chhhhhcccCCCChhHHHHHHHHHHHHHHHH-HhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 201 ELYNKITTEGRLSEDDAKIYFLQILSAVKHL-HDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 201 ~l~~~~~~~~~~~~~~~~~~~~ql~~~L~~l-H~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
..-......++...+..+-.|++.-|.-| +.+++||.||.-=|+|+. +|.+.++|-+-|..
T Consensus 252 --~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 252 --AAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKLYIIDVSQSVE 313 (520)
T ss_pred --cCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEEEEEEcccccc
Confidence 00011223566777777777777666654 467999999999999986 78899999886654
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0025 Score=55.89 Aligned_cols=85 Identities=15% Similarity=0.048 Sum_probs=53.8
Q ss_pred ccCccCceeEEEeEEeecccccccccceEEEEeecccc-----cchHHHHHHHHHHHHHhhcC--CC-ceeeeeeeeeec
Q psy2579 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAK-----LTPKARKMLSREIVSMESVH--HP-NIIRLYEVLETF 141 (267)
Q Consensus 70 ~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~Ei~~l~~l~--hp-nIv~~~~~~~~~ 141 (267)
.||.|....||++... ..+..|+||.-.+.. ..+-..++..-|...|+... -| .+++++.+ ++
T Consensus 2 EigdGnlN~VfrV~~~-------~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~ 72 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQ-------EGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DT 72 (370)
T ss_pred cCCCCceEEEEEEEcC-------CCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--cc
Confidence 5899999999999853 222578998654211 11233456667888887652 23 56666665 56
Q ss_pred CeEEEEEeecCCCc-hhhhhhcc
Q psy2579 142 GKIFLVVEYASGGE-LYNKITTE 163 (267)
Q Consensus 142 ~~~~iv~e~~~~gs-l~~~l~~~ 163 (267)
....++||+++... +...+-..
T Consensus 73 e~~~~vMEdL~~~~ilR~~Li~g 95 (370)
T TIGR01767 73 EMAVTVMEDLSHHKIARKGLIEG 95 (370)
T ss_pred ccceehHhhCccchHHHHHHHcC
Confidence 66779999996544 44444443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0062 Score=52.56 Aligned_cols=29 Identities=17% Similarity=0.264 Sum_probs=26.8
Q ss_pred CCcccCCCCCcEEeecCCceEEecccccc
Q psy2579 235 DIIHRDIKAENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 235 ~ivHrDlkp~NIll~~~~~~kl~DFGla~ 263 (267)
.++|+|+.+.|++++..+-+-+.||+++.
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~ 227 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELAT 227 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccc
Confidence 58999999999999998889999999886
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0043 Score=53.23 Aligned_cols=82 Identities=13% Similarity=0.080 Sum_probs=47.5
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCc-eeeeeeeeeecCeEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPN-IIRLYEVLETFGKIFLV 147 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~~~~~~~~~~~~~iv 147 (267)
+.+..|-...||+........ ....+..+++|+...... ......+|..++..+...+ .+++++++. . .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~-~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDA-LSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCccc-ccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence 346667777888876421000 012246789999755321 1123567888888874322 345555543 2 368
Q ss_pred EeecCCCchhh
Q psy2579 148 VEYASGGELYN 158 (267)
Q Consensus 148 ~e~~~~gsl~~ 158 (267)
++|++|..+..
T Consensus 76 ~e~i~G~~l~~ 86 (302)
T cd05156 76 EEFIPSRTLTT 86 (302)
T ss_pred hheeCCCcCCH
Confidence 99999877654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0044 Score=54.38 Aligned_cols=78 Identities=15% Similarity=0.062 Sum_probs=45.7
Q ss_pred ccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCce-eeeeeeeeecCeEEEEE
Q psy2579 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNI-IRLYEVLETFGKIFLVV 148 (267)
Q Consensus 70 ~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~~~~~~~~~~~~~iv~ 148 (267)
.+-.|-.-.+|++...... ...+..|.+|+..... ....++ .+|..+++.+..-++ .++++.+.. + .++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~---~~~~~~~v~Ri~g~~t--~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~ 112 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKE---GNLGRKVLVRIYGEGV--ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPN-G---RVE 112 (344)
T ss_pred EcCCcccceeEEEEeCCCC---CCCCCeEEEEEccCCC--Ceeech-HHHHHHHHHHHHcCCCCceEEEECC-c---eEE
Confidence 4555788889987642111 0123678999886542 121222 568888888743333 355565532 2 589
Q ss_pred eecCCCchh
Q psy2579 149 EYASGGELY 157 (267)
Q Consensus 149 e~~~~gsl~ 157 (267)
+|+++.++.
T Consensus 113 efi~g~~l~ 121 (344)
T PLN02236 113 EFIHARTLS 121 (344)
T ss_pred EeeCCCCCC
Confidence 999776653
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.012 Score=52.50 Aligned_cols=85 Identities=14% Similarity=0.130 Sum_probs=56.0
Q ss_pred ecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-----chHHHHHHHHHHHHHhhcC---CCceeeeeeeee
Q psy2579 68 QNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-----TPKARKMLSREIVSMESVH---HPNIIRLYEVLE 139 (267)
Q Consensus 68 ~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~Ei~~l~~l~---hpnIv~~~~~~~ 139 (267)
.+.||.|....||+..+. +..+.||.-..... .+....+-..|+..|+.+. ..++++++.++.
T Consensus 37 ~~eiggGn~N~VyrV~~~---------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de 107 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS---------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR 107 (418)
T ss_pred EEEcCCCceeeEEEEEcC---------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC
Confidence 567999999999997652 24588987762221 1123455556677776653 357888888876
Q ss_pred ecCeEEEEEeecCC--Cchhhhhhcc
Q psy2579 140 TFGKIFLVVEYASG--GELYNKITTE 163 (267)
Q Consensus 140 ~~~~~~iv~e~~~~--gsl~~~l~~~ 163 (267)
+...++||++++ ..+..-+-..
T Consensus 108 --d~~vlvME~L~~~~~ilr~~Ll~G 131 (418)
T PLN02756 108 --TMALIGMRYLEPPHIILRKGLIAG 131 (418)
T ss_pred --CCCEEEEeecCCcceehhhhhccC
Confidence 556889999987 3455554443
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0068 Score=53.85 Aligned_cols=88 Identities=16% Similarity=0.092 Sum_probs=56.4
Q ss_pred ecccCccCceeEEEeEEeecccccccccceEEEEeecc----cccchHHHHHHHHHHHHHhhcC--CC-ceeeeeeeeee
Q psy2579 68 QNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDK----AKLTPKARKMLSREIVSMESVH--HP-NIIRLYEVLET 140 (267)
Q Consensus 68 ~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~~Ei~~l~~l~--hp-nIv~~~~~~~~ 140 (267)
.+.||.|.-..||++.+. ..+..|+||.-.+ ....+-..++..-|...|+... -| .+++++.+ +
T Consensus 34 ~~eigdGnlN~VfrV~~~-------~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D 104 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDE-------QKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--D 104 (409)
T ss_pred eeEcCCCceEEEEEEeeC-------CCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--C
Confidence 456899999999999873 1135688886532 1112334566777888887762 33 56667665 5
Q ss_pred cCeEEEEEeecCCCc-hhhhhhccC
Q psy2579 141 FGKIFLVVEYASGGE-LYNKITTEG 164 (267)
Q Consensus 141 ~~~~~iv~e~~~~gs-l~~~l~~~~ 164 (267)
+....+|||+++... |...+-...
T Consensus 105 ~e~~~~vMEdL~~~~ilR~~Li~G~ 129 (409)
T PRK12396 105 SVMNCCVMEDLSDHTILRTALINHE 129 (409)
T ss_pred cHHhhHHHHhCcccHHHHHHHHcCC
Confidence 667789999996533 444444433
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.00045 Score=63.83 Aligned_cols=137 Identities=18% Similarity=0.194 Sum_probs=94.7
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCc-eeeeeeeeeecCe
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPN-IIRLYEVLETFGK 143 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~~~~~~~~~~~ 143 (267)
|......++|+++.+++.+...+ +....+.+... ....-++++|.+++||| .+..++.+.....
T Consensus 244 s~~fh~fvK~altknpKkRptae--------klL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~ 308 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAE--------KLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY 308 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChh--------hheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence 55666799999999999987522 23335555332 23446889999999999 7777777777788
Q ss_pred EEEEEeecCCC-chhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 144 IFLVVEYASGG-ELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 144 ~~iv~e~~~~g-sl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
.++.+++|.++ +... ..-.+.-.+..-+...+.+
T Consensus 309 ~~i~~~i~s~~rs~~~---------------------------------------------~~~~se~~~~~~~~~~~~r 343 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSAL---------------------------------------------EMTVSEIALEQYQFAYPLR 343 (829)
T ss_pred cchhhhhhcCCccccc---------------------------------------------cCChhhHhhhhhhhhhhhh
Confidence 88888888775 2110 0001111244445556667
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.-.++++++|+--=+||| ||+..+ +..+..||+.+..+.
T Consensus 344 ~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 344 KETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred hhcccccccccccccCcc----cccccc-cccccccccCCcccC
Confidence 778899999998888998 777654 778889999877654
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0081 Score=48.75 Aligned_cols=29 Identities=28% Similarity=0.492 Sum_probs=20.7
Q ss_pred CCcccCCCCCcEEe-ecCCceEEecccccc
Q psy2579 235 DIIHRDIKAENVFL-SVRGIVKLGDLGFST 263 (267)
Q Consensus 235 ~ivHrDlkp~NIll-~~~~~~kl~DFGla~ 263 (267)
.++|.|+.|.||++ +.++.++++||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 47899999999999 889999999998775
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.024 Score=48.17 Aligned_cols=30 Identities=13% Similarity=0.202 Sum_probs=25.0
Q ss_pred CCcccCCCCCcEEeecCCc-eEEeccccccc
Q psy2579 235 DIIHRDIKAENVFLSVRGI-VKLGDLGFSTK 264 (267)
Q Consensus 235 ~ivHrDlkp~NIll~~~~~-~kl~DFGla~~ 264 (267)
.++|+|+.|.||+++.++. .-|+||+.|..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987554 56999998763
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.039 Score=47.08 Aligned_cols=82 Identities=17% Similarity=0.005 Sum_probs=51.4
Q ss_pred CccCceeEEEeEEeec-ccccccccceEEEEeecccccch---HHHHHHHHHHHHHhhcC-------------CCceeee
Q psy2579 72 GRGNFSTVKMAIHEIY-VPILCTYISYLAIKILDKAKLTP---KARKMLSREIVSMESVH-------------HPNIIRL 134 (267)
Q Consensus 72 G~G~fg~V~~a~~~~~-~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~Ei~~l~~l~-------------hpnIv~~ 134 (267)
|.|-.|.+|++.-... ..........+.||......... .....+.+|+...+.+- .....++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 6788899999877541 11112334678999986322211 12356788888777541 1245667
Q ss_pred eeeeeecCeEEEEEeecCC
Q psy2579 135 YEVLETFGKIFLVVEYASG 153 (267)
Q Consensus 135 ~~~~~~~~~~~iv~e~~~~ 153 (267)
+.+...++...||||-+..
T Consensus 82 ~~~~~~~~~~~lvlEDL~~ 100 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDLSE 100 (294)
T ss_pred EEeccCCCceeeehhhhhh
Confidence 7766666678999998753
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.022 Score=49.75 Aligned_cols=28 Identities=21% Similarity=0.446 Sum_probs=24.7
Q ss_pred CcccCCCCCcEEeec-CCceEEecccccc
Q psy2579 236 IIHRDIKAENVFLSV-RGIVKLGDLGFST 263 (267)
Q Consensus 236 ivHrDlkp~NIll~~-~~~~kl~DFGla~ 263 (267)
++|.|+-|.|||++. ++.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 689999999999975 4689999998775
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.11 Score=52.23 Aligned_cols=31 Identities=23% Similarity=0.402 Sum_probs=26.0
Q ss_pred CCCcccCCCCCcEEeecCC--ceE-Eeccccccc
Q psy2579 234 RDIIHRDIKAENVFLSVRG--IVK-LGDLGFSTK 264 (267)
Q Consensus 234 ~~ivHrDlkp~NIll~~~~--~~k-l~DFGla~~ 264 (267)
.++||.|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5799999999999998775 454 999998753
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.11 Score=45.38 Aligned_cols=29 Identities=24% Similarity=0.269 Sum_probs=26.1
Q ss_pred CcccCCCCCcEEeecCCc-eEEeccccccc
Q psy2579 236 IIHRDIKAENVFLSVRGI-VKLGDLGFSTK 264 (267)
Q Consensus 236 ivHrDlkp~NIll~~~~~-~kl~DFGla~~ 264 (267)
+||.|+.|.||+++.+.. +-++|||.|..
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 999999999999998884 99999998763
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.045 Score=46.79 Aligned_cols=74 Identities=15% Similarity=0.164 Sum_probs=46.6
Q ss_pred EecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc---CCCceeeeeeeeeecCe
Q psy2579 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV---HHPNIIRLYEVLETFGK 143 (267)
Q Consensus 67 ~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~~~~~~~~~~~ 143 (267)
-.+.++.|....+|+.. ..+..+.||+-.. .....+..|..-|+.| .--.+++++++....+.
T Consensus 21 ~~~~v~GG~i~~a~~~~---------~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~ 86 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD---------TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD 86 (288)
T ss_dssp EEEEE--SSSSEEEEEE---------TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC
T ss_pred eeEecCCCChhheEEEE---------CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC
Confidence 34568889999999875 3357889998752 2234577888888877 34567888998888888
Q ss_pred EEEEEeecCCC
Q psy2579 144 IFLVVEYASGG 154 (267)
Q Consensus 144 ~~iv~e~~~~g 154 (267)
.|++|||++.+
T Consensus 87 ~fLlle~l~~~ 97 (288)
T PF03881_consen 87 AFLLLEFLEMG 97 (288)
T ss_dssp CEEEEE-----
T ss_pred ceEEEEeecCC
Confidence 89999999875
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.69 Score=40.23 Aligned_cols=28 Identities=18% Similarity=0.107 Sum_probs=24.1
Q ss_pred CCCcccCCCCCcEEeecCCceEEecccccc
Q psy2579 234 RDIIHRDIKAENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 234 ~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 263 (267)
.++||+|+.+.||+++ + .+.++||+.|.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4789999999999995 4 57899999876
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.01 Score=51.45 Aligned_cols=48 Identities=29% Similarity=0.438 Sum_probs=33.6
Q ss_pred hHHHHHHHHHHHHHHHHH------hCCCcccCCCCCcEEeecCC------------------ceEEeccccccc
Q psy2579 215 DDAKIYFLQILSAVKHLH------DRDIIHRDIKAENVFLSVRG------------------IVKLGDLGFSTK 264 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH------~~~ivHrDlkp~NIll~~~~------------------~~kl~DFGla~~ 264 (267)
+-++.++.|+ ||-|+- ..+++|-||||+|||+-+.. .++|.||.+|+.
T Consensus 275 ~YvkfifLQi--aLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 275 EYVKFIFLQI--ALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred HHHHHHHHHH--HHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHh
Confidence 3456667777 555522 34689999999999995432 367888888763
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.0065 Score=56.69 Aligned_cols=43 Identities=21% Similarity=0.469 Sum_probs=38.0
Q ss_pred HHHHHHHHHHh-CCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHD-RDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+++.||.|+|. .++||++|.|++|.++..+.+||+.|+++...
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~ 150 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNA 150 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhcc
Confidence 45589999995 58999999999999999999999999987643
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.039 Score=48.38 Aligned_cols=70 Identities=17% Similarity=0.278 Sum_probs=49.9
Q ss_pred CeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHHHHHhC-CCcccCCCCCcEEeecCCceEEecccccc
Q psy2579 188 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR-DIIHRDIKAENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 188 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DFGla~ 263 (267)
..+|++|++.. +-.. .......+++..++.+.+.-+.-+... ..=|||+.-.||||+ .|++.|+||-+||
T Consensus 299 ~y~yl~~kdhg--t~is---~ik~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 299 LYLYLHFKDHG--TPIS---IIKADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred eEEEEEEecCC--ceee---eeecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeee
Confidence 34566666652 2111 112345678888888776666555544 578999999999999 9999999999998
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.026 Score=48.48 Aligned_cols=29 Identities=28% Similarity=0.402 Sum_probs=25.4
Q ss_pred CCCcccCCCCCcEEeecCCceEEecccccc
Q psy2579 234 RDIIHRDIKAENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 234 ~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 263 (267)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.041 Score=48.98 Aligned_cols=163 Identities=15% Similarity=0.035 Sum_probs=83.2
Q ss_pred ccCccCceeEEEeEEee------cccc--cccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeee
Q psy2579 70 ELGRGNFSTVKMAIHEI------YVPI--LCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLET 140 (267)
Q Consensus 70 ~iG~G~fg~V~~a~~~~------~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 140 (267)
.||.|+-+.||+|.-.. ++.. .....+.+|||+.+++. .+.+.+...++... +-+|++.-..+..-
T Consensus 196 PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V-----~~~ir~Dl~Il~f~Akl~~~vP~l~wL~l 270 (565)
T KOG1236|consen 196 PIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNV-----EKQIRLDLGILGFGAKLINNVPDLSWLSL 270 (565)
T ss_pred ccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccH-----HHHHHHHHHHHhhhhhhhhhcCccccccC
Confidence 49999999999996431 1100 01345789999997642 34566777777765 44555544333221
Q ss_pred cCeEEEEEeecCCCchhhhh--hc--cCCCChhhHHHHHHHHHHH--------HhhhccCeEEEEEEEccCCchhhhhcc
Q psy2579 141 FGKIFLVVEYASGGELYNKI--TT--EGRLSEDDAKIYFLQILLY--------EVLETFGKIFLVVEYASGGELYNKITT 208 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l--~~--~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~v~e~~~~~~l~~~~~~ 208 (267)
++. +.++. .+ -+-..++.+...+...... -.........++-+|..|.++..++..
T Consensus 271 ~~~------------vkqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~ 338 (565)
T KOG1236|consen 271 PLE------------VKQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKW 338 (565)
T ss_pred cch------------HHHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhc
Confidence 110 00000 00 0000011111111111110 011112344566667777777777755
Q ss_pred cCCCChhHHHHHHHHHHHHHHH-HHhCCCcccCCCCCcEEeec
Q psy2579 209 EGRLSEDDAKIYFLQILSAVKH-LHDRDIIHRDIKAENVFLSV 250 (267)
Q Consensus 209 ~~~~~~~~~~~~~~ql~~~L~~-lH~~~ivHrDlkp~NIll~~ 250 (267)
. ..++.....++.--..|+-- +--.+++|.|+.|.||++.-
T Consensus 339 ~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 339 K-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred c-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 4 34444444444444444332 33568999999999999953
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.014 Score=50.39 Aligned_cols=50 Identities=26% Similarity=0.360 Sum_probs=33.1
Q ss_pred hHHHHHHHHHHHHHHHHH----hCCCcccCCCCCcEEeecCC------------------ceEEeccccccc
Q psy2579 215 DDAKIYFLQILSAVKHLH----DRDIIHRDIKAENVFLSVRG------------------IVKLGDLGFSTK 264 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH----~~~ivHrDlkp~NIll~~~~------------------~~kl~DFGla~~ 264 (267)
+-++.++.|++.-.-.+- ..+++|-||||+|||+-+.. .++|.||.+|+.
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 350 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQV 350 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHH
Confidence 446667788844332221 34689999999999995432 367778887753
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.28 Score=43.75 Aligned_cols=81 Identities=11% Similarity=-0.061 Sum_probs=44.2
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCC-ceeeeeeeeeecCeEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHP-NIIRLYEVLETFGKIFLV 147 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hp-nIv~~~~~~~~~~~~~iv 147 (267)
+.|..|-...+|++........ ....+.|.+++..... .... .-.+|+.+++.+... .-.++++.+. -+++
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~-~~~~k~Vl~R~~g~~~--~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l 127 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKD-RYPIKSVCIKKSSTYN--SLVI-DNDLQYNIAKLLGDNNFGPKIIGRFG----DFTI 127 (383)
T ss_pred EEeCCcccceEEEEEecCCCCC-ccccceEEEEeccCCC--ceEe-ccHHHHHHHHHHHhCCCCCeEEEecC----CEEE
Confidence 3465688889998864311000 0001235555432211 1111 124689999988544 4455666653 3699
Q ss_pred EeecCCCchh
Q psy2579 148 VEYASGGELY 157 (267)
Q Consensus 148 ~e~~~~gsl~ 157 (267)
.||++|.++.
T Consensus 128 ~efIeGr~l~ 137 (383)
T PTZ00384 128 QEWVEGNTMG 137 (383)
T ss_pred EEEeccccCC
Confidence 9999986664
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.024 Score=45.16 Aligned_cols=27 Identities=30% Similarity=0.486 Sum_probs=24.3
Q ss_pred CcccCCCCCcEEeecCCceEEecccccc
Q psy2579 236 IIHRDIKAENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 236 ivHrDlkp~NIll~~~~~~kl~DFGla~ 263 (267)
.+|+|+.|.|++++.+| ++++||+.|.
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCccc
Confidence 58999999999998777 8899999875
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.077 Score=47.35 Aligned_cols=49 Identities=20% Similarity=0.133 Sum_probs=45.5
Q ss_pred CCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEec
Q psy2579 210 GRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGD 258 (267)
Q Consensus 210 ~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~D 258 (267)
...+|..+++.++.++.+.+-||..|.+-+|++++|+|+++++.+.|.|
T Consensus 112 P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 112 PHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred CccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEc
Confidence 3478999999999999999999999999999999999999999888876
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.99 E-value=0.12 Score=42.39 Aligned_cols=36 Identities=22% Similarity=0.383 Sum_probs=31.4
Q ss_pred HHHHHHHHh--CCCcccCCCCCcEEeecCCceEEeccc
Q psy2579 225 LSAVKHLHD--RDIIHRDIKAENVFLSVRGIVKLGDLG 260 (267)
Q Consensus 225 ~~~L~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DFG 260 (267)
+.+|.-.|+ .+.+|+|..|+|||-+..|.+||.|=+
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChh
Confidence 567788884 479999999999999999999999965
|
The function of this family is unknown. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.58 E-value=0.1 Score=45.04 Aligned_cols=29 Identities=3% Similarity=0.019 Sum_probs=26.9
Q ss_pred CCcccCCCCCcEEeecCCceEEecccccc
Q psy2579 235 DIIHRDIKAENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 235 ~ivHrDlkp~NIll~~~~~~kl~DFGla~ 263 (267)
+++|+|+.++|++++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 267 | ||||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-25 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-24 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-24 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-24 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-24 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-24 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-23 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-23 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-22 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-17 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-16 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-15 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-15 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-15 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-14 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-13 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-13 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-12 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-12 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-12 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-12 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-12 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 8e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-05 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-04 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-04 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-04 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-04 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-04 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-04 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-04 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-04 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-04 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-04 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-04 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-04 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-04 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-04 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-04 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-04 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-04 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-04 |
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 4e-52
Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 59/211 (27%)
Query: 60 KRVALYKLQNELGRGNFSTVKMAIHEI---YVPILCTYISYLAIKILDKAKLTPKARKML 116
+ Y+L +G+GNF+ VK+A H + V AIKI+DK +L P + + L
Sbjct: 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREV----------AIKIIDKTQLNPTSLQKL 61
Query: 117 SREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 176
RE+ M+ ++HPNI++L+EV+ET
Sbjct: 62 FREVRIMKILNHPNIVKLFEVIET------------------------------------ 85
Query: 177 QILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDI 236
E ++L++EYASGGE+++ + GR+ E +A+ F QI+SAV++ H + I
Sbjct: 86 --------EK--TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRI 135
Query: 237 IHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
+HRD+KAEN+ L +K+ D GFS +
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTV 166
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-46
Identities = 46/209 (22%), Positives = 78/209 (37%), Gaps = 54/209 (25%)
Query: 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSR 118
+ Y LG+G F+ T + A KI+ K+ L P R+ +S
Sbjct: 38 RSRRRYVRGRFLGKGGFAKCFEISDAD------TKEVF-AGKIVPKSLLLKPHQREKMSM 90
Query: 119 EIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 178
EI S+ H +++ + E D+ ++
Sbjct: 91 EISIHRSLAHQHVVGFHGFFE-----------------------------DNDFVF---- 117
Query: 179 LLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIH 238
+V+E L L+E +A+ Y QI+ ++LH +IH
Sbjct: 118 -------------VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 164
Query: 239 RDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
RD+K N+FL+ VK+GD G +TK++
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEY 193
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 7e-46
Identities = 46/213 (21%), Positives = 89/213 (41%), Gaps = 53/213 (24%)
Query: 56 TSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARK 114
T +G+++ +K+ N LG+G+F+ V A + T + AIK++DK + +
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAES------IHTGLEV-AIKMIDKKAMYKAGMVQ 56
Query: 115 MLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 174
+ E+ + HP+I+ LY E ++LV+E GE+ + +
Sbjct: 57 RVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK--------- 107
Query: 175 FLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR 234
SE++A+ + QI++ + +LH
Sbjct: 108 ------------------------------------PFSENEARHFMHQIITGMLYLHSH 131
Query: 235 DIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
I+HRD+ N+ L+ +K+ D G +T+L+
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-46
Identities = 53/218 (24%), Positives = 82/218 (37%), Gaps = 64/218 (29%)
Query: 59 GKRVALYKLQNELGRGNFSTVKMAIHEI---YVPILCTYISYLAIKILDKAKL------T 109
G+ Y + LG G F V A+ + V +K + K K+
Sbjct: 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEV----------VVKFIKKEKVLEDCWIE 69
Query: 110 PKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 169
++ EI + V H NII++ ++ E G LV+E
Sbjct: 70 DPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEK------------------- 110
Query: 170 DAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVK 229
+ SG +L+ I RL E A F Q++SAV
Sbjct: 111 --------------------------HGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 230 HLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
+L +DIIHRDIK EN+ ++ +KL D G + L++
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-45
Identities = 46/209 (22%), Positives = 78/209 (37%), Gaps = 54/209 (25%)
Query: 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSR 118
+ Y LG+G F+ T + A KI+ K+ L P R+ +S
Sbjct: 12 RSRRRYVRGRFLGKGGFAKCFEISD------ADTKEVF-AGKIVPKSLLLKPHQREKMSM 64
Query: 119 EIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 178
EI S+ H +++ + E D+ ++
Sbjct: 65 EISIHRSLAHQHVVGFHGFFE-----------------------------DNDFVF---- 91
Query: 179 LLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIH 238
+V+E L L+E +A+ Y QI+ ++LH +IH
Sbjct: 92 -------------VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 138
Query: 239 RDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
RD+K N+FL+ VK+GD G +TK++
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEY 167
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-45
Identities = 47/206 (22%), Positives = 84/206 (40%), Gaps = 60/206 (29%)
Query: 65 YKLQNELGRGNFSTVKMAIHEI---YVPILCTYISYLAIKILDKAKLTPKARKMLSREIV 121
+ L LG G + V++A++ + V A+KI+D + + + +EI
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAV----------AVKIVDMKRA-VDCPENIKKEIC 57
Query: 122 SMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLY 181
+ ++H N+++ Y
Sbjct: 58 INKMLNHENVVKFYGHRRE----------------------------------------- 76
Query: 182 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
+L +EY SGGEL+++I + + E DA+ +F Q+++ V +LH I HRDI
Sbjct: 77 ---GN--IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131
Query: 242 KAENVFLSVRGIVKLGDLGFSTKLQQ 267
K EN+ L R +K+ D G +T +
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRY 157
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-45
Identities = 47/206 (22%), Positives = 84/206 (40%), Gaps = 60/206 (29%)
Query: 65 YKLQNELGRGNFSTVKMAIHEI---YVPILCTYISYLAIKILDKAKLTPKARKMLSREIV 121
+ L LG G + V++A++ + V A+KI+D + + + +EI
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAV----------AVKIVDMKRA-VDCPENIKKEIC 57
Query: 122 SMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLY 181
+ ++H N+++ Y
Sbjct: 58 INKMLNHENVVKFYGHRRE----------------------------------------- 76
Query: 182 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
+L +EY SGGEL+++I + + E DA+ +F Q+++ V +LH I HRDI
Sbjct: 77 ---GN--IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131
Query: 242 KAENVFLSVRGIVKLGDLGFSTKLQQ 267
K EN+ L R +K+ D G +T +
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRY 157
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 7e-45
Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 60/212 (28%)
Query: 60 KRVALYKLQNELGRGNFSTVKMAIHEI---YVPILCTYISYLAIKILDKAKL-TPKARKM 115
++ Y L + LG G F VK+ H++ V A+KIL++ K+ +
Sbjct: 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKV----------AVKILNRQKIRSLDVVGK 57
Query: 116 LSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 175
+ REI +++ HP+II+LY+V+ T
Sbjct: 58 IKREIQNLKLFRHPHIIKLYQVIST----------------------------------- 82
Query: 176 LQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRD 235
T F+V+EY SGGEL++ I GR+ E +A+ F QILSAV + H
Sbjct: 83 ---------PT--DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 236 IIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
++HRD+K ENV L K+ D G S +
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 8e-45
Identities = 63/235 (26%), Positives = 103/235 (43%), Gaps = 18/235 (7%)
Query: 38 IYEKTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISY 97
++ + + + SL + Y L+ +G+G++ V++AI T
Sbjct: 1 MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIE------NQTRAIR 54
Query: 98 LAIKILDKAKL---TPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGG 154
AIKI++K K+ PK + + E+ M+ +HHPNI RLYEV E I LV+E GG
Sbjct: 55 -AIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGG 113
Query: 155 ELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214
L +K+ S + ++ + E + +G + + + E
Sbjct: 114 HLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA------INGSIHGFRESLDFVQRE 167
Query: 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG--IVKLGDLGFSTKLQQ 267
QI SA+ +LH++ I HRDIK EN S +KL D G S + +
Sbjct: 168 KLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK 222
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-44
Identities = 51/219 (23%), Positives = 80/219 (36%), Gaps = 67/219 (30%)
Query: 60 KRVALYKLQNELGRGNFSTVKMAIHEI---YVPILCTYISYLAIKILDKAKLTPKAR--- 113
A Y+L LG+G F TV V AIK++ + ++ +
Sbjct: 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQV----------AIKVIPRNRVLGWSPLSD 77
Query: 114 -KMLSREIVSMESVH----HPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 168
E+ + V HP +IRL + ET LV+E
Sbjct: 78 SVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPL---------------- 121
Query: 169 DDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAV 228
+L++ IT +G L E ++ +F Q+++A+
Sbjct: 122 -----------------------------PAQDLFDYITEKGPLGEGPSRCFFGQVVAAI 152
Query: 229 KHLHDRDIIHRDIKAENVFL-SVRGIVKLGDLGFSTKLQ 266
+H H R ++HRDIK EN+ + RG KL D G L
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH 191
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 8e-44
Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 64/214 (29%)
Query: 54 HETSLGKRVALYKLQNELGRGNFSTVKMAIHEI---YVPILCTYISYLAIKILDKAKLTP 110
+ + Y ++G GNF ++ ++ V A+K +++
Sbjct: 11 LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELV----------AVKYIERGAAID 60
Query: 111 KARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 170
+ + REI++ S+ HPNI+R EV+ T
Sbjct: 61 EN---VQREIINHRSLRHPNIVRFKEVILT------------------------------ 87
Query: 171 AKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKH 230
T + +++EYASGGELY +I GR SED+A+ +F Q+LS V +
Sbjct: 88 --------------PT--HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSY 131
Query: 231 LHDRDIIHRDIKAENVFL--SVRGIVKLGDLGFS 262
H I HRD+K EN L S +K+ D G+S
Sbjct: 132 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS 165
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-43
Identities = 49/217 (22%), Positives = 82/217 (37%), Gaps = 65/217 (29%)
Query: 60 KRVALYKLQNELGRGNFSTVKMAIHEI---YVPILCTYISYLAIKILDKAKLTPKAR--- 113
+ Y++ LG G F +V I V AIK ++K +++
Sbjct: 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV----------AIKHVEKDRISDWGELPN 89
Query: 114 -KMLSREIVSMESVHH--PNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 170
+ E+V ++ V +IRL + E L++E
Sbjct: 90 GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP----------------- 132
Query: 171 AKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKH 230
+L++ IT G L E+ A+ +F Q+L AV+H
Sbjct: 133 ----------------------------VQDLFDFITERGALQEELARSFFWQVLEAVRH 164
Query: 231 LHDRDIIHRDIKAENVFLSV-RGIVKLGDLGFSTKLQ 266
H+ ++HRDIK EN+ + + RG +KL D G L+
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 201
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-43
Identities = 50/215 (23%), Positives = 84/215 (39%), Gaps = 62/215 (28%)
Query: 60 KRVALYKLQNELGRGNFSTVKMAIHEI---YVPILCTYISYLAIKILDKAKL--TPKARK 114
K + Y + + LG G++ VK + A+KIL K KL P
Sbjct: 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRR----------AVKILKKKKLRRIPNGEA 51
Query: 115 MLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 174
+ +EI + + H N+I+L +VL
Sbjct: 52 NVKKEIQLLRRLRHKNVIQLVDVLYN---------------------------------- 77
Query: 175 FLQILLYEVLETFGKIFLVVEYASGG--ELYNKITTEGRLSEDDAKIYFLQILSAVKHLH 232
E K+++V+EY G E+ + + E R A YF Q++ +++LH
Sbjct: 78 ----------EEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLH 126
Query: 233 DRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
+ I+H+DIK N+ L+ G +K+ LG + L
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-43
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 60/214 (28%)
Query: 53 QHETSLGKRVALYKLQNELGRGNFSTVKMAIHEI---YVPILCTYISYLAIKILDKAKL- 108
+ + ++ Y L + LG G F VK+ HE+ V A+KIL++ K+
Sbjct: 6 KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKV----------AVKILNRQKIR 55
Query: 109 TPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 168
+ + REI +++ HP+II+LY+V+ T
Sbjct: 56 SLDVVGKIRREIQNLKLFRHPHIIKLYQVIST---------------------------- 87
Query: 169 DDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAV 228
+ IF+V+EY SGGEL++ I GRL E +++ F QILS V
Sbjct: 88 ----------------PS--DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV 129
Query: 229 KHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
+ H ++HRD+K ENV L K+ D G S
Sbjct: 130 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 163
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-43
Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 61/212 (28%)
Query: 60 KRVALYKLQNELGRGNFSTVKMAIHEI---YVPILCTYISYLAIKILDKAKLTPKARKM- 115
+ + Y ++ LG G+F VK+A H V A+K + + L M
Sbjct: 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKV----------ALKFISRQLLKKSDMHMR 55
Query: 116 LSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 175
+ REI ++ + HP+II+LY+V+ T I +V+EYA
Sbjct: 56 VEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA------------------------ 91
Query: 176 LQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRD 235
GGEL++ I + R++ED+ + +F QI+ A+++ H
Sbjct: 92 -----------------------GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 236 IIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
I+HRD+K EN+ L VK+ D G S +
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-42
Identities = 61/270 (22%), Positives = 105/270 (38%), Gaps = 73/270 (27%)
Query: 10 YYNRHIIERVAIKIL---DKAKLTPKARKMLIYEKTQNQLQNDKKWQHETSLGKRVALYK 66
+ N ++ + + L + L+ K+ ++ L D + + +L Y
Sbjct: 86 FVNTELVGKGKRRPLNNNSEIALSLSRNKVFVFF----DLTVDDQSVYPKALRDE---YI 138
Query: 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARK------MLSREI 120
+ LG G VK+A T AI+I+ K K + + + EI
Sbjct: 139 MSKTLGSGACGEVKLAFERK------TCKKV-AIRIISKRKFAIGSAREADPALNVETEI 191
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
++ ++HP II++ +
Sbjct: 192 EILKKLNHPCIIKIKNFFDA---------------------------------------- 211
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
++V+E GGEL++K+ RL E K+YF Q+L AV++LH+ IIHRD
Sbjct: 212 -------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRD 264
Query: 241 IKAENVFLSVRG---IVKLGDLGFSTKLQQ 267
+K ENV LS + ++K+ D G S L +
Sbjct: 265 LKPENVLLSSQEEDCLIKITDFGHSKILGE 294
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-42
Identities = 34/250 (13%), Positives = 75/250 (30%), Gaps = 70/250 (28%)
Query: 31 PKARKMLIYEKTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIH--EIYV 88
P I N + +K K + Y++ L +G F+ + + + Y
Sbjct: 2 PLGSMKDILSNYSNLIYLNKY---VKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFY- 57
Query: 89 PILCTYISYLAIKILDKAKL---------------TPKARKMLSREIVSMESVHHPNIIR 133
A+K +K+ L E+ + + + +
Sbjct: 58 ----------ALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107
Query: 134 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLV 193
++ + +++++ EY + L ++
Sbjct: 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT---------------------- 145
Query: 194 VEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHD-RDIIHRDIKAENVFLSVRG 252
+ K +L++ ++H+ ++I HRD+K N+ + G
Sbjct: 146 ----------------CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG 189
Query: 253 IVKLGDLGFS 262
VKL D G S
Sbjct: 190 RVKLSDFGES 199
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-42
Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 56/205 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y ++ ELG+G FS V+ +H T + + A KI++ KL+ + + L RE
Sbjct: 8 YDVKEELGKGAFSVVRRCVH------KTTGLEF-AAKIINTKKLSARDFQKLEREARICR 60
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ HPNI+RL++ + ++++ Y
Sbjct: 61 KLQHPNIVRLHDSI-----------------------------QEESFHY---------- 81
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
LV + +GGEL+ I SE DA QIL ++ + H I+HR++K E
Sbjct: 82 -------LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPE 134
Query: 245 NVFLSVRG---IVKLGDLGFSTKLQ 266
N+ L+ + VKL D G + ++
Sbjct: 135 NLLLASKAKGAAVKLADFGLAIEVN 159
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 8e-42
Identities = 39/210 (18%), Positives = 75/210 (35%), Gaps = 59/210 (28%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
+ L + LG+G + V H+ T + AIK+ + + + RE ++
Sbjct: 11 WLLSDILGQGATANVFRGRHKK------TGDLF-AIKVFNNISF-LRPVDVQMREFEVLK 62
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
++H NI++L+ + E
Sbjct: 63 KLNHKNIVKLFAIEEE-------------------------------------------- 78
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGR---LSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
T L++E+ G LY + L E + I ++ + HL + I+HR+I
Sbjct: 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNI 138
Query: 242 KAENVFLSV----RGIVKLGDLGFSTKLQQ 267
K N+ + + + KL D G + +L+
Sbjct: 139 KPGNIMRVIGEDGQSVYKLTDFGAARELED 168
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 9e-42
Identities = 50/204 (24%), Positives = 81/204 (39%), Gaps = 54/204 (26%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSM 123
+ + LG+G F V +A A+K+L K++L L REI
Sbjct: 16 FDIGRPLGKGKFGNVYLARE------KQNKFIM-ALKVLFKSQLEKEGVEHQLRREIEIQ 68
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ HPNI+R+Y D +IY
Sbjct: 69 SHLRHPNILRMYNYFH-----------------------------DRKRIY--------- 90
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
L++E+A GELY ++ GR E + + ++ A+ + H+R +IHRDIK
Sbjct: 91 --------LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKP 142
Query: 244 ENVFLSVRGIVKLGDLGFSTKLQQ 267
EN+ + +G +K+ D G+S
Sbjct: 143 ENLLMGYKGELKIADFGWSVHAPS 166
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-41
Identities = 48/204 (23%), Positives = 79/204 (38%), Gaps = 54/204 (26%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSM 123
+++ LG+G F V +A + A+K+L KA+L L RE+
Sbjct: 11 FEIGRPLGKGKFGNVYLARE------KQSKFIL-ALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ HPNI+RLY D ++Y
Sbjct: 64 SHLRHPNILRLYGYFH-----------------------------DATRVY--------- 85
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
L++EYA G +Y ++ + E Y ++ +A+ + H + +IHRDIK
Sbjct: 86 --------LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 137
Query: 244 ENVFLSVRGIVKLGDLGFSTKLQQ 267
EN+ L G +K+ D G+S
Sbjct: 138 ENLLLGSAGELKIADFGWSVHAPS 161
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-41
Identities = 52/233 (22%), Positives = 92/233 (39%), Gaps = 76/233 (32%)
Query: 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLS- 117
++ Y L++E+G+G++ VK+A +E Y A+K+L K KL +A
Sbjct: 9 CVQLNQYTLKDEIGKGSYGVVKLAYNEN------DNTYY-AMKVLSKKKLIRQAGFPRRP 61
Query: 118 -----------------------REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGG 154
+EI ++ + HPN+++L EVL+ +
Sbjct: 62 PPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNE----------- 110
Query: 155 ELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214
+++V E + G + T LSE
Sbjct: 111 ---------------------------------DHLYMVFELVNQGPVMEVP-TLKPLSE 136
Query: 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
D A+ YF ++ +++LH + IIHRDIK N+ + G +K+ D G S + +
Sbjct: 137 DQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-41
Identities = 55/212 (25%), Positives = 85/212 (40%), Gaps = 63/212 (29%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARK------MLSR 118
Y + LG G VK+A T AIKI+ K K + + +
Sbjct: 12 YIMSKTLGSGACGEVKLAFERK------TCKKV-AIKIISKRKFAIGSAREADPALNVET 64
Query: 119 EIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 178
EI ++ ++HP II++ +
Sbjct: 65 EIEILKKLNHPCIIKIKNFFDA-------------------------------------- 86
Query: 179 LLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIH 238
++V+E GGEL++K+ RL E K+YF Q+L AV++LH+ IIH
Sbjct: 87 ---------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 137
Query: 239 RDIKAENVFLSVRG---IVKLGDLGFSTKLQQ 267
RD+K ENV LS + ++K+ D G S L +
Sbjct: 138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-41
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 56/206 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y + LG+G+F V T Y A+K+++KA K + RE+ ++
Sbjct: 24 YNIVCMLGKGSFGEVLKCKD------RITQQEY-AVKVINKASAKNKDTSTILREVELLK 76
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ HPNI++L+E+L ED + Y
Sbjct: 77 KLDHPNIMKLFEIL-----------------------------EDSSSFY---------- 97
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+V E +GGEL+++I R SE DA Q+ S + ++H +I+HRD+K E
Sbjct: 98 -------IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPE 150
Query: 245 NVFLSVRG---IVKLGDLGFSTKLQQ 267
N+ L + +K+ D G ST QQ
Sbjct: 151 NILLESKEKDCDIKIIDFGLSTCFQQ 176
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-41
Identities = 43/208 (20%), Positives = 78/208 (37%), Gaps = 52/208 (25%)
Query: 65 YKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
++ LG+G F V A + Y AIK + + + + E+
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYY-----------AIKKIRHTE---EKLSTILSEV 53
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
+ + S++H ++R Y +
Sbjct: 54 MLLASLNHQYVVRYYAAWLERRN---------------------------------FVKP 80
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGR-LSEDDAKIYFLQILSAVKHLHDRDIIHR 239
++ +F+ +EY G LY+ I +E D+ F QIL A+ ++H + IIHR
Sbjct: 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHR 140
Query: 240 DIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
D+K N+F+ VK+GD G + + +
Sbjct: 141 DLKPMNIFIDESRNVKIGDFGLAKNVHR 168
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-40
Identities = 39/210 (18%), Positives = 75/210 (35%), Gaps = 59/210 (28%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
+ L + LG+G + V H+ T + AIK+ + + + RE ++
Sbjct: 11 WLLSDILGQGATANVFRGRHKK------TGDLF-AIKVFNNISF-LRPVDVQMREFEVLK 62
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
++H NI++L+ + E
Sbjct: 63 KLNHKNIVKLFAIEEE-------------------------------------------- 78
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGR---LSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
T L++E+ G LY + L E + I ++ + HL + I+HR+I
Sbjct: 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNI 138
Query: 242 KAENVFLSV----RGIVKLGDLGFSTKLQQ 267
K N+ + + + KL D G + +L+
Sbjct: 139 KPGNIMRVIGEDGQSVYKLTDFGAARELED 168
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-40
Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 59/207 (28%)
Query: 65 YKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
Y ++G G+F + YV IK ++ ++++ K R+ RE+
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYV-----------IKEINISRMSSKEREESRREV 74
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
+ ++ HPNI++ E E G +++V++Y GG+L+ +I +
Sbjct: 75 AVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG--------------- 119
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
ED +F+QI A+KH+HDR I+HRD
Sbjct: 120 -----------------------------VLFQEDQILDWFVQICLALKHVHDRKILHRD 150
Query: 241 IKAENVFLSVRGIVKLGDLGFSTKLQQ 267
IK++N+FL+ G V+LGD G + L
Sbjct: 151 IKSQNIFLTKDGTVQLGDFGIARVLNS 177
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-40
Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 56/205 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y ++ ELG+G FS V+ +H T + + A KI++ KL+ + + L RE
Sbjct: 31 YDVKEELGKGAFSVVRRCVH------KTTGLEF-AAKIINTKKLSARDFQKLEREARICR 83
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ HPNI+RL++ + ++++ Y
Sbjct: 84 KLQHPNIVRLHDSI-----------------------------QEESFHY---------- 104
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
LV + +GGEL+ I SE DA QIL ++ + H I+HR++K E
Sbjct: 105 -------LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPE 157
Query: 245 NVFLSVRG---IVKLGDLGFSTKLQ 266
N+ L+ + VKL D G + ++
Sbjct: 158 NLLLASKAKGAAVKLADFGLAIEVN 182
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-40
Identities = 42/208 (20%), Positives = 75/208 (36%), Gaps = 64/208 (30%)
Query: 65 YKLQNELGRGNFSTVKMAIH---EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIV 121
Y + ++G G S V ++ +IY AIK ++ + + EI
Sbjct: 30 YSILKQIGSGGSSKVFQVLNEKKQIY-----------AIKYVNLEEADNQTLDSYRNEIA 78
Query: 122 SMESVHHPN--IIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 179
+ + + IIRLY+ T I++V+E
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECG---------------------------- 110
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
+L + + + + + K Y+ +L AV +H I+H
Sbjct: 111 -------------------NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHS 151
Query: 240 DIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
D+K N FL V G++KL D G + ++Q
Sbjct: 152 DLKPAN-FLIVDGMLKLIDFGIANQMQP 178
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-39
Identities = 53/215 (24%), Positives = 84/215 (39%), Gaps = 54/215 (25%)
Query: 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSR 118
+ ++++ LG G F V IH+ T AIK + +L+PK R+
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQD------TGEQV-AIKQCRQ-ELSPKNRERWCL 61
Query: 119 EIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 178
EI M+ ++HPN++ EV + K+
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKL---------------------------------- 87
Query: 179 LLYEVLETFGKIFLVVEYASGGELYNKITTEGR---LSEDDAKIYFLQILSAVKHLHDRD 235
L +EY GG+L + L E + I SA+++LH+
Sbjct: 88 ------APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 236 IIHRDIKAENVFLSVRG---IVKLGDLGFSTKLQQ 267
IIHRD+K EN+ L I K+ DLG++ +L Q
Sbjct: 142 IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-39
Identities = 43/241 (17%), Positives = 82/241 (34%), Gaps = 64/241 (26%)
Query: 31 PKARKMLIYEKTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIH---EIY 87
R+ + + + + +Y + ++G G S V ++ +IY
Sbjct: 24 KFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIY 83
Query: 88 VPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPN--IIRLYEVLETFGKIF 145
AIK ++ + + EI + + + IIRLY+ T I+
Sbjct: 84 -----------AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132
Query: 146 LVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNK 205
+V+E +L +
Sbjct: 133 MVMECG-----------------------------------------------NIDLNSW 145
Query: 206 ITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
+ + + + K Y+ +L AV +H I+H D+K N FL V G++KL D G + ++
Sbjct: 146 LKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPAN-FLIVDGMLKLIDFGIANQM 204
Query: 266 Q 266
Q
Sbjct: 205 Q 205
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-39
Identities = 47/206 (22%), Positives = 66/206 (32%), Gaps = 62/206 (30%)
Query: 65 YKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
++ + LG G++ V +Y A+K PK R E+
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLY-----------AVKRSMSPFRGPKDRARKLAEV 107
Query: 121 VSMESV-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 179
S E V HP +RL + E G ++L E G L G
Sbjct: 108 GSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGA-------------- 152
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
L E Y L A+ HLH + ++H
Sbjct: 153 -------------------------------SLPEAQVWGYLRDTLLALAHLHSQGLVHL 181
Query: 240 DIKAENVFLSVRGIVKLGDLGFSTKL 265
D+K N+FL RG KLGD G +L
Sbjct: 182 DVKPANIFLGPRGRCKLGDFGLLVEL 207
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-39
Identities = 42/207 (20%), Positives = 75/207 (36%), Gaps = 64/207 (30%)
Query: 65 YKLQNELGRGNFSTVKMAIH---EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIV 121
Y + ++G G S V ++ +IY AIK ++ + + EI
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIY-----------AIKYVNLEEADNQTLDSYRNEIA 59
Query: 122 SMESVHHPN--IIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 179
+ + + IIRLY+ T I++V+E
Sbjct: 60 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECG---------------------------- 91
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
+L + + + + + K Y+ +L AV +H I+H
Sbjct: 92 -------------------NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHS 132
Query: 240 DIKAENVFLSVRGIVKLGDLGFSTKLQ 266
D+K N FL V G++KL D G + ++Q
Sbjct: 133 DLKPAN-FLIVDGMLKLIDFGIANQMQ 158
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-38
Identities = 49/209 (23%), Positives = 80/209 (38%), Gaps = 60/209 (28%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKA------RKMLSR 118
Y ++ +GRG S V+ +H T + A+KI++ R+ R
Sbjct: 96 YDPKDVIGRGVSSVVRRCVHR------ATGHEF-AVKIMEVTAERLSPEQLEEVREATRR 148
Query: 119 EIVSMESVH-HPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
E + V HP+II L + E + ++
Sbjct: 149 ETHILRQVAGHPHIITLIDSY-----------------------------ESSSFMF--- 176
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
LV + GEL++ +T + LSE + + +L AV LH +I+
Sbjct: 177 --------------LVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIV 222
Query: 238 HRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266
HRD+K EN+ L ++L D GFS L+
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHLE 251
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-38
Identities = 54/208 (25%), Positives = 83/208 (39%), Gaps = 55/208 (26%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPK---ARKMLSREIV 121
Y+L +G+G FS V+ I+ T + A+KI+D AK T + + L RE
Sbjct: 26 YELCEVIGKGPFSVVRRCIN------RETGQQF-AVKIVDVAKFTSSPGLSTEDLKREAS 78
Query: 122 SMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLY 181
+ HP+I+ L E + G +++V E+ G +L +I
Sbjct: 79 ICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA----------------- 121
Query: 182 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
SE A Y QIL A+++ HD +IIHRD+
Sbjct: 122 -------------------------DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDV 156
Query: 242 KAENVFLSVRG---IVKLGDLGFSTKLQ 266
K V L+ + VKLG G + +L
Sbjct: 157 KPHCVLLASKENSAPVKLGGFGVAIQLG 184
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-38
Identities = 52/210 (24%), Positives = 82/210 (39%), Gaps = 61/210 (29%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKA-------RKMLS 117
Y+ + LGRG S V+ IH+ T Y A+KI+D + R+
Sbjct: 19 YEPKEILGRGVSSVVRRCIHK------PTCKEY-AVKIIDVTGGGSFSAEEVQELREATL 71
Query: 118 REIVSMESV-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 176
+E+ + V HPNII+L + E + +
Sbjct: 72 KEVDILRKVSGHPNIIQLKDTY-----------------------------ETNTFFF-- 100
Query: 177 QILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDI 236
LV + GEL++ +T + LSE + + +L + LH +I
Sbjct: 101 ---------------LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNI 145
Query: 237 IHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266
+HRD+K EN+ L +KL D GFS +L
Sbjct: 146 VHRDLKPENILLDDDMNIKLTDFGFSCQLD 175
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-38
Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 61/211 (28%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKA----RKMLSREI 120
Y++ ELG G F+ V+ T Y A K + K +L+ R+ + RE+
Sbjct: 7 YEMGEELGSGQFAIVRKCRQ------KGTGKEY-AAKFIKKRRLSSSRRGVSREEIEREV 59
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
+ + HPNII L+++ E+ +
Sbjct: 60 NILREIRHPNIITLHDIF-----------------------------ENKTDVV------ 84
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
L++E SGGEL++ + + L+ED+A + QIL V +LH + I H D
Sbjct: 85 -----------LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFD 133
Query: 241 IKAENVFLSVRGI----VKLGDLGFSTKLQQ 267
+K EN+ L + + +KL D G + K++
Sbjct: 134 LKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-38
Identities = 56/206 (27%), Positives = 85/206 (41%), Gaps = 58/206 (28%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y L+N +GRG++ VK+A+ + T I A K + K + + +EI M+
Sbjct: 11 YTLENTIGRGSWGEVKIAVQK------GTRIRR-AAKKIPKYFV--EDVDRFKQEIEIMK 61
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
S+ HPNIIRLYE ED+ IY
Sbjct: 62 SLDHPNIIRLYETF-----------------------------EDNTDIY---------- 82
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
LV+E +GGEL+ ++ + E DA +LSAV + H ++ HRD+K E
Sbjct: 83 -------LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPE 135
Query: 245 NVFLSVRG---IVKLGDLGFSTKLQQ 267
N +KL D G + + +
Sbjct: 136 NFLFLTDSPDSPLKLIDFGLAARFKP 161
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-38
Identities = 49/214 (22%), Positives = 80/214 (37%), Gaps = 64/214 (29%)
Query: 65 YKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
Y++ +G G++ + +I V K LD +T ++ML E+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILV-----------WKELDYGSMTEAEKQMLVSEV 56
Query: 121 VSMESVHHPNIIRLYE--VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 178
+ + HPNI+R Y+ + T +++V+EY GG+L + IT +
Sbjct: 57 NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK------------- 103
Query: 179 LLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR---- 234
L E+ Q+ A+K H R
Sbjct: 104 -----------------------------ERQYLDEEFVLRVMTQLTLALKECHRRSDGG 134
Query: 235 -DIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
++HRD+K NVFL + VKLGD G + L
Sbjct: 135 HTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 8e-38
Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 58/207 (28%)
Query: 65 YKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLT-PKARKMLSRE 119
++++ ++GRG FS V A A+K + L KAR +E
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPV-----------ALKKVQIFDLMDAKARADCIKE 82
Query: 120 IVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 179
I ++ ++HPN+I+ Y ++ +V+E A G+L I +
Sbjct: 83 IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKK-------------- 128
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
+ + E YF+Q+ SA++H+H R ++HR
Sbjct: 129 ----------------------------QKRLIPERTVWKYFVQLCSALEHMHSRRVMHR 160
Query: 240 DIKAENVFLSVRGIVKLGDLGFSTKLQ 266
DIK NVF++ G+VKLGDLG
Sbjct: 161 DIKPANVFITATGVVKLGDLGLGRFFS 187
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 56/205 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y+L ELG+G FS V+ + + Y A I++ KL+ + + L RE
Sbjct: 13 YQLFEELGKGAFSVVRRCVK------VLAGQEY-AAMIINTKKLSARDHQKLEREARICR 65
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ HPNI+RL++ + ++ Y
Sbjct: 66 LLKHPNIVRLHDSI-----------------------------SEEGHHY---------- 86
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
L+ + +GGEL+ I SE DA QIL AV H H ++HR++K E
Sbjct: 87 -------LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPE 139
Query: 245 NVFLSVRG---IVKLGDLGFSTKLQ 266
N+ L+ + VKL D G + +++
Sbjct: 140 NLLLASKLKGAAVKLADFGLAIEVE 164
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-37
Identities = 40/206 (19%), Positives = 80/206 (38%), Gaps = 53/206 (25%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
+ + +LG G F V + + + IK ++K + + + + EI ++
Sbjct: 24 FIFKRKLGSGAFGDVHLVEER------SSGLER-VIKTINKDR-SQVPMEQIEAEIEVLK 75
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
S+ HPNII+++EV E + +++V+E GGEL +I +
Sbjct: 76 SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVS---------------------- 113
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
LSE Q+++A+ + H + ++H+D+K E
Sbjct: 114 --------------------AQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPE 153
Query: 245 NVFLSVR---GIVKLGDLGFSTKLQQ 267
N+ +K+ D G + +
Sbjct: 154 NILFQDTSPHSPIKIIDFGLAELFKS 179
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-37
Identities = 50/206 (24%), Positives = 77/206 (37%), Gaps = 58/206 (28%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
+ LG G FS V + T + A+K + K+ L EI ++
Sbjct: 11 FIFMEVLGSGAFSEVFLVKQ------RLTGKLF-ALKCIKKSPA--FRDSSLENEIAVLK 61
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ H NI+ L ++ E Y
Sbjct: 62 KIKHENIVTLEDIY-----------------------------ESTTHYY---------- 82
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
LV++ SGGEL+++I G +E DA + Q+LSAVK+LH+ I+HRD+K E
Sbjct: 83 -------LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPE 135
Query: 245 NVFLSVRG---IVKLGDLGFSTKLQQ 267
N+ + + D G S Q
Sbjct: 136 NLLYLTPEENSKIMITDFGLSKMEQN 161
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 7e-37
Identities = 54/206 (26%), Positives = 87/206 (42%), Gaps = 56/206 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y + LG+G+F V T Y A+K+++KA K + RE+ ++
Sbjct: 24 YNIVCMLGKGSFGEVLKCKD------RITQQEY-AVKVINKASAKNKDTSTILREVELLK 76
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ HPNI++L+E+ ED + Y
Sbjct: 77 KLDHPNIMKLFEI------------L-----------------EDSSSFY---------- 97
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+V E +GGEL+++I R SE DA Q+ S + ++H +I+HRD+K E
Sbjct: 98 -------IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPE 150
Query: 245 NVFLSVRG---IVKLGDLGFSTKLQQ 267
N+ L + +K+ D G ST QQ
Sbjct: 151 NILLESKEKDCDIKIIDFGLSTCFQQ 176
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-37
Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 61/212 (28%)
Query: 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKA----RKMLSRE 119
Y + ELG G F+ VK + T + Y A K + K + R+ + RE
Sbjct: 13 FYDIGEELGSGQFAIVKKCREK------STGLEY-AAKFIKKRQSRASRRGVSREEIERE 65
Query: 120 IVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 179
+ + V H N+I L++V E+ +
Sbjct: 66 VSILRQVLHHNVITLHDVY-----------------------------ENRTDVV----- 91
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
L++E SGGEL++ + + LSE++A + QIL V +LH + I H
Sbjct: 92 ------------LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 240 DIKAENVFLSVR----GIVKLGDLGFSTKLQQ 267
D+K EN+ L + +KL D G + +++
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-36
Identities = 54/244 (22%), Positives = 93/244 (38%), Gaps = 59/244 (24%)
Query: 28 KLTPKARKMLIYEKTQNQLQNDKKWQHETSLGKRVAL---YKLQNELGRGNFSTVKMAIH 84
K+ K I + + KK+ + K+ ++ Y + ELG G F V +
Sbjct: 13 KVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVE 72
Query: 85 EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKI 144
+ T + K ++ + + EI M +HHP +I L++ E ++
Sbjct: 73 K------ATGRVF-VAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123
Query: 145 FLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYN 204
L++E+ SGGEL+++I E
Sbjct: 124 VLILEFLSGGELFDRIAAED---------------------------------------- 143
Query: 205 KITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG--IVKLGDLGFS 262
++SE + Y Q +KH+H+ I+H DIK EN+ + VK+ D G +
Sbjct: 144 -----YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 198
Query: 263 TKLQ 266
TKL
Sbjct: 199 TKLN 202
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-36
Identities = 57/209 (27%), Positives = 83/209 (39%), Gaps = 56/209 (26%)
Query: 64 LYKLQN-ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVS 122
Y L + ELGRG F+ V+ I T Y A K L K + R + EI
Sbjct: 29 FYILTSKELGRGKFAVVRQCIS------KSTGQEY-AAKFLKKRRRGQDCRAEILHEIAV 81
Query: 123 MESV-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLY 181
+E P +I L+EV E +I L++EYA+GGE+++ E
Sbjct: 82 LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL----------------- 124
Query: 182 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
+SE+D QIL V +LH +I+H D+
Sbjct: 125 ---------------------------AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDL 157
Query: 242 KAENVFLSVR---GIVKLGDLGFSTKLQQ 267
K +N+ LS G +K+ D G S K+
Sbjct: 158 KPQNILLSSIYPLGDIKIVDFGMSRKIGH 186
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-36
Identities = 53/213 (24%), Positives = 86/213 (40%), Gaps = 61/213 (28%)
Query: 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKA----RKMLSR 118
Y + ELG G F+ VK + T + Y A K + K + R+ + R
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREK------STGLEY-AAKFIKKRQSRASRRGVCREEIER 64
Query: 119 EIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 178
E+ + V HPNII L++V E+ +
Sbjct: 65 EVSILRQVLHPNIITLHDVY-----------------------------ENRTDVV---- 91
Query: 179 LLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIH 238
L++E SGGEL++ + + LSE++A + QIL V +LH + I H
Sbjct: 92 -------------LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
Query: 239 RDIKAENVFLSVR----GIVKLGDLGFSTKLQQ 267
D+K EN+ L + +KL D G + +++
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-36
Identities = 55/230 (23%), Positives = 93/230 (40%), Gaps = 56/230 (24%)
Query: 41 KTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAI 100
Q LQ + G +Y+ +LG G + V + T++ AI
Sbjct: 15 YFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRD------KVTHVER-AI 67
Query: 101 KILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKI 160
KI+ K ++ + L E+ ++ + HPNI++LY+ +
Sbjct: 68 KIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF------------F---------- 105
Query: 161 TTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220
ED Y LV+E GGEL+++I + +E DA +
Sbjct: 106 -------EDKRNYY-----------------LVMECYKGGELFDEIIHRMKFNEVDAAVI 141
Query: 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRG---IVKLGDLGFSTKLQQ 267
Q+LS V +LH +I+HRD+K EN+ L + ++K+ D G S +
Sbjct: 142 IKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-36
Identities = 43/209 (20%), Positives = 72/209 (34%), Gaps = 53/209 (25%)
Query: 65 YKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
+K +G G F V A H + Y IK + + RE+
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTY-----------VIKRVKYN------NEKAEREV 55
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
++ + H NI+ + +Y N ++
Sbjct: 56 KALAKLDHVNIVHYNGC-------WDGFDYDPETSSKNSSRSKT---------------- 92
Query: 181 YEVLETFGKIFLVVEYASGGELYNKI--TTEGRLSEDDAKIYFLQILSAVKHLHDRDIIH 238
+F+ +E+ G L I +L + A F QI V ++H + +I+
Sbjct: 93 -------KCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIN 145
Query: 239 RDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
RD+K N+FL VK+GD G T L+
Sbjct: 146 RDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-36
Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 61/212 (28%)
Query: 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKA----RKMLSRE 119
Y ELG G F+ VK T + Y A K + K + R+ + RE
Sbjct: 12 YYDTGEELGSGQFAVVKKCRE------KSTGLQY-AAKFIKKRRTKSSRRGVSREDIERE 64
Query: 120 IVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 179
+ ++ + HPN+I L+EV E+ +
Sbjct: 65 VSILKEIQHPNVITLHEVY-----------------------------ENKTDVI----- 90
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
L++E +GGEL++ + + L+E++A + QIL+ V +LH I H
Sbjct: 91 ------------LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 240 DIKAENVFLSVR----GIVKLGDLGFSTKLQQ 267
D+K EN+ L R +K+ D G + K+
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-35
Identities = 44/206 (21%), Positives = 68/206 (33%), Gaps = 55/206 (26%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y +LG G FS V + L Y A+K + + + R+ RE
Sbjct: 31 YLFIQKLGEGGFSYVDLVEG------LHDGHFY-ALKRILCHE--QQDREEAQREADMHR 81
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+HPNI+RL E + E +
Sbjct: 82 LFNHPNILRLVAYCLR--------ERGAKHEAW--------------------------- 106
Query: 185 ETFGKIFLVVEYASGGELYNKI----TTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
L++ + G L+N+I L+ED L I ++ +H + HRD
Sbjct: 107 -------LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRD 159
Query: 241 IKAENVFLSVRGIVKLGDLGFSTKLQ 266
+K N+ L G L DLG +
Sbjct: 160 LKPTNILLGDEGQPVLMDLGSMNQAC 185
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 60/205 (29%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
+++++ELGRG S V + T Y A+K+L K +K++ EI +
Sbjct: 55 FEVESELGRGATSIVYRCKQK------GTQKPY-ALKVLKKTV----DKKIVRTEIGVLL 103
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ HPNII+L E+ E +I
Sbjct: 104 RLSHPNIIKLKEIF-----------------------------ETPTEIS---------- 124
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
LV+E +GGEL+++I +G SE DA QIL AV +LH+ I+HRD+K E
Sbjct: 125 -------LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPE 177
Query: 245 NVFLSVRG---IVKLGDLGFSTKLQ 266
N+ + +K+ D G S ++
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVE 202
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 46/248 (18%), Positives = 90/248 (36%), Gaps = 59/248 (23%)
Query: 25 DKAKLTPKARKMLIYEKTQNQLQNDKKWQHETSLGKRVAL---YKLQNELGRGNFSTVKM 81
D+ + + + K++ + K + Y + ELG G F V
Sbjct: 116 DEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHR 175
Query: 82 AIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141
T ++ A K + ++ + +EI +M + HP ++ L++ E
Sbjct: 176 VTER------ATGNNF-AAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226
Query: 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGE 201
++ ++ E+ SGGEL+ K+ E
Sbjct: 227 NEMVMIYEFMSGGELFEKVADE-------------------------------------- 248
Query: 202 LYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG--IVKLGDL 259
++SED+A Y Q+ + H+H+ + +H D+K EN+ + + +KL D
Sbjct: 249 -------HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDF 301
Query: 260 GFSTKLQQ 267
G + L
Sbjct: 302 GLTAHLDP 309
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 57/207 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSM 123
YK Q LG+G+F V + T A+K++ K ++ ++ L RE+ +
Sbjct: 28 YKGQRVLGKGSFGEVILCKD------KITGQEC-AVKVISKRQVKQKTDKESLLREVQLL 80
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ + HPNI++LYE + ED Y
Sbjct: 81 KQLDHPNIMKLYEF------------F-----------------EDKGYFY--------- 102
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
LV E +GGEL+++I + R SE DA Q+LS + ++H I+HRD+K
Sbjct: 103 --------LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKP 154
Query: 244 ENVFLSVRG---IVKLGDLGFSTKLQQ 267
EN+ L + +++ D G ST +
Sbjct: 155 ENLLLESKSKDANIRIIDFGLSTHFEA 181
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-34
Identities = 50/207 (24%), Positives = 83/207 (40%), Gaps = 64/207 (30%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y+++ ++G G++S K IH T + + A+KI+DK+K P EI +
Sbjct: 24 YEVKEDIGVGSYSVCKRCIH------KATNMEF-AVKIIDKSKRDPT------EEIEILL 70
Query: 125 -SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
HPNII L +V +D +Y
Sbjct: 71 RYGQHPNIITLKDVY-----------------------------DDGKYVY--------- 92
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+V E GGEL +KI + SE +A I V++LH + ++HRD+K
Sbjct: 93 --------VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKP 144
Query: 244 ENVFLSVRG----IVKLGDLGFSTKLQ 266
N+ +++ D GF+ +L+
Sbjct: 145 SNILYVDESGNPESIRICDFGFAKQLR 171
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-34
Identities = 39/205 (19%), Positives = 76/205 (37%), Gaps = 57/205 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y + +LGRG F V + + +Y K + + ++ +EI +
Sbjct: 7 YMIAEDLGRGEFGIVHRCVE------TSSKKTY-MAKFVKVKG---TDQVLVKKEISILN 56
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
H NI+ L+E E+ ++ ++ E+ SG +++ +I T
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA-------------------- 96
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
L+E + Y Q+ A++ LH +I H DI+ E
Sbjct: 97 -------------------------FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPE 131
Query: 245 NVFLSVR--GIVKLGDLGFSTKLQQ 267
N+ R +K+ + G + +L+
Sbjct: 132 NIIYQTRRSSTIKIIEFGQARQLKP 156
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-33
Identities = 46/208 (22%), Positives = 80/208 (38%), Gaps = 60/208 (28%)
Query: 64 LYKLQNE-LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVS 122
+Y+LQ + LG G + V+ I+ L T Y A+KI++K ++R + RE+
Sbjct: 13 VYQLQEDVLGEGAHARVQTCIN------LITSQEY-AVKIIEKQPGHIRSR--VFREVEM 63
Query: 123 MESV-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLY 181
+ H N++ L E E++ + Y
Sbjct: 64 LYQCQGHRNVLELIEFF-----------------------------EEEDRFY------- 87
Query: 182 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
LV E GG + + I +E +A + + SA+ LH++ I HRD+
Sbjct: 88 ----------LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 242 KAENVFLSVRG---IVKLGDLGFSTKLQ 266
K EN+ VK+ D + ++
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIK 165
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-33
Identities = 48/207 (23%), Positives = 78/207 (37%), Gaps = 58/207 (28%)
Query: 65 YKL--QNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVS 122
Y + LG G F V T + A KI+ + K ++ + EI
Sbjct: 89 YTVSKTEILGGGRFGQVHKCEET------ATGLKL-AAKIIKTRGM--KDKEEVKNEISV 139
Query: 123 MESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYE 182
M + H N+I+LY+ E+ I LV+EY GGEL+++I E
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES------------------ 181
Query: 183 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIK 242
L+E D ++ QI ++H+H I+H D+K
Sbjct: 182 ---------------------------YNLTELDTILFMKQICEGIRHMHQMYILHLDLK 214
Query: 243 AENVFLSVRG--IVKLGDLGFSTKLQQ 267
EN+ R +K+ D G + + +
Sbjct: 215 PENILCVNRDAKQIKIIDFGLARRYKP 241
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-33
Identities = 55/251 (21%), Positives = 88/251 (35%), Gaps = 67/251 (26%)
Query: 31 PKARKMLIYEKTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPI 90
+ + GK Y +LG G + V +
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKE------ 57
Query: 91 LCTYISYLAIKILDKAKLT-----------PKARKMLSREIVSMESVHHPNIIRLYEVLE 139
+ AIK++ K++ K + + EI ++S+ HPNII+L++V
Sbjct: 58 KNGHSEK-AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-- 114
Query: 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASG 199
+ ED Y LV E+ G
Sbjct: 115 ----------F-----------------EDKKYFY-----------------LVTEFYEG 130
Query: 200 GELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG---IVKL 256
GEL+ +I + E DA QILS + +LH +I+HRDIK EN+ L + +K+
Sbjct: 131 GELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190
Query: 257 GDLGFSTKLQQ 267
D G S+ +
Sbjct: 191 VDFGLSSFFSK 201
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 48/217 (22%), Positives = 85/217 (39%), Gaps = 62/217 (28%)
Query: 54 HETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKAR 113
++ + L LG G+FS + +H + ++ A+KI+ K
Sbjct: 2 KDSPFYQHYDLDLKDKPLGEGSFSICRKCVH------KKSNQAF-AVKIISKRME----- 49
Query: 114 KMLSREIVSMESV-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 172
+EI +++ HPNI++L+EV D
Sbjct: 50 ANTQKEITALKLCEGHPNIVKLHEVF-----------------------------HDQLH 80
Query: 173 IYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLH 232
+ LV+E +GGEL+ +I + SE +A +++SAV H+H
Sbjct: 81 TF-----------------LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH 123
Query: 233 DRDIIHRDIKAENVFLSVRG---IVKLGDLGFSTKLQ 266
D ++HRD+K EN+ + +K+ D GF+
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-32
Identities = 44/210 (20%), Positives = 77/210 (36%), Gaps = 53/210 (25%)
Query: 65 YKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
++ LGRG F V A + Y AIK + AR+ + RE+
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNY-----------AIKRIRLPN-RELAREKVMREV 54
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
++ + HP I+R + + + LY
Sbjct: 55 KALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLY----------------------- 91
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI---YFLQILSAVKHLHDRDII 237
+ ++ L + + + E + + FLQI AV+ LH + ++
Sbjct: 92 -----------IQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLM 140
Query: 238 HRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
HRD+K N+F ++ +VK+GD G T + Q
Sbjct: 141 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 170
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 6e-32
Identities = 48/208 (23%), Positives = 80/208 (38%), Gaps = 54/208 (25%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
+++ L G F+ V A + Y A+K L + + + + +E+ M+
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVG------SGREY-ALKRLLSNE--EEKNRAIIQEVCFMK 80
Query: 125 SV-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ HPNI++ + E
Sbjct: 81 KLSGHPNIVQFCSA---------------------------------------ASIGKEE 101
Query: 184 LETFGKIFLVVEYASGGELY---NKITTEGRLSEDDAKIYFLQILSAVKHLHDRD--IIH 238
+T FL++ G+L K+ + G LS D F Q AV+H+H + IIH
Sbjct: 102 SDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIH 161
Query: 239 RDIKAENVFLSVRGIVKLGDLGFSTKLQ 266
RD+K EN+ LS +G +KL D G +T +
Sbjct: 162 RDLKVENLLLSNQGTIKLCDFGSATTIS 189
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 29/231 (12%), Positives = 65/231 (28%), Gaps = 42/231 (18%)
Query: 46 LQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIK 101
+ + ++ L + KL L G+ S V + E + A+K
Sbjct: 45 WPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDF-----------ALK 93
Query: 102 ILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKI 160
+ + + L + + + + ++
Sbjct: 94 VFTMGAENSRSELERLHEATFAAARLLGESPEEARD--------------------RRRL 133
Query: 161 TTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASG------GELYNKITTEGRLSE 214
++ F Q+ + L++ AS L G
Sbjct: 134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGI 193
Query: 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
I Q++ +L + ++H +N+F+ G + LGD+ K+
Sbjct: 194 LALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-31
Identities = 39/225 (17%), Positives = 71/225 (31%), Gaps = 77/225 (34%)
Query: 65 YKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
+ ++G G F +V + IY AIK K + RE+
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIY-----------AIKRSKKPLAGSVDEQNALREV 61
Query: 121 VSMESV-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 179
+ + H +++R + + + EY +GG L + I+ R
Sbjct: 62 YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYR-------------- 107
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
E + K LQ+ ++++H ++H
Sbjct: 108 ----------------------------IMSYFKEAELKDLLLQVGRGLRYIHSMSLVHM 139
Query: 240 DIKAENVFLSVRG-------------------IVKLGDLGFSTKL 265
DIK N+F+S + K+GDLG T++
Sbjct: 140 DIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-30
Identities = 42/210 (20%), Positives = 74/210 (35%), Gaps = 63/210 (30%)
Query: 65 YKLQNE-LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSM 123
Y+L + LG G V H T A+K+L +E+
Sbjct: 30 YQLSKQVLGLGVNGKVLECFH------RRTGQKC-ALKLLYD-------SPKARQEVDHH 75
Query: 124 ESV-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYE 182
P+I+ + +V E
Sbjct: 76 WQASGGPHIVCILDVYEN------------------------------------------ 93
Query: 183 VLETFGKIFLVVEYASGGELYNKITTEG--RLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
+ + +++E GGEL+++I G +E +A I +A++ LH +I HRD
Sbjct: 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRD 153
Query: 241 IKAENVFLSVRG---IVKLGDLGFSTKLQQ 267
+K EN+ + + ++KL D GF+ + Q
Sbjct: 154 VKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-29
Identities = 43/218 (19%), Positives = 67/218 (30%), Gaps = 67/218 (30%)
Query: 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSM 123
L + LG G+ TV P+ A+K + + EI +
Sbjct: 16 LVVSEKILGYGSSGTVVFQGSFQGRPV--------AVKRMLIDFC-----DIALMEIKLL 62
Query: 124 -ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYE 182
ES HPN+IR Y T +++ +E L + + ++ E+
Sbjct: 63 TESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDEN------------- 108
Query: 183 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIK 242
E + QI S V HLH IIHRD+K
Sbjct: 109 --------------------------LKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 142
Query: 243 AENVFLSVRGI-------------VKLGDLGFSTKLQQ 267
+N+ +S + + D G KL
Sbjct: 143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-28
Identities = 40/217 (18%), Positives = 80/217 (36%), Gaps = 22/217 (10%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
++ +GRG F V A +++ +Y AIK + K++ RE+ ++
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKV------DDCNY-AIKRIRLPNRELAREKVM-REVKALA 59
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL---- 180
+ HP I+R + E +
Sbjct: 60 KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS 119
Query: 181 -------YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI---YFLQILSAVKH 230
+ +++ ++ L + + L + + + F+QI AV+
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179
Query: 231 LHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
LH + ++HRD+K N+F ++ +VK+GD G T + Q
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 33/231 (14%), Positives = 73/231 (31%), Gaps = 35/231 (15%)
Query: 42 TQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIH----EIYVPILCTYISY 97
+ + + ++ E+ LG+R LG+ + A E +
Sbjct: 52 STSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF---------- 101
Query: 98 LAIKILDKAKLTP-KARKMLSREIVSME---SVHHPNIIRLYEVLETFGKIFLVVEYASG 153
+ + + P A K + E++ + + + +++ + +
Sbjct: 102 -EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKM 160
Query: 154 GELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLS 213
+ LS +FL + L+TFG L + +T L
Sbjct: 161 IRVRLDERDMWVLS-----RFFLYPRMQSNLQTFG-----------EVLLSHSSTHKSLV 204
Query: 214 EDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264
LQ++ + LH ++H ++ ++ L RG V L +
Sbjct: 205 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-28
Identities = 45/209 (21%), Positives = 76/209 (36%), Gaps = 63/209 (30%)
Query: 65 YKLQNE-LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSM 123
YK+ ++ LG G V + T + A+K+L RE+
Sbjct: 63 YKVTSQVLGLGINGKVLQIFN------KRTQEKF-ALKMLQD-------CPKARREVELH 108
Query: 124 ESV-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYE 182
P+I+R+ +V E L +
Sbjct: 109 WRASQCPHIVRIVDVYEN-------------------------LYAGRKCLL-------- 135
Query: 183 VLETFGKIFLVVEYASGGELYNKITTEG--RLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
+V+E GGEL+++I G +E +A I A+++LH +I HRD
Sbjct: 136 ---------IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 186
Query: 241 IKAENVFLSVRG---IVKLGDLGFSTKLQ 266
+K EN+ + + I+KL D GF+ +
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETT 215
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-28
Identities = 42/203 (20%), Positives = 69/203 (33%), Gaps = 62/203 (30%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
LG G V + T + A+K+L RE+
Sbjct: 20 KVTSQVLGLGINGKVLQIFN------KRTQEKF-ALKMLQD-------CPKARREVELHW 65
Query: 125 SV-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
P+I+R+ +V E +
Sbjct: 66 RASQCPHIVRIVDVYEN------------------------------------------L 83
Query: 184 LETFGKIFLVVEYASGGELYNKITTEG--RLSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
+ +V+E GGEL+++I G +E +A I A+++LH +I HRD+
Sbjct: 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 143
Query: 242 KAENVFLSVRG---IVKLGDLGF 261
K EN+ + + I+KL D GF
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGF 166
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-28
Identities = 41/225 (18%), Positives = 71/225 (31%), Gaps = 58/225 (25%)
Query: 53 QHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKA 112
+ E LG + L + + LG G F+ V A +K+ A P
Sbjct: 57 KTEFQLGSK--LVYVHHLLGEGAFAQVYEATQGDLNDAKN--KQKFVLKVQKPAN--PWE 110
Query: 113 RKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 172
+ ++ + ++ ++ Y LV E S G L N I
Sbjct: 111 FYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINL---------- 160
Query: 173 IYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLH 232
K T E + + + +++L ++ +H
Sbjct: 161 -------------------------------YKNTPEKVMPQGLVISFAMRMLYMIEQVH 189
Query: 233 DRDIIHRDIKAENVFLSVRGI-----------VKLGDLGFSTKLQ 266
D +IIH DIK +N L + + L DLG S ++
Sbjct: 190 DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-28
Identities = 50/209 (23%), Positives = 77/209 (36%), Gaps = 58/209 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHE---IYVPILCTYISYLAIKILDKAKLTPKARKMLSREIV 121
K E+GRG+F TV + + V A L KLT R+ E
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEV----------AWCELQDRKLTKSERQRFKEEAE 77
Query: 122 SMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLY 181
++ + HPNI+R Y+ E+ + I
Sbjct: 78 MLKGLQHPNIVRFYDSWEST-------------------------VKGKKCIVL------ 106
Query: 182 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRD--IIHR 239
V E + G L + + + + QIL ++ LH R IIHR
Sbjct: 107 -----------VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHR 155
Query: 240 DIKAENVFLSVR-GIVKLGDLGFSTKLQQ 267
D+K +N+F++ G VK+GDLG +T +
Sbjct: 156 DLKCDNIFITGPTGSVKIGDLGLATLKRA 184
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-26
Identities = 34/225 (15%), Positives = 72/225 (32%), Gaps = 27/225 (12%)
Query: 46 LQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEI---YVPILCTYISYLAIKI 102
+ ++ E+ LG+R LG+ + A + + +
Sbjct: 61 WNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF----------EVHV 110
Query: 103 LDK-AKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKIT 161
+ A K + E++ + + + +V F F +V+ ++
Sbjct: 111 PYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRL 170
Query: 162 TEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221
E + +FL + L+TFG L + +T L
Sbjct: 171 DERDMWV--LSRFFLYPRMQSNLQTFG-----------EVLLSHSSTHKSLVHHARLQLT 217
Query: 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266
LQ++ + LH ++H ++ ++ L RG V L +
Sbjct: 218 LQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 52/232 (22%), Positives = 73/232 (31%), Gaps = 69/232 (29%)
Query: 40 EKTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIH----EIYVPILCTYI 95
E + L +K + + V Q +GRG+F V
Sbjct: 35 EDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ--------- 85
Query: 96 SYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGE 155
A+K + E+V+ + P I+ LY G
Sbjct: 86 --CAVKKVR-------LEVFRVEELVACAGLSSPRIVPLYGA------------VREGPW 124
Query: 156 LYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215
+ IF+ E GG L I G L ED
Sbjct: 125 VN--------------------------------IFM--ELLEGGSLGQLIKQMGCLPED 150
Query: 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGI-VKLGDLGFSTKLQ 266
A Y Q L +++LH R I+H D+KA+NV LS G L D G + LQ
Sbjct: 151 RALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 33/209 (15%), Positives = 59/209 (28%), Gaps = 65/209 (31%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSM- 123
+ ++ LG G T+ + A+K + RE+ +
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDV--------AVKRILPECF-----SFADREVQLLR 72
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
ES HPN+IR + + ++ +E L + +
Sbjct: 73 ESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKD------------------- 112
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+ Q S + HLH +I+HRD+K
Sbjct: 113 --------------------------FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKP 146
Query: 244 ENVFLSVRG-----IVKLGDLGFSTKLQQ 267
N+ +S+ + D G KL
Sbjct: 147 HNILISMPNAHGKIKAMISDFGLCKKLAV 175
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-25
Identities = 53/199 (26%), Positives = 80/199 (40%), Gaps = 66/199 (33%)
Query: 71 LGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPK---ARKMLSREIVSM 123
LG G+FSTV +A Y AIKIL+K + + R++ M
Sbjct: 38 LGEGSFSTVVLARELATSREY-----------AIKILEKRHIIKENKVPYVTRERDV--M 84
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ HP ++LY TF +DD K+YF
Sbjct: 85 SRLDHPFFVKLYF---TF--------------------------QDDEKLYF-------- 107
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+ YA GEL I G E + Y +I+SA+++LH + IIHRD+K
Sbjct: 108 ---------GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKP 158
Query: 244 ENVFLSVRGIVKLGDLGFS 262
EN+ L+ +++ D G +
Sbjct: 159 ENILLNEDMHIQITDFGTA 177
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 3e-23
Identities = 34/227 (14%), Positives = 76/227 (33%), Gaps = 57/227 (25%)
Query: 43 QNQLQNDKKWQHETSLGKRVALYKLQNELGRG--NFSTVKMAIHEIYVPILCTYISYLAI 100
+ + +Q +S Y+L +G+G + TV +A ++ Y+ +
Sbjct: 5 HHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYK-------PTGEYVTV 57
Query: 101 KILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKI 160
+ ++ + + L E+ + +HPNI+ + + EL+
Sbjct: 58 RRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT------------FIADNELW--- 102
Query: 161 TTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYN--KITTEGRLSEDDAK 218
+V + + G + ++E
Sbjct: 103 -------------------------------VVTSFMAYGSAKDLICTHFMDGMNELAIA 131
Query: 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
+L A+ ++H +HR +KA ++ +SV G V L L + +
Sbjct: 132 YILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 4e-23
Identities = 57/203 (28%), Positives = 82/203 (40%), Gaps = 70/203 (34%)
Query: 71 LGRGNFSTVKMAIH-------EIYVPILCTYISYLAIKILDKAKLTPKARK----MLSRE 119
LG+G + V +I+ A+K+L KA + A+ R
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIF-----------AMKVLKKAMIVRNAKDTAHTKAERN 73
Query: 120 IVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 179
I +E V HP I+ L Y Q
Sbjct: 74 I--LEEVKHPFIVDLI--------------------------------------YAFQ-- 91
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
T GK++L++EY SGGEL+ ++ EG ED A Y +I A+ HLH + II+R
Sbjct: 92 ------TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYR 145
Query: 240 DIKAENVFLSVRGIVKLGDLGFS 262
D+K EN+ L+ +G VKL D G
Sbjct: 146 DLKPENIMLNHQGHVKLTDFGLC 168
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 5e-23
Identities = 48/284 (16%), Positives = 105/284 (36%), Gaps = 35/284 (12%)
Query: 2 FRTYIANRY--YNRHIIERVAIKILDKAKLTPKARKMLIYEKTQNQLQNDKKWQHETS-- 57
FR + + IK +K + + ++ H S
Sbjct: 68 FRDFCLKHLEEAKPLVEFYEEIKKYEKLETEEERLVCSREIFDTYIMKELLACSHPFSKS 127
Query: 58 LGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLS 117
+ V + ++ ++ F I + L + K + K +
Sbjct: 128 AIEHVQGHLVKKQVPPDLFQPYIEEICQ-----------NLRGDVFQKFIESDKFTRFCQ 176
Query: 118 REIVSMESVHHPNIIRLYEVLE--TFGKIFLVVEYASGGELY-NKITTEGRLSEDDAKIY 174
+ V + N ++ ++ FG+++ A G++Y K + R+ +
Sbjct: 177 WKNVELNIHLTMNDFSVHRIIGRGGFGEVYGC-RKADTGKMYAMKCLDKKRIKMKQGETL 235
Query: 175 FL---QIL-------------LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218
L +L + T K+ +++ +GG+L+ ++ G SE D +
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR 295
Query: 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
Y +I+ ++H+H+R +++RD+K N+ L G V++ DLG +
Sbjct: 296 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 9e-23
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 18/139 (12%)
Query: 140 TFGKIFLVVEYASGGELY----------------NKITTEGRLSEDDAKIYFLQILLYEV 183
++ K+ LV +Y + + TE + E + FL + L+
Sbjct: 21 SYAKVLLV-RLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL-VGLHSC 78
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+T ++F V+EY +GG+L + + +L E+ A+ Y +I A+ +LH+R II+RD+K
Sbjct: 79 FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKL 138
Query: 244 ENVFLSVRGIVKLGDLGFS 262
+NV L G +KL D G
Sbjct: 139 DNVLLDSEGHIKLTDYGMC 157
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 18/139 (12%)
Query: 140 TFGKIFLVVEYASGGELY----------------NKITTEGRLSEDDAKIYFLQILLYEV 183
++ K+ LV +Y + + TE + E + FL + L+
Sbjct: 64 SYAKVLLV-RLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL-VGLHSC 121
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+T ++F V+EY +GG+L + + +L E+ A+ Y +I A+ +LH+R II+RD+K
Sbjct: 122 FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKL 181
Query: 244 ENVFLSVRGIVKLGDLGFS 262
+NV L G +KL D G
Sbjct: 182 DNVLLDSEGHIKLTDYGMC 200
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-22
Identities = 52/194 (26%), Positives = 85/194 (43%), Gaps = 54/194 (27%)
Query: 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPK--ARKMLSREIVSMESVHH 128
LG+G+F V + Y A+K+L KA L + R + R+I + V+H
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLY----AMKVLKKATLKVRDRVRTKMERDI--LVEVNH 85
Query: 129 PNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFG 188
P I++L+ Y Q T G
Sbjct: 86 PFIVKLH--------------------------------------YAFQ--------TEG 99
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
K++L++++ GG+L+ +++ E +E+D K Y ++ A+ HLH II+RD+K EN+ L
Sbjct: 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 159
Query: 249 SVRGIVKLGDLGFS 262
G +KL D G S
Sbjct: 160 DEEGHIKLTDFGLS 173
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-22
Identities = 41/202 (20%), Positives = 76/202 (37%), Gaps = 65/202 (32%)
Query: 71 LGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPK---ARKMLSREIVSM 123
+GRG FS V + ++Y A+KI++K + + + R++ +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVY-----------AMKIMNKWDMLKRGEVSCFREERDV--L 115
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ I +L+ + ++LV+EY GG+L ++ G
Sbjct: 116 VNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE------------------ 157
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
R+ + A+ Y +I+ A+ +H +HRDIK
Sbjct: 158 ---------------------------RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKP 190
Query: 244 ENVFLSVRGIVKLGDLGFSTKL 265
+N+ L G ++L D G KL
Sbjct: 191 DNILLDRCGHIRLADFGSCLKL 212
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 95.9 bits (238), Expect = 1e-22
Identities = 42/139 (30%), Positives = 60/139 (43%), Gaps = 18/139 (12%)
Query: 140 TFGKIFLVVEYASGGELY-----NK-----------ITTEGRLSEDDAKIYFLQILLYEV 183
+FGK+ L E ELY K E R+ K FL L
Sbjct: 353 SFGKVMLS-ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS-C 410
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+T +++ V+EY +GG+L I GR E A Y +I + L + II+RD+K
Sbjct: 411 FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKL 470
Query: 244 ENVFLSVRGIVKLGDLGFS 262
+NV L G +K+ D G
Sbjct: 471 DNVMLDSEGHIKIADFGMC 489
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-22
Identities = 34/139 (24%), Positives = 62/139 (44%), Gaps = 18/139 (12%)
Query: 140 TFGKIFLVVEYASGGELY----------------NKITTEGRLSEDDAKIYFLQILLYEV 183
+FGK+FL E+ + + E R+ + FL ++
Sbjct: 29 SFGKVFLA-EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL-THMFCT 86
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+T +F V+EY +GG+L I + + A Y +I+ ++ LH + I++RD+K
Sbjct: 87 FQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKL 146
Query: 244 ENVFLSVRGIVKLGDLGFS 262
+N+ L G +K+ D G
Sbjct: 147 DNILLDKDGHIKIADFGMC 165
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-22
Identities = 46/138 (33%), Positives = 72/138 (52%), Gaps = 17/138 (12%)
Query: 140 TFGKIFLVVEYASGGELYN-KITTEGRLSEDD------------AKIY--FLQILLYEVL 184
TFGK+ LV + G Y KI + + D FL L Y
Sbjct: 17 TFGKVILV-REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY-AF 74
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+T ++ V+EYA+GGEL+ ++ E +E+ A+ Y +I+SA+++LH RD+++RDIK E
Sbjct: 75 QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLE 134
Query: 245 NVFLSVRGIVKLGDLGFS 262
N+ L G +K+ D G
Sbjct: 135 NLMLDKDGHIKITDFGLC 152
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-22
Identities = 49/203 (24%), Positives = 80/203 (39%), Gaps = 69/203 (33%)
Query: 71 LGRGNFSTVKMAIH-------EIYVPILCTYISYLAIKILDKAKLTPKARK----MLSRE 119
LG G + V + ++Y A+K+L KA + KA+ R+
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLY-----------AMKVLKKATIVQKAKTTEHTRTERQ 110
Query: 120 IVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 179
++ P ++ L+ Y Q
Sbjct: 111 VLE-HIRQSPFLVTLH--------------------------------------YAFQ-- 129
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
T K+ L+++Y +GGEL+ ++ R +E + +IY +I+ A++HLH II+R
Sbjct: 130 ------TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYR 183
Query: 240 DIKAENVFLSVRGIVKLGDLGFS 262
DIK EN+ L G V L D G S
Sbjct: 184 DIKLENILLDSNGHVVLTDFGLS 206
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 5e-22
Identities = 42/202 (20%), Positives = 78/202 (38%), Gaps = 65/202 (32%)
Query: 71 LGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPK---ARKMLSREIVSM 123
+GRG F V + +++ A+KIL+K ++ + A R++ +
Sbjct: 82 IGRGAFGEVAVVKLKNADKVF-----------AMKILNKWEMLKRAETACFREERDV--L 128
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ I L+ + ++LV++Y GG+L LL +
Sbjct: 129 VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLT--------------------LLSKF 168
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
E RL E+ A+ Y +++ A+ +H +HRDIK
Sbjct: 169 -------------------------EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKP 203
Query: 244 ENVFLSVRGIVKLGDLGFSTKL 265
+N+ + + G ++L D G KL
Sbjct: 204 DNILMDMNGHIRLADFGSCLKL 225
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-22
Identities = 42/139 (30%), Positives = 60/139 (43%), Gaps = 18/139 (12%)
Query: 140 TFGKIFLVVEYASGGELY-----NK-----------ITTEGRLSEDDAKIYFLQILLYEV 183
+FGK+ L E ELY K E R+ K FL L
Sbjct: 32 SFGKVMLS-ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS-C 89
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+T +++ V+EY +GG+L I GR E A Y +I + L + II+RD+K
Sbjct: 90 FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKL 149
Query: 244 ENVFLSVRGIVKLGDLGFS 262
+NV L G +K+ D G
Sbjct: 150 DNVMLDSEGHIKIADFGMC 168
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 7e-22
Identities = 45/139 (32%), Positives = 64/139 (46%), Gaps = 18/139 (12%)
Query: 140 TFGKIFLVVEYASGGELY-----NK-----------ITTEGRLSEDDAKIYFLQILLYEV 183
+FGK+ L G+LY K TE R+ FL L
Sbjct: 35 SFGKVMLA-RVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFC-C 92
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+T ++F V+E+ +GG+L I R E A+ Y +I+SA+ LHD+ II+RD+K
Sbjct: 93 FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKL 152
Query: 244 ENVFLSVRGIVKLGDLGFS 262
+NV L G KL D G
Sbjct: 153 DNVLLDHEGHCKLADFGMC 171
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 9e-22
Identities = 47/203 (23%), Positives = 87/203 (42%), Gaps = 58/203 (28%)
Query: 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARK-MLSREIVS 122
L ++G G+ V +A + +A+K++D L + R+ +L E+V
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREK-------HSGRQVAVKMMD---LRKQQRRELLFNEVVI 95
Query: 123 MESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYE 182
M H N++ +Y+ Y G EL+
Sbjct: 96 MRDYQHFNVVEMYK------------SYLVGEELW------------------------- 118
Query: 183 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIK 242
+++E+ GG L + I ++ RL+E+ +L A+ +LH + +IHRDIK
Sbjct: 119 ---------VLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIK 168
Query: 243 AENVFLSVRGIVKLGDLGFSTKL 265
++++ L++ G VKL D GF ++
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQI 191
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-21
Identities = 48/201 (23%), Positives = 74/201 (36%), Gaps = 46/201 (22%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y+LQ +G G + V+ A +AIK ++ K L +EI +M
Sbjct: 17 YELQEVIGSGATAVVQAAYCA-------PKKEKVAIKRINLEKCQTS-MDELLKEIQAMS 68
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
HHPNI+ Y +++LV++ SGG + + I E
Sbjct: 69 QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGE---------------- 112
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
G L E ++L +++LH IHRD+KA
Sbjct: 113 ----------------------HKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAG 150
Query: 245 NVFLSVRGIVKLGDLGFSTKL 265
N+ L G V++ D G S L
Sbjct: 151 NILLGEDGSVQIADFGVSAFL 171
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 39/201 (19%), Positives = 77/201 (38%), Gaps = 60/201 (29%)
Query: 71 LGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV 126
+G+G+F V + ++Y A+K ++K K V V
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMY-----------AMKYMNKQK------------CVERNEV 59
Query: 127 HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLET 186
+ + + ++++ FLV L+ Y Q
Sbjct: 60 RN--VFKELQIMQGLEHPFLV-------NLW----------------YSFQ--------D 86
Query: 187 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENV 246
+F+VV+ GG+L + E+ K++ +++ A+ +L ++ IIHRD+K +N+
Sbjct: 87 EEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNI 146
Query: 247 FLSVRGIVKLGDLGFSTKLQQ 267
L G V + D + L +
Sbjct: 147 LLDEHGHVHITDFNIAAMLPR 167
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-21
Identities = 51/228 (22%), Positives = 96/228 (42%), Gaps = 66/228 (28%)
Query: 42 TQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIH----EIYVPILCTYISY 97
+ + KKW+ + ++ + LG G+F V + H Y
Sbjct: 20 AKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY---------- 69
Query: 98 LAIKILDKAKLTPK---ARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGG 154
A+KILDK K+ + + I +++V+ P +++L +F
Sbjct: 70 -AMKILDKQKVVKLKQIEHTLNEKRI--LQAVNFPFLVKLEF---SF------------- 110
Query: 155 ELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214
+D++ +Y V+EY +GGE+++ + GR SE
Sbjct: 111 -------------KDNSNLYM-----------------VMEYVAGGEMFSHLRRIGRFSE 140
Query: 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
A+ Y QI+ ++LH D+I+RD+K EN+ + +G +++ D GF+
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 47/199 (23%), Positives = 80/199 (40%), Gaps = 65/199 (32%)
Query: 71 LGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPK---ARKMLSREIVSM 123
+G+G+F V +A H Y A+K+L K + K M R ++
Sbjct: 46 IGKGSFGKVLLARHKAEEVFY-----------AVKVLQKKAILKKKEEKHIMSERNVLL- 93
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
++V HP ++ L+ + Q
Sbjct: 94 KNVKHPFLVGLH--------------------------------------FSFQ------ 109
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
T K++ V++Y +GGEL+ + E E A+ Y +I SA+ +LH +I++RD+K
Sbjct: 110 --TADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKP 167
Query: 244 ENVFLSVRGIVKLGDLGFS 262
EN+ L +G + L D G
Sbjct: 168 ENILLDSQGHIVLTDFGLC 186
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-21
Identities = 48/247 (19%), Positives = 96/247 (38%), Gaps = 78/247 (31%)
Query: 37 LIYEKTQNQLQNDK-------KWQHETSLGKRVAL----YKLQNELGRGNFSTVKMAIH- 84
L+Y+ L+ +K +++ + + + + Y++ +GRG F V++ H
Sbjct: 32 LVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK 91
Query: 85 ---EIYVPILCTYISYLAIKILDKAKLTPK---ARKMLSREIVSMESVHHPNIIRLYEVL 138
++Y A+K+L K ++ + A R+I M + P +++L+
Sbjct: 92 STRKVY-----------AMKLLSKFEMIKRSDSAFFWEERDI--MAFANSPWVVQLFYAF 138
Query: 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYAS 198
+ +++V+EY GG+L N L+
Sbjct: 139 QDDRYLYMVMEYMPGGDLVN--------------------LMSN---------------- 162
Query: 199 GGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGD 258
+ E A+ Y +++ A+ +H IHRD+K +N+ L G +KL D
Sbjct: 163 -----------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLAD 211
Query: 259 LGFSTKL 265
G K+
Sbjct: 212 FGTCMKM 218
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-21
Identities = 35/145 (24%), Positives = 56/145 (38%), Gaps = 46/145 (31%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI ++ + H N++ L EV + + +LV E+ +
Sbjct: 73 REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF---------------VDHT-------- 109
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
+ + LE F + Y QI++ + H +II
Sbjct: 110 --ILDDLELFPNGL---------------------DYQVVQKYLFQIINGIGFCHSHNII 146
Query: 238 HRDIKAENVFLSVRGIVKLGDLGFS 262
HRDIK EN+ +S G+VKL D GF+
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFA 171
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 4e-21
Identities = 33/144 (22%), Positives = 51/144 (35%), Gaps = 46/144 (31%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI ++ + HPN++ L EV ++ LV EY
Sbjct: 51 REIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY---------------CDHT-------- 87
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
+ L+ + + E K Q L AV H + I
Sbjct: 88 --VLHELDRYQRGV---------------------PEHLVKSITWQTLQAVNFCHKHNCI 124
Query: 238 HRDIKAENVFLSVRGIVKLGDLGF 261
HRD+K EN+ ++ ++KL D GF
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGF 148
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-21
Identities = 48/203 (23%), Positives = 81/203 (39%), Gaps = 58/203 (28%)
Query: 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARK-MLSREIVS 122
Y ++G+G TV A+ + AI+ ++ L + +K ++ EI+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEV-------AIRQMN---LQQQPKKELIINEILV 70
Query: 123 MESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYE 182
M +PNI+ + Y G EL+
Sbjct: 71 MRENKNPNIVNYLD------------SYLVGDELW------------------------- 93
Query: 183 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIK 242
+V+EY +GG L + + TE + E + L A++ LH +IHRDIK
Sbjct: 94 ---------VVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 243 AENVFLSVRGIVKLGDLGFSTKL 265
++N+ L + G VKL D GF ++
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQI 166
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 6e-21
Identities = 50/204 (24%), Positives = 77/204 (37%), Gaps = 76/204 (37%)
Query: 71 LGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKL--------TPKARKMLSR 118
LG G+F V + Y A+K+L K + T R MLS
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYY-----------AMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 119 EIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 178
V HP IIR++ Q
Sbjct: 63 -------VTHPFIIRMW--------------------------------------GTFQ- 76
Query: 179 LLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIH 238
+IF++++Y GGEL++ + R AK Y ++ A+++LH +DII+
Sbjct: 77 -------DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIY 129
Query: 239 RDIKAENVFLSVRGIVKLGDLGFS 262
RD+K EN+ L G +K+ D GF+
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFA 153
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 7e-21
Identities = 54/201 (26%), Positives = 77/201 (38%), Gaps = 66/201 (32%)
Query: 71 LGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPKARK-----MLSREIV 121
LGRG F V ++Y A K L+K +L K RK M+ ++I
Sbjct: 193 LGRGGFGEVFACQMKATGKLY-----------ACKKLNKKRL--KKRKGYQGAMVEKKI- 238
Query: 122 SMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLY 181
+ VH I+ L ET + LV+ +GG++ I
Sbjct: 239 -LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDI------------------RYHI--- 276
Query: 182 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
YN E A Y QI+S ++HLH R+II+RD+
Sbjct: 277 ---------------------YNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDL 315
Query: 242 KAENVFLSVRGIVKLGDLGFS 262
K ENV L G V++ DLG +
Sbjct: 316 KPENVLLDDDGNVRISDLGLA 336
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 8e-21
Identities = 46/202 (22%), Positives = 74/202 (36%), Gaps = 55/202 (27%)
Query: 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSM 123
L+ ++G+G+F V I ++ AIKI+D + + + + +EI +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVV-------AIKIIDLEEAEDE-IEDIQQEITVL 74
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
P + + Y Y +L+
Sbjct: 75 SQCDSPYVTKYYGS------------YLKDTKLW-------------------------- 96
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+++EY GG + + G L E +IL + +LH IHRDIKA
Sbjct: 97 --------IIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKA 147
Query: 244 ENVFLSVRGIVKLGDLGFSTKL 265
NV LS G VKL D G + +L
Sbjct: 148 ANVLLSEHGEVKLADFGVAGQL 169
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-20
Identities = 35/203 (17%), Positives = 67/203 (33%), Gaps = 56/203 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI-VSM 123
+ E+G G V ++ A+K + + K + ++ V +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVI-------AVKQMR-RSGNKEENKRILMDLDVVL 78
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+S P I++ + T +F+ +E K +G + E L + +
Sbjct: 79 KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPER-----ILGKMTVAI 133
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHD-RDIIHRDIK 242
++ A+ +L + +IHRD+K
Sbjct: 134 VK-----------------------------------------ALYYLKEKHGVIHRDVK 152
Query: 243 AENVFLSVRGIVKLGDLGFSTKL 265
N+ L RG +KL D G S +L
Sbjct: 153 PSNILLDERGQIKLCDFGISGRL 175
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 45/139 (32%), Positives = 74/139 (53%), Gaps = 18/139 (12%)
Query: 140 TFGKIFLVVEYASGGELYN-KITTEGRLSEDDAKIY--------------FLQILLYEVL 184
TFGK+ LV + + G Y KI + + D + FL L Y
Sbjct: 160 TFGKVILV-KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY-SF 217
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLH-DRDIIHRDIKA 243
+T ++ V+EYA+GGEL+ ++ E SED A+ Y +I+SA+ +LH ++++++RD+K
Sbjct: 218 QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 277
Query: 244 ENVFLSVRGIVKLGDLGFS 262
EN+ L G +K+ D G
Sbjct: 278 ENLMLDKDGHIKITDFGLC 296
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-20
Identities = 48/207 (23%), Positives = 77/207 (37%), Gaps = 53/207 (25%)
Query: 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI-VS 122
+++L +G G + V H AIK++D +T + + +EI +
Sbjct: 25 IFELVELVGNGTYGQVYKGRHV-------KTGQLAAIKVMD---VTGDEEEEIKQEINML 74
Query: 123 MESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYE 182
+ HH NI Y + K G
Sbjct: 75 KKYSHHRNIATYYGA-------------------FIKKNPPGMDD--------------- 100
Query: 183 VLETFGKIFLVVEYASGGELYN--KITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
+++LV+E+ G + + K T L E+ +IL + HLH +IHRD
Sbjct: 101 ------QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRD 154
Query: 241 IKAENVFLSVRGIVKLGDLGFSTKLQQ 267
IK +NV L+ VKL D G S +L +
Sbjct: 155 IKGQNVLLTENAEVKLVDFGVSAQLDR 181
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-19
Identities = 44/201 (21%), Positives = 71/201 (35%), Gaps = 61/201 (30%)
Query: 71 LGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV 126
LG+G + V +AIK + + + + L EI + +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVR-----------IAIKEIPERD--SRYSQPLHEEIALHKHL 76
Query: 127 HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLET 186
H NI++ G I + +E GG L L
Sbjct: 77 KHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA---------------------LLR--SK 113
Query: 187 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENV 246
+G + + +E Y QIL +K+LHD I+HRDIK +NV
Sbjct: 114 WGPL--------------------KDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNV 153
Query: 247 FL-SVRGIVKLGDLGFSTKLQ 266
+ + G++K+ D G S +L
Sbjct: 154 LINTYSGVLKISDFGTSKRLA 174
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-19
Identities = 38/143 (26%), Positives = 60/143 (41%), Gaps = 41/143 (28%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI M+ + H NI+RLY+V+ T K+ LV E+ ++D K Y
Sbjct: 52 REISLMKELKHENIVRLYDVIHTENKLTLVFEFM----------------DNDLKKYM-- 93
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
+ T L + K + Q+L + H+ I+
Sbjct: 94 -----------------------DSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKIL 130
Query: 238 HRDIKAENVFLSVRGIVKLGDLG 260
HRD+K +N+ ++ RG +KLGD G
Sbjct: 131 HRDLKPQNLLINKRGQLKLGDFG 153
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 2e-19
Identities = 48/250 (19%), Positives = 89/250 (35%), Gaps = 76/250 (30%)
Query: 27 AKLTPKARKMLIYEKTQNQLQNDKKWQHETSLGKRVA-----LYKLQNELGRGNFSTVKM 81
+LT + + + + + ++ Q + + V Y++ LG+G F V
Sbjct: 146 TRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRV---LGKGGFGEVCA 202
Query: 82 AIH----EIYVPILCTYISYLAIKILDKAKLTPKARK-----MLSREIVSMESVHHPNII 132
++Y A K L+K ++ K RK + ++I +E V+ ++
Sbjct: 203 CQVRATGKMY-----------ACKKLEKKRI--KKRKGEAMALNEKQI--LEKVNSRFVV 247
Query: 133 RLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFL 192
L ET + LV+ +GG+L I G+
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ--------------------------- 280
Query: 193 VVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG 252
E A Y +I ++ LH I++RD+K EN+ L G
Sbjct: 281 -----------------AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG 323
Query: 253 IVKLGDLGFS 262
+++ DLG +
Sbjct: 324 HIRISDLGLA 333
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-19
Identities = 39/199 (19%), Positives = 70/199 (35%), Gaps = 58/199 (29%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
+ +G G+F TV + +A+K+L+ TP+ + E+ +
Sbjct: 27 TVGQRIGSGSFGTVYKG----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 76
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
H NI+ +T +L+
Sbjct: 77 TRHVNILLFMGY-----------------------STAPQLA------------------ 95
Query: 186 TFGKIFLVVEYASGGELYNKI-TTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+V ++ G LY+ + +E + Q + +LH + IIHRD+K+
Sbjct: 96 ------IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSN 149
Query: 245 NVFLSVRGIVKLGDLGFST 263
N+FL VK+GD G +T
Sbjct: 150 NIFLHEDNTVKIGDFGLAT 168
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-19
Identities = 42/202 (20%), Positives = 77/202 (38%), Gaps = 55/202 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
++ +ELG GN V H+ ++ A K++ ++ P R + RE+ +
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVM-------ARKLIH-LEIKPAIRNQIIRELQVLH 86
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ P I+ Y + G+I + +E+ GG S D
Sbjct: 87 ECNSPYIVGFYGAFYSDGEISICMEHMDGG------------SLDQ-------------- 120
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHD-RDIIHRDIKA 243
+ K GR+ E + ++ + +L + I+HRD+K
Sbjct: 121 -----------------VLKKA---GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 160
Query: 244 ENVFLSVRGIVKLGDLGFSTKL 265
N+ ++ RG +KL D G S +L
Sbjct: 161 SNILVNSRGEIKLCDFGVSGQL 182
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-19
Identities = 43/204 (21%), Positives = 80/204 (39%), Gaps = 54/204 (26%)
Query: 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSM 123
++++ ELG G F V A ++ + A K+++ + EI +
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNK-------ETGALAAAKVIETKSEEEL--EDYIVEIEIL 70
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ HP I++L GK+++++E+ GG + D +
Sbjct: 71 ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGG------------AVDA---------IMLE 109
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+ L+E ++ Q+L A+ LH + IIHRD+KA
Sbjct: 110 ------------------------LDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKA 145
Query: 244 ENVFLSVRGIVKLGDLGFSTKLQQ 267
NV +++ G ++L D G S K +
Sbjct: 146 GNVLMTLEGDIRLADFGVSAKNLK 169
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-19
Identities = 42/201 (20%), Positives = 74/201 (36%), Gaps = 56/201 (27%)
Query: 66 KLQNELGRGNFSTVKMAI-HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
++ ++G G+F TV A H V A+KIL + + RE+ M+
Sbjct: 40 NIKEKIGAGSFGTVHRAEWHGSDV----------AVKILMEQDFHAERVNEFLREVAIMK 89
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ HPNI+ + + +V EY S G LY + G + D +
Sbjct: 90 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDER------------ 137
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRD--IIHRDIK 242
+ A + + +LH+R+ I+HR++K
Sbjct: 138 -------RRLSMA------------------------YDVAKGMNYLHNRNPPIVHRNLK 166
Query: 243 AENVFLSVRGIVKLGDLGFST 263
+ N+ + + VK+ D G S
Sbjct: 167 SPNLLVDKKYTVKVCDFGLSR 187
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-19
Identities = 32/143 (22%), Positives = 52/143 (36%), Gaps = 46/143 (32%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI ++ + HPNII L + I LV ++ + D
Sbjct: 61 REIKLLQELSHPNIIGLLDAFGHKSNISLVFDF---------------METD-------- 97
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
L +++ + + K Y L L +++LH I+
Sbjct: 98 --LEVIIKDNSLVL---------------------TPSHIKAYMLMTLQGLEYLHQHWIL 134
Query: 238 HRDIKAENVFLSVRGIVKLGDLG 260
HRD+K N+ L G++KL D G
Sbjct: 135 HRDLKPNNLLLDENGVLKLADFG 157
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-19
Identities = 43/209 (20%), Positives = 72/209 (34%), Gaps = 62/209 (29%)
Query: 64 LYKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPK-ARKMLSR 118
L+ E+G G+F V A E+ +AIK + + + + +
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEV-----------VAIKKMSYSGKQSNEKWQDIIK 103
Query: 119 EIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 178
E+ ++ + HPN I+ Y +
Sbjct: 104 EVRFLQKLRHPNTIQYRG------------CYLREHTAW--------------------- 130
Query: 179 LLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIH 238
LV+EY G + L E + L + +LH ++IH
Sbjct: 131 -------------LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177
Query: 239 RDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
RD+KA N+ LS G+VKLGD G ++ +
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSASIMAP 206
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 4e-19
Identities = 32/143 (22%), Positives = 58/143 (40%), Gaps = 45/143 (31%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI ++ ++HPNI++L +V+ T K++LV E+ L +D
Sbjct: 51 REISLLKELNHPNIVKLLDVIHTENKLYLVFEF---------------LHQD-------- 87
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
L + ++ + K Y Q+L + H ++
Sbjct: 88 --LKKFMDASALTGI--------------------PLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 238 HRDIKAENVFLSVRGIVKLGDLG 260
HRD+K +N+ ++ G +KL D G
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFG 148
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 4e-19
Identities = 40/200 (20%), Positives = 72/200 (36%), Gaps = 59/200 (29%)
Query: 65 YKLQNELGRGNFSTVKMAIHEI----YVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
Y+++ + G + +A+ V +K L +A+ M E
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPV----------VLKGL-VHSGDAEAQAMAMAER 130
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
+ V HP+I++++ +E + V Y
Sbjct: 131 QFLAEVVHPSIVQIFNFVEHTDRHGDPVGY------------------------------ 160
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
+V+EY G L +L +A Y L+IL A+ +LH +++ D
Sbjct: 161 -----------IVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSYLHSIGLVYND 207
Query: 241 IKAENVFLSVRGIVKLGDLG 260
+K EN+ L+ +KL DLG
Sbjct: 208 LKPENIMLTEEQ-LKLIDLG 226
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-19
Identities = 42/204 (20%), Positives = 75/204 (36%), Gaps = 56/204 (27%)
Query: 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSM 123
++ + +LG G++ +V AIH+ +AIK + + + +EI M
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHK-------ETGQIVAIKQVP----VESDLQEIIKEISIM 78
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ P++++ Y +++V+EY G S D + +
Sbjct: 79 QQCDSPHVVKYYGSYFKNTDLWIVMEYCGAG------------SVSD---------IIRL 117
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
L+ED+ L +++LH IHRDIKA
Sbjct: 118 ------------------------RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKA 153
Query: 244 ENVFLSVRGIVKLGDLGFSTKLQQ 267
N+ L+ G KL D G + +L
Sbjct: 154 GNILLNTEGHAKLADFGVAGQLTD 177
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 6e-19
Identities = 42/197 (21%), Positives = 72/197 (36%), Gaps = 50/197 (25%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
K LG G F TV + ++P +AIK L + +PKA K + E M S
Sbjct: 18 KKIKVLGSGAFGTVYKGL---WIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMAS 73
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
V +P++ RL + T + L+ + G L + +++
Sbjct: 74 VDNPHVCRLLGICLT-STVQLITQLMPFGCLLD----------------YVR-------- 108
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
+ + + +QI + +L DR ++HRD+ A N
Sbjct: 109 ---------------------EHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN 147
Query: 246 VFLSVRGIVKLGDLGFS 262
V + VK+ D G +
Sbjct: 148 VLVKTPQHVKITDFGLA 164
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-19
Identities = 47/208 (22%), Positives = 72/208 (34%), Gaps = 62/208 (29%)
Query: 65 YKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
K E+GRG + +V +H +I A+K + + + K +K L ++
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIM-----------AVKRIR-STVDEKEQKQLLMDL 71
Query: 121 -VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 179
V M S P I++ Y L G ++ +E S
Sbjct: 72 DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTS---------------------FDKF 110
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD-AKIYFLQILSAVKHLHD-RDII 237
V + E+ KI L + A+ HL + II
Sbjct: 111 YKYVYSVLD---------------------DVIPEEILGKI-TLATVKALNHLKENLKII 148
Query: 238 HRDIKAENVFLSVRGIVKLGDLGFSTKL 265
HRDIK N+ L G +KL D G S +L
Sbjct: 149 HRDIKPSNILLDRSGNIKLCDFGISGQL 176
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 6e-19
Identities = 49/235 (20%), Positives = 86/235 (36%), Gaps = 60/235 (25%)
Query: 31 PKARKMLIYEKTQNQLQNDKKWQ-HETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVP 89
P + + ++ Q E L K +LG+GNF +V+M Y P
Sbjct: 15 PTTENLYFQGAMGSAFEDRDPTQFEERHL-------KFLQQLGKGNFGSVEMCR---YDP 64
Query: 90 ILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK--IFLV 147
+ +A+K L + T + + REI ++S+ H NI++ V + G+ + L+
Sbjct: 65 LQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122
Query: 148 VEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKIT 207
+EY G L + +LQ
Sbjct: 123 MEYLPYGSLRD----------------YLQ-----------------------------K 137
Query: 208 TEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
+ R+ Y QI +++L + IHRD+ N+ + VK+GD G +
Sbjct: 138 HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-19
Identities = 44/209 (21%), Positives = 76/209 (36%), Gaps = 65/209 (31%)
Query: 65 YKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
+ ELGRG + V+ H +I A+K + A + + +K L ++
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIM-----------AVKRIR-ATVNSQEQKRLLMDL 56
Query: 121 -VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGG--ELYNKITTEGRLSEDDAKIYFLQ 177
+SM +V P + Y L G +++ +E + Y ++ +G
Sbjct: 57 DISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKG------------- 103
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHD-RDI 236
+ ED + I+ A++HLH +
Sbjct: 104 --------------------------------QTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 237 IHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
IHRD+K NV ++ G VK+ D G S L
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYL 160
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 7e-19
Identities = 30/143 (20%), Positives = 57/143 (39%), Gaps = 46/143 (32%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI ++ + H NI+RL++VL + K+ LV E+ +D
Sbjct: 50 REICLLKELKHKNIVRLHDVLHSDKKLTLVFEF---------------CDQD-------- 86
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
L + ++ + K + Q+L + H R+++
Sbjct: 87 --LKKYFDSCNGDL---------------------DPEIVKSFLFQLLKGLGFCHSRNVL 123
Query: 238 HRDIKAENVFLSVRGIVKLGDLG 260
HRD+K +N+ ++ G +KL + G
Sbjct: 124 HRDLKPQNLLINRNGELKLANFG 146
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 7e-19
Identities = 36/143 (25%), Positives = 58/143 (40%), Gaps = 46/143 (32%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI ++ +HHPNI+ L +V+ + + LV E+ + +D
Sbjct: 68 REISLLKELHHPNIVSLIDVIHSERCLTLVFEF---------------MEKD-------- 104
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
L +VL+ + KIY Q+L V H H I+
Sbjct: 105 --LKKVLDENKTGL---------------------QDSQIKIYLYQLLRGVAHCHQHRIL 141
Query: 238 HRDIKAENVFLSVRGIVKLGDLG 260
HRD+K +N+ ++ G +KL D G
Sbjct: 142 HRDLKPQNLLINSDGALKLADFG 164
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-19
Identities = 41/199 (20%), Positives = 72/199 (36%), Gaps = 51/199 (25%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
K +LG G+F V++ Y P +A+K L K + L +EI + +
Sbjct: 24 KRIRDLGEGHFGKVELCR---YDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRN 79
Query: 126 VHHPNIIRLYEVLETFGK--IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
++H NI++ + G I L++E+ G L +L
Sbjct: 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE----------------YLP------ 117
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+ +++ Y +QI + +L R +HRD+ A
Sbjct: 118 -----------------------KNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAA 154
Query: 244 ENVFLSVRGIVKLGDLGFS 262
NV + VK+GD G +
Sbjct: 155 RNVLVESEHQVKIGDFGLT 173
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 9e-19
Identities = 45/199 (22%), Positives = 78/199 (39%), Gaps = 52/199 (26%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
K +LG+GNF +V+M Y P+ +A+K L + T + + REI ++S
Sbjct: 13 KFLQQLGKGNFGSVEMCR---YDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKS 67
Query: 126 VHHPNIIRLYEVLETFGK--IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ H NI++ V + G+ + L++EY G L + +LQ
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD----------------YLQ------ 105
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+ R+ Y QI +++L + IHRD+
Sbjct: 106 -----------------------KHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLAT 142
Query: 244 ENVFLSVRGIVKLGDLGFS 262
N+ + VK+GD G +
Sbjct: 143 RNILVENENRVKIGDFGLT 161
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 1e-18
Identities = 34/143 (23%), Positives = 62/143 (43%), Gaps = 46/143 (32%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI ++ + H NI++LY+V+ T ++ LV E+ L +D
Sbjct: 49 REISILKELKHSNIVKLYDVIHTKKRLVLVFEH---------------LDQD-------- 85
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
L ++L+ AK + LQ+L+ + + HDR ++
Sbjct: 86 --LKKLLDVCEGGL---------------------ESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 238 HRDIKAENVFLSVRGIVKLGDLG 260
HRD+K +N+ ++ G +K+ D G
Sbjct: 123 HRDLKPQNLLINREGELKIADFG 145
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-18
Identities = 48/206 (23%), Positives = 73/206 (35%), Gaps = 57/206 (27%)
Query: 58 LGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYIS-YLAIKILDKAKLT--PKARK 114
L R Y+L LG G S V +A +A+K+L +A L P
Sbjct: 10 LSDR---YELGEILGFGGMSEVHLA--------RDLRDHRDVAVKVL-RADLARDPSFYL 57
Query: 115 MLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 174
RE + +++HP I+ +Y+ E G L
Sbjct: 58 RFRREAQNAAALNHPAIVAVYDTGEAET---------PAGPLP----------------- 91
Query: 175 FLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR 234
++V+EY G L + + TEG ++ A A+ H
Sbjct: 92 ----------------YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 235 DIIHRDIKAENVFLSVRGIVKLGDLG 260
IIHRD+K N+ +S VK+ D G
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFG 161
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-18
Identities = 32/143 (22%), Positives = 61/143 (42%), Gaps = 46/143 (32%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
RE+ ++ + H NI+ L++++ T + LV EY L +D
Sbjct: 49 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY---------------LDKD-------- 85
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
L + L+ G I + + K++ Q+L + + H + ++
Sbjct: 86 --LKQYLDDCGNII---------------------NMHNVKLFLFQLLRGLAYCHRQKVL 122
Query: 238 HRDIKAENVFLSVRGIVKLGDLG 260
HRD+K +N+ ++ RG +KL D G
Sbjct: 123 HRDLKPQNLLINERGELKLADFG 145
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-18
Identities = 40/207 (19%), Positives = 74/207 (35%), Gaps = 62/207 (29%)
Query: 59 GKRVALYKLQNELGRGNFSTVKMAIHEI---YVPILCTYISYLAIKILDKAKLT--PKAR 113
G + Y+L+ +GRG V A + V A+K++ L+ P R
Sbjct: 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIV----------ALKLM-SETLSSDPVFR 78
Query: 114 KMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 173
+ RE + + P+++ +++ E G++++ + +G +L + +G L+ A
Sbjct: 79 TRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRA-- 136
Query: 174 YFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHD 233
+ I+ QI SA+ H
Sbjct: 137 --VAIVR------------------------------------------QIGSALDAAHA 152
Query: 234 RDIIHRDIKAENVFLSVRGIVKLGDLG 260
HRD+K EN+ +S L D G
Sbjct: 153 AGATHRDVKPENILVSADDFAYLVDFG 179
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-18
Identities = 46/199 (23%), Positives = 73/199 (36%), Gaps = 53/199 (26%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
K +LG G+F V + Y P +A+K L KA P+ R +EI + +
Sbjct: 34 KKIRDLGEGHFGKVSLYC---YDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRT 89
Query: 126 VHHPNIIRLYEVLETFGK--IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
++H +II+ E G + LV+EY G L + +L
Sbjct: 90 LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD----------------YLP------ 127
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+ ++ QI + +LH + IHRD+ A
Sbjct: 128 -------------------------RHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAA 162
Query: 244 ENVFLSVRGIVKLGDLGFS 262
NV L +VK+GD G +
Sbjct: 163 RNVLLDNDRLVKIGDFGLA 181
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-18
Identities = 32/197 (16%), Positives = 62/197 (31%), Gaps = 54/197 (27%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
LG+G F H + +K L + + ++ +E+ M
Sbjct: 13 IHGEVLGKGCFGQAIKVTH-------RETGEVMVMKELIR--FDEETQRTFLKEVKVMRC 63
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+ HPN+++ VL ++ + EY GG L ++
Sbjct: 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRG----------------IIK-------- 99
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
+ + + + I S + +LH +IIHRD+ + N
Sbjct: 100 ---------------------SMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHN 138
Query: 246 VFLSVRGIVKLGDLGFS 262
+ V + D G +
Sbjct: 139 CLVRENKNVVVADFGLA 155
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-18
Identities = 53/208 (25%), Positives = 79/208 (37%), Gaps = 65/208 (31%)
Query: 58 LGKRVALYKLQNELGRGNFSTVKMAIHEI---YVPILCTYISYLAIKILDKAKLT--PKA 112
+ +R YK+ ++LG G STV +A I V AIK + +
Sbjct: 9 INER---YKIVDKLGGGGMSTVYLAEDTILNIKV----------AIKAI-FIPPREKEET 54
Query: 113 RKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 172
K RE+ + + H NI+ + +V E+D
Sbjct: 55 LKRFEREVHNSSQLSHQNIVSMIDV-----------------------------DEED-- 83
Query: 173 IYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLH 232
+LV+EY G L I + G LS D A + QIL +KH H
Sbjct: 84 ---------------DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH 128
Query: 233 DRDIIHRDIKAENVFLSVRGIVKLGDLG 260
D I+HRDIK +N+ + +K+ D G
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFG 156
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-18
Identities = 28/202 (13%), Positives = 49/202 (24%), Gaps = 64/202 (31%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYL----AIKILD-KAKLTPKARKMLSRE 119
Y+L G A+ L A+ +D + L +
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTA-----------LDRQVALTFVDPQGVLPDDVLQETLSR 81
Query: 120 IVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 179
+ + + P + R+ +V+ T +V E+ GG L
Sbjct: 82 TLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQ---------------------- 119
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
EV + S A + +A H +
Sbjct: 120 --EVAD------------------------TSPSPVGAIRAMQSLAAAADAAHRAGVALS 153
Query: 240 DIKAENVFLSVRGIVKLGDLGF 261
V +S+ G V L
Sbjct: 154 IDHPSRVRVSIDGDVVLAYPAT 175
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-18
Identities = 31/198 (15%), Positives = 66/198 (33%), Gaps = 56/198 (28%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
++ +G+G F V V AI+++D + K RE+++
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGEV----------AIRLIDIERDNEDQLKAFKREVMAYRQ 85
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
H N++ + + ++ G LY+ ++ +
Sbjct: 86 TRHENVVLFMGACMSPPHLAIITSLCKGRTLYS--------------------VVRDAKI 125
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
+ + A +I+ + +LH + I+H+D+K++N
Sbjct: 126 VL-DVNKTRQIA------------------------QEIVKGMGYLHAKGILHKDLKSKN 160
Query: 246 VFLSVRGIVKLGDLGFST 263
VF G V + D G +
Sbjct: 161 VFYD-NGKVVITDFGLFS 177
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-18
Identities = 34/197 (17%), Positives = 73/197 (37%), Gaps = 50/197 (25%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
+ LG G F TV + ++P + + IK++ + K ++ + ++ ++++ S
Sbjct: 16 RKLKVLGSGVFGTVHKGV---WIPEGESIKIPVCIKVI-EDKSGRQSFQAVTDHMLAIGS 71
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+ H +I+RL + + LV +Y G L + ++
Sbjct: 72 LDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLD----------------HVR-------- 106
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
G L + +QI + +L + ++HR++ A N
Sbjct: 107 ---------------------QHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARN 145
Query: 246 VFLSVRGIVKLGDLGFS 262
V L V++ D G +
Sbjct: 146 VLLKSPSQVQVADFGVA 162
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-17
Identities = 42/197 (21%), Positives = 72/197 (36%), Gaps = 50/197 (25%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
K LG G F TV + ++P +AIK L + +PKA K + E M S
Sbjct: 18 KKIKVLGSGAFGTVYKGL---WIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMAS 73
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
V +P++ RL + T + L+ + G L + +++
Sbjct: 74 VDNPHVCRLLGICLT-STVQLITQLMPFGCLLD----------------YVR-------- 108
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
+ + + +QI + +L DR ++HRD+ A N
Sbjct: 109 ---------------------EHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN 147
Query: 246 VFLSVRGIVKLGDLGFS 262
V + VK+ D G +
Sbjct: 148 VLVKTPQHVKITDFGLA 164
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 1e-17
Identities = 35/150 (23%), Positives = 57/150 (38%), Gaps = 44/150 (29%)
Query: 118 REIVSMESVHHPNIIRLYEVL--ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 175
REI + + HPN+I L +V K++L+ +YA E D
Sbjct: 67 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA----------------EHD----- 105
Query: 176 LQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRD 235
L+ +++ +L K QIL + +LH
Sbjct: 106 ----LWHIIKFHRA-------------SKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 148
Query: 236 IIHRDIKAENVFLSV----RGIVKLGDLGF 261
++HRD+K N+ + RG VK+ D+GF
Sbjct: 149 VLHRDLKPANILVMGEGPERGRVKIADMGF 178
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-17
Identities = 49/228 (21%), Positives = 83/228 (36%), Gaps = 61/228 (26%)
Query: 39 YEKTQNQLQNDK-KWQ-HETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYIS 96
+ QL + E L K ++LG+GNF +V++ Y P+ +
Sbjct: 4 HHHHHAQLYACQDPTIFEERHL-------KYISQLGKGNFGSVELCR---YDPLGDNTGA 53
Query: 97 YLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK--IFLVVEYASGG 154
+A+K L + + R REI ++++H I++ V G+ + LV+EY G
Sbjct: 54 LVAVKQL-QHSGPDQQRDFQ-REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 111
Query: 155 ELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214
L + FLQ RL
Sbjct: 112 CLRD----------------FLQ-----------------------------RHRARLDA 126
Query: 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
+Y QI +++L R +HRD+ A N+ + VK+ D G +
Sbjct: 127 SRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-17
Identities = 31/146 (21%), Positives = 55/146 (37%), Gaps = 44/146 (30%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI ++ + H N++ L E+ T+
Sbjct: 65 REIKILQLLKHENVVNLIEI----------------------CRTKASPYNRCK------ 96
Query: 178 ILLYEVLETFGKIFLVVEYAS---GGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR 234
G I+LV ++ G L N + + + K +L+ + ++H
Sbjct: 97 ----------GSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN 143
Query: 235 DIIHRDIKAENVFLSVRGIVKLGDLG 260
I+HRD+KA NV ++ G++KL D G
Sbjct: 144 KILHRDMKAANVLITRDGVLKLADFG 169
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 5e-17
Identities = 31/151 (20%), Positives = 57/151 (37%), Gaps = 53/151 (35%)
Query: 118 REI---VSMESVHHPNIIRLYEVL-----ETFGKIFLVVEYASGGELYNKITTEGRLSED 169
RE+ +E+ HPN++RL++V + K+ LV E+ + +D
Sbjct: 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH---------------VDQD 104
Query: 170 DAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVK 229
L L+ + + + K Q+L +
Sbjct: 105 ----------LTTYLDKVPEPGV--------------------PTETIKDMMFQLLRGLD 134
Query: 230 HLHDRDIIHRDIKAENVFLSVRGIVKLGDLG 260
LH ++HRD+K +N+ ++ G +KL D G
Sbjct: 135 FLHSHRVVHRDLKPQNILVTSSGQIKLADFG 165
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 7e-17
Identities = 35/151 (23%), Positives = 54/151 (35%), Gaps = 53/151 (35%)
Query: 118 REIV---SMESVHHPNIIRLYEVL-----ETFGKIFLVVEYASGGELYNKITTEGRLSED 169
RE+ +E+ HPN++RL +V + K+ LV E+ + +D
Sbjct: 60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH---------------VDQD 104
Query: 170 DAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVK 229
L L+ L + K Q L +
Sbjct: 105 ----------LRTYLDKAPPPGL--------------------PAETIKDLMRQFLRGLD 134
Query: 230 HLHDRDIIHRDIKAENVFLSVRGIVKLGDLG 260
LH I+HRD+K EN+ ++ G VKL D G
Sbjct: 135 FLHANCIVHRDLKPENILVTSGGTVKLADFG 165
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-17
Identities = 34/148 (22%), Positives = 56/148 (37%), Gaps = 52/148 (35%)
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
RE+ ++ + H NII L V+ ++ L+ EYA E+D K Y
Sbjct: 82 REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA----------------ENDLKKY--- 122
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
+ +S K + Q+++ V H R +
Sbjct: 123 ----------------------------MDKNPDVSMRVIKSFLYQLINGVNFCHSRRCL 154
Query: 238 HRDIKAENVFLSV-----RGIVKLGDLG 260
HRD+K +N+ LSV ++K+GD G
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFG 182
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-16
Identities = 22/205 (10%), Positives = 53/205 (25%), Gaps = 55/205 (26%)
Query: 66 KLQNELGRGNFSTVKMAI-HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
+L + + + +K+L + + + + E +
Sbjct: 13 NFLTKLNENHSGELWKGRWQGNDI----------VVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 125 SVHHPNIIRLYEVLET--FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYE 182
HPN++ + ++ L+ + G LYN L
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYN----------------VLHEGTNF 106
Query: 183 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIK 242
V++ + ++ A G + FL H + I +
Sbjct: 107 VVDQSQAVKFALDMARG-------------------MAFL-------HTLEPLIPRHALN 140
Query: 243 AENVFLSVRGIVKLGDLGFSTKLQQ 267
+ +V + ++ Q
Sbjct: 141 SRSVMIDEDMTARISMADVKFSFQS 165
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-16
Identities = 47/197 (23%), Positives = 77/197 (39%), Gaps = 25/197 (12%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
L LG G F V A + + +A+K+L K +P + L E ++
Sbjct: 26 VLGKTLGEGEFGKVVKA--TAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLKQ 82
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
V+HP++I+LY G + L+VEYA G L FL+
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG----------------FLRESRKVGPG 126
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
G S E L+ D + QI +++L + ++HRD+ A N
Sbjct: 127 YLG------SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180
Query: 246 VFLSVRGIVKLGDLGFS 262
+ ++ +K+ D G S
Sbjct: 181 ILVAEGRKMKISDFGLS 197
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 6e-16
Identities = 49/207 (23%), Positives = 74/207 (35%), Gaps = 64/207 (30%)
Query: 66 KLQNELGRGNFSTVKMAI-HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
+++ +GRG F V A V AIK + + RK E+ +
Sbjct: 11 EVEEVVGRGAFGVVCKAKWRAKDV----------AIKQI----ESESERKAFIVELRQLS 56
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
V+HPNI++LY + LV+EYA GG LYN + L A
Sbjct: 57 RVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAA------------ 102
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRD---IIHRDI 241
+ + LQ V +LH +IHRD+
Sbjct: 103 -------HAMSWC------------------------LQCSQGVAYLHSMQPKALIHRDL 131
Query: 242 KAENVFLSVRG-IVKLGDLGFSTKLQQ 267
K N+ L G ++K+ D G + +Q
Sbjct: 132 KPPNLLLVAGGTVLKICDFGTACDIQT 158
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 9e-16
Identities = 49/213 (23%), Positives = 74/213 (34%), Gaps = 62/213 (29%)
Query: 60 KRVALYKLQNELGRGNFSTVKMAI-----HEIYVPILCTYISYLAIKILDKAKLTPKARK 114
KR L ELG GNF +V+ + +I V AIK+L K +
Sbjct: 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDV----------AIKVL-KQGTEKADTE 381
Query: 115 MLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 174
+ RE M + +P I+RL V + LV+E A GG L+
Sbjct: 382 EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK---------------- 424
Query: 175 FLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR 234
FL + + Q+ +K+L ++
Sbjct: 425 FLV-----------------------------GKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 235 DIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
+ +HR++ A NV L R K+ D G S L
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-15
Identities = 46/198 (23%), Positives = 74/198 (37%), Gaps = 32/198 (16%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
L LG G F V MA +A+K+L K T K L E+ M+
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKM 96
Query: 126 V-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ H NII L G ++++VEYAS G L +L+ +
Sbjct: 97 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE----------------YLRARRPPGM 140
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
E E +++ D Q+ +++L + IHRD+ A
Sbjct: 141 EY--------------SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186
Query: 245 NVFLSVRGIVKLGDLGFS 262
NV ++ ++K+ D G +
Sbjct: 187 NVLVTENNVMKIADFGLA 204
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-15
Identities = 57/262 (21%), Positives = 95/262 (36%), Gaps = 42/262 (16%)
Query: 5 YIANRYYNRHIIERVAIKILDKAKLTPKARK--MLIYEKTQNQLQNDKKWQHETSLGKRV 62
Y + D T + ++ ++ +L D +W+ R
Sbjct: 15 PTTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELP-----RD 69
Query: 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVS 122
L L LG G F V +A ++ +A+K+L K+ T K L E+
Sbjct: 70 RL-VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEM 127
Query: 123 MESV-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLY 181
M+ + H NII L G ++++VEYAS G L +LQ
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE----------------YLQARRP 171
Query: 182 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF-LQILSAVKHLHDRDIIHRD 240
LE E +LS D + Q+ +++L + IHRD
Sbjct: 172 PGLEY--------------SYNPSHNPEEQLSSKD-LVSCAYQVARGMEYLASKKCIHRD 216
Query: 241 IKAENVFLSVRGIVKLGDLGFS 262
+ A NV ++ ++K+ D G +
Sbjct: 217 LAARNVLVTEDNVMKIADFGLA 238
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 53/259 (20%), Positives = 92/259 (35%), Gaps = 65/259 (25%)
Query: 5 YIANRYYNRHIIERVAIKILDKAKLTPKARKMLIYEKTQNQLQNDKKWQHETSLGKRVAL 64
YI+ R + E V L K + K Q + D SL
Sbjct: 137 YISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESL------ 190
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
KL+ +LG G F V MA + + + A+K + K + + E M+
Sbjct: 191 -KLEKKLGAGQFGEVWMATYNKHTKV--------AVKTM---KPGSMSVEAFLAEANVMK 238
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
++ H +++L+ V+ T I+++ E+ + G L + FL+
Sbjct: 239 TLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLD----------------FLK------- 274
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL-QILSAVKHLHDRDIIHRDIKA 243
+ EG I F QI + + R+ IHRD++A
Sbjct: 275 ----------------------SDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRA 312
Query: 244 ENVFLSVRGIVKLGDLGFS 262
N+ +S + K+ D G +
Sbjct: 313 ANILVSASLVCKIADFGLA 331
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 39/197 (19%), Positives = 74/197 (37%), Gaps = 25/197 (12%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
+ ++G G F V A +P + +A+K+L K + + + RE M
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLP--YEPFTMVAVKML-KEEASADMQADFQREAALMAE 106
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+PNI++L V + L+ EY + G+L FL+ + +
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE----------------FLRSMSPHTVC 150
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
+ L ++ +L Q+ + + +L +R +HRD+ N
Sbjct: 151 SLSHSDLSTRARVSSPGPPPLSCAEQLC------IARQVAAGMAYLSERKFVHRDLATRN 204
Query: 246 VFLSVRGIVKLGDLGFS 262
+ +VK+ D G S
Sbjct: 205 CLVGENMVVKIADFGLS 221
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 45/198 (22%), Positives = 72/198 (36%), Gaps = 32/198 (16%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
L LG G F V MA +A+K+L K T K L E+ M+
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKM 142
Query: 126 V-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ H NII L G ++++VEYAS G L +L+
Sbjct: 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE----------------YLRARR---- 182
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
E +++ D Q+ +++L + IHRD+ A
Sbjct: 183 ----------PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 232
Query: 245 NVFLSVRGIVKLGDLGFS 262
NV ++ ++K+ D G +
Sbjct: 233 NVLVTENNVMKIADFGLA 250
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 2e-15
Identities = 47/219 (21%), Positives = 82/219 (37%), Gaps = 25/219 (11%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
KL LGRG F V A + + +A+K+L K T + L E+ +
Sbjct: 25 KLGKPLGRGAFGQVIEA--DAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIH 81
Query: 126 V-HHPNIIRLY-EVLETFGKIFLVVEYASGGELYNKITTEGRLSED-------------- 169
+ HH N++ L + G + ++VE+ G L + ++
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 170 ------DAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223
D K I + + G + E + + L+ + Y Q
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
+ ++ L R IHRD+ A N+ LS + +VK+ D G +
Sbjct: 202 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 43/197 (21%), Positives = 65/197 (32%), Gaps = 49/197 (24%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
Q +G G F V + +AIK L KA T K R E M
Sbjct: 47 TRQKVIGAGEFGEVYKGM---LKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQ 102
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
H NIIRL V+ + + ++ EY G L FL+
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDK----------------FLR-------- 138
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
+G S I + +K+L + + +HRD+ A N
Sbjct: 139 ---------------------EKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARN 177
Query: 246 VFLSVRGIVKLGDLGFS 262
+ ++ + K+ D G S
Sbjct: 178 ILVNSNLVCKVSDFGLS 194
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-15
Identities = 43/203 (21%), Positives = 67/203 (33%), Gaps = 62/203 (30%)
Query: 66 KLQNELGRGNFSTVKMAI------HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSRE 119
++ +G G+ V ++ V AIK L KA T + R+ E
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPV----------AIKAL-KAGYTERQRRDFLSE 100
Query: 120 IVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 179
M HPNIIRL V+ +V EY G L FL+
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT----------------FLR-- 142
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
T +G+ + + + +++L D +HR
Sbjct: 143 ---------------------------THDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHR 175
Query: 240 DIKAENVFLSVRGIVKLGDLGFS 262
D+ A NV + + K+ D G S
Sbjct: 176 DLAARNVLVDSNLVCKVSDFGLS 198
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-15
Identities = 33/201 (16%), Positives = 65/201 (32%), Gaps = 47/201 (23%)
Query: 66 KLQNELGRGNFSTVKMA----IHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIV 121
+ ELG+G+F V + + AIK + + + R E
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRV------AIKTV-NEAASMRERIEFLNEAS 80
Query: 122 SMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLY 181
M+ + +++RL V+ +++E + G+L + +L+
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS----------------YLR---- 120
Query: 182 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
S S +I + +L+ +HRD+
Sbjct: 121 ----------------SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 164
Query: 242 KAENVFLSVRGIVKLGDLGFS 262
A N ++ VK+GD G +
Sbjct: 165 AARNCMVAEDFTVKIGDFGMT 185
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-15
Identities = 45/203 (22%), Positives = 65/203 (32%), Gaps = 62/203 (30%)
Query: 66 KLQNELGRGNFSTVKMAI------HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSRE 119
+ +G G F V EI V AIK L K T K R+ E
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISV----------AIKTL-KVGYTEKQRRDFLGE 96
Query: 120 IVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 179
M HPNIIRL V+ + +V EY G L + FL+
Sbjct: 97 ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS----------------FLR-- 138
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
+ + + I S +K+L D +HR
Sbjct: 139 ---------------------------KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 240 DIKAENVFLSVRGIVKLGDLGFS 262
D+ A N+ ++ + K+ D G
Sbjct: 172 DLAARNILINSNLVCKVSDFGLG 194
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 7e-15
Identities = 47/203 (23%), Positives = 75/203 (36%), Gaps = 63/203 (31%)
Query: 66 KLQNELGRGNFSTVKMAI------HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSRE 119
+L +G G F V I + V AIK K + R+ +E
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAV----------AIKTC-KNCTSDSVREKFLQE 441
Query: 120 IVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 179
++M HP+I++L V+ T +++++E + GEL + FLQ
Sbjct: 442 ALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRS----------------FLQ-- 482
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
+ L +Y Q+ +A+ +L + +HR
Sbjct: 483 ---------------------------VRKFSLDLASLILYAYQLSTALAYLESKRFVHR 515
Query: 240 DIKAENVFLSVRGIVKLGDLGFS 262
DI A NV +S VKLGD G S
Sbjct: 516 DIAARNVLVSSNDCVKLGDFGLS 538
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-15
Identities = 46/198 (23%), Positives = 72/198 (36%), Gaps = 37/198 (18%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
K Q+ +G GNF V A I L AIK + K + + + E+ +
Sbjct: 28 KFQDVIGEGNFGQVLKA--RIKKDGLRMDA---AIKRM-KEYASKDDHRDFAGELEVLCK 81
Query: 126 V-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ HHPNII L E G ++L +EYA G L + FL+
Sbjct: 82 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD----------------FLRKSRVLET 125
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+ +T LS + + + +L + IHRD+ A
Sbjct: 126 D--------------PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 171
Query: 245 NVFLSVRGIVKLGDLGFS 262
N+ + + K+ D G S
Sbjct: 172 NILVGENYVAKIADFGLS 189
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-14
Identities = 43/199 (21%), Positives = 67/199 (33%), Gaps = 34/199 (17%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
LG G F V A Y I +A+K+L K R+ L E+ +
Sbjct: 26 SFGKTLGAGAFGKVVEA--TAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSY 82
Query: 126 V-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ +H NI+ L G ++ EY G+L N FL+
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN----------------FLR------- 119
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF-LQILSAVKHLHDRDIIHRDIKA 243
+ E L + F Q+ + L ++ IHRD+ A
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDL------LSFSYQVAKGMAFLASKNCIHRDLAA 173
Query: 244 ENVFLSVRGIVKLGDLGFS 262
N+ L+ I K+ D G +
Sbjct: 174 RNILLTHGRITKICDFGLA 192
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-14
Identities = 41/197 (20%), Positives = 72/197 (36%), Gaps = 33/197 (16%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
+ ELG F V ++ P +AIK L K K R+ E +
Sbjct: 12 RFMEELGEDRFGKVYKG--HLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRAR 68
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+ HPN++ L V+ + ++ Y S G+L+ FL +
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHE----------------FLVMR------ 106
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
++ G + T + L D QI + +++L ++H+D+ N
Sbjct: 107 --------SPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRN 158
Query: 246 VFLSVRGIVKLGDLGFS 262
V + + VK+ DLG
Sbjct: 159 VLVYDKLNVKISDLGLF 175
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-14
Identities = 52/219 (23%), Positives = 77/219 (35%), Gaps = 67/219 (30%)
Query: 49 DKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAI-----HEIYVPILCTYISYLAIKIL 103
DKK KR L ELG GNF +V+ + +I V AIK+L
Sbjct: 1 DKKLFL-----KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDV----------AIKVL 45
Query: 104 DKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTE 163
K + + RE M + +P I+RL V + + LV+E A GG L+
Sbjct: 46 -KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHK----- 98
Query: 164 GRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223
FL + + Q
Sbjct: 99 -----------FLV-----------------------------GKREEIPVSNVAELLHQ 118
Query: 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
+ +K+L +++ +HRD+ A NV L R K+ D G S
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-14
Identities = 44/205 (21%), Positives = 73/205 (35%), Gaps = 35/205 (17%)
Query: 65 YKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
Y L LG G+F V + A+K K+ R RE+
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKR-----------FALK-----KVLQDPRYKN-REL 51
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
M+ + H NII+L + T G + +L + + +
Sbjct: 52 DIMKVLDHVNIIKLVDYFYTTGD--------EEPKPPQPPDDHNKLGGKNNGVNNHHKSV 103
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGR----LSEDDAKIYFLQILSAVKHLHDRDI 236
+ +++EY L+ + + R + + IY Q+ AV +H I
Sbjct: 104 IVNPSQNKYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI 162
Query: 237 IHRDIKAENVFL-SVRGIVKLGDLG 260
HRDIK +N+ + S +KL D G
Sbjct: 163 CHRDIKPQNLLVNSKDNTLKLCDFG 187
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 36/201 (17%), Positives = 72/201 (35%), Gaps = 62/201 (30%)
Query: 66 KLQNELGRGNFSTVKMAI---HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVS 122
++++LG G + V + + + V A+K L K + +E
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTV----------AVKTL---KEDTMEVEEFLKEAAV 269
Query: 123 MESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYE 182
M+ + HPN+++L V +++ E+ + G L + +L+
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD----------------YLR----- 308
Query: 183 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF-LQILSAVKHLHDRDIIHRDI 241
+ +Y QI SA+++L ++ IHR++
Sbjct: 309 ------------------------ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNL 344
Query: 242 KAENVFLSVRGIVKLGDLGFS 262
A N + +VK+ D G S
Sbjct: 345 AARNCLVGENHLVKVADFGLS 365
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-14
Identities = 38/204 (18%), Positives = 65/204 (31%), Gaps = 63/204 (30%)
Query: 66 KLQNELGRGNFSTVKMAI------HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSRE 119
+GRG+F V +I+ A+K L E
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHC----------AVKSL-NRITDIGEVSQFLTE 76
Query: 120 IVSMESVHHPNIIRLYEV-LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 178
+ M+ HPN++ L + L + G +V+ Y G+L N F++
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN----------------FIR- 119
Query: 179 LLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIH 238
+ D + LQ+ +K+L + +H
Sbjct: 120 ----------------------------NETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 151
Query: 239 RDIKAENVFLSVRGIVKLGDLGFS 262
RD+ A N L + VK+ D G +
Sbjct: 152 RDLAARNCMLDEKFTVKVADFGLA 175
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-14
Identities = 47/203 (23%), Positives = 75/203 (36%), Gaps = 63/203 (31%)
Query: 66 KLQNELGRGNFSTVKMAI------HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSRE 119
+L +G G F V I + V AIK K + R+ +E
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAV----------AIKTC-KNCTSDSVREKFLQE 66
Query: 120 IVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 179
++M HP+I++L V+ T +++++E + GEL + FLQ
Sbjct: 67 ALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRS----------------FLQ-- 107
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHR 239
+ L +Y Q+ +A+ +L + +HR
Sbjct: 108 ---------------------------VRKYSLDLASLILYAYQLSTALAYLESKRFVHR 140
Query: 240 DIKAENVFLSVRGIVKLGDLGFS 262
DI A NV +S VKLGD G S
Sbjct: 141 DIAARNVLVSSNDCVKLGDFGLS 163
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-14
Identities = 38/204 (18%), Positives = 64/204 (31%), Gaps = 63/204 (30%)
Query: 66 KLQNELGRGNFSTVKMAI------HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSRE 119
+GRG+F V +I+ A+K L E
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHC----------AVKSL-NRITDIGEVSQFLTE 140
Query: 120 IVSMESVHHPNIIRLYEV-LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 178
+ M+ HPN++ L + L + G +V+ Y G+L N F++
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN----------------FIR- 183
Query: 179 LLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIH 238
+ D + LQ+ +K L + +H
Sbjct: 184 ----------------------------NETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 215
Query: 239 RDIKAENVFLSVRGIVKLGDLGFS 262
RD+ A N L + VK+ D G +
Sbjct: 216 RDLAARNCMLDEKFTVKVADFGLA 239
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-14
Identities = 44/197 (22%), Positives = 74/197 (37%), Gaps = 51/197 (25%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
L LG G F V + Y I+ +A+K K T ++ E V M++
Sbjct: 15 VLNRILGEGFFGEVYEGV---YTNHKGEKIN-VAVKTC-KKDCTLDNKEKFMSEAVIMKN 69
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+ HP+I++L ++E ++++E GEL + +L+
Sbjct: 70 LDHPHIVKLIGIIEE-EPTWIIMELYPYGELGH----------------YLE-------- 104
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
+ L +Y LQI A+ +L + +HRDI N
Sbjct: 105 ---------------------RNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRN 143
Query: 246 VFLSVRGIVKLGDLGFS 262
+ ++ VKLGD G S
Sbjct: 144 ILVASPECVKLGDFGLS 160
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-14
Identities = 52/259 (20%), Positives = 90/259 (34%), Gaps = 64/259 (24%)
Query: 5 YIANRYYNRHIIERVAIKILDKAKLTPKARKMLIYEKTQNQLQNDKKWQ-HETSLGKRVA 63
YI +R + + VA L + + K Q Q W+ SL
Sbjct: 132 YITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESL----- 186
Query: 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSM 123
+L+ +LG+G F V M + AIK L K + + +E M
Sbjct: 187 --RLEVKLGQGCFGEVWMGTWNGTTRV--------AIKTL---KPGTMSPEAFLQEAQVM 233
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ + H +++LY V+ + I++V EY S G L + L + K L L+
Sbjct: 234 KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD------FLKGETGKYLRLPQLVD-- 284
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
QI S + ++ + +HRD++A
Sbjct: 285 ------------------------------------MAAQIASGMAYVERMNYVHRDLRA 308
Query: 244 ENVFLSVRGIVKLGDLGFS 262
N+ + + K+ D G +
Sbjct: 309 ANILVGENLVCKVADFGLA 327
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-14
Identities = 36/209 (17%), Positives = 73/209 (34%), Gaps = 66/209 (31%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKA-----RKMLSREI 120
+ + ++G+G F V S +AIK L + + RE+
Sbjct: 22 EYEKQIGKGGFGLVHKGRL-------VKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
M +++HPNI++LY + +V+E+ G+LY+++ +
Sbjct: 75 FIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAH--------------- 117
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRD--IIH 238
+ L I ++++ +++ I+H
Sbjct: 118 ------------------------------PIKWSVKLRLMLDIALGIEYMQNQNPPIVH 147
Query: 239 RDIKAENVFLSVRG-----IVKLGDLGFS 262
RD+++ N+FL K+ D G S
Sbjct: 148 RDLRSPNIFLQSLDENAPVCAKVADFGLS 176
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-14
Identities = 43/208 (20%), Positives = 72/208 (34%), Gaps = 73/208 (35%)
Query: 65 YKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIK-ILDKAKLTPKARKMLSRE 119
Y +G G+F V A E+ +AIK +L + +RE
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGEL-----------VAIKKVLQDKRFK-------NRE 97
Query: 120 IVSMESVHHPNIIRLYEVLETFG------KIFLVVEYASGGELYNKITTEGRLSEDDAKI 173
+ M + H NI+RL + G + LV++Y + E
Sbjct: 98 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY---------------VPET---- 138
Query: 174 YFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHD 233
+Y V + + + L K+Y Q+ ++ ++H
Sbjct: 139 ------VYRVARHYSR------------------AKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 234 RDIIHRDIKAENVFL-SVRGIVKLGDLG 260
I HRDIK +N+ L ++KL D G
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFG 202
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-14
Identities = 43/216 (19%), Positives = 72/216 (33%), Gaps = 71/216 (32%)
Query: 66 KLQNELGRGNFSTVKMAI-HEIYVPILCTYISYLAIKIL--DKAKLTPKARKMLSREIVS 122
L+ +G G F V A V A+K D + + + + +E
Sbjct: 10 TLEEIIGIGGFGKVYRAFWIGDEV----------AVKAARHDPDEDISQTIENVRQEAKL 59
Query: 123 MESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYE 182
+ HPNII L V + LV+E+A GG L L
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNR----------------VLS----- 98
Query: 183 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR---DIIHR 239
+I + ++ + +QI + +LHD IIHR
Sbjct: 99 --------------------GKRIPPDILVN------WAVQIARGMNYLHDEAIVPIIHR 132
Query: 240 DIKAENVFLS--------VRGIVKLGDLGFSTKLQQ 267
D+K+ N+ + I+K+ D G + + +
Sbjct: 133 DLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-14
Identities = 36/215 (16%), Positives = 71/215 (33%), Gaps = 73/215 (33%)
Query: 66 KLQNELGRGNFSTVKMAI-HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
++ ++G+G + V M V A+K+ + R+ EI
Sbjct: 40 QMVKQIGKGRYGEVWMGKWRGEKV----------AVKVFFTTEEASWFRE---TEIYQTV 86
Query: 125 SVHHPNIIRLY----EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
+ H NI+ + ++ +++L+ +Y G LY+ +L+
Sbjct: 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYD----------------YLK--- 127
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRD----- 235
+ + L K+ +S + HLH
Sbjct: 128 ----------------------STTLDAKSML-----KL-AYSSVSGLCHLHTEIFSTQG 159
Query: 236 ---IIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
I HRD+K++N+ + G + DLG + K
Sbjct: 160 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS 194
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-14
Identities = 42/197 (21%), Positives = 70/197 (35%), Gaps = 35/197 (17%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
L+ ELG G F V +A +P +A+K L +A + AR+ RE +
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPE--QDKMLVAVKALKEA--SESARQDFQREAELLTM 99
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+ H +I+R + V + +V EY G+L FL+
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNR----------------FLRSH------ 137
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
+ + G L Q+ + + +L +HRD+ N
Sbjct: 138 ---------GPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRN 188
Query: 246 VFLSVRGIVKLGDLGFS 262
+ +VK+GD G S
Sbjct: 189 CLVGQGLVVKIGDFGMS 205
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-14
Identities = 46/204 (22%), Positives = 73/204 (35%), Gaps = 63/204 (30%)
Query: 66 KLQNELGRGNFSTVKMAI------HEIYVPILCTYISYLAIKIL-DKAKLTPKARKMLSR 118
+L +LG G+F V+ + V A+K L P+A R
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSV----------AVKCLKPDVLSQPEAMDDFIR 70
Query: 119 EIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 178
E+ +M S+ H N+IRLY V+ + +V E A G L + L+
Sbjct: 71 EVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLD----------------RLR- 112
Query: 179 LLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIH 238
+G Y +Q+ + +L + IH
Sbjct: 113 ----------------------------KHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 239 RDIKAENVFLSVRGIVKLGDLGFS 262
RD+ A N+ L+ R +VK+GD G
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLM 168
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-14
Identities = 35/197 (17%), Positives = 63/197 (31%), Gaps = 56/197 (28%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
E+G G F V + + AIK + + + + E M
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDKV--------AIKTI---REGAMSEEDFIEEAEVMMK 59
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+ HP +++LY V I LV E+ G L + +L+
Sbjct: 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD----------------YLR-------- 95
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
T G + + L + + +L + +IHRD+ A N
Sbjct: 96 ---------------------TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN 134
Query: 246 VFLSVRGIVKLGDLGFS 262
+ ++K+ D G +
Sbjct: 135 CLVGENQVIKVSDFGMT 151
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-14
Identities = 41/201 (20%), Positives = 68/201 (33%), Gaps = 61/201 (30%)
Query: 66 KLQNELGRGNFSTVKMAI---HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVS 122
L ++GRGNF V V A+K + L P + +E
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLV----------AVKSC-RETLPPDLKAKFLQEARI 165
Query: 123 MESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYE 182
++ HPNI+RL V I++V+E GG+ FL+
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT----------------FLR----- 204
Query: 183 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF-LQILSAVKHLHDRDIIHRDI 241
TEG + + +++L + IHRD+
Sbjct: 205 -------------------------TEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDL 239
Query: 242 KAENVFLSVRGIVKLGDLGFS 262
A N ++ + ++K+ D G S
Sbjct: 240 AARNCLVTEKNVLKISDFGMS 260
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 6e-14
Identities = 52/259 (20%), Positives = 90/259 (34%), Gaps = 64/259 (24%)
Query: 5 YIANRYYNRHIIERVAIKILDKAKLTPKARKMLIYEKTQNQLQNDKKWQ-HETSLGKRVA 63
YI +R + + VA L + + K Q Q W+ SL
Sbjct: 215 YITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESL----- 269
Query: 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSM 123
+L+ +LG+G F V M + AIK L K + + +E M
Sbjct: 270 --RLEVKLGQGCFGEVWMGTWNGTTRV--------AIKTL---KPGTMSPEAFLQEAQVM 316
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ + H +++LY V+ + I++V EY S G L + FL+
Sbjct: 317 KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD----------------FLK------ 353
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
G+ L QI S + ++ + +HRD++A
Sbjct: 354 -------------GETGK---------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 391
Query: 244 ENVFLSVRGIVKLGDLGFS 262
N+ + + K+ D G +
Sbjct: 392 ANILVGENLVCKVADFGLA 410
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-14
Identities = 37/205 (18%), Positives = 64/205 (31%), Gaps = 54/205 (26%)
Query: 66 KLQNELGRGNFSTVKMAI--HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSM 123
L LG+G F +V+ A E + A+K+L + + RE M
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKV------AVKMLKADIIASSDIEEFLREAACM 79
Query: 124 ESVHHPNIIRLYEV------LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
+ HP++ +L V +++ + G+L+ FL
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHA----------------FLL 123
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
L + + I +++L R+ I
Sbjct: 124 ------------------------ASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFI 159
Query: 238 HRDIKAENVFLSVRGIVKLGDLGFS 262
HRD+ A N L+ V + D G S
Sbjct: 160 HRDLAARNCMLAEDMTVCVADFGLS 184
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 6e-14
Identities = 41/215 (19%), Positives = 67/215 (31%), Gaps = 73/215 (33%)
Query: 66 KLQNELGRGNFSTVKMAI-HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
LQ +G+G F V V A+KI + R+ EI
Sbjct: 45 VLQESIGKGRFGEVWRGKWRGEEV----------AVKIFSSREERSWFRE---AEIYQTV 91
Query: 125 SVHHPNIIRLYEVLETFG----KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
+ H NI+ +++LV +Y G L++ +L
Sbjct: 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD----------------YLN--- 132
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR------ 234
+T EG + K+ L S + HLH
Sbjct: 133 ----------------------RYTVTVEGMI-----KL-ALSTASGLAHLHMEIVGTQG 164
Query: 235 --DIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
I HRD+K++N+ + G + DLG + +
Sbjct: 165 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 199
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-14
Identities = 45/199 (22%), Positives = 74/199 (37%), Gaps = 29/199 (14%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
+ LG G F V A Y +A+K+L K K R+ L E+ M
Sbjct: 48 EFGKVLGSGAFGKVMNA--TAYGISKTGVSIQVAVKML-KEKADSSEREALMSELKMMTQ 104
Query: 126 V-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ H NI+ L G I+L+ EY G+L N +L+
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN----------------YLR------- 141
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF-LQILSAVKHLHDRDIIHRDIKA 243
K + + L+ +D + F Q+ ++ L + +HRD+ A
Sbjct: 142 SKREKFSEDEIEYENQKRLEEEEDLNVLTFED-LLCFAYQVAKGMEFLEFKSCVHRDLAA 200
Query: 244 ENVFLSVRGIVKLGDLGFS 262
NV ++ +VK+ D G +
Sbjct: 201 RNVLVTHGKVVKICDFGLA 219
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 7e-14
Identities = 41/198 (20%), Positives = 68/198 (34%), Gaps = 36/198 (18%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
+ LG G F V A + + +A+K+L K+ ++ L E+ M
Sbjct: 49 QFGKTLGAGAFGKVVEA--TAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSH 105
Query: 126 V-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ H NI+ L G + ++ EY G+L N
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN-------------------------- 139
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
FL + S D + Q+ + L ++ IHRD+ A
Sbjct: 140 ------FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAAR 193
Query: 245 NVFLSVRGIVKLGDLGFS 262
NV L+ + K+GD G +
Sbjct: 194 NVLLTNGHVAKIGDFGLA 211
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-14
Identities = 46/198 (23%), Positives = 72/198 (36%), Gaps = 36/198 (18%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
L+ ELG G F V +A P +A+K L T ARK RE + +
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSP--TKDKMLVAVKALKDP--TLAARKDFQREAELLTN 73
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+ H +I++ Y V + +V EY G+L FL+ +
Sbjct: 74 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNK----------------FLRAHGPD--- 114
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF-LQILSAVKHLHDRDIIHRDIKAE 244
A +G L ++ QI S + +L + +HRD+
Sbjct: 115 -----------AMILVDGQPRQAKGELGLSQ-MLHIASQIASGMVYLASQHFVHRDLATR 162
Query: 245 NVFLSVRGIVKLGDLGFS 262
N + +VK+GD G S
Sbjct: 163 NCLVGANLLVKIGDFGMS 180
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-14
Identities = 37/208 (17%), Positives = 65/208 (31%), Gaps = 61/208 (29%)
Query: 66 KLQNELGRGNFSTVKMAI------HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSRE 119
L LG G F +V + V A+K + + + + E
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKV----------AVKTMKLDNSSQREIEEFLSE 86
Query: 120 IVSMESVHHPNIIRLYEV-----LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 174
M+ HPN+IRL V + K +++ + G+L+
Sbjct: 87 AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHT---------------- 130
Query: 175 FLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR 234
+L E T + + + I +++L +R
Sbjct: 131 YLLYSRLE------------------------TGPKHIPLQTLLKFMVDIALGMEYLSNR 166
Query: 235 DIIHRDIKAENVFLSVRGIVKLGDLGFS 262
+ +HRD+ A N L V + D G S
Sbjct: 167 NFLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 9e-14
Identities = 45/209 (21%), Positives = 72/209 (34%), Gaps = 76/209 (36%)
Query: 65 YKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIK--ILDKAKLTPKARKMLSR 118
Y +G G+F V A E+ AIK + DK + +R
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEV------------AIKKVLQDK--------RFKNR 81
Query: 119 EIVSMESVHHPNIIRLYEVL------ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 172
E+ M V HPN++ L + + LV+EY + E
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY---------------VPET--- 123
Query: 173 IYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLH 232
+Y + K + + K+Y Q+L ++ ++H
Sbjct: 124 -------VYRASRHYAK------------------LKQTMPMLLIKLYMYQLLRSLAYIH 158
Query: 233 DRDIIHRDIKAENVFL-SVRGIVKLGDLG 260
I HRDIK +N+ L G++KL D G
Sbjct: 159 SIGICHRDIKPQNLLLDPPSGVLKLIDFG 187
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-13
Identities = 46/199 (23%), Positives = 78/199 (39%), Gaps = 35/199 (17%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
KL LGRG F V A + + +A+K+L K T + L E+ +
Sbjct: 30 KLGKPLGRGAFGQVIEA--DAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIH 86
Query: 126 V-HHPNIIRLYEVLETFGK-IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ HH N++ L G + ++VE+ G L +L+
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST----------------YLR------ 124
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+ F+ + A + +T E + Y Q+ ++ L R IHRD+ A
Sbjct: 125 --SKRNEFVPYKVAPEDLYKDFLTLEHLIC------YSFQVAKGMEFLASRKCIHRDLAA 176
Query: 244 ENVFLSVRGIVKLGDLGFS 262
N+ LS + +VK+ D G +
Sbjct: 177 RNILLSEKNVVKICDFGLA 195
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-13
Identities = 39/215 (18%), Positives = 64/215 (29%), Gaps = 73/215 (33%)
Query: 66 KLQNELGRGNFSTVKMAI-HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
L +G+G + V V A+KI R+ E+ +
Sbjct: 11 TLLECVGKGRYGEVWRGSWQGENV----------AVKIFSSRDEKSWFRE---TELYNTV 57
Query: 125 SVHHPNIIRLY----EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
+ H NI+ + +++L+ Y G LY+ +LQ
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD----------------YLQ--- 98
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRD----- 235
+ T L L I S + HLH
Sbjct: 99 ----------------------LTTLDTVSCLR------IVLSIASGLAHLHIEIFGTQG 130
Query: 236 ---IIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
I HRD+K++N+ + G + DLG + Q
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 165
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 5e-13
Identities = 37/214 (17%), Positives = 58/214 (27%), Gaps = 69/214 (32%)
Query: 66 KLQNELGRGNFSTVKMAI-HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSRE--IVS 122
KL +GRG + V E V A+K+ R+ E I
Sbjct: 16 KLLELIGRGRYGAVYKGSLDERPV----------AVKVFS-----FANRQNFINEKNIYR 60
Query: 123 MESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYE 182
+ + H NI R G+
Sbjct: 61 VPLMEHDNIARFI-----------------VGDERVTADGRMEY---------------- 87
Query: 183 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHD--------- 233
LV+EY G L ++ ++ + + +LH
Sbjct: 88 --------LLVMEYYPNGSLXKYLSLHTSDWVSSCRL-AHSVTRGLAYLHTELPRGDHYK 138
Query: 234 RDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
I HRD+ + NV + G + D G S +L
Sbjct: 139 PAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-13
Identities = 42/198 (21%), Positives = 64/198 (32%), Gaps = 62/198 (31%)
Query: 70 ELGRGNFSTVKMAI-----HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
ELG GNF TVK V A+KIL P + L E M+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTV----------AVKILKNEANDPALKDELLAEANVMQ 73
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ +P I+R+ + E
Sbjct: 74 QLDNPYIVRMIGI----------------------CEAE--------------------- 90
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
LV+E A G L + + + + Q+ +K+L + + +HRD+ A
Sbjct: 91 ----SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAAR 146
Query: 245 NVFLSVRGIVKLGDLGFS 262
NV L + K+ D G S
Sbjct: 147 NVLLVTQHYAKISDFGLS 164
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-13
Identities = 40/200 (20%), Positives = 72/200 (36%), Gaps = 62/200 (31%)
Query: 66 KLQNELGRGNFSTVKMAI-HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
KL +G+G F V + V A+K + K T +A E M
Sbjct: 24 KLLQTIGKGEFGDVMLGDYRGNKV----------AVKCI-KNDATAQA---FLAEASVMT 69
Query: 125 SVHHPNIIRLYEV-LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ H N+++L V +E G +++V EY + G L + +L+
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD----------------YLR------ 107
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL-QILSAVKHLHDRDIIHRDIK 242
+ + D + F + A+++L + +HRD+
Sbjct: 108 -----------------------SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 144
Query: 243 AENVFLSVRGIVKLGDLGFS 262
A NV +S + K+ D G +
Sbjct: 145 ARNVLVSEDNVAKVSDFGLT 164
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 6e-13
Identities = 39/200 (19%), Positives = 80/200 (40%), Gaps = 57/200 (28%)
Query: 65 YKLQNELGRGNFSTVKMAIHEI---YVPILCTYISYLAIK-ILDKAKLTPKARKMLSREI 120
Y++++ +G G++ V A ++ V AIK IL + +++L REI
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVV----------AIKKILRVFEDLIDCKRIL-REI 103
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
+ ++H +++++ +++
Sbjct: 104 AILNRLNHDHVVKVLDIVIP---------------------------------------- 123
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
+ +E F ++++V+E A + T L+E K +L VK++H I+HRD
Sbjct: 124 -KDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRD 181
Query: 241 IKAENVFLSVRGIVKLGDLG 260
+K N ++ VK+ D G
Sbjct: 182 LKPANCLVNQDCSVKVCDFG 201
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 7e-13
Identities = 37/217 (17%), Positives = 63/217 (29%), Gaps = 75/217 (34%)
Query: 66 KLQNELGRGNFSTV-KMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
+L RG F V K + YV A+KI + E+ S+
Sbjct: 27 QLLEVKARGRFGCVWKAQLLNEYV----------AVKIFPIQDKQSWQNE---YEVYSLP 73
Query: 125 SVHHPNIIRLY----EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
+ H NI++ ++L+ + G L + FL+
Sbjct: 74 GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD----------------FLK--- 114
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRD----- 235
N ++ I + + +LH+
Sbjct: 115 ----------------------ANVVSWNELC-----HIA-ETMARGLAYLHEDIPGLKD 146
Query: 236 -----IIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
I HRDIK++NV L + D G + K +
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 8e-13
Identities = 36/204 (17%), Positives = 68/204 (33%), Gaps = 63/204 (30%)
Query: 66 KLQNELGRGNFSTVKMAI------HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSRE 119
+G+G+F V + I AIK L + + RE
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQC----------AIKSL-SRITEMQQVEAFLRE 72
Query: 120 IVSMESVHHPNIIRLYEV-LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 178
+ M ++HPN++ L + L G +++ Y G+L F++
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQ----------------FIR- 115
Query: 179 LLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIH 238
+ + + D + LQ+ +++L ++ +H
Sbjct: 116 ----------------------------SPQRNPTVKDLISFGLQVARGMEYLAEQKFVH 147
Query: 239 RDIKAENVFLSVRGIVKLGDLGFS 262
RD+ A N L VK+ D G +
Sbjct: 148 RDLAARNCMLDESFTVKVADFGLA 171
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 9e-13
Identities = 51/264 (19%), Positives = 90/264 (34%), Gaps = 72/264 (27%)
Query: 5 YIANRYYNRHIIERVAIKILDKAKLTPKARKMLIYEKTQNQLQ--NDKKWQ-HETSLGKR 61
I Y ++++ V D L + K + E T W + L
Sbjct: 139 SIDEEVYFENLMQLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKEL--- 195
Query: 62 VALYKLQNELGRGNFSTVKMAI-HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI 120
KL +G+G F V + V A+K + K T +A E
Sbjct: 196 ----KLLQTIGKGEFGDVMLGDYRGNKV----------AVKCI-KNDATAQA---FLAEA 237
Query: 121 VSMESVHHPNIIRLYEV-LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 179
M + H N+++L V +E G +++V EY + G L + +L+
Sbjct: 238 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD----------------YLR-- 279
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF-LQILSAVKHLHDRDIIH 238
+ + D + F L + A+++L + +H
Sbjct: 280 ---------------------------SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 312
Query: 239 RDIKAENVFLSVRGIVKLGDLGFS 262
RD+ A NV +S + K+ D G +
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLT 336
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-13
Identities = 32/205 (15%), Positives = 63/205 (30%), Gaps = 55/205 (26%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
LG+G F+ + + + + + +K+LDKA + M
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSK 68
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+ H +++ Y V + LV E+ G L +L+
Sbjct: 69 LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDT----------------YLK-------- 104
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
+ ++ Q+ +A+ L + +IH ++ A+N
Sbjct: 105 ---------------------KNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKN 143
Query: 246 VFLSVRG--------IVKLGDLGFS 262
+ L +KL D G S
Sbjct: 144 ILLIREEDRKTGNPPFIKLSDPGIS 168
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-12
Identities = 40/200 (20%), Positives = 67/200 (33%), Gaps = 45/200 (22%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
L LG G F V ++ +A+K L + + E + +
Sbjct: 33 TLIRGLGHGAFGEVYEG--QVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISK 89
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+H NI+R V F+++E +GG+L + FL+
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKS----------------FLR-------- 125
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
E + + L+ D I ++L + IHRDI A N
Sbjct: 126 ---------------ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 170
Query: 246 VFLSVRG---IVKLGDLGFS 262
L+ G + K+GD G +
Sbjct: 171 CLLTCPGPGRVAKIGDFGMA 190
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-12
Identities = 40/200 (20%), Positives = 67/200 (33%), Gaps = 45/200 (22%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
L LG G F V ++ +A+K L + + E + +
Sbjct: 74 TLIRGLGHGAFGEVYEG--QVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISK 130
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+H NI+R V F+++E +GG+L + FL+
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS----------------FLR-------- 166
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
E + + L+ D I ++L + IHRDI A N
Sbjct: 167 ---------------ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 211
Query: 246 VFLSVRG---IVKLGDLGFS 262
L+ G + K+GD G +
Sbjct: 212 CLLTCPGPGRVAKIGDFGMA 231
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-12
Identities = 42/198 (21%), Positives = 69/198 (34%), Gaps = 58/198 (29%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
KL LG G F V M + + + A+K L K + E M+
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTKV--------AVKSL---KQGSMSPDAFLAEANLMKQ 64
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+ H ++RLY V+ T I+++ EY G L + FL+
Sbjct: 65 LQHQRLVRLYAVV-TQEPIYIITEYMENGSLVD----------------FLK-------- 99
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL-QILSAVKHLHDRDIIHRDIKAE 244
T G + + QI + + +R+ IHRD++A
Sbjct: 100 ---------------------TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAA 138
Query: 245 NVFLSVRGIVKLGDLGFS 262
N+ +S K+ D G +
Sbjct: 139 NILVSDTLSCKIADFGLA 156
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-12
Identities = 39/197 (19%), Positives = 65/197 (32%), Gaps = 56/197 (28%)
Query: 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES 125
ELG G F VK + AIK++ K + E M +
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYDV--------AIKMI---KEGSMSEDEFIEEAKVMMN 75
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+ H +++LY V IF++ EY + G L N +L+
Sbjct: 76 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN----------------YLR-------- 111
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
R + A+++L + +HRD+ A N
Sbjct: 112 ---------------------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN 150
Query: 246 VFLSVRGIVKLGDLGFS 262
++ +G+VK+ D G S
Sbjct: 151 CLVNDQGVVKVSDFGLS 167
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-12
Identities = 37/200 (18%), Positives = 72/200 (36%), Gaps = 60/200 (30%)
Query: 66 KLQNELGRGNFSTVKMAI---HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVS 122
++++LG G + V + + + V A+K L K + +E
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTV----------AVKTL---KEDTMEVEEFLKEAAV 62
Query: 123 MESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYE 182
M+ + HPN+++L V +++ E+ + G L + +L+
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD----------------YLR----- 101
Query: 183 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIK 242
+ +S QI SA+++L ++ IHRD+
Sbjct: 102 --------------ECNRQ---------EVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 138
Query: 243 AENVFLSVRGIVKLGDLGFS 262
A N + +VK+ D G S
Sbjct: 139 ARNCLVGENHLVKVADFGLS 158
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-12
Identities = 42/198 (21%), Positives = 76/198 (38%), Gaps = 49/198 (24%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y+ + +G G + +V A +A+K L + + K RE+ ++
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTG-------LRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ H N+I L +V L
Sbjct: 84 HMKHENVIGLLDV----------------------------------------FTPARSL 103
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
E F ++LV G +L N + + +L++D + QIL +K++H DIIHRD+K
Sbjct: 104 EEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPS 161
Query: 245 NVFLSVRGIVKLGDLGFS 262
N+ ++ +K+ D G +
Sbjct: 162 NLAVNEDCELKILDFGLA 179
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 6e-12
Identities = 47/196 (23%), Positives = 67/196 (34%), Gaps = 50/196 (25%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y+ +G G V A + +AIK L + K RE+V M+
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLD-------RNVAIKKLSRPFQNQTHAKRAYRELVLMK 116
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
V+H NII L V + L
Sbjct: 117 CVNHKNIISLLNV----------------------------------------FTPQKTL 136
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
E F ++LV+E L I E L + Q+L +KHLH IIHRD+K
Sbjct: 137 EEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
Query: 245 NVFLSVRGIVKLGDLG 260
N+ + +K+ D G
Sbjct: 194 NIVVKSDCTLKILDFG 209
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-12
Identities = 38/208 (18%), Positives = 69/208 (33%), Gaps = 60/208 (28%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLS------- 117
Y +Q + G++ V + +P+ AIK + + +LS
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPV--------AIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 118 --REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 175
REI + HHPNI+ L +
Sbjct: 76 VLREIRLLNHFHHPNILGLRD--------------------------------------- 96
Query: 176 LQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL-QILSAVKHLHDR 234
I ++ K++LV E +L I + + YF+ IL + LH+
Sbjct: 97 --IFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA 153
Query: 235 DIIHRDIKAENVFLSVRGIVKLGDLGFS 262
++HRD+ N+ L+ + + D +
Sbjct: 154 GVVHRDLHPGNILLADNNDITICDFNLA 181
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 8e-12
Identities = 39/199 (19%), Positives = 62/199 (31%), Gaps = 60/199 (30%)
Query: 66 KLQNELGRGNFSTVKMAI--HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSM 123
L ELG G F VK+ + V A+K++ K + +E +M
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQYDV----------AVKMI---KEGSMSEDEFFQEAQTM 57
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ HP +++ Y V I++V EY S G L N +L+
Sbjct: 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLN----------------YLR------ 95
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+ L + + L IHRD+ A
Sbjct: 96 -----------------------SHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAA 132
Query: 244 ENVFLSVRGIVKLGDLGFS 262
N + VK+ D G +
Sbjct: 133 RNCLVDRDLCVKVSDFGMT 151
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-11
Identities = 46/200 (23%), Positives = 75/200 (37%), Gaps = 65/200 (32%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y+L +LGRG +S V AI+ T + +K L P +K + REI +E
Sbjct: 38 YQLVRKLGRGKYSEVFEAINI-------TNNEKVVVK-----ILKPVKKKKIKREIKILE 85
Query: 125 SV-HHPNIIRLYEVL--ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLY 181
++ PNII L +++ LV E+ ++ D K +
Sbjct: 86 NLRGGPNIITLADIVKDPVSRTPALVFEH---------------VNNTDFKQLY------ 124
Query: 182 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
L++ D + Y +IL A+ + H I+HRD+
Sbjct: 125 ----------------------------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDV 156
Query: 242 KAENVFL-SVRGIVKLGDLG 260
K NV + ++L D G
Sbjct: 157 KPHNVMIDHEHRKLRLIDWG 176
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-11
Identities = 41/199 (20%), Positives = 77/199 (38%), Gaps = 51/199 (25%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y+ +G G + V A+ + +AIK L + + K RE+ ++
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTG-------AKVAIKKLYRPFQSELFAKRAYRELRLLK 79
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ H N+I L +V E L
Sbjct: 80 HMRHENVIGLLDV----------------------------------------FTPDETL 99
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL-QILSAVKHLHDRDIIHRDIKA 243
+ F +LV+ + G +L + E +L ED + + + Q+L ++++H IIHRD+K
Sbjct: 100 DDFTDFYLVMPFM-GTDLGKLMKHE-KLGEDRIQ-FLVYQMLKGLRYIHAAGIIHRDLKP 156
Query: 244 ENVFLSVRGIVKLGDLGFS 262
N+ ++ +K+ D G +
Sbjct: 157 GNLAVNEDCELKILDFGLA 175
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-11
Identities = 44/200 (22%), Positives = 77/200 (38%), Gaps = 57/200 (28%)
Query: 65 YKLQNELGRGNFSTVKMAIHEI---YVPILCTYISYLAIKILDKAKLTPKARKMLSREIV 121
Y +++ +GRG++ V +A + V AIK +++ K + REI
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNV----------AIKKVNRMFEDLIDCKRILREIT 77
Query: 122 SMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLY 181
+ + IIRLY+ +++
Sbjct: 78 ILNRLKSDYIIRLYD-----------------------------------------LIIP 96
Query: 182 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL-QILSAVKHLHDRDIIHRD 240
+ L F ++++V+E A +L T L+E+ K L +L +H+ IIHRD
Sbjct: 97 DDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIK-TILYNLLLGENFIHESGIIHRD 154
Query: 241 IKAENVFLSVRGIVKLGDLG 260
+K N L+ VK+ D G
Sbjct: 155 LKPANCLLNQDCSVKVCDFG 174
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-11
Identities = 44/206 (21%), Positives = 75/206 (36%), Gaps = 67/206 (32%)
Query: 65 YKLQNELGRGNFSTVKMAIHEI---YVPILCTYISYLAIKILDKAKLTPKARKMLS---- 117
Y + +G G + V A + V AIK K++P +
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRV----------AIK-----KISPFEHQTYCQRTL 73
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI + H NII + +
Sbjct: 74 REIKILLRFRHENIIGIND----------------------------------------- 92
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL-QILSAVKHLHDRDI 236
I+ +E +++V + +LY + T+ LS D YFL QIL +K++H ++
Sbjct: 93 IIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHIC-YFLYQILRGLKYIHSANV 149
Query: 237 IHRDIKAENVFLSVRGIVKLGDLGFS 262
+HRD+K N+ L+ +K+ D G +
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLA 175
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-11
Identities = 37/198 (18%), Positives = 72/198 (36%), Gaps = 50/198 (25%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y +G G + +V AI + +AIK L + + K RE++ ++
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSG-------EKVAIKKLSRPFQSEIFAKRAYRELLLLK 78
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ H N+I L +V L
Sbjct: 79 HMQHENVIGLLDV----------------------------------------FTPASSL 98
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
F +LV+ + +L + + SE+ + Q+L +K++H ++HRD+K
Sbjct: 99 RNFYDFYLVMPFM-QTDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPG 155
Query: 245 NVFLSVRGIVKLGDLGFS 262
N+ ++ +K+ D G +
Sbjct: 156 NLAVNEDCELKILDFGLA 173
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 6e-11
Identities = 47/203 (23%), Positives = 81/203 (39%), Gaps = 56/203 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEI---YVPILCTYISYLAIK--ILDKAKLTPKARKMLSRE 119
Y LG G V A+ V AIK +L + + L RE
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRV----------AIKKIVLTDPQS---VKHAL-RE 58
Query: 120 IVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 179
I + + H NI++++E+ + G DD
Sbjct: 59 IKIIRRLDHDNIVKVFEI----------------------LGPSGSQLTDDVG------- 89
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL-QILSAVKHLHDRDIIH 238
L +++V EY +L N + G L E+ A+ F+ Q+L +K++H +++H
Sbjct: 90 ---SLTELNSVYIVQEYM-ETDLANVLEQ-GPLLEEHAR-LFMYQLLRGLKYIHSANVLH 143
Query: 239 RDIKAENVFL-SVRGIVKLGDLG 260
RD+K N+F+ + ++K+GD G
Sbjct: 144 RDLKPANLFINTEDLVLKIGDFG 166
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 8e-11
Identities = 47/196 (23%), Positives = 67/196 (34%), Gaps = 50/196 (25%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y+ +G G V A I +AIK L + K RE+V M+
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILE-------RNVAIKKLSRPFQNQTHAKRAYRELVLMK 79
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
V+H NII L V + L
Sbjct: 80 CVNHKNIIGLLNV----------------------------------------FTPQKSL 99
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
E F +++V+E L I E L + Q+L +KHLH IIHRD+K
Sbjct: 100 EEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 156
Query: 245 NVFLSVRGIVKLGDLG 260
N+ + +K+ D G
Sbjct: 157 NIVVKSDCTLKILDFG 172
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-10
Identities = 48/206 (23%), Positives = 84/206 (40%), Gaps = 67/206 (32%)
Query: 65 YKLQNELGRGNFSTVKMAIHEI---YVPILCTYISYLAIKILDKAKLTPKARKMLS---- 117
++L++ LG G + V A H+ V AIK K+ P + + +
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIV----------AIK-----KIEPFDKPLFALRTL 57
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
REI ++ H NII ++
Sbjct: 58 REIKILKHFKHENIITIFN----------------------------------------- 76
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL-QILSAVKHLHDRDI 236
I + E F +++++ E +L+ I+T+ LS+D + YF+ Q L AVK LH ++
Sbjct: 77 IQRPDSFENFNEVYIIQELM-QTDLHRVISTQ-MLSDDHIQ-YFIYQTLRAVKVLHGSNV 133
Query: 237 IHRDIKAENVFLSVRGIVKLGDLGFS 262
IHRD+K N+ ++ +K+ D G +
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLA 159
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-09
Identities = 36/204 (17%), Positives = 75/204 (36%), Gaps = 59/204 (28%)
Query: 65 YKLQNELGRGNFSTVKMAIH----EIYVPILCTYISYLAIK-ILDKAKLTPKARKMLSRE 119
++++ G+G F TV++ +AIK ++ + + R++ +
Sbjct: 25 FQVERMAGQGTFGTVQLGKEKSTGMS-----------VAIKKVIQDPRF--RNREL--QI 69
Query: 120 IVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 179
+ + +HHPNI++L F + ++Y + E D
Sbjct: 70 MQDLAVLHHPNIVQLQS-------YFYTLGERDRRDIYLNVVME--YVPDT--------- 111
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR--DII 237
L+ + + + K++ Q++ ++ LH ++
Sbjct: 112 LHRCCRNYYR------------------RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVC 153
Query: 238 HRDIKAENVFLSVR-GIVKLGDLG 260
HRDIK NV ++ G +KL D G
Sbjct: 154 HRDIKPHNVLVNEADGTLKLCDFG 177
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 45/202 (22%), Positives = 81/202 (40%), Gaps = 64/202 (31%)
Query: 65 YKLQNELGRGNFSTVKMAIHEI---YVPILCTYISYLAIK-ILDKAKLTPKARKMLSREI 120
Y+L +LG+G + V +I V A+K I D + + A++ REI
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVV----------AVKKIFDAFQNSTDAQRTF-REI 59
Query: 121 VSMESVH-HPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQIL 179
+ + + H NI+ L VL +++D +Y L
Sbjct: 60 MILTELSGHENIVNLLNVL---------------------------RADNDRDVY----L 88
Query: 180 LYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL-QILSAVKHLHDRDIIH 238
+++ +ET +L+ I L + Y + Q++ +K+LH ++H
Sbjct: 89 VFDYMET--------------DLHAVIRAN-ILEPVHKQ-YVVYQLIKVIKYLHSGGLLH 132
Query: 239 RDIKAENVFLSVRGIVKLGDLG 260
RD+K N+ L+ VK+ D G
Sbjct: 133 RDMKPSNILLNAECHVKVADFG 154
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 37/202 (18%), Positives = 72/202 (35%), Gaps = 37/202 (18%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
+K+ +G+G F IY+ + + S + K+ P L E+ +
Sbjct: 37 WKVGLPIGQGGFG-------CIYLADMNSSES-VGSDAPCVVKVEPSDNGPLFTELKFYQ 88
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
P I+ + + + + SG N F+ ++
Sbjct: 89 RAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKN-----------GKSYRFM------IM 131
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+ FG ++Y R S L+IL ++++H+ + +H DIKA
Sbjct: 132 DRFGS--------DLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKAS 181
Query: 245 NVFLSVR--GIVKLGDLGFSTK 264
N+ L+ + V L D G + +
Sbjct: 182 NLLLNYKNPDQVYLVDYGLAYR 203
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 39/209 (18%), Positives = 71/209 (33%), Gaps = 59/209 (28%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKIL-DKAKLTPKAR---KMLSREI 120
Y++ +G+G+F V A ++A+K++ ++ + +A ++L +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDH-------KVHQHVALKMVRNEKRFHRQAAEEIRILEH-L 150
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
+ + N+I + E I + E L + L
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFEL-------------------------LSMNL 185
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
YE++ K S + + IL + LH IIH D
Sbjct: 186 YELI--------------------KKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCD 225
Query: 241 IKAENVFL--SVRGIVKLGDLGFSTKLQQ 267
+K EN+ L R +K+ D G S Q
Sbjct: 226 LKPENILLKQQGRSGIKVIDFGSSCYEHQ 254
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-06
Identities = 13/45 (28%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 222 LQILSAVKHLHDRDIIHRDIKAENVFLSV--RGIVKLGDLGFSTK 264
++L A++ LH+ + +H ++ AEN+F+ + V L GF+ +
Sbjct: 166 CRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-06
Identities = 14/45 (31%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVR--GIVKLGDLGFSTK 264
+++L ++++H+ + +H DIKA N+ L + V L D G S +
Sbjct: 158 IRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 8e-06
Identities = 42/218 (19%), Positives = 75/218 (34%), Gaps = 71/218 (32%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKA--------RKML 116
Y L +LG G+FSTV +A +++A+KI+ K+ +A +++
Sbjct: 21 YILVRKLGWGHFSTVWLAKDM-------VNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 73
Query: 117 SREIVSMESVHHPNIIRLYEVLETFGK----IFLVVEYASGGELYNKITTEGRLSEDDAK 172
+ +S+ +I++L + G + +V E
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE----------------------- 110
Query: 173 IYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLH 232
L L ++ K + K Q+L + ++H
Sbjct: 111 --VLGENLLALI--------------------KKYEHRGIPLIYVKQISKQLLLGLDYMH 148
Query: 233 DR-DIIHRDIKAENVFLS------VRGIVKLGDLGFST 263
R IIH DIK ENV + +K+ DLG +
Sbjct: 149 RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 9e-06
Identities = 38/217 (17%), Positives = 65/217 (29%), Gaps = 42/217 (19%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKI--LDKAKLTPKARKMLSREIVS 122
+ ++G G F V I + + +AIKI ++ L + + EI+
Sbjct: 22 LQRCEKIGEGVFGEVFQTIADH---------TPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 123 -------------MESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 169
I L V G Y + S +
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGS------YPPLLLKAWDHYNSTKGSAN 126
Query: 170 DAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVK 229
D +F L+ +V+E+ GG ++ T+ S AK Q+ +++
Sbjct: 127 DRPDFFKDDQLF----------IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLA 175
Query: 230 HLHDR-DIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
HRD+ NV L + KL
Sbjct: 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSS 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-05
Identities = 14/48 (29%), Positives = 27/48 (56%), Gaps = 7/48 (14%)
Query: 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRG------IVKLGDLGFSTK 264
Q+L+ V+ +H++ +++RDIK +N FL R ++ + D G
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDN-FLIGRPNSKNANMIYVVDFGMVKF 160
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 7e-05
Identities = 13/45 (28%), Positives = 25/45 (55%), Gaps = 3/45 (6%)
Query: 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRG---IVKLGDLGFSTK 264
Q+++ V+ +H + +HRDIK +N + + V + D G + K
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 7e-05
Identities = 11/47 (23%), Positives = 28/47 (59%), Gaps = 5/47 (10%)
Query: 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRG-----IVKLGDLGFSTK 264
Q++S ++++H +++I+RD+K EN + G ++ + D + +
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 1e-04
Identities = 13/45 (28%), Positives = 28/45 (62%), Gaps = 3/45 (6%)
Query: 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRG---IVKLGDLGFSTK 264
Q++S ++++H ++ IHRD+K +N + + +V + D G + K
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 19/60 (31%), Positives = 32/60 (53%), Gaps = 4/60 (6%)
Query: 212 LSEDDAKIYFLQILSAVKHLHDRD--IIHRDIKAENVFL--SVRGIVKLGDLGFSTKLQQ 267
+S + + + Q+ +A+ L + IIH D+K EN+ L R +K+ D G S +L Q
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 2e-04
Identities = 17/42 (40%), Positives = 22/42 (52%), Gaps = 1/42 (2%)
Query: 210 GRLSEDDAKIYFLQILSAVKHLHDR-DIIHRDIKAENVFLSV 250
L K Q+L + +LH + IIH DIK EN+ LSV
Sbjct: 141 QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSV 182
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 39.2 bits (92), Expect = 8e-04
Identities = 9/26 (34%), Positives = 16/26 (61%)
Query: 223 QILSAVKHLHDRDIIHRDIKAENVFL 248
Q+ A++ LH+ + H D+K EN+
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILF 156
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 39.2 bits (92), Expect = 8e-04
Identities = 10/26 (38%), Positives = 16/26 (61%)
Query: 223 QILSAVKHLHDRDIIHRDIKAENVFL 248
+IL A+ +L + H D+K EN+ L
Sbjct: 145 EILKALNYLRKMSLTHTDLKPENILL 170
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 39.8 bits (92), Expect = 8e-04
Identities = 37/252 (14%), Positives = 83/252 (32%), Gaps = 81/252 (32%)
Query: 23 ILDKAKLTPKARKML--IYEKTQNQLQNDKK-------WQHETSLGKRVALYKLQNE--- 70
++ K + M+ +Y + +++L ND + + + L R AL +L+
Sbjct: 94 LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV 153
Query: 71 -----LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI--VSM 123
LG G K +++A+ + K+ + + +I +++
Sbjct: 154 LIDGVLGSG-----K---------------TWVALDVCLSYKV----QCKMDFKIFWLNL 189
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVE--YASGGELYNKITTEGRLSEDDAKIYFLQILLY 181
++ + P VLE K+ ++ + S + + I +L + ++L
Sbjct: 190 KNCNSPE-----TVLEMLQKLLYQIDPNWTSRSDHSSNI----KLRIHSIQAELRRLLKS 240
Query: 182 ----------------EVLETFG---KIFLVVEYAS-----GGELYNKITTEGR---LSE 214
+ F KI L + I+ + L+
Sbjct: 241 KPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 215 DDAKIYFLQILS 226
D+ K L+ L
Sbjct: 301 DEVKSLLLKYLD 312
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 267 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.98 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.98 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.98 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.98 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.98 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.98 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.98 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.98 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.98 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.98 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.98 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.98 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.98 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.98 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.98 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.98 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.97 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.97 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.97 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.97 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.97 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.97 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.97 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.97 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.97 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.97 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.97 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.97 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.97 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.97 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.97 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.97 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.97 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.97 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.97 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.97 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.97 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.97 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.97 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.97 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.97 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.97 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.97 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.97 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.97 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.97 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.97 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.97 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.97 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.97 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.97 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.97 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.97 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.97 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.97 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.97 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.97 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.97 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.96 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.96 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.96 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.96 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.96 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.96 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.96 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.96 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.96 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.96 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.96 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.96 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.96 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.96 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.96 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.96 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.96 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.96 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.96 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.96 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.96 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.96 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.96 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.96 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.96 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.96 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.96 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.96 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.96 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.96 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.96 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.96 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.96 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.96 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.96 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.96 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.96 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.96 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.96 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.96 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.96 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.96 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.96 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.96 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.96 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.96 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.96 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.96 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.96 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.96 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.96 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.96 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.96 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.96 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.95 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.95 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.95 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.95 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.95 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.95 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.95 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.95 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.95 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.95 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.91 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.85 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.54 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.45 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.34 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.95 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.78 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.72 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.6 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.39 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.39 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.36 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.29 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.88 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.81 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.77 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.68 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.63 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.62 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.59 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.56 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.39 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.15 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.13 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.04 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.01 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.22 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.22 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 95.0 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=297.50 Aligned_cols=154 Identities=32% Similarity=0.621 Sum_probs=134.5
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
+++|++++.||+|+||.||+|++. .+++.||||++.....+....+.+.+|+.+++.++|||||++++++.+.
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 95 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKST-------EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN 95 (350)
T ss_dssp CCCEEEEEEC------CEEEEEET-------TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccceEEeEEEecCCCeEEEEEEEC-------CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 467999999999999999999987 5569999999988877777788999999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+.+|+|||||+||+|.+++...+ ...+++..++.++
T Consensus 96 ~~~yiVmEy~~gg~L~~~i~~~~--------------------------------------------~~~~~e~~~~~~~ 131 (350)
T 4b9d_A 96 GSLYIVMDYCEGGDLFKRINAQK--------------------------------------------GVLFQEDQILDWF 131 (350)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTT--------------------------------------------TCCCCHHHHHHHH
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC--------------------------------------------CCCCCHHHHHHHH
Confidence 99999999999999988775431 2357899999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 132 ~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 132 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp HHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred HHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 999999999999999999999999999999999999999998764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=291.33 Aligned_cols=153 Identities=29% Similarity=0.495 Sum_probs=136.3
Q ss_pred cCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeee
Q psy2579 58 LGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 58 ~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~ 137 (267)
.++....|+++++||+|+||.||+|+++ .+++.||||+++..... ..+.+.+|+.+|+.++|||||+++++
T Consensus 69 ~~dp~~~y~~~~~iG~G~fG~V~~a~~~-------~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~ 139 (346)
T 4fih_A 69 PGDPRSYLDNFIKIGEGSTGIVCIATVR-------SSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNS 139 (346)
T ss_dssp SSCGGGTEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCChhHhcEEeEEeecCcCeEEEEEEEC-------CCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 3445567999999999999999999997 55699999999765433 23568899999999999999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
|.+.+.+|+|||||++|+|.+++.. +++++.++
T Consensus 140 ~~~~~~~~ivmEy~~gg~L~~~l~~-----------------------------------------------~~l~e~~~ 172 (346)
T 4fih_A 140 YLVGDELWVVMEFLEGGALTDIVTH-----------------------------------------------TRMNEEQI 172 (346)
T ss_dssp EEETTEEEEEECCCTTEEHHHHHHH-----------------------------------------------SCCCHHHH
T ss_pred EEECCEEEEEEeCCCCCcHHHHHHc-----------------------------------------------CCCCHHHH
Confidence 9999999999999999888776643 36899999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 173 ~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 173 AAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 221 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecC
Confidence 9999999999999999999999999999999999999999999998763
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=286.64 Aligned_cols=151 Identities=32% Similarity=0.501 Sum_probs=135.4
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
.++|++.+.||+|+||+||+|++. .+++.||||++++.... ....+.+.+|+.+++.++|||||+++++|.+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~-------~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 103 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLAREL-------ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 103 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccEEEEEEecccCeEEEEEEEC-------CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 456999999999999999999997 55699999999765432 2335678999999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+.+|+|||||+||+|.+++.. .+.+++.++..+
T Consensus 104 ~~~~yivmEy~~gG~L~~~i~~----------------------------------------------~~~l~e~~~~~~ 137 (311)
T 4aw0_A 104 DEKLYFGLSYAKNGELLKYIRK----------------------------------------------IGSFDETCTRFY 137 (311)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----------------------------------------------HSSCCHHHHHHH
T ss_pred CCEEEEEEecCCCCCHHHHHHH----------------------------------------------cCCCCHHHHHHH
Confidence 9999999999999888766643 347999999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 138 ~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~ 182 (311)
T 4aw0_A 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 182 (311)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence 999999999999999999999999999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=280.31 Aligned_cols=155 Identities=37% Similarity=0.655 Sum_probs=125.3
Q ss_pred cCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeee
Q psy2579 58 LGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYE 136 (267)
Q Consensus 58 ~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~ 136 (267)
.|..+++|++.+.||+|+||+||+|++. .+++.||||++++..... .....+.+|+.+++.++|||||++++
T Consensus 8 ~G~~ig~Y~i~~~lG~G~fg~V~~~~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~ 80 (275)
T 3hyh_A 8 DGAHIGNYQIVKTLGEGSFGKVKLAYHT-------TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80 (275)
T ss_dssp ------CCEEEEEEEC---CCEEEEECT-------TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCEeeCeEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEE
Confidence 3566788999999999999999999986 556999999998765433 33567999999999999999999999
Q ss_pred eeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 137 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 137 ~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
++.+.+..|+||||| +|+|.+.+. ..+++++.+
T Consensus 81 ~~~~~~~~~ivmEy~-~g~L~~~l~----------------------------------------------~~~~l~e~~ 113 (275)
T 3hyh_A 81 VIKSKDEIIMVIEYA-GNELFDYIV----------------------------------------------QRDKMSEQE 113 (275)
T ss_dssp EEECSSEEEEEEECC-CEEHHHHHH----------------------------------------------HSCSCCHHH
T ss_pred EEEECCEEEEEEeCC-CCCHHHHHH----------------------------------------------HcCCCCHHH
Confidence 999999999999998 566665553 445799999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 114 ~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 114 ARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred HHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 99999999999999999999999999999999999999999999998653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=292.59 Aligned_cols=154 Identities=29% Similarity=0.493 Sum_probs=137.2
Q ss_pred ccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeee
Q psy2579 57 SLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYE 136 (267)
Q Consensus 57 ~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~ 136 (267)
+.++....|+++++||+|+||.||+|+++ .+++.||||++...... ..+.+.+|+.+|+.++|||||++++
T Consensus 145 ~~~dp~~~y~~~~~iG~G~fG~V~~a~~~-------~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~ 215 (423)
T 4fie_A 145 DPGDPRSYLDNFIKIGEGSTGIVCIATVR-------SSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYN 215 (423)
T ss_dssp CSSCGGGTEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCChhHhcEeeeEeccCcCcEEEEEEEC-------CCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEE
Confidence 44555677999999999999999999997 55699999999765432 2456889999999999999999999
Q ss_pred eeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 137 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 137 ~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
+|.+.+.+|+|||||+||+|.+++.. +.+++.+
T Consensus 216 ~~~~~~~~~iVmEy~~gG~L~~~i~~-----------------------------------------------~~l~e~~ 248 (423)
T 4fie_A 216 SYLVGDELWVVMEFLEGGALTDIVTH-----------------------------------------------TRMNEEQ 248 (423)
T ss_dssp EEEETTEEEEEEECCTTEEHHHHHHH-----------------------------------------------SCCCHHH
T ss_pred EEEECCEEEEEEeCCCCCcHHHHHhc-----------------------------------------------cCCCHHH
Confidence 99999999999999999888776643 2689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 249 ~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 249 IAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 99999999999999999999999999999999999999999999998763
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=281.05 Aligned_cols=152 Identities=26% Similarity=0.437 Sum_probs=121.1
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
.+++|++++.||+|+||.||+|+++ .+++.||||+++... .....+.+.+|+.+|+.++|||||+++++|..
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 74 (299)
T 4g31_A 3 YLTDFEPIQCLGRGGFGVVFEAKNK-------VDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLE 74 (299)
T ss_dssp HHHHEEEEEEEEECC--EEEEEEET-------TTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred cchhCEEeeEEecCCCeEEEEEEEC-------CCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 3567999999999999999999987 456899999997654 44556789999999999999999999999987
Q ss_pred cCe------------EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcc
Q psy2579 141 FGK------------IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITT 208 (267)
Q Consensus 141 ~~~------------~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~ 208 (267)
.+. +|++||||.+|+|.+++. .
T Consensus 75 ~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~----------------------------------------------~ 108 (299)
T 4g31_A 75 KNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN----------------------------------------------G 108 (299)
T ss_dssp EC----------CEEEEEEEECCCSCCHHHHHH----------------------------------------------T
T ss_pred cCccccccccCCCcEEEEEEecCCCCcHHHHHH----------------------------------------------h
Confidence 654 455555555555555444 3
Q ss_pred cCC---CChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 209 EGR---LSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 209 ~~~---~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
... .++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.+.
T Consensus 109 ~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~ 169 (299)
T 4g31_A 109 RCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169 (299)
T ss_dssp CCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC----
T ss_pred cCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecC
Confidence 333 3456688999999999999999999999999999999999999999999998753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=280.42 Aligned_cols=166 Identities=26% Similarity=0.372 Sum_probs=135.6
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|.+.++||+|+||.||+|.+..... ..++..||||+++.. +....+.|.+|+.+|+.++|||||+++++|.+.+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~--~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCP--EQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC------CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCccc--CCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 569999999999999999998753211 134688999999754 4556678999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+|||||++|||.++++..+... .+...-.....+++.++..++.
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~---------------------------------~~~~~~~~~~~l~~~~~~~i~~ 135 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDA---------------------------------VLMAEGNPPTELTQSQMLHIAQ 135 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHH---------------------------------HHC----CCCCCCHHHHHHHHH
T ss_pred EEEEEEEcCCCCcHHHHHHhcCccc---------------------------------ccccccCCCCCCCHHHHHHHHH
Confidence 9999999999999999997642100 0000111234699999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 136 qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 178 (299)
T 4asz_A 136 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV 178 (299)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHH
T ss_pred HHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceec
Confidence 9999999999999999999999999999999999999999854
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=284.47 Aligned_cols=153 Identities=32% Similarity=0.544 Sum_probs=129.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++++.||+|+||+||+|++.... .+++.||||+++..........++.+|+.+++.++|||||++++++.+.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGS----DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSST----TTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred cccEEEEEEecCCCeEEEEEEEccCC----CCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 56999999999999999999885332 45689999999876554444456889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+|||||+||+|.+++.+ .+++++.++..++.
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~----------------------------------------------~~~l~e~~~~~~~~ 133 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSK----------------------------------------------EVMFTEEDVKFYLA 133 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHH----------------------------------------------HCCCCHHHHHHHHH
T ss_pred EEEEEEEcCCCCCHHHHHHh----------------------------------------------cCCCCHHHHHHHHH
Confidence 99999999999888776643 34799999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 134 qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 134 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp HHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred HHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999999999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=278.42 Aligned_cols=148 Identities=26% Similarity=0.431 Sum_probs=131.6
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.+++++.++||+|+||+||+|++. ..||||+++....+.+..+.|.+|+.+++.++|||||++++++..
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~----------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~- 103 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH----------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK- 103 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS----------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC----------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-
Confidence 356899999999999999999864 458999998777677778899999999999999999999998754
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+|||||++|+|.+++... ..++++.++..++
T Consensus 104 ~~~~iVmEy~~gGsL~~~l~~~---------------------------------------------~~~l~~~~~~~i~ 138 (307)
T 3omv_A 104 DNLAIVTQWCEGSSLYKHLHVQ---------------------------------------------ETKFQMFQLIDIA 138 (307)
T ss_dssp SSCEEEEECCSSCBHHHHHHTS---------------------------------------------CCCCCHHHHHHHH
T ss_pred CeEEEEEEcCCCCCHHHHHhhc---------------------------------------------CCCCCHHHHHHHH
Confidence 6689999999998888777542 2369999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||+++||||||||+|||++.++.+||+|||+|+.+
T Consensus 139 ~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 139 RQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp HHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred HHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 99999999999999999999999999999999999999999865
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=275.26 Aligned_cols=148 Identities=34% Similarity=0.517 Sum_probs=129.9
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee----
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET---- 140 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~---- 140 (267)
|++.++||+|+||.||+|.+. .++..||+|++.....+....+.+.+|+.+++.++|||||+++++|.+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 100 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDT-------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred EEeeeEEecCcCcEEEEEEEC-------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCC
Confidence 478889999999999999987 556899999998877777778889999999999999999999999875
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+.+|+|||||++|+|.+++. ..+++++..+..+
T Consensus 101 ~~~~~lvmEy~~gg~L~~~l~----------------------------------------------~~~~l~~~~~~~~ 134 (290)
T 3fpq_A 101 KKCIVLVTELMTSGTLKTYLK----------------------------------------------RFKVMKIKVLRSW 134 (290)
T ss_dssp EEEEEEEEECCCSCBHHHHHH----------------------------------------------HHSSCCHHHHHHH
T ss_pred CcEEEEEEeCCCCCCHHHHHH----------------------------------------------hcCCCCHHHHHHH
Confidence 345788888888877766654 3457899999999
Q ss_pred HHHHHHHHHHHHhCC--CcccCCCCCcEEeec-CCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRD--IIHRDIKAENVFLSV-RGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~--ivHrDlkp~NIll~~-~~~~kl~DFGla~~l 265 (267)
+.|++.||+|||++| |+||||||+|||++. +|.+||+|||+|+..
T Consensus 135 ~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 135 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp HHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred HHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999999999 999999999999974 789999999999854
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=278.65 Aligned_cols=169 Identities=24% Similarity=0.326 Sum_probs=134.7
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
..+|.+.++||+|+||.||+|.++.... ..++..||||+++.. +....+.|.+|+.+|+.++|||||+++++|.+.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~--~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLP--EQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEG 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC-----CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCccc--CCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3569999999999999999998753211 135688999999754 455678899999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+|||||++|+|.++++......... ........+++++.++..++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~-------------------------------~~~~~~~~~~l~~~~~~~i~ 164 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLL-------------------------------AGGEDVAPGPLGLGQLLAVA 164 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC------------------------------------------CCSCCHHHHHHHH
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccc-------------------------------cccccccCCCCCHHHHHHHH
Confidence 99999999999999999998654311000 00011134579999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||+++||||||||+|||++.++.+||+|||+|+.+
T Consensus 165 ~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~ 208 (329)
T 4aoj_A 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI 208 (329)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred HHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceec
Confidence 99999999999999999999999999999999999999999865
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=276.14 Aligned_cols=171 Identities=22% Similarity=0.306 Sum_probs=137.1
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.+.+++.++||+|+||.||+|.+..... ..+++.||||+++... .....+.|.+|+.+++.++|||||++++++.+.
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~--~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAP--GEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC---------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCcc--CCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 4568999999999999999998753211 1346889999997543 334457899999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+|||||++|||.+++........ .+...+.......+++.++..++
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~------------------------------~~~~~~~~~~~~~l~~~~~~~i~ 151 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSD------------------------------VGSTDDDRTVKSALEPPDFVHLV 151 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCC------------------------------CC-----CCEECCCCHHHHHHHH
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCcccc------------------------------ccccccccccccCCCHHHHHHHH
Confidence 999999999999999999976533111 01111112234579999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||+++||||||||+|||++.++.+||+|||+|+.+
T Consensus 152 ~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~ 195 (308)
T 4gt4_A 152 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV 195 (308)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGG
T ss_pred HHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceec
Confidence 99999999999999999999999999999999999999999865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=277.63 Aligned_cols=145 Identities=32% Similarity=0.421 Sum_probs=129.2
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
...|++.++||+|+||.||+|+++ .+++.||||+++..... .+|+.+++.++|||||++++++.+.
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~-------~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~ 122 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDK-------QTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREG 122 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEET
T ss_pred hhheEeCcEeccCCCeEEEEEEEC-------CCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 456999999999999999999997 55699999999765432 4699999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+.+|+|||||+||+|.+++.. .+++++..+..++
T Consensus 123 ~~~~ivmEy~~gg~L~~~l~~----------------------------------------------~~~l~e~~~~~~~ 156 (336)
T 4g3f_A 123 PWVNIFMELLEGGSLGQLIKQ----------------------------------------------MGCLPEDRALYYL 156 (336)
T ss_dssp TEEEEEECCCTTCBHHHHHHH----------------------------------------------HSSCCHHHHHHHH
T ss_pred CEEEEEEeccCCCcHHHHHHH----------------------------------------------cCCCCHHHHHHHH
Confidence 999999999999888776643 3479999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCC-ceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRG-IVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~l~ 266 (267)
.|++.||+|||++|||||||||+|||++.+| .+||+|||+|+.+.
T Consensus 157 ~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 157 GQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp HHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred HHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 9999999999999999999999999999988 69999999998653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=275.45 Aligned_cols=149 Identities=24% Similarity=0.426 Sum_probs=129.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec-
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF- 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~- 141 (267)
++|++++.||+|+||.||+|+++ .+++.||||+++...........+.+|+.+|+.++|||||++++++...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~-------~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 126 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRR-------LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV 126 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred CCeEEEEEEecccCeEEEEEEEC-------CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence 45999999999999999999997 5569999999987766666678899999999999999999999987643
Q ss_pred -----CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 142 -----GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 142 -----~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
+.+|+|||||+ |+|. +.+...+++++.+
T Consensus 127 ~~~~~~~~~ivmE~~~-g~L~----------------------------------------------~~i~~~~~l~~~~ 159 (398)
T 4b99_A 127 PYGEFKSVYVVLDLME-SDLH----------------------------------------------QIIHSSQPLTLEH 159 (398)
T ss_dssp CTTTCCCEEEEEECCS-EEHH----------------------------------------------HHHTSSSCCCHHH
T ss_pred ccccCCEEEEEEeCCC-CCHH----------------------------------------------HHHHhcCCCCHHH
Confidence 45777777774 3444 4444556899999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+
T Consensus 160 ~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 160 VRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred HHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 9999999999999999999999999999999999999999999999865
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=268.89 Aligned_cols=172 Identities=23% Similarity=0.313 Sum_probs=137.0
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCC-Cceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHH-PNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~~~~~~~~ 140 (267)
.++|++.+.||+|+||.||+|.+...... .+++.||||++.... .....+.+.+|+.+|+.+.| ||||+++++|..
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~--~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKT--ATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSST--TCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcc--cCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 35699999999999999999998743311 335789999997654 34456779999999999955 999999999876
Q ss_pred c-CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 141 F-GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 141 ~-~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
. +.+|+|||||++|+|.++++........ ......-.....+++.++..
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~------------------------------~~~~~~~~~~~~l~~~~~~~ 189 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVP------------------------------YKVAPEDLYKDFLTLEHLIC 189 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCC------------------------------C-------CTTCBCHHHHHH
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhccccccc------------------------------ccccchhhccccCCHHHHHH
Confidence 5 5789999999999999999764221000 00000001234689999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
++.|++.||+|||+++||||||||+|||++.++.+||+|||+|+.+.
T Consensus 190 ~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~ 236 (353)
T 4ase_A 190 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 236 (353)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred HHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcc
Confidence 99999999999999999999999999999999999999999998753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=260.56 Aligned_cols=143 Identities=24% Similarity=0.387 Sum_probs=122.0
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC-
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG- 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~- 142 (267)
+|.+.++||+|+||+||+|.+. ++.||||+++... ........|+..+..++|||||++++++...+
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~---------g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~ 71 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWR---------GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNG 71 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEET---------TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred EEEEEEEEeeCCCeEEEEEEEC---------CEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC
Confidence 4899999999999999999863 4789999996542 22223446777778899999999999998764
Q ss_pred ---eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 143 ---KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 143 ---~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
.+|+|||||++|+|.++++.. ++++..+..
T Consensus 72 ~~~~~~lV~Ey~~~gsL~~~l~~~-----------------------------------------------~l~~~~~~~ 104 (303)
T 3hmm_A 72 TWTQLWLVSDYHEHGSLFDYLNRY-----------------------------------------------TVTVEGMIK 104 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHC-----------------------------------------------CBCHHHHHH
T ss_pred CceEEEEEecCCCCCcHHHHHHhC-----------------------------------------------CCCHHHHHH
Confidence 578999999998888777532 688999999
Q ss_pred HHHHHHHHHHHHHhC--------CCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDR--------DIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~--------~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 105 i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp HHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 999999999999987 9999999999999999999999999999764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=262.52 Aligned_cols=146 Identities=21% Similarity=0.391 Sum_probs=128.1
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~ 141 (267)
+.|++.++||+|+||+||+|+++... .+++.||||.+..... ..++.+|+.+++.+ +|||||+++++|.+.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~----~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQV----GPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTT----SCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CcEEEEEEEecccCcEEEEEEEcccC----CCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 45999999999999999999986432 3468999999865432 24578999999998 799999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+|||||++|+|.+++. .+++.+++.++
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~-------------------------------------------------~l~~~~~~~~~ 123 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN-------------------------------------------------SLSFQEVREYM 123 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT-------------------------------------------------TCCHHHHHHHH
T ss_pred CEEEEEEeCCCcccHHHHHc-------------------------------------------------CCCHHHHHHHH
Confidence 99999999999988876552 58899999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecC-CceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVR-GIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DFGla~~l 265 (267)
.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 124 ~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 124 LNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 999999999999999999999999999877 79999999999754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=275.27 Aligned_cols=157 Identities=23% Similarity=0.403 Sum_probs=133.2
Q ss_pred ccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch----HHHHHHHHHHHHHhhcCCCcee
Q psy2579 57 SLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP----KARKMLSREIVSMESVHHPNII 132 (267)
Q Consensus 57 ~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv 132 (267)
+....+++|++++.||+|+||.||+|++. .+++.||||++++..... .......+++.+++.++|||||
T Consensus 183 ~~~~slddf~i~k~LG~G~fG~V~la~~~-------~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV 255 (689)
T 3v5w_A 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKA-------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255 (689)
T ss_dssp TCCCCGGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBC
T ss_pred CCCCchHHeEEEEEEecccCeEEEEEEEC-------CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEe
Confidence 33455788999999999999999999997 566999999997654321 1122233446777788999999
Q ss_pred eeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCC
Q psy2579 133 RLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRL 212 (267)
Q Consensus 133 ~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~ 212 (267)
+++++|.+.+.+|+|||||.||+|.+++.. .+.+
T Consensus 256 ~l~~~f~~~~~lylVmEy~~GGdL~~~l~~----------------------------------------------~~~l 289 (689)
T 3v5w_A 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----------------------------------------------HGVF 289 (689)
T ss_dssp CEEEEEECSSEEEEEECCCCSCBHHHHHHH----------------------------------------------HCCC
T ss_pred EEEEEEEECCEEEEEEecCCCCcHHHHHHh----------------------------------------------cCCC
Confidence 999999999999999999999888766643 3479
Q ss_pred ChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 213 SEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 213 ~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 290 ~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 290 SEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999999999999999999999999999999999999999999998764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=272.34 Aligned_cols=153 Identities=27% Similarity=0.556 Sum_probs=135.2
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
..+++|++.+.||+|+||.||+|+++ .+++.||+|++.... ....+.+.+|+.+|+.++|||||+++++|.
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~-------~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 224 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTER-------ATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEEC-------CCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34578999999999999999999997 556899999997653 344577899999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
+.+.+|+|||||.||+|.+++... .+.+++.++..
T Consensus 225 ~~~~~~iv~E~~~gg~L~~~i~~~---------------------------------------------~~~l~e~~~~~ 259 (573)
T 3uto_A 225 DDNEMVMIYEFMSGGELFEKVADE---------------------------------------------HNKMSEDEAVE 259 (573)
T ss_dssp CSSEEEEEEECCCCCBHHHHHTCT---------------------------------------------TSCEEHHHHHH
T ss_pred ECCEEEEEEeecCCCcHHHHHHHh---------------------------------------------CCCCCHHHHHH
Confidence 999999999999998887766432 23689999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecC--CceEEeccccccccC
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVR--GIVKLGDLGFSTKLQ 266 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~--~~~kl~DFGla~~l~ 266 (267)
++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 260 ~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 260 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred HHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 99999999999999999999999999999854 899999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=244.93 Aligned_cols=154 Identities=42% Similarity=0.725 Sum_probs=138.9
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
...+++|++.+.||+|+||.||+|.+. .+++.||||++.....+......+.+|+.+++.++||||+++++++
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 83 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHI-------LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 445778999999999999999999986 4568999999988776777778899999999999999999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
...+..|+||||+.+|+|.+++. ..+++++..+.
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~----------------------------------------------~~~~l~~~~~~ 117 (328)
T 3fe3_A 84 ETEKTLYLIMEYASGGEVFDYLV----------------------------------------------AHGRMKEKEAR 117 (328)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHH----------------------------------------------HHCCCCHHHHH
T ss_pred EECCEEEEEEECCCCCcHHHHHH----------------------------------------------HcCCCCHHHHH
Confidence 99999999999999877766654 33468999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 118 ~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 118 SKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred HHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 99999999999999999999999999999999999999999999754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=234.40 Aligned_cols=155 Identities=28% Similarity=0.479 Sum_probs=136.7
Q ss_pred ccccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeee
Q psy2579 55 ETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRL 134 (267)
Q Consensus 55 ~~~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~ 134 (267)
....+...++|++.+.||+|+||.||+|.+. .+++.||||++....... .+.+.+|+.+++.++||||+++
T Consensus 12 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~ 82 (297)
T 3fxz_A 12 IVSVGDPKKKYTRFEKIGQGASGTVYTAMDV-------ATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNY 82 (297)
T ss_dssp HSBSSCGGGTBCCCEEEEEETTEEEEEEEBT-------TTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccCcCChhhceeeeeeeccCCCeEEEEEEEC-------CCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeE
Confidence 3455666778999999999999999999986 456899999997654332 3568899999999999999999
Q ss_pred eeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCCh
Q psy2579 135 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214 (267)
Q Consensus 135 ~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~ 214 (267)
++++...+..|+|||||.+|+|.+++... .+++
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------------------------------------------~~~~ 115 (297)
T 3fxz_A 83 LDSYLVGDELWVVMEYLAGGSLTDVVTET-----------------------------------------------CMDE 115 (297)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHHHS-----------------------------------------------CCCH
T ss_pred eEEEEECCEEEEEEECCCCCCHHHHHhhc-----------------------------------------------CCCH
Confidence 99999999999999999998887766432 5889
Q ss_pred hHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+|+.+
T Consensus 116 ~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 116 GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (297)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence 999999999999999999999999999999999999999999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-32 Score=239.31 Aligned_cols=160 Identities=21% Similarity=0.307 Sum_probs=141.3
Q ss_pred hccccCceecceEEecccCcc--CceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCce
Q psy2579 54 HETSLGKRVALYKLQNELGRG--NFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNI 131 (267)
Q Consensus 54 ~~~~~~~~~~~y~~~~~iG~G--~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI 131 (267)
..++.....++|++.+.||+| +||.||+|.+. .+++.||||++............+.+|+.+++.++||||
T Consensus 16 ~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 88 (389)
T 3gni_B 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYK-------PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI 88 (389)
T ss_dssp --CCCCCCGGGEEEEEEEEEETTTTEEEEEEEET-------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred hhhcccCCCCcEEEEecccCCcCCceEEEEEEEc-------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCC
Confidence 344555567789999999999 99999999986 456899999998877667777889999999999999999
Q ss_pred eeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCC
Q psy2579 132 IRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGR 211 (267)
Q Consensus 132 v~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~ 211 (267)
+++++++...+..|+|||||.+|+|.+++.... ...
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------------~~~ 124 (389)
T 3gni_B 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHF--------------------------------------------MDG 124 (389)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHHTC--------------------------------------------TTC
T ss_pred CcEeEEEEECCEEEEEEEccCCCCHHHHHhhhc--------------------------------------------ccC
Confidence 999999999999999999999988887775431 236
Q ss_pred CChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 212 LSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 212 ~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 125 ~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 125 MNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 89999999999999999999999999999999999999999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-32 Score=234.66 Aligned_cols=155 Identities=25% Similarity=0.325 Sum_probs=135.9
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++.+.||+|+||.||+|.+..++ ..+..||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPG----QRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTT----SCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCC----CCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 3467999999999999999999987443 334679999997543 44566789999999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+||||+++|+|.+++... ...+++..+..+
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~i 156 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTH---------------------------------------------DGQFTIMQLVGM 156 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTT---------------------------------------------TTCSCHHHHHHH
T ss_pred CCccEEEeeCCCCCcHHHHHHhc---------------------------------------------ccCCCHHHHHHH
Confidence 99999999999998887776532 236899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 157 ~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred HHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999999999999999999999999999999999865
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-32 Score=230.94 Aligned_cols=150 Identities=26% Similarity=0.455 Sum_probs=132.1
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+. .+++.||+|++............+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 74 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNR-------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCceeeeEecCCCCeEEEEEEEC-------CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC
Confidence 57999999999999999999986 45689999999877666666678899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..++||||+.+ ++.+.+. ...+.+++..+..++.
T Consensus 75 ~~~lv~e~~~~-~l~~~~~---------------------------------------------~~~~~l~~~~~~~~~~ 108 (292)
T 3o0g_A 75 KLTLVFEFCDQ-DLKKYFD---------------------------------------------SCNGDLDPEIVKSFLF 108 (292)
T ss_dssp EEEEEEECCSE-EHHHHHH---------------------------------------------HTTTCCCHHHHHHHHH
T ss_pred EEEEEEecCCC-CHHHHHH---------------------------------------------hCCCCCCHHHHHHHHH
Confidence 99999999986 3332222 1234799999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++||+||||||+||+++.++.+||+|||+|+.+
T Consensus 109 ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 109 QLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF 151 (292)
T ss_dssp HHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred HHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999999999999999999999999999999764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-32 Score=237.76 Aligned_cols=164 Identities=29% Similarity=0.546 Sum_probs=140.3
Q ss_pred hhhhhccccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCC
Q psy2579 50 KKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHH 128 (267)
Q Consensus 50 ~~~~~~~~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h 128 (267)
..|.........+++|++++.||+|+||.||+|.+. .+++.||+|++...... ......+.+|+.+++.++|
T Consensus 28 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h 100 (350)
T 1rdq_E 28 KKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK-------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100 (350)
T ss_dssp HHHHSCCCCCCCGGGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC
T ss_pred hhhccccccCCCHHHCEEEEEeecCcCcEEEEEEEC-------CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCC
Confidence 344444455556788999999999999999999986 45689999999765422 2334678899999999999
Q ss_pred CceeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcc
Q psy2579 129 PNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITT 208 (267)
Q Consensus 129 pnIv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~ 208 (267)
|||+++++++.+.+..|+||||+.+|+|.+++..
T Consensus 101 p~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~---------------------------------------------- 134 (350)
T 1rdq_E 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------------------------------------------- 134 (350)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----------------------------------------------
T ss_pred CCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHH----------------------------------------------
Confidence 9999999999999999999999998888766643
Q ss_pred cCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 209 EGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 209 ~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.+.+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.+.
T Consensus 135 ~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 135 IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc
Confidence 3468999999999999999999999999999999999999999999999999998653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-32 Score=230.74 Aligned_cols=150 Identities=22% Similarity=0.362 Sum_probs=134.8
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .++..||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~-------~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 79 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHR-------ETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD 79 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-------TTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred hhHeeccceecCCCCEEEEEEEEC-------CCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC
Confidence 467999999999999999999986 45689999988543 456678899999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..++||||+.+|+|.+++... ...+++..+..++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~i~ 114 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSM---------------------------------------------DSQYPWSQRVSFA 114 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHC---------------------------------------------CTTSCHHHHHHHH
T ss_pred CeeEEEEEecCCCcHHHHHHhc---------------------------------------------cCCCCHHHHHHHH
Confidence 9999999999998888777542 2368999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 115 ~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 115 KDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLM 158 (310)
T ss_dssp HHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceec
Confidence 99999999999999999999999999999999999999999764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-32 Score=234.53 Aligned_cols=197 Identities=20% Similarity=0.283 Sum_probs=131.2
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|++. .+++.||||++.... .....+.+.+|+.+++.++||||++++++|...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 76 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNK-------VDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLET 76 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEET-------TTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEEC
T ss_pred hhcCceeeEecCCCCeEEEEEEEc-------CCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEe
Confidence 467999999999999999999986 456899999997654 344567899999999999999999999998765
Q ss_pred Ce---------EEEEEeecCCCchhhhhhccCCCChhhHH-HH-HHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccC
Q psy2579 142 GK---------IFLVVEYASGGELYNKITTEGRLSEDDAK-IY-FLQILLYEVLETFGKIFLVVEYASGGELYNKITTEG 210 (267)
Q Consensus 142 ~~---------~~iv~e~~~~gsl~~~l~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~ 210 (267)
+. .++..+....................... .. ................+++||++++++|.+.+....
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 156 (332)
T 3qd2_B 77 PPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC 156 (332)
T ss_dssp CSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC
T ss_pred ccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc
Confidence 42 22222211100000000000000000000 00 000001111223345788888888888888877654
Q ss_pred C---CChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 211 R---LSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 211 ~---~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
. .++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+|+.+.
T Consensus 157 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 215 (332)
T 3qd2_B 157 SLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 215 (332)
T ss_dssp SGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECS
T ss_pred CccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccc
Confidence 4 4455689999999999999999999999999999999999999999999998653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-32 Score=237.46 Aligned_cols=152 Identities=30% Similarity=0.505 Sum_probs=131.7
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhc-CCCceeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESV-HHPNIIRLYEV 137 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~ 137 (267)
..+++|++++.||+|+||.||+|++. .+++.||||++..... .......+.+|..+++.+ +||||++++++
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 92 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVK-------ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCC 92 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEc-------CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEE
Confidence 34577999999999999999999986 4568999999976532 223346688999999988 79999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
+.+.+..|+|||||.+|+|..++.. .+.+++..+
T Consensus 93 ~~~~~~~~lv~E~~~gg~L~~~l~~----------------------------------------------~~~~~~~~~ 126 (353)
T 3txo_A 93 FQTPDRLFFVMEFVNGGDLMFHIQK----------------------------------------------SRRFDEARA 126 (353)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHH----------------------------------------------HSSCCHHHH
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHH----------------------------------------------cCCCCHHHH
Confidence 9999999999999999888766543 346899999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 127 ~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 127 RFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred HHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999999999999999999999999999999999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-32 Score=235.97 Aligned_cols=150 Identities=31% Similarity=0.524 Sum_probs=132.2
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
.++|++++.||+|+||.||+|++. .+++.||+|++..... .......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 76 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREK-------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence 467999999999999999999986 4568999999976432 12234668899999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+||||+.+|+|..++.. .+.+++..+..+
T Consensus 77 ~~~~~lv~E~~~gg~L~~~l~~----------------------------------------------~~~~~~~~~~~~ 110 (337)
T 1o6l_A 77 HDRLCFVMEYANGGELFFHLSR----------------------------------------------ERVFTEERARFY 110 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----------------------------------------------HSCCCHHHHHHH
T ss_pred CCEEEEEEeCCCCCcHHHHHHh----------------------------------------------cCCCCHHHHHHH
Confidence 9999999999999888665543 346899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
+.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 111 ~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 154 (337)
T 1o6l_A 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred HHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhh
Confidence 99999999999999999999999999999999999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=244.51 Aligned_cols=155 Identities=26% Similarity=0.481 Sum_probs=133.9
Q ss_pred cCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeee
Q psy2579 58 LGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYE 136 (267)
Q Consensus 58 ~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~ 136 (267)
.....++|++.+.||+|+||.||+|++. .+++.||+|++...... ......+.+|+.+++.++||||+++++
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~-------~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 136 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHK-------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEEC-------CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3445677999999999999999999986 45689999999753321 112245789999999999999999999
Q ss_pred eeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 137 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 137 ~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
++.+.+..|+|||||.+|+|.+++.. ..+++..
T Consensus 137 ~~~~~~~~~lV~E~~~gg~L~~~l~~-----------------------------------------------~~~~e~~ 169 (410)
T 3v8s_A 137 AFQDDRYLYMVMEYMPGGDLVNLMSN-----------------------------------------------YDVPEKW 169 (410)
T ss_dssp EEECSSEEEEEECCCTTEEHHHHHHH-----------------------------------------------CCCCHHH
T ss_pred EEEECCEEEEEEeCCCCCcHHHHHHc-----------------------------------------------CCCCHHH
Confidence 99999999999999999888776643 2588999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.+.
T Consensus 170 ~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 170 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 99999999999999999999999999999999999999999999997653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.98 E-value=8.8e-32 Score=236.50 Aligned_cols=174 Identities=25% Similarity=0.310 Sum_probs=140.8
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~ 139 (267)
..++|++.+.||+|+||.||+|.+.........++..||||+++... .......+.+|+.+++.+ +||||+++++++.
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 45679999999999999999999864322222455789999997653 445567899999999999 8999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+..|+||||+.+|+|.+++.......... ...........+++.++..
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~ 207 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEY------------------------------SYDINRVPEEQMTFKDLVS 207 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------------------------------------CCCCCCHHHHHH
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccc------------------------------cccccccccccCCHHHHHH
Confidence 9999999999999999999988654311000 0000001234689999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 208 i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 253 (370)
T 2psq_A 208 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 253 (370)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred HHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCccc
Confidence 9999999999999999999999999999999999999999999865
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.7e-32 Score=244.45 Aligned_cols=150 Identities=23% Similarity=0.369 Sum_probs=121.5
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|++. .+++.||||++...........++.+|+.+++.++||||+++++++...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 124 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDK-------LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPK 124 (458)
T ss_dssp CTTEEECCC-------CEEEEEEC-------C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred CCCeEEeeEeeecCCeEEEEEEEC-------CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence 356999999999999999999987 4568999999977655666678899999999999999999999998443
Q ss_pred -----CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 142 -----GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 142 -----~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
+..|+|||++. |+| .+.+.....+++..
T Consensus 125 ~~~~~~~~~lv~e~~~-~~L----------------------------------------------~~~~~~~~~l~~~~ 157 (458)
T 3rp9_A 125 DVEKFDELYVVLEIAD-SDF----------------------------------------------KKLFRTPVYLTELH 157 (458)
T ss_dssp CTTTCCCEEEEECCCS-EEH----------------------------------------------HHHHHSSCCCCHHH
T ss_pred CcccCceEEEEEeccc-cch----------------------------------------------hhhcccCCCCCHHH
Confidence 46788888764 344 44444555799999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 158 ~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 158 IKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred HHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 9999999999999999999999999999999999999999999999865
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-31 Score=228.78 Aligned_cols=150 Identities=33% Similarity=0.470 Sum_probs=133.5
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||.||+|.+. .++..||+|++..... .......+.+|+.+++.++||||+++++++...
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 83 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDT-------ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED 83 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET-------TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS
T ss_pred ccEEEEEEEccCCCEEEEEEEEC-------CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC
Confidence 56999999999999999999986 4568999999865443 345567899999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+||||+.+++|.+++.. .+++++..+..++
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~----------------------------------------------~~~~~~~~~~~~~ 117 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIES----------------------------------------------HGPLSVDTAINFT 117 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----------------------------------------------HCSCCHHHHHHHH
T ss_pred CeEEEEEeCCCCCCHHHHHHh----------------------------------------------cCCCCHHHHHHHH
Confidence 999999999998887766543 3468999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 118 ~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 118 NQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp HHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred HHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 99999999999999999999999999999999999999999765
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.1e-32 Score=230.24 Aligned_cols=152 Identities=34% Similarity=0.629 Sum_probs=126.6
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch------------------------HHHHHH
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP------------------------KARKML 116 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~------------------------~~~~~~ 116 (267)
.+++|++.+.||+|+||.||+|.+. .+++.||||++....... ...+.+
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNE-------NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV 83 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEET-------TTTEEEEEEEEECC-------------------------------CHH
T ss_pred eecceEEEeEEeecCCEEEEEEEEC-------CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHH
Confidence 4578999999999999999999986 456899999997654221 123568
Q ss_pred HHHHHHHhhcCCCceeeeeeeeee--cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEE
Q psy2579 117 SREIVSMESVHHPNIIRLYEVLET--FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVV 194 (267)
Q Consensus 117 ~~Ei~~l~~l~hpnIv~~~~~~~~--~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~ 194 (267)
.+|+.+++.++||||+++++++.. .+..|+||||+.+++|.+.+
T Consensus 84 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---------------------------------- 129 (298)
T 2zv2_A 84 YQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---------------------------------- 129 (298)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----------------------------------
T ss_pred HHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----------------------------------
Confidence 899999999999999999999986 56789999999887775432
Q ss_pred EEccCCchhhhhcccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 195 EYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 195 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
...++++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+|+.+.
T Consensus 130 -------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 188 (298)
T 2zv2_A 130 -------------TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188 (298)
T ss_dssp -------------CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECS
T ss_pred -------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCccccc
Confidence 22368999999999999999999999999999999999999999999999999997653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-31 Score=235.13 Aligned_cols=152 Identities=34% Similarity=0.563 Sum_probs=134.7
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .++..||+|++..........+.+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 100 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHK-------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE 100 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ccCeEEeeEEecCCCeEEEEEEEC-------CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 356999999999999999999986 4568999999987776666778899999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+|||||.+|+|.+.+. ....+++..+..++
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~----------------------------------------------~~~~~~~~~~~~~~ 134 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIV----------------------------------------------AREFYSEADASHCI 134 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHT----------------------------------------------TCSCCCHHHHHHHH
T ss_pred CEEEEEEecCCCCCHHHHHH----------------------------------------------HcCCCCHHHHHHHH
Confidence 99999999999877766553 33468999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCC---ceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRG---IVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~---~~kl~DFGla~~l~ 266 (267)
.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 135 ~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 135 QQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp HHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred HHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999999999999999999997654 59999999998653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-31 Score=230.49 Aligned_cols=155 Identities=26% Similarity=0.420 Sum_probs=133.2
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
....++|++.+.||+|+||.||+|.+. +..||||++............+.+|+.+++.++||||+++++++
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 103 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEWH---------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET---------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEEC---------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 334567999999999999999999763 47899999988776777778899999999999999999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
...+..++||||+.+|+|.+++..... ...+++..+.
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------~~~~~~~~~~ 140 (309)
T 3p86_A 104 TQPPNLSIVTEYLSRGSLYRLLHKSGA-------------------------------------------REQLDERRRL 140 (309)
T ss_dssp CSTTCCEEEEECCTTCBHHHHHHSTTH-------------------------------------------HHHSCHHHHH
T ss_pred EECCceEEEEecCCCCcHHHHHhhcCC-------------------------------------------CCCCCHHHHH
Confidence 999999999999999998887764310 1138899999
Q ss_pred HHHHHHHHHHHHHHhCC--CcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRD--IIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||+|||++| ++||||||+||+++.++.+||+|||+|+..
T Consensus 141 ~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 141 SMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp HHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred HHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999999999 999999999999999999999999998743
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-32 Score=244.12 Aligned_cols=154 Identities=25% Similarity=0.440 Sum_probs=133.7
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
...++|++.+.||+|+||.||+|++. .+++.||+|++....... .....+.+|+.++..++||||++++++|
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLK-------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEc-------CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34567999999999999999999986 456899999997543211 1223488999999999999999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
.+.+..|+|||||.+|+|.+++... .+.+++..+.
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~---------------------------------------------~~~l~e~~~~ 178 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKF---------------------------------------------EDRLPEEMAR 178 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTT---------------------------------------------TTCCCHHHHH
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHc---------------------------------------------cCCCCHHHHH
Confidence 9999999999999998888777542 2368999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 179 ~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 179 FYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 99999999999999999999999999999999999999999999765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-31 Score=230.18 Aligned_cols=149 Identities=25% Similarity=0.460 Sum_probs=131.9
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .++..||+|++... ......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVET-------SSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhceEeeeEEecCCCeEEEEEEEC-------CCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 356999999999999999999986 45689999998754 23456688999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..++|||||.+|+|.+++... ...+++..+..++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~---------------------------------------------~~~~~~~~~~~i~ 108 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTS---------------------------------------------AFELNEREIVSYV 108 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSS---------------------------------------------SCCCCHHHHHHHH
T ss_pred CEEEEEEEeCCCCCHHHHHHhc---------------------------------------------CCCCCHHHHHHHH
Confidence 9999999999998887766432 2368999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeec--CCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSV--RGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~--~~~~kl~DFGla~~l 265 (267)
.|++.||.|||++|++||||||+|||++. ++.+||+|||+|+.+
T Consensus 109 ~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 109 HQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp HHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 99999999999999999999999999987 789999999999865
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-31 Score=241.29 Aligned_cols=152 Identities=34% Similarity=0.556 Sum_probs=133.6
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .+++.||+|++............+.+|+.+++.++||||+++++++.+.
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~-------~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 82 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKV-------LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE 82 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEET-------TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS
T ss_pred cCCeEEEEEeccCCCeEEEEEEEC-------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC
Confidence 356999999999999999999986 4568999999988776666778899999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+|||||.+|+|.+.+. ..+.+++..+..++
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~----------------------------------------------~~~~~~e~~~~~i~ 116 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIV----------------------------------------------AREYYSEADASHCI 116 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHH----------------------------------------------HCSCCCHHHHHHHH
T ss_pred CEEEEEEEeCCCCCHHHHHH----------------------------------------------HcCCCCHHHHHHHH
Confidence 99999999999877766554 33468999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEee---cCCceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLS---VRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~---~~~~~kl~DFGla~~l~ 266 (267)
.|++.||.|||++||+||||||+|||++ .++.+||+|||+|+.+.
T Consensus 117 ~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 117 QQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp HHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred HHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999999999999999999999998 45789999999997653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-31 Score=230.29 Aligned_cols=151 Identities=27% Similarity=0.473 Sum_probs=128.3
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++++.||+|+||.||+|.+. +++.||+|++............+.+|+.+++.++||||+++++++.+
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 90 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS--------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET--------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC--------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc
Confidence 3467999999999999999999873 36899999997665455556778999999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..++||||+++ +|.+.+... ...+++..+..+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~~~~~---------------------------------------------~~~~~~~~~~~~ 124 (311)
T 3niz_A 91 ERCLTLVFEFMEK-DLKKVLDEN---------------------------------------------KTGLQDSQIKIY 124 (311)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTC---------------------------------------------TTCCCHHHHHHH
T ss_pred CCEEEEEEcCCCC-CHHHHHHhc---------------------------------------------cCCCCHHHHHHH
Confidence 9999999999985 555544322 235899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 125 ~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred HHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceec
Confidence 999999999999999999999999999999999999999999764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=5.4e-32 Score=233.21 Aligned_cols=153 Identities=30% Similarity=0.550 Sum_probs=133.6
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
.+++|++.+.||+|+||.||+|++. .+++.||+|++...... ....+.+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 76 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSR-------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 76 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE
Confidence 3567999999999999999999986 45689999999765322 123466889999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
+.+..|+||||+.+|+|.+++.. ...+++..+..
T Consensus 77 ~~~~~~lv~e~~~gg~L~~~l~~----------------------------------------------~~~~~~~~~~~ 110 (318)
T 1fot_A 77 DAQQIFMIMDYIEGGELFSLLRK----------------------------------------------SQRFPNPVAKF 110 (318)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH----------------------------------------------TSSCCHHHHHH
T ss_pred eCCEEEEEEeCCCCCCHHHHHHH----------------------------------------------cCCCCHHHHHH
Confidence 99999999999998888766643 34688999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.+.
T Consensus 111 ~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 111 YAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp HHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred HHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999999999999999999999999999999999998653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.8e-32 Score=239.11 Aligned_cols=152 Identities=23% Similarity=0.483 Sum_probs=134.0
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
..++|++++.||+|+||.||+|.+. .+++.||+|++...... ......+.+|+.+++.++||||+++++++.
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~-------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKN-------DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 4567999999999999999999986 55689999999765422 233467889999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
+.+..|+||||+.+|+|..++.. ...+++..+..
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~----------------------------------------------~~~l~~~~~~~ 119 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQ----------------------------------------------NVHFKEETVKL 119 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHT----------------------------------------------TCCCCHHHHHH
T ss_pred eCCEEEEEEecCCCCcHHHHHHh----------------------------------------------cCCCCHHHHHH
Confidence 99999999999999888766543 34689999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 120 ~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 120 FICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 9999999999999999999999999999999999999999999865
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-31 Score=232.58 Aligned_cols=151 Identities=28% Similarity=0.508 Sum_probs=134.1
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhc-CCCceeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESV-HHPNIIRLYEVL 138 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~ 138 (267)
.+++|++.+.||+|+||.||+|++. .+++.||+|++...... ......+.+|+.++..+ +||||+++++++
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 79 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLK-------KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEEC-------CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence 3567999999999999999999986 45689999999876543 34567788999999988 899999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
.+.+..|+||||+.+|+|..++.. .+.+++..++
T Consensus 80 ~~~~~~~lv~e~~~gg~L~~~l~~----------------------------------------------~~~l~~~~~~ 113 (345)
T 3a8x_A 80 QTESRLFFVIEYVNGGDLMFHMQR----------------------------------------------QRKLPEEHAR 113 (345)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHH----------------------------------------------HSSCCHHHHH
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHH----------------------------------------------cCCCCHHHHH
Confidence 999999999999998888766543 3468999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 114 ~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 114 FYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred HHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccc
Confidence 9999999999999999999999999999999999999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-32 Score=241.40 Aligned_cols=154 Identities=25% Similarity=0.399 Sum_probs=134.1
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
...++|++.+.||+|+||.||+|++. .+++.||||++++.... ......+.+|..++..++||||+++++++
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~-------~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMK-------QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 34567999999999999999999986 45689999999754321 12234578999999999999999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
.+.+..|+|||||.+|+|.+++... ...+++..++
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~---------------------------------------------~~~l~~~~~~ 165 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKF---------------------------------------------GERIPAEMAR 165 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH---------------------------------------------SSCCCHHHHH
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhc---------------------------------------------CCCCCHHHHH
Confidence 9999999999999998887776542 1268999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 166 ~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 166 FYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL 212 (412)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheec
Confidence 99999999999999999999999999999999999999999999765
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=231.88 Aligned_cols=151 Identities=31% Similarity=0.543 Sum_probs=129.7
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++.+.||+|+||.||+|.+. .+++.||||++..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 76 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNR-------VTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HhhhceeeeEEecCCCEEEEEEEEC-------CCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 3467999999999999999999986 4568999999975542 2334668899999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+|||||.+|+|.+++. ....+++..+..+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~----------------------------------------------~~~~~~~~~~~~i 110 (323)
T 3tki_A 77 GNIQYLFLEYCSGGELFDRIE----------------------------------------------PDIGMPEPDAQRF 110 (323)
T ss_dssp SSEEEEEEECCTTEEGGGGSB----------------------------------------------TTTBCCHHHHHHH
T ss_pred CCeEEEEEEcCCCCcHHHHHh----------------------------------------------hcCCCCHHHHHHH
Confidence 999999999998877766553 3346899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 111 ~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 111 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (323)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeecccee
Confidence 999999999999999999999999999999999999999999754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-32 Score=238.18 Aligned_cols=151 Identities=28% Similarity=0.507 Sum_probs=132.2
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhc-CCCceeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESV-HHPNIIRLYEVL 138 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~ 138 (267)
.+++|++++.||+|+||.||+|++. .+++.||+|++++..... .....+.+|..++..+ +||||+++++++
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~-------~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 122 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLK-------KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 122 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE
Confidence 4567999999999999999999986 456899999998765432 3346688999999887 899999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
.+.+..|+|||||.+|+|..++.. .+.+++..+.
T Consensus 123 ~~~~~~~lV~E~~~gg~L~~~l~~----------------------------------------------~~~l~~~~~~ 156 (396)
T 4dc2_A 123 QTESRLFFVIEYVNGGDLMFHMQR----------------------------------------------QRKLPEEHAR 156 (396)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH----------------------------------------------HSSCCHHHHH
T ss_pred EECCEEEEEEEcCCCCcHHHHHHH----------------------------------------------cCCCCHHHHH
Confidence 999999999999999888666543 3468999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 157 ~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 157 FYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred HHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 9999999999999999999999999999999999999999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=234.30 Aligned_cols=153 Identities=33% Similarity=0.538 Sum_probs=132.9
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch----HHHHHHHHHHHHHhhcCCCceeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP----KARKMLSREIVSMESVHHPNIIRLYE 136 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~~~~ 136 (267)
..+.|++.+.||+|+||.||+|.+. .++..||+|++....... ...+.+.+|+.+++.++||||+++++
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~-------~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~ 82 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREK-------STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHD 82 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEEC-------CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEE
Confidence 3456999999999999999999986 456899999998755322 13467899999999999999999999
Q ss_pred eeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 137 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 137 ~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
++.+.+..|+|||||.+|+|.+++. ..+.+++..
T Consensus 83 ~~~~~~~~~lv~e~~~gg~L~~~l~----------------------------------------------~~~~l~~~~ 116 (361)
T 2yab_A 83 VYENRTDVVLILELVSGGELFDFLA----------------------------------------------QKESLSEEE 116 (361)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHT----------------------------------------------TCSCCBHHH
T ss_pred EEEeCCEEEEEEEcCCCCcHHHHHH----------------------------------------------hcCCCCHHH
Confidence 9999999999999998877766654 334689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC----ceEEeccccccccC
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG----IVKLGDLGFSTKLQ 266 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~----~~kl~DFGla~~l~ 266 (267)
+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 117 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 999999999999999999999999999999998777 79999999998653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=234.86 Aligned_cols=153 Identities=35% Similarity=0.645 Sum_probs=132.4
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~ 137 (267)
+..+++|++.+.||+|+||.||+|.+. .+++.||+|++....... .....+.+|+.+++.++||||++++++
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 77 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHY-------KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 345788999999999999999999986 556899999997543221 223568899999999999999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
+...+..++||||+ +|+|.+.+. ..+.+++..+
T Consensus 78 ~~~~~~~~lv~E~~-~g~l~~~l~----------------------------------------------~~~~l~~~~~ 110 (336)
T 3h4j_B 78 ITTPTDIVMVIEYA-GGELFDYIV----------------------------------------------EKKRMTEDEG 110 (336)
T ss_dssp EECSSEEEEEECCC-CEEHHHHHH----------------------------------------------HHCSCCHHHH
T ss_pred EEeCCEEEEEEECC-CCcHHHHHH----------------------------------------------HcCCCCHHHH
Confidence 99999999999998 566655443 3457999999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..++.|++.||.|||++|++||||||+|||++.++.+||+|||+|+.+
T Consensus 111 ~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 111 RRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp HHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred HHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 999999999999999999999999999999999999999999999764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-32 Score=237.83 Aligned_cols=151 Identities=26% Similarity=0.402 Sum_probs=133.9
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .++..||||++... ........+.+|+.+++.++||||+++++++...
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 184 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLR-------ADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 184 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEe-------cCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence 457999999999999999999986 45689999999754 3445567789999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+||||+.+|+|.+++... ...+++..+..++
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------------~~~~~~~~~~~~~ 219 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTE---------------------------------------------GARLRVKTLLQMV 219 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHH---------------------------------------------GGGCCHHHHHHHH
T ss_pred CCcEEEEEcCCCCCHHHHHHhc---------------------------------------------CCCCCHHHHHHHH
Confidence 9999999999998888777532 1258889999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++|++||||||+|||++.++.+||+|||+|+..
T Consensus 220 ~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 220 GDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred HHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 99999999999999999999999999999999999999999754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=239.46 Aligned_cols=150 Identities=27% Similarity=0.418 Sum_probs=130.5
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .+++.||||++...........++.+|+.+++.++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 97 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDK-------NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPD 97 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEET-------TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred cCCEEEEEEEeecCCEEEEEEEEC-------CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 356999999999999999999986 4568999999987655666678899999999999999999999998766
Q ss_pred -----CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 142 -----GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 142 -----~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
+..|+|||++++ +|. +.+.....+++..
T Consensus 98 ~~~~~~~~~lv~e~~~~-~L~----------------------------------------------~~~~~~~~l~~~~ 130 (432)
T 3n9x_A 98 DLLKFDELYIVLEIADS-DLK----------------------------------------------KLFKTPIFLTEEH 130 (432)
T ss_dssp CTTTCCCEEEEEECCSE-EHH----------------------------------------------HHHHSSCCCCHHH
T ss_pred CCCcCCeEEEEEecCCc-CHH----------------------------------------------HHHhccCCCCHHH
Confidence 467788887653 554 4444455799999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 131 ~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 131 IKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 9999999999999999999999999999999999999999999999865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-32 Score=234.20 Aligned_cols=153 Identities=25% Similarity=0.464 Sum_probs=131.8
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhc-CCCceeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESV-HHPNIIRLYEV 137 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~ 137 (267)
...++|++.+.||+|+||.||+|++. .+++.||||+++..... ......+.+|..++..+ +||||++++++
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~ 86 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFK-------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT 86 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEET-------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEE
Confidence 35677999999999999999999986 45689999999765321 22345678899999877 99999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
+.+.+..|+|||||.+|+|.+++.. .+.+++..+
T Consensus 87 ~~~~~~~~lv~E~~~gg~L~~~l~~----------------------------------------------~~~~~~~~~ 120 (345)
T 1xjd_A 87 FQTKENLFFVMEYLNGGDLMYHIQS----------------------------------------------CHKFDLSRA 120 (345)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH----------------------------------------------HSSCCHHHH
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHH----------------------------------------------cCCCCHHHH
Confidence 9999999999999999888766643 346899999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 121 ~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 121 TFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred HHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 999999999999999999999999999999999999999999999853
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-32 Score=235.16 Aligned_cols=155 Identities=34% Similarity=0.527 Sum_probs=131.7
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc---hHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT---PKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
+.|++.+.||+|+||.||+|.+. .+++.||||++...... ....+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 96 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINR-------ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS 96 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 45999999999999999999986 45689999999654321 113467899999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+..|+|||||.+|+|.+.+.... .....+++..+..
T Consensus 97 ~~~~~~lv~e~~~g~~L~~~l~~~~------------------------------------------~~~~~~~~~~~~~ 134 (351)
T 3c0i_A 97 SDGMLYMVFEFMDGADLCFEIVKRA------------------------------------------DAGFVYSEAVASH 134 (351)
T ss_dssp ETTEEEEEEECCSSCBHHHHHHHHH------------------------------------------HTTCCCCHHHHHH
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHhc------------------------------------------ccCCCCCHHHHHH
Confidence 9999999999999999977664320 1223589999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCc---eEEeccccccccC
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGI---VKLGDLGFSTKLQ 266 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~---~kl~DFGla~~l~ 266 (267)
++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+.+.
T Consensus 135 i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 184 (351)
T 3c0i_A 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184 (351)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEec
Confidence 9999999999999999999999999999987654 9999999997653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=235.12 Aligned_cols=154 Identities=26% Similarity=0.353 Sum_probs=129.8
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
..+|++.+.||+|+||.||+|.+.... ..+..||||+++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPS----KKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTT----SCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCC----CCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 457999999999999999999876432 346789999997653 455667899999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+||||+++|+|.+++... ...+++..+..++
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~---------------------------------------------~~~~~~~~~~~i~ 153 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKH---------------------------------------------DAQFTVIQLVGML 153 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTT---------------------------------------------TTCSCHHHHHHHH
T ss_pred CceEEEEeCCCCCcHHHHHHhC---------------------------------------------CCCCCHHHHHHHH
Confidence 9999999999998888777542 2268899999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 154 ~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred HHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999999999999999999999999999999865
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=227.03 Aligned_cols=149 Identities=29% Similarity=0.496 Sum_probs=129.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+ .+++.||+|++............+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~--------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN--------NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK 73 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE--------TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS
T ss_pred ccchhhhhcccCCCEEEEEEEc--------CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC
Confidence 5699999999999999999987 23588999999766544444467889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..++|||++.+ +|.+.+... .+.+++..+..++.
T Consensus 74 ~~~lv~e~~~~-~l~~~~~~~---------------------------------------------~~~~~~~~~~~~~~ 107 (288)
T 1ob3_A 74 RLVLVFEHLDQ-DLKKLLDVC---------------------------------------------EGGLESVTAKSFLL 107 (288)
T ss_dssp CEEEEEECCSE-EHHHHHHTS---------------------------------------------TTCCCHHHHHHHHH
T ss_pred eEEEEEEecCC-CHHHHHHhc---------------------------------------------ccCCCHHHHHHHHH
Confidence 99999999975 665554321 24688999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 108 qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 108 QLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF 150 (288)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred HHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence 9999999999999999999999999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=233.42 Aligned_cols=174 Identities=25% Similarity=0.334 Sum_probs=141.8
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~ 139 (267)
..++|++.+.||+|+||.||+|.+..........+..||||++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34679999999999999999999864432222445789999997653 455667899999999999 9999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+..|+||||+.+|+|.+++......... ............+++..+..
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------------------------------~~~~~~~~~~~~l~~~~~~~ 195 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLE------------------------------YSYNPSHNPEEQLSSKDLVS 195 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSS------------------------------SCCCCCSSCCCCCCHHHHHH
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccc------------------------------cccccccccccccCHHHHHH
Confidence 999999999999999999988765321000 00000111234699999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 196 i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 241 (382)
T 3tt0_A 196 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241 (382)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCS
T ss_pred HHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCccccc
Confidence 9999999999999999999999999999999999999999999865
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=223.85 Aligned_cols=157 Identities=20% Similarity=0.216 Sum_probs=134.4
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+..++......+..||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 3569999999999999999999876543222334689999996543 33456789999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..++||||+.+|+|.+++... ...+++..+..++
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~i~ 119 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKN---------------------------------------------KNCINILWKLEVA 119 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHT---------------------------------------------GGGCCHHHHHHHH
T ss_pred CCCEEEEECCCCCCHHHHHHhC---------------------------------------------CCCCCHHHHHHHH
Confidence 9999999999998888777543 1248899999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCc--------eEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGI--------VKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~--------~kl~DFGla~~l 265 (267)
.|++.||.|||++|++||||||+|||++.++. +||+|||+|+..
T Consensus 120 ~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~ 171 (289)
T 4fvq_A 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171 (289)
T ss_dssp HHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTT
T ss_pred HHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccc
Confidence 99999999999999999999999999998887 999999999754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-31 Score=220.88 Aligned_cols=148 Identities=23% Similarity=0.391 Sum_probs=131.2
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .+..||+|++....... +.+.+|+.+++.++||||+++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 77 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL--------NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--------TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhhceeeheecCCCccEEEEEEec--------CCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 356999999999999999999874 34679999998665443 4688999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..+++|||+++++|.+++... ...+++..+..++
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~i~ 112 (269)
T 4hcu_A 78 APICLVFEFMEHGCLSDYLRTQ---------------------------------------------RGLFAAETLLGMC 112 (269)
T ss_dssp SSEEEEEECCTTCBHHHHHHTT---------------------------------------------TTCCCHHHHHHHH
T ss_pred CceEEEEEeCCCCcHHHHHHhc---------------------------------------------CcccCHHHHHHHH
Confidence 9999999999998888776532 2358999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 113 ~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 113 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 156 (269)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred HHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccc
Confidence 99999999999999999999999999999999999999999754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=235.47 Aligned_cols=153 Identities=29% Similarity=0.524 Sum_probs=125.1
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHH-HhhcCCCceeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVS-MESVHHPNIIRLYE 136 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~-l~~l~hpnIv~~~~ 136 (267)
....++|++++.||+|+||.||+|++. .++..||||++.+..... .....+.+|..+ ++.++||||+++++
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~ 106 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHK-------AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHF 106 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEET-------TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEc-------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEE
Confidence 345678999999999999999999986 456899999998765432 334556777776 56789999999999
Q ss_pred eeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 137 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 137 ~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
++.+.+..|+||||+.+|+|.+++.. .+.+++..
T Consensus 107 ~~~~~~~~~lv~E~~~gg~L~~~l~~----------------------------------------------~~~~~~~~ 140 (373)
T 2r5t_A 107 SFQTADKLYFVLDYINGGELFYHLQR----------------------------------------------ERCFLEPR 140 (373)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHH----------------------------------------------HSSCCHHH
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHh----------------------------------------------cCCCCHHH
Confidence 99999999999999999888766643 34688999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 141 ~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 141 ARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred HHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 999999999999999999999999999999999999999999999985
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=226.07 Aligned_cols=151 Identities=28% Similarity=0.436 Sum_probs=134.0
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .+++.||+|++............+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 74 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNR-------DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK 74 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccceEeeEEeecCCeEEEEEEeC-------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC
Confidence 357999999999999999999986 4568999999977766666678889999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..++||||+.+++|..++. ....+++..+..++
T Consensus 75 ~~~~lv~e~~~~~~l~~~~~----------------------------------------------~~~~~~~~~~~~i~ 108 (311)
T 4agu_A 75 RRLHLVFEYCDHTVLHELDR----------------------------------------------YQRGVPEHLVKSIT 108 (311)
T ss_dssp TEEEEEEECCSEEHHHHHHH----------------------------------------------TSSCCCHHHHHHHH
T ss_pred CeEEEEEEeCCCchHHHHHh----------------------------------------------hhcCCCHHHHHHHH
Confidence 99999999999877765543 33468999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 109 ~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 109 WQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL 152 (311)
T ss_dssp HHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence 99999999999999999999999999999999999999999764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=226.51 Aligned_cols=154 Identities=27% Similarity=0.398 Sum_probs=129.8
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|++.... ..+++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~---~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQ---DNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTC---SSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEeccc---CCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 356999999999999999999853211 145689999999754 345567899999999999999999999998554
Q ss_pred --CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 142 --GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 142 --~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
...++||||+.+|+|.+++... ..++++..+..
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~ 118 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKH---------------------------------------------KERIDHIKLLQ 118 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHC---------------------------------------------GGGCCHHHHHH
T ss_pred CCCceEEEEEeCCCCCHHHHHHhc---------------------------------------------ccccCHHHHHH
Confidence 4588999999888887776542 12588999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||+|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 119 ~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred HHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 9999999999999999999999999999999999999999999865
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=232.74 Aligned_cols=155 Identities=32% Similarity=0.568 Sum_probs=134.2
Q ss_pred cCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeee
Q psy2579 58 LGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 58 ~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~ 137 (267)
.+...+.|++.+.||+|+||.||+|.+. .+++.||+|++.... ......+.+|+.+++.++||||++++++
T Consensus 46 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~-------~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~ 116 (387)
T 1kob_A 46 QGSVYDYYDILEELGSGAFGVVHRCVEK-------ATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDA 116 (387)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEE
T ss_pred CCccccceEEEEEEecCCCEEEEEEEEC-------CCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEE
Confidence 3455678999999999999999999986 456899999997553 3345678899999999999999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
+...+..++|||||.+|+|.+++... ...+++..+
T Consensus 117 ~~~~~~~~lv~E~~~gg~L~~~l~~~---------------------------------------------~~~l~~~~~ 151 (387)
T 1kob_A 117 FEDKYEMVLILEFLSGGELFDRIAAE---------------------------------------------DYKMSEAEV 151 (387)
T ss_dssp EECSSEEEEEEECCCCCBHHHHTTCT---------------------------------------------TCCBCHHHH
T ss_pred EEeCCEEEEEEEcCCCCcHHHHHHhh---------------------------------------------cCCCCHHHH
Confidence 99999999999999998887766432 226899999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeec--CCceEEeccccccccC
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSV--RGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~--~~~~kl~DFGla~~l~ 266 (267)
..++.|++.||+|||++||+||||||+|||++. .+.+||+|||+|+.+.
T Consensus 152 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 152 INYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999999999999999999999999999974 4679999999998653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=234.04 Aligned_cols=149 Identities=27% Similarity=0.438 Sum_probs=121.6
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-CCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-HPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~ 140 (267)
.++|++.+.||+|+||.||+|.+. .+++.||||++............+.+|+.+++.+. ||||+++++++..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 80 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDR-------RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA 80 (388)
T ss_dssp HTTEEEEEC-------CEEEEEET-------TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred cCceEEEEEeeeCCCeEEEEEEEC-------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec
Confidence 456999999999999999999986 45689999999766556666778899999999996 9999999999975
Q ss_pred cC--eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 141 FG--KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 141 ~~--~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
.+ ..|+|||||+ |+|...+.. ..+++..+.
T Consensus 81 ~~~~~~~lv~e~~~-~~L~~~~~~-----------------------------------------------~~~~~~~~~ 112 (388)
T 3oz6_A 81 DNDRDVYLVFDYME-TDLHAVIRA-----------------------------------------------NILEPVHKQ 112 (388)
T ss_dssp TTSSCEEEEEECCS-EEHHHHHHH-----------------------------------------------TCCCHHHHH
T ss_pred CCCCEEEEEecccC-cCHHHHHHc-----------------------------------------------CCCCHHHHH
Confidence 54 6899999987 466554432 368899999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 113 ~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 113 YVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred HHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99999999999999999999999999999999999999999999764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-31 Score=222.91 Aligned_cols=154 Identities=27% Similarity=0.410 Sum_probs=125.1
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++.+.||+|+||.||+|.+.... ..+..||+|.+.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPE----NPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC------CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCC----CCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 3467999999999999999999986432 335679999987643 4455678999999999999999999999984
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+||||+.+++|.+++... ...+++..+..+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~~ 121 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVR---------------------------------------------KYSLDLASLILY 121 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHT---------------------------------------------TTTSCHHHHHHH
T ss_pred cCccEEEEecCCCCCHHHHHHhc---------------------------------------------CCCCCHHHHHHH
Confidence 56788999999888887766532 225889999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 122 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred HHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999999999999999999999999999999999765
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=228.99 Aligned_cols=155 Identities=35% Similarity=0.547 Sum_probs=125.5
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc--hHHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT--PKARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
..++|++.+.||+|+||.||+|++.... .+++.||+|++...... ......+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGA----NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSST----TTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccC----CCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 3467999999999999999999875322 45689999999865432 23345678999999999999999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
...+..|+|||||.+|+|.+++.. .+.+++..+.
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~----------------------------------------------~~~~~~~~~~ 124 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLER----------------------------------------------EGIFMEDTAC 124 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHH----------------------------------------------HSSCCHHHHH
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHh----------------------------------------------CCCCCHHHHH
Confidence 999999999999998887766543 3468889999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 125 ~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 125 FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred HHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999999999999999999999999999998753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=232.49 Aligned_cols=151 Identities=26% Similarity=0.458 Sum_probs=131.9
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhc-CCCceeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESV-HHPNIIRLYEVL 138 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~ 138 (267)
.+++|++.+.||+|+||.||+|++. .+++.||||+++..... ......+.+|..++..+ +||||+++++++
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 90 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERK-------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 90 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEET-------TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence 4567999999999999999999986 45689999999765321 22346688999999988 899999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
.+.+..|+||||+.+|+|.+++.. .+.+++..++
T Consensus 91 ~~~~~~~lv~E~~~gg~L~~~l~~----------------------------------------------~~~~~~~~~~ 124 (353)
T 2i0e_A 91 QTMDRLYFVMEYVNGGDLMYHIQQ----------------------------------------------VGRFKEPHAV 124 (353)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHH----------------------------------------------HSSCCHHHHH
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHh----------------------------------------------cCCCCHHHHH
Confidence 999999999999998888766643 3468999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 125 ~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 125 FYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred HHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 9999999999999999999999999999999999999999999985
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-31 Score=226.08 Aligned_cols=150 Identities=30% Similarity=0.410 Sum_probs=129.3
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~ 141 (267)
++|++.++||+|+||+||+|.+. .+++.||||++...............|+..+..+ +||||+++++++...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSK-------EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-------TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hheeeeheeccCCCeEEEEEEEC-------CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 56999999999999999999986 4568999999877655555556666777666665 999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+|||++ +++|.+.+... ...+++..+..++
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~---------------------------------------------~~~l~~~~~~~i~ 163 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAW---------------------------------------------GASLPEAQVWGYL 163 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHH---------------------------------------------CSCCCHHHHHHHH
T ss_pred CEEEEEEecc-CCCHHHHHHhc---------------------------------------------CCCCCHHHHHHHH
Confidence 9999999999 55666555432 2368999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 164 ~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 164 RDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp HHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999999999999999999999999999999999999998765
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=240.38 Aligned_cols=153 Identities=39% Similarity=0.665 Sum_probs=134.4
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
..+++|++.+.||+|+||.||+|.+. .+++.||||++....... .....+.+|+.+++.++||||+++++++
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 85 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHE-------LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEET-------TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 35678999999999999999999986 456899999997653222 2346789999999999999999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
...+..|+|||||.+|+|.+++. ..+.+++..+.
T Consensus 86 ~~~~~~~lv~E~~~gg~L~~~l~----------------------------------------------~~~~l~~~~~~ 119 (476)
T 2y94_A 86 STPSDIFMVMEYVSGGELFDYIC----------------------------------------------KNGRLDEKESR 119 (476)
T ss_dssp ECSSEEEEEEECCSSEEHHHHTT----------------------------------------------SSSSCCHHHHH
T ss_pred EECCEEEEEEeCCCCCcHHHHHH----------------------------------------------hcCCCCHHHHH
Confidence 99999999999998877766554 34468999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 120 ~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 120 RLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp HHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred HHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 99999999999999999999999999999999999999999999865
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-31 Score=227.46 Aligned_cols=151 Identities=32% Similarity=0.535 Sum_probs=132.0
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch----HHHHHHHHHHHHHhhcCCCceeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP----KARKMLSREIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~~~~~ 137 (267)
.+.|++.+.||+|+||.||+|.+. .++..||+|++....... ...+.+.+|+.+++.++||||++++++
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 82 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREK-------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV 82 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEET-------TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccceEeceEEeeCCCeEEEEEEEC-------CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 355999999999999999999986 456899999997654321 135678999999999999999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
+...+..++||||+.+|+|.+++. ....+++..+
T Consensus 83 ~~~~~~~~lv~e~~~~~~L~~~l~----------------------------------------------~~~~~~~~~~ 116 (326)
T 2y0a_A 83 YENKTDVILILELVAGGELFDFLA----------------------------------------------EKESLTEEEA 116 (326)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHT----------------------------------------------TSSCCBHHHH
T ss_pred EEeCCEEEEEEEcCCCCCHHHHHH----------------------------------------------hcCCcCHHHH
Confidence 999999999999999877776654 3346899999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC----ceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG----IVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~----~~kl~DFGla~~l 265 (267)
..++.|++.||.|||++|++||||||+||+++.++ .+||+|||+|+.+
T Consensus 117 ~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 99999999999999999999999999999998887 8999999999865
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=229.41 Aligned_cols=155 Identities=26% Similarity=0.431 Sum_probs=126.2
Q ss_pred ccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeee
Q psy2579 57 SLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYE 136 (267)
Q Consensus 57 ~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~ 136 (267)
..+..+++|++.+.||+|+||.||+|.+. .+++.||||++............+.+|+.+++.++||||+++++
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDT-------VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEET-------TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEE
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEEC-------CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEE
Confidence 34456678999999999999999999986 45689999999876655555677889999999999999999999
Q ss_pred eeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 137 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 137 ~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
++...+..|+||||+.+ +|.+++. ....+++..
T Consensus 101 ~~~~~~~~~lv~e~~~~-~L~~~~~----------------------------------------------~~~~~~~~~ 133 (329)
T 3gbz_A 101 VIHHNHRLHLIFEYAEN-DLKKYMD----------------------------------------------KNPDVSMRV 133 (329)
T ss_dssp EEEETTEEEEEEECCSE-EHHHHHH----------------------------------------------HCTTCCHHH
T ss_pred EEecCCEEEEEEecCCC-CHHHHHh----------------------------------------------hcCCCCHHH
Confidence 99999999999999874 6655443 344689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEee-----cCCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS-----VRGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~-----~~~~~kl~DFGla~~l 265 (267)
+..++.|++.||+|||++||+||||||+|||++ ..+.+||+|||+|+.+
T Consensus 134 ~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 134 IKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred HHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 999999999999999999999999999999994 4456999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-31 Score=226.11 Aligned_cols=153 Identities=25% Similarity=0.454 Sum_probs=130.7
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+. .+++.||||++...... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHK-------KTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCEEEEEEecCCCCeEEEEEEEC-------CCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence 56999999999999999999986 45689999999765422 23466789999999999999999999988765
Q ss_pred --eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 143 --KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 143 --~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
..|+||||+.+|+|.+++.... ....+++..+..+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~-------------------------------------------~~~~~~~~~~~~i 117 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPS-------------------------------------------NAYGLPESEFLIV 117 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGG-------------------------------------------GTTCCCHHHHHHH
T ss_pred CceEEEEEeCCCCCCHHHHHHHhc-------------------------------------------cccCCCHHHHHHH
Confidence 7899999999988887776431 1224899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEe----ecCCceEEeccccccccC
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFL----SVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll----~~~~~~kl~DFGla~~l~ 266 (267)
+.|++.||+|||++||+||||||+|||+ +.++.+||+|||+|+.+.
T Consensus 118 ~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 9999999999999999999999999999 677789999999998653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-31 Score=229.95 Aligned_cols=148 Identities=36% Similarity=0.640 Sum_probs=128.7
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++.+.||+|+||.||+|++. .+++.||||++....... ..+.+|+.+++.++||||+++++++..
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~ 87 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDK-------LTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILT 87 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEET-------TTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEEC-------CCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEee
Confidence 4567999999999999999999986 456899999997654322 457899999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+|||||.+|+|.+++. ..+++++..+..+
T Consensus 88 ~~~~~lv~e~~~~~~L~~~l~----------------------------------------------~~~~~~~~~~~~i 121 (361)
T 3uc3_A 88 PTHLAIIMEYASGGELYERIC----------------------------------------------NAGRFSEDEARFF 121 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHH----------------------------------------------HHSSCCHHHHHHH
T ss_pred CCEEEEEEEeCCCCCHHHHHH----------------------------------------------hcCCCCHHHHHHH
Confidence 999999999999888766654 3346899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCc--eEEeccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGI--VKLGDLGFSTK 264 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFGla~~ 264 (267)
+.|++.||+|||++||+||||||+|||++.++. +||+|||+|+.
T Consensus 122 ~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 122 FQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp HHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 999999999999999999999999999987765 99999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-31 Score=227.03 Aligned_cols=160 Identities=22% Similarity=0.319 Sum_probs=122.2
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+...+ .....||||++..........+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQED----GSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-----------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred hhHeEEeceecccCCeEEEEEEEcccC----CcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 356999999999999999999886432 1124899999987665666678899999999999999999999999877
Q ss_pred CeE------EEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 142 GKI------FLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 142 ~~~------~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
... +++|||+.+|+|.+++..... -.....+++.
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~----------------------------------------~~~~~~~~~~ 137 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRI----------------------------------------GENPFNLPLQ 137 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC-------------------------------------------CCCCCHH
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhc----------------------------------------cccccccCHH
Confidence 655 899999999998877754311 0112258999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 138 ~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~ 187 (323)
T 3qup_A 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI 187 (323)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred HHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccc
Confidence 99999999999999999999999999999999999999999999999764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=220.10 Aligned_cols=149 Identities=25% Similarity=0.415 Sum_probs=128.9
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
...+|++.+.||+|+||.||+|.+. ++..||+|++....... +.+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR--------GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET--------TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc--------CCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 3456999999999999999999774 34679999998665443 568899999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+||||+.+++|.+++... ...+++..+..+
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~i 125 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREM---------------------------------------------RHRFQTQQLLEM 125 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCG---------------------------------------------GGCCCHHHHHHH
T ss_pred CCCeEEEEeccCCCcHHHHHHHh---------------------------------------------ccCCCHHHHHHH
Confidence 99999999999998888776532 236899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 126 ~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 126 CKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp HHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred HHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence 999999999999999999999999999999999999999999865
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=243.09 Aligned_cols=156 Identities=26% Similarity=0.394 Sum_probs=135.8
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
...++|++.+.||+|+||.||+|.+. .+++.||+|++...... ......+.+|+.+++.++||||+++++++
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~-------~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 253 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVR-------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY 253 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence 44567999999999999999999986 45689999999765322 22345688999999999999999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
.+.+..|+||||+.+|+|.+++.... ...+++..+.
T Consensus 254 ~~~~~l~lVmEy~~gg~L~~~l~~~~--------------------------------------------~~~l~e~~~~ 289 (576)
T 2acx_A 254 ETKDALCLVLTLMNGGDLKFHIYHMG--------------------------------------------QAGFPEARAV 289 (576)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHSSS--------------------------------------------SCCCCHHHHH
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcC--------------------------------------------CCCCCHHHHH
Confidence 99999999999999989887765431 2258999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.+.
T Consensus 290 ~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 290 FYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999999999999999999999999999999999998653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=226.73 Aligned_cols=158 Identities=21% Similarity=0.306 Sum_probs=136.4
Q ss_pred cccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeee
Q psy2579 56 TSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLY 135 (267)
Q Consensus 56 ~~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~ 135 (267)
.......++|++.+.||+|+||.||+|.+. ++..||||.+.... ....+.+.+|+.+++.++||||++++
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~ 101 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLR--------DGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLI 101 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECT--------TCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEE
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEEC--------CCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 344556678999999999999999999863 35889999987653 34456789999999999999999999
Q ss_pred eeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 136 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 136 ~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
+++...+..++||||+.+|+|.+++..... ....+++.
T Consensus 102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------~~~~~~~~ 139 (321)
T 2qkw_B 102 GFCDERNEMILIYKYMENGNLKRHLYGSDL------------------------------------------PTMSMSWE 139 (321)
T ss_dssp EECCCTTCCEEEEECCTTCBTGGGSSSSCC------------------------------------------CSCCCCHH
T ss_pred EEEcCCCeEEEEEEcCCCCcHHHHHhccCC------------------------------------------CccccCHH
Confidence 999999999999999999999877754311 12358999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++..
T Consensus 140 ~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 140 QRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999999999999999999999999999999999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-31 Score=221.31 Aligned_cols=156 Identities=23% Similarity=0.389 Sum_probs=134.7
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 140 (267)
.++|++.+.||+|+||.||+|.+. .+++.||+|++............+.+|+..+..+ +||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~ 82 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKR-------LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE 82 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEc-------CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence 456999999999999999999986 4568999999987665556667889999999999 99999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..++||||+++++|.+++.... .....+++..+..+
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------~~~~~~~~~~~~~i 120 (289)
T 1x8b_A 83 DDHMLIQNEYCNGGSLADAISENY------------------------------------------RIMSYFKEAELKDL 120 (289)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHH------------------------------------------HHTCCCCHHHHHHH
T ss_pred CCeEEEEEEecCCCcHHHHHHhhc------------------------------------------ccccCCCHHHHHHH
Confidence 999999999999999988775421 11246899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecC-------------------CceEEeccccccccC
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVR-------------------GIVKLGDLGFSTKLQ 266 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~-------------------~~~kl~DFGla~~l~ 266 (267)
+.|++.||+|||++|++||||||+||+++.+ ..++|+|||+++.+.
T Consensus 121 ~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~ 185 (289)
T 1x8b_A 121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185 (289)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETT
T ss_pred HHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccC
Confidence 9999999999999999999999999999844 479999999987653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=237.05 Aligned_cols=149 Identities=23% Similarity=0.251 Sum_probs=116.1
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc------chHHHHHHHHHHHHHhhcC--------
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL------TPKARKMLSREIVSMESVH-------- 127 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~Ei~~l~~l~-------- 127 (267)
.++|++.+.||+|+||.||+|++. ++.||||++..... .....+.+.+|+.+++.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~ 89 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIAD---------HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCN 89 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEET---------TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSS
T ss_pred cccchheeeecccCceEEEEEEeC---------CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccc
Confidence 356999999999999999999862 48999999987542 2223466889999998886
Q ss_pred -CCceeeeeeeee-----------------e-------------cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHH
Q psy2579 128 -HPNIIRLYEVLE-----------------T-------------FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 176 (267)
Q Consensus 128 -hpnIv~~~~~~~-----------------~-------------~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~ 176 (267)
||||+++.+.+. + .+..|+|||||.+|++
T Consensus 90 ~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~l-------------------- 149 (336)
T 2vuw_A 90 RTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID-------------------- 149 (336)
T ss_dssp BCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEE--------------------
T ss_pred cCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCcc--------------------
Confidence 666666666543 2 4455555555555443
Q ss_pred HHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHHHHH-hCCCcccCCCCCcEEeecCC---
Q psy2579 177 QILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLH-DRDIIHRDIKAENVFLSVRG--- 252 (267)
Q Consensus 177 ~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH-~~~ivHrDlkp~NIll~~~~--- 252 (267)
.+.+.. ..+++..+..++.|++.||+||| ++||+||||||+|||++.++
T Consensus 150 --------------------------l~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~ 202 (336)
T 2vuw_A 150 --------------------------LEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKK 202 (336)
T ss_dssp --------------------------TGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSE
T ss_pred --------------------------HHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcc
Confidence 333322 46899999999999999999999 99999999999999999887
Q ss_pred -----------------ceEEeccccccccC
Q psy2579 253 -----------------IVKLGDLGFSTKLQ 266 (267)
Q Consensus 253 -----------------~~kl~DFGla~~l~ 266 (267)
.+||+|||+|+.+.
T Consensus 203 ~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~ 233 (336)
T 2vuw_A 203 LHYTLNGKSSTIPSCGLQVSIIDYTLSRLER 233 (336)
T ss_dssp EEEEETTEEEEEECTTEEEEECCCTTCBEEE
T ss_pred eeeeccCccccccCCCceEEEeeccccEecC
Confidence 89999999998653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=231.21 Aligned_cols=162 Identities=23% Similarity=0.278 Sum_probs=134.2
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+..... ..++..||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPN--DPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-------CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCC--CCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 4679999999999999999999653210 1456789999996543 445556788999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+|||||.+|+|.+++....... .....+++..+..++
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~---------------------------------------~~~~~~~~~~~~~i~ 187 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRP---------------------------------------SQPSSLAMLDLLHVA 187 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCS---------------------------------------SSCCCCCHHHHHHHH
T ss_pred CCCEEEEEeCCCCCHHHHHHhhcccc---------------------------------------CccccccHHHHHHHH
Confidence 99999999999999998887543210 122368999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCC---ceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRG---IVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~---~~kl~DFGla~~l 265 (267)
.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.+
T Consensus 188 ~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~ 234 (367)
T 3l9p_A 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234 (367)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHH
T ss_pred HHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcccccc
Confidence 9999999999999999999999999998555 5999999999743
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-31 Score=227.88 Aligned_cols=178 Identities=21% Similarity=0.304 Sum_probs=140.0
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
....++|++.+.||+|+||.||+|.+..... ..++..||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLP--YEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSST--TSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCC--CCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3445679999999999999999999863211 1345889999997654 445567899999999999999999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhh----hhcccCCCCh
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYN----KITTEGRLSE 214 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~----~~~~~~~~~~ 214 (267)
...+..|+||||+.+|+|.+++............ ...+.. .......+++
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~l~~ 173 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS--------------------------HSDLSTRARVSSPGPPPLSC 173 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC------------------------------------------------CCCCH
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccc--------------------------cccccccccccccCCCCCCH
Confidence 9999999999999999999999765321100000 000000 0011357999
Q ss_pred hHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.+
T Consensus 174 ~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 224 (343)
T 1luf_A 174 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 224 (343)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCccc
Confidence 999999999999999999999999999999999999999999999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-31 Score=219.22 Aligned_cols=148 Identities=24% Similarity=0.399 Sum_probs=130.8
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. ++..||+|++....... +.+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK--------GQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKE 75 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET--------TTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheeeeeeeccCCCceEEEEEec--------CceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 456999999999999999999764 34679999997665443 5688999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..++|||++++++|.+++... ...+++..+..++
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~i~ 110 (268)
T 3sxs_A 76 YPIYIVTEYISNGCLLNYLRSH---------------------------------------------GKGLEPSQLLEMC 110 (268)
T ss_dssp SSEEEEEECCTTCBHHHHHHHH---------------------------------------------GGGCCHHHHHHHH
T ss_pred CceEEEEEccCCCcHHHHHHHc---------------------------------------------CCCCCHHHHHHHH
Confidence 9999999999998887776532 1258999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||.|||++|++||||||+||+++.++.++|+|||+|+.+
T Consensus 111 ~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 111 YDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV 154 (268)
T ss_dssp HHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred HHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceec
Confidence 99999999999999999999999999999999999999999754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=227.72 Aligned_cols=152 Identities=28% Similarity=0.412 Sum_probs=128.5
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
..++|++.+.||+|+||.||+|.+. .+++.||||++..... .......+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 82 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDL-------RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGE 82 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEEC-------CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeee
Confidence 4466999999999999999999986 4568999999987543 3345678899999999999999999999987
Q ss_pred ecCe----EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 140 TFGK----IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 140 ~~~~----~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
..+. .|+||||+++++|.+++. ..+++++.
T Consensus 83 ~~~~~~~~~~lv~e~~~g~~L~~~l~----------------------------------------------~~~~~~~~ 116 (311)
T 3ork_A 83 AETPAGPLPYIVMEYVDGVTLRDIVH----------------------------------------------TEGPMTPK 116 (311)
T ss_dssp EEETTEEEEEEEEECCCEEEHHHHHH----------------------------------------------HHCSCCHH
T ss_pred ccCCCCcccEEEEecCCCCCHHHHHH----------------------------------------------hcCCCCHH
Confidence 6543 478888887766665553 34478999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 117 ~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred HHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 99999999999999999999999999999999999999999999999754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=227.38 Aligned_cols=155 Identities=30% Similarity=0.492 Sum_probs=118.4
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++++.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 75 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNK-------TTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTE 75 (317)
T ss_dssp ---------------CEEEEEECS-------SSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT
T ss_pred ccceeEeeEECCCCCEEEEEEEEC-------CCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEEC
Confidence 356999999999999999999886 456899999997554 222335678999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+||||+. |+|.+++..... ......+++..+..++
T Consensus 76 ~~~~lv~e~~~-~~L~~~l~~~~~----------------------------------------~~~~~~~~~~~~~~~~ 114 (317)
T 2pmi_A 76 NKLTLVFEFMD-NDLKKYMDSRTV----------------------------------------GNTPRGLELNLVKYFQ 114 (317)
T ss_dssp TEEEEEEECCC-CBHHHHHHHHHS----------------------------------------SSCCCCCCHHHHHHHH
T ss_pred CeEEEEEEecC-CCHHHHHHhccc----------------------------------------cccccCCCHHHHHHHH
Confidence 99999999998 478776653210 0112358999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 115 ~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp HHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred HHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 99999999999999999999999999999999999999999764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-31 Score=220.87 Aligned_cols=156 Identities=28% Similarity=0.489 Sum_probs=136.0
Q ss_pred cCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeee
Q psy2579 58 LGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYE 136 (267)
Q Consensus 58 ~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~ 136 (267)
++..+++|++.+.||+|+||.||+|.+. .+++.||+|++....... .....+.+|+.+++.++||||+++++
T Consensus 6 ~g~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 78 (278)
T 3cok_A 6 IGEKIEDFKVGNLLGKGSFAGVYRAESI-------HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78 (278)
T ss_dssp HCSSGGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEE
T ss_pred cccccccceeeeeecCCCceEEEEEEEc-------cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEE
Confidence 4566788999999999999999999885 456899999996543221 22467899999999999999999999
Q ss_pred eeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 137 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 137 ~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
++...+..|++||++.+++|.+++... ..++++..
T Consensus 79 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~ 113 (278)
T 3cok_A 79 YFEDSNYVYLVLEMCHNGEMNRYLKNR---------------------------------------------VKPFSENE 113 (278)
T ss_dssp EEECSSEEEEEEECCTTEEHHHHHHTC---------------------------------------------SSCCCHHH
T ss_pred EEccCCeEEEEEecCCCCcHHHHHhhc---------------------------------------------cCCCCHHH
Confidence 999999999999999998887766532 23689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.+
T Consensus 114 ~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 114 ARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 9999999999999999999999999999999999999999999998764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-31 Score=231.31 Aligned_cols=149 Identities=26% Similarity=0.394 Sum_probs=122.4
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .+++.||||++...........++.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 96 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDG-------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD 96 (367)
T ss_dssp BSSEEEEEEC------CEEEEEET-------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred cceEEEeEEeeecCCeEEEEEEEC-------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecC
Confidence 356999999999999999999986 5568999999976655666678899999999999999999999998765
Q ss_pred C------eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 142 G------KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 142 ~------~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
+ ..|+|||++ +++|.+++. . ..+++.
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~----------------------------------------------~-~~l~~~ 128 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFM-GTDLGKLMK----------------------------------------------H-EKLGED 128 (367)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHH----------------------------------------------H-CCCCHH
T ss_pred CccccCceEEEEEecC-CCCHHHHHh----------------------------------------------c-CCCCHH
Confidence 3 357777777 555554443 2 368999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+|+..
T Consensus 129 ~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 129 RIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 99999999999999999999999999999999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-31 Score=240.68 Aligned_cols=159 Identities=31% Similarity=0.394 Sum_probs=137.5
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~ 137 (267)
+...++|++.+.||+|+||.||+|++. .+++.||+|++....... .....+.+|+.+++.++||||++++++
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~-------~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 253 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMK-------ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYA 253 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEEC-------CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 345578999999999999999999986 456899999997654322 234678899999999999999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
+.+.+..|+||||+.+|+|..++..... ....+++..+
T Consensus 254 ~~~~~~l~lVmE~~~gg~L~~~l~~~~~------------------------------------------~~~~l~e~~~ 291 (543)
T 3c4z_A 254 FETKTDLCLVMTIMNGGDIRYHIYNVDE------------------------------------------DNPGFQEPRA 291 (543)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHTSST------------------------------------------TSCSCCHHHH
T ss_pred EeeCCEEEEEEEeccCCCHHHHHHHhhc------------------------------------------ccccccHHHH
Confidence 9999999999999999999877754311 1236899999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.+.
T Consensus 292 ~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999999999999999999999999999999999998653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=225.08 Aligned_cols=152 Identities=28% Similarity=0.431 Sum_probs=133.5
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++.+.||+|+||.||+|.+. .+++.||+|++............+.+|+.+++.++||||+++++++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 95 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNK-------DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEET-------TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEEC-------CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence 4567999999999999999999986 456899999997776666667788999999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+||||+.+++|..+.. ....+++..+..+
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~----------------------------------------------~~~~~~~~~~~~~ 129 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLEL----------------------------------------------FPNGLDYQVVQKY 129 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHH----------------------------------------------STTCCCHHHHHHH
T ss_pred CCEEEEEEecCCcchHHHHHh----------------------------------------------hccCCCHHHHHHH
Confidence 999999999998877755433 3346899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 130 ~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 130 LFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred HHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 999999999999999999999999999999999999999999754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=219.69 Aligned_cols=151 Identities=34% Similarity=0.563 Sum_probs=134.1
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .++..||+|++.....+......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHK-------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE 77 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEc-------CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC
Confidence 356999999999999999999986 4568999999988776777778899999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..+++||++.+++|.+.+. ....+++..+..++
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~----------------------------------------------~~~~~~~~~~~~~~ 111 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIV----------------------------------------------AREFYSEADASHCI 111 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHH----------------------------------------------HHSSCCHHHHHHHH
T ss_pred CEEEEEEecCCCCCHHHHHH----------------------------------------------hcCCCCHHHHHHHH
Confidence 99999999999877765553 33468999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCc---eEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGI---VKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~---~kl~DFGla~~l 265 (267)
.|++.||.|||++|++||||||+||+++.++. +||+|||+|...
T Consensus 112 ~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 112 QQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp HHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999999999999999999999976654 999999999754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=240.00 Aligned_cols=156 Identities=32% Similarity=0.541 Sum_probs=134.3
Q ss_pred ccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeee
Q psy2579 57 SLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYE 136 (267)
Q Consensus 57 ~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~ 136 (267)
..|...++|++.+.||+|+||.||+|.+. .+++.||||++............+.+|+.+++.++||||+++++
T Consensus 16 ~~g~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 88 (486)
T 3mwu_A 16 FQGTFAERYNIVCMLGKGSFGEVLKCKDR-------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88 (486)
T ss_dssp TCCHHHHHEEEEEEEECCSSSEEEEEEET-------TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccCChhcceEEeEEEeecCCEEEEEEEEC-------CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 33445567999999999999999999986 45689999999765433344567899999999999999999999
Q ss_pred eeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 137 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 137 ~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
++...+..|+|||||.+|+|.+.+. ....+++..
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~~~----------------------------------------------~~~~~~~~~ 122 (486)
T 3mwu_A 89 ILEDSSSFYIVGELYTGGELFDEII----------------------------------------------KRKRFSEHD 122 (486)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHH----------------------------------------------HHSSCCHHH
T ss_pred EEEcCCEEEEEEEcCCCCcHHHHHH----------------------------------------------hcCCCCHHH
Confidence 9999999999999999887766554 334689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEee---cCCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS---VRGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~---~~~~~kl~DFGla~~l 265 (267)
+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||+|+.+
T Consensus 123 ~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred HHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 999999999999999999999999999999995 4567999999999765
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-31 Score=238.37 Aligned_cols=150 Identities=23% Similarity=0.396 Sum_probs=133.3
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
..+|++.+.||+|+||.||+|.+. .++..||||+++..... .+.+.+|+.+++.++||||+++++++...
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEG-------GGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeEecCCCCeEEEEEEEc-------CCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 456999999999999999999986 44589999999765432 46789999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+||||+.+|+|.+++.... ...+++..+..++
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~--------------------------------------------~~~~~~~~~~~i~ 324 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECN--------------------------------------------RQEVSAVVLLYMA 324 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSC--------------------------------------------TTTSCHHHHHHHH
T ss_pred CcEEEEEEccCCCCHHHHHHhcC--------------------------------------------cCCCCHHHHHHHH
Confidence 99999999999999988776431 2358889999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 325 ~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 325 TQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred HHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 99999999999999999999999999999999999999999865
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=227.69 Aligned_cols=157 Identities=25% Similarity=0.406 Sum_probs=130.3
Q ss_pred cccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeee
Q psy2579 56 TSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLY 135 (267)
Q Consensus 56 ~~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~ 135 (267)
......+++|++.+.||+|+||.||+|++. .+++.||+|++............+.+|+.+++.++||||++++
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 82 (351)
T 3mi9_A 10 CPFCDEVSKYEKLAKIGQGTFGEVFKARHR-------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 82 (351)
T ss_dssp CTTSCBGGGEEEEEECSSCSTTSEEEEEET-------TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccccceeEEEEEecCCCcEEEEEEEC-------CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHh
Confidence 344556788999999999999999999986 4568999999976654444445678999999999999999999
Q ss_pred eeeeec--------CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhc
Q psy2579 136 EVLETF--------GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKIT 207 (267)
Q Consensus 136 ~~~~~~--------~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~ 207 (267)
+++... +..|+||||+.+ ++...+. .
T Consensus 83 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~---------------------------------------------~ 116 (351)
T 3mi9_A 83 EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLS---------------------------------------------N 116 (351)
T ss_dssp EEEEEC--------CEEEEEEECCSE-EHHHHHH---------------------------------------------C
T ss_pred heeeccccccccCCceEEEEEeccCC-CHHHHHh---------------------------------------------h
Confidence 998874 456777777764 3333332 1
Q ss_pred ccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 208 TEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 208 ~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 117 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 117 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 2346899999999999999999999999999999999999999999999999999754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=226.28 Aligned_cols=150 Identities=27% Similarity=0.414 Sum_probs=131.0
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
..|++.+.||+|+||.||+|.+. .+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 126 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDV-------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 126 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hheeeeeEEccCCCEEEEEEEEc-------cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 45999999999999999999986 4568999999976543 334557789999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+||||+. |++.+.+.. ...++++..+..++
T Consensus 127 ~~~~lv~e~~~-g~l~~~l~~---------------------------------------------~~~~l~~~~~~~i~ 160 (348)
T 1u5q_A 127 HTAWLVMEYCL-GSASDLLEV---------------------------------------------HKKPLQEVEIAAVT 160 (348)
T ss_dssp TEEEEEEECCS-EEHHHHHHH---------------------------------------------HTSCCCHHHHHHHH
T ss_pred CeEEEEEecCC-CCHHHHHHH---------------------------------------------hcCCCCHHHHHHHH
Confidence 99999999997 466554432 23468999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||.|||++|++||||||+|||++.++.+||+|||+|+.+
T Consensus 161 ~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 161 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp HHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred HHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 99999999999999999999999999999999999999999765
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=219.87 Aligned_cols=158 Identities=24% Similarity=0.348 Sum_probs=131.4
Q ss_pred cCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeee
Q psy2579 58 LGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 58 ~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~ 137 (267)
++.....|++.+.||+|+||.||+|.+.... .....||+|.+.... .......+.+|+.+++.++||||++++++
T Consensus 20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 94 (298)
T 3f66_A 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDND----GKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGI 94 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEC---------CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred cCccceehhhcceeeecCCceEEEEEEecCC----CceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeE
Confidence 3444556999999999999999999875332 334578999987643 44556789999999999999999999998
Q ss_pred e-eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 138 L-ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 138 ~-~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
+ ...+..+++||++.+|+|.+++... ...+++..
T Consensus 95 ~~~~~~~~~~v~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~ 129 (298)
T 3f66_A 95 CLRSEGSPLVVLPYMKHGDLRNFIRNE---------------------------------------------THNPTVKD 129 (298)
T ss_dssp ECCSSSCCEEEEECCTTCBHHHHHHCT---------------------------------------------TCCCCHHH
T ss_pred EEcCCCceEEEEeCCCCCCHHHHHHhc---------------------------------------------ccCCCHHH
Confidence 5 4556789999999998887777542 23578899
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 130 ~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 130 LIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred HHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 9999999999999999999999999999999999999999999999764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-31 Score=236.57 Aligned_cols=149 Identities=29% Similarity=0.417 Sum_probs=126.0
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++++.||+|+||.||+|.+. .+++.||||++............+.+|+.+++.++||||+++++++..
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 132 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDA-------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 132 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEET-------TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred ecCCeEEEEEeecCCCeEEEEEEEC-------CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEcc
Confidence 3577999999999999999999986 456899999998765566667889999999999999999999999865
Q ss_pred c------CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCCh
Q psy2579 141 F------GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214 (267)
Q Consensus 141 ~------~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~ 214 (267)
. ...|+||||+.++ +. +.+. ..+++
T Consensus 133 ~~~~~~~~~~~lv~E~~~~~-l~----------------------------------------------~~~~--~~l~~ 163 (464)
T 3ttj_A 133 QKTLEEFQDVYLVMELMDAN-LC----------------------------------------------QVIQ--MELDH 163 (464)
T ss_dssp CCSTTTCCEEEEEEECCSEE-HH----------------------------------------------HHHT--SCCCH
T ss_pred CCccccCCeEEEEEeCCCCC-HH----------------------------------------------HHHh--hcCCH
Confidence 4 3568888887653 22 2221 24889
Q ss_pred hHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 164 ~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 164 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 999999999999999999999999999999999999999999999999764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=239.48 Aligned_cols=157 Identities=31% Similarity=0.568 Sum_probs=129.3
Q ss_pred cccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeee
Q psy2579 56 TSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLY 135 (267)
Q Consensus 56 ~~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~ 135 (267)
...+...+.|++.+.||+|+||.||+|.+. .++..||+|++............+.+|+.+++.++||||++++
T Consensus 30 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 102 (494)
T 3lij_A 30 SKKGHLSEMYQRVKKLGSGAYGEVLLCRDK-------VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102 (494)
T ss_dssp CCBCCHHHHEEEEEEEECC---EEEEEEET-------TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cCCCchhcCeEEeeEEecCCCEEEEEEEEC-------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 334444567999999999999999999986 4568999999987654444456789999999999999999999
Q ss_pred eeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 136 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 136 ~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
+++...+..|+|||||.+|+|.+.+. ...++++.
T Consensus 103 ~~~~~~~~~~lv~e~~~~g~L~~~~~----------------------------------------------~~~~~~~~ 136 (494)
T 3lij_A 103 DFFEDKRNYYLVMECYKGGELFDEII----------------------------------------------HRMKFNEV 136 (494)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHH----------------------------------------------HHSSCCHH
T ss_pred EEEEeCCEEEEEEecCCCCcHHHHHH----------------------------------------------HcCCCCHH
Confidence 99999999999999999877766554 33468999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecC---CceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVR---GIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~---~~~kl~DFGla~~l 265 (267)
.+..++.|++.||.|||++||+||||||+|||++.. +.+||+|||+|+.+
T Consensus 137 ~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 137 DAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999999999999999999999999999999764 45999999999765
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=225.27 Aligned_cols=173 Identities=25% Similarity=0.314 Sum_probs=137.2
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 140 (267)
.++|++.+.||+|+||.||+|.+.........++..||+|++.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4679999999999999999999853322222456789999997653 445567899999999999 99999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+||||+.+|+|.+++......... ......-.....+++..+..+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~i 162 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGME------------------------------YSYDINRVPEEQMTFKDLVSC 162 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCC------------------------------SCC--------CCCHHHHHHH
T ss_pred CCceEEEEECCCCCcHHHHHHHhcccccc------------------------------ccccccccccccCCHHHHHHH
Confidence 99999999999999999998765321100 000000011235899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 163 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 207 (334)
T 2pvf_A 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207 (334)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccc
Confidence 999999999999999999999999999999999999999999764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=238.10 Aligned_cols=152 Identities=30% Similarity=0.496 Sum_probs=124.8
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
..++|++.+.||+|+||.||+|.+. .+++.||||++..... .......+.+|+.+++.++||||+++++++.
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEK-------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEc-------CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence 3567999999999999999999986 5568999999976532 2334566789999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+..|+|||||.+|+|.+++.. ...+++..+..
T Consensus 219 ~~~~~~lv~e~~~~~~L~~~l~~----------------------------------------------~~~~~~~~~~~ 252 (446)
T 4ejn_A 219 THDRLCFVMEYANGGELFFHLSR----------------------------------------------ERVFSEDRARF 252 (446)
T ss_dssp ETTEEEEEECCCSSCBHHHHHHH----------------------------------------------HSCCCHHHHHH
T ss_pred eCCEEEEEEeeCCCCcHHHHHHh----------------------------------------------cCCCCHHHHHH
Confidence 99999999999999888766543 34689999999
Q ss_pred HHHHHHHHHHHHHh-CCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHD-RDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+..
T Consensus 253 ~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 253 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp HHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred HHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 99999999999998 99999999999999999999999999999753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=220.42 Aligned_cols=158 Identities=27% Similarity=0.502 Sum_probs=134.4
Q ss_pred cCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeee
Q psy2579 58 LGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 58 ~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~ 137 (267)
.|...++|++.+.||+|+||.||+|.+. .++..||+|++..... ....+.+.+|+.+++.++||||++++++
T Consensus 17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 88 (285)
T 3is5_A 17 QGTIDDLFIFKRKLGSGAFGDVHLVEER-------SSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEV 88 (285)
T ss_dssp SSCHHHHEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCChhhheeecceeccCCCeEEEEEEEc-------cCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHh
Confidence 3444567999999999999999999986 4568999999976542 2334678899999999999999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
+...+..|+|||++.+|+|.+.+... ......+++..+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~------------------------------------------~~~~~~~~~~~~ 126 (285)
T 3is5_A 89 FEDYHNMYIVMETCEGGELLERIVSA------------------------------------------QARGKALSEGYV 126 (285)
T ss_dssp EECSSEEEEEECCCSCCBHHHHHHHH------------------------------------------HHHTCCCCHHHH
T ss_pred eecCCeEEEEEEeCCCCcHHHHHHhh------------------------------------------hhcccCCCHHHH
Confidence 99999999999999999988766432 112347899999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEe---ecCCceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFL---SVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~l 265 (267)
..++.|++.||+|||++|++||||||+||++ +.++.+||+|||+|+.+
T Consensus 127 ~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 127 AELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred HHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999999999999999999999999 44578999999999754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=224.49 Aligned_cols=147 Identities=29% Similarity=0.506 Sum_probs=130.3
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
..|+..+.||+|+||.||+|.+. .+++.||||++..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~-------~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREK-------HSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE 115 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred hhhhccEEeccCCCeEEEEEEEC-------CCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence 34888889999999999999985 4568999999976542 23466889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..++||||+.+++|.+++.. ..+++..+..++.
T Consensus 116 ~~~lv~e~~~~~~L~~~l~~-----------------------------------------------~~l~~~~~~~i~~ 148 (321)
T 2c30_A 116 ELWVLMEFLQGGALTDIVSQ-----------------------------------------------VRLNEEQIATVCE 148 (321)
T ss_dssp EEEEEECCCCSCBHHHHHTT-----------------------------------------------CCCCHHHHHHHHH
T ss_pred EEEEEEecCCCCCHHHHHHh-----------------------------------------------cCCCHHHHHHHHH
Confidence 99999999999888766532 2689999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 149 qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 191 (321)
T 2c30_A 149 AVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 191 (321)
T ss_dssp HHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeec
Confidence 9999999999999999999999999999999999999998765
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=229.28 Aligned_cols=153 Identities=33% Similarity=0.442 Sum_probs=131.7
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch------HHHHHHHHHHHHHhhcCCCceeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP------KARKMLSREIVSMESVHHPNIIRL 134 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~Ei~~l~~l~hpnIv~~ 134 (267)
..++|++.+.||+|+||.||+|.+. .+++.||||++....... .....+.+|+.+++.++||||+++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 94 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDK-------EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKV 94 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEET-------TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCE
T ss_pred cccceEEEeEEEecCCEEEEEEEEC-------CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 3456999999999999999999986 456899999998764322 133457789999999999999999
Q ss_pred eeeeeecCeEEEEEeecCCC-chhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCC
Q psy2579 135 YEVLETFGKIFLVVEYASGG-ELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLS 213 (267)
Q Consensus 135 ~~~~~~~~~~~iv~e~~~~g-sl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~ 213 (267)
++++...+..++|||++.+| +|.+++ .....++
T Consensus 95 ~~~~~~~~~~~lv~e~~~~g~~l~~~~----------------------------------------------~~~~~l~ 128 (335)
T 3dls_A 95 LDIFENQGFFQLVMEKHGSGLDLFAFI----------------------------------------------DRHPRLD 128 (335)
T ss_dssp EEEEECSSEEEEEEECCTTSCBHHHHH----------------------------------------------HTCCCCC
T ss_pred EEEEeeCCEEEEEEEeCCCCccHHHHH----------------------------------------------HhcCCCC
Confidence 99999999999999998765 665544 3445789
Q ss_pred hhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 214 EDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 214 ~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 129 ~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 129 EPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 99999999999999999999999999999999999999999999999998653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-30 Score=221.28 Aligned_cols=161 Identities=22% Similarity=0.298 Sum_probs=129.8
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++.+.||+|+||.||+|.+.... .++..||+|++..........+.+.+|+.+++.++||||+++++++..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQED----GTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTT----SCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccC----CceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 3467999999999999999999886432 345789999998776666677889999999999999999999999887
Q ss_pred cCe-----EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 141 FGK-----IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 141 ~~~-----~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
.+. .+++||++.+|+|.+++..... -.....+++.
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~----------------------------------------~~~~~~~~~~ 147 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRL----------------------------------------ETGPKHIPLQ 147 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTB----------------------------------------TTSCCCCCHH
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhh----------------------------------------hcCCccCCHH
Confidence 653 5899999999888877643211 0123468999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 148 ~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~ 197 (313)
T 3brb_A 148 TLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI 197 (313)
T ss_dssp HHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC---
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceec
Confidence 99999999999999999999999999999999999999999999999764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=221.16 Aligned_cols=154 Identities=23% Similarity=0.361 Sum_probs=128.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec-
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF- 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~- 141 (267)
..|++.+.||+|+||.||+|.+.... ..+++.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~---~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEG---DNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTS---SSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhccCCCCceEEEEEEEcccc---CccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 45999999999999999999853211 1457899999997654 223346789999999999999999999999876
Q ss_pred -CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 142 -GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 142 -~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
...+++|||+.+|+|.+++... ...+++..+..+
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~~ 131 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKN---------------------------------------------KNKINLKQQLKY 131 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHH---------------------------------------------TTTCCHHHHHHH
T ss_pred CceEEEEEEeCCCCcHHHHHHhc---------------------------------------------cccCCHHHHHHH
Confidence 6688999999988887766432 236899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||+|||++|++||||||+||+++.++.++|+|||+|+.+
T Consensus 132 ~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 132 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred HHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 999999999999999999999999999999999999999999765
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=224.70 Aligned_cols=146 Identities=23% Similarity=0.308 Sum_probs=126.0
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++.+.||+|+||.||+|.+. ++.||||++.... .......+|+.+++.++||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 89 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL---------NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKR 89 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET---------TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC---------CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceecc
Confidence 3467999999999999999999764 4889999996542 334456679999999999999999999987
Q ss_pred cC----eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 141 FG----KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 141 ~~----~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
.+ ..|+|||||.+|+|.+++.. ..+++..
T Consensus 90 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----------------------------------------------~~~~~~~ 122 (322)
T 3soc_A 90 GTSVDVDLWLITAFHEKGSLSDFLKA-----------------------------------------------NVVSWNE 122 (322)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHH-----------------------------------------------CCBCHHH
T ss_pred CCCCCceEEEEEecCCCCCHHHHHHh-----------------------------------------------cCCCHHH
Confidence 54 36889999888888776643 2588999
Q ss_pred HHHHHHHHHHHHHHHHhC----------CCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDR----------DIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~----------~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+|+.+
T Consensus 123 ~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~ 181 (322)
T 3soc_A 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181 (322)
T ss_dssp HHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccc
Confidence 999999999999999999 9999999999999999999999999999754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=219.54 Aligned_cols=157 Identities=31% Similarity=0.500 Sum_probs=136.1
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
...++|++.+.||+|+||.||+|.+. .+++.||+|++..........+.+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRK-------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CchhheeeehhccCCCCcEEEEEEEC-------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 45678999999999999999999986 45689999999877766677788999999999999999999999875
Q ss_pred e--cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 140 T--FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 140 ~--~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
. .+..|++|||+++++|.+++.... .....+++..+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------~~~~~~~~~~~ 113 (279)
T 2w5a_A 76 DRTNTTLYIVMEYCEGGDLASVITKGT------------------------------------------KERQYLDEEFV 113 (279)
T ss_dssp EGGGTEEEEEEECCTTEEHHHHHHHHH------------------------------------------HTTCCCCHHHH
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHhhc------------------------------------------ccCCCCCHHHH
Confidence 4 578999999999988887775321 11235899999
Q ss_pred HHHHHHHHHHHHHHHhCC-----CcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRD-----IIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~-----ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..++.|++.||+|||++| ++||||||+||+++.++.+||+|||+++.+
T Consensus 114 ~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~ 166 (279)
T 2w5a_A 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166 (279)
T ss_dssp HHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC
T ss_pred HHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheee
Confidence 999999999999999999 999999999999999999999999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-30 Score=220.81 Aligned_cols=179 Identities=23% Similarity=0.337 Sum_probs=139.7
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
...+|++.+.||+|+||.||+|.+..... ..++..||+|++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKG--RAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGG--CSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCc--ccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 34669999999999999999998853321 1345889999997543 45566789999999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhh-hhcccCCCChhHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYN-KITTEGRLSEDDAKI 219 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~-~~~~~~~~~~~~~~~ 219 (267)
.+..+++|||+.+|+|.+++.............. ....... .......+++..+..
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~ 154 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG-----------------------GSRNSSSLDHPDERALTMGDLIS 154 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC---------------------------------------CEECHHHHHH
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCccccc-----------------------ccccccccccccccCcCHHHHHH
Confidence 9999999999999999999986543211000000 0000000 001223588999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||.|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 155 i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~ 200 (314)
T 2ivs_A 155 FAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200 (314)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccc
Confidence 9999999999999999999999999999999999999999999764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=224.08 Aligned_cols=153 Identities=28% Similarity=0.370 Sum_probs=124.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+..++. ....+||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 89 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGE---KVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC-------CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCc---eEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence 569999999999999999999864331 112457888886433 334457789999999999999999999999865
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++++++.+|+|.+++... ...+++..+..++.
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~---------------------------------------------~~~~~~~~~~~~~~ 124 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREH---------------------------------------------KDNIGSQYLLNWCV 124 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHS---------------------------------------------TTSCCHHHHHHHHH
T ss_pred CeEEEEEecCCCcHHHHHHhc---------------------------------------------CCCCCHHHHHHHHH
Confidence 478899999998887776542 23689999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 125 qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred HHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 9999999999999999999999999999999999999999754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-30 Score=218.12 Aligned_cols=145 Identities=17% Similarity=0.145 Sum_probs=127.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||.||+|.+. .+++.||||++...... ......+.+|+.+++.++||||+++++++...
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 103 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDT-------ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR 103 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEET-------TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred CcEEEEEEEcccCCeEEEEEEec-------CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC
Confidence 66999999999999999999986 45689999999876543 45567899999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+||||+++++|.+++.. .....++..++
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~------------------------------------------------~~~~~~~~~i~ 135 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADT------------------------------------------------SPSPVGAIRAM 135 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTT------------------------------------------------CCCHHHHHHHH
T ss_pred CcEEEEEEecCCCCHHHHHhc------------------------------------------------CCChHHHHHHH
Confidence 999999999999888776632 13555788899
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla 262 (267)
.|++.||+|||++||+||||||+|||++.+|.+||+++|..
T Consensus 136 ~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 136 QSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp HHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred HHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecccc
Confidence 99999999999999999999999999999999999987754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=236.17 Aligned_cols=157 Identities=34% Similarity=0.538 Sum_probs=131.0
Q ss_pred ccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-----------HHHHHHHHHHHHHhh
Q psy2579 57 SLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-----------KARKMLSREIVSMES 125 (267)
Q Consensus 57 ~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~~Ei~~l~~ 125 (267)
..+...++|++.+.||+|+||.||+|.+. .++..||+|++....... ...+.+.+|+.+++.
T Consensus 30 ~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 102 (504)
T 3q5i_A 30 KEGKIGESYFKVRKLGSGAYGEVLLCKEK-------NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102 (504)
T ss_dssp ECSCGGGTEEEEEEEEC--CEEEEEEEET-------TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHT
T ss_pred cCCCcccceEEEeEecccCCeEEEEEEEC-------CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHh
Confidence 33445577999999999999999999986 456899999997654321 234678999999999
Q ss_pred cCCCceeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhh
Q psy2579 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNK 205 (267)
Q Consensus 126 l~hpnIv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~ 205 (267)
++||||+++++++...+..|+|||||.+|+|.+.+.
T Consensus 103 l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~-------------------------------------------- 138 (504)
T 3q5i_A 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII-------------------------------------------- 138 (504)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH--------------------------------------------
T ss_pred CCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHH--------------------------------------------
Confidence 999999999999999999999999999877766554
Q ss_pred hcccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC---ceEEeccccccccC
Q psy2579 206 ITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG---IVKLGDLGFSTKLQ 266 (267)
Q Consensus 206 ~~~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~---~~kl~DFGla~~l~ 266 (267)
....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 139 --~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 200 (504)
T 3q5i_A 139 --NRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200 (504)
T ss_dssp --HHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECC
T ss_pred --HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcC
Confidence 334689999999999999999999999999999999999998776 69999999997653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-30 Score=222.68 Aligned_cols=155 Identities=26% Similarity=0.343 Sum_probs=130.7
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
..+|++.+.||+|+||.||+|.+.... ...+..||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~---~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSS---GKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC------CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCC---CCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 456999999999999999999886432 1224579999997543 445567799999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..++|||++.+|+|.+++... ...+++..+..++
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~i~ 153 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREK---------------------------------------------DGEFSVLQLVGML 153 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHT---------------------------------------------TTCSCHHHHHHHH
T ss_pred CCcEEEEeCCCCCcHHHHHHhC---------------------------------------------CCCCCHHHHHHHH
Confidence 9999999999998887776532 2368999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||.|||++|++||||||+||+++.++.+||+|||+++.+
T Consensus 154 ~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 154 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred HHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999999999999999999999999999999765
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=224.05 Aligned_cols=146 Identities=19% Similarity=0.286 Sum_probs=128.2
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||.||+|.+. .+++.||||++...... ..+.+|+.+++.+ +||||+++++++...
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 77 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNL-------YTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCG 77 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEET-------TTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEET
T ss_pred CCeEEEEEeeccCCceEEEEEEC-------CCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecC
Confidence 46999999999999999999986 45689999998754322 3578999999999 999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..++|||++ +++|.+++... ...+++..+..++
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~---------------------------------------------~~~~~~~~~~~i~ 111 (330)
T 2izr_A 78 KYNAMVLELL-GPSLEDLFDLC---------------------------------------------DRTFSLKTVLMIA 111 (330)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT---------------------------------------------TTCCCHHHHHHHH
T ss_pred CccEEEEEeC-CCCHHHHHHHc---------------------------------------------CCCCCHHHHHHHH
Confidence 9999999999 88887766532 2368999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCc-----eEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGI-----VKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~-----~kl~DFGla~~l 265 (267)
.|++.||+|||++||+||||||+|||++.++. +||+|||+|+.+
T Consensus 112 ~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 112 IQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp HHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred HHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99999999999999999999999999998887 999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-30 Score=218.60 Aligned_cols=151 Identities=23% Similarity=0.391 Sum_probs=133.6
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
...+|++.+.||+|+||.||+|.+. .++..||+|++.... ...+.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEG-------GGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccceeEEeecCCCCceeEEEeEec-------CCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 3456999999999999999999986 456899999997543 345678899999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+|||++.+++|.+++.... ...+++..+..+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~--------------------------------------------~~~~~~~~~~~i 116 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECN--------------------------------------------RQEVSAVVLLYM 116 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCC--------------------------------------------TTTSCHHHHHHH
T ss_pred CCCEEEEEEcCCCCcHHHHHHhcc--------------------------------------------cCCccHhHHHHH
Confidence 999999999999988887775431 235899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||++|++||||||+||+++.++.++|+|||+|+.+
T Consensus 117 ~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp HHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred HHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 999999999999999999999999999999999999999999764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-30 Score=219.44 Aligned_cols=174 Identities=22% Similarity=0.287 Sum_probs=139.0
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~ 139 (267)
..++|++.+.||+|+||.||+|.+..... ..++..||+|++.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIK--SDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSS--TTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccc--cchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 34679999999999999999998642110 1456899999997654 344567899999999999 9999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhh-hcccCCCChhHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNK-ITTEGRLSEDDAK 218 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~-~~~~~~~~~~~~~ 218 (267)
..+..+++||++.+|+|.+++........... ..... -....++++..+.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~ 148 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSK-----------------------------TSPAIMEDDELALDLEDLL 148 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC-------------------------------------------CCCCHHHHH
T ss_pred cCCCcEEEEecCCCCCHHHHHHhccccccccc-----------------------------ccccccccccccCCHHHHH
Confidence 99999999999999999999876533110000 00000 1123468999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.++.|++.||.|||++|++||||||+||+++.++.+||+|||+|+.+.
T Consensus 149 ~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 196 (313)
T 1t46_A 149 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196 (313)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTT
T ss_pred HHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEcccccccccc
Confidence 999999999999999999999999999999999999999999998653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-30 Score=220.57 Aligned_cols=156 Identities=24% Similarity=0.378 Sum_probs=131.3
Q ss_pred ccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeee
Q psy2579 57 SLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLY 135 (267)
Q Consensus 57 ~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~ 135 (267)
..+..+++|++.+.||+|+||.||+|.+. .+++.||+|++...... ......+.+|+.+++.++||||++++
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~ 100 (309)
T 2h34_A 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDT-------VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100 (309)
T ss_dssp ------CCEEEEEEEEECSSSEEEEEEET-------TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CCCcEeccEEEEEEEcCCCCeeEEEEEEc-------CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 45666788999999999999999999986 45689999999765433 34567899999999999999999999
Q ss_pred eeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 136 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 136 ~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
+++...+..|++||++.+++|.+++.. .+++++.
T Consensus 101 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----------------------------------------------~~~~~~~ 134 (309)
T 2h34_A 101 DFGEIDGQLYVDMRLINGVDLAAMLRR----------------------------------------------QGPLAPP 134 (309)
T ss_dssp EEEEETTEEEEEEECCCCEEHHHHHHH----------------------------------------------HCSCCHH
T ss_pred EEEeeCCeEEEEEEecCCCCHHHHHHh----------------------------------------------cCCCCHH
Confidence 999999999999999998887766643 3468999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++..
T Consensus 135 ~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 135 RAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred HHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 99999999999999999999999999999999999999999999998754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=228.70 Aligned_cols=156 Identities=24% Similarity=0.267 Sum_probs=128.6
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC---CCceeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH---HPNIIRLYEVL 138 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~~~~~~ 138 (267)
..+|++.+.||+|+||.||+|.+..... ..+++.||||++.... ...+.+|+.++..++ |+||+.+++++
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLND--AKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC---------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcc--cccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 4569999999999999999996432111 1456899999997542 235677888888876 99999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
...+..|+|||||.+|+|.+++..... .....+++..+.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------~~~~~l~~~~~~ 175 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKN-----------------------------------------TPEKVMPQGLVI 175 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHT-----------------------------------------STTCSCCHHHHH
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhc-----------------------------------------ccccCCCHHHHH
Confidence 999999999999999999888764211 023469999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeec-----------CCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSV-----------RGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~-----------~~~~kl~DFGla~~l 265 (267)
.++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+.+
T Consensus 176 ~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~ 233 (365)
T 3e7e_A 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233 (365)
T ss_dssp HHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEG
T ss_pred HHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhh
Confidence 99999999999999999999999999999998 899999999999754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-30 Score=221.30 Aligned_cols=166 Identities=20% Similarity=0.263 Sum_probs=137.2
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++.+.||+|+||.||+|.+..... ..++..||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVK--DEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEET--TEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccC--CCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 34679999999999999999998863211 1345889999997543 34556678999999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..++|||++.+|+|.+++..... ....-.....+++..+..+
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------~~~~~~~~~~~~~~~~~~i 143 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRP------------------------------------AMANNPVLAPPSLSKMIQM 143 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHH------------------------------------HHHHCTTCCCCCHHHHHHH
T ss_pred CCccEEEEEeCCCCcHHHHHHHhch------------------------------------hhccCCCCCCcCHHHHHHH
Confidence 9999999999999999988864311 0000011235789999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 144 ~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~ 188 (322)
T 1p4o_A 144 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 188 (322)
T ss_dssp HHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGG
T ss_pred HHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCcccccc
Confidence 999999999999999999999999999999999999999999754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-30 Score=217.42 Aligned_cols=151 Identities=33% Similarity=0.509 Sum_probs=131.0
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
...|++.+.||+|+||.||+|.+. .++..||+|++.....+......+.+|+.+++.++||||+++++++...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 97 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDT-------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 97 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEec-------CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc
Confidence 344999999999999999999886 4568999999988777777788899999999999999999999998753
Q ss_pred ----CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 142 ----GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 142 ----~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
+..++||||+++|+|.+++. ....+++..+
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~l~----------------------------------------------~~~~~~~~~~ 131 (290)
T 1t4h_A 98 VKGKKCIVLVTELMTSGTLKTYLK----------------------------------------------RFKVMKIKVL 131 (290)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHH----------------------------------------------HHSSCCHHHH
T ss_pred cCCCceEEEEEEecCCCCHHHHHH----------------------------------------------HccCCCHHHH
Confidence 45788888888777766554 3346889999
Q ss_pred HHHHHHHHHHHHHHHhCC--CcccCCCCCcEEee-cCCceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRD--IIHRDIKAENVFLS-VRGIVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DFGla~~l 265 (267)
..++.|++.||.|||++| ++||||||+||+++ .++.+||+|||+|+..
T Consensus 132 ~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp HHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred HHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 999999999999999999 99999999999997 7889999999999653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=218.83 Aligned_cols=153 Identities=31% Similarity=0.559 Sum_probs=133.0
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
..+++|++.+.||+|+||.||+|.+. .++..||+|++....... .....+.+|+.+++.++||||+++++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREK-------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEc-------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE
Confidence 34577999999999999999999986 456899999996544322 2246688999999999999999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
...+..+++|||+.+|+|.+.+.. ...+++..+.
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~----------------------------------------------~~~~~~~~~~ 112 (279)
T 3fdn_A 79 HDATRVYLILEYAPLGTVYRELQK----------------------------------------------LSKFDEQRTA 112 (279)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHH----------------------------------------------HSSCCHHHHH
T ss_pred ecCCEEEEEEecCCCCcHHHHHHh----------------------------------------------cCCCCHHHHH
Confidence 999999999999998777665543 3468999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||+|||++|++||||||+||+++.++.++|+|||++...
T Consensus 113 ~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 113 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp HHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred HHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 99999999999999999999999999999999999999999998654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-30 Score=223.49 Aligned_cols=147 Identities=25% Similarity=0.437 Sum_probs=129.6
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCC--Cceeeeeeeeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHH--PNIIRLYEVLET 140 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~~~~~~~~ 140 (267)
.+|++.+.||+|+||.||+|.+. +++.||||++..........+.+.+|+.+++.++| |||+++++++..
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 80 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNE--------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 80 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECT--------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CEEEEEEEEecCCCeEEEEEEeC--------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence 45999999999999999999873 35889999998776666777889999999999976 999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+||| +.+++|.+++. ....+++.++..+
T Consensus 81 ~~~~~lv~e-~~~~~L~~~l~----------------------------------------------~~~~~~~~~~~~i 113 (343)
T 3dbq_A 81 DQYIYMVME-CGNIDLNSWLK----------------------------------------------KKKSIDPWERKSY 113 (343)
T ss_dssp SSEEEEEEC-CCSEEHHHHHH----------------------------------------------HSCCCCHHHHHHH
T ss_pred CCEEEEEEe-CCCCCHHHHHH----------------------------------------------hcCCCCHHHHHHH
Confidence 999999999 56666665554 4457899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||++||+||||||+|||++ ++.+||+|||+|+.+
T Consensus 114 ~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 114 WKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred HHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 99999999999999999999999999997 688999999999865
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-30 Score=219.62 Aligned_cols=150 Identities=27% Similarity=0.394 Sum_probs=129.8
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec--C
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF--G 142 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~--~ 142 (267)
|++++.||+|+||.||+|.+.... ..+++.||||++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~---~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTN---DGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC-----CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HhhhheecCCCCeEEEEEEEccCC---CCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 599999999999999998764322 2467899999997653 455677899999999999999999999999874 5
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..++||||+.+|+|.+++... .+++..+..++.
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~-----------------------------------------------~~~~~~~~~i~~ 141 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH-----------------------------------------------SIGLAQLLLFAQ 141 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS-----------------------------------------------CCCHHHHHHHHH
T ss_pred eEEEEEecccCCcHHHHHhhC-----------------------------------------------CCCHHHHHHHHH
Confidence 788999999888887766432 588999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 142 ~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 142 QICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp HHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred HHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999999999999999999999999999999765
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=219.66 Aligned_cols=148 Identities=26% Similarity=0.429 Sum_probs=125.2
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. ..||+|+++.........+.+.+|+.+++.++||||+++++++ ..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~----------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH----------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS----------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred ccceeeeeEecCCCCeEEEEEEEc----------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 456999999999999999999764 4599999987776777778899999999999999999999965 45
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..+++|||+.+++|.+++... ...+++..+..++
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~i~ 126 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHAS---------------------------------------------ETKFEMKKLIDIA 126 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC------------------------------------------------CCHHHHHHHH
T ss_pred CccEEEEEecCCCcHHHHHhhc---------------------------------------------cCCCCHHHHHHHH
Confidence 6688999999988887766432 2368999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||.|||++|++||||||+||+++.++.+||+|||+|+..
T Consensus 127 ~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred HHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccc
Confidence 99999999999999999999999999999999999999998754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=227.92 Aligned_cols=149 Identities=26% Similarity=0.416 Sum_probs=116.4
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++++.||+|+||.||+|.+. .+++.||||++.....+......+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 100 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDT-------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 100 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEET-------TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred CCceEEeeEEeecCCeEEEEEEEC-------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 366999999999999999999986 4568999999977655566678899999999999999999999998654
Q ss_pred ------CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 142 ------GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 142 ------~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
+..|+++|++ +++|.+++ .. ..+++.
T Consensus 101 ~~~~~~~~~~lv~e~~-~~~L~~~~----------------------------------------------~~-~~l~~~ 132 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLM-GADLNNIV----------------------------------------------KC-QKLTDD 132 (367)
T ss_dssp SSGGGCCCCEEEEECC-CEECC----------------------------------------------------CCCCHH
T ss_pred CccccCCeEEEEeccc-CCCHHHHH----------------------------------------------hc-CCCCHH
Confidence 4567777776 44554333 22 468999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 133 ~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 133 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred HHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 99999999999999999999999999999999999999999999999764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=229.60 Aligned_cols=153 Identities=25% Similarity=0.452 Sum_probs=130.5
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+. .+++.||||++..... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHK-------KTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CceEEEEEEEcCCCeEEEEEEEC-------CCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence 46999999999999999999986 4568999999976442 223466789999999999999999999988765
Q ss_pred --eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 143 --KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 143 --~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
..++|||||.+|+|.+++.... ....+++..+..+
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------~~~~l~~~~~~~i 117 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPS-------------------------------------------NAYGLPESEFLIV 117 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGG-------------------------------------------GTTCCCHHHHHHH
T ss_pred CCeeEEEEecCCCCCHHHHHHhhh-------------------------------------------cccCCCHHHHHHH
Confidence 7899999999988887775431 1124899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEe----ecCCceEEeccccccccC
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFL----SVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll----~~~~~~kl~DFGla~~l~ 266 (267)
+.|++.||+|||++||+||||||+|||+ +.++.+||+|||+|+.+.
T Consensus 118 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred HHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 9999999999999999999999999999 667789999999998653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=233.21 Aligned_cols=149 Identities=22% Similarity=0.419 Sum_probs=129.7
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .+..||||+++..... .+.+.+|+.+++.++||||+++++++. .
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN--------KHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-K 254 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET--------TTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred hHHeEEEEEcccCCceEEEEEEEC--------CccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence 456999999999999999999873 3477999999765432 467899999999999999999999986 6
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+|||||.+|+|.+++... ....+++..+..++
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~--------------------------------------------~~~~~~~~~~~~~~ 290 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSD--------------------------------------------EGSKQPLPKLIDFS 290 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSH--------------------------------------------HHHTCCHHHHHHHH
T ss_pred CccEEEEeecCCCcHHHHHHhc--------------------------------------------cCCCCCHHHHHHHH
Confidence 6789999999999988877542 11257888999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 291 ~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 291 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp HHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred HHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 999999999999999999999999999999999999999998653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-30 Score=223.66 Aligned_cols=180 Identities=23% Similarity=0.316 Sum_probs=135.4
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVL 138 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~ 138 (267)
...++|++.+.||+|+||.||+|.+..... ..++..||+|++.... .......+.+|+.+++.+ +||||+++++++
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISK--TGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSS--SSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCHHHceeeeeecCCCCceeEEeeeecccc--CCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345679999999999999999999743211 1345789999997543 334457789999999999 999999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
...+..|+||||+++|+|.+++.............+.. ......-.....+++..+.
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~l~~~~~~ 175 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN-----------------------QKRLEEEEDLNVLTFEDLL 175 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC--------------------------------------------CCHHHHH
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhh-----------------------hcccccccccccCCHHHHH
Confidence 99999999999999999999998654321111000000 0000000112358999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||+|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 176 ~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~ 222 (344)
T 1rjb_A 176 CFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222 (344)
T ss_dssp HHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCG
T ss_pred HHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCccc
Confidence 99999999999999999999999999999999999999999999754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=225.66 Aligned_cols=201 Identities=24% Similarity=0.320 Sum_probs=136.9
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 140 (267)
.++|++.+.||+|+||.||+|.+..... ..+++.||||++.... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDK--TATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSS--TTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccceeeceeecCCCCceEEEEEeccccc--cccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 4569999999999999999998753211 1456899999997653 344567799999999999 89999999999887
Q ss_pred cCe-EEEEEeecCCCchhhhhhccCCCChh--h--HHH-----HHHHHH--HHHhhh--ccCeEEEEEEEccCCchhhhh
Q psy2579 141 FGK-IFLVVEYASGGELYNKITTEGRLSED--D--AKI-----YFLQIL--LYEVLE--TFGKIFLVVEYASGGELYNKI 206 (267)
Q Consensus 141 ~~~-~~iv~e~~~~gsl~~~l~~~~~~~~~--~--~~~-----~~~~~~--~~~~~~--~~~~~~~v~e~~~~~~l~~~~ 206 (267)
.+. .+++||||.+|+|.+++......... . ... +..... +..... ......-...+.....+.+..
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 654 99999999999999999876431100 0 000 000000 000000 000000000001111111111
Q ss_pred c-------ccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 207 T-------TEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 207 ~-------~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
. ....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence 1 1224899999999999999999999999999999999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-30 Score=216.82 Aligned_cols=151 Identities=35% Similarity=0.555 Sum_probs=131.8
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
...++|++.+.||+|+||.||+|.+. .++..||+|.+...... ..+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQK-------GTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFE 76 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeC-------CCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34466999999999999999999986 45588999998765432 2467889999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+..|+||||+.+++|.+.+. ....+++..+..
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~----------------------------------------------~~~~~~~~~~~~ 110 (277)
T 3f3z_A 77 DNTDIYLVMELCTGGELFERVV----------------------------------------------HKRVFRESDAAR 110 (277)
T ss_dssp CSSEEEEEEECCCSCBHHHHHH----------------------------------------------HHCSCCHHHHHH
T ss_pred cCCeEEEEEeccCCCcHHHHHH----------------------------------------------HcCCCCHHHHHH
Confidence 9999999999998877766554 334689999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEe---ecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFL---SVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~l 265 (267)
++.|++.||+|||++|++||||||+||++ +.++.++|+|||+|+.+
T Consensus 111 i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 111 IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 99999999999999999999999999999 77889999999999764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-30 Score=218.04 Aligned_cols=155 Identities=26% Similarity=0.394 Sum_probs=125.0
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++.+.||+|+||.||+|.+. .+++.||+|++............+.++...++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~ 77 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHV-------PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR 77 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEec-------CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence 4467999999999999999999986 456899999998765444455556666667888899999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+|||++++ +|.+++.. .......+++..+..+
T Consensus 78 ~~~~~lv~e~~~~-~l~~~l~~------------------------------------------~~~~~~~~~~~~~~~i 114 (290)
T 3fme_A 78 EGDVWICMELMDT-SLDKFYKQ------------------------------------------VIDKGQTIPEDILGKI 114 (290)
T ss_dssp SSSEEEEEECCSE-EHHHHHHH------------------------------------------HHHTTCCCCHHHHHHH
T ss_pred cCCEEEEEehhcc-chHHHHHH------------------------------------------HHhcCCCCCHHHHHHH
Confidence 9999999999974 66555432 1223457999999999
Q ss_pred HHHHHHHHHHHHhC-CCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDR-DIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||+|||++ |++||||||+||+++.++.+||+|||+|+.+
T Consensus 115 ~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 115 AVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp HHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred HHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999999999998 9999999999999999999999999998754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=225.87 Aligned_cols=155 Identities=29% Similarity=0.446 Sum_probs=123.6
Q ss_pred cCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch---HHHHHHHHHHHHHhhcCCCceeee
Q psy2579 58 LGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP---KARKMLSREIVSMESVHHPNIIRL 134 (267)
Q Consensus 58 ~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~~ 134 (267)
.+...++|++.+.||+|+||.||+|.+. .+++.||||++....... .....+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 77 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDK-------NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECS-------SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCE
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEEC-------CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeE
Confidence 4456678999999999999999999986 456899999997644322 123568899999999999999999
Q ss_pred eeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCCh
Q psy2579 135 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214 (267)
Q Consensus 135 ~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~ 214 (267)
++++...+..++|||++++ +|...+... ...+++
T Consensus 78 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---------------------------------------------~~~~~~ 111 (346)
T 1ua2_A 78 LDAFGHKSNISLVFDFMET-DLEVIIKDN---------------------------------------------SLVLTP 111 (346)
T ss_dssp EEEECCTTCCEEEEECCSE-EHHHHHTTC---------------------------------------------CSSCCS
T ss_pred EEEEeeCCceEEEEEcCCC-CHHHHHHhc---------------------------------------------CcCCCH
Confidence 9999999999999999985 565544322 236889
Q ss_pred hHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 112 ~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 112 SHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp SHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred HHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 999999999999999999999999999999999999999999999999865
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-30 Score=217.65 Aligned_cols=153 Identities=22% Similarity=0.327 Sum_probs=130.5
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
..|++.+.||+|+||.||+|.+.... ..+..||+|.+.... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQA----QNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE 95 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSS----SCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred eEEccCceeccCCCceEEEEEEecCC----Cceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence 34888899999999999999876432 334579999997543 4455678999999999999999999999998766
Q ss_pred eE-EEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 143 KI-FLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 143 ~~-~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
.. +++||++.+|+|.+++... ...+++..+..++
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~---------------------------------------------~~~~~~~~~~~i~ 130 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSP---------------------------------------------QRNPTVKDLISFG 130 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCT---------------------------------------------TCCCBHHHHHHHH
T ss_pred CCcEEEEecccCCCHHHHHhcc---------------------------------------------ccCCCHHHHHHHH
Confidence 54 8999999998887776542 2368889999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 131 ~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred HHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 99999999999999999999999999999999999999999754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-30 Score=225.31 Aligned_cols=149 Identities=37% Similarity=0.563 Sum_probs=120.6
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
...++|++.+.||+|+||.||+|.+. .+++.||||++.... ..+.+.+|+.+++.++||||+++++++.
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~ 118 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQK-------GTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFE 118 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEEC-------CCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEe
Confidence 34466999999999999999999986 456899999997542 2356789999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+..++||||+.+|+|.+.+. ..+.+++..+..
T Consensus 119 ~~~~~~lv~e~~~~~~L~~~l~----------------------------------------------~~~~~~~~~~~~ 152 (349)
T 2w4o_A 119 TPTEISLVLELVTGGELFDRIV----------------------------------------------EKGYYSERDAAD 152 (349)
T ss_dssp CSSEEEEEECCCCSCBHHHHHT----------------------------------------------TCSSCCHHHHHH
T ss_pred cCCeEEEEEEeCCCCCHHHHHH----------------------------------------------hcCCCCHHHHHH
Confidence 9999999999999877766554 334689999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeec---CCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSV---RGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~---~~~~kl~DFGla~~l 265 (267)
++.|++.||.|||++|++||||||+|||++. ++.+||+|||+|+.+
T Consensus 153 i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 153 AVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred HHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999999999999999999999975 889999999999764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-30 Score=223.01 Aligned_cols=149 Identities=25% Similarity=0.394 Sum_probs=129.5
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-----CCceeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-----HPNIIRLYE 136 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-----hpnIv~~~~ 136 (267)
.++|++.+.||+|+||.||+|.+. .+++.||||++... ......+.+|+.+++.+. ||||+++++
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHI-------DNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEEC-------CCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 356999999999999999999986 45689999999642 344566788999999986 999999999
Q ss_pred eeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 137 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 137 ~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
++...+..|+|||++ +++|.+++.... ...+++..
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~--------------------------------------------~~~~~~~~ 138 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNN--------------------------------------------YNGFHIED 138 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTT--------------------------------------------TCCCCHHH
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcC--------------------------------------------CCCCCHHH
Confidence 999999999999999 888877775431 12588999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeec-------------------------CCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSV-------------------------RGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~-------------------------~~~~kl~DFGla~~l 265 (267)
+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+..
T Consensus 139 ~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~ 212 (360)
T 3llt_A 139 IKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK 212 (360)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEET
T ss_pred HHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceec
Confidence 9999999999999999999999999999999975 789999999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-30 Score=224.86 Aligned_cols=149 Identities=28% Similarity=0.415 Sum_probs=125.8
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++.+.||+|+||.||+|.+. .+++.||||++............+.+|+.+++.++||||+++++++..
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 95 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDA-------ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP 95 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhhheeEeeeeEecCCEEEEEEEEC-------CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecc
Confidence 4577999999999999999999986 456899999998765556667789999999999999999999999876
Q ss_pred cC------eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCCh
Q psy2579 141 FG------KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214 (267)
Q Consensus 141 ~~------~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~ 214 (267)
.+ ..|+||||+.+ +|.+.+ . ..+++
T Consensus 96 ~~~~~~~~~~~lv~e~~~~-~l~~~~----------------------------------------------~--~~~~~ 126 (371)
T 2xrw_A 96 QKSLEEFQDVYIVMELMDA-NLCQVI----------------------------------------------Q--MELDH 126 (371)
T ss_dssp CCSTTTCCEEEEEEECCSE-EHHHHH----------------------------------------------H--SCCCH
T ss_pred ccccccccceEEEEEcCCC-CHHHHH----------------------------------------------h--hccCH
Confidence 54 67888888764 443333 2 25889
Q ss_pred hHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 127 ~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 127 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred HHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 999999999999999999999999999999999999999999999999764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-30 Score=215.11 Aligned_cols=150 Identities=31% Similarity=0.554 Sum_probs=132.0
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .+++.||+|++..... ....+.+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNR-------VTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREG 77 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred ecceEEEEEeecCCCcEEEEEEEC-------CCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC
Confidence 456999999999999999999986 4568999999976543 23457789999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|++||++.+++|.+++. ....+++..+..++
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~----------------------------------------------~~~~~~~~~~~~~~ 111 (276)
T 2yex_A 78 NIQYLFLEYCSGGELFDRIE----------------------------------------------PDIGMPEPDAQRFF 111 (276)
T ss_dssp TEEEEEEECCTTEEGGGGSB----------------------------------------------TTTBCCHHHHHHHH
T ss_pred CEEEEEEEecCCCcHHHHHh----------------------------------------------hccCCCHHHHHHHH
Confidence 99999999998877766553 33468999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++|++|+||||+||+++.++.++|+|||+++.+
T Consensus 112 ~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 99999999999999999999999999999999999999998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-30 Score=214.75 Aligned_cols=156 Identities=27% Similarity=0.365 Sum_probs=132.4
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
+...++|++.+.||+|+||.||+|.+.... .++..||+|++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 82 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHK----GEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGII 82 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTT----CCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCC----CCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 445577999999999999999999886432 334679999997653 445567899999999999999999999998
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
.. +..|++||++.+++|.+++... ...+++..+.
T Consensus 83 ~~-~~~~~v~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~ 116 (281)
T 3cc6_A 83 EE-EPTWIIMELYPYGELGHYLERN---------------------------------------------KNSLKVLTLV 116 (281)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHH---------------------------------------------TTTCCHHHHH
T ss_pred cC-CCCEEEEecCCCCCHHHHHHhc---------------------------------------------cccCCHHHHH
Confidence 65 4568899999888887766432 2358899999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.+
T Consensus 117 ~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 117 LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred HHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999999999999999999999999999999999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=235.04 Aligned_cols=152 Identities=35% Similarity=0.570 Sum_probs=132.6
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
..++|++.+.||+|+||.||+|.+. .+++.||||++...... ......+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 96 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDK-------ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 96 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEEC-------CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3456999999999999999999986 45689999999765433 234577899999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+..|+|||+|.+|+|.+.+. ....+++..+..
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~~~----------------------------------------------~~~~~~~~~~~~ 130 (484)
T 3nyv_A 97 DKGYFYLVGEVYTGGELFDEII----------------------------------------------SRKRFSEVDAAR 130 (484)
T ss_dssp CSSEEEEEECCCCSCBHHHHHH----------------------------------------------TCSCCBHHHHHH
T ss_pred eCCEEEEEEecCCCCCHHHHHH----------------------------------------------hcCCCCHHHHHH
Confidence 9999999999999877766554 334689999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEe---ecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFL---SVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~l 265 (267)
++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 131 i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 131 IIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred HHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999999999999999999999 56789999999999764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-30 Score=221.95 Aligned_cols=152 Identities=32% Similarity=0.526 Sum_probs=132.4
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch----HHHHHHHHHHHHHhhcCCCceeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP----KARKMLSREIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~~~~~ 137 (267)
.++|++.+.||+|+||.||+|.+. .++..||+|++....... ...+.+.+|+.+++.++||||++++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 83 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREK-------STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDV 83 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hccEEEeeEeeecCCEEEEEEEEC-------CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 356999999999999999999986 456899999997654322 135678999999999999999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
+...+..++|||++.+++|.+++.. ...+++..+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~----------------------------------------------~~~~~~~~~ 117 (321)
T 2a2a_A 84 YENRTDVVLILELVSGGELFDFLAQ----------------------------------------------KESLSEEEA 117 (321)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHT----------------------------------------------CSCEEHHHH
T ss_pred EecCCEEEEEEEcCCCCcHHHHHHh----------------------------------------------cCCCCHHHH
Confidence 9999999999999998887766643 346889999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC----ceEEeccccccccC
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG----IVKLGDLGFSTKLQ 266 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~----~~kl~DFGla~~l~ 266 (267)
..++.|++.||+|||++|++||||||+||+++.++ .+||+|||+|+.+.
T Consensus 118 ~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 99999999999999999999999999999999888 79999999997653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=226.34 Aligned_cols=176 Identities=34% Similarity=0.469 Sum_probs=134.1
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc---chHHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL---TPKARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
.++|++.+.||+|+||.||+|.+. .++..||+|++..... .....+.+.+|+.+++.++||||+++++++
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 97 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIEN-------QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY 97 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheeecceeeecCCeEEEEEEEC-------CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh
Confidence 356999999999999999999986 4568999999976532 334567899999999999999999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccC--------------Cchhh
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASG--------------GELYN 204 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~--------------~~l~~ 204 (267)
.+.+..++|||||.+|+|.+++........ ....++.... +++..
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDST---------------------GKCAMDVVKTQICPCPECNEEAINGSIHG 156 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTT---------------------TEEEEEEECCCCCCSHHHHHHHHHSCC--
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccc---------------------ccccccccccccccccccccccccccccc
Confidence 999999999999999999998863211000 0000000000 00110
Q ss_pred hhcc-cCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC--ceEEecccccccc
Q psy2579 205 KITT-EGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG--IVKLGDLGFSTKL 265 (267)
Q Consensus 205 ~~~~-~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~--~~kl~DFGla~~l 265 (267)
.... ...+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||+|+.+
T Consensus 157 ~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~ 220 (345)
T 3hko_A 157 FRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEF 220 (345)
T ss_dssp CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEG
T ss_pred ccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccc
Confidence 0000 11246788899999999999999999999999999999998776 8999999999754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-30 Score=226.94 Aligned_cols=154 Identities=24% Similarity=0.336 Sum_probs=126.0
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeee-e
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLE-T 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~-~ 140 (267)
...|++.+.||+|+||.||+|.+.... .....||+|.+.... .......+.+|+.+++.++||||+++++++. .
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDND----GKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETT----TEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCC----CcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 345999999999999999999986432 234679999987543 3455678999999999999999999999864 4
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..++||||+.+|+|.+++... ...+++..+..+
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~---------------------------------------------~~~~~~~~~~~i 197 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNE---------------------------------------------THNPTVKDLIGF 197 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCT---------------------------------------------TCCCBHHHHHHH
T ss_pred CCCeEEEEECCCCCCHHHHHhhc---------------------------------------------ccCCCHHHHHHH
Confidence 56789999999998888777543 225788899999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 198 ~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 198 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred HHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccc
Confidence 999999999999999999999999999999999999999999754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-30 Score=225.48 Aligned_cols=148 Identities=32% Similarity=0.545 Sum_probs=123.5
Q ss_pred ceEE--ecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 64 LYKL--QNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 64 ~y~~--~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.|++ .+.||+|+||.||+|.+. .++..||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~-------~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 158 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEET-------ATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESK 158 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEET-------TTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred ceeeecceEEecCcCEEEEEEEEc-------CCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3555 678999999999999986 456899999997653 24457789999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..++||||+++|+|.+.+... ...+++..+..++
T Consensus 159 ~~~~lv~E~~~~~~L~~~l~~~---------------------------------------------~~~l~~~~~~~i~ 193 (373)
T 2x4f_A 159 NDIVLVMEYVDGGELFDRIIDE---------------------------------------------SYNLTELDTILFM 193 (373)
T ss_dssp SEEEEEEECCTTCEEHHHHHHT---------------------------------------------GGGCCHHHHHHHH
T ss_pred CEEEEEEeCCCCCcHHHHHHhc---------------------------------------------CCCCCHHHHHHHH
Confidence 9999999999998887766432 2258899999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEe--ecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFL--SVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll--~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++||+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 194 ~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 194 KQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp HHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred HHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 999999999999999999999999999 45678999999999865
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-30 Score=219.07 Aligned_cols=152 Identities=24% Similarity=0.449 Sum_probs=127.9
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
+++|++.+.||+|+||.||+|.+. .+++.||+|++............+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 74 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred cchhhhhhhhccCCCeeEEEEEEc-------CCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecC
Confidence 467999999999999999999986 4568999999976544333446788999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|++||++. ++|.+++... ....+++..+..++
T Consensus 75 ~~~~lv~e~~~-~~L~~~~~~~--------------------------------------------~~~~~~~~~~~~~~ 109 (299)
T 2r3i_A 75 NKLYLVFEFLH-QDLKKFMDAS--------------------------------------------ALTGIPLPLIKSYL 109 (299)
T ss_dssp TEEEEEEECCS-EEHHHHHHHT--------------------------------------------TTTCCCHHHHHHHH
T ss_pred CceEEEEEccc-CCHHHHHHhh--------------------------------------------hccCCCHHHHHHHH
Confidence 99999999998 5776666432 11358889999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||.|||++|++||||||+||+++.++.+||+|||+++.+
T Consensus 110 ~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 153 (299)
T 2r3i_A 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF 153 (299)
T ss_dssp HHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred HHHHHHHHHHHHCCccCCCCCHHHeEEcCCCCEEECcchhhhhc
Confidence 99999999999999999999999999999999999999998654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-30 Score=216.24 Aligned_cols=151 Identities=30% Similarity=0.422 Sum_probs=133.6
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
.++|++.+.||+|+||.||+|.+. .+++.||+|++..... .....+.+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 86 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDA-------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED 86 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEEC-------CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence 456999999999999999999986 4568999999976543 34556788999999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..+++||++.+++|.+++. ....+++..+..+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~~~----------------------------------------------~~~~~~~~~~~~i 120 (294)
T 2rku_A 87 NDFVFVVLELCRRRSLLELHK----------------------------------------------RRKALTEPEARYY 120 (294)
T ss_dssp SSEEEEEEECCTTCBHHHHHH----------------------------------------------HHCSCCHHHHHHH
T ss_pred CCEEEEEEecCCCCCHHHHHH----------------------------------------------hcCCCCHHHHHHH
Confidence 999999999999877766553 3346899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||+|||++|++||||||+||+++.++.+||+|||+++.+
T Consensus 121 ~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 121 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 999999999999999999999999999999999999999999764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-30 Score=220.92 Aligned_cols=151 Identities=30% Similarity=0.422 Sum_probs=134.0
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..+|++.+.||+|+||.||+|.+. .+++.||+|++..... .....+.+.+|+.+++.++||||+++++++..
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 112 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDA-------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED 112 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 456999999999999999999986 4568999999976543 34556789999999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|++|||+.+++|.+++. ....+++..+..+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~~~----------------------------------------------~~~~l~~~~~~~i 146 (335)
T 2owb_A 113 NDFVFVVLELCRRRSLLELHK----------------------------------------------RRKALTEPEARYY 146 (335)
T ss_dssp SSEEEEEECCCTTCBHHHHHH----------------------------------------------HHCSCCHHHHHHH
T ss_pred CCeEEEEEecCCCCCHHHHHh----------------------------------------------ccCCCCHHHHHHH
Confidence 999999999999877766553 2346899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||++|++||||||+||+++.++.+||+|||+++.+
T Consensus 147 ~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 147 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 999999999999999999999999999999999999999999765
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-30 Score=212.94 Aligned_cols=147 Identities=23% Similarity=0.397 Sum_probs=130.5
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+. ++..||+|++....... +.+.+|+.+++.++||||+++++++...+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 76 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL--------NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA 76 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET--------TTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred hheeeeeEecCCCceeEEEEEec--------CCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 56999999999999999999874 34689999998765433 56889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++||++++++|.+++... ...+++..+..++.
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~---------------------------------------------~~~~~~~~~~~~~~ 111 (267)
T 3t9t_A 77 PICLVTEFMEHGCLSDYLRTQ---------------------------------------------RGLFAAETLLGMCL 111 (267)
T ss_dssp SCEEEECCCTTCBHHHHHHHT---------------------------------------------TTCCCHHHHHHHHH
T ss_pred CeEEEEeCCCCCcHHHHHhhC---------------------------------------------cccCCHHHHHHHHH
Confidence 999999999998887776542 23588999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++|++|+||||+||+++.++.++|+|||+++..
T Consensus 112 ~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 112 DVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 154 (267)
T ss_dssp HHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred HHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccc
Confidence 9999999999999999999999999999999999999999764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-29 Score=216.32 Aligned_cols=156 Identities=33% Similarity=0.530 Sum_probs=130.1
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
.+++|++.+.||+|+||.||+|.+. .++..||+|++..... .......+.+|+.+++.++||||+++++++.
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 102 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACL-------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 102 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEET-------TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEc-------CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4567999999999999999999986 4568999999976443 3456678999999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+..+++||++.+++|.+++... ......+++..+..
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~------------------------------------------~~~~~~~~~~~~~~ 140 (310)
T 2wqm_A 103 EDNELNIVLELADAGDLSRMIKHF------------------------------------------KKQKRLIPERTVWK 140 (310)
T ss_dssp ETTEEEEEEECCCSCBHHHHHHHH------------------------------------------HHTTCCCCHHHHHH
T ss_pred cCCcEEEEEecCCCCCHHHHHHHh------------------------------------------cccccCCCHHHHHH
Confidence 999999999999999998776532 11234689999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.+
T Consensus 141 i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 141 YFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred HHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999999999999999999999999999999999998754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-30 Score=213.81 Aligned_cols=153 Identities=12% Similarity=0.208 Sum_probs=134.4
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
+...++|++.+.||+|+||.||+|.+. +..||+|++.....+....+.+.+|+.+++.++||||+++++++
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 76 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ---------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET---------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEE
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC---------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEE
Confidence 335567999999999999999999874 47899999988776777778899999999999999999999999
Q ss_pred eec--CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 139 ETF--GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 139 ~~~--~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
... +..+++|||+++|+|.+++.... ...+++..
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------------~~~~~~~~ 112 (271)
T 3kmu_A 77 QSPPAPHPTLITHWMPYGSLYNVLHEGT--------------------------------------------NFVVDQSQ 112 (271)
T ss_dssp CTTTSSSCEEEEECCTTCBHHHHHHSCS--------------------------------------------SCCCCHHH
T ss_pred ccCCCCCeEeeecccCCCcHHHHHhhcc--------------------------------------------cCCCCHHH
Confidence 887 77899999999988887775431 12589999
Q ss_pred HHHHHHHHHHHHHHHHhCC--CcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRD--IIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++..
T Consensus 113 ~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 113 AVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred HHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 9999999999999999999 99999999999999999999998887654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-29 Score=215.74 Aligned_cols=152 Identities=28% Similarity=0.441 Sum_probs=128.6
Q ss_pred ecceEEec-ccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 62 VALYKLQN-ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~-~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..+|++.+ .||+|+||.||+|.+... ..+..||||++..........+.+.+|+.+++.++||||+++++++ .
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMK-----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECS-----SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred chhhhhccCccccccCeeeEeeeecCC-----CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 35699998 999999999999976422 3458899999987665556678899999999999999999999998 5
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..+++||++.+++|.+++. ....+++..+..+
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~----------------------------------------------~~~~~~~~~~~~i 122 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQ----------------------------------------------QNRHVKDKNIIEL 122 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHH----------------------------------------------HCTTCCHHHHHHH
T ss_pred CCCcEEEEEeCCCCCHHHHHH----------------------------------------------hCcCCCHHHHHHH
Confidence 677889999988877766654 3346889999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||+|||++|++||||||+||+++.++.+||+|||+++.+
T Consensus 123 ~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 999999999999999999999999999999999999999999765
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=225.54 Aligned_cols=149 Identities=24% Similarity=0.419 Sum_probs=125.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+. .+++.||+|++..... ......+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSK-------LTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK 73 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS
T ss_pred CceEEEEEEcCCCCEEEEEEEEC-------CCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC
Confidence 57999999999999999999986 4568999999965432 222234568999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..++||||+.+ +|.+++... ...+++..+..++.
T Consensus 74 ~~~lv~e~~~~-~l~~~~~~~---------------------------------------------~~~~~~~~~~~~~~ 107 (324)
T 3mtl_A 74 SLTLVFEYLDK-DLKQYLDDC---------------------------------------------GNIINMHNVKLFLF 107 (324)
T ss_dssp CEEEEEECCSE-EHHHHHHHT---------------------------------------------TTCCCHHHHHHHHH
T ss_pred EEEEEeccccc-CHHHHHHhc---------------------------------------------CCCCCHHHHHHHHH
Confidence 99999999974 666555432 23588999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++||+||||||+||+++.++.+||+|||+|+..
T Consensus 108 qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 150 (324)
T 3mtl_A 108 QLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAK 150 (324)
T ss_dssp HHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred HHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence 9999999999999999999999999999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-30 Score=230.72 Aligned_cols=148 Identities=24% Similarity=0.429 Sum_probs=128.9
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++.+.||+|+||.||+|.+. +..||||+++... ..+.+.+|+.+++.++||||+++++++..
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~---------~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 257 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR---------GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVE 257 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET---------TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec---------CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEc
Confidence 4567999999999999999999763 4689999997653 23568899999999999999999999876
Q ss_pred cC-eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 141 FG-KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 141 ~~-~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
.+ ..|+|||||.+|+|.+++...+ ...+++..+..
T Consensus 258 ~~~~~~iv~e~~~~g~L~~~l~~~~--------------------------------------------~~~~~~~~~~~ 293 (450)
T 1k9a_A 258 EKGGLYIVTEYMAKGSLVDYLRSRG--------------------------------------------RSVLGGDCLLK 293 (450)
T ss_dssp TTSCEEEEEECCTTCBHHHHHHHHC--------------------------------------------TTTCCHHHHHH
T ss_pred CCCceEEEEEecCCCcHHHHHHhcC--------------------------------------------CCCCCHHHHHH
Confidence 65 7999999999988888776431 12378899999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||+|||++|++||||||+|||++.++.+||+|||+|+..
T Consensus 294 ~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 294 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 9999999999999999999999999999999999999999999754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-29 Score=214.88 Aligned_cols=150 Identities=24% Similarity=0.432 Sum_probs=127.6
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHH-----HHHHHHHHHHhhcCCCceeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKAR-----KMLSREIVSMESVHHPNIIRLYE 136 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~-----~~~~~Ei~~l~~l~hpnIv~~~~ 136 (267)
.++|++.+.||+|+||.||+|.+. .+++.||+|++.......... +.+.+|+.+++.++||||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 90 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLV-------KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG 90 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEET-------TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hccceehhccccCCceeEEEEEEc-------CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhe
Confidence 466999999999999999999986 456899999997654332221 67899999999999999999999
Q ss_pred eeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 137 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 137 ~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
++.... +++|||+.+|+|.+.+... ...+++..
T Consensus 91 ~~~~~~--~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~ 123 (287)
T 4f0f_A 91 LMHNPP--RMVMEFVPCGDLYHRLLDK---------------------------------------------AHPIKWSV 123 (287)
T ss_dssp EETTTT--EEEEECCTTCBHHHHHHCT---------------------------------------------TSCCCHHH
T ss_pred eecCCC--eEEEEecCCCCHHHHHhcc---------------------------------------------cCCccHHH
Confidence 987655 6899999888887666432 23689999
Q ss_pred HHHHHHHHHHHHHHHHhCC--CcccCCCCCcEEeecCCc-----eEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRD--IIHRDIKAENVFLSVRGI-----VKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~--ivHrDlkp~NIll~~~~~-----~kl~DFGla~~l 265 (267)
+..++.|++.||+|||++| ++||||||+||+++.++. +||+|||+|+..
T Consensus 124 ~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~ 179 (287)
T 4f0f_A 124 KLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS 179 (287)
T ss_dssp HHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCC
T ss_pred HHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccc
Confidence 9999999999999999999 999999999999988776 999999999754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-30 Score=231.54 Aligned_cols=148 Identities=26% Similarity=0.413 Sum_probs=127.8
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.+.|++.+.||+|+||.||+|.+. .+..||||+++..... .+.+.+|+.+++.++||||+++++++..
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWN--------GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--------TTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hhHceeeeeecCCCCeEEEEEEEC--------CCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 456999999999999999999874 2357999999865533 3568999999999999999999999876
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+||||+.+|+|.+++... ....+++..+..++
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~--------------------------------------------~~~~~~~~~~~~i~ 286 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGE--------------------------------------------TGKYLRLPQLVDMA 286 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHH--------------------------------------------HHTTCCHHHHHHHH
T ss_pred CceEEEehhhcCCCHHHHHHhc--------------------------------------------CCCCCCHHHHHHHH
Confidence 7789999999998888777532 12358899999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++|++||||||+|||++.++.+||+|||+|+.+
T Consensus 287 ~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 287 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred HHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 99999999999999999999999999999999999999999865
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-30 Score=219.70 Aligned_cols=153 Identities=26% Similarity=0.401 Sum_probs=131.2
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeee--e
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLE--T 140 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~--~ 140 (267)
.+|++.+.||+|+||.||+|++.... ..++..||||++... .....+.+.+|+.+++.++||||+++++++. .
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLG---DNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTS---SSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCC---CCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 46999999999999999999853221 145689999999765 3455677999999999999999999999886 4
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+||||+++++|.+++... ...+++..+..+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~i 132 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRH---------------------------------------------RARLDASRLLLY 132 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHH---------------------------------------------GGGCCHHHHHHH
T ss_pred CceEEEEEeecCCCCHHHHHHhc---------------------------------------------ccCCCHHHHHHH
Confidence 46688999999988887766532 225899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||+|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 133 ~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 133 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred HHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 999999999999999999999999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-30 Score=220.95 Aligned_cols=145 Identities=34% Similarity=0.602 Sum_probs=124.9
Q ss_pred cceEEe---cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-CCceeeeeeee
Q psy2579 63 ALYKLQ---NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-HPNIIRLYEVL 138 (267)
Q Consensus 63 ~~y~~~---~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~~~~~~ 138 (267)
.+|++. +.||+|+||.||+|.+. .+++.||||++... ....+.+|+.+++.+. ||||+++++++
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~ 75 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHK-------KSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVF 75 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEET-------TTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEEC-------CCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEE
Confidence 447775 67999999999999986 45689999999643 2356778999999996 99999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
.+.+..|+|||||.+|+|.+++.. .+.+++..+.
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~----------------------------------------------~~~~~~~~~~ 109 (325)
T 3kn6_A 76 HDQLHTFLVMELLNGGELFERIKK----------------------------------------------KKHFSETEAS 109 (325)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHH----------------------------------------------CSCCCHHHHH
T ss_pred EcCCEEEEEEEccCCCcHHHHHHh----------------------------------------------cCCCCHHHHH
Confidence 999999999999998887766643 3468999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC---ceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG---IVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~---~~kl~DFGla~~l 265 (267)
.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 110 ~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 110 YIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999999999999999999998766 8999999999754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-30 Score=216.28 Aligned_cols=148 Identities=29% Similarity=0.488 Sum_probs=123.6
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec-
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF- 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~- 141 (267)
++|++.+.||+|+||.||+|.+. .+++.||||++... ......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNA-------LDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERR 75 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECC
T ss_pred ccchhhheeccCCcEEEEEEEEc-------CCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhc
Confidence 56999999999999999999986 45689999999643 34567789999999999999999999988653
Q ss_pred ------------CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhccc
Q psy2579 142 ------------GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTE 209 (267)
Q Consensus 142 ------------~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~ 209 (267)
+..|++||++++|+|.+++... .
T Consensus 76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~ 110 (303)
T 1zy4_A 76 NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE---------------------------------------------N 110 (303)
T ss_dssp CCCC------CEEEEEEEEECCCSCBHHHHHHHS---------------------------------------------C
T ss_pred chhhhhcccccCCceEEEEecCCCCCHHHhhhcc---------------------------------------------c
Confidence 3456666666665555554321 2
Q ss_pred CCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 210 GRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 210 ~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.+
T Consensus 111 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 166 (303)
T 1zy4_A 111 LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166 (303)
T ss_dssp GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCT
T ss_pred cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhc
Confidence 25778899999999999999999999999999999999999999999999999765
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=223.77 Aligned_cols=153 Identities=22% Similarity=0.341 Sum_probs=126.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|++.+.||+|+||.||+|.+..++. ....+||+|.+.... .......+.+|+.+++.++||||+++++++. .+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGE---SIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTC---SCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCc---eEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 569999999999999999999864331 112358888875433 2222345778999999999999999999986 56
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..++||||+.+|+|.+++... .+.+++..+..++.
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~~~~ 122 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQH---------------------------------------------RGALGPQLLLNWGV 122 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSS---------------------------------------------GGGSCTTHHHHHHH
T ss_pred ccEEEEEeCCCCCHHHHHHHc---------------------------------------------cccCCHHHHHHHHH
Confidence 788999999998887766532 23688999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 123 qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 123 QIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp HHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred HHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 9999999999999999999999999999999999999999865
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-30 Score=227.24 Aligned_cols=151 Identities=35% Similarity=0.605 Sum_probs=125.6
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc------hHHHHHHHHHHHHHhhcCCCceeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT------PKARKMLSREIVSMESVHHPNIIRLY 135 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~Ei~~l~~l~hpnIv~~~ 135 (267)
.++|++.+.||+|+||.||+|.+. .+++.||||++...... ......+.+|+.+++.++||||++++
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~ 206 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFER-------KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK 206 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCC
T ss_pred hccEEEEeEEeeCCCeEEEEEEEC-------CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEE
Confidence 356999999999999999999986 55689999999765422 12234588999999999999999999
Q ss_pred eeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 136 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 136 ~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
+++. .+..|+||||+.+|+|.+++. ....+++.
T Consensus 207 ~~~~-~~~~~lv~e~~~~g~L~~~l~----------------------------------------------~~~~~~~~ 239 (419)
T 3i6u_A 207 NFFD-AEDYYIVLELMEGGELFDKVV----------------------------------------------GNKRLKEA 239 (419)
T ss_dssp EEEE-SSEEEEEEECCTTCBGGGGTS----------------------------------------------SSCCCCHH
T ss_pred EEEe-cCceEEEEEcCCCCcHHHHHh----------------------------------------------ccCCCCHH
Confidence 9975 456788888888877765543 44578999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC---ceEEeccccccccC
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG---IVKLGDLGFSTKLQ 266 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~---~~kl~DFGla~~l~ 266 (267)
.+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 240 ~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~ 293 (419)
T 3i6u_A 240 TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293 (419)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecC
Confidence 9999999999999999999999999999999997544 59999999998653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-29 Score=216.77 Aligned_cols=148 Identities=30% Similarity=0.510 Sum_probs=131.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
..|++.+.||+|+||.||+|.+. .+++.||||++...... .....+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 93 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDN-------RTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 93 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HHHHHhhhhcccCCeEEEEEEEC-------CCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 45999999999999999999885 45689999999765432 34567899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+||||+.+++|.+++.. +++++..+..++.
T Consensus 94 ~~~lv~e~~~~~~L~~~~~~-----------------------------------------------~~~~~~~~~~~~~ 126 (303)
T 3a7i_A 94 KLWIIMEYLGGGSALDLLEP-----------------------------------------------GPLDETQIATILR 126 (303)
T ss_dssp EEEEEEECCTTEEHHHHHTT-----------------------------------------------SCCCHHHHHHHHH
T ss_pred eEEEEEEeCCCCcHHHHHhc-----------------------------------------------CCCCHHHHHHHHH
Confidence 99999999999888766532 3689999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++|++|+||||+||+++.++.++|+|||+++.+
T Consensus 127 qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 127 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL 169 (303)
T ss_dssp HHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceec
Confidence 9999999999999999999999999999999999999999764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-30 Score=220.61 Aligned_cols=144 Identities=31% Similarity=0.464 Sum_probs=125.4
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-CCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-HPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~ 139 (267)
..++|++.+.||+|+||.||+|.+. .+++.||||++.... ...+.+|+.+++.++ ||||+++++++.
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 101 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINI-------TNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVK 101 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred CCCceEEEEEecccCCeEEEEEEEC-------CCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeec
Confidence 3467999999999999999999986 456899999996432 356889999999996 999999999998
Q ss_pred e--cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 140 T--FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 140 ~--~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
. ....+++||++.+++|.+++. .+++..+
T Consensus 102 ~~~~~~~~lv~e~~~~~~l~~~~~-------------------------------------------------~~~~~~~ 132 (330)
T 3nsz_A 102 DPVSRTPALVFEHVNNTDFKQLYQ-------------------------------------------------TLTDYDI 132 (330)
T ss_dssp CTTTCCEEEEEECCCCCCHHHHGG-------------------------------------------------GCCHHHH
T ss_pred cCCCCceEEEEeccCchhHHHHHH-------------------------------------------------hCCHHHH
Confidence 7 567889999998877765442 3788899
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC-ceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG-IVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~l 265 (267)
..++.|++.||+|||++|++||||||+|||++.++ .+||+|||+|+.+
T Consensus 133 ~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999999999999999999999999777 8999999999754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=227.15 Aligned_cols=154 Identities=31% Similarity=0.505 Sum_probs=132.0
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc--hHHHHHHHHHHHHHhhc-CCCceeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT--PKARKMLSREIVSMESV-HHPNIIRLYEVL 138 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~ 138 (267)
+++|++.+.||+|+||.||+|++.... .+++.||||+++..... ......+.+|+.+++.+ +||||+++++++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGH----DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSST----TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccC----CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 467999999999999999999885321 45789999999764321 12335577899999999 799999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
...+..|+||||+.+|+|.+++.. ...+++..+.
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~----------------------------------------------~~~~~~~~~~ 162 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQ----------------------------------------------RERFTEHEVQ 162 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHH----------------------------------------------HSCCCHHHHH
T ss_pred eeCceEEEEeecCCCCCHHHHHHH----------------------------------------------cCCCCHHHHH
Confidence 999999999999999888766643 3468899999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 163 ~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 163 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred HHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 99999999999999999999999999999999999999999999754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-30 Score=218.54 Aligned_cols=149 Identities=28% Similarity=0.468 Sum_probs=127.8
Q ss_pred ecceEEe-cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeee
Q psy2579 62 VALYKLQ-NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLE 139 (267)
Q Consensus 62 ~~~y~~~-~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~ 139 (267)
.+.|++. +.||+|+||.||+|.+. .+++.||||++.... ......+.+|+.++..+ +||||+++++++.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~ 81 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINL-------ITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECS-------SSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEc-------CCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 4569996 78999999999999986 456899999997653 23346788999999985 7999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+..|+||||+.+|+|.+++.. ...+++..+..
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~----------------------------------------------~~~~~~~~~~~ 115 (316)
T 2ac3_A 82 EEDRFYLVFEKMRGGSILSHIHK----------------------------------------------RRHFNELEASV 115 (316)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHH----------------------------------------------HSSCCHHHHHH
T ss_pred eCCEEEEEEEcCCCCcHHHHHhc----------------------------------------------cCCCCHHHHHH
Confidence 99999999999998888766643 34688999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCc---eEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGI---VKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~---~kl~DFGla~~l 265 (267)
++.|++.||+|||++|++||||||+||+++.++. +||+|||+++.+
T Consensus 116 i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 116 VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred HHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999999999999999999999988775 999999998754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-30 Score=220.89 Aligned_cols=152 Identities=36% Similarity=0.556 Sum_probs=132.5
Q ss_pred cceEEe-cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeee
Q psy2579 63 ALYKLQ-NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLET 140 (267)
Q Consensus 63 ~~y~~~-~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 140 (267)
+.|.+. +.||+|+||.||+|.+. .+++.||+|++............+.+|+.++..+ +||||+++++++..
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISK-------STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hEEeeccceeCCCCCeEEEEEEEC-------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 458887 88999999999999986 4568999999987655545567789999999999 57999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..++||||+.+|+|.+++... ....+++..+..+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~--------------------------------------------~~~~~~~~~~~~i 136 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPE--------------------------------------------LAEMVSENDVIRL 136 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSC--------------------------------------------C-CCCCHHHHHHH
T ss_pred CCeEEEEEEecCCCcHHHHHHHh--------------------------------------------cccCCCHHHHHHH
Confidence 99999999999998887766432 1246899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeec---CCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSV---RGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~---~~~~kl~DFGla~~l 265 (267)
+.|++.||+|||++|++||||||+||+++. ++.+||+|||+|+.+
T Consensus 137 ~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 137 IKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred HHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 999999999999999999999999999987 789999999999765
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-30 Score=226.83 Aligned_cols=149 Identities=29% Similarity=0.463 Sum_probs=124.5
Q ss_pred CceecceEEe-cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhh-cCCCceeeeee
Q psy2579 59 GKRVALYKLQ-NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES-VHHPNIIRLYE 136 (267)
Q Consensus 59 ~~~~~~y~~~-~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~-l~hpnIv~~~~ 136 (267)
+..+++|.+. +.||+|+||.||+|.+. .+++.||||++... ..+.+|+.++.. .+||||+++++
T Consensus 57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~-------~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~ 122 (400)
T 1nxk_A 57 NAIIDDYKVTSQVLGLGINGKVLQIFNK-------RTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVD 122 (400)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred CcccccceeccceeeeccCeEEEEEEEC-------CCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeE
Confidence 4456778887 68999999999999986 45689999998632 246678888754 58999999999
Q ss_pred eeee----cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCC
Q psy2579 137 VLET----FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRL 212 (267)
Q Consensus 137 ~~~~----~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~ 212 (267)
++.. .+..|+|||||.+|+|.+++.... ...+
T Consensus 123 ~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--------------------------------------------~~~l 158 (400)
T 1nxk_A 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRG--------------------------------------------DQAF 158 (400)
T ss_dssp EEEEEETTEEEEEEEEECCCSEEHHHHHHCC-----------------------------------------------CC
T ss_pred EEeecccCCcEEEEEEEeCCCCcHHHHHHHhC--------------------------------------------CCCC
Confidence 9876 567888999998888877765421 1258
Q ss_pred ChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeec---CCceEEecccccccc
Q psy2579 213 SEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSV---RGIVKLGDLGFSTKL 265 (267)
Q Consensus 213 ~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~---~~~~kl~DFGla~~l 265 (267)
++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+..
T Consensus 159 ~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 159 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp BHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 99999999999999999999999999999999999987 789999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-30 Score=214.77 Aligned_cols=152 Identities=39% Similarity=0.648 Sum_probs=132.9
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
..++|++.+.||+|+||.||+|.+. .+++.||||++...... ......+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 81 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQ-------LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEEC-------CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 4578999999999999999999986 45689999999754322 223467889999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+..|++||++.+++|.+++.. ...+++..+..
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~----------------------------------------------~~~~~~~~~~~ 115 (276)
T 2h6d_A 82 TPTDFFMVMEYVSGGELFDYICK----------------------------------------------HGRVEEMEARR 115 (276)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----------------------------------------------HCSCCHHHHHH
T ss_pred cCCeEEEEEeccCCCcHHHHHhc----------------------------------------------cCCCCHHHHHH
Confidence 99999999999988777766543 34688999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.+
T Consensus 116 ~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp HHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred HHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999999999999999999999999999999999999765
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-30 Score=224.24 Aligned_cols=155 Identities=17% Similarity=0.226 Sum_probs=123.1
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHH---------HHHHHHHHHHHhhcCCCceee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKA---------RKMLSREIVSMESVHHPNIIR 133 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~---------~~~~~~Ei~~l~~l~hpnIv~ 133 (267)
++|++.+.||+|+||.||+|.+..... ...++.||||++......... .....+|+..++.++||||++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSES--VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSC--CCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccc--cccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 379999999999999999998864321 123588999998765321100 122445667778889999999
Q ss_pred eeeeeeec----CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhccc
Q psy2579 134 LYEVLETF----GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTE 209 (267)
Q Consensus 134 ~~~~~~~~----~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~ 209 (267)
+++++... ...|+||||| +++|.+++... .
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---------------------------------------------~ 146 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---------------------------------------------A 146 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---------------------------------------------T
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---------------------------------------------c
Confidence 99998775 4588888888 87777666432 2
Q ss_pred CCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEee--cCCceEEecccccccc
Q psy2579 210 GRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS--VRGIVKLGDLGFSTKL 265 (267)
Q Consensus 210 ~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~--~~~~~kl~DFGla~~l 265 (267)
..+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+|||+|+.+
T Consensus 147 ~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~ 204 (364)
T 3op5_A 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204 (364)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEES
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceec
Confidence 4699999999999999999999999999999999999999 8899999999999764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-29 Score=213.45 Aligned_cols=152 Identities=28% Similarity=0.434 Sum_probs=129.6
Q ss_pred ecceEEec-ccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 62 VALYKLQN-ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~-~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
.++|.+.+ .||+|+||.||+|.+... .++..||+|++.... .....+.+.+|+.+++.++||||+++++++ .
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMR-----KKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC--------CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred HHHhhhhhccccccCceeEEEeEeccC-----CCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 35588887 999999999999987532 345789999997653 445667899999999999999999999998 5
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..++|||++.+++|.+++... ...+++..+..+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~~ 115 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGK---------------------------------------------REEIPVSNVAEL 115 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTC---------------------------------------------TTTSCHHHHHHH
T ss_pred CCCcEEEEEeCCCCCHHHHHHhC---------------------------------------------CccCCHHHHHHH
Confidence 56789999999988887766432 236899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||++|++||||||+||+++.++.++|+|||+|+.+
T Consensus 116 ~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 116 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 999999999999999999999999999999999999999999765
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-30 Score=221.19 Aligned_cols=172 Identities=23% Similarity=0.322 Sum_probs=137.9
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEV 137 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~ 137 (267)
....++|++.+.||+|+||.||+|.+..++.. .....||+|++.... .......+.+|+.+++.+ +||||++++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKE--DAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSS--CCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcc--cchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 33456799999999999999999998643210 223589999997654 345567899999999999 89999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
+...+..|+||||+.+|+|.+++....... ............+++..+
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------------------------------~~~~~~~~~~~~~~~~~~ 166 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVL--------------------------------ETDPAFAIANSTASTRDL 166 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHH--------------------------------SCC-------CCCCHHHH
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccc--------------------------------cccccccccccccCHHHH
Confidence 999999999999999999998886531100 000000112346899999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..++.|++.||+|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 167 ~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 214 (333)
T 2i1m_A 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214 (333)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCG
T ss_pred HHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECcccccccc
Confidence 999999999999999999999999999999999999999999999854
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-29 Score=224.47 Aligned_cols=147 Identities=25% Similarity=0.434 Sum_probs=128.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC--CCceeeeeeeeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH--HPNIIRLYEVLET 140 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~--hpnIv~~~~~~~~ 140 (267)
..|++.+.||+|+||.||+|.+. .++.||||++............+.+|+.+++.++ ||||+++++++..
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~ 127 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE--------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 127 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT--------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CceEEEEEEccCCCeEEEEEEcC--------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence 35999999999999999999873 2688999999877666677788999999999996 5999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+||| +.+++|.+++. ....+++.++..+
T Consensus 128 ~~~~~lv~E-~~~~~L~~~l~----------------------------------------------~~~~~~~~~~~~i 160 (390)
T 2zmd_A 128 DQYIYMVME-CGNIDLNSWLK----------------------------------------------KKKSIDPWERKSY 160 (390)
T ss_dssp SSEEEEEEE-CCSEEHHHHHH----------------------------------------------HCSSCCHHHHHHH
T ss_pred CCEEEEEEe-cCCCCHHHHHH----------------------------------------------hcCCCCHHHHHHH
Confidence 999999999 66666665554 3346888899999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||++||+||||||+|||++ ++.+||+|||+|+.+
T Consensus 161 ~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 161 WKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp HHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred HHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 99999999999999999999999999995 689999999999865
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-30 Score=217.72 Aligned_cols=149 Identities=28% Similarity=0.485 Sum_probs=128.6
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++.+.||+|+||.||+|.+. .++..||+|++.... ......+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 87 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNK-------ETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYH 87 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEET-------TTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CccceeecceeccCCCeEEEEEEEc-------CCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeee
Confidence 4466999999999999999999986 456899999987543 2334678899999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..++|||++.+++|.+++... ...+++..+..+
T Consensus 88 ~~~~~lv~e~~~~~~l~~~~~~~---------------------------------------------~~~~~~~~~~~~ 122 (302)
T 2j7t_A 88 DGKLWIMIEFCPGGAVDAIMLEL---------------------------------------------DRGLTEPQIQVV 122 (302)
T ss_dssp C-CEEEEEECCTTEEHHHHHHHH---------------------------------------------TSCCCHHHHHHH
T ss_pred CCeEEEEEEeCCCCcHHHHHHhh---------------------------------------------ccCCCHHHHHHH
Confidence 99999999999998887665432 236899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 263 (267)
+.|++.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 123 ~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 123 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred HHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 9999999999999999999999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=223.30 Aligned_cols=153 Identities=24% Similarity=0.319 Sum_probs=131.0
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+ .++..||||++...... .....+.+|+.+++.++||||+++++++...
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGRL--------ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEECC--------SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred hhccccceeEecCCCcEEEEEEe--------cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 45699999999999999999975 34688999999765422 2223688999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..++||||+.+|+|.+++..... ...++++..+..++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------~~~~~~~~~~~~i~ 137 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPE------------------------------------------SQPPLDWPKRQRIA 137 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCST------------------------------------------TCCCCCHHHHHHHH
T ss_pred CceEEEEEeccCCCHHHHHHhccc------------------------------------------cCCCCCHHHHHHHH
Confidence 999999999999999888765421 22358999999999
Q ss_pred HHHHHHHHHHHhC---CCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDR---DIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++ |++||||||+|||++.++.+||+|||+|+.+
T Consensus 138 ~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184 (326)
T ss_dssp HHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred HHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence 9999999999999 9999999999999999999999999999754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-30 Score=218.29 Aligned_cols=152 Identities=26% Similarity=0.351 Sum_probs=129.0
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee--
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET-- 140 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~-- 140 (267)
++|++.+.||+|+||.||+|.+. .+++.||||++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGL-------HDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRER 99 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEET-------TTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEec-------CCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence 56999999999999999999986 45689999998654 34556788999999999999999999999873
Q ss_pred --cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 141 --FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 141 --~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
.+..|++|||+.+|+|.+++... ......+++..+.
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~------------------------------------------~~~~~~~~~~~~~ 137 (317)
T 2buj_A 100 GAKHEAWLLLPFFKRGTLWNEIERL------------------------------------------KDKGNFLTEDQIL 137 (317)
T ss_dssp TTEEEEEEEEECCTTCBHHHHHHHH------------------------------------------HTTTCCCCHHHHH
T ss_pred CCCceeEEEEEeCCCCcHHHHHHHH------------------------------------------HhcCCCCCHHHHH
Confidence 34788999999998887766532 1123468999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++..
T Consensus 138 ~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 138 WLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred HHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999999999999999999999999999999999987653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-30 Score=216.13 Aligned_cols=152 Identities=32% Similarity=0.616 Sum_probs=132.2
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
..++|++.+.||+|+||.||+|.+. .++..||+|++....... .....+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREK-------QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEc-------CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 4567999999999999999999986 456899999996543221 22467889999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+..|++||++.+|+|.+.+.. .+.+++..+..
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~----------------------------------------------~~~~~~~~~~~ 118 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQK----------------------------------------------HGRFDEQRSAT 118 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHH----------------------------------------------HSSCCHHHHHH
T ss_pred cCCEEEEEEEeCCCCcHHHHHHh----------------------------------------------cCCCCHHHHHH
Confidence 99999999999998777766543 34688999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus 119 ~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 119 FMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp HHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 9999999999999999999999999999999999999999998654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-30 Score=218.28 Aligned_cols=152 Identities=28% Similarity=0.397 Sum_probs=123.1
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch---HHHHHHHHHHHHHhhc---CCCceeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP---KARKMLSREIVSMESV---HHPNIIRLY 135 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~Ei~~l~~l---~hpnIv~~~ 135 (267)
.++|++.+.||+|+||.||+|.+. .+++.||||++....... .....+.+|+.+++.+ +||||++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~ 80 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDP-------HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLM 80 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECT-------TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred ccceEEEEEEecCCCeEEEEEEEC-------CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEee
Confidence 357999999999999999999986 456899999997543211 1123466777777766 499999999
Q ss_pred eeeeecC-----eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccC
Q psy2579 136 EVLETFG-----KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEG 210 (267)
Q Consensus 136 ~~~~~~~-----~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~ 210 (267)
+++.... ..+++||++. ++|.+++.... ..
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--------------------------------------------~~ 115 (308)
T 3g33_A 81 DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAP--------------------------------------------PP 115 (308)
T ss_dssp EEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCC--------------------------------------------TT
T ss_pred eeeeccCCCCceeEEEEehhhh-cCHHHHHhhcc--------------------------------------------CC
Confidence 9998765 4788888887 46666554321 12
Q ss_pred CCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 211 RLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 211 ~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 116 ~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 170 (308)
T 3g33_A 116 GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY 170 (308)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTS
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcccccc
Confidence 4899999999999999999999999999999999999999999999999999764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=229.84 Aligned_cols=161 Identities=16% Similarity=0.147 Sum_probs=121.2
Q ss_pred cCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHH---HHHhhcCCCceee
Q psy2579 58 LGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREI---VSMESVHHPNIIR 133 (267)
Q Consensus 58 ~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei---~~l~~l~hpnIv~ 133 (267)
.+...++|++.+.||+|+||.||+|.+. .+++.||||++..... .....+.+.+|+ .+++.++||||++
T Consensus 68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~ 140 (377)
T 3byv_A 68 LGERPRTLVRGTVLGQEDPYAYLEATDQ-------ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140 (377)
T ss_dssp SSCCCEEEEEEEEEEEETTEEEEEEEC--------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHH
T ss_pred cCCCCceEEEcceeecCCCEEEEEEEEC-------CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHH
Confidence 3444577999999999999999999986 4568999999976532 334567889999 4555568999999
Q ss_pred ee-------eeeeecCe-----------------EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCe
Q psy2579 134 LY-------EVLETFGK-----------------IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGK 189 (267)
Q Consensus 134 ~~-------~~~~~~~~-----------------~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (267)
++ +++...+. .|++|||+ +|+|.+++.......+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~--------------------- 198 (377)
T 3byv_A 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS--------------------- 198 (377)
T ss_dssp HHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTT---------------------
T ss_pred HHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccccc---------------------
Confidence 98 55554432 56666666 4566555543211000
Q ss_pred EEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 190 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 199 ------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~ 256 (377)
T 3byv_A 199 ------------------THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256 (377)
T ss_dssp ------------------TTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEET
T ss_pred ------------------ccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheec
Confidence 0112344788889999999999999999999999999999999999999999999854
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-29 Score=215.31 Aligned_cols=154 Identities=34% Similarity=0.490 Sum_probs=132.9
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc---c----hHHHHHHHHHHHHHhhcC-CCc
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL---T----PKARKMLSREIVSMESVH-HPN 130 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~---~----~~~~~~~~~Ei~~l~~l~-hpn 130 (267)
....++|++.+.||+|+||.||+|.+. .+++.||||++..... . ....+.+.+|+.+++.+. |||
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~ 85 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHK-------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN 85 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred cchhhccceeeeecCCCceEEEEEEEc-------CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 345577999999999999999999986 4568999999976531 1 233567889999999995 999
Q ss_pred eeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccC
Q psy2579 131 IIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEG 210 (267)
Q Consensus 131 Iv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~ 210 (267)
|+++++++...+..++|||++.+++|.+++.. ..
T Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----------------------------------------------~~ 119 (298)
T 1phk_A 86 IIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----------------------------------------------KV 119 (298)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----------------------------------------------HS
T ss_pred EeeeeeeeccCCeEEEEEeccCCCcHHHHHhc----------------------------------------------cC
Confidence 99999999999999999999998787766543 34
Q ss_pred CCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 211 RLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 211 ~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++.+
T Consensus 120 ~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 120 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 6899999999999999999999999999999999999999999999999998764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-29 Score=214.43 Aligned_cols=150 Identities=33% Similarity=0.578 Sum_probs=131.2
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch----HHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP----KARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
++|++.+.||+|+||.||+|.+. .+++.||+|++....... ...+.+.+|+.+++.++||||+++++++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 77 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQK-------GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF 77 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEc-------CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee
Confidence 45999999999999999999986 456899999997654332 1356789999999999999999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
...+..+++||++.+++|.+++. ....+++..+.
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~----------------------------------------------~~~~~~~~~~~ 111 (283)
T 3bhy_A 78 ENKTDVVLILELVSGGELFDFLA----------------------------------------------EKESLTEDEAT 111 (283)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHH----------------------------------------------HHSSCCHHHHH
T ss_pred cCCCeEEEEEeecCCCcHHHHHH----------------------------------------------hcCCCCHHHHH
Confidence 99999999999998877776654 23468999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC----ceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG----IVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~----~~kl~DFGla~~l 265 (267)
.++.|++.||.|||++|++||||||+||+++.++ .++|+|||+++.+
T Consensus 112 ~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 112 QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 9999999999999999999999999999998877 8999999999765
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-29 Score=221.27 Aligned_cols=149 Identities=26% Similarity=0.426 Sum_probs=133.0
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHK-------PSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred cccceeeeeecCCCCeEEEEEEEC-------CCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence 456999999999999999999986 456899999997653 455667899999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+||||+.+++|.+++.. .+.+++..+..++
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~----------------------------------------------~~~~~~~~~~~i~ 137 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKK----------------------------------------------AGRIPEQILGKVS 137 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHH----------------------------------------------HSSCCHHHHHHHH
T ss_pred CEEEEEEECCCCCCHHHHHHH----------------------------------------------cCCCCHHHHHHHH
Confidence 999999999999888766643 3468899999999
Q ss_pred HHHHHHHHHHHhC-CCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 222 LQILSAVKHLHDR-DIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 222 ~ql~~~L~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
.|++.||.|||++ |++||||||+||+++.++.++|+|||+|+.
T Consensus 138 ~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 138 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp HHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred HHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 9999999999996 999999999999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-30 Score=234.34 Aligned_cols=149 Identities=26% Similarity=0.414 Sum_probs=129.5
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .+..||||+++..... .+.+.+|+.+++.++||||+++++++..
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWN--------GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--------TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hhhhhhheecccCCCeEEEEEEEC--------CCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 456999999999999999999874 2357999999865533 3568999999999999999999999866
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+||||+.+|+|.+++... ....+++..+..++
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~--------------------------------------------~~~~l~~~~~~~i~ 369 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGE--------------------------------------------TGKYLRLPQLVDMA 369 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHH--------------------------------------------HHTTCCHHHHHHHH
T ss_pred ccceEeeehhcCCcHHHHHhhc--------------------------------------------CCCCCCHHHHHHHH
Confidence 7789999999998888777532 12358899999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 370 ~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 370 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred HHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 999999999999999999999999999999999999999998653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-30 Score=221.35 Aligned_cols=145 Identities=32% Similarity=0.543 Sum_probs=124.7
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 140 (267)
.++|++.+.||+|+||.||+|.+. .+++.||||++...... ..+|+.++..+ +||||+++++++.+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~ 87 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHK-------ATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDD 87 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEc
Confidence 356999999999999999999986 45689999999765432 34688888887 89999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+|||||.+|+|.+.+. ..+.+++..+..+
T Consensus 88 ~~~~~lv~E~~~gg~L~~~i~----------------------------------------------~~~~~~~~~~~~~ 121 (342)
T 2qr7_A 88 GKYVYVVTELMKGGELLDKIL----------------------------------------------RQKFFSEREASAV 121 (342)
T ss_dssp SSEEEEEECCCCSCBHHHHHH----------------------------------------------TCTTCCHHHHHHH
T ss_pred CCEEEEEEeCCCCCcHHHHHH----------------------------------------------HcCCCCHHHHHHH
Confidence 999999999999877766554 3346899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecC----CceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVR----GIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~----~~~kl~DFGla~~l 265 (267)
+.|++.||+|||++||+||||||+|||+... +.+||+|||+|+.+
T Consensus 122 ~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 122 LFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999999999999999999998443 35999999999865
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=217.73 Aligned_cols=164 Identities=26% Similarity=0.386 Sum_probs=132.5
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccc--eEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYIS--YLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVL 138 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~ 138 (267)
.++|++.+.||+|+||.||+|.+..+ +. .||+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKD-------GLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEET-------TEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccC-------Ccccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 46799999999999999999998743 34 45999986532 344557789999999999 999999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhh-hcccCCCChhHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNK-ITTEGRLSEDDA 217 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~-~~~~~~~~~~~~ 217 (267)
...+..|+|||++++|+|.+++.......... .... -.....+++..+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~~ 144 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP-------------------------------AFAIANSTASTLSSQQL 144 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCH-------------------------------HHHHHTTBSCSSCHHHH
T ss_pred eeCCceEEEEecCCCCCHHHHHHhcccccccc-------------------------------cccccccccccCCHHHH
Confidence 99999999999999999999887542110000 0000 012346899999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
+.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.
T Consensus 145 ~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~ 191 (327)
T 1fvr_A 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG 191 (327)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEES
T ss_pred HHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCcc
Confidence 99999999999999999999999999999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=213.83 Aligned_cols=147 Identities=27% Similarity=0.388 Sum_probs=122.5
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee--
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET-- 140 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~-- 140 (267)
++|++.+.||+|+||.||+|.+. .+++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 77 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHR-------IDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFD 77 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEET-------TTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEE
T ss_pred cccceeeeeccCCceEEEEEEEc-------CCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccc
Confidence 56999999999999999999986 456899999997543 346789999999999999999998865
Q ss_pred --------------cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhh
Q psy2579 141 --------------FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKI 206 (267)
Q Consensus 141 --------------~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~ 206 (267)
.+..+++|||+.+|+|.+++...
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------------------------------------- 114 (284)
T 2a19_B 78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR------------------------------------------- 114 (284)
T ss_dssp EC---------CCEEEEEEEEECCCCSCBHHHHHHHG-------------------------------------------
T ss_pred cCcccccccccccCcceEEEEEeccCCCCHHHHHhhc-------------------------------------------
Confidence 23356666666666665554321
Q ss_pred cccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 207 TTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 207 ~~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
....+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++.+.
T Consensus 115 -~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 173 (284)
T 2a19_B 115 -RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK 173 (284)
T ss_dssp -GGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESS
T ss_pred -cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheecc
Confidence 12468999999999999999999999999999999999999999999999999987653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-30 Score=216.54 Aligned_cols=143 Identities=25% Similarity=0.377 Sum_probs=119.8
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhh--cCCCceeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES--VHHPNIIRLYEVLE 139 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~~~~~~~ 139 (267)
.++|++.+.||+|+||.||+|.+. ++.||||++.... ...+.+|.+++.. ++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~ 72 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQ---------GENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDM 72 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEET---------TEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEEC---------CEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence 356999999999999999999763 4789999986532 2345566666666 79999999999865
Q ss_pred ec----CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 140 TF----GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 140 ~~----~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
.. +..|+||||+.+|+|.+++.. ..+++.
T Consensus 73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-----------------------------------------------~~~~~~ 105 (301)
T 3q4u_A 73 TSRHSSTQLWLITHYHEMGSLYDYLQL-----------------------------------------------TTLDTV 105 (301)
T ss_dssp EEETTEEEEEEEECCCTTCBHHHHHTT-----------------------------------------------CCBCHH
T ss_pred cccCCCceeEEehhhccCCCHHHHHhh-----------------------------------------------cccCHH
Confidence 43 457888888888887766632 268899
Q ss_pred HHHHHHHHHHHHHHHHH--------hCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLH--------DRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH--------~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+..++.|++.||+||| ++|++||||||+|||++.++.+||+|||+|+.+
T Consensus 106 ~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 163 (301)
T 3q4u_A 106 SCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163 (301)
T ss_dssp HHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeec
Confidence 99999999999999999 999999999999999999999999999998653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=217.55 Aligned_cols=154 Identities=27% Similarity=0.415 Sum_probs=130.1
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
..+|++.+.||+|+||.||+|.+.... ..+++.||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQ---DNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTS---SSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred HHHceeeeeeccCCCeEEEEEEecccc---CCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 456999999999999999999853211 145789999999764 345567899999999999999999999998765
Q ss_pred C--eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 142 G--KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 142 ~--~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
+ ..++|||++++++|.+++... ...+++..+..
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~ 149 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKH---------------------------------------------KERIDHIKLLQ 149 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHS---------------------------------------------TTSSCHHHHHH
T ss_pred CCCceEEEEECCCCCCHHHHHHhc---------------------------------------------ccCCCHHHHHH
Confidence 4 678899998888887766542 13588999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||.|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 150 i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 150 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 9999999999999999999999999999999999999999999765
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=218.28 Aligned_cols=150 Identities=36% Similarity=0.601 Sum_probs=123.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc------hHHHHHHHHHHHHHhhcCCCceeeeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT------PKARKMLSREIVSMESVHHPNIIRLYE 136 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~Ei~~l~~l~hpnIv~~~~ 136 (267)
++|++.+.||+|+||.||+|.+. .+++.||||++...... ......+.+|+.+++.++||||+++++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 82 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFER-------KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN 82 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEE
T ss_pred hceeEeeEEecCCCEEEEEEEEc-------CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEee
Confidence 46999999999999999999986 45689999999765421 122345889999999999999999999
Q ss_pred eeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 137 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 137 ~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
++...+ .|+||||+.+++|.+.+. ....+++..
T Consensus 83 ~~~~~~-~~lv~e~~~~~~L~~~~~----------------------------------------------~~~~~~~~~ 115 (322)
T 2ycf_A 83 FFDAED-YYIVLELMEGGELFDKVV----------------------------------------------GNKRLKEAT 115 (322)
T ss_dssp EEESSS-EEEEEECCTTEETHHHHS----------------------------------------------TTCCCCHHH
T ss_pred EEcCCc-eEEEEecCCCCcHHHHHh----------------------------------------------ccCCCCHHH
Confidence 986654 788888888877765553 344689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCc---eEEeccccccccC
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGI---VKLGDLGFSTKLQ 266 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~---~kl~DFGla~~l~ 266 (267)
+..++.|++.||.|||++|++||||||+||+++.++. +||+|||+++.+.
T Consensus 116 ~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 116 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 9999999999999999999999999999999987664 9999999998653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=220.92 Aligned_cols=147 Identities=24% Similarity=0.398 Sum_probs=126.2
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec-
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF- 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~- 141 (267)
++|++.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 98 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDN-------LNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 98 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred ccEEEEEEeecCCCeEEEEEEEC-------CCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence 46999999999999999999986 456899999997543 344557789999999999999999999998765
Q ss_pred ----CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 142 ----GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 142 ----~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
...|++||++.+ +|.+.+.. ..+++..+
T Consensus 99 ~~~~~~~~iv~e~~~~-~L~~~l~~-----------------------------------------------~~~~~~~~ 130 (364)
T 3qyz_A 99 IEQMKDVYIVQDLMET-DLYKLLKT-----------------------------------------------QHLSNDHI 130 (364)
T ss_dssp TTTCCCEEEEEECCSE-EHHHHHHH-----------------------------------------------CCCCHHHH
T ss_pred ccccceEEEEEcccCc-CHHHHHHh-----------------------------------------------CCCCHHHH
Confidence 357888888763 55544432 36899999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 131 ~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 131 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 999999999999999999999999999999999999999999999754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=219.14 Aligned_cols=153 Identities=28% Similarity=0.367 Sum_probs=125.2
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+..++. ....+||+|.+.... .......+.+|+.+++.++||||+++++++...+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGE---KVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTC---SCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCc---eEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 569999999999999999999864331 112346888775433 3334567899999999999999999999998654
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
.+++++++.+|+|.+++... ...+++..+..++.
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~---------------------------------------------~~~~~~~~~~~i~~ 124 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREH---------------------------------------------KDNIGSQYLLNWCV 124 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHT---------------------------------------------TTCCCHHHHHHHHH
T ss_pred -ceEEEEecCCCcHHHHHHhc---------------------------------------------CCCCCHHHHHHHHH
Confidence 78889999998887766542 23689999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 125 qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred HHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 9999999999999999999999999999999999999999764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=214.43 Aligned_cols=151 Identities=28% Similarity=0.466 Sum_probs=128.0
Q ss_pred cCceecceEEe-cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHH-hhcCCCceeeee
Q psy2579 58 LGKRVALYKLQ-NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSM-ESVHHPNIIRLY 135 (267)
Q Consensus 58 ~~~~~~~y~~~-~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l-~~l~hpnIv~~~ 135 (267)
.+..+++|.+. +.||+|+||.||+|.+. .+++.||+|++... ..+.+|+.++ +.++||||++++
T Consensus 12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~ 77 (299)
T 3m2w_A 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNK-------RTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIV 77 (299)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEE
T ss_pred ccccccchhhcCcccccCCCeEEEEEEEc-------CCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHH
Confidence 45566779998 77999999999999986 45689999998642 3466788888 556999999999
Q ss_pred eeeee----cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCC
Q psy2579 136 EVLET----FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGR 211 (267)
Q Consensus 136 ~~~~~----~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~ 211 (267)
+++.. .+..|+||||+.+|+|.+++.... ...
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------------~~~ 113 (299)
T 3m2w_A 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRG--------------------------------------------DQA 113 (299)
T ss_dssp EEEEEEETTEEEEEEEECCCCSCBHHHHHHHCT--------------------------------------------TCC
T ss_pred hhhhhhcCCCceEEEEEeecCCCcHHHHHHhcc--------------------------------------------CCC
Confidence 99987 677899999999888877775431 236
Q ss_pred CChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeec---CCceEEeccccccccC
Q psy2579 212 LSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSV---RGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 212 ~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~---~~~~kl~DFGla~~l~ 266 (267)
+++..+..++.|++.||.|||++|++||||||+||+++. ++.+||+|||+|+.+.
T Consensus 114 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 114 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 899999999999999999999999999999999999998 7889999999997653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=212.20 Aligned_cols=148 Identities=28% Similarity=0.397 Sum_probs=120.7
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch--HHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP--KARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
.++|++.+.||+|+||.||+|.+. +..||||++....... ...+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI---------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL 76 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET---------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheeeeeeeccCCCeEEEEEEEc---------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 467999999999999999999863 4789999987654322 23467889999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+..+++|||+.+++|.+++. ..++++..+..
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~-----------------------------------------------~~~~~~~~~~~ 109 (271)
T 3dtc_A 77 KEPNLCLVMEFARGGPLNRVLS-----------------------------------------------GKRIPPDILVN 109 (271)
T ss_dssp CC--CEEEEECCTTEEHHHHHT-----------------------------------------------SSCCCHHHHHH
T ss_pred cCCceEEEEEcCCCCCHHHHhh-----------------------------------------------cCCCCHHHHHH
Confidence 9999999999999988866553 23689999999
Q ss_pred HHHHHHHHHHHHHhCC---CcccCCCCCcEEeec--------CCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRD---IIHRDIKAENVFLSV--------RGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~---ivHrDlkp~NIll~~--------~~~~kl~DFGla~~l 265 (267)
++.|++.||.|||++| ++||||||+||+++. ++.+||+|||+|+.+
T Consensus 110 i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~ 166 (271)
T 3dtc_A 110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW 166 (271)
T ss_dssp HHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----
T ss_pred HHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccc
Confidence 9999999999999999 899999999999986 678999999999754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=222.05 Aligned_cols=147 Identities=24% Similarity=0.392 Sum_probs=125.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+. .+++.||||++............+.+|+.+++.++||||+++++++...+
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 114 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDK-------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 114 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred ccEEEEeEEecCCCeEEEEEEEC-------CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence 56999999999999999999986 45689999999876666666788999999999999999999999998766
Q ss_pred eE------EEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 143 KI------FLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 143 ~~------~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
.. |++||++. ++|.+. + ...+++..
T Consensus 115 ~~~~~~~~~lv~e~~~-~~l~~~----------------------------------------------~--~~~~~~~~ 145 (371)
T 4exu_A 115 SLRNFYDFYLVMPFMQ-TDLQKI----------------------------------------------M--GMEFSEEK 145 (371)
T ss_dssp SSTTCCCCEEEEECCC-EEHHHH----------------------------------------------T--TSCCCHHH
T ss_pred CcccceeEEEEEcccc-ccHHHH----------------------------------------------h--hcCCCHHH
Confidence 54 78888776 344332 2 12489999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+|+..
T Consensus 146 ~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 146 IQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred HHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 9999999999999999999999999999999999999999999999754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-30 Score=224.59 Aligned_cols=157 Identities=18% Similarity=0.198 Sum_probs=111.5
Q ss_pred ccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhc--CCCceee
Q psy2579 57 SLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESV--HHPNIIR 133 (267)
Q Consensus 57 ~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l--~hpnIv~ 133 (267)
..+.....|++.+.||+|+||.||+|.+. .+++.||||++..... .....+.+.+|+.+++.+ +||||++
T Consensus 56 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~ 128 (371)
T 3q60_A 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDV-------ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128 (371)
T ss_dssp TTTCCEEEEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-------
T ss_pred cCCCCceeeeeeeeccCCCCEEEEEEEEC-------CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhh
Confidence 33444556999999999999999999986 4568999999988664 334566788886555555 6999888
Q ss_pred eee-------eeeec-----------------CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCe
Q psy2579 134 LYE-------VLETF-----------------GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGK 189 (267)
Q Consensus 134 ~~~-------~~~~~-----------------~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (267)
++. ++... ...|+|||||+ |+|.+++...
T Consensus 129 ~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-------------------------- 181 (371)
T 3q60_A 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-------------------------- 181 (371)
T ss_dssp ---CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--------------------------
T ss_pred hceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--------------------------
Confidence 663 33332 22677777776 6666665432
Q ss_pred EEEEEEEccCCchhhhhcccCCCChhHH------HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccc
Q psy2579 190 IFLVVEYASGGELYNKITTEGRLSEDDA------KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 190 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~------~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 263 (267)
...+++... ..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 182 -------------------~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~ 242 (371)
T 3q60_A 182 -------------------DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242 (371)
T ss_dssp -------------------HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEE
T ss_pred -------------------ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceee
Confidence 113444444 5777999999999999999999999999999999999999999998
Q ss_pred ccC
Q psy2579 264 KLQ 266 (267)
Q Consensus 264 ~l~ 266 (267)
...
T Consensus 243 ~~~ 245 (371)
T 3q60_A 243 KVG 245 (371)
T ss_dssp ETT
T ss_pred ecC
Confidence 653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=214.58 Aligned_cols=146 Identities=29% Similarity=0.527 Sum_probs=116.3
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec-
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF- 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~- 141 (267)
++|++.+.||+|+||.||+|.+. .+++.||+|++... +....+.+.+|+.+++.++||||+++++++...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDN-------DCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp TTEEEEEECC-----CEEEEEET-------TTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred CceeEEEEeccCCCeEEEEEEEC-------CCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 56999999999999999999986 45689999998754 345567889999999999999999999987432
Q ss_pred -------------CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcc
Q psy2579 142 -------------GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITT 208 (267)
Q Consensus 142 -------------~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~ 208 (267)
+..|++||++. |+| .+.+.
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L----------------------------------------------~~~~~- 113 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDL----------------------------------------------ANVLE- 113 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEH----------------------------------------------HHHHT-
T ss_pred cccccccccccccCceeEEeeccC-CCH----------------------------------------------HHHhh-
Confidence 44555555554 344 44443
Q ss_pred cCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEee-cCCceEEecccccccc
Q psy2579 209 EGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS-VRGIVKLGDLGFSTKL 265 (267)
Q Consensus 209 ~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~-~~~~~kl~DFGla~~l 265 (267)
.+++++..+..++.|++.||+|||++|++||||||+||+++ .++.+||+|||+|+.+
T Consensus 114 ~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~ 171 (320)
T 2i6l_A 114 QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171 (320)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC
T ss_pred cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcccccc
Confidence 24689999999999999999999999999999999999997 5679999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-30 Score=240.03 Aligned_cols=151 Identities=26% Similarity=0.460 Sum_probs=132.0
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhc-CCCceeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESV-HHPNIIRLYEVL 138 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~ 138 (267)
.+++|++++.||+|+||.||+|.+. .+++.||||+++.... .......+.+|..++..+ +||+|+.+++++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~-------~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~ 411 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERK-------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 411 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEES-------SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred cccceEEEEEEccCCCEEEEEEEEC-------CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence 4678999999999999999999987 4568999999976432 123346678899999988 899999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
.+.+.+|+||||+.+|+|..++.. .+.+++..+.
T Consensus 412 ~~~~~~~lV~E~~~gg~L~~~l~~----------------------------------------------~~~~~~~~~~ 445 (674)
T 3pfq_A 412 QTMDRLYFVMEYVNGGDLMYHIQQ----------------------------------------------VGRFKEPHAV 445 (674)
T ss_dssp BCSSEEEEEEECCCSCBHHHHHHH----------------------------------------------HSSCCHHHHH
T ss_pred EeCCEEEEEEeCcCCCcHHHHHHh----------------------------------------------cCCCCHHHHH
Confidence 999999999999999888766643 3468999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTK 264 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~ 264 (267)
.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 446 ~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 446 FYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp HHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 9999999999999999999999999999999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=212.40 Aligned_cols=148 Identities=26% Similarity=0.420 Sum_probs=127.2
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .+..||+|++...... .+.+.+|+.+++.++||||+++++++. .
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 79 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN--------GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET--------TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred HHhhhheeeecCCCCeEEEEEEEc--------CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEc-C
Confidence 356999999999999999999863 3468999999765433 356889999999999999999999986 4
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..+++||++.+++|.+++... ....+++..+..++
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~--------------------------------------------~~~~~~~~~~~~i~ 115 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTP--------------------------------------------SGIKLTINKLLDMA 115 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSH--------------------------------------------HHHTCCHHHHHHHH
T ss_pred CCcEEEEecCCCCCHHHHHhcC--------------------------------------------CCCCCCHHHHHHHH
Confidence 5688999999888887766432 11258899999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++|++||||||+||+++.++.+||+|||+++.+
T Consensus 116 ~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 99999999999999999999999999999999999999999765
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=218.29 Aligned_cols=148 Identities=28% Similarity=0.452 Sum_probs=126.5
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 81 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHK-------PTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPD 81 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred ccceEEeeEEcCCCCeEEEEEEEC-------CCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccc
Confidence 456999999999999999999986 456899999996543 344566788999999999999999999987654
Q ss_pred -----CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 142 -----GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 142 -----~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
+..|++||++. |+|.+.+. . ..+++..
T Consensus 82 ~~~~~~~~~lv~e~~~-~~L~~~~~----------------------------------------------~-~~~~~~~ 113 (353)
T 2b9h_A 82 SFENFNEVYIIQELMQ-TDLHRVIS----------------------------------------------T-QMLSDDH 113 (353)
T ss_dssp CSTTCCCEEEEECCCS-EEHHHHHH----------------------------------------------H-CCCCHHH
T ss_pred ccCccceEEEEEeccC-ccHHHHHh----------------------------------------------h-cCCCHHH
Confidence 56788888876 35554442 2 3689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 114 ~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 114 IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 9999999999999999999999999999999999999999999999865
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=234.35 Aligned_cols=151 Identities=27% Similarity=0.446 Sum_probs=128.7
Q ss_pred cceEEec-ccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 63 ALYKLQN-ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~-~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++.+.+ .||+|+||.||+|.+... .++..||||+++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMR-----KKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECS-----SCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred cceeEcCcEEecCCCcEEEEEEEecC-----CCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 3456666 899999999999988632 235789999997653 33345779999999999999999999999876
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+|||||.+|+|.+++... ...+++..+..++
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~---------------------------------------------~~~l~~~~~~~i~ 442 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGK---------------------------------------------REEIPVSNVAELL 442 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTC---------------------------------------------TTTSCHHHHHHHH
T ss_pred CCeEEEEEeCCCCcHHHHHhhc---------------------------------------------cCCCCHHHHHHHH
Confidence 5689999999998887776532 2358999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 443 ~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 443 HQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred HHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 99999999999999999999999999999999999999999865
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=215.45 Aligned_cols=155 Identities=29% Similarity=0.461 Sum_probs=131.2
Q ss_pred ccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeee
Q psy2579 57 SLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLY 135 (267)
Q Consensus 57 ~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~ 135 (267)
......++|++.+.||+|+||.||+|.+. .+++.||||++...... ...+.+|+.+++.+ +||||++++
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~ 87 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHV-------KTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYY 87 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEE
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEEC-------CCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeee
Confidence 34445677999999999999999999986 45689999999755322 35688999999999 899999999
Q ss_pred eeeee------cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhccc
Q psy2579 136 EVLET------FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTE 209 (267)
Q Consensus 136 ~~~~~------~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~ 209 (267)
+++.. .+..|+||||+.+|+|.+++... ..
T Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------------------------------------~~ 123 (326)
T 2x7f_A 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--------------------------------------------KG 123 (326)
T ss_dssp EEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS--------------------------------------------GG
T ss_pred eEEeeccCccccceEEEEEEcCCCCcHHHHHHhc--------------------------------------------cc
Confidence 99987 46788999999888887776542 12
Q ss_pred CCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 210 GRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 210 ~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++.+
T Consensus 124 ~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 124 NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp GCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 36889999999999999999999999999999999999999999999999998764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=214.08 Aligned_cols=149 Identities=28% Similarity=0.455 Sum_probs=126.2
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
....|++.+.||+|+||.||+|.+. .+++.||+|++..... ...+.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHK-------ETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEET-------TTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEEC-------CCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 3456999999999999999999986 4568999999976432 2458899999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|++||++.+++|.+++... ...+++..+..+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~---------------------------------------------~~~~~~~~~~~i 130 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLR---------------------------------------------NKTLTEDEIATI 130 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHH---------------------------------------------TCCCCHHHHHHH
T ss_pred CCEEEEEeecCCCCCHHHHHHhc---------------------------------------------CCCCCHHHHHHH
Confidence 99999999999998887766421 236899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.+
T Consensus 131 ~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 131 LQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 999999999999999999999999999999999999999999754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=212.84 Aligned_cols=153 Identities=33% Similarity=0.560 Sum_probs=132.6
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++.+.||+|+||.||+|.+. .+++.||+|++............+.+|+.+++.++||||+++++++..
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDR-------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEc-------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC
Confidence 3456999999999999999999986 456899999997665544556778999999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..+++||++.+++|.+.+. ....+++..+..+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~----------------------------------------------~~~~~~~~~~~~i 126 (287)
T 2wei_A 93 SSSFYIVGELYTGGELFDEII----------------------------------------------KRKRFSEHDAARI 126 (287)
T ss_dssp SSEEEEEECCCCSCBHHHHHH----------------------------------------------HHSSCCHHHHHHH
T ss_pred CCeEEEEEEccCCCCHHHHHH----------------------------------------------hcCCCCHHHHHHH
Confidence 999999999998877766553 2346899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecC---CceEEeccccccccC
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVR---GIVKLGDLGFSTKLQ 266 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~---~~~kl~DFGla~~l~ 266 (267)
+.|++.||.|||++|++|+||||+||+++.+ +.+||+|||+++.+.
T Consensus 127 ~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 127 IKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred HHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 9999999999999999999999999999764 479999999987653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-30 Score=217.41 Aligned_cols=159 Identities=30% Similarity=0.441 Sum_probs=119.3
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++.+.||+|+||.||+|.+. .++..||||++..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 84 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCA-------PKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVV 84 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC-----------CEEEEECCC-----------------CCCCCCCTTBCCEEEEEES
T ss_pred chhhhhhhheeccccceEEEEEEEC-------CCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence 3467999999999999999999886 4458999999875532 2345678899999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..++|||++.+++|.+++..... ........+++..+..+
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------~~~~~~~~~~~~~~~~i 126 (303)
T 2vwi_A 85 KDELWLVMKLLSGGSVLDIIKHIVA--------------------------------------KGEHKSGVLDESTIATI 126 (303)
T ss_dssp SSCEEEEEECCTTCBHHHHHHHHHH--------------------------------------TTTTTTCSSCHHHHHHH
T ss_pred cCCcEEEehhccCCchHHHHHHHhh--------------------------------------ccccccCCCCHHHHHHH
Confidence 9999999999999999887753200 00012346899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||++|++||||||+||+++.++.+||+|||+++.+
T Consensus 127 ~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred HHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 999999999999999999999999999999999999999998654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=213.48 Aligned_cols=154 Identities=31% Similarity=0.475 Sum_probs=122.7
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
.++|++.+.||+|+||.||+|.+.... .....||+|++...... ....+.+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPS----GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTT----SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCC----CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 356999999999999999999875322 22347999999765432 3556789999999999999999999999887
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+ .+++||++.+++|.+++... ...+++..+..+
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~~ 126 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKH---------------------------------------------QGHFLLGTLSRY 126 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHH---------------------------------------------GGGSCHHHHHHH
T ss_pred CC-ceeeEecccCCCHHHHHHhc---------------------------------------------cCCcCHHHHHHH
Confidence 55 88999999988887766532 235889999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|||++|++|+||||+||+++.++.+||+|||+++.+
T Consensus 127 ~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 127 AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 999999999999999999999999999999999999999998765
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=212.12 Aligned_cols=146 Identities=19% Similarity=0.260 Sum_probs=127.7
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||.||+|.+. .+++.||||++...... ..+.+|+.+++.+ +|||++++++++...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 78 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNL-------LNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEG 78 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEET-------TTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred cceEEEEEEeecCCEEEEEEEEC-------CCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence 45999999999999999999985 45689999998654322 3477899999999 899999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
...+++||++ +++|.+++... ..++++..+..++
T Consensus 79 ~~~~lv~e~~-~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~i~ 112 (298)
T 1csn_A 79 LHNVLVIDLL-GPSLEDLLDLC---------------------------------------------GRKFSVKTVAMAA 112 (298)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT---------------------------------------------TTCCCHHHHHHHH
T ss_pred ceeEEEEEec-CCCHHHHHHHh---------------------------------------------ccCCCHHHHHHHH
Confidence 9999999999 88887776532 2258999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCc-----eEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGI-----VKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~-----~kl~DFGla~~l 265 (267)
.|++.||+|||++|++||||||+||+++.++. +||+|||+|+.+
T Consensus 113 ~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 113 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp HHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred HHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99999999999999999999999999987775 999999999764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=219.49 Aligned_cols=152 Identities=32% Similarity=0.528 Sum_probs=132.4
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc--c----hHHHHHHHHHHHHHhhc-CCCceeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL--T----PKARKMLSREIVSMESV-HHPNIIRL 134 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~--~----~~~~~~~~~Ei~~l~~l-~hpnIv~~ 134 (267)
.++|++.+.||+|+||.||+|.+. .+++.||||++..... . ....+.+.+|+.+++.+ +||||+++
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~-------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHR-------ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred hhhcccceEEecCCCEEEEEEEEC-------CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 356999999999999999999985 4568999999976542 1 22356788999999999 89999999
Q ss_pred eeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCCh
Q psy2579 135 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214 (267)
Q Consensus 135 ~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~ 214 (267)
++++...+..|+||||+.+++|.+++.. ...+++
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~----------------------------------------------~~~l~~ 199 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTE----------------------------------------------KVALSE 199 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHH----------------------------------------------HSSCCH
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHh----------------------------------------------cCCCCH
Confidence 9999999999999999999888766542 346899
Q ss_pred hHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..+.
T Consensus 200 ~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 200 KETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 9999999999999999999999999999999999999999999999987653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=218.91 Aligned_cols=148 Identities=24% Similarity=0.384 Sum_probs=126.2
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .+++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 95 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDK-------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 95 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred CceEEEeeeEecCCCeEEEEEEEC-------CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecc
Confidence 356999999999999999999986 4568999999987665666678899999999999999999999998766
Q ss_pred Ce------EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 142 GK------IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 142 ~~------~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
+. .|++||++. ++|. +.+. ..+++.
T Consensus 96 ~~~~~~~~~~lv~e~~~-~~l~----------------------------------------------~~~~--~~~~~~ 126 (353)
T 3coi_A 96 SSLRNFYDFYLVMPFMQ-TDLQ----------------------------------------------KIMG--LKFSEE 126 (353)
T ss_dssp SSGGGCCCCEEEEECCS-EEGG----------------------------------------------GTTT--SCCCHH
T ss_pred cccccceeEEEEecccc-CCHH----------------------------------------------HHhc--CCCCHH
Confidence 43 377777765 3443 3332 258999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+|+..
T Consensus 127 ~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 127 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 99999999999999999999999999999999999999999999999764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=214.12 Aligned_cols=148 Identities=32% Similarity=0.522 Sum_probs=127.5
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+. .+++.||+|++..... .....+.+|+.+++.++||||+++++++...+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQR-------LTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTT 79 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccceeeeeccCCCCceEEEEEEC-------CCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCC
Confidence 56999999999999999999986 4568999999975432 23356889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++||++.+++|.+.+. ..+.+++..+..++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~----------------------------------------------~~~~~~~~~~~~~~~ 113 (304)
T 2jam_A 80 HYYLVMQLVSGGELFDRIL----------------------------------------------ERGVYTEKDASLVIQ 113 (304)
T ss_dssp EEEEEECCCCSCBHHHHHH----------------------------------------------HHSCCCHHHHHHHHH
T ss_pred EEEEEEEcCCCccHHHHHH----------------------------------------------HcCCCCHHHHHHHHH
Confidence 9999999999877766553 234689999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEe---ecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFL---SVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++|++||||||+||++ +.++.++|+|||+++..
T Consensus 114 qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 114 QVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp HHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred HHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 99999999999999999999999999 77889999999998754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=221.77 Aligned_cols=182 Identities=24% Similarity=0.285 Sum_probs=120.5
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. .+++.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~-------~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~ 72 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDI-------ESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTT 72 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEET-------TTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred cceEEEEEEEEeccCEEEEEEEEC-------CCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeec
Confidence 356999999999999999999986 5568999999865432 234799999999999999999998664
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhh----cccCCCChhHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKI----TTEGRLSEDDA 217 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~----~~~~~~~~~~~ 217 (267)
+.......... .....+..... ...-...............++|||++++ +|.+.+ .....+++..+
T Consensus 73 ~~~~~~~~~~~--~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~ 143 (383)
T 3eb0_A 73 GDEEPKPPQPP--DDHNKLGGKNN------GVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLI 143 (383)
T ss_dssp ---------------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHH
T ss_pred Ccccccccccc--ccccccccccc------ccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHH
Confidence 43100000000 00000000000 0000000000011223456677777764 444333 34568999999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEee-cCCceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLS-VRGIVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~-~~~~~kl~DFGla~~l 265 (267)
..++.|++.||.|||++||+||||||+|||++ .++.+||+|||+|+.+
T Consensus 144 ~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 192 (383)
T 3eb0_A 144 SIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL 192 (383)
T ss_dssp HHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCccc
Confidence 99999999999999999999999999999998 6889999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=214.35 Aligned_cols=171 Identities=24% Similarity=0.333 Sum_probs=135.5
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 140 (267)
.++|++.+.||+|+||.||+|.+..... ..+++.||||++.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDK--TATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSS--TTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCc--cccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 4569999999999999999998753211 1456899999997653 344557789999999999 79999999999877
Q ss_pred cC-eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 141 FG-KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 141 ~~-~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
.+ ..+++|||+.+|+|.+++......... ............+++..+..
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~ 152 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVP------------------------------YKVAPEDLYKDFLTLEHLIC 152 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEEC------------------------------C-------CTTCEEHHHHHH
T ss_pred CCCceEEEEEcCCCCcHHHHHHhccccccc------------------------------ccccchhhhccccCHHHHHH
Confidence 64 599999999999999988765321000 00000001123488999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||.|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 153 ~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 198 (316)
T 2xir_A 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198 (316)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred HHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCcccccc
Confidence 9999999999999999999999999999999999999999999764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=215.21 Aligned_cols=152 Identities=32% Similarity=0.571 Sum_probs=126.4
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc--hHHHHHHHHHHHHHhhcCCCceeeeeeee-
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT--PKARKMLSREIVSMESVHHPNIIRLYEVL- 138 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~- 138 (267)
.++|++.+.||+|+||.||+|.+. .++..||+|++...... ......+.+|+.+++.++||||+++++++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDS-------ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLY 76 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBT-------TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccceeEeeEEecCCCeEEEEEEEC-------CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence 467999999999999999999885 45689999999765422 23457799999999999999999999998
Q ss_pred -eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 139 -ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 139 -~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
...+..|+||||+.++ +.+.+... ....+++..+
T Consensus 77 ~~~~~~~~lv~e~~~~~-l~~~~~~~--------------------------------------------~~~~~~~~~~ 111 (305)
T 2wtk_C 77 NEEKQKMYMVMEYCVCG-MQEMLDSV--------------------------------------------PEKRFPVCQA 111 (305)
T ss_dssp CC---CEEEEEECCSEE-HHHHHHHS--------------------------------------------TTCSCCHHHH
T ss_pred cCCCCeEEEEehhccCC-HHHHHHhC--------------------------------------------cccccCHHHH
Confidence 4456789999999876 43333221 1346899999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.+
T Consensus 112 ~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 112 HGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 999999999999999999999999999999999999999999999764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=216.03 Aligned_cols=161 Identities=22% Similarity=0.258 Sum_probs=129.7
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+..... ..++..||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPN--DPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC----------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCC--CCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 3569999999999999999998542110 1456889999996443 445566789999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+||||+.+++|.+++....... .....+++..+..++
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~---------------------------------------~~~~~~~~~~~~~i~ 146 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRP---------------------------------------SQPSSLAMLDLLHVA 146 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCS---------------------------------------SSTTSCCHHHHHHHH
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccc---------------------------------------cccccccHHHHHHHH
Confidence 99999999999999998887543210 012358899999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecC---CceEEeccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVR---GIVKLGDLGFSTK 264 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~---~~~kl~DFGla~~ 264 (267)
.|++.||.|||++|++||||||+||+++.+ ..+||+|||+++.
T Consensus 147 ~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~ 192 (327)
T 2yfx_A 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192 (327)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred HHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccc
Confidence 999999999999999999999999999844 4699999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=233.56 Aligned_cols=149 Identities=29% Similarity=0.458 Sum_probs=127.6
Q ss_pred eEEe-cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 65 YKLQ-NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 65 y~~~-~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
+.+. +.||+|+||.||+|.+... ..+..||||+++.........+.+.+|+.+++.++|||||++++++.. +.
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~ 443 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMK-----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES 443 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECS-----SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred ccccCCEeccCCCEEEEEEEEcCC-----CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CC
Confidence 4443 4799999999999977532 345889999998766555566789999999999999999999999864 56
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.++|||||.+|+|.+++.. ...+++..+..++.|
T Consensus 444 ~~lv~E~~~~g~L~~~l~~----------------------------------------------~~~l~~~~~~~i~~q 477 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQ----------------------------------------------NRHVKDKNIIELVHQ 477 (635)
T ss_dssp EEEEEECCTTEEHHHHHHH----------------------------------------------CTTCCHHHHHHHHHH
T ss_pred EEEEEEccCCCCHHHHHhh----------------------------------------------CCCCCHHHHHHHHHH
Confidence 8899999988777766643 346889999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 478 i~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 519 (635)
T 4fl3_A 478 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 519 (635)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred HHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence 999999999999999999999999999999999999999865
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-29 Score=233.14 Aligned_cols=155 Identities=26% Similarity=0.410 Sum_probs=132.4
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++.+.||+|+||.||+|.+.... ..+..||||.+.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~----~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPE----NPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSS----SCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCC----CccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 3467999999999999999999986432 335789999987543 4455678999999999999999999999985
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+||||+.+|+|.+++... ...+++..+..+
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~---------------------------------------------~~~l~~~~~~~i 496 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVR---------------------------------------------KFSLDLASLILY 496 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHT---------------------------------------------TTTCCHHHHHHH
T ss_pred cCceEEEEEcCCCCcHHHHHHhc---------------------------------------------cCCCCHHHHHHH
Confidence 46689999999988887776532 125889999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 497 ~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 497 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred HHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 9999999999999999999999999999999999999999998653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=219.51 Aligned_cols=151 Identities=21% Similarity=0.219 Sum_probs=121.9
Q ss_pred cceEEecccCccCceeEEEeEEeeccccc-ccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceee--------
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPIL-CTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIR-------- 133 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~-------- 133 (267)
++|++.+.||+|+||.||+|.+..+.... ...++.||+|++... ..+.+|+.+++.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 67999999999999999999987432100 013689999998654 35778999999999999998
Q ss_pred -------eeeeeee-cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhh
Q psy2579 134 -------LYEVLET-FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNK 205 (267)
Q Consensus 134 -------~~~~~~~-~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~ 205 (267)
+++++.. .+..|+||||+ +++|.+++...
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~------------------------------------------ 151 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS------------------------------------------ 151 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS------------------------------------------
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC------------------------------------------
Confidence 5566655 67788888888 87777766532
Q ss_pred hcccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC--ceEEecccccccc
Q psy2579 206 ITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG--IVKLGDLGFSTKL 265 (267)
Q Consensus 206 ~~~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~--~~kl~DFGla~~l 265 (267)
....+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||+|+.+
T Consensus 152 --~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~ 211 (352)
T 2jii_A 152 --PKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211 (352)
T ss_dssp --GGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCS
T ss_pred --CcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeec
Confidence 124699999999999999999999999999999999999999988 9999999999764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-29 Score=215.24 Aligned_cols=143 Identities=22% Similarity=0.411 Sum_probs=121.0
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhh--cCCCceeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES--VHHPNIIRLYEVLE 139 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~~~~~~~ 139 (267)
.++|++.+.||+|+||.||+|.+. +..||||++.... . ....+|..++.. ++||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~---~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 101 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR---------GEKVAVKVFFTTE---E--ASWFRETEIYQTVLMRHENILGFIAADI 101 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET---------TEEEEEEEEEGGG---H--HHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC---------CceEEEEEEeccc---c--chhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence 456999999999999999999863 4889999985432 2 234445555554 49999999999998
Q ss_pred ec----CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 140 TF----GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 140 ~~----~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
.. +..|+||||+.+|+|.+++.. ..+++.
T Consensus 102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-----------------------------------------------~~~~~~ 134 (337)
T 3mdy_A 102 KGTGSWTQLYLITDYHENGSLYDYLKS-----------------------------------------------TTLDAK 134 (337)
T ss_dssp ESCGGGCEEEEEECCCTTCBHHHHHHH-----------------------------------------------CCBCHH
T ss_pred cCCCCCCceEEEEeccCCCcHHHHhhc-----------------------------------------------cCCCHH
Confidence 87 788999999998888776643 258899
Q ss_pred HHHHHHHHHHHHHHHHHhC--------CCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDR--------DIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~--------~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.+..++.|++.||.|||++ |++||||||+|||++.++.+||+|||+|+.+
T Consensus 135 ~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 192 (337)
T 3mdy_A 135 SMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192 (337)
T ss_dssp HHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceee
Confidence 9999999999999999999 9999999999999999999999999999754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=218.41 Aligned_cols=156 Identities=17% Similarity=0.327 Sum_probs=132.3
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch---------------HHHHHHHHHHHHHhh
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP---------------KARKMLSREIVSMES 125 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~---------------~~~~~~~~Ei~~l~~ 125 (267)
..++|++.+.||+|+||.||+|.+ +++.||||++....... .....+.+|+.+++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 99 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK---------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE---------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTT
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc---------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHh
Confidence 457899999999999999999987 24899999997543221 112678999999999
Q ss_pred cCCCceeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhh
Q psy2579 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNK 205 (267)
Q Consensus 126 l~hpnIv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~ 205 (267)
++||||+++++++...+..|+||||+++|+|.+++.....
T Consensus 100 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------------------------------- 139 (348)
T 2pml_X 100 IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV---------------------------------------- 139 (348)
T ss_dssp CCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEES----------------------------------------
T ss_pred CCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhh----------------------------------------
Confidence 9999999999999999999999999999888776321100
Q ss_pred hcc--cCCCChhHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 206 ITT--EGRLSEDDAKIYFLQILSAVKHLHD-RDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 206 ~~~--~~~~~~~~~~~~~~ql~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.. ...+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||+++.+
T Consensus 140 l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 202 (348)
T 2pml_X 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202 (348)
T ss_dssp SCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEecccccccc
Confidence 111 3479999999999999999999999 99999999999999999999999999999764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-29 Score=216.12 Aligned_cols=150 Identities=23% Similarity=0.369 Sum_probs=122.3
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc---------chHHHHHHHHHHHHHhhcCCCcee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL---------TPKARKMLSREIVSMESVHHPNII 132 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~~Ei~~l~~l~hpnIv 132 (267)
.++|++.+.||+|+||.||+|.+. .+..||||++..... .....+.+.+|+.+++.++||||+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDS--------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECT--------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccceEEeEEeccCCCEEEEEEECC--------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 355999999999999999999873 368999999865432 223357799999999999999999
Q ss_pred eeeeeeeec-----CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhc
Q psy2579 133 RLYEVLETF-----GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKIT 207 (267)
Q Consensus 133 ~~~~~~~~~-----~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~ 207 (267)
++++++... ...|+|||++. |+|.+.+..
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--------------------------------------------- 126 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--------------------------------------------- 126 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---------------------------------------------
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---------------------------------------------
Confidence 999998543 35788888887 455544432
Q ss_pred ccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 208 TEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 208 ~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+|+..
T Consensus 127 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (362)
T 3pg1_A 127 QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARED 184 (362)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC----
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCccccc
Confidence 2236899999999999999999999999999999999999999999999999999743
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.8e-29 Score=213.18 Aligned_cols=150 Identities=29% Similarity=0.435 Sum_probs=126.2
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-CCceeeeeeeee--
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-HPNIIRLYEVLE-- 139 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~-- 139 (267)
.+|++.+.||+|+||.||+|.+. .+++.||||++... .......+.+|+.++..+. ||||+++++++.
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDV-------GSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEET-------TTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred ceEEEEEEEccCCceEEEEEEEC-------CCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 46999999999999999999986 45689999998554 3445577899999999995 999999999984
Q ss_pred ------ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCC
Q psy2579 140 ------TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLS 213 (267)
Q Consensus 140 ------~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~ 213 (267)
.....+++||++. |+|.+++... ...++++
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-------------------------------------------~~~~~~~ 134 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKM-------------------------------------------ESRGPLS 134 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHH-------------------------------------------HTTCSCC
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHh-------------------------------------------hccCCCC
Confidence 3345788888885 5666555321 1234699
Q ss_pred hhHHHHHHHHHHHHHHHHHhCC--CcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 214 EDDAKIYFLQILSAVKHLHDRD--IIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 214 ~~~~~~~~~ql~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+..+..++.|++.||.|||++| ++||||||+|||++.++.+||+|||+|+.+
T Consensus 135 ~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 188 (337)
T 3ll6_A 135 CDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceec
Confidence 9999999999999999999999 999999999999999999999999999765
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=209.39 Aligned_cols=150 Identities=28% Similarity=0.411 Sum_probs=127.4
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
.|.....||+|+||.||+|.+. .++..||||.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDL-------SNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEET-------TTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEeecCcEEEEEEEEC-------CCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 3444558999999999999986 456899999997653 3445678999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.+++||++.+++|.+++..... ...+++..+..++.|
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------~~~~~~~~~~~~~~q 130 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWG-------------------------------------------PLKDNEQTIGFYTKQ 130 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTC-------------------------------------------CCTTCHHHHHHHHHH
T ss_pred EEEEEEeCCCCCHHHHHHhhcc-------------------------------------------CCCccHHHHHHHHHH
Confidence 9999999999898877754311 124678889999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeec-CCceEEecccccccc
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSV-RGIVKLGDLGFSTKL 265 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~l 265 (267)
++.||.|||++|++|+||||+||+++. ++.+||+|||+++.+
T Consensus 131 i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 131 ILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred HHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 999999999999999999999999987 899999999999764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-29 Score=214.59 Aligned_cols=148 Identities=23% Similarity=0.318 Sum_probs=117.8
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
+..+++|++.+.||+|+||.||+|.+. ++.||||++.... ........|+..+..++||||+++++.+
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~ 76 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSLD---------ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGD 76 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEET---------TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred CcChHHhheeeecccCCCeEEEEEEEC---------CeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecc
Confidence 345677999999999999999999652 4889999996542 1112223444445568999999999855
Q ss_pred ee-----cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCC
Q psy2579 139 ET-----FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLS 213 (267)
Q Consensus 139 ~~-----~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~ 213 (267)
.. ....++|||||++|+|.+++... ..+
T Consensus 77 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----------------------------------------------~~~ 109 (336)
T 3g2f_A 77 ERVTADGRMEYLLVMEYYPNGSLXKYLSLH-----------------------------------------------TSD 109 (336)
T ss_dssp EEECTTSCEEEEEEECCCTTCBHHHHHHHC-----------------------------------------------CBC
T ss_pred cccccCCCceEEEEEecCCCCcHHHHHhhc-----------------------------------------------ccc
Confidence 32 23567888888887777666432 457
Q ss_pred hhHHHHHHHHHHHHHHHHHhC---------CCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 214 EDDAKIYFLQILSAVKHLHDR---------DIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 214 ~~~~~~~~~ql~~~L~~lH~~---------~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+|+.+
T Consensus 110 ~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~ 170 (336)
T 3g2f_A 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred hhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeec
Confidence 888999999999999999999 9999999999999999999999999999764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-29 Score=211.46 Aligned_cols=149 Identities=23% Similarity=0.312 Sum_probs=128.7
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccc--cchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAK--LTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
|...+.||+|+||.||+|.+. +..||+|++.... ......+.+.+|+.+++.++||||+++++++...+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 103 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVN---------NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD 103 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESS---------SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccCCccccCCCeEEEEEEEC---------CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCC
Confidence 445578999999999999752 4789999987543 23345678999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++||++.+++|.+++... ....++++..+..++.
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~-------------------------------------------~~~~~~~~~~~~~i~~ 140 (307)
T 2nru_A 104 DLCLVYVYMPNGSLLDRLSCL-------------------------------------------DGTPPLSWHMRCKIAQ 140 (307)
T ss_dssp SCEEEEECCTTCBHHHHHHTG-------------------------------------------GGCCCCCHHHHHHHHH
T ss_pred ceEEEEEecCCCcHHHHHHhc-------------------------------------------cCCCCCCHHHHHHHHH
Confidence 999999999999998777532 1234689999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||++|++||||||+||+++.++.+||+|||+|+..
T Consensus 141 ~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 183 (307)
T 2nru_A 141 GAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS 183 (307)
T ss_dssp HHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccc
Confidence 9999999999999999999999999999999999999998754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-29 Score=234.07 Aligned_cols=148 Identities=25% Similarity=0.421 Sum_probs=126.2
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+.. .+++.||||++.... .......+.+|+.+++.++||||+++++++...+
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRN------VNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGG------GTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred CceEEEEEEeeCCCeEEEEEEEcC------CCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 679999999999999999999862 246889999986543 4455678899999999999999999999998876
Q ss_pred e-----EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 143 K-----IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 143 ~-----~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
. .|+||||+++++|.+.+. . .+++..+
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~----------------------------------------------~--~l~~~~~ 184 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKG----------------------------------------------Q--KLPVAEA 184 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC--------------------------------------------------C--CCCHHHH
T ss_pred CCCCceeEEEEEeCCCCcHHHHHh----------------------------------------------C--CCCHHHH
Confidence 5 688888888877754332 1 6899999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
..++.|++.||.|||++||+||||||+|||++.+ .+||+|||+++.+.
T Consensus 185 ~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 185 IAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred HHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 9999999999999999999999999999999875 89999999998653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=217.00 Aligned_cols=152 Identities=20% Similarity=0.261 Sum_probs=120.1
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchH---------HHHHHHHHHHHHhhcCCCceee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPK---------ARKMLSREIVSMESVHHPNIIR 133 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~---------~~~~~~~Ei~~l~~l~hpnIv~ 133 (267)
++|++.+.||+|+||.||+|.+.... .++..||+|++........ ....+.+|+..++.++||||++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKP----EKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSC----GGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCC----CccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 46999999999999999999986422 3568899999976542111 1133668899999999999999
Q ss_pred eeeeeee----cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhccc
Q psy2579 134 LYEVLET----FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTE 209 (267)
Q Consensus 134 ~~~~~~~----~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~ 209 (267)
+++++.. .+..|+|||++ +++|.+++. ..
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~----------------------------------------------~~ 145 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISG----------------------------------------------QN 145 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCB----------------------------------------------GG
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHH----------------------------------------------hc
Confidence 9999987 67788888888 767765553 33
Q ss_pred CCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC--ceEEecccccccc
Q psy2579 210 GRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG--IVKLGDLGFSTKL 265 (267)
Q Consensus 210 ~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~--~~kl~DFGla~~l 265 (267)
+.+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.+
T Consensus 146 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~ 203 (345)
T 2v62_A 146 GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203 (345)
T ss_dssp GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEES
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceec
Confidence 4689999999999999999999999999999999999999887 9999999999754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=210.19 Aligned_cols=148 Identities=24% Similarity=0.447 Sum_probs=123.0
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..++|++.+.||+|+||.||+|.+. +..||+|++.... ..+.+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR---------GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVE 85 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET---------TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred ChhhceEEeEEecCCCceEEEEEEc---------CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 3567999999999999999999763 4789999997543 34678899999999999999999998654
Q ss_pred c-CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 141 F-GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 141 ~-~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
. +..|++||++.+++|.+++.... ...+++..+..
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------------~~~~~~~~~~~ 121 (278)
T 1byg_A 86 EKGGLYIVTEYMAKGSLVDYLRSRG--------------------------------------------RSVLGGDCLLK 121 (278)
T ss_dssp C--CCEEEECCCTTEEHHHHHHHHH--------------------------------------------HHHCCHHHHHH
T ss_pred CCCceEEEEecCCCCCHHHHHHhcc--------------------------------------------cccCCHHHHHH
Confidence 4 57899999999988887765320 11378899999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||.|||++|++||||||+||+++.++.++|+|||+++..
T Consensus 122 ~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 122 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred HHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 9999999999999999999999999999999999999999998754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-29 Score=213.02 Aligned_cols=153 Identities=24% Similarity=0.394 Sum_probs=125.6
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc---CCCceeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV---HHPNIIRLYEVL 138 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~~~~~~ 138 (267)
.++|++.+.||+|+||.||+|.+.. .+++.||+|++............+.+|+.+++.+ +||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~ 83 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLK------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVC 83 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecC------CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeee
Confidence 4679999999999999999998841 3458899999976543332234566788777766 899999999998
Q ss_pred e-----ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCC
Q psy2579 139 E-----TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLS 213 (267)
Q Consensus 139 ~-----~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~ 213 (267)
. ..+..+++||++. |+|.+++... ....++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--------------------------------------------~~~~~~ 118 (326)
T 1blx_A 84 TVSRTDRETKLTLVFEHVD-QDLTTYLDKV--------------------------------------------PEPGVP 118 (326)
T ss_dssp EEEECSSEEEEEEEEECCS-CBHHHHHHHS--------------------------------------------CTTCSC
T ss_pred eecccCCCceEEEEEecCC-CCHHHHHHhc--------------------------------------------ccCCCC
Confidence 7 4567888888887 4776665432 122489
Q ss_pred hhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 214 EDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 214 ~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 119 ~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 170 (326)
T 1blx_A 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 170 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred HHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccc
Confidence 9999999999999999999999999999999999999999999999999764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-28 Score=218.98 Aligned_cols=149 Identities=26% Similarity=0.359 Sum_probs=127.3
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc------CCCceeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV------HHPNIIRLY 135 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l------~hpnIv~~~ 135 (267)
..+|++.+.||+|+||.||+|.+. .+++.||||++... ......+.+|+.+++.+ .||||++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~-------~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDH-------KVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEET-------TTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred cCcEEEEEEcccCccEEEEEEEEC-------CCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 456999999999999999999986 45689999999653 33446677888888877 577999999
Q ss_pred eeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 136 EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 136 ~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
+++...+..|++||++. ++|.+++.... ...+++.
T Consensus 166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--------------------------------------------~~~~~~~ 200 (429)
T 3kvw_A 166 ENFTFRNHICMTFELLS-MNLYELIKKNK--------------------------------------------FQGFSLP 200 (429)
T ss_dssp EEEEETTEEEEEECCCC-CBHHHHHHHTT--------------------------------------------TCCCCHH
T ss_pred eecccCCeEEEEEeccC-CCHHHHHHhcc--------------------------------------------CCCCCHH
Confidence 99999999999999996 57766665431 1258999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCc--eEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGI--VKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFGla~~l 265 (267)
.+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+..
T Consensus 201 ~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp HHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 99999999999999999999999999999999999887 999999999754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=211.02 Aligned_cols=146 Identities=32% Similarity=0.503 Sum_probs=121.7
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|.+. +..||+|.+... ...+.+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 71 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR---------AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL-- 71 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET---------TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--
T ss_pred HhHeeeeeEeecCCCceEEEEEEC---------CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--
Confidence 456999999999999999999864 477999998643 34567899999999999999999999886
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..++||||+++|+|.+++..... ...+++..+..++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------~~~~~~~~~~~~~ 108 (307)
T 2eva_A 72 NPVCLVMEYAEGGSLYNVLHGAEP-------------------------------------------LPYYTAAHAMSWC 108 (307)
T ss_dssp TTTEEEEECCTTCBHHHHHHCSSS-------------------------------------------EECCCHHHHHHHH
T ss_pred CCcEEEEEcCCCCCHHHHHhccCC-------------------------------------------CCccCHHHHHHHH
Confidence 447899999999888877764311 1247888999999
Q ss_pred HHHHHHHHHHHh---CCCcccCCCCCcEEeecCCc-eEEecccccccc
Q psy2579 222 LQILSAVKHLHD---RDIIHRDIKAENVFLSVRGI-VKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~---~~ivHrDlkp~NIll~~~~~-~kl~DFGla~~l 265 (267)
.|++.||+|||+ +|++||||||+||+++.++. +||+|||+|+.+
T Consensus 109 ~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp HHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred HHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 999999999999 89999999999999998886 799999998754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-29 Score=228.75 Aligned_cols=142 Identities=16% Similarity=0.126 Sum_probs=111.2
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeeccccc--------chHHHHHHHHHHHHHhhc-CCCceeeeeeeee
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL--------TPKARKMLSREIVSMESV-HHPNIIRLYEVLE 139 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~ 139 (267)
...+.|++|.+..++.. ..++.||+|++..... .....+.+.+|+.+|+++ .|+||++++++++
T Consensus 240 ~~~~~~~~~~h~~~rr~-------~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e 312 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRY-------FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE 312 (569)
T ss_dssp CC-C--------CCEEE-------EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE
T ss_pred hccccCCcccccccccc-------cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Confidence 34677777777776665 3458899999976431 233457799999999999 8999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
+.+..|||||||+|++|.+.+.. .+++++. .
T Consensus 313 d~~~~yLVMEyv~G~~L~d~i~~----------------------------------------------~~~l~~~---~ 343 (569)
T 4azs_A 313 NAQSGWLVMEKLPGRLLSDMLAA----------------------------------------------GEEIDRE---K 343 (569)
T ss_dssp CSSEEEEEEECCCSEEHHHHHHT----------------------------------------------TCCCCHH---H
T ss_pred ECCEEEEEEecCCCCcHHHHHHh----------------------------------------------CCCCCHH---H
Confidence 99999999999999887776654 3355544 4
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
++.||+.||+|+|++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 344 I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 344 ILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp HHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred HHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 78999999999999999999999999999999999999999998754
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=217.39 Aligned_cols=150 Identities=20% Similarity=0.368 Sum_probs=127.7
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
-..++|++.+.||+|+||.||+|.+. ..||+|++..........+.+.+|+.+++.++||||+++++++.
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~----------~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWH----------GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEES----------SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEc----------CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 34567999999999999999999874 45899999876544444456788999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+..+++||++.+++|.+++... ...+++..+..
T Consensus 100 ~~~~~~iv~e~~~~~~L~~~l~~~---------------------------------------------~~~~~~~~~~~ 134 (319)
T 2y4i_B 100 SPPHLAIITSLCKGRTLYSVVRDA---------------------------------------------KIVLDVNKTRQ 134 (319)
T ss_dssp CSSCEEEECBCCCSEEHHHHTTSS---------------------------------------------CCCCCSHHHHH
T ss_pred cCCceEEEeecccCCcHHHHHHhc---------------------------------------------CCCCCHHHHHH
Confidence 999999999999998887776532 22588999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||+|||++|++||||||+||+++ ++.++|+|||+|+..
T Consensus 135 i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 135 IAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred HHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 999999999999999999999999999998 789999999997653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=211.52 Aligned_cols=158 Identities=27% Similarity=0.361 Sum_probs=128.1
Q ss_pred cCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHH-HHhhcCCCceeeeee
Q psy2579 58 LGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIV-SMESVHHPNIIRLYE 136 (267)
Q Consensus 58 ~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~-~l~~l~hpnIv~~~~ 136 (267)
.....++|++.+.||+|+||.||+|.+. .+++.||||++..... ......+.+|+. +++.++||||+++++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~ 88 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHK-------PSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYG 88 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEET-------TTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEE
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEc-------CCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeee
Confidence 3344577999999999999999999986 4568999999976543 333445556665 777789999999999
Q ss_pred eeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 137 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 137 ~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
++...+..++|||++.+ +|.+++... .......+++..
T Consensus 89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------------------------------------~~~~~~~~~~~~ 126 (327)
T 3aln_A 89 ALFREGDCWICMELMST-SFDKFYKYV-----------------------------------------YSVLDDVIPEEI 126 (327)
T ss_dssp EEECSSEEEEEECCCSE-EHHHHHHHH-----------------------------------------HHTTCCCCCHHH
T ss_pred EEEeCCceEEEEeecCC-ChHHHHHHH-----------------------------------------HhhhcccCcHHH
Confidence 99999999999999985 665544311 000134689999
Q ss_pred HHHHHHHHHHHHHHHHhC-CCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDR-DIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||+|+.+
T Consensus 127 ~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 127 LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred HHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 999999999999999999 9999999999999999999999999999765
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-28 Score=212.27 Aligned_cols=142 Identities=24% Similarity=0.402 Sum_probs=123.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhh--cCCCceeeeeeeeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMES--VHHPNIIRLYEVLET 140 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~--l~hpnIv~~~~~~~~ 140 (267)
++|++.+.||+|+||.||+|.+. ++.||||++... ....+.+|+.++.. ++||||+++++++..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWR---------GEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET---------TEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred ccEEEEeeecCCCCcEEEEEEEc---------CccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 46999999999999999999863 488999998643 23457788888887 799999999999987
Q ss_pred cC----eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 141 FG----KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 141 ~~----~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
.+ ..|++|||+.+|+|.+++.. ..+++..
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----------------------------------------------~~~~~~~ 140 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR-----------------------------------------------YTVTVEG 140 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH-----------------------------------------------CCBCHHH
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc-----------------------------------------------cCccHHH
Confidence 76 78999999998888776643 2588999
Q ss_pred HHHHHHHHHHHHHHHH--------hCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLH--------DRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH--------~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||+|+.+
T Consensus 141 ~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 197 (342)
T 1b6c_B 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197 (342)
T ss_dssp HHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceec
Confidence 9999999999999999 899999999999999999999999999998754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-29 Score=221.64 Aligned_cols=148 Identities=28% Similarity=0.401 Sum_probs=119.2
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
...|++.+.||+|+||.||+|.+. .+++.||||.+.... ....+|+.+++.++||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~-------~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~ 119 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLC-------DSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSS 119 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEEC-------CCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEecc
Confidence 446999999999999999999986 456899999986542 1234799999999999999999998543
Q ss_pred C------eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 142 G------KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 142 ~------~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
+ ..++||||+.+ ++.+.+. ........+++.
T Consensus 120 ~~~~~~~~~~lv~e~~~~-~l~~~~~------------------------------------------~~~~~~~~l~~~ 156 (420)
T 1j1b_A 120 GEKKDEVYLNLVLDYVPE-TVYRVAR------------------------------------------HYSRAKQTLPVI 156 (420)
T ss_dssp ETTTTEEEEEEEEECCCE-EHHHHHH------------------------------------------HHHHTTCCCCHH
T ss_pred CCCCcceeEEeehhcccc-cHHHHHH------------------------------------------HHhhccCCCCHH
Confidence 2 36678888775 3333222 111234579999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecC-CceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVR-GIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DFGla~~l 265 (267)
.+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 157 ~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp HHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999999999999999999999999999999999965 57899999999865
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-29 Score=213.96 Aligned_cols=152 Identities=32% Similarity=0.507 Sum_probs=129.0
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch----HHHHHHHHHHHHHhhcC--CCceeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP----KARKMLSREIVSMESVH--HPNIIRLY 135 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~Ei~~l~~l~--hpnIv~~~ 135 (267)
.++|++.+.||+|+||.||+|.+. .+++.||||++....... .....+.+|+.+++.++ ||||++++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRV-------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEET-------TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred cCceEEEEEEeeCCCeEEEEEEEC-------CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 456999999999999999999886 456899999997654322 12245678999999995 59999999
Q ss_pred eeeeecCeEEEEEeecCC-CchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCCh
Q psy2579 136 EVLETFGKIFLVVEYASG-GELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214 (267)
Q Consensus 136 ~~~~~~~~~~iv~e~~~~-gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~ 214 (267)
+++...+..+++||++.+ ++|.+++. ..+.+++
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~----------------------------------------------~~~~l~~ 148 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFIT----------------------------------------------ERGALQE 148 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHH----------------------------------------------HHCSCCH
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHh----------------------------------------------ccCCCCH
Confidence 999999999999999876 66655543 3456899
Q ss_pred hHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEee-cCCceEEeccccccccC
Q psy2579 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS-VRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~-~~~~~kl~DFGla~~l~ 266 (267)
..+..++.|++.||+|||++||+||||||+||+++ .++.+||+|||+|+.+.
T Consensus 149 ~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~ 201 (320)
T 3a99_A 149 ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 201 (320)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccc
Confidence 99999999999999999999999999999999999 78899999999997653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-28 Score=208.44 Aligned_cols=148 Identities=25% Similarity=0.424 Sum_probs=128.7
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC--CCceeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH--HPNIIRLYEVLE 139 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~--hpnIv~~~~~~~ 139 (267)
..+|++.+.||+|+||.||+|.+. +++.||+|++............+.+|+.+++.++ ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE--------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT--------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcC--------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 355999999999999999999873 3588999999877666677788999999999996 599999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+..+++|| +.+++|.+++. ....+++..+..
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~----------------------------------------------~~~~~~~~~~~~ 131 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLK----------------------------------------------KKKSIDPWERKS 131 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHH----------------------------------------------HCSSCCHHHHHH
T ss_pred cCCEEEEEEe-cCCCcHHHHHH----------------------------------------------hcCCCCHHHHHH
Confidence 9999999999 66666665554 344688999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||.|||++|++||||||+||+++ ++.+||+|||+|+.+
T Consensus 132 i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 132 YWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 176 (313)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred HHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccc
Confidence 999999999999999999999999999996 589999999999764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-28 Score=208.46 Aligned_cols=154 Identities=23% Similarity=0.333 Sum_probs=120.3
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
...+++|++.+.||+|+||.||+|.+. .+++.||||++............+.++..+++.++||||+++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 93 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFR-------KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF 93 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEET-------TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEe-------cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEE
Confidence 334677999999999999999999986 4568999999987654444455566666778888999999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
...+..|+|||++ ++.+...... ....+++..+.
T Consensus 94 ~~~~~~~lv~e~~-~~~~~~l~~~---------------------------------------------~~~~~~~~~~~ 127 (318)
T 2dyl_A 94 ITNTDVFIAMELM-GTCAEKLKKR---------------------------------------------MQGPIPERILG 127 (318)
T ss_dssp ECSSEEEEEECCC-SEEHHHHHHH---------------------------------------------HTSCCCHHHHH
T ss_pred ecCCcEEEEEecc-CCcHHHHHHH---------------------------------------------hccCCCHHHHH
Confidence 9999999999999 3333222211 13468999999
Q ss_pred HHHHHHHHHHHHHHhC-CCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDR-DIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||.|||++ |++||||||+||+++.++.+||+|||+++.+
T Consensus 128 ~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 128 KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp HHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred HHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 9999999999999995 9999999999999999999999999998754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-28 Score=213.78 Aligned_cols=154 Identities=26% Similarity=0.399 Sum_probs=114.7
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
..+++|++.+.||+|+||.||+|.+. .++..||||++...... .....+|+..++.++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~ 89 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEK-------STGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFY 89 (360)
T ss_dssp HHHTTEEEC----------CEEEEET-------TTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred hhccceEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence 34567999999999999999999986 45689999988654322 234667888889999999999999997
Q ss_pred ecCe-------EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCC
Q psy2579 140 TFGK-------IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRL 212 (267)
Q Consensus 140 ~~~~-------~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~ 212 (267)
..+. .++||||+.++.+ ..+ .+.......+
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~l~-~~~------------------------------------------~~~~~~~~~~ 126 (360)
T 3e3p_A 90 TLGERDRRDIYLNVVMEYVPDTLH-RCC------------------------------------------RNYYRRQVAP 126 (360)
T ss_dssp EECSSCTTCEEEEEEEECCSCBHH-HHH------------------------------------------HHHHTTTCCC
T ss_pred ccccccccceeEEEEeecccccHH-HHH------------------------------------------HHHhhcccCC
Confidence 6544 7888888876322 211 1223345578
Q ss_pred ChhHHHHHHHHHHHHHHHHH--hCCCcccCCCCCcEEeec-CCceEEeccccccccC
Q psy2579 213 SEDDAKIYFLQILSAVKHLH--DRDIIHRDIKAENVFLSV-RGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 213 ~~~~~~~~~~ql~~~L~~lH--~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~l~ 266 (267)
++..+..++.|++.||.||| ++||+||||||+|||++. ++.+||+|||+|+.+.
T Consensus 127 ~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~ 183 (360)
T 3e3p_A 127 PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183 (360)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCC
T ss_pred CHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecC
Confidence 99999999999999999999 999999999999999997 8999999999998653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-28 Score=206.08 Aligned_cols=146 Identities=20% Similarity=0.246 Sum_probs=120.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeee-eec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVL-ETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~-~~~ 141 (267)
++|++.+.||+|+||.||+|.+. .+++.||||++...... ..+.+|+.+++.++|++++..+..+ ...
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDI-------AAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEET-------TTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred CceEEeeeecCCCCeEEEEEEEc-------CCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence 56999999999999999999986 45689999987554322 3578899999999887766666554 667
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..+++||++ +++|.+++... ..++++..+..++
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~---------------------------------------------~~~~~~~~~~~i~ 111 (296)
T 4hgt_A 78 DYNVMVMELL-GPSLEDLFNFC---------------------------------------------SRKFSLKTVLLLA 111 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT---------------------------------------------TSCCCHHHHHHHH
T ss_pred CceEEEEEcc-CCCHHHHHHHh---------------------------------------------cCCCCHHHHHHHH
Confidence 7889999999 87887766432 2368999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEe---ecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFL---SVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~l 265 (267)
.|++.||.|||++|++||||||+|||+ +.++.+||+|||+|+.+
T Consensus 112 ~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 112 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999999999999999999999999999 78899999999999865
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-28 Score=215.88 Aligned_cols=135 Identities=28% Similarity=0.367 Sum_probs=111.7
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC--------CCceeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH--------HPNIIRL 134 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~--------hpnIv~~ 134 (267)
++|++.+.||+|+||.||+|++. .+++.||||++... ....+.+.+|+.+++.++ ||||+++
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~ 106 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDI-------QGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQL 106 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred CeEEEEEEeeecCCeeEEEEEec-------CCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence 67999999999999999999886 45689999999643 345577889999999985 7889999
Q ss_pred eeeee----ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccC
Q psy2579 135 YEVLE----TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEG 210 (267)
Q Consensus 135 ~~~~~----~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~ 210 (267)
++++. .....|+|||++.+ ++.+.+... ...
T Consensus 107 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--------------------------------------------~~~ 141 (397)
T 1wak_A 107 LDDFKISGVNGTHICMVFEVLGH-HLLKWIIKS--------------------------------------------NYQ 141 (397)
T ss_dssp EEEEEEEETTEEEEEEEECCCCC-BHHHHHHHT--------------------------------------------TTS
T ss_pred ecceeecCCCCceEEEEEeccCc-cHHHHHHhc--------------------------------------------ccC
Confidence 99987 45678899999844 443333221 123
Q ss_pred CCChhHHHHHHHHHHHHHHHHHhC-CCcccCCCCCcEEeecCC
Q psy2579 211 RLSEDDAKIYFLQILSAVKHLHDR-DIIHRDIKAENVFLSVRG 252 (267)
Q Consensus 211 ~~~~~~~~~~~~ql~~~L~~lH~~-~ivHrDlkp~NIll~~~~ 252 (267)
.+++..+..++.|++.||+|||++ ||+||||||+|||++.++
T Consensus 142 ~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 142 GLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence 689999999999999999999998 999999999999998765
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-28 Score=209.37 Aligned_cols=149 Identities=26% Similarity=0.368 Sum_probs=127.1
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCc------eeeeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPN------IIRLYE 136 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn------Iv~~~~ 136 (267)
++|++.+.||+|+||.||+|.+.. .+++.||||++... ....+.+.+|+.+++.++|++ ++++++
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~ 84 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHK------AGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE 84 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETT------TTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred CceEEEEEEecCCCeEEEEEEecC------CCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence 579999999999999999998742 34689999999643 344567889999999887664 999999
Q ss_pred eeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 137 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 137 ~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
++...+..++|||++ +++|.+++.... ..++++..
T Consensus 85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~--------------------------------------------~~~~~~~~ 119 (339)
T 1z57_A 85 WFEHHGHICIVFELL-GLSTYDFIKENG--------------------------------------------FLPFRLDH 119 (339)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTT--------------------------------------------TCCCCHHH
T ss_pred ccccCCcEEEEEcCC-CCCHHHHHHhcC--------------------------------------------CCCCcHHH
Confidence 999999999999999 777777665431 12588999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeec-------------------CCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSV-------------------RGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~-------------------~~~~kl~DFGla~~l 265 (267)
+..++.|++.||+|||++|++||||||+|||++. ++.+||+|||+|+..
T Consensus 120 ~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~ 187 (339)
T 1z57_A 120 IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187 (339)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEET
T ss_pred HHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccC
Confidence 9999999999999999999999999999999987 668999999998754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=216.56 Aligned_cols=148 Identities=29% Similarity=0.383 Sum_probs=118.5
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
...+|++.+.||+|+||.||+|.+.. + ..||+|.+..... ...+|+.+++.++||||+++++++..
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~-------~-~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~ 103 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVE-------S-DEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYS 103 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETT-------T-EEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECC-------C-CeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEe
Confidence 34569999999999999999998752 2 3478887754321 12369999999999999999999866
Q ss_pred cCe------EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCCh
Q psy2579 141 FGK------IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214 (267)
Q Consensus 141 ~~~------~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~ 214 (267)
.+. .++||||+.++.+.... ........+++
T Consensus 104 ~~~~~~~~~~~lv~e~~~~~l~~~~~-------------------------------------------~~~~~~~~~~~ 140 (394)
T 4e7w_A 104 NGDKKDEVFLNLVLEYVPETVYRASR-------------------------------------------HYAKLKQTMPM 140 (394)
T ss_dssp ESSSSSCEEEEEEEECCSEEHHHHHH-------------------------------------------HHHHTTSCCCH
T ss_pred cCCCCCceEEEEEeeccCccHHHHHH-------------------------------------------HHHhhcCCCCH
Confidence 543 77888888764332211 11223457999
Q ss_pred hHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEee-cCCceEEecccccccc
Q psy2579 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS-VRGIVKLGDLGFSTKL 265 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~-~~~~~kl~DFGla~~l 265 (267)
..+..++.|++.||+|||++||+||||||+|||++ .++.+||+|||+|+.+
T Consensus 141 ~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 141 LLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 99999999999999999999999999999999999 7999999999999764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=217.10 Aligned_cols=156 Identities=27% Similarity=0.444 Sum_probs=117.0
Q ss_pred cceEEe-cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee-
Q psy2579 63 ALYKLQ-NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET- 140 (267)
Q Consensus 63 ~~y~~~-~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~- 140 (267)
+.|++. ++||+|+||.||+|.+... .++..||||++...... ..+.+|+.+++.++||||+++++++..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~-----~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDG-----KDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSS-----SCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccC-----CCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 448874 4799999999999997522 34688999999765433 357789999999999999999999954
Q ss_pred -cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 141 -FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 141 -~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
....|+||||+.+ +|.+.+..... .........+++..++.
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~~~~~~-------------------------------------~~~~~~~~~l~~~~~~~ 132 (405)
T 3rgf_A 91 ADRKVWLLFDYAEH-DLWHIIKFHRA-------------------------------------SKANKKPVQLPRGMVKS 132 (405)
T ss_dssp TTTEEEEEEECCSE-EHHHHHHHHHH-------------------------------------HC-------CCHHHHHH
T ss_pred CCCeEEEEEeCCCC-CHHHHHHHhcc-------------------------------------ccccccccCCCHHHHHH
Confidence 6789999999874 66665542200 00001122589999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEe----ecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFL----SVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll----~~~~~~kl~DFGla~~l 265 (267)
++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 133 i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 182 (405)
T 3rgf_A 133 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182 (405)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC--
T ss_pred HHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceec
Confidence 99999999999999999999999999999 67789999999999764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-29 Score=212.58 Aligned_cols=151 Identities=34% Similarity=0.521 Sum_probs=121.5
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch----HHHHHHHHHHHHHhhc----CCCceee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP----KARKMLSREIVSMESV----HHPNIIR 133 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~Ei~~l~~l----~hpnIv~ 133 (267)
.++|++.+.||+|+||.||+|.+. .+++.||||++....... .....+.+|+.++..+ +||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~ 102 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRL-------TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR 102 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECT-------TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred hhceEEeeEEEcCCCEEEEEEEEc-------cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence 456999999999999999999886 456899999997654322 2234466899999998 8999999
Q ss_pred eeeeeeecCeEEEEEee-cCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCC
Q psy2579 134 LYEVLETFGKIFLVVEY-ASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRL 212 (267)
Q Consensus 134 ~~~~~~~~~~~~iv~e~-~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~ 212 (267)
+++++...+..++++|+ +.+++|.+++. ....+
T Consensus 103 ~~~~~~~~~~~~~v~e~~~~~~~L~~~l~----------------------------------------------~~~~~ 136 (312)
T 2iwi_A 103 LLDWFETQEGFMLVLERPLPAQDLFDYIT----------------------------------------------EKGPL 136 (312)
T ss_dssp EEEEC-----CEEEEECCSSEEEHHHHHH----------------------------------------------HHCSC
T ss_pred EEEEEecCCeEEEEEEecCCCCCHHHHHH----------------------------------------------hcCCC
Confidence 99999998889999998 67766665553 34468
Q ss_pred ChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEee-cCCceEEecccccccc
Q psy2579 213 SEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS-VRGIVKLGDLGFSTKL 265 (267)
Q Consensus 213 ~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~-~~~~~kl~DFGla~~l 265 (267)
++..+..++.|++.||+|||++|++||||||+||+++ .++.+||+|||+++.+
T Consensus 137 ~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~ 190 (312)
T 2iwi_A 137 GEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190 (312)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEEC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhc
Confidence 9999999999999999999999999999999999999 8899999999998765
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.95 E-value=9.2e-28 Score=203.70 Aligned_cols=147 Identities=20% Similarity=0.237 Sum_probs=123.3
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeee-ee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVL-ET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~-~~ 140 (267)
.++|++.+.||+|+||.||+|.+. .+++.||||++...... ..+.+|+.+++.++|++++..+..+ ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDI-------AAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-------TTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEc-------CCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 356999999999999999999986 45689999998765432 3578999999999888766655554 66
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..+++||++ +++|.+++... ..++++..+..+
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~---------------------------------------------~~~~~~~~~~~i 110 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFC---------------------------------------------SRKFSLKTVLLL 110 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHT---------------------------------------------TTCCCHHHHHHH
T ss_pred CCceEEEEEec-CCCHHHHHHhh---------------------------------------------ccCCCHHHHHHH
Confidence 67789999999 87887666422 236899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEe---ecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFL---SVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~l 265 (267)
+.|++.||+|||++|++||||||+||++ +.++.+||+|||+|+.+
T Consensus 111 ~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 9999999999999999999999999999 48889999999999764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=216.80 Aligned_cols=148 Identities=20% Similarity=0.240 Sum_probs=125.1
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCC-Cceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHH-PNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h-pnIv~~~~~~~~ 140 (267)
.++|++.+.||+|+||.||+|.+. .+++.||||++...... ..+.+|+.+++.++| ++|..+..++..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNI-------QTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEET-------TTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEEC-------CCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 356999999999999999999986 45689999998755433 347789999999966 666677777778
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..++||||+ +++|.+++... ...+++..++.+
T Consensus 75 ~~~~~lvme~~-g~sL~~ll~~~---------------------------------------------~~~l~~~~~~~i 108 (483)
T 3sv0_A 75 GDYNVLVMDLL-GPSLEDLFNFC---------------------------------------------SRKLSLKTVLML 108 (483)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHT---------------------------------------------TTCCCHHHHHHH
T ss_pred CCEEEEEEECC-CCCHHHHHHhh---------------------------------------------cCCCCHHHHHHH
Confidence 88899999999 87887766432 236999999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEe---ecCCceEEeccccccccC
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFL---SVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~l~ 266 (267)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.+.
T Consensus 109 ~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred HHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999999999999999999999999 588999999999998653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=206.91 Aligned_cols=148 Identities=29% Similarity=0.477 Sum_probs=118.7
Q ss_pred eecceEEec-ccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 61 RVALYKLQN-ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 61 ~~~~y~~~~-~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
..++|++.+ .||+|+||.||+|.+. .+++.||||++... .... .+....++.+.||||+++++++.
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~---~~~~---~e~~~~~~~~~h~~i~~~~~~~~ 92 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHR-------RTGQKCALKLLYDS---PKAR---QEVDHHWQASGGPHIVCILDVYE 92 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEESS---HHHH---HHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEEC-------CCCCEEEEEEecCc---HHHH---HHHHHHHHhcCCCChHHHHHHHh
Confidence 346699966 5999999999999986 45689999998643 2211 22233456679999999999987
Q ss_pred e----cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 140 T----FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 140 ~----~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
. ....++|||||.+|+|.+++.... ...+++.
T Consensus 93 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--------------------------------------------~~~l~~~ 128 (336)
T 3fhr_A 93 NMHHGKRCLLIIMECMEGGELFSRIQERG--------------------------------------------DQAFTER 128 (336)
T ss_dssp EEETTEEEEEEEEECCTTEEHHHHHHTC---------------------------------------------CCCCBHH
T ss_pred hccCCCceEEEEEeccCCCCHHHHHHhcC--------------------------------------------CCCCCHH
Confidence 6 445889999998888877765431 1368999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeec---CCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSV---RGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~---~~~~kl~DFGla~~l 265 (267)
.+..++.|++.||.|||++|++||||||+||+++. ++.+||+|||+|+..
T Consensus 129 ~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 129 EAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 99999999999999999999999999999999976 445999999999754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=227.66 Aligned_cols=157 Identities=31% Similarity=0.453 Sum_probs=127.8
Q ss_pred cCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeee
Q psy2579 58 LGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 58 ~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~ 137 (267)
.+...++|++.+.||+|+||.||+|.+. .++..||||++... ........+.+|+.+++.++||||++++++
T Consensus 9 pg~~~grY~i~~~LG~G~fG~Vyla~~~-------~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v 80 (676)
T 3qa8_A 9 PTQTCGPWEMKERLGTGGFGYVLRWIHQ-------DTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREV 80 (676)
T ss_dssp --------CCCCCCCBCSSSBCCCCCCT-------TTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEEC
T ss_pred CCCCCCCeEEEEEEeeCCCeEEEEEEEC-------CCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeee
Confidence 3445678999999999999999999886 45689999998764 355667889999999999999999999998
Q ss_pred eee------cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCC
Q psy2579 138 LET------FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGR 211 (267)
Q Consensus 138 ~~~------~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~ 211 (267)
+.. .+..|+|||||.+|+|.+++.... ....
T Consensus 81 ~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~-------------------------------------------~~~~ 117 (676)
T 3qa8_A 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-------------------------------------------NCCG 117 (676)
T ss_dssp CTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSS-------------------------------------------CTTC
T ss_pred ecccccccCCCeEEEEEEeCCCCCHHHHHHhcc-------------------------------------------cCCC
Confidence 765 566788888888888877665431 1225
Q ss_pred CChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCc---eEEecccccccc
Q psy2579 212 LSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGI---VKLGDLGFSTKL 265 (267)
Q Consensus 212 ~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~---~kl~DFGla~~l 265 (267)
+++..+..++.|++.||+|||++|++||||||+||+++.++. +||+|||+|+.+
T Consensus 118 lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~ 174 (676)
T 3qa8_A 118 LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 174 (676)
T ss_dssp CCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccc
Confidence 889999999999999999999999999999999999997764 999999999865
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=205.84 Aligned_cols=149 Identities=19% Similarity=0.337 Sum_probs=124.6
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCc------eeeeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPN------IIRLYE 136 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn------Iv~~~~ 136 (267)
++|++.+.||+|+||.||+|.+.. ..+..||+|++... ......+.+|+.+++.++|++ ++.+++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 89 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHA------RGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSD 89 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETT------TTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecC------CCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence 679999999999999999999862 22378999999643 344567889999999987766 999999
Q ss_pred eeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 137 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 137 ~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
++...+..|+|||++ ++++.+.+... ...++++..
T Consensus 90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~--------------------------------------------~~~~~~~~~ 124 (355)
T 2eu9_A 90 WFNFHGHMCIAFELL-GKNTFEFLKEN--------------------------------------------NFQPYPLPH 124 (355)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHT--------------------------------------------TTCCCCHHH
T ss_pred eeeeCCeEEEEEecc-CCChHHHHHhc--------------------------------------------cCCCCCHHH
Confidence 999999999999999 44554444322 113689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEe-------------------ecCCceEEecccccccc
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFL-------------------SVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll-------------------~~~~~~kl~DFGla~~l 265 (267)
+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+|+..
T Consensus 125 ~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~ 192 (355)
T 2eu9_A 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192 (355)
T ss_dssp HHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEET
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccc
Confidence 99999999999999999999999999999999 66789999999999753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=208.47 Aligned_cols=148 Identities=29% Similarity=0.365 Sum_probs=124.2
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-----------CCce
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-----------HPNI 131 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------hpnI 131 (267)
++|++.+.||+|+||.||+|.+. .+++.||||++... ......+.+|+.+++.+. ||||
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i 88 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDM-------VNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 88 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CeEEEEEeeeecCCeEEEEEEec-------CCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchH
Confidence 56999999999999999999986 45689999999643 334566889999999886 8999
Q ss_pred eeeeeeeeecC----eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhc
Q psy2579 132 IRLYEVLETFG----KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKIT 207 (267)
Q Consensus 132 v~~~~~~~~~~----~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~ 207 (267)
+++++++...+ ..+++||++ +++|.+++...
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-------------------------------------------- 123 (373)
T 1q8y_A 89 LKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY-------------------------------------------- 123 (373)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHT--------------------------------------------
T ss_pred HHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHh--------------------------------------------
Confidence 99999998765 788899988 77776666432
Q ss_pred ccCCCChhHHHHHHHHHHHHHHHHHhC-CCcccCCCCCcEEeecC------CceEEecccccccc
Q psy2579 208 TEGRLSEDDAKIYFLQILSAVKHLHDR-DIIHRDIKAENVFLSVR------GIVKLGDLGFSTKL 265 (267)
Q Consensus 208 ~~~~~~~~~~~~~~~ql~~~L~~lH~~-~ivHrDlkp~NIll~~~------~~~kl~DFGla~~l 265 (267)
....+++..+..++.|++.||+|||++ ||+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 124 ~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~ 188 (373)
T 1q8y_A 124 EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188 (373)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEET
T ss_pred hccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEccccccccc
Confidence 123589999999999999999999998 99999999999999543 37999999999764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.7e-27 Score=206.08 Aligned_cols=151 Identities=26% Similarity=0.361 Sum_probs=126.2
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-CC-----ceeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-HP-----NIIRL 134 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp-----nIv~~ 134 (267)
..++|++.+.||+|+||.||+|.+. .+++.||||++... ......+.+|+.+++.++ |+ +|+++
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDR-------VEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEET-------TTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEc-------CCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 4577999999999999999999986 45689999999743 334566788999988884 55 49999
Q ss_pred eeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCCh
Q psy2579 135 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214 (267)
Q Consensus 135 ~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~ 214 (267)
++++...+..|+|||++.+ +|.+++.... ...+++
T Consensus 122 ~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~--------------------------------------------~~~~~~ 156 (382)
T 2vx3_A 122 KRHFMFRNHLCLVFEMLSY-NLYDLLRNTN--------------------------------------------FRGVSL 156 (382)
T ss_dssp EEEEEETTEEEEEEECCCC-BHHHHHHHTT--------------------------------------------TSCCCH
T ss_pred eeeeccCCceEEEEecCCC-CHHHHHhhcC--------------------------------------------cCCCCH
Confidence 9999999999999999964 7777665431 135899
Q ss_pred hHHHHHHHHHHHHHHHHH--hCCCcccCCCCCcEEee--cCCceEEeccccccccC
Q psy2579 215 DDAKIYFLQILSAVKHLH--DRDIIHRDIKAENVFLS--VRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH--~~~ivHrDlkp~NIll~--~~~~~kl~DFGla~~l~ 266 (267)
..+..++.|++.||.||| +.||+||||||+|||++ .++.+||+|||+|+.+.
T Consensus 157 ~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~ 212 (382)
T 2vx3_A 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212 (382)
T ss_dssp HHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred HHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecc
Confidence 999999999999999999 57999999999999995 47789999999997653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-27 Score=210.30 Aligned_cols=150 Identities=27% Similarity=0.301 Sum_probs=117.6
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~ 142 (267)
.|.+.+.||+|+||+||.+.. .+++.||||++.... .+.+.+|+.+++.+ +||||+++++++...+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~--------~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 82 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGS--------FQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDR 82 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEE--------SSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred eeeccCeEeeCCCeEEEEEEE--------ECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 366778899999999986532 346899999986532 24578899999886 8999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+|||+|. |+|.+++........ .....++..+..++.
T Consensus 83 ~~~lv~E~~~-gsL~~~l~~~~~~~~---------------------------------------~~~~~~~~~~~~i~~ 122 (434)
T 2rio_A 83 FLYIALELCN-LNLQDLVESKNVSDE---------------------------------------NLKLQKEYNPISLLR 122 (434)
T ss_dssp EEEEEECCCS-EEHHHHHHTC---------------------------------------------------CCHHHHHH
T ss_pred eEEEEEecCC-CCHHHHHhccCCCch---------------------------------------hhhhccchhHHHHHH
Confidence 9999999996 599888865422100 001134556788999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecC-------------CceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVR-------------GIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~-------------~~~kl~DFGla~~l~ 266 (267)
|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 123 qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~ 179 (434)
T 2rio_A 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179 (434)
T ss_dssp HHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECC
T ss_pred HHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecC
Confidence 99999999999999999999999999754 489999999998653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=195.67 Aligned_cols=134 Identities=18% Similarity=0.207 Sum_probs=105.5
Q ss_pred EecccCccCceeEEEeEEeecccccccccceEEEEeecccccch----------------HHHHHHHHHHHHHhhcCCCc
Q psy2579 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP----------------KARKMLSREIVSMESVHHPN 130 (267)
Q Consensus 67 ~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~----------------~~~~~~~~Ei~~l~~l~hpn 130 (267)
+.+.||+|+||.||+|.+ . +++.||||++.....+. .....+.+|+.+++.++ |
T Consensus 94 ~~~~iG~G~~g~Vy~~~~-~-------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS-E-------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp EEEEEEECSSEEEEEEEE-T-------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred ecCEeccCCCceEEEEEe-C-------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 339999999999999987 2 35889999997543211 24567899999999998 4
Q ss_pred eeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccC
Q psy2579 131 IIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEG 210 (267)
Q Consensus 131 Iv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~ 210 (267)
+++.+++.. +..|+||||+++|+|.+ +
T Consensus 164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l-------------------------------------------------- 190 (282)
T 1zar_A 164 -LAVPKVYAW-EGNAVLMELIDAKELYR-V-------------------------------------------------- 190 (282)
T ss_dssp -SSSCCEEEE-ETTEEEEECCCCEEGGG-C--------------------------------------------------
T ss_pred -CCcCeEEec-cceEEEEEecCCCcHHH-c--------------------------------------------------
Confidence 666665533 55688888888877754 2
Q ss_pred CCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 211 RLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 211 ~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.......++.|++.||.|||++||+||||||+|||++ ++.+||+|||+|+.+.
T Consensus 191 --~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~~~ 243 (282)
T 1zar_A 191 --RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG 243 (282)
T ss_dssp --CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEETT
T ss_pred --chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeECC
Confidence 1123456999999999999999999999999999999 9999999999998653
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.7e-27 Score=208.65 Aligned_cols=143 Identities=22% Similarity=0.335 Sum_probs=116.8
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~ 142 (267)
.|++.+.||+|+||+|+.... .+++.||||++...... .+.+|+.+++.+ +||||+++++++.+.+
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~--------~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 91 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGM--------FDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQ 91 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEE--------SSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred EEecCCeeecCcCEEEEEEEE--------eCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 499999999999999764322 34688999999654432 256799999999 8999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+|||+|. |+|.+++.... ...++..+..++.
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~~---------------------------------------------~~~~~~~~~~i~~ 125 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQKD---------------------------------------------FAHLGLEPITLLQ 125 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSSS---------------------------------------------CCCCSSCHHHHHH
T ss_pred EEEEEEECCC-CCHHHHHHhcC---------------------------------------------CCccchhHHHHHH
Confidence 9999999996 47777665431 2355567789999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeec---CC--ceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSV---RG--IVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~---~~--~~kl~DFGla~~l 265 (267)
|++.||.|||++||+||||||+|||++. ++ .+||+|||+|+.+
T Consensus 126 qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 126 QTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp HHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred HHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 9999999999999999999999999953 23 5789999999765
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.6e-26 Score=207.03 Aligned_cols=135 Identities=19% Similarity=0.158 Sum_probs=104.2
Q ss_pred EecccCccCceeEEEeEEeecccccccccceEEEEeecccccch------HHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP------KARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 67 ~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
..+.||+|+||.||+|.+. +..+++|......... ...+++.+|+.+++.++||||+++..++..
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~---------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 410 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYL---------DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD 410 (540)
T ss_dssp --------CCEEEEEEECS---------SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE
T ss_pred CCCEEeeCCCEEEEEEEEC---------CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe
Confidence 4568999999999999432 4778999875543221 124568999999999999999966666667
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+|||||++++|.+++. . +..+
T Consensus 411 ~~~~~lVmE~~~ggsL~~~l~----------------------------------------------~--------~~~i 436 (540)
T 3en9_A 411 LDNKRIMMSYINGKLAKDVIE----------------------------------------------D--------NLDI 436 (540)
T ss_dssp TTTTEEEEECCCSEEHHHHST----------------------------------------------T--------CTHH
T ss_pred CCccEEEEECCCCCCHHHHHH----------------------------------------------H--------HHHH
Confidence 777899999998888876553 1 4578
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+.|++.||+|||++||+||||||+|||++. .+||+|||+|+.+.
T Consensus 437 ~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 437 AYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp HHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999999999999999999998 99999999998764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=200.50 Aligned_cols=172 Identities=15% Similarity=0.112 Sum_probs=114.0
Q ss_pred ccCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcCC-Cceeee
Q psy2579 57 SLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVHH-PNIIRL 134 (267)
Q Consensus 57 ~~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h-pnIv~~ 134 (267)
..+.....|++.+.||+|+||.||+|.+. .+++.||||++..... .....+.+.+|+.+++.+.| +|....
T Consensus 72 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~-------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~ 144 (413)
T 3dzo_A 72 ELGERPRTLVRGTVLGQEDPYAYLEATDQ-------ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144 (413)
T ss_dssp SSSSCCEEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHH
T ss_pred cCCCCceeEEEecccccCCCEEEEEEEec-------CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHH
Confidence 34445566999999999999999999986 5568999999974432 22335678999999999977 322221
Q ss_pred e---------eeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhh
Q psy2579 135 Y---------EVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNK 205 (267)
Q Consensus 135 ~---------~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~ 205 (267)
. +.....+...++. +..+ .........+++|++. +++|.++
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~----------------------------~~~~~~~~~~~~~~~~-~~~L~~l 194 (413)
T 3dzo_A 145 KVHLRFIFPFDLVKDPQKKKMIR-VRLD----------------------------ERDMWVLSRFFLYPRM-QSNLQTF 194 (413)
T ss_dssp HHHTCBCCCCEEEECCC--------------------------------------------CCSEEEEEECC-SEEHHHH
T ss_pred HHhcccccchhhcccCCCCcccc-ccCC----------------------------CccccccceEEEeehh-cCCHHHH
Confidence 1 1111111110000 0000 0000112234444443 3455555
Q ss_pred hc-------ccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 206 IT-------TEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 206 ~~-------~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 195 l~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~ 261 (413)
T 3dzo_A 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261 (413)
T ss_dssp HHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEET
T ss_pred HHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeec
Confidence 52 1235778899999999999999999999999999999999999999999999998754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=180.64 Aligned_cols=143 Identities=20% Similarity=0.174 Sum_probs=105.8
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccce--EEEEeecccccch----------------------HHHHHHHHHH
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISY--LAIKILDKAKLTP----------------------KARKMLSREI 120 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~--vaiK~~~~~~~~~----------------------~~~~~~~~Ei 120 (267)
|++.+.||+|+||.||+|.+. .++.. ||||++....... .....+.+|+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~-------~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 121 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGV-------FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEF 121 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEE-------ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEc-------CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHH
Confidence 889999999999999999885 34577 9999976542110 1124678999
Q ss_pred HHHhhcCCCce--eeeeeeeeecCeEEEEEeecCC-CchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEc
Q psy2579 121 VSMESVHHPNI--IRLYEVLETFGKIFLVVEYASG-GELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYA 197 (267)
Q Consensus 121 ~~l~~l~hpnI--v~~~~~~~~~~~~~iv~e~~~~-gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~ 197 (267)
.++..+.|+++ +.+++. +..++||||+++ |++..
T Consensus 122 ~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~--------------------------------------- 158 (258)
T 1zth_A 122 RNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAP--------------------------------------- 158 (258)
T ss_dssp HHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECC---------------------------------------
T ss_pred HHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccc---------------------------------------
Confidence 99999988764 333332 356788888842 32221
Q ss_pred cCCchhhhhcccCCCChhHHHHHHHHHHHHHHHHH-hCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 198 SGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLH-DRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 198 ~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH-~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+|.+... ..++..+..++.|++.||.||| ++||+||||||+|||++. .++|+|||+|..+
T Consensus 159 ---~L~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 159 ---TLVELGR---ELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ---BHHHHGG---GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred ---cHHHHhh---ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 2222211 1235678899999999999999 999999999999999988 9999999999865
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.85 E-value=8.3e-22 Score=172.24 Aligned_cols=138 Identities=12% Similarity=0.153 Sum_probs=93.7
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc------------hHHHHH--------HHHHHHHHh
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT------------PKARKM--------LSREIVSME 124 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~--------~~~Ei~~l~ 124 (267)
|++.+.||.|+||.||+|.+ ..++.||||+++....+ ...... ..+|...|.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d--------~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD--------EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC--------TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCEeeeCCceEEEEEEC--------CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 99999999999999999987 34689999998643211 000111 234566666
Q ss_pred hcCCCceeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhh
Q psy2579 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYN 204 (267)
Q Consensus 125 ~l~hpnIv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~ 204 (267)
.+.+.++....-+. ....++||||++|++|..
T Consensus 169 rL~~~gv~vp~p~~--~~~~~LVME~i~G~~L~~---------------------------------------------- 200 (397)
T 4gyi_A 169 ALYEEGFPVPEPIA--QSRHTIVMSLVDALPMRQ---------------------------------------------- 200 (397)
T ss_dssp HHHHTTCSCCCEEE--EETTEEEEECCSCEEGGG----------------------------------------------
T ss_pred HHHhcCCCCCeeee--ccCceEEEEecCCccHhh----------------------------------------------
Confidence 66444432111111 112357777776655432
Q ss_pred hhcccCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC----------ceEEeccccccc
Q psy2579 205 KITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG----------IVKLGDLGFSTK 264 (267)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~----------~~kl~DFGla~~ 264 (267)
.. ....+..++.|++.+|.+||++|+|||||||.|||++.+| .+.|+||+-|..
T Consensus 201 l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 201 VS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred hc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 11 1234567889999999999999999999999999998877 389999996643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=4.3e-14 Score=117.60 Aligned_cols=87 Identities=15% Similarity=0.042 Sum_probs=69.6
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 140 (267)
+..|++...+|.|+.+.||++... +..+++|+....... ....+.+|+.+++.+ .+..++++++++..
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~---------~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~ 81 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE---------NENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH 81 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS---------SCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC---------CCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEec
Confidence 456999999999999999998632 478999998653211 123588899999998 47788899999999
Q ss_pred cCeEEEEEeecCCCchhhh
Q psy2579 141 FGKIFLVVEYASGGELYNK 159 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~ 159 (267)
.+..|++||+++|.++.+.
T Consensus 82 ~~~~~lv~e~i~G~~l~~~ 100 (263)
T 3tm0_A 82 DGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp TTEEEEEEECCSSEEHHHH
T ss_pred CCceEEEEEecCCeehhhc
Confidence 8999999999999888664
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.45 E-value=4.4e-13 Score=110.82 Aligned_cols=84 Identities=14% Similarity=0.085 Sum_probs=61.6
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCc--eeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPN--IIRLYEVL 138 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~~~~~~ 138 (267)
.+..|.+....+.|..+.||++.. .++..+++|+..... ...+.+|+.+++.+.+.+ +++++++.
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~--------~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~ 84 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSA--------QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVV 84 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEEC--------TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEE
T ss_pred hcCCCceEecccCCCCceEEEEec--------CCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEec
Confidence 344577655555667799999853 334679999976431 134778999999885434 56688888
Q ss_pred eecCeEEEEEeecCCCchh
Q psy2579 139 ETFGKIFLVVEYASGGELY 157 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~ 157 (267)
...+..+++||+++|.++.
T Consensus 85 ~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 85 TEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp ECSSCEEEEEECCSSEETT
T ss_pred cCCCCCEEEEEecCCcccC
Confidence 8888899999999998884
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.34 E-value=6.5e-12 Score=109.22 Aligned_cols=81 Identities=19% Similarity=0.328 Sum_probs=55.0
Q ss_pred EecccCccCceeEEEeEEeecccccccccceEEEEeec--ccccchHHHHHHHHHHHHHhhcC--CCceeeeeeeeeec-
Q psy2579 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILD--KAKLTPKARKMLSREIVSMESVH--HPNIIRLYEVLETF- 141 (267)
Q Consensus 67 ~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~Ei~~l~~l~--hpnIv~~~~~~~~~- 141 (267)
-++.|+.|.++.||+.... +..+++|+.. ..... .....+.+|+.+++.+. +..+++++.++.+.
T Consensus 42 ~~~~l~~G~sn~~y~v~~~---------~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~ 111 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP---------GQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDES 111 (359)
T ss_dssp EEEECCC-CCSCEEEEECS---------SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT
T ss_pred eEEEcCCcccceEEEEEEC---------CceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC
Confidence 3566899999999998642 2578888876 33211 12346788999999996 45678888887766
Q ss_pred --CeEEEEEeecCCCchh
Q psy2579 142 --GKIFLVVEYASGGELY 157 (267)
Q Consensus 142 --~~~~iv~e~~~~gsl~ 157 (267)
+..|++||+++|..+.
T Consensus 112 ~~g~~~~vme~v~G~~l~ 129 (359)
T 3dxp_A 112 VIGRAFYIMEFVSGRVLW 129 (359)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCeEEEEEecCCeecC
Confidence 4578888888876663
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=1.1e-08 Score=86.74 Aligned_cols=75 Identities=13% Similarity=0.011 Sum_probs=51.6
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCc--eeeeeeeeeecC---
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPN--IIRLYEVLETFG--- 142 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpn--Iv~~~~~~~~~~--- 142 (267)
+.++.|.+..||+.. ..+++|+.... .....+.+|+.+++.+ .+.. +.+++......+
T Consensus 26 ~~~~~G~~n~v~~v~------------~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~ 89 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN------------RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQ 89 (304)
T ss_dssp CEEEECSSEEEEEST------------TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCS
T ss_pred EecCCCCcceEEEEC------------CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCC
Confidence 348999999999863 45788986432 3456788999999887 4333 345555443332
Q ss_pred eEEEEEeecCCCchhhh
Q psy2579 143 KIFLVVEYASGGELYNK 159 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~ 159 (267)
..|+||++++|.++...
T Consensus 90 ~~~~vm~~i~G~~l~~~ 106 (304)
T 3sg8_A 90 MSFAGFTKIKGVPLTPL 106 (304)
T ss_dssp CSCEEEECCCCEECCHH
T ss_pred cceEEEcccCCeECCcc
Confidence 46889999999888653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=7.2e-08 Score=80.02 Aligned_cols=79 Identities=11% Similarity=0.105 Sum_probs=58.2
Q ss_pred cCccCce-eEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeecCeEEEEE
Q psy2579 71 LGRGNFS-TVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETFGKIFLVV 148 (267)
Q Consensus 71 iG~G~fg-~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~~~~~iv~ 148 (267)
+..|..| .||+.... ..+..+.+|+-... ....+.+|...|+.+ .+--+.+++.++.+.+..|++|
T Consensus 32 ~~~G~S~~~v~rl~~~-------~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm 99 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGK-------PNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT 99 (272)
T ss_dssp EECSSSSCEEEEEECC-------TTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ccCCCcCCeEEEEEec-------CCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence 4455555 58886553 33467899986432 335678899999888 3445778899999999999999
Q ss_pred eecCCCchhhhhh
Q psy2579 149 EYASGGELYNKIT 161 (267)
Q Consensus 149 e~~~~gsl~~~l~ 161 (267)
|+++|.++.+...
T Consensus 100 e~l~G~~~~~~~~ 112 (272)
T 4gkh_A 100 TAIPGKTAFQVLE 112 (272)
T ss_dssp ECCCSEEHHHHHH
T ss_pred EeeCCcccccccc
Confidence 9999988876654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.72 E-value=2.4e-07 Score=78.63 Aligned_cols=75 Identities=16% Similarity=0.134 Sum_probs=54.4
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCC---ceeeeeeeee-ecCeE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHP---NIIRLYEVLE-TFGKI 144 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hp---nIv~~~~~~~-~~~~~ 144 (267)
+.++.|....||+. +..+++|+.. .......+.+|+.+++.+.+. .+.+++.+.. ..+..
T Consensus 25 ~~l~~G~~n~v~~v------------g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~ 88 (306)
T 3tdw_A 25 ESLGEGFRNYAILV------------NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNP 88 (306)
T ss_dssp EEEEECSSEEEEEE------------TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCE
T ss_pred eecCCCcceeEEEE------------CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCce
Confidence 34788888899987 1567888852 223456788999999999642 3566666663 45678
Q ss_pred EEEEeecCCCchhhh
Q psy2579 145 FLVVEYASGGELYNK 159 (267)
Q Consensus 145 ~iv~e~~~~gsl~~~ 159 (267)
|++||+++|.++...
T Consensus 89 ~~v~e~i~G~~l~~~ 103 (306)
T 3tdw_A 89 FVGYRKVQGQILGED 103 (306)
T ss_dssp EEEEECCCSEECHHH
T ss_pred EEEEeccCCeECchh
Confidence 999999999888663
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=1.7e-06 Score=74.75 Aligned_cols=92 Identities=13% Similarity=0.057 Sum_probs=57.7
Q ss_pred Eeccc-CccCceeEEEeEEeecccccccccceEEEEeeccccc-chHHHHHHHHHHHHHhhcC-C--Cceeeeeeeeeec
Q psy2579 67 LQNEL-GRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVSMESVH-H--PNIIRLYEVLETF 141 (267)
Q Consensus 67 ~~~~i-G~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h--pnIv~~~~~~~~~ 141 (267)
..+.| +.|....+|+........ ....+..+++|+...... .......+.+|+.+++.+. + ..+.+++.++...
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~-~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQD-GRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEET-TEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEECCCCCccceEEEEEEecccC-CCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 34567 889899999876421000 000246788998754320 0000134678888888873 3 4577788776655
Q ss_pred ---CeEEEEEeecCCCchhhh
Q psy2579 142 ---GKIFLVVEYASGGELYNK 159 (267)
Q Consensus 142 ---~~~~iv~e~~~~gsl~~~ 159 (267)
+..|++||+++|..+.+.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~~~ 123 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPPDV 123 (357)
T ss_dssp TTTSSCEEEEECCCCBCCCBT
T ss_pred CccCCceEEEEecCCCChhhc
Confidence 467899999999887653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=1.8e-06 Score=75.67 Aligned_cols=80 Identities=20% Similarity=0.113 Sum_probs=50.8
Q ss_pred ecccCccCceeEEEeEEeecccccccccceEEEEeeccccc--c---hHHHHHHHHHHHHHhhcC-C-C-ceeeeeeeee
Q psy2579 68 QNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL--T---PKARKMLSREIVSMESVH-H-P-NIIRLYEVLE 139 (267)
Q Consensus 68 ~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~--~---~~~~~~~~~Ei~~l~~l~-h-p-nIv~~~~~~~ 139 (267)
.+.||.|.++.||++... ..+..|++|....... . +....++..|+.+++.+. + | .+++++.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~-------~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-- 105 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQ-------EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-- 105 (397)
T ss_dssp EEECCSSSSEEEEEEEC-----------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--
T ss_pred EEECCCCceEEEEEEEEC-------CCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--
Confidence 356999999999999754 2246799998653211 0 011245678999988773 2 3 34455544
Q ss_pred ecCeEEEEEeecCCCch
Q psy2579 140 TFGKIFLVVEYASGGEL 156 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl 156 (267)
+.+..++|||++.+...
T Consensus 106 d~~~~~lvmE~l~g~~~ 122 (397)
T 2olc_A 106 DTEMAVTVMEDLSHLKI 122 (397)
T ss_dssp ETTTTEEEECCCTTSEE
T ss_pred cCCccEEEEEeCCCcch
Confidence 34556899999987544
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.29 E-value=1.6e-05 Score=67.81 Aligned_cols=31 Identities=19% Similarity=0.256 Sum_probs=27.8
Q ss_pred hCCCcccCCCCCcEEeecCCceEEecccccc
Q psy2579 233 DRDIIHRDIKAENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 233 ~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 263 (267)
..+++|+|+.|.||+++.++.+.|+||+.|.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 3579999999999999888899999999874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.88 E-value=9.8e-05 Score=65.18 Aligned_cols=31 Identities=23% Similarity=0.393 Sum_probs=27.3
Q ss_pred HhCCCcccCCCCCcEEeecCCceEEecccccc
Q psy2579 232 HDRDIIHRDIKAENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 232 H~~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 263 (267)
+...++|+|++|.|||++.++ +.++||+.|.
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~ 260 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSF 260 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccc
Confidence 466899999999999998776 9999998875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.81 E-value=6.5e-05 Score=63.75 Aligned_cols=75 Identities=17% Similarity=0.267 Sum_probs=59.0
Q ss_pred ecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC---CCceeeeeeeeeecCeE
Q psy2579 68 QNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH---HPNIIRLYEVLETFGKI 144 (267)
Q Consensus 68 ~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~---hpnIv~~~~~~~~~~~~ 144 (267)
.+.|+.|....+|+... .+..+++|+.... ....+.+|...|+.+. ...+++++.+....+..
T Consensus 41 ~~~l~gG~~n~~y~v~~---------~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND---------EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp EEEECCSSSSEEEEEES---------SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eEEeCCccceeeeEEEE---------CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 45689999999999853 2367888987542 2456788999998883 36788899988888999
Q ss_pred EEEEeecCCCch
Q psy2579 145 FLVVEYASGGEL 156 (267)
Q Consensus 145 ~iv~e~~~~gsl 156 (267)
|++||++++..+
T Consensus 107 ~lvme~l~G~~~ 118 (312)
T 3jr1_A 107 FLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCCCCCC
T ss_pred EEEEEeccCCCC
Confidence 999999999765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00013 Score=61.75 Aligned_cols=77 Identities=12% Similarity=0.023 Sum_probs=45.2
Q ss_pred EecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCc--eeeeeee------e
Q psy2579 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPN--IIRLYEV------L 138 (267)
Q Consensus 67 ~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn--Iv~~~~~------~ 138 (267)
-++.|+.|....+|+.... . ..+++|+..... ....+..|+.++..+...+ +++++.. .
T Consensus 26 ~~~~i~~G~~n~~~~v~~~--------~-g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~ 92 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT--------K-DPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLG 92 (322)
T ss_dssp EEEEECC---EEEEEEEES--------S-CCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCE
T ss_pred EeeccCCCcccceEEEEeC--------C-ccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEE
Confidence 3456888888999988542 2 367899886521 1234556787777763212 3344422 1
Q ss_pred eecCeEEEEEeecCCCch
Q psy2579 139 ETFGKIFLVVEYASGGEL 156 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl 156 (267)
...+..++++++++|..+
T Consensus 93 ~~~g~~~~l~~~l~G~~~ 110 (322)
T 2ppq_A 93 ELSGRPAALISFLEGMWL 110 (322)
T ss_dssp EETTEEEEEEECCCCBCC
T ss_pred EECCEEEEEEEeCCCcCC
Confidence 234678999999998765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.68 E-value=0.0012 Score=55.74 Aligned_cols=75 Identities=13% Similarity=0.057 Sum_probs=47.5
Q ss_pred cCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCC--Cceeeeeee-----eeecCe
Q psy2579 71 LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHH--PNIIRLYEV-----LETFGK 143 (267)
Q Consensus 71 iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--pnIv~~~~~-----~~~~~~ 143 (267)
++ |....||+... ..+..+++|+......+. ..+..|..+++.+.. -.+++++.. ....+.
T Consensus 34 l~-g~~n~~y~v~~--------~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~ 101 (328)
T 1zyl_A 34 LN-SYENRVYQFQD--------EDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGF 101 (328)
T ss_dssp EC-CSSSEEEEECC--------TTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTE
T ss_pred ec-CcccceEEEEc--------CCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCE
Confidence 55 77888998743 234678999986443222 345678888877732 224444443 223567
Q ss_pred EEEEEeecCCCchh
Q psy2579 144 IFLVVEYASGGELY 157 (267)
Q Consensus 144 ~~iv~e~~~~gsl~ 157 (267)
.++++++++|..+.
T Consensus 102 ~~~l~~~i~G~~~~ 115 (328)
T 1zyl_A 102 YFAVFPSVGGRQFE 115 (328)
T ss_dssp EEEEEECCCCEECC
T ss_pred EEEEEEecCCCCCC
Confidence 78999999986653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00042 Score=61.42 Aligned_cols=82 Identities=13% Similarity=0.137 Sum_probs=49.9
Q ss_pred ecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCce-eeeeeeeeecCeEEE
Q psy2579 68 QNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNI-IRLYEVLETFGKIFL 146 (267)
Q Consensus 68 ~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~~~~~~~~~~~~~i 146 (267)
++.|+.|....||++............+..+.+|+..... . ...+.+|..+++.+...++ +++++.+.. .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 3468888889999996531100000124678999984321 1 1234579988888843333 566666532 38
Q ss_pred EEeecCCCchh
Q psy2579 147 VVEYASGGELY 157 (267)
Q Consensus 147 v~e~~~~gsl~ 157 (267)
++||++|.++.
T Consensus 150 v~e~l~G~~l~ 160 (429)
T 1nw1_A 150 LEEYIPSRPLS 160 (429)
T ss_dssp EECCCCEEECC
T ss_pred EEEEeCCcccC
Confidence 99999875653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00014 Score=61.13 Aligned_cols=72 Identities=17% Similarity=0.072 Sum_probs=43.5
Q ss_pred ecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCce-eeeeeeeeecCeEEE
Q psy2579 68 QNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNI-IRLYEVLETFGKIFL 146 (267)
Q Consensus 68 ~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~~~~~~~~~~~~~i 146 (267)
++.|+.|....+|+. ..+++|+....... .-...+|+.+++.+...++ .+++... .+.-++
T Consensus 23 i~~l~gG~tN~~~~~-------------~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~ 84 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-------------GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVD--PATGVM 84 (301)
T ss_dssp CEEEESCSSEEEEEE-------------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCE
T ss_pred eeEcCCcccccccee-------------eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEE
Confidence 566889999999998 23688887543111 1112457777777632222 4555543 334578
Q ss_pred EEeec-CCCchh
Q psy2579 147 VVEYA-SGGELY 157 (267)
Q Consensus 147 v~e~~-~~gsl~ 157 (267)
++||+ ++.++.
T Consensus 85 v~e~i~~g~~l~ 96 (301)
T 3dxq_A 85 VTRYIAGAQTMS 96 (301)
T ss_dssp EEECCTTCEECC
T ss_pred EEeecCCCccCC
Confidence 99999 665554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00029 Score=61.34 Aligned_cols=82 Identities=12% Similarity=0.030 Sum_probs=45.7
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-CCceeeeeeeeeecCeEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-HPNIIRLYEVLETFGKIFLV 147 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~iv 147 (267)
+.|..|-...+|++......+.....+..+.+|+..... .....+.+|..+++.+. +.-..++++.+.. .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 357778888899987532111111234688999864321 12244568999998873 3333566666543 299
Q ss_pred EeecCCCchh
Q psy2579 148 VEYASGGELY 157 (267)
Q Consensus 148 ~e~~~~gsl~ 157 (267)
|||++|..+.
T Consensus 129 ~e~i~G~~l~ 138 (379)
T 3feg_A 129 EQYIPSRPLK 138 (379)
T ss_dssp EECCSEEECC
T ss_pred EEEecCccCC
Confidence 9999986664
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00032 Score=59.74 Aligned_cols=31 Identities=26% Similarity=0.311 Sum_probs=26.8
Q ss_pred hCCCcccCCCCCcEEeecC----CceEEecccccc
Q psy2579 233 DRDIIHRDIKAENVFLSVR----GIVKLGDLGFST 263 (267)
Q Consensus 233 ~~~ivHrDlkp~NIll~~~----~~~kl~DFGla~ 263 (267)
...++|+|+.+.|||++.+ +.+.|+||+.|.
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 4579999999999999874 679999999875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0028 Score=52.72 Aligned_cols=78 Identities=10% Similarity=0.022 Sum_probs=53.8
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-C--Cceeeeeeeeeec
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-H--PNIIRLYEVLETF 141 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h--pnIv~~~~~~~~~ 141 (267)
..-+..+|.|..+.||+... .+|+.|.+|+....... ....+.+|+..|+.|. . .-+++++.+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l--------~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---- 82 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVEL--------ADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGW---- 82 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE--------TTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEE----
T ss_pred eEEEEecCCCCCeEEEEEEE--------CCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEec----
Confidence 45567799999999999975 45688999987544321 2245778999998873 2 234555554
Q ss_pred CeEEEEEeecCCCch
Q psy2579 142 GKIFLVVEYASGGEL 156 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl 156 (267)
+..+++||++.++..
T Consensus 83 ~~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 83 DDRTLAMEWVDERPP 97 (288)
T ss_dssp ETTEEEEECCCCCCC
T ss_pred cCceEEEEeecccCC
Confidence 234789999987554
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0035 Score=55.94 Aligned_cols=76 Identities=13% Similarity=0.038 Sum_probs=46.8
Q ss_pred ecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCce-eeeeeeeeecCeEEE
Q psy2579 68 QNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNI-IRLYEVLETFGKIFL 146 (267)
Q Consensus 68 ~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnI-v~~~~~~~~~~~~~i 146 (267)
++.|+.|-...+|++... ..+..+++|+.......- . ...+|..+++.|...++ +++++.+. + .+
T Consensus 113 i~~lsgG~tN~~y~v~~~-------~~~~~~vLRi~g~~~~~~--i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~ 178 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDM-------SKQAKYLIRLYGPKTDEI--I-NREREKKISCILYNKNIAKKIYVFFT--N--GR 178 (458)
T ss_dssp EEEECC--CEEEEEEEET-------TTTEEEEEEEECC-CCSC--S-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EE
T ss_pred EEEcCCCeEeEEEEEEEC-------CCCceEEEEECCCChhhh--c-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eE
Confidence 356888888999998653 123678899875432110 0 11478999988854444 56777663 2 25
Q ss_pred EEeecCCCchh
Q psy2579 147 VVEYASGGELY 157 (267)
Q Consensus 147 v~e~~~~gsl~ 157 (267)
++||++|.++.
T Consensus 179 v~e~I~G~~l~ 189 (458)
T 2qg7_A 179 IEEFMDGYALS 189 (458)
T ss_dssp EEECCCSEECC
T ss_pred EEEeeCCccCC
Confidence 99999986653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0013 Score=56.84 Aligned_cols=81 Identities=10% Similarity=-0.028 Sum_probs=43.5
Q ss_pred cccCccCceeEEEeEEeeccc-ccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCc-eeeeeeeeeecCeEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVP-ILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPN-IIRLYEVLETFGKIFL 146 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~~~~~~~~~~~~~i 146 (267)
..|+.|....+|+........ .....+..+++|+..... .. ......|..+++.+...+ ++++++.+ . -++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~ 111 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR 111 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence 457888888999986531100 000012578899875432 11 111356888888774333 44666544 2 278
Q ss_pred EEeecCCCch
Q psy2579 147 VVEYASGGEL 156 (267)
Q Consensus 147 v~e~~~~gsl 156 (267)
+++|++|..+
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999998655
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0044 Score=52.92 Aligned_cols=30 Identities=23% Similarity=0.224 Sum_probs=26.8
Q ss_pred CCCcccCCCCCcEEeecCCceEEecccccc
Q psy2579 234 RDIIHRDIKAENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 234 ~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 263 (267)
..++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 468999999999999988889999998765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.22 E-value=0.019 Score=50.65 Aligned_cols=82 Identities=10% Similarity=-0.084 Sum_probs=47.0
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-CCceeeeeeeeeecCeEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-HPNIIRLYEVLETFGKIFLV 147 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~~~iv 147 (267)
+.+..|-...+|+.............+..+++|+....... . -...+|..+++.+. +.-..++++.+ .+ +.|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~--~-idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK--F-YDSKVELDVFRYLSNINIAPNIIADF--PE--GRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C--C-CCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch--h-cCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEE
Confidence 45777888889998764211000011477899987543211 1 11246888887773 32244555533 22 789
Q ss_pred EeecCCCchh
Q psy2579 148 VEYASGGELY 157 (267)
Q Consensus 148 ~e~~~~gsl~ 157 (267)
++|++|..+.
T Consensus 149 ~efI~G~~l~ 158 (424)
T 3mes_A 149 EEFIDGEPLT 158 (424)
T ss_dssp EECCCSEECC
T ss_pred EEEeCCccCC
Confidence 9999986653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.22 E-value=0.032 Score=48.69 Aligned_cols=28 Identities=25% Similarity=0.401 Sum_probs=24.0
Q ss_pred CcccCCCCCcEEee------cCCceEEecccccc
Q psy2579 236 IIHRDIKAENVFLS------VRGIVKLGDLGFST 263 (267)
Q Consensus 236 ivHrDlkp~NIll~------~~~~~kl~DFGla~ 263 (267)
++|+|+.+.|||+. .++.+.++||-.|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 67999999999993 45679999998875
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=95.00 E-value=0.0021 Score=57.51 Aligned_cols=64 Identities=11% Similarity=0.064 Sum_probs=18.2
Q ss_pred EEecccCccCceeEEEeEEeecccccccccceEEE------EeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 66 KLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAI------KILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 66 ~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vai------K~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
.+.+.|| ||+||+|.+.. ...+||+ |.......+.+....+.+|..+++.++|||+++.+++-.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~-------~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYK-------KHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC----------------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccc-------cCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3456677 99999998852 2357888 776655555555567889999999999999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 267 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-31 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-31 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-31 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-31 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-30 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-30 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-30 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-30 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-30 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-29 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-29 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-29 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-28 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-28 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-28 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-27 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-26 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-26 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-26 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-26 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-26 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-26 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-26 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-26 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-25 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-25 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-25 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-25 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-25 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-24 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-24 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-24 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-23 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-23 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-23 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-23 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-23 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-23 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-23 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-22 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-22 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-22 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-22 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-22 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-22 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-22 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-22 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-21 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-21 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-21 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-20 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-20 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-20 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-20 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-18 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-18 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-11 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 1e-31
Identities = 39/203 (19%), Positives = 67/203 (33%), Gaps = 56/203 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
+ +G G+F TV V A+K+L+ TP+ + E+ +
Sbjct: 10 ITVGQRIGSGSFGTVYKGKWHGDV----------AVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
H NI+ T ++ +V ++ G LY+ +
Sbjct: 60 KTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHII--------------------- 97
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
E + Q + +LH + IIHRD+K+
Sbjct: 98 ------------------------ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSN 133
Query: 245 NVFLSVRGIVKLGDLGFSTKLQQ 267
N+FL VK+GD G +T +
Sbjct: 134 NIFLHEDLTVKIGDFGLATVKSR 156
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 2e-31
Identities = 45/204 (22%), Positives = 78/204 (38%), Gaps = 54/204 (26%)
Query: 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSM 123
+++ ELG G F V A ++ A K++D + + EI +
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNK-------ETSVLAAAKVIDTKS--EEELEDYMVEIDIL 63
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
S HPNI++L + +++++E+ +GG + + R
Sbjct: 64 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER------------------ 105
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
L+E ++ Q L A+ +LHD IIHRD+KA
Sbjct: 106 ---------------------------PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKA 138
Query: 244 ENVFLSVRGIVKLGDLGFSTKLQQ 267
N+ ++ G +KL D G S K +
Sbjct: 139 GNILFTLDGDIKLADFGVSAKNTR 162
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-31
Identities = 51/245 (20%), Positives = 89/245 (36%), Gaps = 34/245 (13%)
Query: 24 LDKAKLTPKARKMLIYEKTQNQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAI 83
L ++T + Y + + D KW+ + LG G F V A
Sbjct: 5 LQMVQVTGSSDNEYFYVDF-REYEYDLKWEFPREN------LEFGKVLGSGAFGKVMNAT 57
Query: 84 HEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETFG 142
+ +A+K+L + K R+ L E+ M + H NI+ L G
Sbjct: 58 AYGISKTGVSIQ--VAVKMLKE-KADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114
Query: 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGEL 202
I+L+ EY G+L N + ++ +D Y Q L E
Sbjct: 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE------------------- 155
Query: 203 YNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
L+ +D + Q+ ++ L + +HRD+ A NV ++ +VK+ D G +
Sbjct: 156 ----EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 263 TKLQQ 267
+
Sbjct: 212 RDIMS 216
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 115 bits (289), Expect = 6e-31
Identities = 50/215 (23%), Positives = 80/215 (37%), Gaps = 56/215 (26%)
Query: 55 ETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARK 114
E G Y + ELG G F V + + K ++ P +
Sbjct: 21 EVKQGSVYDYYDILEELGSGAFGVVHRCVEK-------ATGRVFVAKFINTPY--PLDKY 71
Query: 115 MLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 174
+ EI M +HHP +I L++ E ++ L++E+ SGGEL+++I E
Sbjct: 72 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED---------- 121
Query: 175 FLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR 234
++SE + Y Q +KH+H+
Sbjct: 122 -----------------------------------YKMSEAEVINYMRQACEGLKHMHEH 146
Query: 235 DIIHRDIKAENVFLSVR--GIVKLGDLGFSTKLQQ 267
I+H DIK EN+ + VK+ D G +TKL
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 114 bits (286), Expect = 2e-30
Identities = 42/204 (20%), Positives = 77/204 (37%), Gaps = 56/204 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y + ELG G F V + A K + ++ + +EI +M
Sbjct: 28 YDIHEELGTGAFGVVHRVTER-------ATGNNFAAKFVMTPHE--SDKETVRKEIQTMS 78
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ HP ++ L++ E ++ ++ E+ SGGEL+ K+ E
Sbjct: 79 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-------------------- 118
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
++SED+A Y Q+ + H+H+ + +H D+K E
Sbjct: 119 -------------------------NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPE 153
Query: 245 NVFLSVR--GIVKLGDLGFSTKLQ 266
N+ + + +KL D G + L
Sbjct: 154 NIMFTTKRSNELKLIDFGLTAHLD 177
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 2e-30
Identities = 47/204 (23%), Positives = 79/204 (38%), Gaps = 54/204 (26%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSM 123
+++ LG+G F V +A + LA+K+L KA+L L RE+
Sbjct: 8 FEIGRPLGKGKFGNVYLAREK-------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ HPNI+RLY +++L++EYA G +Y ++ + E Y ++
Sbjct: 61 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA---- 116
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+A+ + H + +IHRDIK
Sbjct: 117 ------------------------------------------NALSYCHSKRVIHRDIKP 134
Query: 244 ENVFLSVRGIVKLGDLGFSTKLQQ 267
EN+ L G +K+ D G+S
Sbjct: 135 ENLLLGSAGELKIADFGWSVHAPS 158
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 3e-30
Identities = 40/204 (19%), Positives = 75/204 (36%), Gaps = 55/204 (26%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
++ +ELG GN V H+ +A K++ ++ P R + RE+ +
Sbjct: 8 FEKISELGAGNGGVVFKVSHK-------PSGLVMARKLIHL-EIKPAIRNQIIRELQVLH 59
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ P I+ Y + G+I + +E+ GG L + GR+ E + ++
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----- 114
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR-DIIHRDIKA 243
+ +L ++ I+HRD+K
Sbjct: 115 -----------------------------------------KGLTYLREKHKIMHRDVKP 133
Query: 244 ENVFLSVRGIVKLGDLGFSTKLQQ 267
N+ ++ RG +KL D G S +L
Sbjct: 134 SNILVNSRGEIKLCDFGVSGQLID 157
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 5e-30
Identities = 48/210 (22%), Positives = 80/210 (38%), Gaps = 56/210 (26%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y++ +G G++ + + + L K LD +T ++ML E+ +
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRK-------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 58
Query: 125 SVHHPNIIRLYEVL--ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYE 182
+ HPNI+R Y+ + T +++V+EY GG+L + IT +
Sbjct: 59 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK----------------- 101
Query: 183 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRD-----II 237
L E+ Q+ A+K H R ++
Sbjct: 102 -------------------------ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL 136
Query: 238 HRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
HRD+K NVFL + VKLGD G + L
Sbjct: 137 HRDLKPANVFLDGKQNVKLGDFGLARILNH 166
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 112 bits (280), Expect = 7e-30
Identities = 41/205 (20%), Positives = 71/205 (34%), Gaps = 54/205 (26%)
Query: 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKL-TPKARKMLSREIVS 122
L+ E+G G+F V A +AIK + + + + + + +E+
Sbjct: 16 LFSDLREIGHGSFGAVYFARDV-------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 123 MESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYE 182
++ + HPN I+ +LV+EY G + L E + L
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL--- 125
Query: 183 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIK 242
+ +LH ++IHRD+K
Sbjct: 126 -------------------------------------------QGLAYLHSHNMIHRDVK 142
Query: 243 AENVFLSVRGIVKLGDLGFSTKLQQ 267
A N+ LS G+VKLGD G ++ +
Sbjct: 143 AGNILLSEPGLVKLGDFGSASIMAP 167
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-29
Identities = 48/199 (24%), Positives = 76/199 (38%), Gaps = 54/199 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSM 123
+K LG G+FSTV +A AIKIL+K + ++RE M
Sbjct: 10 FKFGKILGEGSFSTVVLAREL-------ATSREYAIKILEKRHIIKENKVPYVTRERDVM 62
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ HP ++LY + K++ + YA GEL I G E + Y +I+
Sbjct: 63 SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV---- 118
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
SA+++LH + IIHRD+K
Sbjct: 119 ------------------------------------------SALEYLHGKGIIHRDLKP 136
Query: 244 ENVFLSVRGIVKLGDLGFS 262
EN+ L+ +++ D G +
Sbjct: 137 ENILLNEDMHIQITDFGTA 155
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 7e-29
Identities = 50/206 (24%), Positives = 77/206 (37%), Gaps = 52/206 (25%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
K E+GRG+F TV + +A L KLT R+ E ++
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDT-------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ HPNI+R Y+ E+ +
Sbjct: 64 GLQHPNIVRFYDSWES------------------------------------------TV 81
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRD--IIHRDIK 242
+ I LV E + G L + + + + QIL ++ LH R IIHRD+K
Sbjct: 82 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK 141
Query: 243 AENVFL-SVRGIVKLGDLGFSTKLQQ 267
+N+F+ G VK+GDLG +T +
Sbjct: 142 CDNIFITGPTGSVKIGDLGLATLKRA 167
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 8e-29
Identities = 46/202 (22%), Positives = 83/202 (41%), Gaps = 54/202 (26%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
+ L LG G + V++A++ +A+KI+D + + + +EI +
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNR-------VTEEAVAVKIVDMKRA-VDCPENIKKEICINK 58
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
++H N+++ Y +L +EY SGGEL+++I + + E DA+ +F Q++
Sbjct: 59 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 113
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+ V +LH I HRDIK E
Sbjct: 114 -----------------------------------------AGVVYLHGIGITHRDIKPE 132
Query: 245 NVFLSVRGIVKLGDLGFSTKLQ 266
N+ L R +K+ D G +T +
Sbjct: 133 NLLLDERDNLKISDFGLATVFR 154
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 3e-28
Identities = 46/225 (20%), Positives = 76/225 (33%), Gaps = 38/225 (16%)
Query: 44 NQLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKIL 103
QL D KW+ + LG G F V A Y I +A+K+L
Sbjct: 10 TQLPYDHKWEFPRNR------LSFGKTLGAGAFGKVVEATA--YGLIKSDAAMTVAVKML 61
Query: 104 DKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITT 162
+ R+ L E+ + + +H NI+ L G ++ EY G+L N +
Sbjct: 62 KPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRR 120
Query: 163 EGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222
+ S E L +D +
Sbjct: 121 KRDS----------------------------FICSKTSPAIMEDDELALDLEDLLSFSY 152
Query: 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
Q+ + L ++ IHRD+ A N+ L+ I K+ D G + ++
Sbjct: 153 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 3e-28
Identities = 42/203 (20%), Positives = 77/203 (37%), Gaps = 56/203 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y ++G+G TV A+ +AI+ ++ + ++++ EI+ M
Sbjct: 22 YTRFEKIGQGASGTVYTAMDV-------ATGQEVAIRQMNLQQQ--PKKELIINEILVMR 72
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+PNI+ + ++++V+EY +GG L
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT--------------------------- 105
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+ TE + E + L A++ LH +IHRDIK++
Sbjct: 106 --------------------DVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 145
Query: 245 NVFLSVRGIVKLGDLGFSTKLQQ 267
N+ L + G VKL D GF ++
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITP 168
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 106 bits (265), Expect = 6e-28
Identities = 36/203 (17%), Positives = 71/203 (34%), Gaps = 25/203 (12%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
+ ++G G F V A +P + +A+K+L + + + + RE M
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPY--EPFTMVAVKMLKE-EASADMQADFQREAALMA 71
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+PNI++L V + L+ EY + G+L + + +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCS-------------- 117
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+ LS + Q+ + + +L +R +HRD+
Sbjct: 118 --------LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169
Query: 245 NVFLSVRGIVKLGDLGFSTKLQQ 267
N + +VK+ D G S +
Sbjct: 170 NCLVGENMVVKIADFGLSRNIYS 192
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 5e-27
Identities = 44/223 (19%), Positives = 77/223 (34%), Gaps = 36/223 (16%)
Query: 45 QLQNDKKWQHETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILD 104
+L D +W E + L LG G F V +A ++ +A+K+L
Sbjct: 1 ELPEDPRW--ELPRDR----LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK 54
Query: 105 KAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEG 164
++S + H NII L G ++++VEYAS G L +
Sbjct: 55 SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 114
Query: 165 RLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 224
+ + E +LS D Q+
Sbjct: 115 PPGLEYS------------------------------YNPSHNPEEQLSSKDLVSCAYQV 144
Query: 225 LSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
+++L + IHRD+ A NV ++ ++K+ D G + +
Sbjct: 145 ARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 1e-26
Identities = 48/204 (23%), Positives = 78/204 (38%), Gaps = 51/204 (25%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSM 123
+L +LG G+F V+ + + A+K L L+ P+A RE+ +M
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSV----AVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
S+ H N+IRLY V+ T + +V E A G L +++
Sbjct: 66 HSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKH-------------------- 104
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+G Y +Q+ + +L + IHRD+ A
Sbjct: 105 -------------------------QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAA 139
Query: 244 ENVFLSVRGIVKLGDLGFSTKLQQ 267
N+ L+ R +VK+GD G L Q
Sbjct: 140 RNLLLATRDLVKIGDFGLMRALPQ 163
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 1e-26
Identities = 39/205 (19%), Positives = 76/205 (37%), Gaps = 57/205 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y + +LGRG F V + + K + K+ + ++ +EI +
Sbjct: 7 YMIAEDLGRGEFGIVHRCVET-------SSKKTYMAKFV---KVKGTDQVLVKKEISILN 56
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
H NI+ L+E E+ ++ ++ E+ SG +++ +I T
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA-------------------- 96
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
L+E + Y Q+ A++ LH +I H DI+ E
Sbjct: 97 -------------------------FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPE 131
Query: 245 NVFLSVR--GIVKLGDLGFSTKLQQ 267
N+ R +K+ + G + +L+
Sbjct: 132 NIIYQTRRSSTIKIIEFGQARQLKP 156
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 3e-26
Identities = 37/201 (18%), Positives = 70/201 (34%), Gaps = 45/201 (22%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y+ ++G+G F V A H +A+K + REI ++
Sbjct: 12 YEKLAKIGQGTFGEVFKARHR-------KTGQKVALKKVLMENEKEGFPITALREIKILQ 64
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ H N++ L E+ T + +
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCK----------------------------------- 89
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
G I+LV ++ + + + K +L+ + ++H I+HRD+KA
Sbjct: 90 ---GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAA 146
Query: 245 NVFLSVRGIVKLGDLGFSTKL 265
NV ++ G++KL D G +
Sbjct: 147 NVLITRDGVLKLADFGLARAF 167
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 3e-26
Identities = 44/199 (22%), Positives = 70/199 (35%), Gaps = 37/199 (18%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
K Q+ +G GNF V A + AIK + + + + + E+ +
Sbjct: 12 IKFQDVIGEGNFGQVLKARIK-----KDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLC 65
Query: 125 SV-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ HHPNII L E G ++L +EYA G L + + L D A
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS------ 119
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
T LS + + + +L + IHRD+ A
Sbjct: 120 ------------------------TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA 155
Query: 244 ENVFLSVRGIVKLGDLGFS 262
N+ + + K+ D G S
Sbjct: 156 RNILVGENYVAKIADFGLS 174
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 4e-26
Identities = 42/198 (21%), Positives = 70/198 (35%), Gaps = 52/198 (26%)
Query: 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHH 128
ELG GNF TVK +++ + +A+KIL P + L E M+ + +
Sbjct: 13 KELGSGNFGTVKKGYYQMK-----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN 67
Query: 129 PNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFG 188
P I+R+ + E
Sbjct: 68 PYIVRMIGICE-----------------------------------------------AE 80
Query: 189 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFL 248
LV+E A G L + + + + Q+ +K+L + + +HRD+ A NV L
Sbjct: 81 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL 140
Query: 249 SVRGIVKLGDLGFSTKLQ 266
+ K+ D G S L+
Sbjct: 141 VTQHYAKISDFGLSKALR 158
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 6e-26
Identities = 41/203 (20%), Positives = 72/203 (35%), Gaps = 56/203 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
KL LG G F V M + + + A+K L + ++P A E M+
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKV--------AVKSLKQGSMSPDA---FLAEANLMK 63
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ H ++RLY V T I+++ EY G L + + T
Sbjct: 64 QLQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSG------------------- 103
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+L+ + QI + + +R+ IHRD++A
Sbjct: 104 -------------------------IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAA 138
Query: 245 NVFLSVRGIVKLGDLGFSTKLQQ 267
N+ +S K+ D G + ++
Sbjct: 139 NILVSDTLSCKIADFGLARLIED 161
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 9e-26
Identities = 38/204 (18%), Positives = 72/204 (35%), Gaps = 58/204 (28%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
KL +G+G F V + + + +A+K + + E M
Sbjct: 9 LKLLQTIGKGEFGDVMLGDYRG---------NKVAVKCIKN----DATAQAFLAEASVMT 55
Query: 125 SVHHPNIIRLYEV-LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+ H N+++L V +E G +++V EY + G L + + + GR
Sbjct: 56 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR------------------ 97
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
L D + L + A+++L + +HRD+ A
Sbjct: 98 --------------------------SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 131
Query: 244 ENVFLSVRGIVKLGDLGFSTKLQQ 267
NV +S + K+ D G + +
Sbjct: 132 RNVLVSEDNVAKVSDFGLTKEASS 155
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 100 bits (250), Expect = 9e-26
Identities = 52/211 (24%), Positives = 80/211 (37%), Gaps = 61/211 (28%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-------PKARKMLS 117
Y+ + LGRG S V+ IH+ A+KI+D + R+
Sbjct: 5 YEPKEILGRGVSSVVRRCIHK-------PTCKEYAVKIIDVTGGGSFSAEEVQELREATL 57
Query: 118 REIVSMESVH-HPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 176
+E+ + V HPNII+L + ET FLV + GEL++ +T + LSE + +
Sbjct: 58 KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 117
Query: 177 QILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDI 236
+L + LH +I
Sbjct: 118 ALL----------------------------------------------EVICALHKLNI 131
Query: 237 IHRDIKAENVFLSVRGIVKLGDLGFSTKLQQ 267
+HRD+K EN+ L +KL D GFS +L
Sbjct: 132 VHRDLKPENILLDDDMNIKLTDFGFSCQLDP 162
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 100 bits (249), Expect = 2e-25
Identities = 51/206 (24%), Positives = 81/206 (39%), Gaps = 57/206 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y ++ LG G FS V +A + +AIK + K L + EI +
Sbjct: 11 YDFRDVLGTGAFSEVILAEDK-------RTQKLVAIKCIAKKAL-EGKEGSMENEIAVLH 62
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ HPNI+ L ++
Sbjct: 63 KIKHPNIVA----------------------------------------------LDDIY 76
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
E+ G ++L+++ SGGEL+++I +G +E DA Q+L AVK+LHD I+HRD+K E
Sbjct: 77 ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPE 136
Query: 245 NVFLSVR---GIVKLGDLGFSTKLQQ 267
N+ + + D G S
Sbjct: 137 NLLYYSLDEDSKIMISDFGLSKMEDP 162
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 99.8 bits (248), Expect = 2e-25
Identities = 38/203 (18%), Positives = 67/203 (33%), Gaps = 50/203 (24%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
K++ +G G F V ++ ++AIK L T K R+ E M
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKL----PGKREIFVAIKTLKS-GYTEKQRRDFLSEASIMG 82
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
HPN+I L V+ + ++ E+ G L
Sbjct: 83 QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD--------------------------- 115
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+G+ + I + +K+L D + +HRD+ A
Sbjct: 116 ------------------SFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAAR 157
Query: 245 NVFLSVRGIVKLGDLGFSTKLQQ 267
N+ ++ + K+ D G S L+
Sbjct: 158 NILVNSNLVCKVSDFGLSRFLED 180
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 100 bits (250), Expect = 3e-25
Identities = 40/207 (19%), Positives = 76/207 (36%), Gaps = 57/207 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
+ + +GRG F V A+K LDK ++ K + L+ M
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKA-------DTGKMYAMKCLDKKRIKMKQGETLALNERIML 58
Query: 125 SV----HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
S+ P I+ + T K+ +++ +GG+L+ ++ G SE D + Y +I+
Sbjct: 59 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII- 117
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
++H+H+R +++RD
Sbjct: 118 ---------------------------------------------LGLEHMHNRFVVYRD 132
Query: 241 IKAENVFLSVRGIVKLGDLGFSTKLQQ 267
+K N+ L G V++ DLG + +
Sbjct: 133 LKPANILLDEHGHVRISDLGLACDFSK 159
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 99.4 bits (247), Expect = 4e-25
Identities = 46/204 (22%), Positives = 82/204 (40%), Gaps = 54/204 (26%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSM 123
+++ LG G+F V + Y A+K+L K + K + + E + +
Sbjct: 6 FQILRTLGTGSFGRVHLIRSR-------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 58
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
V HP IIR++ + +IF++++Y GGEL++ + R AK Y ++ L
Sbjct: 59 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA-- 116
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
+++LH +DII+RD+K
Sbjct: 117 --------------------------------------------LEYLHSKDIIYRDLKP 132
Query: 244 ENVFLSVRGIVKLGDLGFSTKLQQ 267
EN+ L G +K+ D GF+ +
Sbjct: 133 ENILLDKNGHIKITDFGFAKYVPD 156
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.6 bits (245), Expect = 5e-25
Identities = 42/197 (21%), Positives = 72/197 (36%), Gaps = 52/197 (26%)
Query: 70 ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHP 129
ELG GNF +V+ ++ + +AIK+L + + + RE M + +P
Sbjct: 16 ELGCGNFGSVRQGVYR-----MRKKQIDVAIKVLKQ-GTEKADTEEMMREAQIMHQLDNP 69
Query: 130 NIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGK 189
I+RL V + + LV+E A GG L+ +
Sbjct: 70 YIVRLIGVCQAE-ALMLVMEMAGGGPLHKFL----------------------------- 99
Query: 190 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLS 249
+ + + Q+ +K+L +++ +HRD+ A NV L
Sbjct: 100 ----------------VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV 143
Query: 250 VRGIVKLGDLGFSTKLQ 266
R K+ D G S L
Sbjct: 144 NRHYAKISDFGLSKALG 160
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.8 bits (243), Expect = 5e-25
Identities = 37/203 (18%), Positives = 65/203 (32%), Gaps = 56/203 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
ELG G F VK + AIK++ + + + E M
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDV--------AIKMIKEGSM---SEDEFIEEAKVMM 54
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
++ H +++LY V IF++ EY + G L N +
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--------------------- 93
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
R + A+++L + +HRD+ A
Sbjct: 94 ------------------------RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAAR 129
Query: 245 NVFLSVRGIVKLGDLGFSTKLQQ 267
N ++ +G+VK+ D G S +
Sbjct: 130 NCLVNDQGVVKVSDFGLSRYVLD 152
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 97.1 bits (241), Expect = 1e-24
Identities = 42/204 (20%), Positives = 68/204 (33%), Gaps = 50/204 (24%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSM 123
Y+L LG G S V +A +A+K+L P RE +
Sbjct: 9 YELGEILGFGGMSEVHLARDL-------RLHRDVAVKVLRADLARDPSFYLRFRREAQNA 61
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
+++HP I+ +Y+ E
Sbjct: 62 AALNHPAIVAVYDTGEAETPA--------------------------------------- 82
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
++V+EY G L + + TEG ++ A A+ H IIHRD+K
Sbjct: 83 ---GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 139
Query: 244 ENVFLSVRGIVKLGDLGFSTKLQQ 267
N+ +S VK+ D G + +
Sbjct: 140 ANIMISATNAVKVMDFGIARAIAD 163
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 96.3 bits (239), Expect = 3e-24
Identities = 36/203 (17%), Positives = 71/203 (34%), Gaps = 54/203 (26%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
++++LG G + V + + Y +A+K L + + +E M+
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDT---MEVEEFLKEAAVMK 68
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ HPN+++L V +++ E+ + G L + + R
Sbjct: 69 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR------------------- 109
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+S QI SA+++L ++ IHRD+ A
Sbjct: 110 -------------------------QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 144
Query: 245 NVFLSVRGIVKLGDLGFSTKLQQ 267
N + +VK+ D G S +
Sbjct: 145 NCLVGENHLVKVADFGLSRLMTG 167
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.7 bits (240), Expect = 5e-24
Identities = 40/205 (19%), Positives = 73/205 (35%), Gaps = 55/205 (26%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT--PKARKMLSREIVS 122
+ L LG+G+F V +A + + AIK L K + + + V
Sbjct: 4 FILHKMLGKGSFGKVFLAEFK-------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 56
Query: 123 MESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYE 182
+ HP + ++ +T +F V+EY +GG+L I + + A Y +I+L
Sbjct: 57 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL-- 114
Query: 183 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIK 242
++ LH + I++RD+K
Sbjct: 115 --------------------------------------------GLQFLHSKGIVYRDLK 130
Query: 243 AENVFLSVRGIVKLGDLGFSTKLQQ 267
+N+ L G +K+ D G +
Sbjct: 131 LDNILLDKDGHIKIADFGMCKENML 155
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 96.0 bits (238), Expect = 1e-23
Identities = 52/242 (21%), Positives = 102/242 (42%), Gaps = 56/242 (23%)
Query: 26 KAKLTPKARKMLIYEKTQNQLQND--KKWQHETSLGKRVALYKLQNELGRGNFSTVKMAI 83
A K + ++ + + D KKW+ + ++ + LG G+F V +
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 84 HEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142
H+ ++ A+KILDK K+ K + E +++V+ P +++L +
Sbjct: 62 HK-------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGEL 202
+++V+EY +GGE+++ + GR SE A+ Y QI+L
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL---------------------- 152
Query: 203 YNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFS 262
++LH D+I+RD+K EN+ + +G +++ D GF+
Sbjct: 153 ------------------------TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 263 TK 264
+
Sbjct: 189 KR 190
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.4 bits (234), Expect = 1e-23
Identities = 42/203 (20%), Positives = 74/203 (36%), Gaps = 51/203 (25%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
+L +G G F V I+ +AIK + R+ +E ++M
Sbjct: 9 IELGRCIGEGQFGDVHQGIY----MSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMR 63
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
HP+I++L V+ T +++++E + GEL + +
Sbjct: 64 QFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVR--------------------- 101
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+ L +Y Q+ +A+ +L + +HRDI A
Sbjct: 102 ------------------------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAAR 137
Query: 245 NVFLSVRGIVKLGDLGFSTKLQQ 267
NV +S VKLGD G S ++
Sbjct: 138 NVLVSSNDCVKLGDFGLSRYMED 160
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 1e-23
Identities = 33/203 (16%), Positives = 74/203 (36%), Gaps = 39/203 (19%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
+ ELG+G+F V + + V + +AIK +++A + + R E M+
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAA-SMRERIEFLNEASVMK 78
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ +++RL V+ +++E + G+L + + + ++ +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL----------- 127
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
S +I + +L+ +HRD+ A
Sbjct: 128 -------------------------APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR 162
Query: 245 NVFLSVRGIVKLGDLGFSTKLQQ 267
N ++ VK+GD G + + +
Sbjct: 163 NCMVAEDFTVKIGDFGMTRDIYE 185
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 1e-23
Identities = 40/204 (19%), Positives = 76/204 (37%), Gaps = 33/204 (16%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
KL LGRG F V A +A+K+L + + R ++S + +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKT--ATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 125 SVHHPNIIRLYEV-LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
HH N++ L + G + ++VE+ G L + ++
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN------------------ 114
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
++ + + L+ + Y Q+ ++ L R IHRD+ A
Sbjct: 115 ------------EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 162
Query: 244 ENVFLSVRGIVKLGDLGFSTKLQQ 267
N+ LS + +VK+ D G + + +
Sbjct: 163 RNILLSEKNVVKICDFGLARDIYK 186
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 2e-23
Identities = 52/229 (22%), Positives = 88/229 (38%), Gaps = 56/229 (24%)
Query: 45 QLQNDKKWQHETSL---GKRVAL--YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLA 99
QL K +L ++V + ++L LG G + V + Y A
Sbjct: 1 QLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLY----A 56
Query: 100 IKILDKAKLT--PKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELY 157
+K+L KA + K + E +E + +
Sbjct: 57 MKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL------------------------- 91
Query: 158 NKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217
+ L+ +T K+ L+++Y +GGEL+ ++ R +E +
Sbjct: 92 --------------------VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV 131
Query: 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266
+IY +I+ A++HLH II+RDIK EN+ L G V L D G S +
Sbjct: 132 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.2 bits (231), Expect = 5e-23
Identities = 40/203 (19%), Positives = 73/203 (35%), Gaps = 56/203 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
+L+ +LG+G F V M + AIK L ++P+A +E M+
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRV--------AIKTLKPGTMSPEA---FLQEAQVMK 67
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ H +++LY V+ + I++V EY S G L
Sbjct: 68 KLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLL--------------------------- 99
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+ K T L QI S + ++ + +HRD++A
Sbjct: 100 -----------------DFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 142
Query: 245 NVFLSVRGIVKLGDLGFSTKLQQ 267
N+ + + K+ D G + ++
Sbjct: 143 NILVGENLVCKVADFGLARLIED 165
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (232), Expect = 6e-23
Identities = 46/204 (22%), Positives = 79/204 (38%), Gaps = 54/204 (26%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSM 123
+ LG+G F V + + Y A+KIL K + E +
Sbjct: 7 FDYLKLLGKGTFGKVILVREK-------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 124 ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
++ HP + L +T ++ V+EYA+GGEL+ ++ E +E+ A+ Y +I+
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV---- 115
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
SA+++LH RD+++RDIK
Sbjct: 116 ------------------------------------------SALEYLHSRDVVYRDIKL 133
Query: 244 ENVFLSVRGIVKLGDLGFSTKLQQ 267
EN+ L G +K+ D G +
Sbjct: 134 ENLMLDKDGHIKITDFGLCKEGIS 157
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 92.6 bits (229), Expect = 7e-23
Identities = 42/203 (20%), Positives = 73/203 (35%), Gaps = 54/203 (26%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y ++G G + V A + Y A+K + K REI ++
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNN--------YGETFALKKIRLEKEDEGIPSTTIREISILK 55
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ H NI++ LY+V+
Sbjct: 56 ELKHSNIVK----------------------------------------------LYDVI 69
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
T ++ LV E+ EG L AK + LQ+L+ + + HDR ++HRD+K +
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQ 129
Query: 245 NVFLSVRGIVKLGDLGFSTKLQQ 267
N+ ++ G +K+ D G +
Sbjct: 130 NLLINREGELKIADFGLARAFGI 152
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.4 bits (231), Expect = 1e-22
Identities = 37/203 (18%), Positives = 67/203 (33%), Gaps = 51/203 (25%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y + +G G + V A +AIK + + + REI +
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDN-------VNKVRVAIKKISPFE-HQTYCQRTLREIKILL 61
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
H NII + +++ + Y
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVY---------------------------------- 87
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+V + G +LY + LS D + QIL +K++H +++HRD+K
Sbjct: 88 --------LVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 138
Query: 245 NVFLSVRGIVKLGDLGFSTKLQQ 267
N+ L+ +K+ D G +
Sbjct: 139 NLLLNTTCDLKICDFGLARVADP 161
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.9 bits (230), Expect = 1e-22
Identities = 43/210 (20%), Positives = 75/210 (35%), Gaps = 63/210 (30%)
Query: 65 YKLQNE-LGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREI-VS 122
YK+ ++ LG G V ++ A+K+L RE+ +
Sbjct: 13 YKVTSQVLGLGINGKVLQIFNK-------RTQEKFALKMLQD-------CPKARREVELH 58
Query: 123 MESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYE 182
+ P+I+R+ +V E
Sbjct: 59 WRASQCPHIVRIVDVYENLY---------------------------------------- 78
Query: 183 VLETFGKIFLVVEYASGGELYNKITTEG--RLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
+ +V+E GGEL+++I G +E +A I A+++LH +I HRD
Sbjct: 79 --AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 136
Query: 241 IKAENVFLS---VRGIVKLGDLGFSTKLQQ 267
+K EN+ + I+KL D GF+ +
Sbjct: 137 VKPENLLYTSKRPNAILKLTDFGFAKETTS 166
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.7 bits (227), Expect = 1e-22
Identities = 34/203 (16%), Positives = 64/203 (31%), Gaps = 56/203 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
E+G G F V + + AIK + + ++ + E M
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKV--------AIKTIREGAMS---EEDFIEEAEVMM 55
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ HP +++LY V I LV E+ G L + + T+ L
Sbjct: 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF----------------- 98
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+ + L + + +L + +IHRD+ A
Sbjct: 99 ----------------------------AAETLLGMCLDVCEGMAYLEEACVIHRDLAAR 130
Query: 245 NVFLSVRGIVKLGDLGFSTKLQQ 267
N + ++K+ D G + +
Sbjct: 131 NCLVGENQVIKVSDFGMTRFVLD 153
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.9 bits (227), Expect = 2e-22
Identities = 36/203 (17%), Positives = 72/203 (35%), Gaps = 52/203 (25%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
++ ++G G + V A ++ +A+K + T REI ++
Sbjct: 4 FQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
++HPNI++L +V+ T K++LV E+
Sbjct: 57 ELNHPNIVKLLDVIHTENKLYLVFEF---------------------------------- 82
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+ + + + K Y Q+L + H ++HRD+K +
Sbjct: 83 -----------LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 131
Query: 245 NVFLSVRGIVKLGDLGFSTKLQQ 267
N+ ++ G +KL D G +
Sbjct: 132 NLLINTEGAIKLADFGLARAFGV 154
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.2 bits (228), Expect = 3e-22
Identities = 43/207 (20%), Positives = 74/207 (35%), Gaps = 57/207 (27%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y +G G+F V A C +AIK + + K + +RE+ M
Sbjct: 22 YTDTKVIGNGSFGVVYQAKL-------CDSGELVAIKKVLQDK------RFKNRELQIMR 68
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ H NI+RL + G E ++Y
Sbjct: 69 KLDHCNIVRLRYFFYSSG-------------------------EKKDEVY---------- 93
Query: 185 ETFGKIFLVVEYASGG---ELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDI 241
+ LV++Y + + L K+Y Q+ ++ ++H I HRDI
Sbjct: 94 -----LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDI 148
Query: 242 KAENVFLSVRG-IVKLGDLGFSTKLQQ 267
K +N+ L ++KL D G + +L +
Sbjct: 149 KPQNLLLDPDTAVLKLCDFGSAKQLVR 175
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.0 bits (225), Expect = 5e-22
Identities = 45/202 (22%), Positives = 71/202 (35%), Gaps = 50/202 (24%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
+K LG G F TV + +P +AIK L +A +PKA K + E M
Sbjct: 11 FKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMA 66
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
SV +P++ RL + T + L+ + G L
Sbjct: 67 SVDNPHVCRLLGICLT-STVQLITQLMPFGCL---------------------------- 97
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
L + + + +QI + +L DR ++HRD+ A
Sbjct: 98 -----------------LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR 140
Query: 245 NVFLSVRGIVKLGDLGFSTKLQ 266
NV + VK+ D G + L
Sbjct: 141 NVLVKTPQHVKITDFGLAKLLG 162
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.1 bits (223), Expect = 5e-22
Identities = 48/210 (22%), Positives = 82/210 (39%), Gaps = 59/210 (28%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT----PKARKMLSREI 120
Y++ LG G F +V I + +AIK ++K +++ + E+
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRV-------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 58
Query: 121 VSMESVH--HPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQI 178
V ++ V +IRL + E L++E
Sbjct: 59 VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP------------------------- 93
Query: 179 LLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIH 238
+L++ IT G L E+ A+ +F Q+L AV+H H+ ++H
Sbjct: 94 --------------------VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLH 133
Query: 239 RDIKAENVFLSV-RGIVKLGDLGFSTKLQQ 267
RDIK EN+ + + RG +KL D G L+
Sbjct: 134 RDIKDENILIDLNRGELKLIDFGSGALLKD 163
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.9 bits (222), Expect = 7e-22
Identities = 42/203 (20%), Positives = 67/203 (33%), Gaps = 49/203 (24%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Q +G G F V + + + AIK L KA T K R E M
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPV---AIKTL-KAGYTEKQRVDFLGEAGIMG 64
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
H NIIRL V+ + + ++ EY G L + +
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK--------------------- 103
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+G S I + +K+L + + +HRD+ A
Sbjct: 104 ------------------------DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAAR 139
Query: 245 NVFLSVRGIVKLGDLGFSTKLQQ 267
N+ ++ + K+ D G S L+
Sbjct: 140 NILVNSNLVCKVSDFGLSRVLED 162
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 9e-22
Identities = 40/203 (19%), Positives = 74/203 (36%), Gaps = 49/203 (24%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y+ +G G + V A+ + +AIK L + + K RE+ ++
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDG-------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLK 72
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ H N+I L +V E L
Sbjct: 73 HMRHENVIGLLDVFTP----------------------------------------DETL 92
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+ F +LV+ + G K+ +L ED + Q+L ++++H IIHRD+K
Sbjct: 93 DDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPG 150
Query: 245 NVFLSVRGIVKLGDLGFSTKLQQ 267
N+ ++ +K+ D G + +
Sbjct: 151 NLAVNEDCELKILDFGLARQADS 173
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.0 bits (220), Expect = 2e-21
Identities = 49/211 (23%), Positives = 83/211 (39%), Gaps = 61/211 (28%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT----PKARKMLSREI 120
Y ELG G F+ VK + + A K + K + +R+ + RE+
Sbjct: 12 YDTGEELGSGQFAVVKKCREK-------STGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 121 VSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
++ + HPN+I L+EV E + L++E +GGEL++ + + L+E++A + QIL
Sbjct: 65 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
V +LH I H D
Sbjct: 125 ----------------------------------------------GVYYLHSLQIAHFD 138
Query: 241 IKAENVFLSVRGI----VKLGDLGFSTKLQQ 267
+K EN+ L R + +K+ D G + K+
Sbjct: 139 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 2e-21
Identities = 41/202 (20%), Positives = 64/202 (31%), Gaps = 56/202 (27%)
Query: 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT---PKARKMLSREIVSMES 125
+ LG G F+TV A + +AIK + + + REI ++
Sbjct: 4 DFLGEGQFATVYKARDK-------NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 56
Query: 126 VHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLE 185
+ HPNII L +
Sbjct: 57 LSHPNIIG----------------------------------------------LLDAFG 70
Query: 186 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAEN 245
I LV ++ L+ K Y L L +++LH I+HRD+K N
Sbjct: 71 HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNN 130
Query: 246 VFLSVRGIVKLGDLGFSTKLQQ 267
+ L G++KL D G +
Sbjct: 131 LLLDENGVLKLADFGLAKSFGS 152
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.8 bits (219), Expect = 3e-21
Identities = 39/203 (19%), Positives = 69/203 (33%), Gaps = 51/203 (25%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSM- 123
Y+ E+G G + V A L ++A+K + RE+ +
Sbjct: 9 YECVAEIGEGAYGKVFKARD------LKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 62
Query: 124 --ESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLY 181
E+ HPN++RL++V
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRT-------------------------------------- 84
Query: 182 EVLETFGKIFLVVEYASGGEL-YNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
+ K+ LV E+ Y E + + K Q+L + LH ++HRD
Sbjct: 85 ---DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRD 141
Query: 241 IKAENVFLSVRGIVKLGDLGFST 263
+K +N+ ++ G +KL D G +
Sbjct: 142 LKPQNILVTSSGQIKLADFGLAR 164
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.0 bits (212), Expect = 2e-20
Identities = 33/207 (15%), Positives = 61/207 (29%), Gaps = 55/207 (26%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
LQ +G+G F V +A+KI + + EI
Sbjct: 5 IVLQESIGKGRFGEVWRGKWRG---------EEVAVKIFSSRE---ERSWFREAEIYQTV 52
Query: 125 SVHHPNIIRLYEVLE----TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILL 180
+ H NI+ T+ +++LV +Y G L++ + ++ + L
Sbjct: 53 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALST-- 109
Query: 181 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRD 240
A + V I HRD
Sbjct: 110 ------------------------------------ASGLAHLHMEIVGTQGKPAIAHRD 133
Query: 241 IKAENVFLSVRGIVKLGDLGFSTKLQQ 267
+K++N+ + G + DLG + +
Sbjct: 134 LKSKNILVKKNGTCCIADLGLAVRHDS 160
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.1 bits (212), Expect = 4e-20
Identities = 42/203 (20%), Positives = 73/203 (35%), Gaps = 49/203 (24%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y+ + +G G + +V A +A+K L + + K RE+ ++
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDT-------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ H N+I L +V L
Sbjct: 73 HMKHENVIGLLDVFTP----------------------------------------ARSL 92
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
E F ++LV G N I +L++D + QIL +K++H DIIHRD+K
Sbjct: 93 EEFNDVYLVTHL--MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPS 150
Query: 245 NVFLSVRGIVKLGDLGFSTKLQQ 267
N+ ++ +K+ D G +
Sbjct: 151 NLAVNEDCELKILDFGLARHTDD 173
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.4 bits (210), Expect = 4e-20
Identities = 38/203 (18%), Positives = 71/203 (34%), Gaps = 53/203 (26%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y+ ++G G + TV A + +A+K + REI ++
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNR-------ETHEIVALKRVRLDDDDEGVPSSALREICLLK 56
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
+ H NI+R L++VL
Sbjct: 57 ELKHKNIVR----------------------------------------------LHDVL 70
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
+ K+ LV E+ + G L + K + Q+L + H R+++HRD+K +
Sbjct: 71 HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQ 130
Query: 245 NVFLSVRGIVKLGDLGFSTKLQQ 267
N+ ++ G +KL + G +
Sbjct: 131 NLLINRNGELKLANFGLARAFGI 153
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 85.7 bits (211), Expect = 4e-20
Identities = 45/205 (21%), Positives = 75/205 (36%), Gaps = 61/205 (29%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y+L +LGRG +S V AI+ T + +KIL K +K + REI +E
Sbjct: 37 YQLVRKLGRGKYSEVFEAINI-------TNNEKVVVKILKPVK-----KKKIKREIKILE 84
Query: 125 SV-HHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEV 183
++ PNII L ++++
Sbjct: 85 NLRGGPNIITLADIVKD------------------------------------------- 101
Query: 184 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKA 243
LV E+ + + L++ D + Y +IL A+ + H I+HRD+K
Sbjct: 102 -PVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKP 157
Query: 244 ENVFLSVRG-IVKLGDLGFSTKLQQ 267
NV + ++L D G +
Sbjct: 158 HNVMIDHEHRKLRLIDWGLAEFYHP 182
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.4 bits (210), Expect = 9e-20
Identities = 44/199 (22%), Positives = 65/199 (32%), Gaps = 50/199 (25%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y+ +G G V A +AIK L + K RE+V M+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDA-------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 71
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
V+H NII L V + L
Sbjct: 72 CVNHKNIISLLNVFTP----------------------------------------QKTL 91
Query: 185 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAE 244
E F ++LV+E + L + Q+L +KHLH IIHRD+K
Sbjct: 92 EEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 148
Query: 245 NVFLSVRGIVKLGDLGFST 263
N+ + +K+ D G +
Sbjct: 149 NIVVKSDCTLKILDFGLAR 167
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.2 bits (197), Expect = 3e-18
Identities = 38/205 (18%), Positives = 65/205 (31%), Gaps = 51/205 (24%)
Query: 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSM 123
+ +GRG+F V + A+K L++ E + M
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTL----LDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIM 82
Query: 124 ESVHHPNIIRLYEV-LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYE 182
+ HPN++ L + L + G +V+ Y G+L N I E
Sbjct: 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----------------- 125
Query: 183 VLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIK 242
+ D + LQ+ +K L + +HRD+
Sbjct: 126 ----------------------------NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLA 157
Query: 243 AENVFLSVRGIVKLGDLGFSTKLQQ 267
A N L + VK+ D G + +
Sbjct: 158 ARNCMLDEKFTVKVADFGLARDMYD 182
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 79.9 bits (196), Expect = 4e-18
Identities = 31/216 (14%), Positives = 62/216 (28%), Gaps = 62/216 (28%)
Query: 55 ETSLGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARK 114
E +G R Y+L ++G G+F + + +AIK+
Sbjct: 2 ELRVGNR---YRLGRKIGSGSFGDIYLGTDI-------AAGEEVAIKLECV----KTKHP 47
Query: 115 MLSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 174
L E + + I G
Sbjct: 48 QLHIESKIYKMMQGGVGIPTIRWCGAEG-------------------------------- 75
Query: 175 FLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDR 234
+V+E + S + Q++S ++++H +
Sbjct: 76 -------------DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 235 DIIHRDIKAENVFLSVRG---IVKLGDLGFSTKLQQ 267
+ IHRD+K +N + + +V + D G + K +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 67.9 bits (165), Expect = 6e-14
Identities = 28/214 (13%), Positives = 61/214 (28%), Gaps = 64/214 (29%)
Query: 58 LGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLS 117
+G YK+ +G G+F + + +AIK + P+ R
Sbjct: 3 VGVH---YKVGRRIGEGSFGVIFEGTNL-------LNNQQVAIKFEPRRSDAPQLR---- 48
Query: 118 REIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 177
E + + + I
Sbjct: 49 DEYRTYKLLAGCTGI--------------------------------------------- 63
Query: 178 ILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRDII 237
+Y + LV++ + S + Q+L+ V+ +H++ ++
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123
Query: 238 HRDIKAENVFLS-----VRGIVKLGDLGFSTKLQ 266
+RDIK +N + ++ + D G +
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 60.8 bits (146), Expect = 2e-11
Identities = 41/211 (19%), Positives = 71/211 (33%), Gaps = 49/211 (23%)
Query: 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSME 124
Y L +LG G+FSTV +A +++A+KI+ K+ +A + EI ++
Sbjct: 15 YILVRKLGWGHFSTVWLAKDM-------VNNTHVAMKIVRGDKVYTEAAE---DEIKLLQ 64
Query: 125 SVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVL 184
V+ + + + I L
Sbjct: 65 RVNDADNTKEDSMGANH-------------------------------ILKLLDHFNHKG 93
Query: 185 ETFGKIFLVVEYASGGELY-NKITTEGRLSEDDAKIYFLQILSAVKHLH-DRDIIHRDIK 242
+ +V E L K + K Q+L + ++H IIH DIK
Sbjct: 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIK 153
Query: 243 AENVFLSVRGI------VKLGDLGFSTKLQQ 267
ENV + + +K+ DLG + +
Sbjct: 154 PENVLMEIVDSPENLIQIKIADLGNACWYDE 184
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 45.9 bits (108), Expect = 1e-06
Identities = 30/210 (14%), Positives = 54/210 (25%), Gaps = 66/210 (31%)
Query: 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKM-------- 115
+ + +G G S V E + +K + K K
Sbjct: 1 VDAIGKLMGEGKESAVFNCYSEKFGEC--------VVKFHKVGHTSFKKVKEKRDYGDLH 52
Query: 116 LSREIVSMESVHHPNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 175
S + + +L + + YA
Sbjct: 53 FSVLAIRSARNEFRALQKLQGL-------AVPKVYA------------------------ 81
Query: 176 LQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAVKHLHDRD 235
+ +++E ELY ++ IL V + R
Sbjct: 82 -----------WEGNAVLMELIDAKELYRVR-------VENPDEVLDMILEEVAKFYHRG 123
Query: 236 IIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265
I+H D+ NV +S GI + D S ++
Sbjct: 124 IVHGDLSQYNVLVSEEGI-WIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 267 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.98 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.95 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.77 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.55 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.14 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.66 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.52 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.95 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=272.87 Aligned_cols=150 Identities=31% Similarity=0.554 Sum_probs=130.7
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
+++|++++.||+|+||+||+|+++ .+++.||||+++.... ....+.+.+|+.+++.++|||||++++++.+.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~-------~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~ 75 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNR-------VTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREG 75 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred CcceEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence 457999999999999999999997 4568999999976542 23446789999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+|||||++|+|.+++. ..+.+++.++..++
T Consensus 76 ~~~~ivmEy~~gg~L~~~l~----------------------------------------------~~~~l~e~~~~~i~ 109 (271)
T d1nvra_ 76 NIQYLFLEYCSGGELFDRIE----------------------------------------------PDIGMPEPDAQRFF 109 (271)
T ss_dssp TEEEEEEECCTTEEGGGGSB----------------------------------------------TTTBCCHHHHHHHH
T ss_pred ceeEEEEeccCCCcHHHHHh----------------------------------------------cCCCCCHHHHHHHH
Confidence 99999999999877766553 33469999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 110 ~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 110 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 153 (271)
T ss_dssp HHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheee
Confidence 99999999999999999999999999999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-39 Score=273.16 Aligned_cols=153 Identities=27% Similarity=0.485 Sum_probs=135.0
Q ss_pred cCceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeee
Q psy2579 58 LGKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 58 ~~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~ 137 (267)
.++...+|+++++||+|+||.||+|++. .+++.||||+++..... ..+.+.+|+.+++.++|||||+++++
T Consensus 15 ~~dp~~~Y~~~~~iG~G~fg~Vy~a~~~-------~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~ 85 (293)
T d1yhwa1 15 VGDPKKKYTRFEKIGQGASGTVYTAMDV-------ATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDS 85 (293)
T ss_dssp SSCTTTTBCSCEECCCSSSCEEEEEEBT-------TTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCcccccEEEEEEecCcCcEEEEEEEC-------CCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEE
Confidence 3444456999999999999999999986 45689999999765433 24678999999999999999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
+.+.+..|+|||||.+|+|.+++.. .++++.++
T Consensus 86 ~~~~~~~~ivmEy~~gg~L~~~~~~-----------------------------------------------~~l~~~~~ 118 (293)
T d1yhwa1 86 YLVGDELWVVMEYLAGGSLTDVVTE-----------------------------------------------TCMDEGQI 118 (293)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHH-----------------------------------------------SCCCHHHH
T ss_pred EEECCEEEEEEEecCCCcHHHHhhc-----------------------------------------------cCCCHHHH
Confidence 9999999999999999888765532 36899999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.+.
T Consensus 119 ~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~ 167 (293)
T d1yhwa1 119 AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (293)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeec
Confidence 9999999999999999999999999999999999999999999998753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-39 Score=266.79 Aligned_cols=152 Identities=31% Similarity=0.571 Sum_probs=134.6
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch-HHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP-KARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
+++|++.+.||+|+||.||+|+++ .+++.||+|++.+..... .....+.+|+.+++.++|||||++++++.+
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 77 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREK-------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 77 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhHeEEEEEEecCCCcEEEEEEEC-------CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE
Confidence 467999999999999999999987 456899999997654322 335678999999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+|||||.+|+|.+++.. .+++++..+..+
T Consensus 78 ~~~~~ivmEy~~~g~L~~~l~~----------------------------------------------~~~l~e~~~~~i 111 (263)
T d2j4za1 78 ATRVYLILEYAPLGTVYRELQK----------------------------------------------LSKFDEQRTATY 111 (263)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----------------------------------------------HSSCCHHHHHHH
T ss_pred CCEEEEEEeecCCCcHHHHHhh----------------------------------------------cCCCCHHHHHHH
Confidence 9999999999999887766543 346899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 112 ~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 112 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred HHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC
Confidence 9999999999999999999999999999999999999999998754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-39 Score=268.72 Aligned_cols=157 Identities=31% Similarity=0.502 Sum_probs=131.4
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
+.++|++++.||+|+||.||+|+++ .+++.||||++.....++...+.+.+|+.+++.++|||||++++++.+
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 74 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRK-------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 74 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred CchhCEEeEEEecCCCeEEEEEEEC-------CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence 3467999999999999999999987 456899999998887777777889999999999999999999999864
Q ss_pred --cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 141 --FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 141 --~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
.+.+|+|||||++|+|.+++... ......+++..++
T Consensus 75 ~~~~~~~ivmEy~~~g~L~~~i~~~------------------------------------------~~~~~~l~e~~~~ 112 (269)
T d2java1 75 RTNTTLYIVMEYCEGGDLASVITKG------------------------------------------TKERQYLDEEFVL 112 (269)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHH------------------------------------------HHHTCCCCHHHHH
T ss_pred CCCCEEEEEEecCCCCcHHHHHHhc------------------------------------------cccCCCCCHHHHH
Confidence 46689999999999988776532 1133579999999
Q ss_pred HHHHHHHHHHHHHHhCC-----CcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 219 IYFLQILSAVKHLHDRD-----IIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~-----ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.++.|++.||+|||++| |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 113 ~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 113 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp HHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred HHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 99999999999999976 9999999999999999999999999998653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-38 Score=269.22 Aligned_cols=150 Identities=23% Similarity=0.406 Sum_probs=133.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||+||+|.+. .+++.||||+++..... .+.+.+|+.+++.++|||||+++++|.+.+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEG-------GGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEC-------CCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 46999999999999999999987 45589999999765432 356899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|++||||++|+|.+++... ....+++..+..++.
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~--------------------------------------------~~~~~~~~~~~~i~~ 122 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLREC--------------------------------------------NRQEVSAVVLLYMAT 122 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHS--------------------------------------------CTTTSCHHHHHHHHH
T ss_pred eeEEEeecccCcchHHHhhhc--------------------------------------------cccchHHHHHHHHHH
Confidence 999999999999988877543 123689999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 123 qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 123 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred HHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecC
Confidence 99999999999999999999999999999999999999998753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-39 Score=270.58 Aligned_cols=149 Identities=30% Similarity=0.500 Sum_probs=132.7
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+.|++++.||+|+||.||+|++. .++..||||+++... ....+.+.+|+.+++.++|||||++++++.+.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNK-------ETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCeEEeEEEeeCCCcEEEEEEEC-------CCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 35999999999999999999987 456899999997653 334567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+|||||.+|+|.+++... .+++++.++..++.
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~---------------------------------------------~~~l~e~~~~~i~~ 117 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLEL---------------------------------------------ERPLTESQIQVVCK 117 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHH---------------------------------------------TSCCCHHHHHHHHH
T ss_pred eEEEEEecCCCCcHHHHHHhc---------------------------------------------CCCCCHHHHHHHHH
Confidence 999999999998887665432 23699999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 118 qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 118 QTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp HHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhcc
Confidence 9999999999999999999999999999999999999999754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-38 Score=267.70 Aligned_cols=155 Identities=25% Similarity=0.387 Sum_probs=128.6
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.+.|++.+.||+|+||+||+|.++.++ .....||||.+.... +....+.+.+|+.+|+.++|||||++++++...
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPG----KREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC-------CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCC----CEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 456999999999999999999987443 223468999986543 455667899999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+|||||.+|+|.+++... .+.+++.++..++
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~---------------------------------------------~~~l~~~~~~~i~ 134 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQN---------------------------------------------DGQFTVIQLVGML 134 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTT---------------------------------------------TTCSCHHHHHHHH
T ss_pred CEEEEEEEecCCCcceeeeccc---------------------------------------------cCCCCHHHHHHHH
Confidence 9999999999998887766532 2368999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 135 ~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 135 RGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred HHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999999999999999999999999999999999998654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.9e-38 Score=272.15 Aligned_cols=154 Identities=32% Similarity=0.572 Sum_probs=134.7
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
+...+.|++++.||+|+||.||+|++. .+++.||||+++... ......+.+|+.+++.++|||||+++++|
T Consensus 25 ~~~~d~Y~i~~~lG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~ 95 (352)
T d1koba_ 25 GSVYDYYDILEELGSGAFGVVHRCVEK-------ATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAF 95 (352)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEE
T ss_pred CCcccceEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 344567999999999999999999986 456899999997653 33456788999999999999999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
.+.+..|+|||||.+|+|.+.+... ..++++.+++
T Consensus 96 ~~~~~~~ivmE~~~gg~L~~~~~~~---------------------------------------------~~~l~e~~~~ 130 (352)
T d1koba_ 96 EDKYEMVLILEFLSGGELFDRIAAE---------------------------------------------DYKMSEAEVI 130 (352)
T ss_dssp ECSSEEEEEEECCCCCBHHHHTTCT---------------------------------------------TCCBCHHHHH
T ss_pred EECCEEEEEEEcCCCChHHHHHHhc---------------------------------------------CCCCCHHHHH
Confidence 9999999999999998887655432 2369999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEee--cCCceEEeccccccccC
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLS--VRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~--~~~~~kl~DFGla~~l~ 266 (267)
.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+.+.
T Consensus 131 ~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 131 NYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence 9999999999999999999999999999997 56899999999998764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-38 Score=266.59 Aligned_cols=150 Identities=27% Similarity=0.384 Sum_probs=133.4
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.|++++.||+|+||.||+|++. .+++.||||+++..... ....+.+.+|+.+++.++|||||++++++.+.+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 88 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDV-------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEET-------TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred hcEeeEEEecCCCeEEEEEEEC-------CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC
Confidence 4999999999999999999986 45689999999876543 345677999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+|||||.+|++...+. ...++++.++..++.
T Consensus 89 ~~~iv~E~~~~g~l~~~~~----------------------------------------------~~~~l~e~~~~~i~~ 122 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEV----------------------------------------------HKKPLQEVEIAAVTH 122 (309)
T ss_dssp EEEEEEECCSEEHHHHHHH----------------------------------------------HTSCCCHHHHHHHHH
T ss_pred EEEEEEEecCCCchHHHHH----------------------------------------------hCCCCCHHHHHHHHH
Confidence 9999999999877754332 334799999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
|++.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 123 qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 123 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp HHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred HHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 99999999999999999999999999999999999999998653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-38 Score=271.73 Aligned_cols=149 Identities=27% Similarity=0.437 Sum_probs=133.3
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++++.||+|+||+||+|++. .+++.||+|+++... .+.....+.+|+.+++.++|||||+++++|.+.+
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~-------~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 77 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHK-------PSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 77 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEET-------TTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred cCCEEEEEEecCCCeEEEEEEEC-------CCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 56999999999999999999986 556899999997643 4455678999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+|||||.+|+|.+++.+ .+.+++..+..++.
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~----------------------------------------------~~~l~~~~~~~~~~ 111 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKK----------------------------------------------AGRIPEQILGKVSI 111 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHH----------------------------------------------HSSCCHHHHHHHHH
T ss_pred EEEEEEEcCCCCcHHHHHhh----------------------------------------------cCCCCHHHHHHHHH
Confidence 99999999999888766643 34689999999999
Q ss_pred HHHHHHHHHHh-CCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHD-RDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 112 qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 112 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp HHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred HHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 99999999997 59999999999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-38 Score=264.57 Aligned_cols=148 Identities=25% Similarity=0.395 Sum_probs=130.3
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||.||+|++. ..||||+++....+....+.+.+|+.+++.++|||||++++++..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~----------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~- 75 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH----------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA- 75 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS----------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC----------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-
Confidence 356999999999999999999764 459999998777677778889999999999999999999998754
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..++|||||++|+|.+++... ..++++..+..++
T Consensus 76 ~~~~lv~Ey~~~g~L~~~l~~~---------------------------------------------~~~~~~~~~~~i~ 110 (276)
T d1uwha_ 76 PQLAIVTQWCEGSSLYHHLHII---------------------------------------------ETKFEMIKLIDIA 110 (276)
T ss_dssp SSCEEEEECCCEEEHHHHHHTS---------------------------------------------CCCCCHHHHHHHH
T ss_pred cEEEEEEecCCCCCHHHHHhhc---------------------------------------------cCCCCHHHHHHHH
Confidence 5678999999988887766532 2368999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++|||||||||+|||++.++.+||+|||+|+.+
T Consensus 111 ~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 111 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred HHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeec
Confidence 99999999999999999999999999999999999999999765
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-37 Score=269.33 Aligned_cols=153 Identities=27% Similarity=0.550 Sum_probs=134.7
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
..+++|++.+.||+|+||.||+|+++ .+++.||||++.... ....+.+.+|+.+++.++|||||++++++.
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~-------~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 93 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTER-------ATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEET-------TTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 34567999999999999999999987 456899999997653 344577899999999999999999999999
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
+.+..|+|||||.+|+|.+++... .+++++..+..
T Consensus 94 ~~~~~~ivmE~~~gg~L~~~l~~~---------------------------------------------~~~l~e~~~~~ 128 (350)
T d1koaa2 94 DDNEMVMIYEFMSGGELFEKVADE---------------------------------------------HNKMSEDEAVE 128 (350)
T ss_dssp ETTEEEEEECCCCSCBHHHHHTCT---------------------------------------------TSCBCHHHHHH
T ss_pred ECCEEEEEEEcCCCCCHHHHHHhh---------------------------------------------cCCCCHHHHHH
Confidence 999999999999998887766432 23699999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeec--CCceEEeccccccccC
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSV--RGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~--~~~~kl~DFGla~~l~ 266 (267)
++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.+.
T Consensus 129 i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 129 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 9999999999999999999999999999964 5789999999998764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-38 Score=265.78 Aligned_cols=151 Identities=32% Similarity=0.505 Sum_probs=133.6
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||.||+|++. .+++.||||++...... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 80 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLAREL-------ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 80 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS
T ss_pred CCCEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC
Confidence 56999999999999999999986 45689999999765432 23356789999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+|||||.+|+|.+++. ..+.+++..+..++
T Consensus 81 ~~~~ivmEy~~gg~L~~~~~----------------------------------------------~~~~l~e~~~~~~~ 114 (288)
T d1uu3a_ 81 EKLYFGLSYAKNGELLKYIR----------------------------------------------KIGSFDETCTRFYT 114 (288)
T ss_dssp SEEEEEECCCTTEEHHHHHH----------------------------------------------HHSSCCHHHHHHHH
T ss_pred CEEEEEEEccCCCCHHHhhh----------------------------------------------ccCCCCHHHHHHHH
Confidence 99999999999877766554 34579999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 115 ~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 115 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred HHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecc
Confidence 999999999999999999999999999999999999999998653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-37 Score=267.58 Aligned_cols=151 Identities=30% Similarity=0.508 Sum_probs=134.3
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
+++|++++.||+|+||.||+|++. .+++.||||++++.... ......+.+|+.+|+.++||||+++++++.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~-------~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREK-------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred hHhcEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence 467999999999999999999987 55689999999765432 2335678899999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+.+|+|||||.+|+|..++. ..+.+++..++.+
T Consensus 77 ~~~~~iv~ey~~gg~L~~~~~----------------------------------------------~~~~~~e~~~~~~ 110 (337)
T d1o6la_ 77 HDRLCFVMEYANGGELFFHLS----------------------------------------------RERVFTEERARFY 110 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHH----------------------------------------------HHSCCCHHHHHHH
T ss_pred ccccccceeccCCCchhhhhh----------------------------------------------cccCCcHHHHHHH
Confidence 999999999999977766554 3457899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 111 ~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred HHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccc
Confidence 999999999999999999999999999999999999999999865
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-37 Score=257.72 Aligned_cols=148 Identities=23% Similarity=0.391 Sum_probs=126.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|++. ++..||||+++...... +.+.+|+.+++.++|||||++++++...+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~--------~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL--------NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA 73 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET--------TTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC--------CCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCC
Confidence 45999999999999999999874 34679999997654333 56899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+|||||++|+|.+++... ...+++..+..++.
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~---------------------------------------------~~~~~~~~~~~i~~ 108 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQ---------------------------------------------RGLFAAETLLGMCL 108 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTT---------------------------------------------TTCCCHHHHHHHHH
T ss_pred ceEEEEEecCCCcHHHHhhcc---------------------------------------------ccCCCHHHHHHHHH
Confidence 999999999998888776543 23688999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
|++.||+|+|+++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 109 qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 109 DVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 152 (263)
T ss_dssp HHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred HHHHHHHhhhccceeecccchhheeecCCCCeEecccchheecc
Confidence 99999999999999999999999999999999999999998653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-37 Score=257.11 Aligned_cols=148 Identities=34% Similarity=0.523 Sum_probs=128.5
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec---
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF--- 141 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~--- 141 (267)
|++.++||+|+||+||+|.+. .++..||+|.+.....+....+.+.+|+.+++.++|||||+++++|.+.
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~-------~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 83 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDT-------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred EEeeeEEecCcCcEEEEEEEC-------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecccc
Confidence 578889999999999999986 4568999999988776777778899999999999999999999998752
Q ss_pred -CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 142 -GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 142 -~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
+.+|+|||||++|+|.+++. ....+++..+..+
T Consensus 84 ~~~~~ivmE~~~~g~L~~~l~----------------------------------------------~~~~~~~~~~~~~ 117 (270)
T d1t4ha_ 84 KKCIVLVTELMTSGTLKTYLK----------------------------------------------RFKVMKIKVLRSW 117 (270)
T ss_dssp CEEEEEEEECCCSCBHHHHHH----------------------------------------------HHSSCCHHHHHHH
T ss_pred CCEEEEEEeCCCCCcHHHHHh----------------------------------------------ccccccHHHHHHH
Confidence 45778888888777665554 3457899999999
Q ss_pred HHHHHHHHHHHHhCC--CcccCCCCCcEEee-cCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRD--IIHRDIKAENVFLS-VRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DFGla~~l 265 (267)
+.|++.||+|||++| |+||||||+|||++ .++.+||+|||+|+..
T Consensus 118 ~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 118 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp HHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred HHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999999999 99999999999996 5789999999999854
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-37 Score=265.07 Aligned_cols=152 Identities=30% Similarity=0.555 Sum_probs=133.9
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
+.+|++++.||+|+||+||+|+++ .+++.||||+++..... ....+.+.+|+.+++.++|||||++++++.+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 75 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSR-------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD 75 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred hhHeEEEEEEecCcCcEEEEEEEC-------CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee
Confidence 467999999999999999999986 45689999999765432 2335678999999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+|||||.||++...+. ....+++..+..+
T Consensus 76 ~~~~~ivmE~~~gg~l~~~~~----------------------------------------------~~~~~~~~~~~~~ 109 (316)
T d1fota_ 76 AQQIFMIMDYIEGGELFSLLR----------------------------------------------KSQRFPNPVAKFY 109 (316)
T ss_dssp SSEEEEEECCCCSCBHHHHHH----------------------------------------------HTSSCCHHHHHHH
T ss_pred CCeeeeEeeecCCcccccccc----------------------------------------------ccccccccHHHHH
Confidence 999999999999877765554 3446888899999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.+.
T Consensus 110 ~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 110 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp HHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred HHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEec
Confidence 9999999999999999999999999999999999999999998764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.8e-37 Score=257.16 Aligned_cols=151 Identities=34% Similarity=0.511 Sum_probs=134.0
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-------hHHHHHHHHHHHHHhhcC-CCceeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-------PKARKMLSREIVSMESVH-HPNIIRL 134 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~Ei~~l~~l~-hpnIv~~ 134 (267)
++|++.+.||+|+||+||+|++. .+++.||||+++..... ....+.+.+|+.+++.++ ||||+++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~-------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 75 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHK-------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 75 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred ccCEEceEEecCcCeEEEEEEEC-------CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEE
Confidence 56999999999999999999986 45689999999765432 223467889999999996 9999999
Q ss_pred eeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCCh
Q psy2579 135 YEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214 (267)
Q Consensus 135 ~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~ 214 (267)
++++.+++..|+|||||++|||.+++. ..+++++
T Consensus 76 ~~~~~~~~~~~ivmE~~~~g~L~~~l~----------------------------------------------~~~~l~e 109 (277)
T d1phka_ 76 KDTYETNTFFFLVFDLMKKGELFDYLT----------------------------------------------EKVTLSE 109 (277)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHH----------------------------------------------HHSSCCH
T ss_pred EeecccCcceEEEEEcCCCchHHHHHH----------------------------------------------hcCCCCH
Confidence 999999999999999999988876664 3347999
Q ss_pred hHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 110 ~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 110 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 9999999999999999999999999999999999999999999999998754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-37 Score=261.51 Aligned_cols=150 Identities=25% Similarity=0.472 Sum_probs=131.6
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|++.+.||+|+||+||+|.+. .+++.||||+++... .....+.+|+.+|+.++|||||+++++|.+.
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~-------~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVET-------SSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred ccceEEEEEEecCCCeEEEEEEEC-------CCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 466999999999999999999987 456899999997653 3335688999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+|||||.+|+|.+++... ..++++.++..++
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~---------------------------------------------~~~l~e~~~~~i~ 108 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTS---------------------------------------------AFELNEREIVSYV 108 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSS---------------------------------------------SCCCCHHHHHHHH
T ss_pred CEEEEEEecCCCCcHHHHHHhc---------------------------------------------CCCCCHHHHHHHH
Confidence 9999999999998887766432 2368999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecC--CceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVR--GIVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~--~~~kl~DFGla~~l~ 266 (267)
.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 109 ~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 109 HQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp HHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 999999999999999999999999999854 489999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-37 Score=257.03 Aligned_cols=152 Identities=28% Similarity=0.446 Sum_probs=129.2
Q ss_pred cceEEec-ccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 63 ALYKLQN-ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~-~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.+|.+.+ +||+|+||.||+|.++.. .++..||||+++... .....+.+.+|+.+++.++|||||++++++.+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~-----~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMR-----KKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC--------CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred cCeEECCcEEecccCeEEEEEEEecC-----CCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence 4588888 499999999999988632 234689999997653 45566789999999999999999999999865
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+|||||++|+|.+++... ...+++..+..++
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~---------------------------------------------~~~l~~~~~~~i~ 115 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGK---------------------------------------------REEIPVSNVAELL 115 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTC---------------------------------------------TTTSCHHHHHHHH
T ss_pred CeEEEEEEeCCCCcHHHHhhcc---------------------------------------------ccCCCHHHHHHHH
Confidence 5688999999998887765432 2368999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 116 ~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 116 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp HHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred HHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999999999999999999999999999999999998653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-37 Score=262.53 Aligned_cols=149 Identities=34% Similarity=0.598 Sum_probs=121.5
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+.|++.+.||+|+||+||+|+++ .+++.||||++...... .....+.+|+.+++.++|||||++++++.+.+
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDK-------RTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGG 80 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEET-------TTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cceEEEEEEeeccCeEEEEEEEC-------CCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 45999999999999999999986 45689999999765533 23456889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+|||||++|+|.+++. ..+.+++.++..++.
T Consensus 81 ~~~lvmE~~~gg~L~~~l~----------------------------------------------~~~~l~e~~~~~~~~ 114 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIV----------------------------------------------EKGFYTERDASRLIF 114 (307)
T ss_dssp EEEEEECCCCSCBHHHHHH----------------------------------------------TCSCCCHHHHHHHHH
T ss_pred EEEEEEeccCCCcHHHhhh----------------------------------------------cccCCCHHHHHHHHH
Confidence 9999999999888776664 334799999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEee---cCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLS---VRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~---~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++||+||||||+|||+. .++.+||+|||+|+.+
T Consensus 115 qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 115 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred HHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999999999999999999994 4789999999999865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-37 Score=257.11 Aligned_cols=148 Identities=26% Similarity=0.434 Sum_probs=128.4
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.++ ++..||||+++..... .+.+.+|+.+++.++|||||++++++.. +
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~--------~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN--------GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET--------TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred HHeEEeEEEecCCCcEEEEEEEC--------CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 56999999999999999999873 3478999999765433 3568999999999999999999998754 5
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+|||||++|+|.+++... ...++++..+..++.
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~--------------------------------------------~~~~l~~~~~~~i~~ 116 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTP--------------------------------------------SGIKLTINKLLDMAA 116 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSH--------------------------------------------HHHTCCHHHHHHHHH
T ss_pred CeEEEEEeCCCCcHHHHHhhc--------------------------------------------CCCCCCHHHHHHHHH
Confidence 678999999998887765432 122589999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 117 qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp HHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred HHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 99999999999999999999999999999999999999998764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.5e-37 Score=265.40 Aligned_cols=155 Identities=29% Similarity=0.534 Sum_probs=136.1
Q ss_pred CceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeee
Q psy2579 59 GKRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 59 ~~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~ 137 (267)
...+++|++++.||+|+||.||+|+++ .+++.||||+++..... ....+.+.+|+.+++.++|||||+++++
T Consensus 37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~-------~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~ 109 (350)
T d1rdqe_ 37 TAQLDQFDRIKTLGTGSFGRVMLVKHK-------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCCccCeEEEEEeecCcCcEEEEEEEC-------CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccc
Confidence 334678999999999999999999987 45689999999764432 2335678999999999999999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
+...+..++|||++.+|+|...+. ..+.+++..+
T Consensus 110 ~~~~~~~~~v~e~~~~g~l~~~l~----------------------------------------------~~~~l~e~~~ 143 (350)
T d1rdqe_ 110 FKDNSNLYMVMEYVAGGEMFSHLR----------------------------------------------RIGRFSEPHA 143 (350)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHH----------------------------------------------HHCCCCHHHH
T ss_pred cccccccccccccccccchhhhHh----------------------------------------------hcCCCCHHHH
Confidence 999999999999999877766554 3347899999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 144 ~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred HHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 9999999999999999999999999999999999999999999998764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-37 Score=261.40 Aligned_cols=151 Identities=24% Similarity=0.407 Sum_probs=127.9
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|+++++||+|+||.||+|.+. .+++.||||+++...........+.+|+.+++.++|||||+++++|.+.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~ 74 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 74 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCEeccEEecCcCeEEEEEEEC-------CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc
Confidence 57999999999999999999997 45689999999766544444578899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+|||+|.++.+...... ....+++..+..++.
T Consensus 75 ~~~iv~e~~~~~~~~~~~~~---------------------------------------------~~~~l~e~~~~~~~~ 109 (298)
T d1gz8a_ 75 KLYLVFEFLHQDLKKFMDAS---------------------------------------------ALTGIPLPLIKSYLF 109 (298)
T ss_dssp EEEEEEECCSEEHHHHHHHT---------------------------------------------TTTCCCHHHHHHHHH
T ss_pred ceeEEEeecCCchhhhhhhh---------------------------------------------cccCCCHHHHHHHHH
Confidence 99999999976444322211 234699999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++|||||||||+|||++.++.+||+|||+|+..
T Consensus 110 qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 110 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF 152 (298)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred HHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceec
Confidence 9999999999999999999999999999999999999999754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-37 Score=257.92 Aligned_cols=151 Identities=32% Similarity=0.543 Sum_probs=132.7
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch----HHHHHHHHHHHHHhhcCCCceeeeeeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP----KARKMLSREIVSMESVHHPNIIRLYEVL 138 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~Ei~~l~~l~hpnIv~~~~~~ 138 (267)
++|++.+.||+|+||+||+|+++ .+++.||||++++..... ...+.+.+|+.+++.++|||||+++++|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~-------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~ 82 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREK-------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY 82 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEEC-------CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 45999999999999999999986 556899999997654322 2357789999999999999999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
.+.+..|+|||||++|+|.+++.. .+++++..++
T Consensus 83 ~~~~~~~iv~E~~~gg~L~~~i~~----------------------------------------------~~~l~~~~~~ 116 (293)
T d1jksa_ 83 ENKTDVILILELVAGGELFDFLAE----------------------------------------------KESLTEEEAT 116 (293)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHH----------------------------------------------HSSCCHHHHH
T ss_pred EECCEEEEEEEcCCCccccchhcc----------------------------------------------ccccchhHHH
Confidence 999999999999999888766643 3469999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC----ceEEeccccccccC
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG----IVKLGDLGFSTKLQ 266 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~----~~kl~DFGla~~l~ 266 (267)
.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 117 ~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred HHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 9999999999999999999999999999998776 59999999998754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-36 Score=255.00 Aligned_cols=154 Identities=26% Similarity=0.350 Sum_probs=129.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
+.|++.+.||+|+||.||+|.++.++. .....||||.+.... +......+.+|+.+++.++|||||++++++...+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~---~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSG---KKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC------CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCC---EEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 459999999999999999999874331 223579999997554 4455667999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++||+|.+|++.+.+... ...+++.++..++.
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~---------------------------------------------~~~~~~~~~~~i~~ 117 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREK---------------------------------------------DGEFSVLQLVGMLR 117 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHT---------------------------------------------TTCSCHHHHHHHHH
T ss_pred ceEEEEEecccCcchhhhhcc---------------------------------------------cccccHHHHHHHHH
Confidence 999999999998887655432 24689999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 118 ~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 118 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred HHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999999999999999999999999999999999865
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-36 Score=260.67 Aligned_cols=177 Identities=23% Similarity=0.348 Sum_probs=133.7
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||+||+|++...... .....||+|.+.... .......+.+|+.+++.+ +|||||++++++.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKT--GVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSS--SCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcc--cceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 5699999999999999999998743311 223579999986543 334456789999999998 899999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+|||||++|+|.+++.............+ .. ............+++..++.++
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~----------------------~~-~~~~~~~~~~~~l~~~~~~~i~ 170 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY----------------------EN-QKRLEEEEDLNVLTFEDLLCFA 170 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC--------------------------------------------CCHHHHHHHH
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhh----------------------cc-ccccccccccCCCCHHHHHHHH
Confidence 999999999999999999987643221111000 00 0001111123468999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 171 ~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~ 214 (325)
T d1rjba_ 171 YQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214 (325)
T ss_dssp HHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCG
T ss_pred HHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccc
Confidence 99999999999999999999999999999999999999999865
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-36 Score=253.91 Aligned_cols=146 Identities=29% Similarity=0.457 Sum_probs=123.8
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecCeEEEEE
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFGKIFLVV 148 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~~~iv~ 148 (267)
++||+|+||.||+|.++.. .+++.||||+++....++...+.+.+|+.++++++|||||++++++.. +..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMK-----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECS-----SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccC-----CcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEE
Confidence 4699999999999987632 345789999998766566667889999999999999999999999865 4578999
Q ss_pred eecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHHHHHHH
Q psy2579 149 EYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILSAV 228 (267)
Q Consensus 149 e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~L 228 (267)
|||++|+|.+++.. ..++++..+..++.|++.||
T Consensus 87 E~~~~g~L~~~l~~----------------------------------------------~~~l~~~~~~~i~~qi~~gl 120 (277)
T d1xbba_ 87 EMAELGPLNKYLQQ----------------------------------------------NRHVKDKNIIELVHQVSMGM 120 (277)
T ss_dssp ECCTTEEHHHHHHH----------------------------------------------CTTCCHHHHHHHHHHHHHHH
T ss_pred EcCCCCcHHHHHhh----------------------------------------------ccCCCHHHHHHHHHHHHHHH
Confidence 99998887766543 34689999999999999999
Q ss_pred HHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 229 KHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 229 ~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 121 ~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 158 (277)
T ss_dssp HHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred hhHHhCCcccCCCcchhhcccccCcccccchhhhhhcc
Confidence 99999999999999999999999999999999998653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-36 Score=250.41 Aligned_cols=148 Identities=25% Similarity=0.419 Sum_probs=131.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.++||+|+||+||+|+++ ++..||||+++...... +.+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~--------~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR--------GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET--------TTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred HHCEEeEEEecCCCeEEEEEEEC--------CCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence 46999999999999999999974 34789999998765443 56899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..++||||+++|++.+++... ...+++..+..++.
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~---------------------------------------------~~~~~~~~~~~i~~ 107 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREM---------------------------------------------RHRFQTQQLLEMCK 107 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSG---------------------------------------------GGCCCHHHHHHHHH
T ss_pred ceEEEEEccCCCcHHHhhhcc---------------------------------------------ccCCcHHHHHHHHH
Confidence 999999999998887765432 23688999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
|++.||+|||++||+||||||+||+++.++.+||+|||+|+.+.
T Consensus 108 qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 108 DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp HHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred HHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheecc
Confidence 99999999999999999999999999999999999999998654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.4e-36 Score=261.72 Aligned_cols=152 Identities=24% Similarity=0.444 Sum_probs=129.5
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchH-HHHHHH---HHHHHHhhcCCCceeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPK-ARKMLS---REIVSMESVHHPNIIRLYEV 137 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~---~Ei~~l~~l~hpnIv~~~~~ 137 (267)
+++|++.+.||+|+||.||+|++. .+++.||||++........ ....+. +|+.+++.++|||||+++++
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~-------~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~ 75 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKA-------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA 75 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEEC-------CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEE
Confidence 467999999999999999999986 5568999999975443221 122333 45777778899999999999
Q ss_pred eeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 138 LETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 138 ~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
+.+.+..|+|||||.+|+|.+++.. ...+++..+
T Consensus 76 ~~~~~~~~ivmE~~~gg~L~~~l~~----------------------------------------------~~~~~e~~~ 109 (364)
T d1omwa3 76 FHTPDKLSFILDLMNGGDLHYHLSQ----------------------------------------------HGVFSEADM 109 (364)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHH----------------------------------------------HCSCCHHHH
T ss_pred EEECCEEEEEEEecCCCcHHHHHHh----------------------------------------------cccccHHHH
Confidence 9999999999999999888766643 346889999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.+.
T Consensus 110 ~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 110 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred HHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999999999999999999999999999999999998764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-36 Score=249.32 Aligned_cols=153 Identities=27% Similarity=0.418 Sum_probs=124.5
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+...+ ..+..||||.++... .....+.+.+|+.+++.++|||||++++++. .+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~----~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPE----NPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC------CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCC----ceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 46999999999999999999986433 334678999986543 4455678999999999999999999999985 56
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+|||||.+|++.+++... ...+++..+..++.
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~---------------------------------------------~~~l~~~~~~~~~~ 115 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVR---------------------------------------------KYSLDLASLILYAY 115 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHT---------------------------------------------TTTSCHHHHHHHHH
T ss_pred eEEEEEEeccCCcHHhhhhcc---------------------------------------------CCCCCHHHHHHHHH
Confidence 789999999988887655432 33689999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
|++.||.|||++|++||||||+||+++.++.+||+|||+|+.+.
T Consensus 116 qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 116 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred HHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 99999999999999999999999999999999999999998653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.9e-36 Score=253.32 Aligned_cols=149 Identities=28% Similarity=0.454 Sum_probs=132.0
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|+++++||+|+||+||+|++. +++.||||+++..........++.+|+.+++.++||||+++++++...+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~--------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 73 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN--------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK 73 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET--------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS
T ss_pred CCceeccEEecCCCcEEEEEEeC--------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC
Confidence 57999999999999999999873 3588999999876655545678999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++||++.++.+.... ...+.+++..+..++.
T Consensus 74 ~~~i~~e~~~~~~~~~~~----------------------------------------------~~~~~l~~~~~~~i~~ 107 (286)
T d1ob3a_ 74 RLVLVFEHLDQDLKKLLD----------------------------------------------VCEGGLESVTAKSFLL 107 (286)
T ss_dssp CEEEEEECCSEEHHHHHH----------------------------------------------TSTTCCCHHHHHHHHH
T ss_pred ceeEEEEeehhhhHHHHH----------------------------------------------hhcCCcchhhhHHHHH
Confidence 999999999875554433 3345799999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++||+||||||+|||++.++.+||+|||+|..+
T Consensus 108 qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 108 QLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF 150 (286)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred HHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceec
Confidence 9999999999999999999999999999999999999998764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-36 Score=251.00 Aligned_cols=147 Identities=26% Similarity=0.412 Sum_probs=127.2
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|++. .+..||||+++..... .+.+.+|+.+++.++|||||++++++. .+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~--------~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~ 84 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWN--------GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS-EE 84 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--------TTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred HHEEEeeEEeeCCCeEEEEEEEC--------CCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEe-cC
Confidence 56999999999999999999884 2356999999765443 356899999999999999999999985 45
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..|+|||||++|+|..++... ....+++.++..++.
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~--------------------------------------------~~~~l~~~~~~~i~~ 120 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGE--------------------------------------------TGKYLRLPQLVDMAA 120 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHH--------------------------------------------HHTTCCHHHHHHHHH
T ss_pred CeEEEEEecCCCchhhhhhhc--------------------------------------------ccccchHHHHHHHHH
Confidence 688999999998887766532 223689999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 121 ~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 121 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred HHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 9999999999999999999999999999999999999999865
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-35 Score=250.84 Aligned_cols=180 Identities=21% Similarity=0.276 Sum_probs=139.4
Q ss_pred eecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee
Q psy2579 61 RVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET 140 (267)
Q Consensus 61 ~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~ 140 (267)
+.++|++++.||+|+||.||+|++..... ..+++.||||+++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~--~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLP--YEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSST--TSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCcc--CCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 34569999999999999999999853211 1345789999997543 45567789999999999999999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..+++||++++|+|.+++.............. ... ............+++..+..+
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~---------------------~~~-~~~~~~~~~~~~l~~~~~~~i 145 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS---------------------DLS-TRARVSSPGPPPLSCAEQLCI 145 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC--------------------------------------------CCCCHHHHHHH
T ss_pred CCceEEEEEecCCCcHHHHHHhcCcccccccccc---------------------ccc-hhhhccccCCCCCCHHHHHHH
Confidence 9999999999999999999976543221110000 000 000011122346899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||+|||++++|||||||+|||++.++.+||+|||+|+.+
T Consensus 146 ~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~ 190 (301)
T d1lufa_ 146 ARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190 (301)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHH
T ss_pred HHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheec
Confidence 999999999999999999999999999999999999999999754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-36 Score=253.49 Aligned_cols=147 Identities=28% Similarity=0.400 Sum_probs=123.1
Q ss_pred EecccCccCceeEEEeEEeecccccccccceEEEEeecccccch---HHHHHHHHHHHHHhhcCCCceeeeeeeeeecCe
Q psy2579 67 LQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP---KARKMLSREIVSMESVHHPNIIRLYEVLETFGK 143 (267)
Q Consensus 67 ~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~~ 143 (267)
.++.||+|+||+||+|++. .+++.||||+++...... .....+.+|+.+++.++|||||++++++...+.
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~ 74 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDK-------NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 74 (299)
T ss_dssp EEEEEEEETTEEEEEEECS-------SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred cceEeccCcCeEEEEEEEC-------CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCc
Confidence 4678999999999999987 456899999997654322 123568899999999999999999999999999
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.|+|||||.++++.... .....+++..+..++.|
T Consensus 75 ~~ivmE~~~~~~~~~~~----------------------------------------------~~~~~l~~~~~~~~~~q 108 (299)
T d1ua2a_ 75 ISLVFDFMETDLEVIIK----------------------------------------------DNSLVLTPSHIKAYMLM 108 (299)
T ss_dssp CEEEEECCSEEHHHHHT----------------------------------------------TCCSSCCSSHHHHHHHH
T ss_pred eeehhhhhcchHHhhhh----------------------------------------------hcccCCCHHHHHHHHHH
Confidence 99999999886654333 23446899999999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
++.||+|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 109 il~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 109 TLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 151 (299)
T ss_dssp HHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred HHHHHHHhhccceecccCCcceEEecCCCccccccCccccccC
Confidence 9999999999999999999999999999999999999998654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-35 Score=248.64 Aligned_cols=154 Identities=31% Similarity=0.486 Sum_probs=123.6
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.+|++++.||+|+||.||+|++.... .....||||+++..... .+..+.+.+|+.+++.++||||+++++++.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~----~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPS----GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTT----SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCC----CcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence 45999999999999999999886432 23457999999776543 3456789999999999999999999999976
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..++|||||++|++.+.+... ...+++..+..++
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~---------------------------------------------~~~l~~~~~~~~~ 117 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKH---------------------------------------------QGHFLLGTLSRYA 117 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHH---------------------------------------------GGGSCHHHHHHHH
T ss_pred cchheeeeeecCcchhhhhhcc---------------------------------------------cCCCCHHHHHHHH
Confidence 4678999999998887655432 2368999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.|++.||.|||++||+||||||+||+++.++.+||+|||+|+.+.
T Consensus 118 ~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 118 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp HHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred HHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 999999999999999999999999999999999999999998763
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-35 Score=252.54 Aligned_cols=150 Identities=26% Similarity=0.466 Sum_probs=129.7
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHh-hcCCCceeeeeeeeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSME-SVHHPNIIRLYEVLET 140 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~-~l~hpnIv~~~~~~~~ 140 (267)
.+|++.+.||+|+||+||+|.+. .+++.||||++++.... ....+.+.+|+.++. .++|||||++++++.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~-------~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~ 74 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFK-------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 74 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCeEEeeEEecCCCcEEEEEEEC-------CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc
Confidence 56999999999999999999987 45699999999764322 223455667777665 6899999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+|||||++|+|.+++.. ...+++.++..+
T Consensus 75 ~~~~yivmEy~~~g~L~~~i~~----------------------------------------------~~~~~e~~~~~~ 108 (320)
T d1xjda_ 75 KENLFFVMEYLNGGDLMYHIQS----------------------------------------------CHKFDLSRATFY 108 (320)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----------------------------------------------HSSCCHHHHHHH
T ss_pred CCceeEEEeecCCCcHHHHhhc----------------------------------------------cCCCCHHHHHHH
Confidence 9999999999999888766643 346889999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||+|||++|++||||||+|||++.++.+||+|||+|+.+
T Consensus 109 ~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 109 AAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred HHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhc
Confidence 999999999999999999999999999999999999999999865
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-35 Score=247.99 Aligned_cols=151 Identities=25% Similarity=0.407 Sum_probs=135.7
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|+++++||+|+||+||+|++. .+++.||||+++..........++.+|+.+++.++||||+++++++...+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 74 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNR-------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCEeeeEEecCcCeEEEEEEEC-------CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc
Confidence 57999999999999999999986 45689999999877656667788999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++++++.++++..++. ..+.+++..+..++.
T Consensus 75 ~~~iv~~~~~~~~l~~~~~----------------------------------------------~~~~~~~~~~~~~~~ 108 (292)
T d1unla_ 75 KLTLVFEFCDQDLKKYFDS----------------------------------------------CNGDLDPEIVKSFLF 108 (292)
T ss_dssp EEEEEEECCSEEHHHHHHH----------------------------------------------TTTCCCHHHHHHHHH
T ss_pred ceeEEeeeccccccccccc----------------------------------------------cccccchhHHHHHHH
Confidence 9999999998877655443 345788999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
|++.||+|||++||+||||||+|||++.++.+||+|||.|+...
T Consensus 109 q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 109 QLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp HHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred HHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhccc
Confidence 99999999999999999999999999999999999999998653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.7e-35 Score=246.23 Aligned_cols=150 Identities=28% Similarity=0.430 Sum_probs=129.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc-hHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT-PKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||.||+|.+. .+++.||||+++..... +.....+.+|+.+++.++||||+++++++...
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~ 79 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDL-------RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeec
Confidence 45999999999999999999986 45689999999876543 45567899999999999999999999998775
Q ss_pred Ce----EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 142 GK----IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 142 ~~----~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
+. .|+|||||++|+|...+ ...+++++.++
T Consensus 80 ~~~~~~~~lvmE~~~g~~L~~~~----------------------------------------------~~~~~l~~~~~ 113 (277)
T d1o6ya_ 80 TPAGPLPYIVMEYVDGVTLRDIV----------------------------------------------HTEGPMTPKRA 113 (277)
T ss_dssp CSSSEEEEEEEECCCEEEHHHHH----------------------------------------------HHHCSCCHHHH
T ss_pred cCCCceEEEEEECCCCCEehhhh----------------------------------------------cccCCCCHHHH
Confidence 43 77888888776665444 34557999999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..++.|++.||+|||++||+||||||+|||++.++..+|+|||+++.+
T Consensus 114 ~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 114 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence 999999999999999999999999999999999999999999988754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-35 Score=248.32 Aligned_cols=165 Identities=20% Similarity=0.265 Sum_probs=138.3
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|++.+.||+|+||.||+|.+...... .++..||||+++... .......+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~--~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETT--EEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccC--CCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 5699999999999999999998643211 334789999997654 4455677999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..++|||||.+|+|.+++..... ..........+++..+..++.
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~------------------------------------~~~~~~~~~~~~~~~~~~i~~ 140 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRP------------------------------------AMANNPVLAPPSLSKMIQMAG 140 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHH------------------------------------HHHHCTTCCCCCHHHHHHHHH
T ss_pred ceeEEEeecCCCCHHHHHHhccc------------------------------------ccccccccCCCCHHHHHHHHH
Confidence 99999999999999988864311 011111223578999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
|++.||.|||+++|+||||||+|||++.++++||+|||+|+.+.
T Consensus 141 ~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~ 184 (308)
T d1p4oa_ 141 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 184 (308)
T ss_dssp HHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGG
T ss_pred HHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceecc
Confidence 99999999999999999999999999999999999999998653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-35 Score=250.01 Aligned_cols=153 Identities=28% Similarity=0.377 Sum_probs=126.7
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
.+|++++.||+|+||+||+|.+..++. ....+||+|.++... +....+.+.+|+.+++.++|||||++++++.+ +
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGE---KVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC-------CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCC---EEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 459999999999999999999874431 123479999886543 33445779999999999999999999999976 4
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..+++++++.+|+|.+.+... ...+++..+..++.
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~---------------------------------------------~~~~~~~~~~~i~~ 118 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREH---------------------------------------------KDNIGSQYLLNWCV 118 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHT---------------------------------------------SSSCCHHHHHHHHH
T ss_pred CeeEEEEeccCCccccccccc---------------------------------------------ccCCCHHHHHHHHH
Confidence 577888999888887655432 34689999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 119 qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 119 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred HHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 9999999999999999999999999999999999999999865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-35 Score=252.56 Aligned_cols=148 Identities=29% Similarity=0.469 Sum_probs=124.3
Q ss_pred eecceEEec-ccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeee
Q psy2579 61 RVALYKLQN-ELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVL 138 (267)
Q Consensus 61 ~~~~y~~~~-~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~ 138 (267)
.+++|+++. .||+|+||.||+|++. .+++.||||+++.. ..+.+|+.++.++ +|||||+++++|
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~ 74 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNK-------RTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVY 74 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEEC-------CCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence 457799986 5999999999999986 45689999998643 3467899987655 899999999998
Q ss_pred ee----cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCCh
Q psy2579 139 ET----FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214 (267)
Q Consensus 139 ~~----~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~ 214 (267)
.+ ....|+|||||+||+|.+++...+ ..++++
T Consensus 75 ~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~--------------------------------------------~~~l~e 110 (335)
T d2ozaa1 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRG--------------------------------------------DQAFTE 110 (335)
T ss_dssp EEEETTEEEEEEEEECCCSEEHHHHHHSCS--------------------------------------------CCCEEH
T ss_pred eecccCCCEEEEEEECCCCCcHHHHHHhcC--------------------------------------------CCCcCH
Confidence 76 356889999998888877765421 236899
Q ss_pred hHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeec---CCceEEeccccccccC
Q psy2579 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSV---RGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~---~~~~kl~DFGla~~l~ 266 (267)
.+++.++.|++.||+|||++||+||||||+|||++. .+.+||+|||+|+.+.
T Consensus 111 ~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 111 REASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence 999999999999999999999999999999999975 4579999999998653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-35 Score=252.63 Aligned_cols=149 Identities=26% Similarity=0.402 Sum_probs=123.1
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|+++++||+|+||+||+|.+. .+++.||||+++....+....+.+.+|+.+|+.++|||||+++++|...+
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDG-------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp SSEEEEEEC------CEEEEEET-------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred CcEEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence 56999999999999999999986 45699999999877666677788999999999999999999999987654
Q ss_pred ------eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhH
Q psy2579 143 ------KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDD 216 (267)
Q Consensus 143 ------~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 216 (267)
..|+||||| +++|.... ...++++..
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~-----------------------------------------------~~~~l~~~~ 122 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLM-----------------------------------------------KHEKLGEDR 122 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHH-----------------------------------------------HHCCCCHHH
T ss_pred cccccceEEEEEecc-cccHHHHH-----------------------------------------------HhccccHHH
Confidence 357777777 33333222 234799999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 217 AKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 217 ~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 123 ~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 123 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 99999999999999999999999999999999999999999999998754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-35 Score=248.36 Aligned_cols=151 Identities=31% Similarity=0.514 Sum_probs=127.5
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccch----HHHHHHHHHHHHHhhcC--CCceeeeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTP----KARKMLSREIVSMESVH--HPNIIRLYE 136 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~Ei~~l~~l~--hpnIv~~~~ 136 (267)
++|++.+.||+|+||.||+|++. .+++.||||++....... ....++.+|+.+++.++ |||||++++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~ 76 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRV-------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 76 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred CeEEEeEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEE
Confidence 46999999999999999999986 456899999997654321 12234678999999986 899999999
Q ss_pred eeeecCeEEEEEeecCC-CchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 137 VLETFGKIFLVVEYASG-GELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 137 ~~~~~~~~~iv~e~~~~-gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
++.+++..|+|||++.+ +++.++ +.....+++.
T Consensus 77 ~~~~~~~~~lv~e~~~~~~~l~~~----------------------------------------------~~~~~~l~e~ 110 (273)
T d1xwsa_ 77 WFERPDSFVLILERPEPVQDLFDF----------------------------------------------ITERGALQEE 110 (273)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHH----------------------------------------------HHHHCSCCHH
T ss_pred EEeeCCeEEEEEEeccCcchHHHH----------------------------------------------HhccCCCCHH
Confidence 99999999999999876 344333 3344579999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecC-CceEEeccccccccC
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVR-GIVKLGDLGFSTKLQ 266 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DFGla~~l~ 266 (267)
+++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 111 ~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 111 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 999999999999999999999999999999999854 799999999998643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-34 Score=244.97 Aligned_cols=173 Identities=25% Similarity=0.343 Sum_probs=134.3
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||.||+|++..++.....++..||||+++... .......+.+|...+..+ +|||||+++++|.+.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 569999999999999999999876554434555789999997654 445567788999999888 899999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..++|||||++|+|.+++......... ............+++..+..++
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~------------------------------~~~~~~~~~~~~l~~~~~~~~~ 141 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLE------------------------------YSYNPSHNPEEQLSSKDLVSCA 141 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------------------------------------CCCCCHHHHHHHH
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccc------------------------------cccccccCccccCCHHHHHHHH
Confidence 9999999999999999999765321100 0001111234579999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 142 ~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~ 186 (299)
T d1fgka_ 142 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186 (299)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGG
T ss_pred HHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhcccc
Confidence 999999999999999999999999999999999999999998653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-34 Score=244.06 Aligned_cols=173 Identities=22% Similarity=0.293 Sum_probs=139.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||.||+|.+..... ..+++.||||+++... .......+.+|+.+++.+ +|||||++++++.+.
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~--~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIK--SDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSS--TTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeecCCeEEEEEEEecccc--CCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 569999999999999999998753211 1456899999997654 345566799999999999 799999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|++||||++|+|.+++............ ...........+++..+..++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~~~~~~~~ 151 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKT----------------------------SPAIMEDDELALDLEDLLSFS 151 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC------------------------------------------CCCCHHHHHHHH
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccc----------------------------ccccccccccCCCHHHHHHHH
Confidence 9999999999999999999876432111100 011111234579999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.|++.||+|||++|++||||||+||+++.++.+|++|||+|+.+.
T Consensus 152 ~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~ 196 (311)
T d1t46a_ 152 YQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196 (311)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTT
T ss_pred HHHHHHHHHHHhCCeeecccccccccccccCcccccccchheecc
Confidence 999999999999999999999999999999999999999998654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=247.35 Aligned_cols=162 Identities=23% Similarity=0.348 Sum_probs=124.4
Q ss_pred ceecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeee
Q psy2579 60 KRVALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLE 139 (267)
Q Consensus 60 ~~~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~ 139 (267)
+.+++|+++++||+|+||+||+|++. .+++.||||++...........++.+|+.+|+.++||||+++++++.
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~ 79 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHR-------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 79 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CccCCEEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeee
Confidence 45788999999999999999999986 45689999999776655555577889999999999999999999986
Q ss_pred ecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 140 TFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 140 ~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
.....+...+ ...|++||++.++.+.........+++..+..
T Consensus 80 ~~~~~~~~~~--------------------------------------~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~ 121 (318)
T d3blha1 80 TKASPYNRCK--------------------------------------GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121 (318)
T ss_dssp C------------------------------------------------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHH
T ss_pred cccccccccC--------------------------------------ceEEEEEeccCCCccchhhhcccccccHHHHH
Confidence 5432111111 12344444444344444444456799999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 122 i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 122 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 99999999999999999999999999999999999999999997653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-34 Score=245.46 Aligned_cols=168 Identities=26% Similarity=0.363 Sum_probs=134.6
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 140 (267)
.++|++.+.||+|+||.||+|.++.++ ....||||.++... .....+.+.+|+.+++.+ +|||||++++++.+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 82 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDG-----LRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 82 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETT-----EEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCC-----eEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence 367999999999999999999997432 12357888875433 334567799999999999 79999999999999
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+|||||++|+|.+++.......... ...........+++..+..+
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~------------------------------~~~~~~~~~~~l~~~~~~~~ 132 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDP------------------------------AFAIANSTASTLSSQQLLHF 132 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCH------------------------------HHHHHTTBSCSSCHHHHHHH
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccch------------------------------hhhccccccCCCCHHHHHHH
Confidence 999999999999999999997653211000 00011123457999999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||.|+|++|++||||||+|||++.++.+||+|||+|+..
T Consensus 133 ~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~ 177 (309)
T d1fvra_ 133 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ 177 (309)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESS
T ss_pred HHHHHHHHHhhhcCCccccccccceEEEcCCCceEEccccccccc
Confidence 999999999999999999999999999999999999999999754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3e-34 Score=246.24 Aligned_cols=144 Identities=31% Similarity=0.457 Sum_probs=124.0
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 140 (267)
.++|+++++||+|+||+||+|++. .+++.||||+++... .+++.+|+.+|+.+ .||||++++++|..
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINI-------TNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CcCeEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence 357999999999999999999986 456899999996542 35688999999999 59999999999875
Q ss_pred c--CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 141 F--GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 141 ~--~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
. ...++|||||.+++|.... +.+++..++
T Consensus 102 ~~~~~~~~v~e~~~~~~L~~~~-------------------------------------------------~~l~e~~i~ 132 (328)
T d3bqca1 102 PVSRTPALVFEHVNNTDFKQLY-------------------------------------------------QTLTDYDIR 132 (328)
T ss_dssp TTTCSEEEEEECCCSCBGGGTT-------------------------------------------------TSCCHHHHH
T ss_pred cCCCceeEEEeecCCCcHHHHh-------------------------------------------------cCCCHHHHH
Confidence 4 5688899998887774422 268999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC-ceEEeccccccccC
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG-IVKLGDLGFSTKLQ 266 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~l~ 266 (267)
.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 133 ~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 133 FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred HHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999999999999999999999999998765 69999999998653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-34 Score=244.04 Aligned_cols=170 Identities=24% Similarity=0.339 Sum_probs=124.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||.||+|.+..... ..+++.||||+++... .....+.+.+|+..+..+ +||||+.+++++...
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~--~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDK--TATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTS--SSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCc--ccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 469999999999999999999864331 1345789999997654 334456677888888776 799999999987665
Q ss_pred -CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 142 -GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 142 -~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
+..+++||||++|+|.+++......... ............+++.++..+
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~------------------------------~~~~~~~~~~~~l~~~~~~~~ 139 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVP------------------------------YKVAPEDLYKDFLTLEHLICY 139 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------------------------------------CBCHHHHHHH
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccc------------------------------cccchhhhhcccCCHHHHHHH
Confidence 5689999999999999998765321000 000011112346899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 140 ~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~ 184 (299)
T d1ywna1 140 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 184 (299)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------C
T ss_pred HHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhc
Confidence 999999999999999999999999999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-34 Score=249.17 Aligned_cols=147 Identities=26% Similarity=0.384 Sum_probs=121.2
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC-
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG- 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~- 142 (267)
+|++++.||+|+||+||+|.+. .+++.||||++++.. .....+.+.+|+.+|+.++||||+++++++....
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDN-------VNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp TEEEEEECC---CCCEEEEEET-------TTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred CeEEEEEEeeccCeEEEEEEEC-------CCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 4999999999999999999986 456899999997654 3455678899999999999999999999987653
Q ss_pred ---eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 143 ---KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 143 ---~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..+++++++.+|+|.+++.. .++++..++.
T Consensus 81 ~~~~~~~l~~~~~~g~L~~~l~~-----------------------------------------------~~l~~~~i~~ 113 (345)
T d1pmea_ 81 EQMKDVYLVTHLMGADLYKLLKT-----------------------------------------------QHLSNDHICY 113 (345)
T ss_dssp TTCCCEEEEEECCCEEHHHHHHH-----------------------------------------------CCCCHHHHHH
T ss_pred cccceEEEEEeecCCchhhhhhc-----------------------------------------------CCCCHHHHHH
Confidence 22333445556666655532 3699999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 114 i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 114 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 9999999999999999999999999999999999999999999764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-34 Score=242.36 Aligned_cols=152 Identities=24% Similarity=0.332 Sum_probs=127.3
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee-cCe
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET-FGK 143 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~-~~~ 143 (267)
+.+.++||+|+||+||+|++...+ .+...||||.++... +....+++.+|+.++++++||||+++++++.. ++.
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~----~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 103 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDND----GKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 103 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC--------CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTE
T ss_pred eccceEEeecCCeEEEEEEEECCC----CEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCc
Confidence 344578999999999999986432 234579999997533 45567889999999999999999999999875 468
Q ss_pred EEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHHH
Q psy2579 144 IFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQ 223 (267)
Q Consensus 144 ~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~q 223 (267)
.++|||||++|+|.+++... ...+++..+..++.|
T Consensus 104 ~~lv~E~~~~g~l~~~~~~~---------------------------------------------~~~~~~~~~~~i~~q 138 (311)
T d1r0pa_ 104 PLVVLPYMKHGDLRNFIRNE---------------------------------------------THNPTVKDLIGFGLQ 138 (311)
T ss_dssp EEEEEECCTTCBHHHHHHCT---------------------------------------------TCCCBHHHHHHHHHH
T ss_pred eEEEEEEeecCchhhhhccc---------------------------------------------cccchHHHHHHHHHH
Confidence 99999999998887776543 225677889999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 224 ILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 224 l~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
++.||.|+|+.+|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 139 ia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 139 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181 (311)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred HHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence 9999999999999999999999999999999999999998653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-34 Score=247.60 Aligned_cols=149 Identities=26% Similarity=0.371 Sum_probs=124.6
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG 142 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~ 142 (267)
++|+++++||+|+||+||+|++. .+++.||||+++....+....+++.+|+.+++.++|||||++++++....
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDT-------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 90 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEET-------TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CCeEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence 45999999999999999999986 45699999999877766667778999999999999999999999986432
Q ss_pred -----eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 143 -----KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 143 -----~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
..+++++++.+|+|.+++. .+++++.++
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~-----------------------------------------------~~~l~e~~~ 123 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVK-----------------------------------------------CQKLTDDHV 123 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHT-----------------------------------------------TCCCCHHHH
T ss_pred ccccCceEEEEEeecCCchhhhcc-----------------------------------------------cccccHHHH
Confidence 3355556666666655442 236999999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
+.++.|++.||+|||++||+||||||+|||++.++.+|++|||+|...
T Consensus 124 ~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred HHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc
Confidence 999999999999999999999999999999999999999999998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-34 Score=240.17 Aligned_cols=148 Identities=24% Similarity=0.430 Sum_probs=123.4
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeee-
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLET- 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~- 140 (267)
.++|++++.||+|+||.||+|++. +..||||+++... ..+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR---------GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 72 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET---------TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC---------CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence 456999999999999999999874 3679999997543 33568899999999999999999998854
Q ss_pred cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHH
Q psy2579 141 FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIY 220 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~ 220 (267)
.+..|+||||+++|+|.+++... ....+++..+..+
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~--------------------------------------------~~~~l~~~~~~~i 108 (262)
T d1byga_ 73 KGGLYIVTEYMAKGSLVDYLRSR--------------------------------------------GRSVLGGDCLLKF 108 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHH--------------------------------------------HHHHCCHHHHHHH
T ss_pred CCcEEEEEeccCCCCHHHHHHhc--------------------------------------------CCCCCCHHHHHHH
Confidence 46689999999999998877542 1124889999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 221 FLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 221 ~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
+.|++.||.|||+++++||||||+|||++.++.+||+|||+|+...
T Consensus 109 ~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 109 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred HHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 9999999999999999999999999999999999999999998653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-34 Score=246.42 Aligned_cols=147 Identities=27% Similarity=0.351 Sum_probs=121.3
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC-
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG- 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~- 142 (267)
.|+.++.||+|+||+||+|++. .+++.||||++..... ...+|+.+++.++||||++++++|...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLC-------DSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcEeeeEEeeCcCeEEEEEEEC-------CCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 5999999999999999999987 4568999999976532 2347999999999999999999986532
Q ss_pred -----eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHH
Q psy2579 143 -----KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDA 217 (267)
Q Consensus 143 -----~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 217 (267)
.+|+|||||+++.+.... ........+++.++
T Consensus 88 ~~~~~~~~lv~Ey~~~~~~~~l~-------------------------------------------~~~~~~~~l~~~~~ 124 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPETVYRVAR-------------------------------------------HYSRAKQTLPVIYV 124 (350)
T ss_dssp CCSCCEEEEEEECCSEEHHHHHH-------------------------------------------HHHHTTCCCCHHHH
T ss_pred cCCceEEEEEEeccCCccHHHHH-------------------------------------------hhhhccCCCCHHHH
Confidence 478888888765432221 22233457999999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCC-ceEEeccccccccC
Q psy2579 218 KIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRG-IVKLGDLGFSTKLQ 266 (267)
Q Consensus 218 ~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~l~ 266 (267)
+.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 125 ~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp HHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 99999999999999999999999999999999775 89999999998653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-34 Score=245.03 Aligned_cols=154 Identities=31% Similarity=0.507 Sum_probs=133.1
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc--hHHHHHHHHHHHHHhhcCC-Cceeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT--PKARKMLSREIVSMESVHH-PNIIRLYEVL 138 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~~l~~l~h-pnIv~~~~~~ 138 (267)
+++|++++.||+|+||+||+|.+.... .+++.||||+++..... ....+.+.+|+.++++++| |||+++++++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGH----DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 98 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSST----TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred hhceEEEEEEecCCCeEEEEEEECccC----CCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence 467999999999999999999885332 45789999999765432 2234568899999999965 8999999999
Q ss_pred eecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHH
Q psy2579 139 ETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAK 218 (267)
Q Consensus 139 ~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 218 (267)
.+....+++||++.+|+|.+.+.. .+.+++..+.
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~----------------------------------------------~~~~~e~~~~ 132 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQ----------------------------------------------RERFTEHEVQ 132 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHH----------------------------------------------HSCCCHHHHH
T ss_pred ccCCceeeeeecccccHHHHHHHh----------------------------------------------cccccHHHHH
Confidence 999999999999999888766653 3467889999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 219 IYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 219 ~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.|++.||+|+|++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 133 ~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 133 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred HHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999999999999999999999999999999999865
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-33 Score=242.15 Aligned_cols=148 Identities=28% Similarity=0.404 Sum_probs=124.3
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeec
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETF 141 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~ 141 (267)
.++|+++++||+|+||+||+|++. .+++.||||++.....+.....++.+|+.+++.++|||||+++++|...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~-------~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~ 88 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDA-------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 88 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEET-------TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cCCeEEEEEeecCcCeEEEEEEEC-------CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecc
Confidence 367999999999999999999987 4569999999987766677778899999999999999999999998643
Q ss_pred ------CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChh
Q psy2579 142 ------GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSED 215 (267)
Q Consensus 142 ------~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~ 215 (267)
+..|+|||||.++.+.. + ...+++.
T Consensus 89 ~~~~~~~~~~iv~Ey~~~~l~~~-~------------------------------------------------~~~~~~~ 119 (355)
T d2b1pa1 89 KTLEEFQDVYLVMELMDANLCQV-I------------------------------------------------QMELDHE 119 (355)
T ss_dssp CSTTTCCEEEEEEECCSEEHHHH-H------------------------------------------------TSCCCHH
T ss_pred cccccCceeEEEEeccchHHHHh-h------------------------------------------------hcCCCHH
Confidence 56788888886543321 1 2358999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 216 DAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 216 ~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
.++.++.|++.||+|||++||+||||||+|||++.++.++++|||+++..
T Consensus 120 ~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred HHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence 99999999999999999999999999999999999999999999998754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-33 Score=238.74 Aligned_cols=152 Identities=24% Similarity=0.366 Sum_probs=124.0
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc---CCCceeeeeeeee
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV---HHPNIIRLYEVLE 139 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l---~hpnIv~~~~~~~ 139 (267)
++|+++++||+|+||+||+|++.. .+++.||||+++...........+.+|+.+++.+ +||||++++++|.
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~ 80 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLK------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 80 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEEC------CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence 569999999999999999999852 2357899999976554433334566788887766 7999999999985
Q ss_pred e-----cCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCCh
Q psy2579 140 T-----FGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSE 214 (267)
Q Consensus 140 ~-----~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~ 214 (267)
. .+..+++||+|.++++..... .....+++
T Consensus 81 ~~~~~~~~~~~~~~e~~~~~~~~~~~~---------------------------------------------~~~~~~~~ 115 (305)
T d1blxa_ 81 VSRTDRETKLTLVFEHVDQDLTTYLDK---------------------------------------------VPEPGVPT 115 (305)
T ss_dssp EEECSSEEEEEEEEECCSCBHHHHHHH---------------------------------------------SCTTCSCH
T ss_pred ccccccCceEEEEEEeccCCchhhhhh---------------------------------------------ccCCCCCH
Confidence 3 346788888888766543222 12346899
Q ss_pred hHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 215 DDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 215 ~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
..++.++.|++.||+|||++||+||||||+|||++..+.+||+|||+++..
T Consensus 116 ~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 116 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred HHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 999999999999999999999999999999999999999999999998754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-33 Score=236.10 Aligned_cols=143 Identities=24% Similarity=0.384 Sum_probs=119.9
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCceeeeeeeeeecC-
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNIIRLYEVLETFG- 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv~~~~~~~~~~- 142 (267)
.|.+.+.||+|+||.||+|++. +..||||+++... ........|+..+..++|||||++++++...+
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~---------g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~ 71 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWR---------GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNG 71 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEET---------TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred EEEEEEEEeeCCCeEEEEEEEC---------CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCC
Confidence 4899999999999999999863 4789999996542 22222345666667789999999999998764
Q ss_pred ---eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHH
Q psy2579 143 ---KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKI 219 (267)
Q Consensus 143 ---~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~ 219 (267)
..|+|||||.+|+|.+++++. ++++.....
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~l~~~-----------------------------------------------~l~~~~~~~ 104 (303)
T d1vjya_ 72 TWTQLWLVSDYHEHGSLFDYLNRY-----------------------------------------------TVTVEGMIK 104 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHC-----------------------------------------------CBCHHHHHH
T ss_pred cceEEEEEEecccCCCHHHHHhcC-----------------------------------------------CCCHHHHHH
Confidence 578899999888887776542 588999999
Q ss_pred HHHHHHHHHHHHHh--------CCCcccCCCCCcEEeecCCceEEecccccccc
Q psy2579 220 YFLQILSAVKHLHD--------RDIIHRDIKAENVFLSVRGIVKLGDLGFSTKL 265 (267)
Q Consensus 220 ~~~ql~~~L~~lH~--------~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l 265 (267)
++.|++.||+|+|+ +||+||||||+|||++.++.+||+|||+|+.+
T Consensus 105 ~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp HHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 99999999999996 59999999999999999999999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.98 E-value=3.9e-32 Score=229.48 Aligned_cols=147 Identities=19% Similarity=0.273 Sum_probs=124.8
Q ss_pred cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-CCceeeeeeeeeec
Q psy2579 63 ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-HPNIIRLYEVLETF 141 (267)
Q Consensus 63 ~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~ 141 (267)
++|++.+.||+|+||+||+|++. .+++.||||+++..... ..+.+|++.++.++ |+|++.+++++...
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~-------~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 73 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNL-------LNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEG 73 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEET-------TTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred CceEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecC
Confidence 46999999999999999999986 45689999998654322 34678999999995 49999999999999
Q ss_pred CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHH
Q psy2579 142 GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYF 221 (267)
Q Consensus 142 ~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 221 (267)
+..|+|||+| +++|.+.+... ...+++..+..++
T Consensus 74 ~~~~~vme~~-~~~l~~~~~~~---------------------------------------------~~~~~~~~~~~i~ 107 (293)
T d1csna_ 74 LHNVLVIDLL-GPSLEDLLDLC---------------------------------------------GRKFSVKTVAMAA 107 (293)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT---------------------------------------------TTCCCHHHHHHHH
T ss_pred CccEEEEEec-CCCHHHHHHhh---------------------------------------------ccchhhHHHHHHH
Confidence 9999999998 56666555432 2368999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCcEEeec-----CCceEEeccccccccC
Q psy2579 222 LQILSAVKHLHDRDIIHRDIKAENVFLSV-----RGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 222 ~ql~~~L~~lH~~~ivHrDlkp~NIll~~-----~~~~kl~DFGla~~l~ 266 (267)
.|++.||+|||++||+||||||+|||++. .+.+||+|||+|+.+.
T Consensus 108 ~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 108 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp HHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred HHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999999999999999999999999974 5689999999998653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=3.2e-31 Score=224.34 Aligned_cols=146 Identities=19% Similarity=0.252 Sum_probs=118.4
Q ss_pred ceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCc-eeeeeeeeeecC
Q psy2579 64 LYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPN-IIRLYEVLETFG 142 (267)
Q Consensus 64 ~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpn-Iv~~~~~~~~~~ 142 (267)
+|++.+.||+|+||.||+|++. .+++.||||++...... ..+.+|+.+++.++|+| |+.+.+++...+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~-------~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDI-------AAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEET-------TTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred EEEEeEEEeeCCCcEEEEEEEC-------CCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 5999999999999999999986 45689999998765322 34778999999997665 555566667778
Q ss_pred eEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcccCCCChhHHHHHHH
Q psy2579 143 KIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFL 222 (267)
Q Consensus 143 ~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 222 (267)
..++|||+|.+ ++...+. .....+++..+..++.
T Consensus 77 ~~~ivme~~~~-~l~~~~~---------------------------------------------~~~~~~~~~~~~~~~~ 110 (299)
T d1ckia_ 77 YNVMVMELLGP-SLEDLFN---------------------------------------------FCSRKFSLKTVLLLAD 110 (299)
T ss_dssp EEEEEEECCCC-BHHHHHH---------------------------------------------HTTTCCCHHHHHHHHH
T ss_pred EEEEEEEEcCC-chhhhhh---------------------------------------------hccCCCcHHHHHHHHH
Confidence 88999998854 3332222 2234799999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCcEEeec---CCceEEeccccccccC
Q psy2579 223 QILSAVKHLHDRDIIHRDIKAENVFLSV---RGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 223 ql~~~L~~lH~~~ivHrDlkp~NIll~~---~~~~kl~DFGla~~l~ 266 (267)
|++.||+|||++||+||||||+|||++. +..++|+|||+|+.+.
T Consensus 111 qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 111 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp HHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred HHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9999999999999999999999999854 4579999999998754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.95 E-value=2.1e-27 Score=188.00 Aligned_cols=136 Identities=18% Similarity=0.217 Sum_probs=105.5
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccc----------------hHHHHHHHHHHHHHhhcCC
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLT----------------PKARKMLSREIVSMESVHH 128 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~----------------~~~~~~~~~Ei~~l~~l~h 128 (267)
+.+.++||+|+||.||+|.+ .+++.||||++.....+ ........+|...+..+.|
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~--------~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~ 73 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS--------EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 73 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE--------TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred chhCCEeeeCcceEEEEEEC--------CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccC
Confidence 46778999999999999987 34688999987643211 1123445678999999999
Q ss_pred CceeeeeeeeeecCeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCchhhhhcc
Q psy2579 129 PNIIRLYEVLETFGKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGELYNKITT 208 (267)
Q Consensus 129 pnIv~~~~~~~~~~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~ 208 (267)
++++..+++.. .+++||+++++.+.
T Consensus 74 ~~v~~~~~~~~----~~lvme~~~~~~~~--------------------------------------------------- 98 (191)
T d1zara2 74 LAVPKVYAWEG----NAVLMELIDAKELY--------------------------------------------------- 98 (191)
T ss_dssp SSSCCEEEEET----TEEEEECCCCEEGG---------------------------------------------------
T ss_pred CCcceEEEecC----CEEEEEeecccccc---------------------------------------------------
Confidence 99998876532 26888888764332
Q ss_pred cCCCChhHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEeecCCceEEeccccccccC
Q psy2579 209 EGRLSEDDAKIYFLQILSAVKHLHDRDIIHRDIKAENVFLSVRGIVKLGDLGFSTKLQ 266 (267)
Q Consensus 209 ~~~~~~~~~~~~~~ql~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~l~ 266 (267)
.+++..+..++.|++.+|.|||++||+||||||+|||++.+ .++|+|||+|+.+.
T Consensus 99 --~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~ 153 (191)
T d1zara2 99 --RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVG 153 (191)
T ss_dssp --GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETT
T ss_pred --chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCC
Confidence 24556677899999999999999999999999999999865 58999999997653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.94 E-value=7.1e-27 Score=202.26 Aligned_cols=156 Identities=27% Similarity=0.321 Sum_probs=121.2
Q ss_pred cCcee--cceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC--------
Q psy2579 58 LGKRV--ALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-------- 127 (267)
Q Consensus 58 ~~~~~--~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-------- 127 (267)
+|..+ ++|+++++||+|+||+||+|++. .+++.||||+++... ...+.+.+|+.+++.++
T Consensus 6 ~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~-------~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~ 75 (362)
T d1q8ya_ 6 KGEPYKDARYILVRKLGWGHFSTVWLAKDM-------VNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKED 75 (362)
T ss_dssp TTCEETTTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHH
T ss_pred CCCCccCCcEEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhh
Confidence 35544 35999999999999999999986 556899999997543 33456788999888775
Q ss_pred ---CCceeeeeeeeeec--CeEEEEEeecCCCchhhhhhccCCCChhhHHHHHHHHHHHHhhhccCeEEEEEEEccCCch
Q psy2579 128 ---HPNIIRLYEVLETF--GKIFLVVEYASGGELYNKITTEGRLSEDDAKIYFLQILLYEVLETFGKIFLVVEYASGGEL 202 (267)
Q Consensus 128 ---hpnIv~~~~~~~~~--~~~~iv~e~~~~gsl~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l 202 (267)
||||+++++++... ...+.+++++..+......
T Consensus 76 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------------------ 113 (362)
T d1q8ya_ 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL------------------------------------------ 113 (362)
T ss_dssp HHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHH------------------------------------------
T ss_pred hcCcCceEEEEEEeeeccccceeeeeeecccccccccc------------------------------------------
Confidence 57899999988654 4566777766554332211
Q ss_pred hhhhcccCCCChhHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEeecCC------ceEEeccccccccC
Q psy2579 203 YNKITTEGRLSEDDAKIYFLQILSAVKHLHD-RDIIHRDIKAENVFLSVRG------IVKLGDLGFSTKLQ 266 (267)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~ql~~~L~~lH~-~~ivHrDlkp~NIll~~~~------~~kl~DFGla~~l~ 266 (267)
........+++..+..++.|++.||+|||+ +||+||||||+|||++.++ .++++|||.|+...
T Consensus 114 -~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~ 183 (362)
T d1q8ya_ 114 -IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183 (362)
T ss_dssp -HHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETT
T ss_pred -cccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccc
Confidence 122234578999999999999999999998 8999999999999998765 39999999997643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.77 E-value=2.8e-08 Score=80.09 Aligned_cols=89 Identities=13% Similarity=0.014 Sum_probs=62.3
Q ss_pred ecceEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhc-CCCceeeeeeeeee
Q psy2579 62 VALYKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESV-HHPNIIRLYEVLET 140 (267)
Q Consensus 62 ~~~y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~hpnIv~~~~~~~~ 140 (267)
+..|+..+..+.++.+.||+... .+..+.+|........ ....+.+|...+..+ .+--+.+++.+...
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~---------~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~ 81 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG---------ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH 81 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC---------SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEEe---------CCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEec
Confidence 34577777665566678998742 2356788887644321 123467788888877 34456788888888
Q ss_pred cCeEEEEEeecCCCchhhhhh
Q psy2579 141 FGKIFLVVEYASGGELYNKIT 161 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~~~l~ 161 (267)
++..++||++.+|.++.....
T Consensus 82 ~~~~~lv~~~l~G~~~~~~~~ 102 (263)
T d1j7la_ 82 DGWSNLLMSEADGVLCSEEYE 102 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHTT
T ss_pred CCceEEEEEeccccccccccc
Confidence 999999999999988866543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.55 E-value=4.3e-07 Score=72.55 Aligned_cols=75 Identities=16% Similarity=0.106 Sum_probs=52.4
Q ss_pred cCccCc-eeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC--CCceeeeeeeeeecCeEEEE
Q psy2579 71 LGRGNF-STVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH--HPNIIRLYEVLETFGKIFLV 147 (267)
Q Consensus 71 iG~G~f-g~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~--hpnIv~~~~~~~~~~~~~iv 147 (267)
+..|.. +.||+... ..+..+.+|....... ..+.+|+..++.+. ...+.+++.+..+++..+++
T Consensus 18 ~~~G~s~~~v~r~~~--------~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v 84 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA--------QGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 84 (255)
T ss_dssp CSCTTSSCEEEEEEC--------TTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred cCCcccCCeEEEEEe--------CCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence 455543 67888754 3456788898755432 23667888887763 33467788888888999999
Q ss_pred EeecCCCchhh
Q psy2579 148 VEYASGGELYN 158 (267)
Q Consensus 148 ~e~~~~gsl~~ 158 (267)
|++++|.++..
T Consensus 85 ~~~i~G~~~~~ 95 (255)
T d1nd4a_ 85 LGEVPGQDLLS 95 (255)
T ss_dssp EECCSSEETTT
T ss_pred EEeeecccccc
Confidence 99999877644
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.14 E-value=4.8e-06 Score=71.01 Aligned_cols=80 Identities=19% Similarity=0.075 Sum_probs=50.8
Q ss_pred cccCccCceeEEEeEEeecccccccccceEEEEeecccc-----cchHHHHHHHHHHHHHhhc-CC--Cceeeeeeeeee
Q psy2579 69 NELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAK-----LTPKARKMLSREIVSMESV-HH--PNIIRLYEVLET 140 (267)
Q Consensus 69 ~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~Ei~~l~~l-~h--pnIv~~~~~~~~ 140 (267)
+.||.|....||+..+. .+++.|++|.-.+.. ..+...++...|...++.+ .+ ..+++++.+ +
T Consensus 32 ~eig~G~~N~vfrV~~~-------~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d 102 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQ-------EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D 102 (392)
T ss_dssp EECCSSSSEEEEEEEC-----------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred EEeCCCceEeEEEEEeC-------CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c
Confidence 45899999999999764 335778899654311 0111234566788888766 33 345666654 4
Q ss_pred cCeEEEEEeecCCCchh
Q psy2579 141 FGKIFLVVEYASGGELY 157 (267)
Q Consensus 141 ~~~~~iv~e~~~~gsl~ 157 (267)
.....++||++.+..+.
T Consensus 103 ~~~~~lvmE~L~~~~~~ 119 (392)
T d2pula1 103 TEMAVTVMEDLSHLKIA 119 (392)
T ss_dssp TTTTEEEECCCTTSEEH
T ss_pred CCCCEEEEeccCCcccc
Confidence 55668999999886653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.66 E-value=8.2e-05 Score=61.37 Aligned_cols=69 Identities=13% Similarity=0.091 Sum_probs=44.5
Q ss_pred eeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcCCCcee--eee-----eeeeecCeEEEEEe
Q psy2579 77 STVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVHHPNII--RLY-----EVLETFGKIFLVVE 149 (267)
Q Consensus 77 g~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~hpnIv--~~~-----~~~~~~~~~~iv~e 149 (267)
-.||++.. .+|..|++|+..+...+. ..+..|...+..|...++. ... ..+...+..+.+++
T Consensus 36 N~vy~v~~--------~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~ 104 (325)
T d1zyla1 36 NRVYQFQD--------EDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 104 (325)
T ss_dssp SEEEEECC--------TTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred ceeEEEEc--------CCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEe
Confidence 46888864 456889999987654433 4466788888777422221 111 22345677899999
Q ss_pred ecCCCch
Q psy2579 150 YASGGEL 156 (267)
Q Consensus 150 ~~~~gsl 156 (267)
++.|..+
T Consensus 105 ~~~G~~~ 111 (325)
T d1zyla1 105 SVGGRQF 111 (325)
T ss_dssp CCCCEEC
T ss_pred ecCCcCC
Confidence 9988554
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.52 E-value=0.00037 Score=58.85 Aligned_cols=84 Identities=13% Similarity=0.114 Sum_probs=53.0
Q ss_pred eEEecccCccCceeEEEeEEeecccccccccceEEEEeecccccchHHHHHHHHHHHHHhhcC-CCceeeeeeeeeecCe
Q psy2579 65 YKLQNELGRGNFSTVKMAIHEIYVPILCTYISYLAIKILDKAKLTPKARKMLSREIVSMESVH-HPNIIRLYEVLETFGK 143 (267)
Q Consensus 65 y~~~~~iG~G~fg~V~~a~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-hpnIv~~~~~~~~~~~ 143 (267)
.++ +.|+.|-.-.+|++...............|.+++..... .. -...+|..+++.+. +.-.+++++++..
T Consensus 45 l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~--- 116 (395)
T d1nw1a_ 45 LRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TE---SHLVAESVIFTLLSERHLGPKLYGIFSG--- 116 (395)
T ss_dssp EEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CH---HHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred eEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-hh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC---
Confidence 444 458888888999987653322222334668888875322 22 22457888888883 4334577777643
Q ss_pred EEEEEeecCCCchh
Q psy2579 144 IFLVVEYASGGELY 157 (267)
Q Consensus 144 ~~iv~e~~~~gsl~ 157 (267)
.+|+||++|..+.
T Consensus 117 -g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 117 -GRLEEYIPSRPLS 129 (395)
T ss_dssp -EEEECCCCEEECC
T ss_pred -ceEEEEeccccCC
Confidence 6899999886553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.95 E-value=0.0016 Score=52.80 Aligned_cols=30 Identities=30% Similarity=0.433 Sum_probs=27.3
Q ss_pred CCCcccCCCCCcEEeecCCceEEecccccc
Q psy2579 234 RDIIHRDIKAENVFLSVRGIVKLGDLGFST 263 (267)
Q Consensus 234 ~~ivHrDlkp~NIll~~~~~~kl~DFGla~ 263 (267)
.|+||+|+.++|++++.+...-+.||+.|.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988888999999875
|